Citrus Sinensis ID: 001924
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 995 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.281 | 0.133 | 0.535 | 9e-89 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.294 | 0.168 | 0.449 | 5e-71 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.275 | 0.184 | 0.462 | 5e-71 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.281 | 0.155 | 0.456 | 2e-70 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.275 | 0.207 | 0.465 | 3e-70 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.275 | 0.209 | 0.462 | 1e-69 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.274 | 0.103 | 0.449 | 2e-69 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.293 | 0.111 | 0.440 | 4e-69 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.284 | 0.180 | 0.458 | 9e-69 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.274 | 0.173 | 0.463 | 4e-68 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 328 bits (842), Expect = 9e-89, Method: Compositional matrix adjust.
Identities = 174/325 (53%), Positives = 212/325 (65%), Gaps = 45/325 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ ERNIL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI-------------NNTIDLSGPETDG 852
IVHRDLKPDN+LI GHIKLTDFGLSKIG+I N + S T+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 853 IMPSDAH-----------------------YPEYQQT----DNRNRHSAVGTPDYLAPEI 885
M D+ YP+ + T + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL--NRKIPWPCVPSDMSFE 943
LLGT HG DWW++GIIL+EF+TG PPF ++PE+IF +IL +R++ W P ++S E
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISSE 1820
Query: 944 AQDLINRFLIHDPNQRLGANGAAEV 968
A+DLI + L DP +RLGANGA EV
Sbjct: 1821 AKDLILKLLNPDPYKRLGANGAYEV 1845
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (690), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 141/314 (44%), Positives = 194/314 (61%), Gaps = 21/314 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
DSV + GVS P + E +DFE IK IS GA+G VFL R ++T FA+K + K
Sbjct: 433 DSV-EGRGVSQPSQKTPSE----EDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 487
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 488 NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 547
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 548 LPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 607
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 608 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 653
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IIL+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RLG
Sbjct: 654 IILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLG 713
Query: 962 ANGAAEVFHCKIFI 975
+ A EV F+
Sbjct: 714 TSSAYEVKQHPFFM 727
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 134/290 (46%), Positives = 181/290 (62%), Gaps = 16/290 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R + T FA+K + K ++I +N I ++ ER+IL NP
Sbjct: 398 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENP 457
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D++R+Y AE VLALEYLH+ G
Sbjct: 458 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYG 517
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSK+GL+N T +L Y + + D
Sbjct: 518 IVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNL--------------YEGHIEKD 563
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 564 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 623
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975
+++ I WP + ++QDLI R L + +RLG GA EV F+
Sbjct: 624 VISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFL 673
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 135/296 (45%), Positives = 185/296 (62%), Gaps = 16/296 (5%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K+ S +DFE IK IS GA+G VFL R ++T FA+K + K ++I +N I++ ER+I
Sbjct: 504 KKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDI 563
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+ R+Y AE VLAL
Sbjct: 564 LTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLAL 623
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L Y
Sbjct: 624 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------Y 669
Query: 861 PEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
+ + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++
Sbjct: 670 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 729
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
PE +F +++ +I WP + +AQDL ++ L +P +RLG A EV F
Sbjct: 730 PEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFF 785
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 135/290 (46%), Positives = 179/290 (61%), Gaps = 16/290 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 388 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 447
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 448 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 507
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 508 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 553
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++ +G DWW++G+IL+EF+ G PF ++PE +F
Sbjct: 554 AREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQ 613
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975
+++ +I WP + +AQDLI R L P RLG G EV F+
Sbjct: 614 VVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFL 663
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 265 bits (678), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 134/290 (46%), Positives = 179/290 (61%), Gaps = 16/290 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 366 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 425
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 426 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLALEYLHNYG 485
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 486 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 531
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F
Sbjct: 532 AREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQ 591
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975
+++ +I WP + +AQDLI R L P RLG G EV F+
Sbjct: 592 VVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFL 641
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 265 bits (676), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 130/289 (44%), Positives = 180/289 (62%), Gaps = 16/289 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+ R + + FA+K + K ++I +N I++ ER+IL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV + SF R +L +VMEY+ GGD +L++ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNL--------------YEGHIEKD 737
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 738 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 797
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
+++ +I WP +AQDLI L +P +RLG GA EV + F
Sbjct: 798 VISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFF 846
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 138/313 (44%), Positives = 191/313 (61%), Gaps = 21/313 (6%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 548 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 603 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 662
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 663 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 722
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 723 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 768
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IIL+EF+ G PF ++PE +F +++ +I WP +AQ+LI L +P +RLG
Sbjct: 769 IILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNPLERLG 828
Query: 962 ANGAAEVFHCKIF 974
GA EV + F
Sbjct: 829 TGGAYEVKQHRFF 841
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 9e-69, Method: Compositional matrix adjust.
Identities = 137/299 (45%), Positives = 184/299 (61%), Gaps = 16/299 (5%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S K+ +DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ E
Sbjct: 363 SKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVE 422
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
R+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE V
Sbjct: 423 RDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETV 482
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 483 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL------------ 530
Query: 858 AHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 531 --YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 588
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
++PE +F +++ I WP + EAQ LI+ L +P RLGA GA EV F
Sbjct: 589 GDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFF 647
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 260 bits (664), Expect = 4e-68, Method: Compositional matrix adjust.
Identities = 134/289 (46%), Positives = 180/289 (62%), Gaps = 16/289 (5%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ ER+IL NP
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 434
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE VLALEYLH+ G
Sbjct: 435 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYG 494
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 495 IVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL--------------YEGHIEKD 540
Query: 868 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 541 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 600
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
+++ I WP + +AQ LI+ L +P RLGA GA EV F
Sbjct: 601 VISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFF 649
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 995 | ||||||
| 255538590 | 1106 | kinase, putative [Ricinus communis] gi|2 | 0.906 | 0.815 | 0.712 | 0.0 | |
| 359492673 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.970 | 0.871 | 0.686 | 0.0 | |
| 145324180 | 1067 | protein kinase-like protein [Arabidopsis | 0.940 | 0.877 | 0.584 | 0.0 | |
| 145336472 | 1042 | protein kinase-like protein [Arabidopsis | 0.940 | 0.898 | 0.584 | 0.0 | |
| 110740013 | 1042 | similar to IRE homolog 1 [Arabidopsis th | 0.940 | 0.898 | 0.583 | 0.0 | |
| 7767670 | 1092 | F27F5.23 [Arabidopsis thaliana] | 0.940 | 0.857 | 0.569 | 0.0 | |
| 297852258 | 1101 | predicted protein [Arabidopsis lyrata su | 0.932 | 0.842 | 0.561 | 0.0 | |
| 302142471 | 948 | unnamed protein product [Vitis vinifera] | 0.580 | 0.609 | 0.750 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.828 | 0.590 | 0.481 | 0.0 | |
| 356520647 | 1296 | PREDICTED: uncharacterized protein LOC10 | 0.827 | 0.635 | 0.482 | 0.0 |
| >gi|255538590|ref|XP_002510360.1| kinase, putative [Ricinus communis] gi|223551061|gb|EEF52547.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1293 bits (3345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 659/925 (71%), Positives = 737/925 (79%), Gaps = 23/925 (2%)
Query: 65 EEVRKGKKIAQWFTSYISKFNI-----VSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLN 119
+E KGKKI +W SY SK VS N E E K +D + RR K + NHL+
Sbjct: 60 KEFHKGKKITRWLASYFSKGTSQVTADVSSNIEKRSLEHKTLDKFEQRRIKFVNGENHLD 119
Query: 120 EKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKE 179
Q E +S SK SKGLKSFSHELGP+GGIP + PRAHSY+DLKELL + HSRFDAAKE
Sbjct: 120 GNQPSVEILSQSKASKGLKSFSHELGPRGGIPPAQPRAHSYSDLKELLGSFHSRFDAAKE 179
Query: 180 VVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDL 239
VVN+ELA+FA+D M+VLE +DS E +M EDLLILAQ C+EM FR CE IVQDL
Sbjct: 180 VVNAELASFARDAMDVLEIIDSSLQEELKMAEDLLILAQLCMEMACSQFRLKCEIIVQDL 239
Query: 240 TEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETS 299
TEKR QCQ GLVKWL TRMLFILTRCTRLL FQK++EPI EKSL K KKCLESVP+V+ S
Sbjct: 240 TEKRLQCQTGLVKWLYTRMLFILTRCTRLLQFQKDTEPIDEKSLRKLKKCLESVPSVDMS 299
Query: 300 WVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSVF 356
WV + ++DLD A QK + K+K+ GQ +S++PE C ES D TS S+
Sbjct: 300 WVANHVIDDTDLDDALNQKGDIKRKLQGQNNLSSLPEAVCCGSQESDDQSGVTSGKDSLD 359
Query: 357 IEQNFPPQKSQHYSRMQEQQ------------SHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
EQ QKS++ S + +Q + + + K S EQ + LDG
Sbjct: 360 FEQKLSCQKSRNESLFEVRQFCETDKSAISNSVNNSSCSLHDQEKFLDDSLQEQERVLDG 419
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE+VPISHLESHSYICAYADKC+LNCLDVDERL L+E+LEQI ES N +
Sbjct: 420 SDLVICRICEEIVPISHLESHSYICAYADKCDLNCLDVDERLSNLAEMLEQIVESRNMNV 479
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
H GSPENSR Q+ NSA T + SPKISEWRNKGVEGMFEDIHEMDTA IDDSHL +N
Sbjct: 480 HQSHGSPENSRPQNANSATT-EACSPKISEWRNKGVEGMFEDIHEMDTAFIDDSHLPPVN 538
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+GHLG+KL YGA SSTGSMTS+SSTNTPKAGHFD FWLE N+P+ELEDV QMI LADI
Sbjct: 539 LKGHLGMKLCNYGAPSSTGSMTSLSSTNTPKAGHFDSFWLEHNNPSELEDVPQMINLADI 598
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
AR VA+TD SKEGS EFLLACM DLQDVLQHSKLKALVIDTFG RIEKLLREKY+LAC++
Sbjct: 599 ARSVANTDLSKEGSYEFLLACMQDLQDVLQHSKLKALVIDTFGGRIEKLLREKYLLACDI 658
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
D KSP S SK KENSRL+LD+ SQSS +STP+HSSHKERTSIDDFEIIKPISRGAFG+V
Sbjct: 659 TDAKSPKSDSKLKENSRLLLDNASQSSAMSTPVHSSHKERTSIDDFEIIKPISRGAFGKV 718
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
FLARKR TGDLFAIKVLKKLDM+RKND++RILAERNILITVRNPFVVRFFYSFTCRDNLY
Sbjct: 719 FLARKRITGDLFAIKVLKKLDMLRKNDVQRILAERNILITVRNPFVVRFFYSFTCRDNLY 778
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHD
Sbjct: 779 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHD 838
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883
GHIKLTDFGLSKIGLIN+T+DL+GPET+ SDAH P + QT+ NR SAVGTPDYLAP
Sbjct: 839 GHIKLTDFGLSKIGLINSTMDLAGPETNEDEVSDAHNP-HIQTEETNRQSAVGTPDYLAP 897
Query: 884 EILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFE 943
EILLGTEHGYAADWWSVGIILFE ITGIPPFTAE PEIIFDNILNRKIPWP VP MS+E
Sbjct: 898 EILLGTEHGYAADWWSVGIILFELITGIPPFTAERPEIIFDNILNRKIPWPPVPESMSYE 957
Query: 944 AQDLINRFLIHDPNQRLGANGAAEV 968
AQDLINR + +DP+QRLG+NG+AEV
Sbjct: 958 AQDLINRLITYDPDQRLGSNGSAEV 982
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492673|ref|XP_002282958.2| PREDICTED: uncharacterized protein LOC100259179 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1290 bits (3339), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 683/995 (68%), Positives = 771/995 (77%), Gaps = 29/995 (2%)
Query: 12 GIPSGLNRIKTRGGVSKP---------DELTESRSYGVSRPPQKHKQKTVAQGHVKLANS 62
GIP+GLNRIKTR SK D+ ESR G+SRPP K +GH K A S
Sbjct: 16 GIPTGLNRIKTRRESSKDQLNWKPDDDDKFHESRPRGISRPPANQKHN---KGHAKFAGS 72
Query: 63 FTEEVRKGKKIAQWFTSYISK-----FNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNH 117
E KGKKIA+WFTS++SK F+ V P ++S S+ K D E RTK EG H
Sbjct: 73 I-EGFHKGKKIARWFTSHLSKDSSQGFDDVPPKVQDSNSKVKAPDKEGSTRTKQWKEGKH 131
Query: 118 LNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAA 177
L KQS E +SS KV KGLKSFSHELGPKGGIP S+PRAHSYNDLKELL +LHSRFDAA
Sbjct: 132 LTGKQSSPEGLSSIKVPKGLKSFSHELGPKGGIPPSHPRAHSYNDLKELLGSLHSRFDAA 191
Query: 178 KEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQ 237
KEVVN EL++ D+M+ L++ DS S G++M E LLILAQQC+EMT FR CETIVQ
Sbjct: 192 KEVVNVELSSLTGDIMDALQRNDS--SPGQKMAEGLLILAQQCMEMTPSEFRIKCETIVQ 249
Query: 238 DLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVE 297
LTEKRQ CQ +KWL TRMLFILTRCTRLL FQK+SEPI EKSLH F KCLES+PAVE
Sbjct: 250 GLTEKRQHCQTAFLKWLFTRMLFILTRCTRLLRFQKDSEPIDEKSLHNFTKCLESIPAVE 309
Query: 298 TSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKS 354
+W P +S DY S K++AK ++ + +VS++ E + C E D TS S
Sbjct: 310 MNWAPYSRIVDSGSDYDSNGKSDAKHELQWRNRVSSLLEQTWCRSEEPADKSGITSRKDS 369
Query: 355 VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICE 414
+ + Q Q SQ +Q G+ + + GS HE + LDGSDSVICRICE
Sbjct: 370 MVLVQKPLSQNSQIDFLPHIEQDGDYPGKSMNSFED--GSLHEPERGLDGSDSVICRICE 427
Query: 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENS 474
E VP SHLESHSYICAYADKC+L LD+DERL KL+EILEQI ES N + SPENS
Sbjct: 428 ENVPTSHLESHSYICAYADKCDLKYLDIDERLSKLAEILEQIIESRNLNFQASFCSPENS 487
Query: 475 RTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKL 533
R Q NSA+ +G SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KL
Sbjct: 488 RMQITNSAVISEGCSPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKL 547
Query: 534 SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDF 593
S YGA SSTGSMTS+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD
Sbjct: 548 SQYGAPSSTGSMTSMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDL 607
Query: 594 SKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSF 652
SKEGS +FLLACM DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S
Sbjct: 608 SKEGSCDFLLACMEDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSD 667
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTG 712
++ KE+SRL+ D+ S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTG
Sbjct: 668 NRIKESSRLLFDNASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTG 727
Query: 713 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772
DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGG
Sbjct: 728 DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGG 787
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
DLYSLLRK+GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFG
Sbjct: 788 DLYSLLRKLGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFG 847
Query: 833 LSKIGLINNTIDLSGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890
LSKIGLIN+T+DLSGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTE
Sbjct: 848 LSKIGLINSTVDLSGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTE 907
Query: 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINR 950
HGYAADWWSVGIILFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINR
Sbjct: 908 HGYAADWWSVGIILFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINR 967
Query: 951 FLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985
FLIHDP+ RLGANG +EV F + +++Q
Sbjct: 968 FLIHDPDLRLGANGLSEVKTHPFFKGVNWDTLALQ 1002
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324180|ref|NP_001077679.1| protein kinase-like protein [Arabidopsis thaliana] gi|332193965|gb|AEE32086.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1058 bits (2735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/977 (58%), Positives = 701/977 (71%), Gaps = 41/977 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEV 968
L+H+P +RLGANGAAEV
Sbjct: 933 LVHEPEKRLGANGAAEV 949
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145336472|ref|NP_175130.2| protein kinase-like protein [Arabidopsis thaliana] gi|332193964|gb|AEE32085.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1057 bits (2733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/977 (58%), Positives = 701/977 (71%), Gaps = 41/977 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEV 968
L+H+P +RLGANGAAEV
Sbjct: 933 LVHEPEKRLGANGAAEV 949
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110740013|dbj|BAF01910.1| similar to IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1053 bits (2722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/977 (58%), Positives = 700/977 (71%), Gaps = 41/977 (4%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y Q+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPECQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNG
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNG 752
Query: 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
GDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDF
Sbjct: 753 GDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDF 812
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 813 GLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEH 872
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
GYAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR
Sbjct: 873 GYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRL 932
Query: 952 LIHDPNQRLGANGAAEV 968
L+H+P +RLGANGAAEV
Sbjct: 933 LVHEPEKRLGANGAAEV 949
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7767670|gb|AAF69167.1|AC007915_19 F27F5.23 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/1002 (56%), Positives = 701/1002 (69%), Gaps = 66/1002 (6%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVSKPDELTESRSYGVSRPPQKHKQKT-VAQGH 56
A +N D G IPSGLNRIKTR S P E S V +PP QKT V +GH
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGPR--PEDSSDTVLKPPFNRNQKTIVPRGH 59
Query: 57 VKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGN 116
+ S +E RKG K+++W SY K++ P S + + KLR + +
Sbjct: 60 GRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSE-------EIKLRGKNS 111
Query: 117 HLNEKQSLAEHVSSSKVSK--GLKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRF 174
+E++ + ++ SK G+KSFSHELGP+GG+ + YPR HSYNDLKELL +LHSRF
Sbjct: 112 GKDEEKMIKISETNPPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELLGSLHSRF 171
Query: 175 DAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCET 234
D AKE V+ +L F +DV +EKMD E +EM E LL +A+ C+EMTS RA CE+
Sbjct: 172 DVAKETVDKKLDVFVRDVKEAMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCES 231
Query: 235 IVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVP 294
IVQDLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK+CLE +P
Sbjct: 232 IVQDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIP 291
Query: 295 AVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSEN 352
A+ET W +P +S Y YQ+ A +K + K S E + ++ ++ +
Sbjct: 292 ALETDWGSTPRVDDSGSGYPEYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAARE 351
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
+Q FP + Q S++ EQ+ ++ + E SN E G+ L GSD VICRI
Sbjct: 352 GYAAAKQEFPSHEPQFDSKVVEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRI 404
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPE 472
CEE VP+ HLE HSYICAYADKCE+NC+DVDERLLKL EILEQI +S + +S G E
Sbjct: 405 CEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLE 464
Query: 473 NSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLK 532
NS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K
Sbjct: 465 NSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAK 522
Query: 533 LSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTD 592
+ SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED++ M++L+DIARC A TD
Sbjct: 523 FCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTD 581
Query: 593 FSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTS 651
FSKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS
Sbjct: 582 FSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVG 641
Query: 652 FSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTT 711
K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+VFLARKRTT
Sbjct: 642 NIKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTT 692
Query: 712 GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFYSFTCRDNL 762
GD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFYSFTCRDNL
Sbjct: 693 GDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLMLLMQVRFFYSFTCRDNL 752
Query: 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822
YLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA+
Sbjct: 753 YLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAY 812
Query: 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 882
+GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+ + Q + R RHSAVGTPDYLA
Sbjct: 813 NGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLA 872
Query: 883 PEILLGTEHG----------------YAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
PEILLGTEHG YAADWWS GI+LFE +TGIPPFTA PE IFDNI
Sbjct: 873 PEILLGTEHGLDTTFKSGFHEAPVNCYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNI 932
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
LN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEV
Sbjct: 933 LNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEV 974
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852258|ref|XP_002894010.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297339852|gb|EFH70269.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/1018 (56%), Positives = 706/1018 (69%), Gaps = 90/1018 (8%)
Query: 4 ASQNNHDNG------IPSGLNRIKTRGGVS--KPDELTESRSYGVSRPPQKHKQKT-VAQ 54
A +N D G IPSGLNRIKTR S +P++ +++ V +PP QK V +
Sbjct: 2 AEENRKDRGVSSTVAIPSGLNRIKTRLASSGLRPEDSSDT----VVKPPFNRNQKIIVPR 57
Query: 55 GHVKLANSFTEEVRKGKKIAQWFTSYISKFNIVSPN---TENSGSEDKDVDVEDPRRTKL 111
G+ + S +E RKG K+++W SY K++ P + + SED KL
Sbjct: 58 GYGRTTGSSKQE-RKGTKLSRWLASYKPKYSCHPPKYACSSTTSSED----------IKL 106
Query: 112 RHEGNHLNEKQSLAEHVSSSKV----SKGLKSFSHELGPKGGIPSSYPRAHSYNDLKELL 167
R G + + + + VS + + S G+KSFSHELGP+GG+ + YPR HSYNDLKELL
Sbjct: 107 R--GKNCGKDEEMIIKVSETNLPCSKSMGIKSFSHELGPRGGVQTPYPRPHSYNDLKELL 164
Query: 168 DTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCL 227
+LHSRFD AKE V+ +L F DV +EKMD P E +EM E+LL +A+ C+EMTS
Sbjct: 165 GSLHSRFDVAKETVDKKLDVFVIDVKEAMEKMDPPCPEDREMAEELLDVARACMEMTSAQ 224
Query: 228 FRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFK 287
RA CE+IV DLT KR+QCQ GLVKWL +++LFILT CTR+++FQKE+EPI E S KFK
Sbjct: 225 LRATCESIVHDLTRKRKQCQAGLVKWLFSQLLFILTHCTRVVMFQKETEPIDESSFRKFK 284
Query: 288 KCLESVPAVETSWVPSPGTAESDLDYASYQKANAKKKISGQQKVSTVPEISDCSCSESLD 347
+CLE +PA+ET W +P +S Y YQ+ A +K ++ S E + + D
Sbjct: 285 ECLERIPALETDWGSTPRVDDSGSGYPKYQRDEAGQKFKRRETESLESETTFDYVIPN-D 343
Query: 348 HTSENKS---VFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDG 404
H++ + +Q FP Q+ Q S++ +Q+ ++ + E P ++ L
Sbjct: 344 HSNNAATEGYAVAKQEFPSQEPQFDSKVVQQRFYLSD----EYEHKMLNEPVKE---LGR 396
Query: 405 SDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSS 464
SD VICRICEE VP+SHLE HSYICAYADKCE+NCLDVDERLLKL EILEQI +S + +S
Sbjct: 397 SDYVICRICEEEVPLSHLEPHSYICAYADKCEINCLDVDERLLKLEEILEQIIDSRSLNS 456
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLN 524
G ENS + S + +G SPKI+EWRNKG+EGMFED+HEMDTA ID+S+ +N
Sbjct: 457 FTQAGGLENSVLR--KSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIN 514
Query: 525 LRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 584
L+ H+G K+ + SSSTGS+TSVSSTNTP+ HFD +WLER+ P E ED+Q M++L+DI
Sbjct: 515 LKSHVGAKICHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHCP-EQEDLQLMMDLSDI 573
Query: 585 ARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACEL 643
ARC A TD SKEGS ++++ACM D+Q VL+ KLKALVIDTFG RIEKLL EKY+ A EL
Sbjct: 574 ARCGASTDLSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLYAREL 633
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
+KS K E+ +L+ S + + K+R SIDDFEIIKPISRGAFG+V
Sbjct: 634 TADKSSVGNVKESED---VLEHASATPQLLL------KDRISIDDFEIIKPISRGAFGKV 684
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV---------VRFFY 754
FLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNILITVR PF+ VRFFY
Sbjct: 685 FLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLAEHLILLMQVRFFY 744
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLALEYLHSL IVHRDLK
Sbjct: 745 SFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLK 804
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
PDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D + +H+ + Q + R RHSA
Sbjct: 805 PDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTGSHHFQKNQEEERIRHSA 864
Query: 875 VGTPDYLAPEILLGTEH------------------------GYAADWWSVGIILFEFITG 910
VGTPDYLAPEILLGTEH GYA+DWWSVGI+LFE ITG
Sbjct: 865 VGTPDYLAPEILLGTEHGLDTTLYLGFSEAIGNYIQLLGLAGYASDWWSVGIVLFELITG 924
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
IPPFTA PEIIFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEV
Sbjct: 925 IPPFTAARPEIIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEV 982
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142471|emb|CBI19674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/622 (75%), Positives = 510/622 (81%), Gaps = 44/622 (7%)
Query: 376 QSHIVEGRIVEVTKSNCGSPHEQGQSL-------DGSDSVICRICEEVVPISHLESHSYI 428
Q IV GR++ N E G L DGSDSVICRICEE VP SHLESHSYI
Sbjct: 252 QIMIVMGRVM----PNMNYSGETGYLLSLSKLGADGSDSVICRICEENVPTSHLESHSYI 307
Query: 429 CAYADKCELNCLDVDERLLKLSEILEQISES-CNSSSHPILGSPENSRTQSMNSAITYDG 487
CAYADKC+L LD+DERL KL+EILEQI ES C
Sbjct: 308 CAYADKCDLKYLDIDERLSKLAEILEQIIESRC--------------------------- 340
Query: 488 YSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMT 546
SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMT
Sbjct: 341 -SPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMT 399
Query: 547 SVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACM 605
S+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM
Sbjct: 400 SMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACM 459
Query: 606 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS 665
DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+
Sbjct: 460 EDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDN 519
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIKVLKKLDM
Sbjct: 520 ASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIKVLKKLDM 579
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCLE
Sbjct: 580 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCLE 639
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
EDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+DL
Sbjct: 640 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVDL 699
Query: 846 SGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
SGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGII
Sbjct: 700 SGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGII 759
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
LFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGAN
Sbjct: 760 LFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGAN 819
Query: 964 GAAEVFHCKIFIKKTENCVSMQ 985
G +EV F + +++Q
Sbjct: 820 GLSEVKTHPFFKGVNWDTLALQ 841
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/888 (48%), Positives = 568/888 (63%), Gaps = 64/888 (7%)
Query: 137 LKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVL 196
+KSFSHEL KG P + + N+L+E+L + ++FD AKE VNS+LA FA D++ +L
Sbjct: 295 IKSFSHELNSKGVWPFPFSKPRRLNNLEEILVVIRAKFDKAKEDVNSDLAIFAADLVGIL 354
Query: 197 EKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLST 256
EK + +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K L T
Sbjct: 355 EKNADTHPDWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLKQLHT 414
Query: 257 RMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPSPGTA 307
RMLFILTRCTRLL F KES EP+ + LH K + +T +A
Sbjct: 415 RMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKFIPPSVGRDTK----SSSA 470
Query: 308 ESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQNFP- 362
L +S + + ++ + G +K PE +D ++ D +S + + FP
Sbjct: 471 AKALKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKLFDSSSGRNRMASWKKFPS 530
Query: 363 -----PQ-----KSQHYSRMQEQQSHIVEGRIVEVT------------------------ 388
P+ K Q+Y R++ ++ + +V
Sbjct: 531 PTGRSPKEAVQLKDQNYGRVESSKASNNKRFTSDVDLSTAKPSELLPVKDSLDHASKHQH 590
Query: 389 KSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLK 448
K + G +Q + +S+ICRICEE VP SH+E HS ICA AD+C+ L V+ERL++
Sbjct: 591 KVSWGYWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICAVADRCDQKGLSVNERLVR 650
Query: 449 LSEILEQISESCNS-SSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDI 507
+S+ LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M +
Sbjct: 651 ISDTLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDMLDCF 710
Query: 508 HEMDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLE 565
E D + D G ++ + G K +SS GSMT S TP+ D
Sbjct: 711 PEADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAG 770
Query: 566 RNHPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKALVIDT 624
+ +E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL ++T
Sbjct: 771 KGAYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDALTVET 830
Query: 625 FGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERT 684
FG+RIEKL+REKY+ E++D + + S ++ ++ D V +S S P+HSS ++RT
Sbjct: 831 FGTRIEKLIREKYLQLTEMVDVEKIDTESTVDDD--ILEDDVVRSLRTS-PIHSS-RDRT 886
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
SIDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIKVLKK DMIRKN +E ILAER+ILITV
Sbjct: 887 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILITV 946
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
RNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLALEYLH
Sbjct: 947 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLALEYLH 1006
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDAH--Y 860
SL +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D +
Sbjct: 1007 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDETDVF 1066
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF AE P+
Sbjct: 1067 TSADQRERREKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNAEHPQ 1126
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
IIFDNILNRKIPWP VP +MS EA DLI+R L DPNQRLG+ GA+EV
Sbjct: 1127 IIFDNILNRKIPWPAVPEEMSPEALDLIDRLLTEDPNQRLGSKGASEV 1174
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520647|ref|XP_003528972.1| PREDICTED: uncharacterized protein LOC100816852 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/887 (48%), Positives = 564/887 (63%), Gaps = 64/887 (7%)
Query: 137 LKSFSHELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVL 196
+KSFSHEL KG P + + N+L+E+L + ++FD AKE VNS+LA FA D++ +L
Sbjct: 292 IKSFSHELNSKGVWPFPFSKPRRLNNLEEILVVIRAKFDKAKEDVNSDLAIFAADLVGIL 351
Query: 197 EKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLST 256
EK E +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K L T
Sbjct: 352 EKNADTHPEWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLKQLHT 411
Query: 257 RMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPSPGTA 307
RMLFILTRCTRLL F KES EP+ + LH KC+ +T +A
Sbjct: 412 RMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKCIPPSVGRDTK----SSSA 467
Query: 308 ESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQNFP- 362
L +S + + ++ + G +K PE +D ++ + +S + + FP
Sbjct: 468 TKVLKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKHFNSSSGRNRMASWKKFPS 527
Query: 363 -----PQ-----KSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGS------- 405
P+ K Q+Y R++ ++ + +V + H SLD +
Sbjct: 528 PTGRSPKEAVQLKDQNYGRIESSKASNNKRFSSDVDTAKPSELHPVKDSLDHASKHQHKV 587
Query: 406 ---------------DSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLS 450
+S+ICRICEE VP SH+E HS ICA AD+C+ L V+ERL +++
Sbjct: 588 SWGHWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICALADRCDQKGLSVNERLGRIA 647
Query: 451 EILEQISESCNSS-SHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHE 509
E LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M + E
Sbjct: 648 ETLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPE 707
Query: 510 MDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERN 567
D + D G ++ + G K +SS GSMT S TP+ D +
Sbjct: 708 ADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKG 767
Query: 568 HPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKALVIDTFG 626
+E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL ++TFG
Sbjct: 768 AYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDALTVETFG 827
Query: 627 SRIEKLLREKYILACELLD-EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTS 685
+RIEKL+REKY+ E++D EK T + + S ++P+HSS ++RTS
Sbjct: 828 TRIEKLIREKYLQLTEMVDVEKIDTESTVDDDLLE----DDVVRSLRTSPIHSS-RDRTS 882
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
IDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIKVLKK DMIRKN +E ILAER+ILITVR
Sbjct: 883 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILITVR 942
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
NPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLALEYLHS
Sbjct: 943 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLALEYLHS 1002
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDAH--YP 861
L +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D +
Sbjct: 1003 LHVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDETDVFT 1062
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF AE P+
Sbjct: 1063 SEDQRERRKKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNAEHPQT 1122
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
IFDNILNRKIPWP VP +MS +AQDLI+R L DPNQRLG+ GA+EV
Sbjct: 1123 IFDNILNRKIPWPAVPEEMSPQAQDLIDRLLTEDPNQRLGSKGASEV 1169
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 995 | ||||||
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.814 | 0.759 | 0.617 | 8.3e-264 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.603 | 0.462 | 0.534 | 2.5e-194 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.622 | 0.501 | 0.502 | 1.3e-184 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.811 | 0.690 | 0.448 | 2.3e-170 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.271 | 0.197 | 0.436 | 3.2e-81 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.164 | 0.078 | 0.682 | 5.2e-80 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.270 | 0.368 | 0.476 | 5.7e-69 | |
| POMBASE|SPAPB18E9.02c | 1318 | ppk18 "serine/threonine protei | 0.196 | 0.148 | 0.492 | 3.3e-67 | |
| CGD|CAL0002056 | 1923 | RIM15 [Candida albicans (taxid | 0.213 | 0.110 | 0.424 | 5.4e-67 | |
| POMBASE|SPCC1450.11c | 1338 | cek1 "serine/threonine protein | 0.171 | 0.127 | 0.569 | 6.8e-67 |
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2538 (898.5 bits), Expect = 8.3e-264, P = 8.3e-264
Identities = 511/828 (61%), Positives = 611/828 (73%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HELGP+GG+ + YPR HSYNDLKELL +LHSRFD AKE V+ +L F +DV +EKMD
Sbjct: 139 HELGPRGGVQTPYPRPHSYNDLKELLGSLHSRFDVAKETVDKKLDVFVRDVKEAMEKMDP 198
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL +++LFI
Sbjct: 199 SCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWLFSQLLFI 258
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYASYQKANA 321
LT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y YQ+ A
Sbjct: 259 LTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYPEYQRNEA 318
Query: 322 KKKISGQQKVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRMQEQQSHIVE 381
+K + K S E + DH N + + + K + S + S +VE
Sbjct: 319 GQKFKRRDKESLESETA-LDYVVPNDH-GNNAA---REGYAAAKQEFPSHEPQFDSKVVE 373
Query: 382 GRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLD 441
R + +E G+ L GSD VICRICEE VP+ HLE HSYICAYADKCE+NC+D
Sbjct: 374 QRFYLSDEYEDKMSNEPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYADKCEINCVD 433
Query: 442 VDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVE 501
VDERLLKL EILEQI +S + +S G ENS + S + +G SPKI+EWRNKG+E
Sbjct: 434 VDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLRK--SGVASEGCSPKINEWRNKGLE 491
Query: 502 GMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDP 561
GMFED+HEMDTA ID+S+ ++L+ H+G K NTP+ HFD
Sbjct: 492 GMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTNTPRTSHFDS 551
Query: 562 FWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKAL 620
+WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q VL+ KLKAL
Sbjct: 552 YWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAVLKQGKLKAL 610
Query: 621 VIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSH 680
VIDTFG RIEKLL EKY+ A EL +KS S KE S +L+ S +TP
Sbjct: 611 VIDTFGGRIEKLLCEKYLHARELTADKS--SVGNIKE-SEDVLEHAS-----ATP-QLLL 661
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDIERIL ERNI
Sbjct: 662 KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNI 721
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
LITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIAELVLAL
Sbjct: 722 LITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLAL 781
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D +++H+
Sbjct: 782 EYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHH 841
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGIPPFTA PE
Sbjct: 842 FQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPE 901
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEV
Sbjct: 902 KIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEV 949
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1561 (554.6 bits), Expect = 2.5e-194, Sum P(3) = 2.5e-194
Identities = 334/625 (53%), Positives = 409/625 (65%)
Query: 360 NFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPI 419
NFPP K H + H + + G EQ + S++CRICEE VP
Sbjct: 565 NFPPAKDSH--EHSSKHRHNI----------SWGYWGEQ-PLISEESSIMCRICEEEVPT 611
Query: 420 SHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSPENSRTQS 478
+H+E HS +C ADK + L VDERL+ ++ L++I+E+ + S SP+ + +
Sbjct: 612 THVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKDSLAAAESPDGMKVSN 671
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHLGLKLXXX 536
+ D SP++S+W KG E M + E D + +DD L ++ R G K
Sbjct: 672 SHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSDQG 731
Query: 537 XXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKE 596
TP+ + + + +D+ QM ELADIA+C AD +
Sbjct: 732 MTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPGDD 791
Query: 597 GS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKY 655
S FLL+C+ DL+ V+ K AL ++TFG+RIEKL+REKY+ CEL+D++ S
Sbjct: 792 QSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLSTV 851
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
+ + D V +S S P+H ++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLF
Sbjct: 852 IDEDAPLEDDVVRSLRTS-PVHP--RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIKVLKK DMIRKN +E ILAER+ILI VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 776 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
SLLR +GCLEED+ R+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGTEH 891
+GLIN+T DL+GP G D +Q + R + SAVGTPDYLAPEILLGT H
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
G ADWWSVGIILFE I GIPPF AE P+ IFDNILNRKIPWP VP +MS EA D+I+RF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 952 LIHDPNQRLGANGAAEVFHCKIFIK 976
L DP+QRLGA GAAEV IF K
Sbjct: 1149 LTEDPHQRLGARGAAEVKQ-HIFFK 1172
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1482 (526.7 bits), Expect = 1.3e-184, Sum P(3) = 1.3e-184
Identities = 320/637 (50%), Positives = 408/637 (64%)
Query: 353 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 412
K V I + K S + Q H+ + R ++ G H+ + S+ICRI
Sbjct: 500 KLVAISDDMAVAKLPEVSSAKASQEHMSKNRH-NISWGYWG--HQS--CISEESSIICRI 554
Query: 413 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSP 471
CEE +P +H+E HS ICA ADK + + VDERL+ ++ LE+I+++ S + SP
Sbjct: 555 CEEEIPTTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKDSLAAVESP 614
Query: 472 ENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHL 529
E + + + D SPK+S+W +G E M + E D + +DD L S++ R
Sbjct: 615 EGMKISNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRF 674
Query: 530 GLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVA 589
G K TP+ + + + +D QM ELADIARC A
Sbjct: 675 GPKSDQGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAA 734
Query: 590 DT-DFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKS 648
+ + + LL+C+ DL+ V+ K AL+++TFG+RIEKL++EKY+ CEL+D++
Sbjct: 735 NAIPVDDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK 794
Query: 649 PTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 708
T E++ L D V +S S P+H ++R SIDDFE++K ISRGAFG V LARK
Sbjct: 795 GTIID---EDAPLE-DDVVRSLRTS-PVHL--RDRISIDDFEVMKSISRGAFGHVILARK 847
Query: 709 RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768
TTGDLFAIKVL+K DMIRKN +E ILAER+ILI RNPFVVRFFYSFTC +NLYLVMEY
Sbjct: 848 NTTGDLFAIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEY 907
Query: 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828
LNGGD YS+LRK+GCL+E AR+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGH+KL
Sbjct: 908 LNGGDFYSMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKL 967
Query: 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 888
TDFGLSK+GLINNT DLSGP + P+ D++ SAVGTPDYLAPEILLG
Sbjct: 968 TDFGLSKVGLINNTDDLSGPVSSATSLLVEEKPKLPTLDHKR--SAVGTPDYLAPEILLG 1025
Query: 889 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 948
T HG ADWWSVGIIL+EF+ GIPPF A+ P+ IFDNILNR I WP VP DMS EA+DLI
Sbjct: 1026 TGHGATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDLI 1085
Query: 949 NRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985
+R L DP+QRLGA GAAEV F N ++ Q
Sbjct: 1086 DRLLTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQ 1122
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1635 (580.6 bits), Expect = 2.3e-170, Sum P(2) = 2.3e-170
Identities = 384/857 (44%), Positives = 519/857 (60%)
Query: 142 HELGPKGGIPSSYPRAHSYNDLKELLDTLHSRFDAAKEVVNSELATFAKDVMNVLEKMDS 201
HEL KG P R+ + ++E++ + ++FD KE V+++L FA ++ LE
Sbjct: 201 HELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADLGVFAGYLVTTLESTPE 260
Query: 202 PSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLSTRMLFI 261
+ E + LEDLL+ A+QC M + F CE IVQ L +KRQ+ +G +K R+LFI
Sbjct: 261 SNKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLKQAHNRLLFI 320
Query: 262 LTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDL-DYASYQKAN 320
LTRC RL+ F+KES + E L + L + V + + DL QK N
Sbjct: 321 LTRCNRLVQFRKESGYVEEHILGMHQ--LSDLGVYPEQMVEI--SRQQDLLREKEIQKIN 376
Query: 321 AKKKISGQQKVSTVPEISD---CSCSESLDHTSENKSVFIEQNFPP--QKSQHYSRMQEQ 375
K+ ++G+Q +D + + S D TS N + + P +K++ + +
Sbjct: 377 EKQNLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKNRSLNNTPKA 436
Query: 376 QSHI-VEGRIV-EVTKSNCGSPHEQGQSLDGS---------------DSVICRICEEVVP 418
+ ++ ++ + N SP Q S D S +S+ICRICE +P
Sbjct: 437 KGESKIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVTYDNSMICRICEVEIP 496
Query: 419 ISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQS 478
+ H+E HS IC AD+C+L ++V+ RL +++E LE+I ES S + +S S
Sbjct: 497 VVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKSSVTPRAVADSARLS 556
Query: 479 MNSAITYDGYSPKISEWRNKGVEGMFEDI-HEMDTACIDDSHLGSLNLRGHLGLKLXXXX 537
NS+ D + E + + M + + +T +D+ LN+ + +
Sbjct: 557 -NSSRQED-----LDEISQRCSDDMLDCVPRSQNTFSLDE-----LNILNEMSM---TNG 602
Query: 538 XXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEG 597
TP+ D R +ELE+ QQ+ +L DIAR VA+ +
Sbjct: 603 TKDSSAGSLTPPSPATPRNSQVDLLLSGRKTISELENYQQINKLLDIARSVANVNVCGYS 662
Query: 598 S-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD-EKSPTSFSKY 655
S +F++ + +L+ V+Q K ALV++TFG RIEKLL+EKYI C L+D EK +S +
Sbjct: 663 SLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDEKVDSSNAMP 722
Query: 656 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 715
E S D+V ++PL+ K+RTSI+DFEIIKPISRGAFGRVFLA+KR TGDLF
Sbjct: 723 DEESSADEDTVRSLR--ASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKKRATGDLF 780
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIKVLKK DMIRKN +E ILAERNILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDL+
Sbjct: 781 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLF 840
Query: 776 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
SLLR +GCL+ED+ARIYIAE+VLALEYLHS+ I+HRDLKPDNLLI DGHIKLTDFGLSK
Sbjct: 841 SLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKLTDFGLSK 900
Query: 836 IGLINNTIDLSGPET---DGIMPSDAHYPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH 891
+GLIN+T DLSG + G D ++ Q D+R +H+ VGTPDYLAPEILLG H
Sbjct: 901 VGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPEILLGMGH 960
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
G ADWWSVG+ILFE + GIPPF AE+P+ IF+NI+NR IPWP VP ++S+EA DLIN+
Sbjct: 961 GKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEAHDLINKL 1020
Query: 952 LIHDPNQRLGANGAAEV 968
L +P QRLGA GA EV
Sbjct: 1021 LTENPVQRLGATGAGEV 1037
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 3.2e-81, Sum P(4) = 3.2e-81
Identities = 128/293 (43%), Positives = 186/293 (63%)
Query: 564 LERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVID 623
L R++ E + +IEL +IA + KE L +H + D++++ K +
Sbjct: 676 LTRSNDIPHEKRKMIIELREIALFAVENGI-KEN----LKMIHIMNDIIKNFDPKDDNRE 730
Query: 624 TFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS-----VSQSS------GV 672
+I+ L+ +K + A + D+ +S ++ NS IL S +SQ+
Sbjct: 731 -LAIKIQSLISDK-VNALKRADDVINSSPRIFRTNSPRILKSPREEELSQTPLGGRLRSD 788
Query: 673 STPLHSS---HKER--TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727
S P+H + +K + +I DFE IKPI++G +G+VFLA+K TGD++AIK LKK DMI+
Sbjct: 789 SDPVHQTQIEYKPKGVPTISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKRLKKSDMIK 848
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
KN ++ + ERNIL NPFVV+ +YSF ++ YLVMEYL GGD +SLL+ +G ++E+
Sbjct: 849 KNQLDHVKVERNILAYTSNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDEN 908
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
+A++ IAE VLALEYLHS GIVHRD+KPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 909 MAKMIIAETVLALEYLHSHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLLD 961
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.2e-80, Sum P(6) = 5.2e-80
Identities = 112/164 (68%), Positives = 130/164 (79%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
SS+ SI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ E
Sbjct: 1516 SSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVE 1575
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
RNIL V+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE V
Sbjct: 1576 RNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETV 1635
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
L LEYLH IVHRDLKPDN+LI GHIKLTDFGLSKIG+I++
Sbjct: 1636 LCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDD 1679
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 5.7e-69, Sum P(3) = 5.7e-69
Identities = 134/281 (47%), Positives = 180/281 (64%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 376 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 435
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 436 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 495
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L +G + D E+ D
Sbjct: 496 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY----EGHIEKDTR--EF--VD 547
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F ++
Sbjct: 548 KQ----VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQVV 603
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
+ +I WP + +AQDLI R L P RLG G EV
Sbjct: 604 SDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEV 644
|
|
| POMBASE|SPAPB18E9.02c ppk18 "serine/threonine protein kinase Ppk18 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 3.3e-67, Sum P(3) = 3.3e-67
Identities = 98/199 (49%), Positives = 138/199 (69%)
Query: 666 VSQSSGVSTPLH--SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+S+ G+ST SS K SI D+EIIKPIS+G FG V+L+RK TTG+++AIKVL+K+
Sbjct: 541 LSRQIGISTLSSNISSGKGTPSIQDYEIIKPISKGTFGTVYLSRKNTTGEIYAIKVLRKV 600
Query: 724 DMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
DMI KN + + AER +L+ + FV + +Y+F RD LYLVME++NGGD SLL+ +
Sbjct: 601 DMISKNQVANVKAERAVLMAQEESAFVAKLYYAFQSRDYLYLVMEFMNGGDCASLLKSLY 660
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ E A+IYIAE+ L LE+LH LGI+HRD+KPDN+L++ GH+KL DFGLS++GL
Sbjct: 661 TIPESWAKIYIAEVALGLEHLHRLGIIHRDIKPDNILMSITGHLKLADFGLSQLGLTTRQ 720
Query: 843 IDLSGPETDGIMPSDAHYP 861
+ L + + + P P
Sbjct: 721 LRLQKGKNNILSPPSFQSP 739
|
|
| CGD|CAL0002056 RIM15 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 5.4e-67, Sum P(4) = 5.4e-67
Identities = 93/219 (42%), Positives = 137/219 (62%)
Query: 672 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI 731
VST I D+++IKPIS+GAFG VFL +++ TGD AIK LKK DMI KN +
Sbjct: 880 VSTQQPQPRLSTGGIRDYQVIKPISKGAFGSVFLGKRKLTGDYVAIKCLKKRDMIAKNQV 939
Query: 732 ERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR 790
+ +ER +++ + P+V + + SF RD LYLVMEYLNGGD +LL+ +G + D
Sbjct: 940 LNVKSERAVMMRQSDSPYVAQLYSSFQSRDYLYLVMEYLNGGDCANLLKTLGVIGVDWTP 999
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL----S 846
YIAE+++ ++ LH+ GI+HRDLKPDN+LI +GH+KLTDFGLS++G++ S
Sbjct: 1000 RYIAEIIVGVDDLHNRGIIHRDLKPDNILIDKNGHLKLTDFGLSRLGVVGRQQTQQHRKS 1059
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
GI + E +++ + + +GTP L+P +
Sbjct: 1060 STNEQGIELFRSMLSE--ESNQKKVNPGIGTPFSLSPSL 1096
|
|
| POMBASE|SPCC1450.11c cek1 "serine/threonine protein kinase Cek1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 6.8e-67, Sum P(3) = 6.8e-67
Identities = 98/172 (56%), Positives = 130/172 (75%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
S S + T + +S E SI+D++I+KPIS+GAFG V+LA+KRTTGD FAIK+LKK +MI
Sbjct: 567 SPSPRIHTIVPNSAPEHPSINDYKILKPISKGAFGSVYLAQKRTTGDYFAIKILKKSNMI 626
Query: 727 RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
KN + + AER IL++ +PFV + +Y+F +D LYLVMEYLNGGD SLL+ +G L+
Sbjct: 627 AKNQVINVRAERAILMSQGESPFVAKLYYTFQSKDYLYLVMEYLNGGDCGSLLKTMGVLD 686
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
D R YIAE VL L LH GI+HRD+KP+NLLI+ +GH+KLTDFGLS++G
Sbjct: 687 LDWIRTYIAETVLCLGDLHDRGIIHRDIKPENLLISQNGHLKLTDFGLSRVG 738
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT1G45160 | kinase; kinase; FUNCTIONS IN- kinase activity; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- 25 plant structures; EXPRESSED DURING- 15 growth stages; CONTAINS InterPro DOMAIN/s- Serine/threonine protein kinase (InterPro-IPR002290), Tyrosine protein kinase (InterPro-IPR001245), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein kinase-like (InterPro-IPR011009), AGC-kinase, C-terminal (InterPro-IPR000961), Serine/threonine protein kinase, active site (InterPro-IPR008271), Protein kinase, core (InterPro-IPR000719) [...] (1067 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AT1G69210 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (305 aa) | • | 0.819 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 995 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-140 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-114 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-109 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-102 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-102 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-98 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-97 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-90 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-89 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-87 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-80 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-79 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-78 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-77 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-75 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-74 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-74 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-71 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-70 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-70 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-69 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-69 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-67 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-66 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-66 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-65 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-65 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-65 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-64 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-64 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-63 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-62 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-62 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-62 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-61 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-61 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-60 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-60 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-60 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-59 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-59 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-59 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-59 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-58 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-58 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-57 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-57 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-56 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-55 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-55 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-55 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-54 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-54 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-54 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-53 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-53 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-52 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-52 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-51 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-50 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-50 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-50 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-47 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-46 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-43 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-43 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-42 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-42 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-41 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-40 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-40 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-39 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-39 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-39 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-37 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-37 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-36 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-36 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-36 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-35 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-34 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-33 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-33 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-31 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-29 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-29 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-29 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-28 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-28 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-28 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-27 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-27 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-27 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-23 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-22 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-20 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-08 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 7e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.003 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 419 bits (1080), Expect = e-140
Identities = 159/280 (56%), Positives = 202/280 (72%), Gaps = 20/280 (7%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
IS+GA+GRVFLA+K++TGD++AIKV+KK DMIRKN ++++L ER+IL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF + NLYLVMEYL GGDL SLL VG L+EDVARIYIAE+VLALEYLHS GI+HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
PDN+LI +GH+KLTDFGLSK+GL+ I+L+ E + D R
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE---------------DKR----I 161
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTPDY+APE++LG H DWWS+G IL+EF+ GIPPF E+PE IF NILN KI WP
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
S EA DLI++ L+ DP +RLGA E+ + F
Sbjct: 222 EDVEV-SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 349 bits (899), Expect = e-114
Identities = 125/274 (45%), Positives = 177/274 (64%), Gaps = 30/274 (10%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G+FG+V L RK+ TG L+A+KVLKK +I++ ++E L ERNIL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
+F + LYLV+EY GG+L+S L K G E+ AR Y AE+VLALEYLHSLGI++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P+N+L+ DGHIKLTDFGL+K ++ ++
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS---------------------------SEGSRTNTF 153
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
GTP+YLAPE+LLG +G A DWWS+G++L+E +TG PPF AE + I++ IL + +
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF- 212
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
P +S EA+DLI+ L DP +RLG+ GA E+
Sbjct: 213 --PEFLSPEARDLISGLLQKDPTKRLGSGGAEEI 244
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 339 bits (871), Expect = e-109
Identities = 146/279 (52%), Positives = 184/279 (65%), Gaps = 33/279 (11%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVV 750
+KPIS+GAFG V+LA+KR+TGD FAIKVLKK DMI KN + + AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+ +YSF +D LYLVMEYLNGGD SL++ +G L ED A+ YIAE+VL +E LH GI+H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF--------------------------- 153
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
VGTPDYLAPE +LG +DWWS+G ++FEF+ G PPF AE+P+ +FDNIL+R+
Sbjct: 154 ----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
Query: 931 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
I WP V S EA DLINR L DP +RLGANG E+
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 323 bits (829), Expect = e-102
Identities = 130/280 (46%), Positives = 177/280 (63%), Gaps = 8/280 (2%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE+IK I RGAFG V+L R + TG ++A+KVL+K DMI++N I + AER+IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P++V+ +YSF ++LYLVMEY+ GGDL +LL + E+ AR YIAELVLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN---TIDLSGPETDGIMPSDAHYPEY 863
G +HRD+KPDN+LI DGHIKL DFGL K + L+ +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ +S VGTPDY+APE+L GT +G DWWS+G+IL+E + G PPF +++ + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 924 DNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLG 961
+ I+N K P D +S EA DLI R L DP RLG
Sbjct: 240 NKIINWKESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLG 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 320 bits (823), Expect = e-102
Identities = 123/290 (42%), Positives = 175/290 (60%), Gaps = 35/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE IK + G+FGRV L R + +G +A+K+L K +++ +E +L E+ IL ++R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+V + SF NLYLVMEY+ GG+L+S LRK G E VAR Y A++VLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+NLL+ DG+IK+TDFG +K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRT------------------------ 155
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
++ GTP+YLAPEI+L +G A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 156 -----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIF 974
L K+ PS S +A+DLI L D +RLG NG ++ + F
Sbjct: 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = 4e-98
Identities = 136/289 (47%), Positives = 187/289 (64%), Gaps = 12/289 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFE IK IS GA+G V+L R + T FA+K + K ++I +N I+++ ER+IL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PFVV F SF + +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L +G + D +Q
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKDTREFLDKQV 176
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F +
Sbjct: 177 --------CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975
++ I WP + +AQDLI+R L +P +RLG GA EV + F+
Sbjct: 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 305 bits (785), Expect = 5e-97
Identities = 125/278 (44%), Positives = 169/278 (60%), Gaps = 31/278 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EI++ + G+FG+V+LAR + TG L AIKV+KK + K D ERIL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+VR + F D LYLVMEY GGDL+ LL+K G L ED AR Y+ +++ ALEYLHS GI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRDLKP+N+L+ DGH+KL DFGL++ Q
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR----------------------------QLDPG 150
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNIL 927
+ VGTP+Y+APE+LLG +G A D WS+G+IL+E +TG PPF + +F I
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
K P+P D+S EA+DLI + L+ DP +RL A A
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 291 bits (746), Expect = 8e-90
Identities = 128/303 (42%), Positives = 178/303 (58%), Gaps = 19/303 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE IK I RGAFG V L +K+ TG ++A+K L+K +M+ K + + AER+IL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV+ +YSF + LYL+MEYL GGD+ +LL K E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSDAHYP 861
G +HRD+KPDNLL+ GHIKL+DFGL GL + LS P
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPS-NFLDFISKP 178
Query: 862 EYQ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+T RNR +S VGTPDY+APE+ L T + DWWS+G+I++E + G PP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971
F +++P+ + I+N K P ++ S EA+DLI R + +RLG NG E+
Sbjct: 239 FCSDNPQETYRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 972 KIF 974
F
Sbjct: 297 PFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 285 bits (731), Expect = 8e-89
Identities = 101/278 (36%), Positives = 161/278 (57%), Gaps = 11/278 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVR 745
DDF+ K I G+F V LA+++ T +AIK+L K +I++ ++ + E+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P +++ +Y+F +NLY V+EY G+L +RK G L+E R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GI+HRDLKP+N+L+ D HIK+TDFG +K+ + D+ + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL---DPNSSPESNKGDATNIDSQIEKNR- 176
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R S VGT +Y++PE+L G ++D W++G I+++ +TG PPF + + F
Sbjct: 177 ---RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
IL + + P + +A+DLI + L+ DP RLG N
Sbjct: 234 ILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVN 268
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 282 bits (724), Expect = 2e-87
Identities = 124/296 (41%), Positives = 178/296 (60%), Gaps = 24/296 (8%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F+ IK + +G GRVFL R + TG LFA+KVL K +MI++N ++R+L E+ IL T+ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH 804
PF+ + SF L LVM+Y GG+L+ LL++ CL E+VAR Y AE++LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET-----DGIMPSDAH 859
LGIV+RDLKP+N+L+ GHI L+DF LSK S E S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK---------QSDVEPPPVSKALRKGSRRS 171
Query: 860 YPEYQQTD------NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
++ + +S VGT +Y+APE++ G HG A DWW++GI+L+E + G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEV 968
F + + F NIL +++ +P P S A+DLI + L+ DP++RLG GAAE+
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEI 286
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 2e-83
Identities = 133/309 (43%), Positives = 178/309 (57%), Gaps = 31/309 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK I GAFG V L RK T L+A+K L+K D++ +N + AER+IL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++G EED+AR YIAEL A+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINN-----TIDLSGPETDGIM 854
+HRD+KPDN+LI DGHIKLTDFGL SK + +++ S E I
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS-EEWSEID 181
Query: 855 PSDAHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
E ++ R HS VGTP+Y+APE+LL T + DWWSVG+IL+E + G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 912 PPFTAESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
PPF A++P ++N + IP + +S EA DLI R L RLG NGA E
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIP-SQ--AKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 968 V-----FHC 971
+ F
Sbjct: 298 IKAHPFFKG 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 260 bits (667), Expect = 5e-80
Identities = 101/279 (36%), Positives = 155/279 (55%), Gaps = 33/279 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+E+++ + G+FG V+ A+ + TG + A+K+LKK + + E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+VR +F +D+LYLVMEY GGDL+ L + G L ED A+ +++ LEYLHS GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLKP+N+L+ +G +K+ DFGL+K L +++
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 869 RNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFD 924
+ + VGTP Y+APE+LL G +G D WS+G+IL+E +TG PPF+ E +
Sbjct: 154 -SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 925 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGA 962
IL + + S S EA+DLI + L DP++R A
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTA 251
|
Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 9e-79
Identities = 109/290 (37%), Positives = 163/290 (56%), Gaps = 35/290 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD E IK + G FGRV L R R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF++R F++ + LY++MEY+ GG+L+S LR G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
GTP+YLAPE++ H A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 159 --------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIF 974
L K+ + P + A+DLI + L+ D +RLG NGA +V + + F
Sbjct: 211 LAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 260 bits (665), Expect = 1e-78
Identities = 110/279 (39%), Positives = 169/279 (60%), Gaps = 36/279 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DF+I+ + +G +G+VFLA+K+ TG++ A+K +KK + + N++ +L ER+IL T ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
++V+ Y+F + LYL MEY+ GGD +LL +G L ED AR Y+AE+ A++ LH LG
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDLKP+N LI GHIKLTDFGLSK + +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA--------------------- 155
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+S VG+PDY+APE+L G + + D+WS+G +L+EF+ G PPF+ +P ++N+
Sbjct: 156 ----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 928 NRK--IPWPC---VPSDMSFEAQDLINRFLIHDPNQRLG 961
K + P ++S EA DLI + LI+DP++R G
Sbjct: 212 YWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFG 249
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 3e-77
Identities = 98/279 (35%), Positives = 159/279 (56%), Gaps = 33/279 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 751
K + +G+FG+V LA + T +L+A+KVLKK +++ +D+E + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +D L+ VMEY+NGGDL +++ G +E AR Y AE+VL L++LH GI++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG--------------------------GVTTS 154
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL +G A DWW++G++L+E + G PF + + +F +IL ++
Sbjct: 155 -TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
+ P +S EA+ ++ FL +P +RLG G ++
Sbjct: 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDI 249
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 6e-75
Identities = 101/287 (35%), Positives = 163/287 (56%), Gaps = 39/287 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ G FGRV L + ++ FA+K +KK ++ E I +E+ IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
+F + +Y++MEY GG+L+++LR G +E AR YIA +VLA EYLH+ GI++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HS 873
P+NLL+ +G++KL DFG +K + + + +
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-----------------------------KLKSGQKTWT 151
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFDNIL--NR 929
GTP+Y+APEI+L + ++ D+WS+GI+L+E +TG PPF E P I+++IL N
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIF 974
K+ + P+ + A+DLI + L +P +RLG G ++ K F
Sbjct: 212 KLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 2e-74
Identities = 127/318 (39%), Positives = 177/318 (55%), Gaps = 52/318 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DF +K I +GAFG V L +K+ TG ++A+K L K +M +K+ + + AER++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV +YSF LYL+ME+L GGDL ++L K EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLS---------------------------KIGLI 839
G +HRD+KPDN+LI GHIKL+DFGLS + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR----HSAVGTPDYLAPEILLGTEHGYAA 895
++I+L+ D I T +NR +S VGTPDY+APEI L +G
Sbjct: 181 VDSINLTMSSKDQI-----------ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---CVPSD--MSFEAQDLINR 950
DWWS+G I+FE + G PPF +E+ + I+N W P D +S EA+DLI R
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIRR 285
Query: 951 FLIHDPNQRLGANGAAEV 968
LI + RLG GA E+
Sbjct: 286 -LITNAENRLGRGGAHEI 302
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 8e-74
Identities = 116/293 (39%), Positives = 168/293 (57%), Gaps = 42/293 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE+++ + GA+G+VFL RK G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
VR PF+V Y+F L+L+++Y+NGG+L++ L + E R+YIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 863 YQQTDNRNR-HSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE-- 917
+ R +S GT +Y+APE++ G G+ A DWWS+G++ FE +TG PFT +
Sbjct: 157 ---AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
Query: 918 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
S I IL K P P MS EA+D I + L DP +RLGANGA E+
Sbjct: 214 QNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 2e-71
Identities = 111/299 (37%), Positives = 174/299 (58%), Gaps = 38/299 (12%)
Query: 681 KERTS---IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
K TS + DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ ++ + E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
++IL+ + +PF+V SF + +Y ++E++ GG+L++ LRK G DVA+ Y AELV
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
LA EYLHS I++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------------------- 166
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
P+ T GTP+YLAPE++ HG A DWW++G++L+EFI G PPF +
Sbjct: 167 -KVPDRTFT-------LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
+P I++ IL ++ + P+ A+DL+ L D +RLG G A+V + F
Sbjct: 219 TPFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 6e-70
Identities = 102/276 (36%), Positives = 150/276 (54%), Gaps = 30/276 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
FE+++ I +GAFG+V + +KR T +FA+K + K + K + +L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V +YSF +N+YLV++ L GGDL Y L +KV E+ + +I E+VLALEYLHS G
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKG 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRD+KPDN+L+ GH+ +TDF ++ T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATK----------------------------VTP 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ S GTP Y+APE+L + A DWWS+G+ +E + G P+ S I
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
++ P+ S EA D IN+ L DP +RLG N
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 7e-70
Identities = 132/301 (43%), Positives = 178/301 (59%), Gaps = 22/301 (7%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK + GAFG V LARK T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VVR +YSF +DNLY VM+Y+ GGD+ SLL ++G ED+AR YIAEL A+E +H +G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL--------------SKIGLINNTIDLSGPETD--G 852
+HRD+KPDN+LI DGHIKLTDFGL S + +++D S D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 853 IMPSDAHYP-EYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
D P E + R HS VGTP+Y+APE+LL T + DWWSVG+IL+E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 909 TGIPPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
G PPF A++P ++N + P + +S EA DLI + L P RLG NGA E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 968 V 968
+
Sbjct: 302 I 302
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 1e-69
Identities = 113/275 (41%), Positives = 167/275 (60%), Gaps = 34/275 (12%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNP 747
+K + +G +G+VF RK T TG +FA+KVLKK ++R + D AERNIL V++P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
F+V Y+F LYL++EYL+GG+L+ L + G ED A Y++E+ LALE+LH G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I++RDLKP+N+L+ GH+KLTDFGL K + T+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT----------------------- 157
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
H+ GT +Y+APEIL+ + HG A DWWS+G ++++ +TG PPFTAE+ + D IL
Sbjct: 158 ----HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
K+ +P ++ EA+DL+ + L +P+ RLGA
Sbjct: 214 KGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 3e-69
Identities = 128/295 (43%), Positives = 182/295 (61%), Gaps = 18/295 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 864
G +HRD+KPDNLL+ GH+KL+DFGL GL PSD +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 865 ---QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+T +NR +S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 918 SPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
+P+ + ++N K P P VP +S +A+DLI RF D R+G+NG E+
Sbjct: 240 TPQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEI 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 1e-67
Identities = 127/294 (43%), Positives = 183/294 (62%), Gaps = 16/294 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 864
G +HRD+KPDNLL+ GH+KL+DFGL GL + +PSD +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 865 ---QTDNRNRH----SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+T RNR S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 918 SPEIIFDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
+P+ + ++N K I P VP +S +A+DLI RF + R+GA G E+
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCC-EWEHRIGAPGVEEI 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 2e-66
Identities = 111/298 (37%), Positives = 168/298 (56%), Gaps = 35/298 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +DF++IK I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ ++V+ Y+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS+G +HRD+KPDN+L+ GH+KL DFG + + + +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKM---DANGMVRCD----- 201
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 919 PEIIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
+ I++ K P D +S +A+DLI FL D RLG NG E+ F
Sbjct: 252 LVGTYSKIMDHKNSL-TFPDDIEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 226 bits (576), Expect = 9e-66
Identities = 131/313 (41%), Positives = 176/313 (56%), Gaps = 46/313 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F IK + GAFG V LA K T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++ E +AR YIAEL LA+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINNTIDLSGPETDGIMPSD-- 857
+HRD+KPDN+LI DGHIKLTDFGL SK + I D + PSD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI-----RQDSMEPSDLW 177
Query: 858 -----------AHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
E + T R HS VGTP+Y+APE+LL + DWWSVG+I
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 904 LFEFITGIPPFTAESPE------IIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHD 955
LFE + G PPF A +P I ++N L+ +P +S EA DLI + L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-------IPPQVKLSPEAVDLITK-LCCS 289
Query: 956 PNQRLGANGAAEV 968
+RLG NGA ++
Sbjct: 290 AEERLGRNGADDI 302
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 1e-65
Identities = 104/273 (38%), Positives = 158/273 (57%), Gaps = 31/273 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA+ + G +A+KVL+K +++K + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF D LY V++Y+NGG+L+ L++ E AR Y AE+ AL YLHSL I++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +GI S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIEHSK------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNILN+ +
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ ++S A+ L+ L D +RLGA
Sbjct: 214 R---LKPNISVSARHLLEGLLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 2e-65
Identities = 105/276 (38%), Positives = 162/276 (58%), Gaps = 34/276 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +G+FG+V RKR T ++A+K ++K ++ ++++ LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF + LYLV+ ++NGG+L+ L++ G + AR Y AEL+ ALE LH +++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P+N+L+ + GHI L DFGL K+ + + D N +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD-------------------------DDKTN--TF 153
Query: 875 VGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GTP+YLAPE+LLG HGY A DWW++G++L+E +TG+PPF E+ ++ IL +
Sbjct: 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
+ P +A+DL+ L DP +RLG NGA E+
Sbjct: 212 F---PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 8e-65
Identities = 119/287 (41%), Positives = 170/287 (59%), Gaps = 35/287 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFEI+K I RGAFG V + + + TG ++A+K+L K +M+++ + ER++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
LG VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLL----------ADGTVQSNV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ I+N K +P +D+S EA+DLI R LI P RLG NG
Sbjct: 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETRLGRNGL 260
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 3e-64
Identities = 93/279 (33%), Positives = 148/279 (53%), Gaps = 30/279 (10%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++ + + RG+FG V+LA + TG+L A+K ++ + +E + E IL ++++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 748 FVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+VR++ S ++ L + +EY++GG L SLL+K G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GIVHRD+K N+L+ DG +KL DFG +K T +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE--------------------- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
S GTP ++APE++ G E+G AAD WS+G + E TG PP++ +
Sbjct: 159 ----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
Query: 926 -ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
I + P P +P +S EA+D + + L DP +R A+
Sbjct: 215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 7e-64
Identities = 106/269 (39%), Positives = 152/269 (56%), Gaps = 30/269 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ TG +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL YLHS +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
+ P +S EA+ L+ L DP QRLG
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLG 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 3e-63
Identities = 97/281 (34%), Positives = 154/281 (54%), Gaps = 31/281 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K + I
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFGGK--------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
+ + + P +S EA + L P +RLG E
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGE 251
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 1e-62
Identities = 115/290 (39%), Positives = 172/290 (59%), Gaps = 35/290 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE++K + GA+G+VFL RK T TG L+A+KVL+K +++K +E ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
VR +PF+V Y+F L+L+++Y++GG++++ L + ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGIV+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK--------------------------E 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
+ + +S GT +Y+APEI+ G HG A DWWS+GI++FE +TG PFT E
Sbjct: 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
Query: 922 IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
+ R + P PS + EAQDL+++ L DP +RLGA GA+E+
Sbjct: 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 5e-62
Identities = 93/276 (33%), Positives = 151/276 (54%), Gaps = 34/276 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+EIIK I +G+FG+V+L R+++ G L+ +K + +M K + E L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYL 803
+++++ SF + L +VMEY +GGDL ++K E+ + +L LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRD+KP N+ + +G +KL DFG+SK+ +++T+DL+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA----------------- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ VGTP YL+PE+ + Y +D WS+G +L+E T PF E+ +
Sbjct: 161 --------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
IL + P P PS S E ++L++ L DP +R
Sbjct: 213 LKILKGQYP-PI-PSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 7e-62
Identities = 107/287 (37%), Positives = 158/287 (55%), Gaps = 37/287 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DF++ + RG FG V + R++ TGD++A+KV+KK ++ + + ER+IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLHS 805
P++ + Y+F +DNLYLVMEY GGDL SLL R +ED+A+ Y+AELVLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+G VHRD+KP+N+LI GHIKL DFG + + ++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSA-----------------ARLTANKMV----- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESP 919
N VGTPDY+APE+L +G DWWS+G+I +E I G PF +
Sbjct: 159 ----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
Query: 920 EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
++NI+N R + +P P +S + DLI L+ +RLG G
Sbjct: 215 AKTYNNIMNFQRFLKFPEDPK-VSSDFLDLIQS-LLCGQKERLGYEG 259
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 9e-62
Identities = 114/284 (40%), Positives = 166/284 (58%), Gaps = 40/284 (14%)
Query: 692 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+K + +G+FG+VFL RK T G L+A+KVLKK + + D R ER+IL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPF 59
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLG 807
+V+ Y+F LYL++++L GGDL++ L K V EEDV + Y+AEL LAL++LHSLG
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG 118
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I++RDLKP+N+L+ +GHIKLTDFGLSK + D
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----------------------------ESID 150
Query: 868 NRNR-HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ + +S GT +Y+APE++ H +ADWWS G+++FE +TG PF + + I
Sbjct: 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
L K+ +P +S EAQ L+ +P RLGA +G E+
Sbjct: 211 LKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEI 251
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 4e-61
Identities = 103/269 (38%), Positives = 161/269 (59%), Gaps = 31/269 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
+ +G+FG+V LAR + +G L+A+KVLKK +++ +D+E + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F D L+ VME++NGGDL ++K +E AR Y AE+ AL +LH GI++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ H+GH KL DFG+ K G+ N G S +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFN-----------GKTTS----------------T 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 933
GTPDY+APEIL +G + DWW++G++L+E + G PF AE+ + +F+ ILN ++ +
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
Query: 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P+ +S +A D++ F+ +P RLG+
Sbjct: 216 ---PTWLSQDAVDILKAFMTKNPTMRLGS 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 7e-61
Identities = 102/278 (36%), Positives = 153/278 (55%), Gaps = 36/278 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 745
F + + RG FG+V LA + TG+L+AIK LKK D+I ++++E ++ E+ I T R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+PF+V F F D++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IV+RDLK DNLL+ +G +K+ DFGL K +G+ D
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------------EGMGFGD-------- 156
Query: 866 TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
R S GTP++LAPE+L T + A DWW +G++++E + G PF + E +FD
Sbjct: 157 -----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+I+N ++ +P +S EA ++ R L +P +RLG+
Sbjct: 212 SIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGS 246
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 1e-60
Identities = 102/273 (37%), Positives = 154/273 (56%), Gaps = 31/273 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751
K + +G+FG+V LA + T + FAIK LKK ++ +D+E + ER +L +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +F +++L+ VMEYLNGGDL ++ G +E AR Y AE++ L++LH GI++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------------KA 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL G ++ + DWWS G++L+E + G PF E + +FD+ILN
Sbjct: 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DR 212
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
P P +S EA+D +++ DP +RLG +G
Sbjct: 213 PH--FPRWISKEAKDCLSKLFERDPTKRLGVDG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 2e-60
Identities = 88/154 (57%), Positives = 120/154 (77%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
SI++F I+KPISRGAFG+V+L RK+ L+A+KV+KK DMI KN + ++ AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
++PF+V +YS +N+YLVMEYL GGD+ SLL G +E++A YI+E+ LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838
GI+HRDLKPDN+LI+++GHIKLTDFGLSK+ L
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 6e-60
Identities = 96/270 (35%), Positives = 161/270 (59%), Gaps = 31/270 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+V LA + T +++AIKVLKK +++ +D++ + E+ IL + ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F +D L+ VMEY+NGGDL +++ +E +R Y AE+ LAL +LH G+++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+L+ +GH KL DFG+ K G++N
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--------------------------- 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL E+G + DWW++G++++E + G PPF A++ + +F++IL+ +
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
+P +S EA ++ F+ +PN+RLG
Sbjct: 214 LYPVW---LSKEAVSILKAFMTKNPNKRLG 240
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 1e-59
Identities = 95/279 (34%), Positives = 144/279 (51%), Gaps = 38/279 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
FEI++ I +G FG V+ AR + TG AIKV+K + K E+I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSL 806
+V+++ S+ +D L++VME+ +GG L LL+ L E EL+ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI+HRD+K N+L+ DG +KL DFGLS Q +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------QLS 149
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 925
D + R++ VGTP ++APE++ G + Y AD WS+GI E G PP++ P + +F
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-- 207
Query: 926 ILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGA 962
P + + S E +D + + L +P +R A
Sbjct: 208 -KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 4e-59
Identities = 101/271 (37%), Positives = 160/271 (59%), Gaps = 31/271 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA++++ G +A+KVL+K +++K + I+AERN+L+ +++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF + LY V++Y+NGG+L+ L++ C E AR Y AE+ A+ YLHSL I++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +G+ P +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGVEPEE------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNIL++ +
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+P + A DL+ L D +RLGA
Sbjct: 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 4e-59
Identities = 109/278 (39%), Positives = 160/278 (57%), Gaps = 35/278 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVR 751
I +G FG+V+ RK+ T ++A+KVL K +++ K ++ + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+SF +LYLV +Y++GG+L+ L+K G ED A+ YIAELVLALE+LH IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GHI L DFGLSK L TDN+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---------------------------TDNKTT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929
++ GT +YLAPE+LL E GY D+WS+G+++FE G PF AE + ++ NI
Sbjct: 154 NTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
K+ +P + +S E + + L +P RLGA+ A
Sbjct: 213 KVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAV 248
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 5e-59
Identities = 109/294 (37%), Positives = 174/294 (59%), Gaps = 42/294 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 743
+FE++K + GA+G+VFL RK + +G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 744 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+R +PF+V Y+F L+L+++Y+NGG+L++ L + +E +IY E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------E 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE--- 917
+ + + +S GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT +
Sbjct: 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
Query: 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
S I IL + P+ P +MS A+D+I R L+ DP +RLG + A E+
Sbjct: 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEI 265
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 106/285 (37%), Positives = 160/285 (56%), Gaps = 32/285 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEYLHS +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFI 975
+ P +S EA+ L+ L DP QRLG + A EV + F+
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-58
Identities = 102/275 (37%), Positives = 159/275 (57%), Gaps = 35/275 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L + +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--IYIAELVLALEYLHSLGIV 809
+ +F ++NL+ VMEYLNGGDL ++ C + D+ R Y AE++ L++LHS GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
+RDLK DN+L+ DGHIK+ DFG+ K ++ DA +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENML----------------GDAKTCTF------ 156
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929
GTPDY+APEILLG ++ + DWWS G++L+E + G PF E +F +I
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--- 208
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
++ PC P ++ EA+D++ + + +P +RLG G
Sbjct: 209 RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 201 bits (511), Expect = 2e-57
Identities = 109/284 (38%), Positives = 161/284 (56%), Gaps = 32/284 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L R++ +G +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
YSF +D L VMEY+NGG+L+ L + ED R Y AE+V AL+YLHS IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ TD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------TDAATMK 153
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
+ P +S +A+ L++ LI DPN+RLG + A E+ F
Sbjct: 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 201 bits (511), Expect = 5e-57
Identities = 114/292 (39%), Positives = 169/292 (57%), Gaps = 35/292 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS+G +HRD+KPDN+L+ GH+KL DFG +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----------KMNKEGMVRCD----- 201
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 919 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
+ I+N K + +P +D+S EA++LI FL D RLG NG E+
Sbjct: 252 LVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEI 301
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 3e-56
Identities = 105/271 (38%), Positives = 158/271 (58%), Gaps = 31/271 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LAR + +A+KVL+K +++K + + I++ERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+SF D LY V++Y+NGG+L+ L++ C E AR Y AE+ AL YLHSL IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GHI LTDFGL K + I N
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---------------ENIEH------------NGTT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + + ++DNILN+
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-- 211
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P P +++ A+ L+ L D +RLGA
Sbjct: 212 PLQLKP-NITNSARHLLEGLLQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 104/287 (36%), Positives = 153/287 (53%), Gaps = 36/287 (12%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERI 734
K + +DF I+ + G+FGRV LA + D AIK +K +I++ ++ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
+ER IL + +PF V + SF LYLV+E++ GG+ ++ LR+ DV Y A
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
++VL EYL SL IV+RDLKP+NLL+ DG IK+TDFG +K+
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------------------ 180
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
D R ++ GTP+Y+APEILL HG AADWW++GI ++E + G PPF
Sbjct: 181 -----------VDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
A P +I+ IL I + P + + L+ + L HD +R G
Sbjct: 229 YANEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYG 272
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-55
Identities = 116/289 (40%), Positives = 164/289 (56%), Gaps = 35/289 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFEIIK I RGAFG V + + + T ++A+K+L K +M+++ + ERN+L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ Y+F + LYLVM+Y GGDL +LL K L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + + DG + S
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQ----------DGTVQSSV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYA-----ADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
+ I+N + +P +D+S EA+DLI R LI +RLG NG +
Sbjct: 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIED 262
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 4e-55
Identities = 93/272 (34%), Positives = 133/272 (48%), Gaps = 66/272 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ G FG V+LAR + TG AIK++KK D + +E +L E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F ++LYLVMEY GG L LL++ G L ED + +++ LEYLHS GI+HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 814 KPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
KP+N+L+ D G +KL DFGLSK+ +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL---------------------------TSDKSLLK 151
Query: 873 SAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ VGTP Y+APE+LLG + +D WS+G+IL+E
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE------------------------- 186
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
+ E +DLI + L DP +R A
Sbjct: 187 --------LP-ELKDLIRKMLQKDPEKRPSAK 209
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 7e-55
Identities = 114/286 (39%), Positives = 166/286 (58%), Gaps = 35/286 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+DFEI+K I RGAFG V + + + +FA+K+L K +M+++ + ER++L+ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
L VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLME----------DGTVQSSV------- 162
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 921 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ I+N K +P +D+S +A+DLI R LI RLG NG
Sbjct: 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNG 259
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 4e-54
Identities = 108/285 (37%), Positives = 159/285 (55%), Gaps = 33/285 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHR 811
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATM 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRL--GANGAAEVFHCKIF 974
+ P +S EA+ L++ L DP QRL G + A E+ K F
Sbjct: 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 6e-54
Identities = 99/271 (36%), Positives = 155/271 (57%), Gaps = 31/271 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 751
K I +G+FG+V LA+++ G +A+KVL+K ++ + + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
YSF + LY V++++NGG+L+ L++ E AR Y AE+ AL YLHS+ IV+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP+N+L+ GH+ LTDFGL K +GI SD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIAQSD------------TT 153
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTP+YLAPE++ + DWW +G +L+E + G+PPF ++DNIL++ +
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ S A ++ L D +RLGA
Sbjct: 214 ---VLRPGASLTAWSILEELLEKDRQRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 7e-54
Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 35/288 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D++++K I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+VV+ F +F LY+VMEY+ GGDL +L+ + E A+ Y AE+VLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G++HRD+KPDN+L+ GH+KL DFG M D +T
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC-------------------MKMD-------ET 195
Query: 867 DNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+AVGTPDY++PE+L +G DWWSVG+ LFE + G PF A+S
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255
Query: 923 FDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEV 968
+ I++ K P D +S A++LI FL D RLG NG E+
Sbjct: 256 YSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEI 301
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 95/273 (34%), Positives = 157/273 (57%), Gaps = 31/273 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 751
K + +G+FG+V LA + G+ FA+K LKK ++ +D+E + E+ +L + NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
+ +F +++L+ VME+LNGGDL ++ G + A Y AE+V L++LHS GI++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLK DN+++ DGHIK+ DFG+ K + DNR
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG--------------------------DNRAS 154
Query: 872 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
+ GTPDY+APEIL G ++ ++ DWWS G++L+E + G PF + + +F++I ++
Sbjct: 155 -TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RV 210
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
P P ++ E++D++ + DP +RLG G
Sbjct: 211 DTPHYPRWITKESKDILEKLFERDPTRRLGVVG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 2e-53
Identities = 97/281 (34%), Positives = 156/281 (55%), Gaps = 31/281 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K + DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----------DGV------------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PF E + +F +I
Sbjct: 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
+ + + P MS EA + + P +RLG E
Sbjct: 214 MEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 251
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 96/279 (34%), Positives = 157/279 (56%), Gaps = 40/279 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
I RG++ +V L + T ++A+KV+KK + DI+ + E+++ T N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+ V+E+++GGDL +++ L E+ AR Y AE+ LAL +LH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ +GHIKLTD+G+ K +GI P D +
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCK---------------EGIRPGDT------------TST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESPE-----IIFD 924
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF +++P+ +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
IL ++I +P +S +A ++ FL DP +RLG +
Sbjct: 216 VILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCH 251
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-52
Identities = 101/300 (33%), Positives = 163/300 (54%), Gaps = 37/300 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 746
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
GI++RDLK DN+++ +GHIK+ DFG+ K ++ DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----------DGV------------- 156
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE------VFHCKIFIKKTEN 980
+ + + P +S EA + + P++RLG E F +I K EN
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 3e-51
Identities = 94/299 (31%), Positives = 149/299 (49%), Gaps = 40/299 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D E +K + +G+ G V+ R + TG ++A+K + + +++L E L + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCES 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 805
P+VV+ + +F + +V+EY++GG L LL+KVG + E V +++ L+YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP NLLI G +K+ DFG+SK+ + NT+D
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD--------------------- 155
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII-- 922
++ VGT Y++PE + G + YAAD WS+G+ L E G PF P
Sbjct: 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 923 FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980
I + P P + S E +D I+ L DP +R AAE+ FIKK +N
Sbjct: 212 MQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHP-FIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 31/273 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRD 812
+F +D+L LVM +NGGDL + VG E A Y A+++ LE+LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LKP+N+L+ G+++++D GL+ ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA-----------------------VELKGGKKI-----K 152
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GTP Y+APE+L G + ++ DW+++G L+E I G PF ++ + + R +
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 933 WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG 964
P S EA+DL L DP +RLG G
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-50
Identities = 95/273 (34%), Positives = 140/273 (51%), Gaps = 30/273 (10%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G FG+V+ A TG+L A+K ++ D K I+ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
R+ +Y+ MEY +GG L LL L+E V R+Y +L+ L YLHS GIVHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
P N+ + H+G IKL DFG + + + E Q S
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK----------------LKNNTTTMGEEVQ-------SL 163
Query: 875 VGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNILNR 929
GTP Y+APE++ G + HG AAD WS+G ++ E TG P++ E I+F
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
K P P +S E +D ++R L DP +R A
Sbjct: 224 KPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTA 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 8e-50
Identities = 88/273 (32%), Positives = 141/273 (51%), Gaps = 34/273 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
++ ++ I GA G V+ A R TG AIK ++ +RK + E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 806
+V ++ S+ D L++VMEY++GG L ++ V E +A + E++ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K DN+L++ DG +KL DFG + L+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQ--------LT-------------------K 168
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ R+S VGTP ++APE++ ++G D WS+GI+ E G PP+ E P I
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ IP P S E +D +N+ L+ DP +R
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-49
Identities = 98/277 (35%), Positives = 157/277 (56%), Gaps = 40/277 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753
I RG++ +V L R + T ++A+KV+KK + DI+ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ +GHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCK---------------EGLRPGDT------------TST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESP-----EIIFD 924
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF ++++P + +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IL ++I +P +S +A ++ FL DP +RLG
Sbjct: 216 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLG 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-49
Identities = 98/275 (35%), Positives = 155/275 (56%), Gaps = 38/275 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 753
I RG++ +V L R + ++A+KV+KK + DI+ + E+++ NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813
F L+LV+EY+NGGDL +++ L E+ AR Y AE+ +AL +LH GI++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K DN+L+ DGHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK---------------EGLGPGD------------TTST 155
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--TAESPEI-----IFDNI 926
GTP+Y+APEIL G E+G++ DWW++G+++FE + G PF ++P++ +F I
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
L + I +P +S +A ++ FL DP +RLG
Sbjct: 216 LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLG 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 78/272 (28%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++++ I RGAFG V+ TGD AIK + I++ ++ I+ E ++L +++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V++ S D+LY+++EY G L +++K G E + +Y+ +++ L YLH G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
++HRD+K N+L DG +KL DFG++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL---------------------------NDV 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+++ S VGTP ++APE++ + A+D WS+G + E +TG PP+ +P I+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
P +P +S E +D + + DPN R
Sbjct: 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 91/291 (31%), Positives = 146/291 (50%), Gaps = 35/291 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F +++ I +G+FG V+ A + T + AIKV+ L+ +++IE I E L R+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEE-AEDEIEDIQQEIQFLSQCRS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P++ +++ SF L+++MEY GG LL K G L+E + E++L LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G +HRD+K N+L++ +G +KL DFG+S G + +T+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMS---------------------- 153
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977
P + S +D ++ L DP +R A E+ K FIKK
Sbjct: 211 PKNNPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHK-FIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 83/271 (30%), Positives = 132/271 (48%), Gaps = 32/271 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRF 752
+ G+FG V+ GD FA+K + D + ++++ E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+ DNLY+ +E + GG L LL+K G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K N+L+ +G +KL DFG++K Q +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK----------------------------QVVEFSFAK 159
Query: 873 SAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
S G+P ++APE++ +G AAD WS+G + E TG PP++ I K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P +P +S EA+D I + L DP+ R A
Sbjct: 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRPTA 249
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-46
Identities = 105/293 (35%), Positives = 150/293 (51%), Gaps = 42/293 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N 746
+ I++ + G+FG V+LAR R A+KVL K + ++ER L E IL ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYL 803
P +V+ + F +LYLVMEY++GG L LL+K G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 804 HSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
HS GI+HRD+KP+N+L+ DG +KL DFGL+K+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL---------------------LPDPG 156
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPFTAES- 918
+ ++VGTP Y+APE+LLG Y ++D WS+GI L+E +TG+PPF E
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 919 ---PEIIFDNILNRKIPWPCVPSDMSF------EAQDLINRFLIHDPNQRLGA 962
IL P P S A DL+ + L DP RL +
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 85/286 (29%), Positives = 143/286 (50%), Gaps = 47/286 (16%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D+E+++ I +G+FG V R+++ G + K + +M K + +++++E NIL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 748 FVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 801
+VR++ R N LY+VMEY GGDL L++K +EE+ + +L+LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 802 YLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
H+ ++HRDLKP N+ + + ++KL DFGL+KI
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------------- 159
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
D+ + VGTP Y++PE L + +D WS+G +++E PPFTA
Sbjct: 160 -------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 917 ESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ L KI + +P S E ++I L DP++R
Sbjct: 213 RNQL-----QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-43
Identities = 87/299 (29%), Positives = 141/299 (47%), Gaps = 43/299 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
DD+E+I+ I GA V+ A + AIK ++D+ + ++ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK---RIDLEKCQTSVDELRKEVQAMSQCN 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEY 802
+P VV+++ SF D L+LVM YL+GG L +++ G L+E + + E++ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS G +HRD+K N+L+ DG +K+ DFG+S A +
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-----------------------ASLAD 154
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 920
+ R + VGTP ++APE+ + HGY AD WS GI E TG P++ P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPEV-MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213
Query: 921 IIFDNILNRKIPWPCVPSDMSFEA-----QDLINRFLIHDPNQRLGANGAAEVFHCKIF 974
+ L P + + ++ + +I+ L DP++R A E+ K F
Sbjct: 214 KVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 92/308 (29%), Positives = 133/308 (43%), Gaps = 65/308 (21%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVR 745
++I+ I GA G VF A+ R TG+ A+K K+ + R + L E L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 804
+P+VV+ F LVMEY+ DL +LR L E + Y+ L+ + Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+ GI+HRDLKP NLLI+ DG +K+ DFGL++ + +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLAR-----------------LFSEEEPRLYSH 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES----- 918
Q V T Y APE+L G D W+VG I E + G P F E+
Sbjct: 160 Q---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
Query: 919 ---------------PE---------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 954
P I F ++ IP + D S EA DL+ L++
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKGLLVY 268
Query: 955 DPNQRLGA 962
DP++RL A
Sbjct: 269 DPSKRLSA 276
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 96/310 (30%), Positives = 142/310 (45%), Gaps = 67/310 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E ++ + G +G V+ AR + TG++ A+K ++ LD N+ E I L E ++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LD----NEEEGIPSTALREISLLKEL 55
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 803
++P +V+ LYLV EY + DL L K G L ++ + + +L+ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRDLKP N+LI DG +KL DFGL++ I P + E
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI---------------PLRTYTHE- 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 921
V T Y APEILLG++H A D WSVG I E ITG P F +S EI
Sbjct: 159 -----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EID 206
Query: 922 ----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHD 955
IF + +P + E DL+++ L ++
Sbjct: 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYN 266
Query: 956 PNQRLGANGA 965
P +R+ A A
Sbjct: 267 PAKRISAKEA 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 39/277 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F+I++ + G++G V+ A + TG + AIKV+ + D++ I+ E +IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
P++V+++ S+ +L++VMEY G D+ + K L E+ + + + LEYL
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYL 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS +HRD+K N+L+ +G KL DFG+S
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--------------------------- 148
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922
R++ +GTP ++APE++ + AD WS+GI E G PP++ P I
Sbjct: 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
F I N+ P P S E D + + L+ DP +R
Sbjct: 209 F-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 94/285 (32%), Positives = 132/285 (46%), Gaps = 48/285 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D+E+I+ I G +G V+ AR TG+L AIKV+K + +D E I E ++L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIA----ELVLA 799
P +V +F S+ RD L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L YLH G +HRD+K N+L+ DG +KL DFG+S + TI
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATI---------------- 155
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
R S +GTP ++APE + + GY D W++GI E PP
Sbjct: 156 ---------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 917 ESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQR 959
P I P P + S D I + L DP +R
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-41
Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 42/281 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 745
DF+++K + +G++G V+ ++ + +A LK++D+ + ER + E IL +V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-----EEDVARIYIAELVLAL 800
+P ++ + +F + L +VMEY GDL + K E+++ RI+I +L+ L
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGL 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ LH I+HRDLK N+L+ + +K+ D G+SK+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKV------------------------ 152
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ +GTP Y+APE+ G + Y +D WS+G +L+E T PPF A S +
Sbjct: 153 -----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
+ + K +P +P S + Q+ I L P R
Sbjct: 208 DLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 92/285 (32%), Positives = 141/285 (49%), Gaps = 33/285 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G EE+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
V+RDLKP+N+L+ GHI+++D GL+ + PE + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA----------VKIPEGESI------------- 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R R VGT Y+APE+L + + D+W +G +++E I G PF ++ + +
Sbjct: 159 --RGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
Query: 927 LNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
R + V + S EA+ + L DP QRLG GA EV
Sbjct: 214 DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-40
Identities = 88/285 (30%), Positives = 137/285 (48%), Gaps = 33/285 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G +E+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA-----------------------VEIPEGETI 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ + ++ DWW +G +++E I G PF ++ + +
Sbjct: 159 RGR-----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 927 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG--ANGAAEV 968
R S+ S A+ + + L DP RLG GA EV
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 32/272 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+F + +L LVM +NGGDL Y++ + E A Y A+++ LE+LH I++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RDLKP+N+L+ +DG+++++D GL+ E + ++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV--------------------------ELKDGQSKT 154
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
+ A GTP ++APE+L G E+ ++ D++++G+ L+E I PF A ++ + R
Sbjct: 155 KGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
Query: 931 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG 961
+ D S ++ L DP +RLG
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLG 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 100/316 (31%), Positives = 144/316 (45%), Gaps = 74/316 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 746
+E I I G +G+V+ AR + TG+L A LKK+ M + + I A R I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 747 PFVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 803
P +VR T + ++Y+V EY++ DL LL E + Y+ +L+ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS GI+HRD+K N+LI +DG +KL DFGL++ Y +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR-----------------------PYTKR 153
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
D NR V T Y PE+LLG T +G D WSVG IL E G P F +
Sbjct: 154 NSADYTNR---VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
Query: 920 -EIIFD-----NILNRKIPWPCVPSDMSF------------------------EAQDLIN 949
E IF+ N WP V S + + A DL++
Sbjct: 211 LEKIFELCGSPTDEN----WPGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265
Query: 950 RFLIHDPNQRLGANGA 965
+ L DP +R+ A+ A
Sbjct: 266 KLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 84/281 (29%), Positives = 138/281 (49%), Gaps = 36/281 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R+ +D+F I G+ G V +A ++TG A+K K+D+ ++ E + E I+
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMR 71
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 801
++P +V + S+ D L++VME+L GG L ++ EE +A + VL AL
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALS 129
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+LH+ G++HRD+K D++L+ DG +KL+DFG + +P
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-------------QVSKEVP------ 170
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 --------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I + P +S + ++R L+ DP QR A
Sbjct: 223 AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATA 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 90/282 (31%), Positives = 137/282 (48%), Gaps = 33/282 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G EE A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ H PE Q
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-----------------------VHVPEGQTI 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ + ++ DWW++G +L+E I G PF +I + +
Sbjct: 159 KGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 927 --LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
L +++ S +A+ L L DP +RLG G
Sbjct: 214 ERLVKEVQEE-YSEKFSPDARSLCKMLLCKDPKERLGCQGGG 254
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 94/283 (33%), Positives = 139/283 (49%), Gaps = 41/283 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF---TAESPEIIFDNIL 927
H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF + I L
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEV 968
+ P S E + L+ L D N+RLG GA EV
Sbjct: 213 TMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 29/273 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 750
K + +GAFGRV+L TG A+K + K ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+++ + L + MEY+ GG + L+ G L E V R Y +++ +EYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RD+K N+L G++KL DFG SK TI SG T +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK---RLQTICSSG------------------TGMK- 165
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNR 929
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 166 --SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IAT 221
Query: 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ P +PS +S +A++ + R + + +R A
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSA 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 87/308 (28%), Positives = 143/308 (46%), Gaps = 62/308 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITVRN 746
++ + I G +G V+ AR + TG++ AIK K+ + +++ A R I L + +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 805
P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + HS
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GI+HRDLKP+NLLI +G +KL DFGL++ Y Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS----------------FGSPVRPYTHY-- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES------ 918
V T Y APE+LLG + D WSVG I E ++ P F +S
Sbjct: 159 ---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 919 --------------PEII---FDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPN 957
P+ + + +P P + + S +A DL+++ L +DP+
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 958 QRLGANGA 965
+R+ A A
Sbjct: 270 KRITAEQA 277
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 34/234 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVR 745
+E++ + GA+G V R + TG++ AIK K+ + ++K L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQLR 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ +V +F + LYLV EY+ L L G L D R YI +L+ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP+N+L++ G +KL DFG ++ L + +Y
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRA-------RPASPLTDY-- 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y APE+L+G T +G D W++G I+ E + G P F +S
Sbjct: 162 ---------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 92/282 (32%), Positives = 145/282 (51%), Gaps = 43/282 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD E + + G G V R TG + A+K ++ L+ I + ++IL E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LE-INEAIQKQILRELDILHKCNS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDV-ARIYIAELVLALEYLH 804
P++V F+ +F ++ + MEY++GG L +L++V G + E + +I +A ++ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I+HRD+KP N+L+ G IKL DFG+S L+N+
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAK------------------- 157
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--SPEI 921
+ VGT Y+APE + G ++ +D WS+G+ L E TG P+ E P+
Sbjct: 158 ---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 922 IFD---NILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 959
IF+ I+N P P +PS S + QD +N LI DP +R
Sbjct: 209 IFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRER 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 90/291 (30%), Positives = 138/291 (47%), Gaps = 33/291 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
VV Y++ +D L LV+ +NGGDL + +G +E A Y AEL LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA-----------------------VQIPEGETV 158
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
R VGT Y+APE++ ++ ++ DWW +G +++E I G PF + + +
Sbjct: 159 RGR-----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
Query: 927 LNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIF 974
R K S +A+ + L +P +RLG NGAA V IF
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 83/275 (30%), Positives = 139/275 (50%), Gaps = 34/275 (12%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
DFEI+ I +G+FG VF ++ ++A+K + M R+ + E + E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSS 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLH 804
+++R++ SF + L +VMEY GDL+ LL R E+ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S I+HRD+K NL + ++K+ D G++K+ L +NT +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTN-------------------FA 158
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
T VGTP YL+PE+ + +D W++G++L+E TG PF A + +
Sbjct: 159 NT-------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I+ +P V S + LI++ L D QR
Sbjct: 212 KIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 85/313 (27%), Positives = 141/313 (45%), Gaps = 64/313 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITVRN 746
+E++KPI GA+G V A + TG AIK K+ + + I+ RIL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 747 PFVVR---FFY--SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
++ S +++Y+V E + DL+ +++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLHS ++HRDLKP N+L+ + +K+ DFGL++ + + G +
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-------EDEKGFLT------ 164
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP- 919
EY V T Y APE+LL + A D WSVG I E +T P F
Sbjct: 165 EY-----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 920 ---EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRFL 952
+I + I + K P + S EA DL+ + L
Sbjct: 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273
Query: 953 IHDPNQRLGANGA 965
+ DP +R+ A+ A
Sbjct: 274 VFDPKKRITADEA 286
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 96/285 (33%), Positives = 144/285 (50%), Gaps = 45/285 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
Y+F D L +++ +NGGDL+ L + G E R Y E++L LE++H+ +V+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF----TAESPEIIFDNI 926
H++VGT Y+APE+L GT + +ADW+S+G +LF+ + G PF T + EI D +
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRM 210
Query: 927 -LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEV 968
L + +P S E + L+ L D ++RLG GA EV
Sbjct: 211 TLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 32/272 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V + + TG ++A K L K + +K+ + L E+ IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 812
+F + +L LVM +NGGDL + VG ++ R+ Y A++ + +LHS+ IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+KP+N+L+ G+ +L+D GL+ + + R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA-----------------------VELKDGKTITQR--- 154
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
GT Y+APEIL + Y DW+++G ++E + G PF ++ + + R +
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 933 WPCVPSDMSF--EAQDLINRFLIHDPNQRLGA 962
+F E++D+ FL P RLG+
Sbjct: 213 DEVKFEHQNFTEESKDICRLFLAKKPEDRLGS 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 36/280 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
D +EII + GAFG+V+ A+ + TG A K++ + + ++E + E +IL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 804
+P +V + ++ + L++++E+ +GG L S++ ++ L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
T + R + +GTP ++APE++ + Y AD WS+GI L E PP +P
Sbjct: 155 STLQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ IL + P PS S D + L+ DP+ R
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 88/289 (30%), Positives = 131/289 (45%), Gaps = 47/289 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
FE+++ I G +G+V+ AR + TG L AIK++ I +++ E I E NIL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 747 -PFVVRFFYSF------TCRDNLYLVMEYLNGG---DLYSLLRKVG-CLEEDVARIYIAE 795
P + F+ +F D L+LVME GG DL LRK G L+E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ L YLH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITG 910
+ T R R++ +GTP ++APE++ E + +D WS+GI E G
Sbjct: 162 ------QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PP P I P P + S + D I+ LI + QR
Sbjct: 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR 263
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 78/273 (28%), Positives = 138/273 (50%), Gaps = 37/273 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 751
I RGA+G V+ + TG + A+K++ LD +D+ I E +L +R P + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
++ S+ L+++MEY GG + +L+ K G + E + I E+++AL+Y+H +G++HR
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125
Query: 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 871
D+K N+L+ + G++KL DFG++ Q ++ R
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAA--------------------------LLNQNSSK-R 158
Query: 872 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930
+ VGTP ++APE++ G + AD WS+GI ++E TG PP++ I K
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218
Query: 931 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGA 962
P + + S ++ + L +P +RL A
Sbjct: 219 PPR--LEDNGYSKLLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 5e-35
Identities = 93/308 (30%), Positives = 137/308 (44%), Gaps = 68/308 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITV-R 745
+++IK + G FG V+LAR + TG+L AIK +KK + E + R + L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYL 803
+P +V+ F D LY V EY+ G +LY L+ RK E V R I +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H G HRDLKP+NLL++ +K+ DFGL++ E P Y +Y
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPP----YTDY 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF--TAESPE 920
V T Y APEILL T + D W++G I+ E T P F ++E +
Sbjct: 159 -----------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 921 I--IFD-----------------NILNRKIPWPCVPSDMSF-------EAQDLINRFLIH 954
+ I + L + P P+ + EA DLI L
Sbjct: 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 955 DPNQRLGA 962
DP +R A
Sbjct: 267 DPKKRPTA 274
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 93/306 (30%), Positives = 133/306 (43%), Gaps = 63/306 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E K + G + V+ AR + TG + AIK +K + RK + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYL 803
++P ++ F + N+ LV E++ DL +++ K L + Y+ + LEYL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRDLKP+NLLIA DG +KL DFGL++ S
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----------------SFGS------- 154
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP--- 919
NR V T Y APE+L G H G D WSVG I E + +P +S
Sbjct: 155 ---PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211
Query: 920 -EIIFDNILNRKIP--WPCVPSDMSF--------------------EAQDLINRFLIHDP 956
IF L WP V S + +A DL+ R L +P
Sbjct: 212 LGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 957 NQRLGA 962
N+R+ A
Sbjct: 271 NKRITA 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 91/286 (31%), Positives = 146/286 (51%), Gaps = 44/286 (15%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
RT +D+F IK I G+ G V +A +++G L A+K K+D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ VV + S+ D L++VME+L GG L ++ EE +A + +A L AL
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALSV 131
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ G++HRD+K D++L+ HDG +KL+DFG ++ +
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEV------------------- 170
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
Query: 920 -EIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
++I DN+ + K PS F ++R L+ DP QR A
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGF-----LDRLLVRDPAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 85/268 (31%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AIK + +K E I+ E ++ ++P +V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P +S +D +NR L D +R A
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSA 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 36/282 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ +F+I K I +G F V+ A G + A+K ++ +M+ + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALE 801
+P V+++ SF + L +V+E + GDL +++ + E Y +L ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++HS I+HRD+KP N+ I G +KL D GL + S T
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAA--------- 163
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 164 ----------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 922 --IFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRL 960
+ I K +P +P+D S E +DL++R + DP +R
Sbjct: 214 YSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITV 744
E+ K + GAFG V+ + G+ A+K LK+ + E L E +I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA-ELVLAL 800
+P +VR T + LY+V EY+ GGDL LRK G L++ + +A ++ +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGM 115
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD----------------IYEDD--- 156
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
Y++ ++APE L + +D WS G++L+E T G P+ S
Sbjct: 157 -YYRKRGG-----GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E + + + + P P + E +L+ + +DP R
Sbjct: 211 EEVLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 96/310 (30%), Positives = 151/310 (48%), Gaps = 65/310 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRN- 746
+EI++ + +GA+G V+ A R T ++ A+K K D R D +R E L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYL 803
P +V+ ++ +YLV EY+ DL++++R LE DV + YI +L+ AL+Y+
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NILE-DVHKRYIMYQLLKALKYI 123
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID-LSGPETDGIMPSDAHYPE 862
HS ++HRDLKP N+L+ D +KL DFGL++ ++ L + ++ +
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPVLT------D 171
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG---------- 910
Y V T Y APEILLG+ Y D WSVG IL E + G
Sbjct: 172 Y-----------VATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 911 ---------IPPFTAE------SP--EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFL 952
I P +AE SP + D++ +R P + S +A DL+ + L
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 953 IHDPNQRLGA 962
+ +PN+RL A
Sbjct: 280 VFNPNKRLTA 289
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 82/275 (29%), Positives = 138/275 (50%), Gaps = 36/275 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRN 746
+ I+ + +GAFG L R+ L V K++++ R ++ ER A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 804
P ++ ++ F + L + MEY NGG LY + +K EE++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
GI+HRD+K N+ + G IKL DFG+SKI + S+ E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-----------------LGSEYSMAE-- 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ VGTP Y++PE+ G ++ + +D W++G +L+E +T F A +P +
Sbjct: 160 --------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I+ + V S S E L++ L DP +R
Sbjct: 212 KIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 74/279 (26%), Positives = 144/279 (51%), Gaps = 36/279 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 746
+ +K I G+FG+ L + + G + V+K++++ + + ER + + + + +++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQY---VIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 804
P +V++ SF NLY+VM+Y GGDLY + ++ ED + ++ LAL+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+K N+ + DG IKL DFG++++ +N+T++L+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA------------------ 158
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ +GTP YL+PEI + +D W++G +L+E T F A + + +
Sbjct: 159 -------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
I+ +P V S S++ ++L+++ +P R N
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 92/320 (28%), Positives = 134/320 (41%), Gaps = 88/320 (27%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR-- 745
+E + I GA+G V+ AR TG A LKK+ + L+E I L T+R
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVA---LKKVRVP--------LSEEGIPLSTLREI 49
Query: 746 ----------NPFVVRFF-YSFTCRDN----LYLVMEYLNGGDLYSLLRKV---GCLEED 787
+P +VR R + L LV E+++ DL + L K G L +
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPE 107
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ + +L+ +++LHS IVHRDLKP N+L+ DG +K+ DFGL++I
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI----------- 156
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
Y + S V T Y APE+LL + + D WSVG I E
Sbjct: 157 ------------Y-----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
Query: 908 ITGIPPFTAESPEI-----IFDNI---------LNRKIPWPCVPS-----------DMSF 942
P F S E IFD I N +P PS ++
Sbjct: 200 FRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICE 258
Query: 943 EAQDLINRFLIHDPNQRLGA 962
E DL+ + L +P++R+ A
Sbjct: 259 EGLDLLKKMLTFNPHKRISA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 84/283 (29%), Positives = 145/283 (51%), Gaps = 38/283 (13%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R+ ++++ IK I G+ G V +AR++ +G A+K++ D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR 73
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 801
++ VV + S+ + L+++ME+L GG L ++ + EE +A + E VL AL
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALC 131
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHY 860
YLHS G++HRD+K D++L+ DG +KL+DFG ++I
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------------------------ 167
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
D R S VGTP ++APE++ T +G D WS+GI++ E + G PP+ ++SP
Sbjct: 168 ----SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
+ + P +S +D + R L +P +R A
Sbjct: 224 QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQ 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 48/282 (17%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ K + GAFG V+ + A+K LK+ + IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 798
+P VV+ T + LY+VMEY+ GGDL S LRK ++ +++L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL--------------------- 152
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917
+ R + ++APE L + +D WS G++L+E T G P+
Sbjct: 153 --YDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
S E + + + N P + E DL+ + DP R
Sbjct: 208 SNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 86/280 (30%), Positives = 139/280 (49%), Gaps = 36/280 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EII + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +P+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPY 70
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLG 807
+V+ +F L++++E+ GG + +++ ++ L E ++ +++ AL+YLHS+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLK N+L+ DG IKL DFG+S N L
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTL---------------------- 164
Query: 868 NRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+ R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P +
Sbjct: 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I + P PS S E +D + L P R A
Sbjct: 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSA 263
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 690 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ K + GAFG V+ A+K LK+ IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY-----IAELVLAL 800
+P +V+ T + L +VMEY+ GGDL LRK E ++ + IA +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---GM 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL----------------------- 153
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
+ + + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 154 YDDDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + P + E L+ + DP R
Sbjct: 211 AEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 84/265 (31%), Positives = 130/265 (49%), Gaps = 31/265 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +NP +V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 176
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P I P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQR 959
P +S +D +NR L D +R
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 693 KPISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + GAFG V+ + K A+K LK+ + + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNV 58
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---------AL 800
VR T + LYLV+EY+ GGDL LRK + + ++ L +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYL S VHRDL N L+ D +K++DFGLS+ ++ T G +P
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLP----- 170
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
R ++APE L +D WS G++L+E T G P+ S
Sbjct: 171 -------IR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E + + + P P E +L+ DP R
Sbjct: 214 EEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 86/265 (32%), Positives = 131/265 (49%), Gaps = 31/265 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G VF A TG AIK ++++ ++ E I+ E ++ ++NP +V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIK---QINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
SF D L++VMEYL GG L ++ + C++E E + ALE+LH+ ++HRD+K
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQR 959
P +S +D +NR L D +R
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 31/265 (11%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +GA G V+ A TG AIK ++++ ++ E I+ E ++ +NP +V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 814
S+ D L++VMEYL GG L ++ + C++E E + AL++LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQR 959
P +S +D +NR L D ++R
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 90/291 (30%), Positives = 138/291 (47%), Gaps = 43/291 (14%)
Query: 689 FEIIKP--ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL-------AERN 739
F+ +K I +G +GRV+LA TTG++ A+K ++ I R +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L + + +V++ T + L + +EY+ GG + S LR G EE + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L YLHS GI+HRDLK DNLL+ DG K++DFG+SK SD
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-------------------KSDDI 161
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF-TA 916
Y DN S G+ ++APE++ GY+A D WS+G ++ E G P+
Sbjct: 162 Y------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
Query: 917 ESPEIIFDNILNRKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGAN 963
E+ +F L K P +P D +S A D +N +P+ R A
Sbjct: 216 EAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 79/275 (28%), Positives = 138/275 (50%), Gaps = 37/275 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIK------VLKKLDMIRKNDIERILAERNILITVRNPF 748
I G+FG V+L ++G+L A+K V +++ ++ + E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+V++ S D+L + +EY+ GG + +LL G EE + R ++ +++ L YLH+ GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L+ + G IK++DFG+SK N+ N
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---------------------TKTN 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF---D 924
R S G+ ++APE++ T + AD WS+G ++ E +TG PF + IF +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
N P +PS++S EA D + + D N+R
Sbjct: 227 NAS------PEIPSNISSEAIDFLEKTFEIDHNKR 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTG-DLFAIK-------VLKKLDMIRKNDIERILAERNI 740
+ +++ + GAFG V+ RK+ G +L A+K K R I I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 741 LI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG---GDLYSLLRKVG--CLEEDVARIYIA 794
+ +R+P +VR++ +F D LY+VM+ + G G+ ++ L++ EE + I++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 795 ELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
++VLAL YLH IVHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
Q+ S VGT Y PEI+ +G AD W+ G IL++ T PP
Sbjct: 163 ----------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 959
F + + + I+ + +P M S + D+I L D R
Sbjct: 213 FYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 36/273 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG V+ T ++ AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+ R++ S+ L+++MEYL GG LL K G LEE + E++ L+YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926
+ R++ VGTP ++APE++ + + + AD WS+GI E G PP + P ++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--L 212
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P P + S ++ + L DP R
Sbjct: 213 IPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR 244
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 83/233 (35%), Positives = 119/233 (51%), Gaps = 29/233 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 745
+ FE++ + GA+G V R + T ++ AIK K D ++ E L E +L T++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+V +F R LYLV EY+ L L + + R YI +L+ A+ + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
IVHRD+KP+NLLI+H+ +KL DFG ++ +LS +G S+A+Y EY
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS----EG---SNANYTEY-- 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y +PE+LLG +G A D WSVG IL E G P F ES
Sbjct: 162 ---------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 98/338 (28%), Positives = 143/338 (42%), Gaps = 110/338 (32%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI------LAER 738
S+D++E + I G +G V+ AR + TG++ A LKKL K + E+ L E
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVA---LKKL----KMEKEKEGFPITSLREI 55
Query: 739 NILITVRNPFVVRFFYSFTCR--------DNLYLVMEYLNGGDLYSLLR---------KV 781
NIL+ +++P +V T + D +Y+VMEY+ DL SL+ +V
Sbjct: 56 NILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 782 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
CL + +L+ + +LH I+HRDLK NLL+ + G +K+ DFGL++
Sbjct: 109 KCL--------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------ 154
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 900
EY + V T Y APE+LLG E+ A D WSV
Sbjct: 155 --------------------EYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 901 GIILFEFITGIPPFTAESP----EIIFD-----------------------------NIL 927
G I E +T P F +S IF N L
Sbjct: 194 GCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+K P +S DL+NR L +DP +R+ A A
Sbjct: 254 RKKFP----ALSLSDNGFDLLNRLLTYDPAKRISAEDA 287
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 86/314 (27%), Positives = 134/314 (42%), Gaps = 71/314 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
++I+ I G F V A+ R TG +AIK +KK +E++ R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 746 NPFVVRF----FYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLAL 800
+P ++R F T R L LV E ++ +LY L++ + L E + Y+ +L+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+++H GI HRD+KP+N+LI D +KL DFG + I P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR------GIYSKPP-----------Y 155
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE-- 917
EY + T Y APE LL +G D W+VG + FE ++ P F
Sbjct: 156 TEY-----------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 918 --------------SPEIIFD----NILNRKIP------WPCVPSDMSFEAQDLINRFLI 953
E++ +N P + + S E DL+ + L
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA 264
Query: 954 HDPNQRLGANGAAE 967
+DP++R+ A A
Sbjct: 265 YDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 35/277 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILITVRNPFVVR 751
+ GAF + AR TG L A+K + + +E + E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 752 FFYSFTCRDNLY-LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
TC D+ + L +E++ GG + LL K G +E V Y +L+ L YLH I+H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 811 RDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
RD+K NLLI G +++ DFG + + +G E G +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAG-EFQGQL--------------- 168
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 925
+GT ++APE+L G ++G + D WSVG ++ E T PP+ AE +IF
Sbjct: 169 -----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-K 222
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I + P +P +S +D+ R L P R +
Sbjct: 223 IASATTA-PSIPEHLSPGLRDVTLRCLELQPEDRPPS 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 50/288 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV--LKKLDMIRKNDIERILAERNILITV 744
+D E I + G G V + TG + A KV + +RK +IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIMHEC 60
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
R+P++V F+ +F +N+ + ME+++ G L + +K G + ++ +V L YL+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+ I+HRD+KP N+L+ G IKL DFG+S LIN+ D
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 916
+ VGT Y++PE + G ++ +D WS+GI + E G PF
Sbjct: 161 ---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 917 -ESPEIIFD---NILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQR 959
+ P I D I+ P P +PS D + +D ++ L+ DP +R
Sbjct: 212 QDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 85/280 (30%), Positives = 138/280 (49%), Gaps = 34/280 (12%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +D F IK I G+ G V +A ++ TG A+K K+D+ ++ E + E I+
Sbjct: 21 REYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMR 74
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ VV + S+ D L++VME+L GG L ++ EE +A + ++ ++ AL Y
Sbjct: 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSY 133
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ G++HRD+K D++L+ DG IKL+DFG + +P
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA-------------QVSKEVP------- 173
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
R S VGTP ++APE++ +G D WS+GI++ E I G PP+ E P
Sbjct: 174 -------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I + P +S + ++ L+ +P+QR A
Sbjct: 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 91/312 (29%), Positives = 141/312 (45%), Gaps = 73/312 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE + + G G V R +G + A K L L+ I+ +I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARK-LIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L+K G + E++ +I IA ++ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 806 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S LI++ +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 157 --------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 922 IF---------------------------------DNILNRKIPWPCVPSD-MSFEAQDL 947
+F D I+N P P +PS S E QD
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQDF 266
Query: 948 INRFLIHDPNQR 959
+++ L +P +R
Sbjct: 267 VDKCLKKNPKER 278
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 93/320 (29%), Positives = 143/320 (44%), Gaps = 69/320 (21%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KK 722
S S SS S+ S+ S+ + E + I GA G V+ R TG L+A+KV+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 723 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
D +R+ +I E IL V +P VV+ F + +++E+++GG L +
Sbjct: 112 EDTVRR----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA 165
Query: 783 CLEE--DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
+ DVAR +++ + YLH IVHRD+KP NLLI ++K+ DFG+S+I +
Sbjct: 166 DEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LA 219
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 895
T+D P + S+VGT Y++PE + G GYA
Sbjct: 220 QTMD----------PCN---------------SSVGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW------------PCVPSDMSFE 943
D WS+G+ + EF G PF + R+ W P P+ S E
Sbjct: 255 DIWSLGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASRE 303
Query: 944 AQDLINRFLIHDPNQRLGAN 963
+ I+ L +P +R A
Sbjct: 304 FRHFISCCLQREPAKRWSAM 323
|
Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 92/316 (29%), Positives = 143/316 (45%), Gaps = 74/316 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILIT 743
++ ++ I G +G V+ AR + TG++ A LKK IR + + E + + E ++L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPSTAIREISLLKE 54
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
+ +P +VR + LYLV E+L+ DL + L+ + + Y+ +L+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y HS ++HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--------------GV-------P 152
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 919
T H V T Y APEILLG+ Y D WS+G I E + P F +S
Sbjct: 153 VRTYT-----HEVV-TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDS- 204
Query: 920 EI-----IFDNILN--RKIPWPCVPSDMSF---------------------EAQDLINRF 951
EI IF L + WP V S + + DL+++
Sbjct: 205 EIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKM 263
Query: 952 LIHDPNQRLGANGAAE 967
L++DP +R+ A A +
Sbjct: 264 LVYDPAKRISAKAALQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-28
Identities = 50/88 (56%), Positives = 62/88 (70%)
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934
+GTPDYLAPE+LLG HG A DWW++G+ LFEF+TGIPPF E+P+ +F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+S AQ+ I L DP +R G
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGL 628
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 37/292 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V +++ S+ L+++MEYL GG LLR G +E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI- 213
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979
K P + + S ++ I+ L DP+ R A E+ K +K +
Sbjct: 214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 84/279 (30%), Positives = 138/279 (49%), Gaps = 36/279 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +EII + GAFG+V+ A+ + TG L A KV+ D + ++E + E +IL + +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 805
P +V+ +F +NL++++E+ GG + +++ ++ L E R+ + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L DG IKL DFG+S NT +
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTI-------------------- 157
Query: 866 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ I + P PS S E +D + + L + + R
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 58/285 (20%)
Query: 688 DFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ EI+K + G FG+V + + + T LF K++K + N IE V
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIE---------PMVH 62
Query: 746 -----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
NP ++ +YS T L+M+Y+ GDL+ LL+K G L E + I +LV AL
Sbjct: 63 QLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 801 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LH I+H D+K +N+L I L D+GL KI I T D
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IG---------TPSCY--D-- 167
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
GT DY +PE + G + + DWW+VG++ +E +TG PF +
Sbjct: 168 ----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 920 EII-FDNILNR---KIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
E + +++L R K+P ++S A D + L ++ N RL
Sbjct: 212 EELDLESLLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRL 253
|
Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 92/317 (29%), Positives = 135/317 (42%), Gaps = 76/317 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILI 742
S+ +FE + I G +G V+ AR T+G++ A LKK+ M + D I L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 743 TVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 799
+R+P +V + D+++LVMEY DL SLL + E + + +L+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L+YLH I+HRDLK NLL+ G +K+ DFGL++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------------------YG 159
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
P T V T Y APE+LLG T + A D W+VG IL E + P +S
Sbjct: 160 LPAKPMTPK------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 919 P----EIIFD-----------------------------NILNRKIPWPCVPSDMSFEAQ 945
++I N L K PW +S
Sbjct: 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW------LSEAGL 267
Query: 946 DLINRFLIHDPNQRLGA 962
L+N L++DP +R A
Sbjct: 268 RLLNFLLMYDPKKRATA 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 33/234 (14%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
R +DFE+I+ I G +G V+ AR TG+L AIKV+K + D + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ +V +F S+ RD L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS G +HRD+K N+L+ +GH+KL DFG+S I TI
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI------------------- 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEI-LLGTEHGY--AADWWSVGIILFEFITGIPP 913
R S +GTP ++APE+ + + GY D W+VGI E PP
Sbjct: 161 ------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+EIIK I G+FG+++LA+ ++ + IK + M K E E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCL-EEDVARIYIAELVLALEYLHSL 806
+V FF SF L++VMEY +GGDL + R+ G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 807 GIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+K N+ ++ +G + KL DFG+++ +N++++L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
++ VGTP YL+PEI + D WS+G +L+E T PF + +
Sbjct: 160 ------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I P P + S + + LI++ P R
Sbjct: 214 ICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 83/322 (25%), Positives = 136/322 (42%), Gaps = 78/322 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRKNDIE 732
++ I+ I GA+G V A +G AIK L++L ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
I+A R+IL F ++Y+VM+ L DL+ ++ L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ +L+ L+Y+HS ++HRDLKP NLL+ D +++ DFG+++ GL ++ +
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKY----- 166
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI--- 908
EY V T Y APE+LL E+ A D WSVG I E +
Sbjct: 167 ------FMTEY-----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
Query: 909 ------------------TGIPP------FTAESPEIIFDNILNRK-IPWPCVPSDMSFE 943
G P ++ N+ ++ +PW + S E
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269
Query: 944 AQDLINRFLIHDPNQRLGANGA 965
A DL+++ L DP +R+ A
Sbjct: 270 ALDLLSQMLQFDPEERITVEQA 291
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 79/268 (29%), Positives = 118/268 (44%), Gaps = 45/268 (16%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
G +V L T F +K L+K + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817
D+++LV+++ GG L+S + K + E+ + + AE+V+AL+ LH GIV RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 877
+L+ GHI+LT F E + +A +N
Sbjct: 116 ILLDDRGHIQLTYFS-------------RWSEVEDSCDGEA-------VENM-------- 147
Query: 878 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 937
Y APE+ +E A DWWS+G ILFE +TG I LN +P
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-------IP 198
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGANGA 965
+S EA+ L+ + L +P +RLGA A
Sbjct: 199 EWVSEEARSLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 78/273 (28%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITVRNPFV 749
++ + +G++G V L R RT G + V+KKL++ + ER AE+ +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 750 VRFFYSFTCRDN-LYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 806
V + S+ D LY+VM + GGDLY L+ K L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLK N+ + IK+ D G++++ + N D++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------- 160
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
+ +GTP Y++PE+ + Y +D W++G ++E T F A+ + I
Sbjct: 161 ------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ K+ P +P D S E +LI L P +R
Sbjct: 215 IEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 36/275 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+E I+ + RGAFG V L R++ L IK + M + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 806
++ ++ +F L +VMEY GG L ++K L+ED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 807 GIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L+ H +K+ DFG+SKI LS S A
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSS-------KSKA------- 158
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924
++ VGTP Y++PE+ G + +D W++G +L+E + F A + P ++
Sbjct: 159 ------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ P + S + + LI L DP++R
Sbjct: 213 IMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 48/289 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII+ I +G +G+VF + G A+K+L D I D E I AE NIL + +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDID-EEIEAEYNILKALSD 73
Query: 747 -PFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 796
P VV+F+ + +D L+LV+E NGG + L L++ +EE + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++ L++LH +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 857 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFITG 910
Q T R R+++VGTP ++APE++ L + + D WS+GI E G
Sbjct: 173 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PP P I P P S E D I + L D +R
Sbjct: 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 33/275 (12%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER----ILAERNILITVRNPFVV 750
+ +GA+G V+ G L A+K ++ LD E+ + E ++L ++++ +V
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVE-LDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 751 RFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+ Y TC D+ + + ME++ GG + S+L + G L E V Y +++ + YLH+ +
Sbjct: 66 Q--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
VHRD+K +N+++ +G IKL DFG ++ + + L G ++ +
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG----LHGTHSNML-------------- 165
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
S GTP ++APE++ + +G +D WS+G +FE TG PP + I
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ P +P S A D + L D ++R A
Sbjct: 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSA 256
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ +++ + G+FGR L + + +A+K ++ + +E E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL--PKSSSAVEDSRKEAVLLAKMKHP 58
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 805
+V F SF +LY+VMEY +GGDL ++ + ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRD+K N+ + +G +KL DFG +++ L+ P Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP-----GAYACTY----- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
VGTP Y+ PEI + +D WS+G IL+E T PF A S + N
Sbjct: 161 ---------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKN 207
Query: 926 ILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
++ + + + +PS S+E + LI + +P R A
Sbjct: 208 LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 90/289 (31%), Positives = 133/289 (46%), Gaps = 48/289 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII+ I +G +G+V+ + G L A+K+L D I D E I AE NIL ++ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVD-EEIEAEYNILQSLPN 77
Query: 747 -PFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 796
P VV+F+ F D L+LV+E NGG + L L L+E + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+L L++LH+ I+HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 857 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEILLGTE---HGYAA--DWWSVGIILFEFITG 910
Q T R R+++VGTP ++APE++ + + Y A D WS+GI E G
Sbjct: 177 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PP P I P P I++ LI D R
Sbjct: 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEAR 278
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 89/319 (27%), Positives = 138/319 (43%), Gaps = 71/319 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
D +E ++ I G +G+V+ AR + TG L A+K +L+M + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 746 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLL----RKVGC-LEEDVARIYIAE 795
+ ++VR + +LYLV EYL+ DL + R G L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L+ + + H G++HRDLKP NLL+ G +K+ D GL + +I +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----AFSIPVK-------- 166
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913
H V T Y APE+LLG+ H D WSVG I E P
Sbjct: 167 --------------SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 914 FTAESPEI-----IFDNI--LNRKIPWPCV-------------PSDMSF-------EAQD 946
F +S E+ IF + ++ WP V P D+S E D
Sbjct: 212 FPGDS-ELQQLLHIFKLLGTPTEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269
Query: 947 LINRFLIHDPNQRLGANGA 965
L+ + L +DP +R+ A A
Sbjct: 270 LLQKMLRYDPAKRISAKAA 288
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 78/273 (28%), Positives = 136/273 (49%), Gaps = 36/273 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG----------------------------QLTDT 154
Query: 869 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--L 212
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P P + + S ++ + L +P+ R
Sbjct: 213 IPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+F I K I RG F V+ A G A+K ++ D++ + E ++L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYL 803
V++++ SF + L +V+E + GDL +++ + E Y +L ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS ++HRD+KP N+ I G +KL D GL + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR---------------------------F 155
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY- 214
Query: 924 DNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 959
L +KI +P +PSD S E + L+N + DP +R
Sbjct: 215 --SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 81/287 (28%), Positives = 135/287 (47%), Gaps = 48/287 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIERILAERNILITVR 745
D+ E++ + +G +G V+ R TG A+K ++ +LD + N +I+ E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGD---LYSLLRKVGCLEEDVARIYIAELVLALEY 802
+P++V F+ +F +Y+ MEY++ G LY+ + EDV R +V L++
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 803 L-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
L I+HRD+KP N+L+ +G +KL DFG+S + S +T+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN---------- 161
Query: 862 EYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYA-----ADWWSVGIILFEFITGIPPFT 915
+G Y+APE I G + +D WS+G+ + E G P+
Sbjct: 162 -------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 916 AESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E+ IF + I P +PS S +AQD + + L PN+R
Sbjct: 209 PETYANIFAQL--SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 90/308 (29%), Positives = 143/308 (46%), Gaps = 62/308 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F+ ++ I G +G V+ AR + TG++ A+K ++ LD + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V+ + LYLV E+L+ DL + + + + + Y+ +L+ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDLKP NLLI +G IKL DFGL++ G+ P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------------PVRTY 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI--- 921
T H V T Y APEILLG + + A D WS+G I E +T F +S EI
Sbjct: 158 T-----HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQL 210
Query: 922 --IFDNI-LNRKIPWPCV--------------PSDMSF-------EAQDLINRFLIHDPN 957
IF + ++ WP V D S + +DL+++ L +DPN
Sbjct: 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN 270
Query: 958 QRLGANGA 965
+R+ A A
Sbjct: 271 KRISAKAA 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D+E+I+ + G +G V+ AR TG+L A+K++K + +D I E ++ ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V +F S+ R+ L++ MEY GG L + G L E E + L YLHS G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRD+K N+L+ +G +KL DFG++ I TI
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVA--AKITATI------------------------ 160
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 913
R S +GTP ++APE+ ++G D W+VGI E PP
Sbjct: 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 90/322 (27%), Positives = 140/322 (43%), Gaps = 89/322 (27%)
Query: 689 FEI------IKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRK 728
FE+ IKPI RGA+G V A+ T + AIK L+++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 729 NDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
D E ++A ++I+ R F +++Y+V E L DL+ ++R L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ ++ +L+ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------- 159
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 906
E M EY V T Y APE+LL +E+ A D WSVG I E
Sbjct: 160 -EKGDFM------TEY-----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 907 FITGIPPFTAE--------------SP-EIIFDNILN-------RKIP-WPCVP-----S 938
+ P F + SP E I N R +P P
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP 261
Query: 939 DMSFEAQDLINRFLIHDPNQRL 960
+ A DL+ + L+ DP++R+
Sbjct: 262 HANPLAIDLLEKMLVFDPSKRI 283
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI-LAERNILITVR 745
+ +E + I G++G VF R R TG + AIK K ++ I++I L E +L ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLK 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P +V F + L+LV EY + L L + + E + + I + + A+ + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRD+KP+N+LI G IKL DFG ++I L+GP D Y +Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDD--------YTDY-- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912
V T Y APE+L+G T++G D W++G + E +TG P
Sbjct: 161 ---------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 86/293 (29%), Positives = 129/293 (44%), Gaps = 56/293 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
+ + + GA G V R + TG +FA+K + N ++IL E I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSC 56
Query: 745 RNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------YIAEL 796
++P++V+++ +F ++ + MEY GG L S+ +KV ++ RI IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 797 VL-ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
VL L YLHS I+HRD+KP N+L+ G +KL DFG+S L+N S T
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVN-----SLAGT----- 162
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
GT Y+APE + G + +D WS+G+ L E PF
Sbjct: 163 ------------------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 916 AESPEI-----IFDNILNRKIPW----PCVPSDMSFEAQDLINRFLIHDPNQR 959
E + I+N P P S E +D I + L DP +R
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 81/266 (30%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 750
K + +GAFGRV+L TG A K ++ ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 751 RFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
+++ R L + MEY+ GG + L+ G L E V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSG---TGI--------------- 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 927
S GTP +++PE++ G +G AD WS+G + E +T PP+ E+ IF +
Sbjct: 167 ---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--I 221
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLI 953
+ P +PS +S A+D + +
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 82/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G +G V+ AR +T AIK + + D ++ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 811
S + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 812 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
D+K DN+L+ + G +K++DFG SK GI P +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK-------------RLAGINPCTETF---------- 169
Query: 871 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 927
GT Y+APE++ GY AD WS+G + E TG PPF P+ +
Sbjct: 170 ----TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
KI P +P +S EA++ I R DP++R A+
Sbjct: 226 MFKIH-PEIPESLSAEAKNFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 83/267 (31%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
K + +GAFGRV+L TG A+K ++ D + + A + ++N R
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 753 FYSFTC-RD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ C RD L + ME++ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRD+K N+L G++KL DFG SK TI LSG G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSG---TGMK------------- 167
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNI 926
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF
Sbjct: 168 -----SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-- 220
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLI 953
+ + P +P +S +D + R +
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D + + + G G V+ A T + A+KV+ LD I ++I++E IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LD-ITVELQKQIMSELEILYKCDSP 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+++ F+ +F + + + E+++GG L + RK+ E + RI +A +V L YL SL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIP--EHVLGRIAVA-VVKGLTYLWSLK 115
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRD+KP N+L+ G +KL DFG+S Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST-----------------------------QLV 146
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
N + VGT Y+APE + G ++G +D WS+GI E G P+
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 87/327 (26%), Positives = 135/327 (41%), Gaps = 80/327 (24%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--T 743
+ +E + I +G FG VF AR + T + A LKK+ M + + I A R I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 744 VRNPFVVRFF---------YSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIY 792
+++ VV Y+ + + YLV E+ DL LL + V ++ ++
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV- 124
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS------------ 172
Query: 853 IMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
+ NR++ V T Y PE+LLG G D W G I+ E T
Sbjct: 173 ------------KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 911 IPPFTAES----------------PEI--------IFDNI-----LNRKIP---WPCVPS 938
P + PE+ +F + RK+ P V
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD 280
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGA 965
A DLI++ L+ DP +R+ A+ A
Sbjct: 281 P---HALDLIDKLLVLDPAKRIDADTA 304
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 39/236 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVL---KKLDMIRKNDIERILAERNI--LIT 743
+E + + G++G V + + TG + AIK + M++K +A R I L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRMLKQ 56
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+R+ +V F + LYLV E+++ L L + L+E R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P Y +Y
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEV--------YTDY 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
V T Y APE+L+G T++G A D W+VG ++ E +TG P F +S
Sbjct: 161 -----------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ +F+I K I RG F V+ A A+K ++ +M+ + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 801
+P V+++ SF + L +V+E + GDL ++ ++ + E Y +L A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-------------------------- 154
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 155 -FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 922 IFDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 959
L +KI +P +P++ S + ++L++ + DP+QR
Sbjct: 214 F---SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 95/340 (27%), Positives = 150/340 (44%), Gaps = 85/340 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L+K G + E + ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 806 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
Query: 922 IF-----------------------------------------DNILNRKIPWPCVPSDM 940
+F D I+N P P +PS +
Sbjct: 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSGV 270
Query: 941 -SFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979
E QD +N+ LI +P +R A+ + H FIK++E
Sbjct: 271 FGAEFQDFVNKCLIKNPAER--ADLKQLMVHA--FIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 93/324 (28%), Positives = 141/324 (43%), Gaps = 71/324 (21%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERI 734
+ +D F+II I G +G+V+ AR + TG+L A+K ++ + IR+ I R
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 735 LAERNIL----ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVA 789
L RNI+ I + F + YLV EY++ DL LL + ED
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ ++ +L+ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFI 908
Y ++R + V T Y PE+LLG E +G A D WS G IL E
Sbjct: 166 -------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
Query: 909 TGIPPFTAES--------------------PEII----FDNILNRKIPWPCVPSDMSF-- 942
T P F A P++I F+ + +K + + SF
Sbjct: 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP 272
Query: 943 -EAQDLINRFLIHDPNQRLGANGA 965
A DL++ L DP++R A A
Sbjct: 273 TPALDLLDHMLTLDPSKRCTAEEA 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 49/247 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 745
FE+++ + G +G+V+ R TG L AIKV+ + +++ E I E N+L R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 746 NPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 797
N + ++ +F + D L+LVME+ G + L++ L+ED E++
Sbjct: 74 N--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L +LH+ ++HRD+K N+L+ + +KL DFG+S
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 169
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIP 912
+ +T R R++ +GTP ++APE++ E + Y +D WS+GI E G P
Sbjct: 170 ----QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 913 PFTAESP 919
P P
Sbjct: 225 PLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 76/258 (29%), Positives = 114/258 (44%), Gaps = 38/258 (14%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI- 742
+ + D+EI+ + G FG V+ AR+ TG + A LKK+ M + D I A R I I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKIL 61
Query: 743 -TVRNPFVVRF---FYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+++P VV R ++Y+V Y++ DL LL L E + Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE-TD 851
+ +L+ + YLH I+HRD+K N+LI + G +K+ DFGL++ D P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP------YDGPPPNPKG 174
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910
G Y + V T Y PE+LLG + A D W +G + E T
Sbjct: 175 GGGGGTRKYT-----------NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 911 IPPFTAESP----EIIFD 924
P +S +IF
Sbjct: 224 RPILQGKSDIDQLHLIFK 241
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 85/309 (27%), Positives = 146/309 (47%), Gaps = 42/309 (13%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
GA G V A++ + G+ FA+KV+ ++ + + D R AE L+ +V+ F
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101
Query: 758 CRDN--------LYLVMEYLNGGDLYSLLR---KVG-CLEEDVARIYIAELVLALEYLHS 805
+D + LV++Y N GDL ++ K E A + +++LA+ ++HS
Sbjct: 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRD+K N+L+ +G +KL DFG SK + T+
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSK--MYAATV---------------------- 197
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924
+D+ R + GTP Y+APEI + AD +S+G++L+E +T PF E+ E++
Sbjct: 198 SDDVGR-TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984
+ R P +P +S E Q+++ L DP +R ++ + CK+FI V
Sbjct: 257 TLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQT 313
Query: 985 QSKLEIELK 993
Q L+
Sbjct: 314 QPGFSGPLR 322
|
Length = 496 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 80/270 (29%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVL--KKLDMIRKNDIERILAERNILITVRNPFVV 750
K + RGAFG V+L TG A+K + ++ + E +L +R+ +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 751 RFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ RD L + +EY+ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 68 QYYGCL--RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
IVHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSG---TGI------------- 166
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDN 925
S GTP +++PE++ G +G AD WSV + E +T PP+ E+ IF
Sbjct: 167 -----KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK- 220
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
+ + P +P +S +D + + + +
Sbjct: 221 -IATQPTKPMLPDGVSDACRDFLKQIFVEE 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 87/321 (27%), Positives = 141/321 (43%), Gaps = 79/321 (24%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAE-------- 737
D E +PI GAFG V+ G A LKK+ + +N +R+ E
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVA---LKKMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 738 -RNIL--ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
N+L + + P + F + +Y+V E + DL+ ++ L D ++++
Sbjct: 58 HDNVLSALDILQPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY 110
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+++ L+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------ 152
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913
+ ++++ V T Y APEIL+G+ H A D WSVG I E +
Sbjct: 153 --------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL 204
Query: 914 FTAESP----EIIFD-------------------NILNRKIPWPCVP------SDMSFEA 944
F A+SP ++I D +IL P +P S + EA
Sbjct: 205 FQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEA 264
Query: 945 QDLINRFLIHDPNQRLGANGA 965
L+ R L+ DP++R+ A A
Sbjct: 265 VHLLCRMLVFDPDKRISAADA 285
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 45/285 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR 745
DD E+I+ + RGA+G V R TG + A+K ++ + + +R+L + +I + +V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA--TVNSQEQKRLLMDLDISMRSVD 58
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 801
P+ V F+ + ++++ ME ++ L +KV + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 802 YLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YLHS L ++HRD+KP N+LI +G +KL DFG+S
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG------------------------- 152
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEIL--LGTEHGY--AADWWSVGIILFEFITGIPPFTA 916
D+ + G Y+APE + + GY +D WS+GI + E TG P+
Sbjct: 153 ---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 917 ESPEIIFDNILN-RKIPWPCVPSD-MSFEAQDLINRFLIHDPNQR 959
+S + F + + P P +P++ S E QD +N+ L + +R
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKER 252
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 91/316 (28%), Positives = 142/316 (44%), Gaps = 75/316 (23%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILI 742
D+ I+ I G +G V+ R + TG + A +KK IR +++ E + + E ++L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVA---MKK---IRLESEEEGVPSTAIREISLLK 54
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLA 799
+++P +V LYL+ E+L+ DL L K ++ ++ + Y+ +++
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ + HS ++HRDLKP NLLI + G IKL DFGL++ GI P +
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------AFGI-PVRVY 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918
E V T Y APE+LLG + D WS+G I E T P F +S
Sbjct: 159 THE------------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
Query: 919 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 949
EI IF IL + WP V S ++ + DL+
Sbjct: 207 -EIDQLFRIF-RILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263
Query: 950 RFLIHDPNQRLGANGA 965
+ LI+DP +R+ A A
Sbjct: 264 KMLIYDPAKRISAKKA 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-22
Identities = 86/311 (27%), Positives = 132/311 (42%), Gaps = 77/311 (24%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK--------LDMIRKNDIERILAERNILIT 743
++P+ GAFG V AR + TG AIK + K R+ + + L NI I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+ + F+ + +++Y V E L G DL+ LL LE+ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS G+VHRDLKP N+LI + +K+ DFGL++I D Y
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-------------------QDPQMTGY 165
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919
V T Y APEI+L ++ D WS G I E + G P F +
Sbjct: 166 -----------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
Query: 920 -EIIFD----------------NILN--------RKIPWPCVPSDMSFEAQDLINRFLIH 954
II D N L +P+ + A DL+ + L+
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 955 DPNQRLGANGA 965
DP +R+ A A
Sbjct: 275 DPQKRISAAEA 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 84/322 (26%), Positives = 143/322 (44%), Gaps = 80/322 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-------------VLKKLDMIRKNDIER 733
++ + I GA+G V A + TG AIK L+++ ++R+ E
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
I+ +I+ F SF +++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIR-------PPSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+++ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++I + D +G T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT--- 167
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGI 911
EY V T Y APEI+L GY A D WSVG IL E ++
Sbjct: 168 --------EY-----------VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 912 PPFTAE--------------SPEII-FDNILNRK-------------IPWPCVPSDMSFE 943
P F + +P + I++ + +PW + + +
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 944 AQDLINRFLIHDPNQRLGANGA 965
A DL+++ L +P++R+ A
Sbjct: 268 ALDLLDKMLTFNPHKRITVEEA 289
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 76/291 (26%), Positives = 135/291 (46%), Gaps = 47/291 (16%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
K ++D E + I G G+V+ R + TG + A+K +++ K + +RIL + ++
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDV 66
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL 798
++ + P++V+ + F ++++ ME L L LL+++ G + ED+ +V
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 799 ALEYL---HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
AL YL H G++HRD+KP N+L+ G++KL DFG+S G +
Sbjct: 126 ALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS-----------------GRL- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGI 911
D++ + + G Y+APE + ++ AD WS+GI L E TG
Sbjct: 166 ----------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 912 PPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQR 959
P+ E + IL P +P + F + ++ L D +R
Sbjct: 216 FPYKNCKTEFEVLTKILQE--EPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 8e-22
Identities = 87/318 (27%), Positives = 138/318 (43%), Gaps = 67/318 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRN 746
+E+IK + +GA+G V AR T + + + KK+ + I +R L E +L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 747 --------PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ F +F + LYL E L DL+ ++R L + + +I +++
Sbjct: 61 HKNITCLYDMDIVFPGNF---NELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS ++HRDLKP NLL+ D +K+ DFGL++ G N + +G
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG----------- 164
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917
EY V T Y APEI+L + A D WSVG IL E + P F +
Sbjct: 165 FMTEY-----------VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213
Query: 918 S-----PEIIF------DNILNR-----------------KIPWPCVPSDMSFEAQDLIN 949
+I+ + L+R K P+ + + + A DL+
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273
Query: 950 RFLIHDPNQRLGANGAAE 967
+ L DP +R+ A E
Sbjct: 274 KLLAFDPTKRISVEEALE 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 74/239 (30%), Positives = 111/239 (46%), Gaps = 48/239 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
D ++ + P+ GA+G+V A TG AIK KL ++ I +R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 745 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
+ V+ FT +L YLV L G DL ++++ + L +D + + +++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQK--LSDDHIQFLVYQIL 128
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L+Y+HS GI+HRDLKP N+ + D +K+ DFGL++ TD M
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------HTDDEM--- 172
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 914
T V T Y APEI+L H Y D WSVG I+ E +TG F
Sbjct: 173 --------TGY------VATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER---ILAERNILITVR 745
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNG--GDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+P + + + +LVMEY G D+ + +K E ++A I L L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQ-GLAYL 131
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS +HRD+K N+L+ G +KL DFG + + + P++
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL----------------VSPAN------ 169
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 53/294 (18%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + +G+FG V+ LA+ G+ AIK + + +R + L E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVM 63
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA----------RI 791
VVR + +VME + GDL S LR E +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKF 121
Query: 792 Y--IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
AE+ + YL + VHRDL N ++A D +K+ DFG+++ I T D
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET-DYYRKG 178
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
G++P ++APE L +D WS G++L+E T
Sbjct: 179 GKGLLPV----------------------RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 910 -GIPPFTAESPEIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRL 960
P+ S E + +++ P P + +L+ ++P R
Sbjct: 217 LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 1e-20
Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 50/287 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 749 VVRFFYSFTCR-------DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLA 799
+ +Y + D L+LVME+ G + L++ K L+E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
L +LH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------------------------ 159
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPF 914
+ +T R R++ +GTP ++APE++ E + + +D WS+GI E G PP
Sbjct: 160 --QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
Query: 915 TAESP-EIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 959
P +F L + P P + S S + Q I L+ + +QR
Sbjct: 217 CDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 86/317 (27%), Positives = 131/317 (41%), Gaps = 80/317 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--------MIRKNDIERILAERNI 740
F+ ++ + G + V+ R RTTG++ A+K + LD IR+ + + L NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHENI 60
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKV-GCLEEDVARIYIAELV 797
VR + L LV EY++ DL Y V G L+ + + + +L+
Sbjct: 61 ---------VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPS 856
+ + H ++HRDLKP NLLI G +KL DFGL++ G+ NT
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS------------ 158
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 915
+ V T Y AP++LLG+ + + D WSVG I+ E ITG P F
Sbjct: 159 ----------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
Query: 916 AESPE----IIFDNI----------------LNRKIPWPCVPSDMSF-------EAQDLI 948
+ E IF + P P D+ DL+
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPHADPLGIDLL 261
Query: 949 NRFLIHDPNQRLGANGA 965
+R L +P R+ A+ A
Sbjct: 262 HRLLQLNPELRISAHDA 278
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-20
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 37/242 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G V + + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 805
P++V F+ +F + + ME+++GG L +L++ + E++ ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 806 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 921
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
Query: 922 IF 923
IF
Sbjct: 213 IF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 85/274 (31%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILITVRNPFVV 750
+ R F+A T G KV+ K M+ ND ER A E + L + +V
Sbjct: 75 VGRNPTTAAFVA---TRGSDPKEKVVAKFVML--ND-ERQAAYARSELHCLAACDHFGIV 128
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+ F F D L L+MEY +GGDL L++ +E + ++VLAL+ +HS
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLK N+ + G IKL DFG SK + ++D++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS------------------- 229
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
S GTP YLAPE+ + AD WS+G+IL+E +T PF S I +
Sbjct: 230 ------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 927 LNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L K P+PC S + L++ L +P R
Sbjct: 284 LYGKYDPFPCPVSS---GMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 85/326 (26%), Positives = 134/326 (41%), Gaps = 75/326 (23%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNIL 741
++ ++ + + G++ V+ R + TG L A+K IR E + E ++L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLAL 800
+++ +V + L LV EYL+ DL + G L R+++ +L+ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y H ++HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------PSKTYS 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----- 914
E V T Y P++LLG TE+ + D W VG I +E TG P F
Sbjct: 162 NE------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 915 TAESPEIIFDNILNRKIP--WPCVPSDMSF------------------------EAQDLI 948
+ IF +L WP V S+ F ++L
Sbjct: 210 VEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELA 268
Query: 949 NRFLIHDPNQRLGANGAAEVFHCKIF 974
+FL ++P +R+ AAE F
Sbjct: 269 LKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-20
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE------RILAERNILI 742
++II+ I +G G V+LA A LKK IR++ E R L E I
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV---GCLEEDVA---------R 790
+ +P +V + + D +Y M Y+ G L SLL+ V L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG--LSKIGLINNTIDLSGP 848
I+ ++ +EY+HS G++HRDLKPDN+L+ G + + D+G + K + +D+
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
E I S P VGTPDY+APE LLG + D +++G+IL++ +
Sbjct: 177 ER-NICYSSMTIP----------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 909 TGIPPFTAES-PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
T P+ + +I + +++ I P+ +P +S + + L DP +R
Sbjct: 226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 78/310 (25%), Positives = 130/310 (41%), Gaps = 66/310 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 744
+E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L +
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLLKEL 56
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 803
++ +VR + L LV EY + DL G ++ ++ + ++ +L+ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
HS ++HRDLKP NLLI +G +KL DFGL++ GI P + E
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR--------------AFGI-PVRCYSAE- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF--------------- 907
V T Y P++L G + + D WS G I E
Sbjct: 160 -----------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
Query: 908 -------ITGIP-----PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
+ G P P ++ P+ + V ++ +DL+ L+ +
Sbjct: 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268
Query: 956 PNQRLGANGA 965
P QR+ A A
Sbjct: 269 PVQRISAEEA 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 94/317 (29%), Positives = 142/317 (44%), Gaps = 69/317 (21%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LIT 743
+D +E ++ I G +G V+ AR R T + A LKK+ + ++++ A R I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED--VARIYIAELVLALE 801
+++ +VR LYLV EYL+ DL + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y HS ++HRDLKP NLLI + +KL DFGL++ GI P
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------------AFGI-PVRTFT 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFTAES 918
E V T Y APEILLG+ H Y+ D WSVG I E + P F +S
Sbjct: 162 HE------------VVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
Query: 919 PEI-----IFDNILN--RKIPWPCVPSDMSFEAQ---------------------DLINR 950
EI IF IL + WP V S +++ DL+++
Sbjct: 209 -EIDELFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266
Query: 951 FLIHDPNQRLGANGAAE 967
L DP++R+ A A E
Sbjct: 267 MLRLDPSKRITARAALE 283
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 8e-20
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 63/264 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
+ ++++E+IK I G FG VFL + + T + F K + + ++ + +++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRE 68
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELV 797
+++ +VR+ F + N LY++ME+ + GDL ++K G +EE +L+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 798 LALEYLHSLG-------IVHRDLKPDNLL----IAHDGHI-------------KLTDFGL 833
AL Y H+L ++HRDLKP N+ I H G I K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 834 SK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
SK IG+ HS VGTP Y +PE+LL
Sbjct: 189 SKNIGI-----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219
Query: 893 Y--AADWWSVGIILFEFITGIPPF 914
Y +D W++G I++E +G PF
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVR 745
IK + G FG+V L R TG+ A+K L ++D ER E IL T+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFER---EIEILRTLD 64
Query: 746 NPFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +V++ +L L+MEYL G L L++ +I + L+L
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQI 118
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++YL S +HRDL N+L+ + +K++DFGL+K ++P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK-----------------VLPE 161
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
D Y S + + APE L ++ A+D WS G+ L+E T P +
Sbjct: 162 DKDY----YYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
Query: 917 ESPEI 921
E
Sbjct: 215 PPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 74/276 (26%), Positives = 130/276 (47%), Gaps = 40/276 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRNPFVVRF 752
+ +G+FG V+L + + +KVLK++ + N E + A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE----LVLALEYLHSLGI 808
SF RD ++ EY G DL L ++ + ++ + E L+L + Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+ T
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSR--LLMGSCDLATTFT------------------ 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
GTP Y++PE L + +D WS+G IL+E F ++ F +++
Sbjct: 167 -------GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVL 215
Query: 929 RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
R + P P +P S + ++ L DP+ R A
Sbjct: 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSA 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 83/313 (26%), Positives = 129/313 (41%), Gaps = 57/313 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERI---------LAERNILIT 743
+ G +G+V A TG + AIK +K ++ D + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
+++ ++ + D + LVM+ + DL ++ RK+ E V I + +++ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI-LLQILNGLNV 134
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH +HRDL P N+ I G K+ DFGL++ SD +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR-------------RYGYPPYSDTLSKD 181
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 921
S V T Y APE+L+G E + +A D WSVG I E +TG P F E+ EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-EI 240
Query: 922 -----IFDNILNRKIP--WP---CVPSDMSF-----------------EAQDLINRFLIH 954
IF +L WP +P F +A DL+ L
Sbjct: 241 DQLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 955 DPNQRLGANGAAE 967
+P +R+ A A +
Sbjct: 300 NPLERISAKEALK 312
|
Length = 335 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 84/319 (26%), Positives = 141/319 (44%), Gaps = 48/319 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +E ++ + G++ V+ + + G L A+KV++ + + + E ++L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V ++ L LV EY++ + + G L + ++++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLKP NLLI+ G +KL DFGL++ + PS + E
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------PSHTYSNE---- 163
Query: 867 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA-----ESPE 920
V T Y P++LLG TE+ D W VG I E I G+ F + E
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215
Query: 921 IIFDNILNRKIP----WPCVPSDMSFEAQDLINRFLIHDP-NQRLGANGAAEVFHCKIFI 975
IF L P WP V S F+ + RF ++ P N R N + V H +
Sbjct: 216 RIF---LVLGTPNEDTWPGVHSLPHFKPE----RFTLYSPKNLRQAWNKLSYVNHAEDLA 268
Query: 976 KKTENCVSMQSKLEIELKL 994
K C +++L + L
Sbjct: 269 SKLLQC-FPKNRLSAQAAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-19
Identities = 75/237 (31%), Positives = 112/237 (47%), Gaps = 44/237 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 744
D + +K + GA+G V A R TG AIK KL ++++ +R E +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 71
Query: 745 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ FT +L YLVM ++ G DL L+ K L ED + + +++
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-KHEKLSEDRIQFLVYQMLK 129
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------------------- 166
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
QTD+ V T Y APE++L H D WSVG I+ E +TG P F
Sbjct: 167 ------QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 73/318 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAERNILITVRN 746
++I + I +G++G V A TG+ AIK K++ + ++ D RIL E +L +R+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KINDVFEHVSDATRILREIKLLRLLRH 58
Query: 747 PFVV---RFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
P +V + R+ ++Y+V E L DL+ +++ L + + ++ +L+ AL+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+H+ + HRDLKP N+L D +K+ DFGL+++ N+T P+ +
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT------------PTAIFWT 164
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 917
+Y V T Y APE L G +++ A D WS+G I E +TG P F +
Sbjct: 165 DY-----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
Query: 918 ---------------SPEII----------FDNILNRKIPWPCVPSDMSFEAQD-----L 947
SPE I + + + +K P VP F D L
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP---VPFSQKFPNADPLALRL 269
Query: 948 INRFLIHDPNQRLGANGA 965
+ R L DP R A A
Sbjct: 270 LERLLAFDPKDRPTAEEA 287
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 43/242 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFA----IKVLKKLDMIRKNDIERILAERNILITV 744
+E + I GA+G+VF AR G F ++V + + + I + R+ L T
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 745 RNPFVVRFF----YSFTCRDN-LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAEL 796
+P VVR F S T R+ L LV E+++ DL + L KV G E + + + +L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------------- 159
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+Q S V T Y APE+LL + + D WSVG I E P F
Sbjct: 160 ----YSFQMALT----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211
Query: 917 ES 918
S
Sbjct: 212 SS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I RG FG VF R R A+K + + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 807
T + +Y+VME + GGD + LR G R+ + EL+ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ +K++DFG+S+ E DG+ S +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR------------EEEDGVYASTGGMKQ----- 157
Query: 868 NRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDN 925
P + APE L + +D WS GI+L+E F G P+ S + +
Sbjct: 158 ---------IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I + + PC P L+ R +DP QR
Sbjct: 209 I-EQGVRLPC-PELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 78/309 (25%), Positives = 129/309 (41%), Gaps = 68/309 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITVRNP 747
++ + G++ V+ R G L A+KV I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V ++ L V EY++ +++ G L R+++ +L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLKP NLLI++ G +KL DFGL++ I PS + E
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------PSQTYSSE----- 163
Query: 868 NRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF--TAESPEII-- 922
V T Y P++LLG T++ A D W G I E + G P F ++ E +
Sbjct: 164 -------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
Query: 923 ---------------FDNILNRKIPW--PCVPSDM---------SFEAQDLINRFLIHDP 956
+ N K W PC P + +A+DL ++ L+ P
Sbjct: 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 957 NQRLGANGA 965
R+ A A
Sbjct: 277 KDRISAQDA 285
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-18
Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 29/255 (11%)
Query: 711 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEYL 769
TG AIK+L+ ++ R E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 770 NGGDLYSLLRKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---H 825
G L +L G L + R+ + +++ AL H+ GIVHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885
K+ DFG+ + + +GTP Y APE
Sbjct: 121 AKVLDFGIGTLL------------------PGVRDADVATLTRT--TEVLGTPTYCAPEQ 160
Query: 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEA 944
L G +D ++ G+I E +TG S EI++ + + P P
Sbjct: 161 LRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHPL 218
Query: 945 QDLINRFLIHDPNQR 959
++ + L DP QR
Sbjct: 219 GQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 82/322 (25%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIK------------VLKKLDMIRKNDIERILAERN 739
++P+ G+ G VF A A+K L+++ +IR+ D + I+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 740 ILIT--VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+L V +++Y+V EY+ DL ++L + G L E+ AR+++ +L+
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLL 124
Query: 798 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
L+Y+HS ++HRDLKP N+ I D +K+ DFGL++I
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------V 165
Query: 857 DAHYPEYQQTDNRNRHSA-----VGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 910
D HY H + T Y +P +LL + A D W+ G I E +TG
Sbjct: 166 DPHY----------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 911 IPPFTA----ESPEIIFDNI----------LNRKIPW--------PCVP-----SDMSFE 943
P F E ++I +++ L IP P P ++ E
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 944 AQDLINRFLIHDPNQRLGANGA 965
A D + + L +P RL A A
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEA 297
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 87/292 (29%), Positives = 125/292 (42%), Gaps = 65/292 (22%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITVRNP 747
+ G + VF R + T +L A+K ++ IR+ + + L NI +T+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHD- 70
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-DVARIYIAELVLALEYLHSL 806
++ T LV EYL+ DL L G L +I++ +L+ L Y H
Sbjct: 71 -IIHTERCLT------LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
I+HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV---------------PTKTYSNE---- 163
Query: 867 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----TAESPEI 921
V T Y P++LLG TE+ D W VG IL+E TG P F E +
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 922 IFDNI-LNRKIPWPCVPSDMSFE--------AQDLINRFLIHDPNQRLGANG 964
IF + + WP + S+ F AQ LIN H P RL +G
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLIN----HAP--RLDTDG 261
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 86/317 (27%), Positives = 130/317 (41%), Gaps = 76/317 (23%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERILAERNI 740
+E + I GA+G V+ AR +G A+K ++ L +R E L +R
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR----EVALLKR-- 55
Query: 741 LITVRNPFVVRFF----YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYI 793
L +P +VR S T R+ + LV E+++ DL + L KV L + + +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+ + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++I +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT--------- 165
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 914 FTAESPE----IIFDNI-LNRKIPWP--------------------CVPSDMSFEAQDLI 948
F S IFD I L + WP VP ++ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 949 NRFLIHDPNQRLGANGA 965
L +P++R+ A A
Sbjct: 266 LEMLTFNPHKRISAFRA 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 56/292 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILI 742
+D + + I RGAFG V + +G + A+K IR E R+L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 743 TVRN-PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSL--LRKVGCLEEDV-ARIYIAEL 796
+ P++V+F+ + + ++ ME ++ Y + E++ +I +A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-T 116
Query: 797 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
V AL YL L I+HRD+KP N+L+ +G+IKL DFG+S G + ++I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI------------ 162
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIP 912
+T + G Y+APE I GY +D WS+GI L+E TG
Sbjct: 163 --------AKTRD------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208
Query: 913 PFTAESPEIIFDNILN-RKIPWPCVPSD----MSFEAQDLINRFLIHDPNQR 959
P+ + +FD + K P + + S + IN LI D ++R
Sbjct: 209 PYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 55/248 (22%)
Query: 689 FEIIKPISRGAFGRVFLAR--KRTTGDLFAIKVLK--KLDM-------IRKNDIERILAE 737
+EI I RG +GRV+ A+ G +AIK K K R+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIY 792
N+ +++ F+ S +YL+ +Y DL+ +++ K + + +
Sbjct: 62 ENV-VSLVEVFLEHADKS------VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINNTIDLSGP 848
+ +++ + YLHS ++HRDLKP N+L+ +G +K+ D GL++ L N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFE 906
D + V T Y APE+LLG H Y A D W++G I E
Sbjct: 172 L-DPV---------------------VVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAE 208
Query: 907 FITGIPPF 914
+T P F
Sbjct: 209 LLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + +G FG V L R + TG++ A+K L+ D ER E IL ++++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHD 65
Query: 748 FVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEY 802
+V+ Y C R NL LVMEYL G L L+K L+ +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRDL N+L+ + +K+ DFGL+K+ +P D Y +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------LPQDKEYYK 166
Query: 863 YQQTDNRNRHSAVGTPDY-LAPEILLGTEHGYAADWWSVGIILFEFIT 909
++ +P + APE L ++ A+D WS G++L+E T
Sbjct: 167 VREPGE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-16
Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 49/230 (21%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 749
+K + GA+G V A + TG+ AIK KL +++I +R E +L +++ V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 750 VRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLE--EDVARIYIAELVLALE 801
+ FT + YLVM Y+ + L+K+ ED + + +++ L+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+HS GI+HRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEMT 172
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
Y V T Y APE++L H D WSVG I+ E +TG
Sbjct: 173 GY-----------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I G+FG V+ AR T ++ AIK + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+ + + +LVMEY G DL + +K E ++A I L L YLHS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSH 144
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L+ G +KL DFG + I P++
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI----------------ASPAN--------- 179
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 180 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ + +LVMEY G DL + +K E ++A + L L YLHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGAL-QGLAYLHSH 134
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG + I + P++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------MAPAN--------- 169
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I +G FG V+ + ++ A+K + + + L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 807
+ +Y+VME + GG L + LRK R+ + +L+ +EYL S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ + +K++DFG+S+ E GI Y +D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------EEEGGI---------YTVSD 152
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
+ T APE L + +D WS GI+L+E F G P+
Sbjct: 153 GLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+ + ++ I +G FG V L R G A+K LK + LAE +++ T+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEY 802
R+P +V+ + LY+V EY+ G L LR G + + ++ +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 44/233 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITV 744
+ ++ + P+ GA+G V A TG A+K L + +I +R E +L +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 73
Query: 745 RNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ FT +++YLV +L G DL +++ K L +D + I +++
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILR 131
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ TD M
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMT--- 175
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
V T Y APEI+L H D WSVG I+ E +TG
Sbjct: 176 --------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G+FG V+ A T ++ A+K + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 755 SFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+ +LVMEY G DL + +K E ++A I L L YLHS ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSHNMIHRD 146
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
+K N+L+ G +KL DFG + S P +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASK---------SSPA----------------------N 175
Query: 873 SAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 914
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 749
+KPI GA G V A TG AIK KL +N +R E ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 750 VRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALE 801
+ FT + +L YLVME ++ L +V ++ D R+ + +++ ++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+LHS GI+HRDLKP N+++ D +K+ DFGL++ M + Y
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTP--Y- 177
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 178 -------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 695 ISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
+ GAFG+VFLA L A+K LK+ + D +R E +L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLE--EDVA--------RIYIAE 795
VRF+ T L +V EY+ GDL LR G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 796 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ + + YL SL VHRDL N L+ +K+ DFG+S+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------- 170
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
D + +Y + R P PE +L + +D WS G++L+E T
Sbjct: 171 --DIYSTDYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 80/285 (28%), Positives = 123/285 (43%), Gaps = 49/285 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILITVRNPFVV 750
+ G + V+ R + T +L A+K IR E + E ++L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIV 809
+L LV EYL+ DL L G + ++++ +L+ L Y H ++
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDLKP NLLI G +KL DFGL++ I P+ + E
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSI---------------PTKTYSNE------- 164
Query: 870 NRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFD 924
V T Y P+ILLG T++ D W VG I +E TG P F + E IF
Sbjct: 165 -----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF- 218
Query: 925 NILNRKI--PWPCVPSDMSFEAQDLINRF--LIHDPNQRLGANGA 965
IL WP + S+ F++ + +H+ RL ++GA
Sbjct: 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGA 263
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++K + G FG V++ + AIK LK+ M E LAE N++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
P +VR Y+ ++ +Y++ EY+ G L L+ ++ + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ I + EY
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDN-------------------EYT 158
Query: 865 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEI 921
R A + APE I GT +D WS GI+L E +T IP +PE+
Sbjct: 159 A-----REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I + L R P P + E +L+ P +R
Sbjct: 213 IQN--LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
+K + G FG V L + R + AIK + + M ++ IE E +++ + +P +V+
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
+ T + LY+V E++ G L + LR + G L +D+ ++ +EYL +H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
RDL N L++ G +K++DFG+++ L + SG A +P
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG----------AKFP--------- 164
Query: 871 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 918
+ PE+ +++ +D WS G++++E F G PF +S
Sbjct: 165 -------VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 80/329 (24%), Positives = 136/329 (41%), Gaps = 81/329 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A G A+K L + + +R E +L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKC 76
Query: 744 VRNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + ++YLVME ++ L +V +E D R+ + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQ 131
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ N
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------- 176
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT------ 909
+ T V T Y APE++LG + D WSVG I+ E +
Sbjct: 177 -------FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
Query: 910 ---------------GIPP--FTAESPEIIFDNILNRK----------IPWPCVPSD--- 939
G P F + + + NR P PS+
Sbjct: 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283
Query: 940 ---MSFEAQDLINRFLIHDPNQRLGANGA 965
+ +A+DL+++ L+ DP++R+ + A
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVDEA 312
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 80/308 (25%), Positives = 129/308 (41%), Gaps = 58/308 (18%)
Query: 688 DFEIIKPISRGAFGRVFLAR---KRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILI 742
D + + + GAFG+VFLA T D L A+K LK + + D +R E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 798
+++ +V+F+ D L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 799 A------------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
+ + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 171
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
D + +Y + H+ + ++ PE ++ + +D WS G+IL+E
Sbjct: 172 ----------DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 907 FIT-GIPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
T G P+ S + + I ++ P C P E D++ +P QRL
Sbjct: 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-PK----EVYDIMLGCWQREPQQRLNI 272
Query: 963 NGAAEVFH 970
++ H
Sbjct: 273 KEIYKILH 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 695 ISRGAFGR--VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752
I + V LA+ + T L A+K + LD K D++ + E +++P ++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVH 810
SF LY+V + G LL+ L E + +++ AL+Y+HS G +H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 811 RDLKPDNLLIAHDGHIKLTDF----GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
R +K ++L++ DG + L+ + K G +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP------------------- 165
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFT 915
+ S P +L+PE+L GY D +SVGI E G PF
Sbjct: 166 ----KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR---TTGD--LFAIKVLKK--LDMIRKNDIERILAERN 739
D + + + GAFG+VFL D L A+K LK+ + RK D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK-DFER---EAE 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------CL 784
+L ++ +V+F+ T D +V EY+ GDL LR G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ +I + ++ + YL S VHRDL N L+ +D +K+ DFG+S+
Sbjct: 121 LSQLLQIAV-QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ +IK ++ G+ GRVF+A K D +K+ +K L E +L V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118
Query: 749 VVR-----FFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
V+R + TC +V+ + + DLY+ L ++ L D A I +++ L Y
Sbjct: 119 VIRMKDTLVSGAITC-----MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH+ I+HRD+K +N+ I + + D G ++ + P G+
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGL--------- 216
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
GT + APE+L ++ AD WS GI+LFE +
Sbjct: 217 ------------AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 77/309 (24%), Positives = 122/309 (39%), Gaps = 70/309 (22%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + G FG+V L TG++ A+K LK+ + ++N E NIL T+ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNT-SGWKKEINILKTLYHE 66
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+V+ Y C + L L+MEY+ G L L K ++ +A+L+L
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQI 116
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--------------------- 155
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
PE + R R + A E L + YA+D WS G+ L+E +T
Sbjct: 156 --AVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK-- 210
Query: 917 ESPEIIFD----------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+SP F+ +L R + PC P + E L+ + R
Sbjct: 211 QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFRP 269
Query: 961 GANGAAEVF 969
+
Sbjct: 270 TFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 73/310 (23%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITV 744
++ + G + VF R + T +L A+K ++ IR+ + + L NI +T+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-VTL 69
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYL 803
+ +V S T LV EYL+ DL + G + +I++ +++ L Y
Sbjct: 70 HD--IVHTDKSLT------LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H ++HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---------------PTKTYSNE- 164
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 920
V T Y P++LLG +E+ D W VG I FE +G P F + E
Sbjct: 165 -----------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
Query: 921 --IIFDNI-LNRKIPWPCVPSDMSF----------------------EAQDLINRFLIHD 955
+IF + + WP + S+ F E +L+ +FL ++
Sbjct: 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE 273
Query: 956 PNQRLGANGA 965
+R+ A A
Sbjct: 274 SKKRISAEEA 283
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 71/303 (23%)
Query: 693 KPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
K + G FG+V F + R A+K+LK+ +++ +L+E N+L V +P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--NASSSELRDLLSEFNLLKQVNHP 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGC-------------LEEDVARI 791
V++ + + + L L++EY G L S LR KVG L+ R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 792 YIAELVLA--------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
+++ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-------- 175
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGI 902
+ + D+ + S P ++A E L + +D WS G+
Sbjct: 176 ------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNI-----LNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
+L+E +T G P+ +PE +F+ + + R P + S E +L+ +P
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTCWKQEP 270
Query: 957 NQR 959
++R
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 698 GAFG----RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 753
G FG V+ RK+ AIKVLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 754 YSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALEYLHSLGI 808
C + L LVME +GG L L ++++ + EL+ + ++YL
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHRDL N+L+ + + K++DFGLSK + D++Y
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK----------------ALGADDSYY-------- 152
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESPEII 922
+ R + + APE + + +D WS GI ++E F G P+ + PE++
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+F + + + G FG V+ + + AIK+LK D++++ D ++ E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-ALEYLHS 805
++ F + + +Y++ E + G L + LR VA I +A V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N+L+ D K+ DFGL+++ I + LS SD P Y+
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---------SDKKIP-YKW 170
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIP 912
T APE +D WS GI+L+E T +P
Sbjct: 171 T---------------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 81/331 (24%), Positives = 136/331 (41%), Gaps = 81/331 (24%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 744 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + +L YLVME ++ L +V +E D R+ + +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQ 127
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T G
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------- 908
Y V T Y APE++LG + D WSVG I+ E +
Sbjct: 174 MMTPY--------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 909 ----------------TGIPPFTAESPEIIFDNILNRK----------IPWPCVPSD--- 939
T P F + + + + NR P P+D
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 940 ---MSFEAQDLINRFLIHDPNQRLGANGAAE 967
+ +A+DL+++ L+ DP +R+ + A +
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 44/231 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITVRN 746
++ + P+ GA+G V A A+K L + +I R E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKH 73
Query: 747 PFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
V+ FT ++ YLV L G DL +++ K L ++ + I +L+ L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGL 131
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+Y+HS GI+HRDLKP N+ + D +++ DFGL++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------- 166
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
Q D+ V T Y APEI+L H D WSVG I+ E + G
Sbjct: 167 ----QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757
G +G V+ + A+K LK+ M ++E L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEED-VARIYIA-ELVLALEYLHSLGIVHRDLKP 815
Y++ E++ G+L LR+ E + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 875
N L+ + +K+ DFGLS++ D H+
Sbjct: 133 RNCLVGENHLVKVADFGLSRL---------------------------MTGDTYTAHAGA 165
Query: 876 GTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 692 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
I+ + G FG+V L R TG+ A+K LK N I + E IL + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 802
+V+ Y C ++ + L+ME+L G L L R + Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRDL N+L+ + +K+ DFGL+K + +D Y
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----------------IETDKEY-- 165
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y D+ + S V + APE L+ ++ A+D WS G+ L+E +T
Sbjct: 166 YTVKDDLD--SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 695 ISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
+ +G FG VF L K A+K K+ D+ ++ I + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV----AVKTCKE-DLPQELKI-KFLSEARILKQYDHPNIVK 56
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLG 807
T R +Y+VME + GGD S LRK ++++ + + L + YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N L+ + +K++DFG+S+ E DGI S +Q
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSG----LKQIP 157
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
+ + APE L + +D WS GI+L+E F G+ P+
Sbjct: 158 IK----------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
D +K + G FG V + R D+ AIK++K+ M IE E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSL 806
+V+ + T + +Y+V EY++ G L + LR+ G + + + + V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
+HRDL N L+ G +K++DFGLS+ L D Y
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL------------------DDEYT----- 156
Query: 867 DNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+VG+ + PE+LL ++ +D W+ G++++E +
Sbjct: 157 ------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+RTSI ++++ + G FG V+ T + A+K LK M D + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEE--DVARIYIAE 795
+R+P +++ + T + +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ + YL + +HRDL N+L+ + K+ DFGL+++ I
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----------------IKE 155
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y+ R A + APE L +D WS GI+L E +T
Sbjct: 156 D-----IYEA-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 744 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 795
V + ++ FT + +L Y+VME ++ L +V +E D R+ + +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQ 134
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T + P
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY------ 185
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 186 -------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 54/238 (22%)
Query: 686 IDDFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
ID E+ +K + G FG V L + R D+ AIK++++ M + IE E +++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMK 55
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +P +V+ + T + +++V EY+ G L + LR+ E +L
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-------TEWLLDMCSD 108
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
A+EYL S G +HRDL N L+ D +K++DFGL++ L
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----------------- 151
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
D Y S+ GT + PE+ + +D WS G++++E +
Sbjct: 152 -DDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S D + KP+ G FG+V +A K A+K+LK D + D+ +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 738 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIY 792
++ + ++ ++ + T LY+++EY + G+L LR D+AR+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 793 IAELVL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
++ +EYL S +HRDL N+L+ + +K+ DFGL++ +N
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VN 188
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
N ID T+G +P ++APE L + + +D WS
Sbjct: 189 N-IDYYKKTTNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSF 225
Query: 901 GIILFEFIT-GIPPFTAESPEIIF 923
G++++E T G P+ E +F
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 45/229 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
++ + + G FG V++ T + A+K LK M E L E I+ +R+
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLALE 801
+V+ + + + +Y+V EY++ G L L+ ++ L + A+I AE +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AE---GMA 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL S +HRDL N+L+ + + K+ DFGL++ LI E D
Sbjct: 118 YLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR--LI---------EDD--------- 156
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
EY R A + APE +D WS GI+L E +T
Sbjct: 157 -EYTA-----REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I G FG V + TG A+K +K D+ + L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDVT----AQAFLEETAVMTKLHHKNLVRLL- 65
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--LEYLHSLGIVHRD 812
+ LY+VME ++ G+L + LR G V ++ L +A +EYL S +VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
L N+L++ DG K++DFGL+++G +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVG------------------------------SMGVD 155
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
++ + APE L + +D WS G++L+E F G P+
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 52/230 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
F I++ + GA G F T + IK ++ E +IL + +P
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPS 144
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL------VL-ALE 801
+++ +FT L++ DLY C I I ++ VL A++
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKT-DLY-------CYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLH I+HRD+K +N+ I H G + L DFG + P D
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAA------------------CFPVDI--- 235
Query: 862 EYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
N N++ GT APE+L +G A D WS GI+LFE T
Sbjct: 236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 33/240 (13%)
Query: 693 KPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + G+FG V + G + A+K LK + + ++ L E I+ ++ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLG 807
+R Y L +V E G L LRK ++ + Y ++ + YL S
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL N+L+A D +K+ DFGL + L N + H Y +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN---------------EDH---YVMEE 158
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNI 926
+ A + APE L +A+D W G+ L+E F G P+ S I I
Sbjct: 159 HLKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 72/325 (22%), Positives = 122/325 (37%), Gaps = 84/325 (25%)
Query: 687 DDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKK---LDMIRKNDIERILAER 738
++ E ++ I +GAFGRVF AR + A+K+LK+ DM + D +R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQR---EA 59
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------------KVGCLE 785
++ +P +V+ + L+ EY+ GDL LR +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 786 EDVARIYIAELVL---------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ + ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 837 GLINNTIDLSGPETDGI----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
I + E D I MP PE + +
Sbjct: 180 --IYSADYYKASENDAIPIRWMP---------------------------PESIFYNRYT 210
Query: 893 YAADWWSVGIILFE-FITGIPPFTAES-PEIIF----DNILNRKIPWPCVPSDMSFEAQD 946
+D W+ G++L+E F G+ P+ + E+I+ N+L+ C P + E +
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------C-PDNCPLELYN 263
Query: 947 LINRFLIHDPNQRLGANGAAEVFHC 971
L+ P+ R A +
Sbjct: 264 LMRLCWSKLPSDR---PSFASINRI 285
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 47/281 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++IK + G FG V++ + A+K LK M E L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLA 799
+V+ Y+ + +Y+V EY++ G L L+ K+ L D+A A++
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV-DMA----AQVAAG 114
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + +HRDL+ N+L+ K+ DFGL++ LI +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDN----------------- 155
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
EY R A + APE L +D WS GI+L E +T G P+ +
Sbjct: 156 --EYTA-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + R PC P D +L+ + DP +R
Sbjct: 209 NREVLEQV-ERGYRMPC-PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 741
D + KP+ GAFG+V A + A+K+LK D + D+ +++E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMM 69
Query: 742 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIAEL 796
+ ++ ++ T LY+V+EY G+L LR E D R L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 797 VL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844
+E+L S +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------- 180
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGII 903
D H+ +Y + R P ++APE L + + +D WS G++
Sbjct: 181 ------------DIHHIDYYRKTTNGR-----LPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 904 LFEFIT-GIPPFTAESPEIIFDNI 926
L+E T G P+ E +F +
Sbjct: 224 LWEIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 44/227 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILI 742
++ + ++++ I +G FG V L R G+ A+K +K ND + LAE +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-------NDATAQAFLAEASVMT 54
Query: 743 TVRNPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLA 799
+R+ +V+ + LY+V EY+ G L LR G L D + ++ A
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+EYL + VHRDL N+L++ D K++DFGL+K + S + G +P
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV--- 163
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
+ APE L + +D WS GI+L+E
Sbjct: 164 -------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-12
Identities = 84/317 (26%), Positives = 133/317 (41%), Gaps = 74/317 (23%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERNIL 741
R+ +++ I G+FG V+ A T + AIK VL+ D KN I+ N +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLNHI 119
Query: 742 ITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGG-----DLYSLLRKVGCLEEDVARI 791
+ F+ ++Y+ + N L +VME++ Y+ R L + ++
Sbjct: 120 NII---FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKL 174
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPET 850
Y +L AL Y+HS I HRDLKP NLLI + H +KL DFG +K +L
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLA--- 223
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909
+ S + + Y APE++LG T + D WS+G I+ E I
Sbjct: 224 -----------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 910 GIPPFTAESP-------------------EIIFDNILNRKIP-------WPCVPSDMSFE 943
G P F+ +S + + N + K P P +
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 944 AQDLINRFLIHDPNQRL 960
A + I++FL ++P +RL
Sbjct: 327 AINFISQFLKYEPLKRL 343
|
Length = 440 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
A+K LK+ + + L E +++ + +P +VR + L LVME G L
Sbjct: 27 AVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLL 83
Query: 776 SLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831
L+K ++ + EL + YL S VHRDL N+L+ + K++DF
Sbjct: 84 KYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 832 GLSK 835
G+S+
Sbjct: 140 GMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITV 744
E IK + GAFG V+ G+ AIKVL++ + K + IL E ++ +V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKA-NKEILDEAYVMASV 66
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLAL 800
+P VVR + L+ + + G L +R +G + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LDVDEK---------- 164
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIP 912
EY + P ++A E +L + + +D WS G+ ++E +T GIP
Sbjct: 165 -EYHAEGGK-------VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
Query: 913 PFTAESPEII 922
E P+++
Sbjct: 217 --AVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 693 KPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ + GAFG+VFLA L A+K LK + D R E +L +++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR------------IYIAE 795
+V+F+ D L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 796 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+ A + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------------- 168
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
D + +Y + H+ + ++ PE ++ + +D WS+G++L+E T
Sbjct: 169 --DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++K + G FG V++ + + A+K LK M ++ L E N++ T+++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
+VR + T + +Y++ EY+ G L L+ + + ++ + A++ + Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ D Y
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARV------------------IEDNEYTA-- 160
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
R A + APE + +D WS GI+L+E +T G P+ S
Sbjct: 161 ------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 692 IKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
I + RG FG VFLA+ + + L +K L+K +N E ++ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDV--------ARIYIA-E 795
VVR CR+ Y+++EY + GDL LR +E + ++ + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ L +++L + VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
D + EY + N A+ +LAPE + + +D WS G++++E F G PF
Sbjct: 166 -DVYNSEYYKLRN-----ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
S E + + + K+ P VP L+ R +P R
Sbjct: 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 693 KPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDI---ERILAERNILITVRN 746
+ G FG V K++ + A+K+LK + ND + +L E N++ + N
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDN----NDPALKDELLREANVMQQLDN 55
Query: 747 PFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALE 801
P++VR C ++ LVME G L L+K + V I ELV + ++
Sbjct: 56 PYIVRMIG--ICEAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMK 109
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL VHRDL N+L+ + K++DFGLSK + +D +Y
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK-----------------ALGADENYY 152
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESP 919
+ + + APE + + +D WS G++++E F G P+ +
Sbjct: 153 KAKTHGK-------WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
E+ ++ C P E DL+ + ++R G
Sbjct: 206 EVT--QMIESGERMEC-PQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID-------DFEIIKP 694
EL D T + Y + +S+S + V + +S D + I+
Sbjct: 47 ELGDSDDVTHATDYDADE----ESLSPQTDVCQ---EPCETTSSSDPASVVRMQYNILSS 99
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
++ G+ G VF+ K GD KV+ K + R E +IL T+ + ++ +
Sbjct: 100 LTPGSEGEVFVCTKH--GDEQRKKVIVKA-VTGGKTPGR---EIDILKTISHRAIINLIH 153
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDL 813
++ + + +VM DL++ + + G L + A I I +L AL YLH GI+HRD+
Sbjct: 154 AYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDV 211
Query: 814 KPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
K +N+ + + L DFG + K+ +T P +
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDT------------PQC--------------Y 245
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
GT + +PE+L + D WS G++LFE
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 693 KPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V +A K A+K+LK D K D+ +++E ++ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEK-DLSDLISEMEMMKMIG 81
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------CLEED---VARIYIAE 795
++ ++ + T LY+++EY + G+L LR C ++ +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 796 LV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------------- 188
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
D H+ +Y + R ++APE L + + +D WS G++L+E
Sbjct: 189 --------DIHHIDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 909 T-GIPPFTAESPEIIF 923
T G P+ E +F
Sbjct: 237 TLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 46/243 (18%)
Query: 695 ISRGAFGRVFLARKRT-----TGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ GAFG V+ +G + A+K L+K ++ + L E +++ +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE------ 801
+V+ + Y++ME + GGDL S LR + + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
YL + +HRDL N L++ G+ +K+ DFGL++ + + D E +G++P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKS--DYYRKEGEGLLPV 177
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 915
++APE LL + +D WS G++++E +T G P+
Sbjct: 178 ----------------------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 916 AES 918
A +
Sbjct: 216 ALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 692 IKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
++ + AFG+++ G L AIK LK D+ E +++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVARI---------- 791
+V T + ++ EYLN GDL+ L VGC ++ +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 792 YIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR--------------- 172
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FIT 909
I +D + R + ++ ++ PE ++ + +D WS G++L+E F
Sbjct: 173 -EIYSADYY---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
Query: 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSD 939
G+ P+ S + + + + R++ PC D
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL-LPC-SED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVL-----------KKLD-MIRKNDIERILAERN 739
+K I RGA ++L GD IK + +LD IR+ ER E
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 740 ILIT-----VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
I+ V P V +N +VMEY+ G L L+ G E +++R
Sbjct: 52 IMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR---- 102
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
E+ + LHS GI+H DL N+++ G I L DFGL++
Sbjct: 103 EIGRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 47/273 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V++ T + AIK LK M+ E L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLG 807
+ + +Y+V E++ G L L+ E D + + +LV + Y+ +
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQLVDMAAQIADGMAYIERMN 122
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDL+ N+L+ + K+ DFGL++ LI + EY
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDN-------------------EYTA-- 159
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926
R A + APE L +D WS GI+L E +T G P+ + + +
Sbjct: 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
R PC P +L+ DP++R
Sbjct: 217 -ERGYRMPC-PQGCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G FG V++ T + AIK LK M E L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 812
+ + +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
L+ N+L+ + K+ DFGL++ LI + EY R
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDN-------------------EYTA-----RQ 161
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 931
A + APE L +D WS GI+L E T G P+ + D + R
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PC P + DL+ + +P +R
Sbjct: 221 RMPC-PPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 70/265 (26%)
Query: 693 KPISRGAFGRVFLA------RKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V +A + + + A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK------------------------ 780
++ ++ + T LY+++EY + G+L LR
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 781 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839
V C + VAR +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 LVSCAYQ-VAR--------GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
D H +Y + R ++APE L + + +D WS
Sbjct: 183 -----------------DVHNIDYYKKTTNGRLPV----KWMAPEALFDRVYTHQSDVWS 221
Query: 900 VGIILFEFIT-GIPPFTAESPEIIF 923
G++L+E T G P+ E +F
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 55/262 (20%)
Query: 692 IKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------YIAELVLAL 800
+V R + LV + + G L +R E+ RI + ++ +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVR------ENKDRIGSQDLLNWCVQIAKGM 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL + +VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------------------ 164
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-- 916
EY + P ++A E +L + +D WS G+ ++E +T G P+
Sbjct: 165 -EYHADGGK-------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
Query: 917 --ESPEIIFDNILNRKIPWPCV 936
E P+++ ++P P +
Sbjct: 217 AREIPDLLEK---GERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 691 IIKPISRGAFGRVFLARKRTTGD---LFAIKVLKK--LDMIRKNDIERILAERNILITVR 745
I K I G FG V R + G AIK LK + R++ L+E +I+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD----FLSEASIMGQFD 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------L 798
+P ++ T + +V EY+ G L + LRK + + +LV
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIAS 117
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL +G VHRDL N+L+ + K++DFGLS++ + + + + G +P
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI-- 173
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ APE + + A+D WS GI+++E ++
Sbjct: 174 --------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 35/151 (23%)
Query: 768 YLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-------ALEYLHSLGIVHRDLKPDNLL 819
Y+N G+L L++ E + + + +LV + YLH G++H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 878
I + +K+TD LS+ DL P D H DN NR P
Sbjct: 150 IDEELQVKITDNALSR--------DL--------FPMDYHC----LGDNENR------PV 183
Query: 879 DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
++A E L+ E+ A+D WS G++L+E +T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 683 RTSIDDFEIIKPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIR-KNDIERILA 736
+ ++ + GAFG+V +R + AIK LK+ + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 790
E ++ +++P +V T ++ EYL GDL+ L VG D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 791 ---------IYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
++IA + A +EYL S VHRDL N L+ +K++DFGLS+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
S +Y R + ++ ++ PE +L + +D WS
Sbjct: 176 ---------------SADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 901 GIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 939
G++L+E F G+ P+ S + + + I +R++ PC P D
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC-PED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERI--LAER 738
I K I G FG V R + G AIK LK +D +R+ L E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEA 56
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV- 797
+I+ +P ++R T + ++ EY+ G L LR+ + + ++
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLR 113
Query: 798 ---LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
++YL + VHRDL N+L+ + K++DFGLS+ +
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR----------------LE 157
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+A Y T + T APE + + A+D WS GI+++E ++
Sbjct: 158 DSEATY-----TTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILIT 743
+F+ IK + GAFG V+ G+ AIK L++ + N + IL E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI----AELVLA 799
V NP V R + L+ + + G L +R+ ++++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LGADEK--------- 164
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY + P ++A E +L + + +D WS G+ ++E +T G P+
Sbjct: 165 --EYHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 693 KPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 750
K + G FG V++A K T A+K +K M +E LAE N++ T+++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGI 808
+ ++ ++ +Y++ E++ G L L+ ++ + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDL+ N+L++ K+ DFGL+++ N G A +P
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----------AKFP------- 166
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-ESPEII 922
+ APE + +D WS GI+L E +T G P+ +PE+I
Sbjct: 167 ---------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLA-RKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
+D + + I G FG V+ + A+K K + E+ L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQ 63
Query: 744 VRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALE 801
+P +V+ +N +++VME G+L S L+ L+ +Y +L AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
YL S VHRD+ N+L++ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 49/166 (29%), Positives = 66/166 (39%), Gaps = 53/166 (31%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LD-MIRKNDIERILAERNILI 742
I++GA ++L GD +K + K LD IR+ ER E +L
Sbjct: 2 IAKGAEAIIYL------GDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLS 52
Query: 743 TVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEEDVAR 790
R N VV DN +VMEY+ G L LLR++G V +
Sbjct: 53 RARKAGVNTPVVYDVD----PDNKTIVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK 105
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
LH GIVH DL N+++ D + L DFGL K
Sbjct: 106 ------------LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 56/258 (21%)
Query: 693 KPISRGAFGRVFLAR----KRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITV- 744
KP+ G FG+V A ++ D A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEMELMKLIG 75
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR------------------KVGCLEE 786
++ ++ T LY+++EY G+L LR + ++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 787 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
V+ Y ++ +EYL S +HRDL N+L+ D +K+ DFGL++ G+ + ID
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GV--HDIDYY 190
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
++G +P ++APE L + + +D WS GI+++E
Sbjct: 191 KKTSNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 907 FIT-GIPPFTAESPEIIF 923
T G P+ E +F
Sbjct: 229 IFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-09
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 64/225 (28%)
Query: 672 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK------------- 718
V PL R S DDF++ + G FG F + D +
Sbjct: 130 VGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRV 189
Query: 719 VLKKLDMIR--------------KNDIERILAERNILITV-RNPFVVR-------FFYSF 756
VLK+++M R K E + E + + RNP +F S
Sbjct: 190 VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSN 249
Query: 757 TC-----RDNLYLVMEYLNGGDLYSLLR-KVG----CLEE-------------------D 787
T + + +LV ++ + L L K+G CLEE +
Sbjct: 250 TADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
V + + +++ L LH +GIVHRD+KP+NLL+ DG +K+ DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ + KN L E I+ +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 774 LYSLLR----KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAH 822
L L + + DV I + L+ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 882
+ IK+ DFG+S+ + + +Y + R AV +++
Sbjct: 166 NYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWMS 200
Query: 883 PE-ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
E ILLG + A+D W+ G+ L+E +T E P
Sbjct: 201 WESILLG-KFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 42/255 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ K + GAFG+V A K A+K+LK ++ E +++E I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--TAHSSEREALMSELKIM 92
Query: 742 ITVRNPF-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVL 798
+ N +V + T + ++ EY GDL + LR+ L + + ++
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ +L S +HRDL N+L+ H G I K+ DFGL++ IM +D
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR----------------DIM-ND 194
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA 916
++Y + +A ++APE + + + +D WS GI+L+E F G P+
Sbjct: 195 SNYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-- 244
Query: 917 ESPEIIFDNILNRKI 931
P + D+ + I
Sbjct: 245 --PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------------- 791
+P ++ + R LYL +EY G+L LRK LE D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 792 --YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ KN L E IL +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKILRP--DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 774 LYSLLRKVGCLEEDV------------------ARIYIA-ELVLALEYLHSLGIVHRDLK 814
L L +++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 815 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 874
N L+ + IK+ DFG+S+ + + +Y + R A
Sbjct: 166 TRNCLVGENLTIKIADFGMSR---------------------NLYAGDYYRIQGR----A 200
Query: 875 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDN 925
V ++A E +L + A+D W+ G+ L+E + P+ + E + +N
Sbjct: 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +++ I G FG V+L AIK +++ M ++ IE E +++ + +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE----EAQVMMKLSH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 805
P +V+ + T R + LV E++ G L LR + G ++ ++ + YL S
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDL N L+ + +K++DFG+++ L D Y
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL------------------DDQYT---- 156
Query: 866 TDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 918
S+ GT + +PE+ +++ +D WS G++++E F G P+ S
Sbjct: 157 -------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 52/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 748
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA------ 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 799
+ + F S + R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 915 TAESPEIIFDN 925
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 70/255 (27%)
Query: 690 EIIKPISRGAFGRVFLA-----------------RKRTTGDLFAIKVLKK-LDMIRKNDI 731
++ + G FG V L L A+KVL+ + D
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDASDNAREDF 66
Query: 732 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------- 780
+ E IL + +P + R T L ++MEY+ GDL L+K
Sbjct: 67 LK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 781 -----VGCLEEDVARIYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
L +Y+A + + + YL SL VHRDL N L+ + IK+ DFG
Sbjct: 124 SKSLSFSTL------LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 894
M + + +Y + R A ++A E +L +
Sbjct: 176 -------------------MSRNLYSSDYYRVQGR----APLPIRWMAWESVLLGKFTTK 212
Query: 895 ADWWSVGIILFEFIT 909
+D W+ G+ L+E +T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 56/293 (19%)
Query: 689 FEIIKPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
F + + + +G FG V L + + A+K+LK D+ +DIE L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 746 NPFVVRFF-YSFTCRDNLYL-----VMEYLNGGDLYS--LLRKVG----CLEEDVARIYI 793
+P V++ S R L ++ ++ GDL++ L+ ++G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
++ +EYL S +HRDL N ++ + + + DFGLSK I
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----------------KI 163
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911
D Y+Q A P +LA E L + +D W+ G+ ++E +T G
Sbjct: 164 YSGDY----YRQG------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
Query: 912 PPFTA-ESPEI----IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
P+ E+ EI I N L + P D + +L+ + +P R
Sbjct: 214 TPYAGVENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 34/139 (24%)
Query: 773 DLYSLL----RKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827
DLY+ L R +G + VAR +L+ A++Y+H GI+HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887
L DFG + G + HY GT D APE+L
Sbjct: 301 LGDFGAACF-------------ARGSWSTPFHY------------GIAGTVDTNAPEVLA 335
Query: 888 GTEHGYAADWWSVGIILFE 906
G + + D WS G+++FE
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 690 EIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
E++ I RG V LAR + TG+ ++ + L+ + + E ++ +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 748 FVVRFFYSFTCRDNLYLV---MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYL 803
+V + +F + L++V M Y + DL G E +A YI + VL AL+Y+
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA--YILQGVLKALDYI 117
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H +G VHR +K ++LI+ DG + L+ GL S + +IN H
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------HGQR 157
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF 914
+ + ++S P +L+PE+L GY A D +SVGI E G PF
Sbjct: 158 LRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 714 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773
L A+K+L+ + K L E I+ ++NP ++R D L ++ EY+ GD
Sbjct: 46 LVAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 774 LYSLL-----RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIA 821
L L ++ + IA L+ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 822 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 881
+ IK+ DFG+S+ + + +Y + R AV ++
Sbjct: 164 NHYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWM 198
Query: 882 APEILLGTEHGYAADWWSVGIILFEFITGIP--PFTAESPEIIFDN 925
A E +L + A+D W+ G+ L+E T P++ S E + +N
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 703 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTCR 759
V+LAR TG L +++ D+ + E + A +N ++ R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRIT---DLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817
L+++ ++ G SLL+ + E + + + L YLH G +HR++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 818 LLIAHDGHIKLTDFGLSKI-GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
+LI+ DG + L+ GLS + L+ N G + + +P++ S
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRN-----GQKAKVVY----DFPQF---------STSV 171
Query: 877 TPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 914
P +L+PE+L +GY +D +SVGI E TG PF
Sbjct: 172 LP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKV-LKKL-DMIRKNDIERILAERNILIT 743
D +++ + GAFG V+ R GD ++V +K L + + D L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 744 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE 801
+ +VR SF R ++++E + GGDL S LR+ E + + + +L+ A +
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 802 ------YLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDG 852
YL +HRD+ N L+ G K+ DFG+++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----------------- 167
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 911
D + Y + R A+ ++ PE L D WS G++L+E F G
Sbjct: 168 ----DIYRASYYRKGGR----AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
Query: 912 PPFT 915
P+
Sbjct: 220 MPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V A + G AIK+LK + +ND E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 745 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 791
+P ++ + R LY+ +EY G+L LRK LE D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 792 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ +++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 53/169 (31%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LDM-IRKNDIERILAERN 739
+ I +GA ++L D + + K LD +R+ ER E
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREAR 51
Query: 740 ILITVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEED 787
IL R +V DN +VMEY+ G L LLR+VG
Sbjct: 52 ILAKAREAGVPVPIVYDVDP----DNGLIVMEYIEGELLKDALEEARPDLLREVG---RL 104
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
V + LH GIVH DL N++++ G I DFGL +
Sbjct: 105 VGK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 7e-08
Identities = 47/160 (29%), Positives = 63/160 (39%), Gaps = 42/160 (26%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRN-- 746
I +GA + + +V K +LD +R ER AE +L R
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRT---ERTRAEARLLSEARRAG 397
Query: 747 ---PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-------SLLRKVGCLEEDVARIYIAEL 796
P + Y + +VMEY+ G DL L+RKVG E VA+
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVG---EIVAK------ 443
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
LH GIVH DL N ++ D + L DFGL K
Sbjct: 444 ------LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 52/251 (20%)
Query: 695 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 748
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS------ 62
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 799
+ + F S R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 914
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 915 TAESPEIIFDN 925
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-07
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIRKNDIERILAERNILIT 743
S F+I+ + G FG+V A R + A+K+++ + R IE E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 744 VRNPF----VVRFFYSFTCRDNLYLVM-EYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ F + R+F + T ++ +VM +Y G L + K G ++A+++
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHR----HLAQIIF 238
Query: 799 ----ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
AL+Y H+ L ++H DLKP+N+L+ + +D P T+
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETS----------------DTVVD---PVTNRA 279
Query: 854 MPSDAHYPEYQQ----TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908
+P D D R+ +A V T Y +PE++LG Y+ D WS+G I++E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 909 TG 910
TG
Sbjct: 340 TG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 71/260 (27%)
Query: 687 DDFEIIKPISRGAFGRVF--LARKRTTGDL---FAIKVLKKLDMIRKNDIERI--LAERN 739
+ +++ + +G+FG V+ AR G+ A+K + + +R ERI L E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEAS 61
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--------- 790
++ VVR + +VME + GDL S LR L +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR---SLRPEAENNPGRPPPTL 118
Query: 791 ----IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
AE+ + YL++ VHRDL N ++AHD +K+ DFG+++ D+
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIY 170
Query: 847 GPETD-------GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
ETD G++P ++APE L ++D WS
Sbjct: 171 --ETDYYRKGGKGLLPV----------------------RWMAPESLKDGVFTTSSDMWS 206
Query: 900 VGIILFEFITGIPPFTAESP 919
G++L+E + AE P
Sbjct: 207 FGVVLWEITS-----LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 695 ISRGAFGRVFLARKRTTG---DLFAIKVLKK--LDMIRKNDIERILAERNILITVRNPFV 749
I G FG V R + G AIK LK + R++ L+E +I+ +P +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFDHPNI 67
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEY 802
+ T + ++ E++ G L S LR ++ + + +LV ++Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L + VHRDL N+L+ + K++DFGLS+ L ++T D P
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSD----------------PT 164
Query: 863 YQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
Y S++G + APE + + A+D WS GI+++E ++
Sbjct: 165 YT--------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751
I G FG+V AR + G AIK +K + K+D E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----------------YIAE 795
+ R LYL +EY G+L LRK LE D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 51/276 (18%)
Query: 657 ENSRLILDSVSQSSGVSTPLHSSHKERTS--IDDFEIIKPISRGAFGRVFL-ARKRTTGD 713
+ S L D + PL + + + F +I + GAFG++F+ A + +T +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEE 175
Query: 714 LFAIKVLKKLDMIRKNDIERILA-------------ERNILITVR--NPFVVRFFYSFTC 758
A + + + K ER++A E IL R + +++
Sbjct: 176 AEARRGVNSTNQ-GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS 234
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLALEYLHSLGIVHRDL 813
N Y++ + + DLYS + +D R + +L+ A+EY+H ++HRD+
Sbjct: 235 EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K +N+ + DG I L DFG MP +++ +
Sbjct: 294 KLENIFLNCDGKIVLGDFGT-------------------AMP-------FEKEREAFDYG 327
Query: 874 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
VGT +PEIL G + D WS G+IL + ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 693 KPISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
K + G FG V L++ + A+K +K LD+ ++IE L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 750 VRFF-YSFTCRDNLYL-----VMEYLNGGDLYSLL--RKVGCLEEDVAR----IYIAELV 797
++ F + ++ ++ GDL+S L ++G L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 691 IIKPISRGAFGRVFLARKRTTGDLFAIKV----LKKLDMIRKNDIERILAERNILITVRN 746
IK + G RV+L T + + +K+ K D R+ I ++LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPV---- 55
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P V+ S YL+ME++ G L +V E++ +AEL+ L L L
Sbjct: 56 PKVL---ASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
+ H DL P N+L+ + + D+ + G
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 50/231 (21%)
Query: 693 KPISRGAFGRVFLARKRTTGD---LFAIKVLKK-LDMIRKNDIERILAERNILITVRNPF 748
K I G FG VF + G AIK LK ++ D L+E +I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF---LSEASIMGQFSHHN 67
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDL----------YSLLRKVGCLEEDVARIYIAELVL 798
++R T ++ EY+ G L +S + VG L A
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA--------- 118
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL + VHRDL N+L+ + K++DFGLS++ + + + + + G +P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPI-- 174
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ APE + + A+D WS GI+++E ++
Sbjct: 175 --------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 692 IKPISRGAFGRVF----LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+K + GAFG V+ + T AIK+L + + N + E I+ ++ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEALIMASMDHP 69
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----YIAELVLALEYL 803
+VR + LV + + G LL V ++++ + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHG---CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+VHRDL N+L+ H+K+TDFGL+++ L G E EY
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------LEGDEK-----------EY 166
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIPPFTA 916
N ++A E + + + +D WS G+ ++E +T GIP T
Sbjct: 167 ------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TR 218
Query: 917 ESPEII 922
E P+++
Sbjct: 219 EIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 36/188 (19%)
Query: 675 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---I 731
PL + DDF + K + GAFG V+ + + K K + + + +
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVY----KASLVNKQSKKEGKYVLKKATEYGAV 175
Query: 732 ERILAERNILITVRNPFVVRFFYSFTC------RDNLYLVMEYLNGGDLYSL-------- 777
E + ER + N F Y F D +LV Y L L
Sbjct: 176 EIWMNER-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPY 233
Query: 778 ------LRKVGCL------EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DG 824
L KV L E + + + +++ AL+ LHS GIVHRD+KP N++ + G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 825 HIKLTDFG 832
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 64/263 (24%)
Query: 695 ISRGAFGRVFLARKRTTGDLF---------AIKVLKKLDMIRKNDIERILAERNILITVR 745
I +G FG V+ G L A+K L ++ + ++E+ L E I+
Sbjct: 3 IGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFS 54
Query: 746 NPFVVRFFYSFTCRDNLYLV-MEYLNGGDLYSLLRK----------VGCLEEDVARIYIA 794
+P V+ + LV + Y+ GDL + +R +G VA+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK---- 109
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
+EYL S VHRDL N ++ +K+ DFGL++
Sbjct: 110 ----GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR------------------- 146
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D + EY N H+ P ++A E L + +D WS G++L+E +T G P
Sbjct: 147 --DIYDKEYYSVHN---HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
Query: 913 PFTAESPEIIFDNILN-RKIPWP 934
P+ I +L R++ P
Sbjct: 202 PYPDVDSFDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 45.9 bits (110), Expect = 2e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 764 LVMEYLNGGDLYS-LLRKVGCLEEDVARIY--IAELVLALEYLHSLGIVHRDLKPDNLLI 820
LVME++ G + + L+ V L ED +Y I EL+ L G+VH DL N+L+
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKL--YREAGLVHGDLSEYNILV 148
Query: 821 AHDGHIKLTDFG 832
DG + + D
Sbjct: 149 -DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL--DMIRKNDIERILAERNILITVRNPFV 749
+K + G FG V GD I V K D + + I + ++ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGI 808
VR +L LV + G L +R+ L+ + ++ + YL +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
VHR+L N+L+ D +++ DFG+ +D YP+ D
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGV----------------------ADLLYPD----DK 164
Query: 869 RNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ +S TP ++A E +L + + +D WS G+ ++E ++ G P+ P + D
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 53/245 (21%)
Query: 693 KPISRGAFGRVF--LAR---KRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 745
+ + +G+FG V+ +A+ K AIK + + +R ERI L E +++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR----ERIEFLNEASVMKEFN 67
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA---------RIYIA-E 795
VVR + ++ME + GDL S LR + E+ I +A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ + YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------------------- 167
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +TD + P +++PE L +D WS G++L+E T
Sbjct: 168 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 216
Query: 915 TAESP 919
AE P
Sbjct: 217 LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 716 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 775
AIK LK D E E + +++P +V T L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 776 SLL------RKVGCLEEDVARI----------YIAELVLALEYLHSLGIVHRDLKPDNLL 819
L VG ++D + ++ +E+L S +VH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ ++K++D GL + + L G + ++P
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMG---NSLLPI----------------------R 191
Query: 880 YLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPS 938
+++PE ++ + +D WS G++L+E F G+ P+ S + + + I NR++ PC P
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPC-PD 249
Query: 939 D 939
D
Sbjct: 250 D 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 72/298 (24%)
Query: 693 KPISRGAFGRVFL--ARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILIT 743
I G FG+V L A + + +K L+ +L +++ R L N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAEL 796
+ C ++ LV+E+ GDL + LR ++DV + E+
Sbjct: 61 LGQ-----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
L +LH +H DL N + D +K+ D+GL+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL--------------------- 148
Query: 857 DAHYPE-YQQTDNRNRHSAVGTPDYLAPEI-------LLGTEHGYAADWWSVGIILFE-F 907
YPE Y T + + +LAPE+ LL + ++ WS+G+ ++E F
Sbjct: 149 -EQYPEDYYITKDCH----AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
Query: 908 ITGIPPFTAESPEIIFDNIL---NRKIPWPCVP---SDMSFEAQDLINRFLIHDPNQR 959
P+ S E + ++ + K+P P + SD +E + +F DP R
Sbjct: 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIK----VLKKLDMIRKNDIERILAERNILITVRNPFVV 750
+ +G F ++F +R GD + +LK LD +N E +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 809
+ C D +V EY+ G L + L+K L ++ +A +L AL +L G+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 810 HRDLKPDNLLIAHDGH--------IKLTDFGLS 834
H ++ N+L+ + IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 30/134 (22%)
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+E+L S VHRDL N+L+A +K+ DFGL++ IM D+
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----------------DIM-HDS 291
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 917
+Y ++ S ++APE + + +D WS GI+L+E F G P+
Sbjct: 292 NYV--------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY--- 340
Query: 918 SPEIIFDNILNRKI 931
P +I D+ KI
Sbjct: 341 -PGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810
R +Y F + L + + +++ C + + + + +++ LEY+H GI H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 26/124 (20%)
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
Y ++ +E+L S +HRDL N+L++ + +K+ DFGL++ D+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DI------ 224
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITG 910
Y+ D + SA ++APE + + +D WS G++L+E F G
Sbjct: 225 -----------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 911 IPPF 914
P+
Sbjct: 274 ASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 18/37 (48%), Positives = 21/37 (56%), Gaps = 1/37 (2%)
Query: 799 ALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLS 834
AL LH GI H DL KP N L+ DG + DF L+
Sbjct: 123 ALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159
|
Length = 365 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
DLY +KV LE+ + Y ++ +E+L S +HRDL N+L++ + +K+ DFG
Sbjct: 170 DLY---KKVLTLEDLIC--YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
L++ D+ + D + DA P ++APE + +
Sbjct: 225 LAR--------DIY-KDPDYVRKGDARLPL----------------KWMAPETIFDRVYT 259
Query: 893 YAADWWSVGIILFE-FITGIPPF 914
+D WS G++L+E F G P+
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+E+L S VHRDL N+LI +K+ DFGL++ IM D++
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----------------DIM-RDSN 294
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
Y ++ S ++APE + + +D WS GI+L+E T G P+
Sbjct: 295 YI--------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 919 PEIIFDNILNR--KIPWPCVPSDMSFE 943
F N + R ++ P SD +E
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 5e-04
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 40/169 (23%)
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNI--------LI 742
IS G V+ AR G+ A+K+ K + K+ + I + R+ L+
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLV 62
Query: 743 TV------RN-----------PFVVRFFYSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCL 784
RN P + + N+ LVME++ + G L+ V
Sbjct: 63 FAWAEKEFRNLKRLYEAGVPVPEPI------LLKKNV-LVMEFIGDDGSPAPRLKDVPLE 115
Query: 785 EEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
EE+ +Y ++V + L G+VH DL N+L HDG + D
Sbjct: 116 EEEAEELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYI 793
LAE L + +VR T + + +V EY++ G L S LRK G L +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
L ++YL +G VH+ L +L+ D K++ F E
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------------RLQEDK-- 158
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
S+A Y T + + APE + A+D WS GI+++E ++
Sbjct: 159 --SEAIY-----TTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 41/193 (21%), Positives = 64/193 (33%), Gaps = 48/193 (24%)
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
A + L L L HR K N+L+ DG +KL G PE
Sbjct: 21 AVCLQCLGALREL---HRQAKSGNILLTWDGLLKL--DGSVAF---------KTPEQSR- 65
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 914 FTAESP-----EIIFDNILNRKIPWPCVPSDMS--FEAQDLINRFLIHDPNQRLGANGAA 966
+ E EI+ + + +S +D + P +R AN
Sbjct: 104 YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN--- 160
Query: 967 EVF-HCKIFIKKT 978
HC+ +T
Sbjct: 161 HYLAHCRALFAET 173
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
ISRG G + + G F +K + ++ I ++I + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKLQHPNIVKLIG 750
Query: 755 SFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIV 809
CR YL+ EY+ G +L +LR + I IA+ AL +LH S +V
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
+L P+ ++I DG D ++ L P TD +
Sbjct: 806 VGNLSPEKIII--DG----KDEPHLRLSL----------------------PGLLCTDTK 837
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
S+ Y+APE + +D + G+IL E +TG P AE
Sbjct: 838 CFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKV-LKKLDMIRKNDIERILAERNILITVRNPFVVR 751
K + G FG V + + + V K+ + ++++E L+E + +P V+R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 752 FFYSFTCRDNL--------YLVMEYLNGGDLYSLL--RKVG----CLEEDVARIYIAELV 797
C + +++ ++ GDL+S L ++G L + ++ ++
Sbjct: 65 LIG--VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824
VMEY++G +LY + R + ED + E++ + + GI+H DL N+L+ D
Sbjct: 109 VMEYIDGVELYRV-RVL----EDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 825 HIKLTDF 831
I + D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ +L S +HRDL N+L+ H K+ DFGL++ I N +++ ++ +A
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRN-------DSNYVVKGNAR 277
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 914
P ++APE + + + +D WS GI+L+E F G P+
Sbjct: 278 LP----------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818
L + L LL ++ L E + + L+ AL L +VH DL P NL
Sbjct: 123 LKLLRQLAAALRRLVAAELLDRLAELWERLLA-ALLALLPALP----LVLVHGDLHPGNL 177
Query: 819 LIAHDGHIK-LTDFGLSKIG 837
L+ G + + DF + +G
Sbjct: 178 LVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDLKPDNLLIAH 822
+VMEY+ G +LY L V +E I + +L + + GIVH DL N+L+
Sbjct: 184 VVMEYIEGVELYRLRLDVENPDE------ILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237
Query: 823 DGHIKLTDF 831
DG I + D+
Sbjct: 238 DGDIVVIDW 246
|
Length = 304 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 995 | |||
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.91 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.58 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.56 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.43 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.22 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.78 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.76 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.67 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.75 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.59 | |
| PLN02236 | 344 | choline kinase | 95.37 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.94 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.51 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.05 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.67 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.83 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.74 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 89.31 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.19 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 87.69 | |
| PTZ00296 | 442 | choline kinase; Provisional | 86.72 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 82.46 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 82.21 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 80.82 |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-67 Score=624.88 Aligned_cols=939 Identities=33% Similarity=0.398 Sum_probs=722.3
Q ss_pred CCCcccccccccCCCC-CCccccccccccCCCCCc---ccccccccccchhcc-cchH-HHHHhhchH--HHHHH-----
Q 001924 12 GIPSGLNRIKTRGGVS-KPDELTESRSYGVSRPPQ---KHKQKTVAQGHVKLA-NSFT-EEVRKGKKI--AQWFT----- 78 (995)
Q Consensus 12 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~--~~~~~----- 78 (995)
-+++|+|+|||+-.-. -+-.|..- -+.|+|- -.||+-|..|+...| |.|. -.-+++-|+ .+|..
T Consensus 80 p~e~df~~IklisngAygavylvrh---~~trqrfa~kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdmvla~ 156 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRH---KETRQRFAMKINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDMVLAV 156 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeec---cccccchhhcccccchhhhccccccCCcceechhhhhcccCCCCcchhhHHh
Confidence 4678999999974221 11111100 1223332 257888888877665 5554 223444444 34443
Q ss_pred hhhccceecCCCCCCCCCCCCCCCcCCccccccccccccchhhhHHHHhhhcccccCCccccccccCCCCCCCCCCccCC
Q 001924 79 SYISKFNIVSPNTENSGSEDKDVDVEDPRRTKLRHEGNHLNEKQSLAEHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAH 158 (995)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (995)
.|.-.+.||-+.--+.+.+-+-+ -+.||-..| ..|..|.-..- -+.+-++++|+||++.||.-.--+.+++
T Consensus 157 Eylh~ygivhrdlkpdnllIT~m-----GhiKlTDfg---Lsk~GLms~at-nl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 157 EYLHSYGIVHRDLKPDNLLITSM-----GHIKLTDFG---LSKKGLMSLAT-NLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred HhhccCCeecCCCCCCcceeeec-----ccccccchh---hhhhhhhhccc-hhhhcchHHHHHHhhhccccCCccccCh
Confidence 37777889988777666554433 234444343 56777765554 6778899999999999998888889999
Q ss_pred CcCCHH--------HHHHHHHHHHHHHHHhhhhh-----HhhhHHHHHHHHhhcCCCCchhhhhHHHHHHHHHHhhhhhc
Q 001924 159 SYNDLK--------ELLDTLHSRFDAAKEVVNSE-----LATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTS 225 (995)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (995)
.|+..+ +.+|.|+.+|+-.++-|..+ +|+|+.|.+...|+++-.-.|-++++++||..+-+|..||.
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 999999 99999999999999999999 99999999999999998899999999999999999999999
Q ss_pred chhhhhhhHHHHhhHHh---HhcccchHHHHhhhhHHHHHHhhhHHhhccccccchhcc--chhhHhhhcccCCcccccc
Q 001924 226 CLFRANCETIVQDLTEK---RQQCQVGLVKWLSTRMLFILTRCTRLLLFQKESEPIAEK--SLHKFKKCLESVPAVETSW 300 (995)
Q Consensus 226 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 300 (995)
=-||+-||-|+|.||.+ ||+|+-+.++|...+|+||+|||+|+-+|.+|...+++- ..++|.-|.+-..++..+|
T Consensus 308 ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss~ 387 (1205)
T KOG0606|consen 308 GALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSSW 387 (1205)
T ss_pred hhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCccccccccccccccccccccccccch
Confidence 99999999999999999 999999999999999999999999999999999999888 6789999999999999999
Q ss_pred cC-------CCCccccchhhHHHHhhhccccccccc--cccccccccccCCcCccccccccccceeccCCCCccccchhh
Q 001924 301 VP-------SPGTAESDLDYASYQKANAKKKISGQQ--KVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSR 371 (995)
Q Consensus 301 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (995)
-- .+-.-++...+-.++- +-.++. +...-|++..-.-+..+++..+| -.--|.+.+-++-
T Consensus 388 ~~l~~~~t~~~~~~~~~~~~~~~~~-----~~~g~k~~~~~~sp~~~kl~~st~~ss~s~~------~~~s~~~~~~~~~ 456 (1205)
T KOG0606|consen 388 ESLAQLETATPREKSSQSSQGEVSP-----SSAGQKDSWKSNSPESSKLELSTALSSVSPN------HPGSPSKSLTSAA 456 (1205)
T ss_pred hhhhccccccccccccccccccccC-----CccccccccccCChhhhhccccchhhhcccc------cCCCccccccchh
Confidence 65 1111111111111111 111111 12222322222222122222222 0122223322221
Q ss_pred h----h------hhhcccccce------EEEEeecC-------C--------------CCCCcCCCCCCCCCceeeeccc
Q 001924 372 M----Q------EQQSHIVEGR------IVEVTKSN-------C--------------GSPHEQGQSLDGSDSVICRICE 414 (995)
Q Consensus 372 ~----~------~~~~~~~~~~------~~~~~~~~-------~--------------~~~~~~~~~~~~~~~~~~~~~~ 414 (995)
- + --++++..+| ++.-++.. | ...|..-+.+..+|+.||||||
T Consensus 457 s~~~~~~~~s~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~d~~i~~~~e 536 (1205)
T KOG0606|consen 457 STLRTALRTSSPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTSDSGICRICE 536 (1205)
T ss_pred hhhccccccCCCCCCccccccCCCCCccccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccCCcccccccc
Confidence 1 1 1113333333 22111100 1 1345666889999999999999
Q ss_pred ccccccccccccccccccccccccccchhhhHHhHHHHHHHHHhhcc--CCCCCCCCCCcccccccCccceeccCCCccc
Q 001924 415 EVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCN--SSSHPILGSPENSRTQSMNSAITYDGYSPKI 492 (995)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (995)
.++|..|.|.|++||+++++|+.+|++++.|+.|+.+.++++..|.. ++.+| -|+|..+..+ +...-++..| +.
T Consensus 537 ~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~-~~~~l~s~lS--~~~~sS~p~S-rd 612 (1205)
T KOG0606|consen 537 AEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP-TGGPLCSPLS--PRSLSSNPSS-RD 612 (1205)
T ss_pred cccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC-cccccccccC--CCCCCCCccc-Cc
Confidence 99999999999999999999999999999999999999999877654 33444 4667777663 5556677777 99
Q ss_pred hhhhccCcchhhhccccccccccccCCCC--cccccccccccccCCccccCCCCccccCCCCCCCCCCCcccccccCCCC
Q 001924 493 SEWRNKGVEGMFEDIHEMDTACIDDSHLG--SLNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPA 570 (995)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (995)
+.|+|+++++|+++.+.++.. +++..+| .+..|-..|-+. .|-..+++|+.+..||..+|...|.|++|.++-++-
T Consensus 613 sspsrd~s~~~~~~~ppI~i~-~~~~~yGft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v 690 (1205)
T KOG0606|consen 613 SSPSRDSSAAMLSLRPPITIH-FSGKKYGFTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPV 690 (1205)
T ss_pred cccccccchhhcCcCCceeee-ccccccCceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCccc
Confidence 999999999999999987654 4455566 778888999998 999999999999999999999999999999999999
Q ss_pred cchhHHHHHhhhh--ccceeccccCCchhh-hhHHHHhcchHHHHhhhccceEEecchh-HHHHHHhhhhhhhhhhhccC
Q 001924 571 ELEDVQQMIELAD--IARCVADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFG-SRIEKLLREKYILACELLDE 646 (995)
Q Consensus 571 ~~~~~~~~~~~~~--~~~~~~~~~~~k~~k-~~~~a~~~~l~~vl~~~kl~~lvid~~g-~Ri~kllr~k~il~~~lL~~ 646 (995)
+..+.+||++|-+ ++||++-+...|... +--.|+....+.+|.+++.+.+++.+++ .|+.+++++.+.-.|+++..
T Consensus 691 ~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~ 770 (1205)
T KOG0606|consen 691 HGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHT 770 (1205)
T ss_pred chhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcc
Confidence 9999999999999 999999888888887 6667899999999999999999999999 77889998888776776544
Q ss_pred CCCCcccccccchhhhhhhcccCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc
Q 001924 647 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726 (995)
Q Consensus 647 ksp~s~S~~~ensrllldslsqssg~~tp~~s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~ 726 (995)
...-..+ .+.+-.+.. ......|..+.. -+.+.+.+.+.+-+-.|.++.++...-..+|...+.|+.......
T Consensus 771 ~~s~~ss----~eS~pgdp~--~sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i 843 (1205)
T KOG0606|consen 771 SRSFLSS----SESLPGDPT--RSLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKI 843 (1205)
T ss_pred ccccccc----cccCCCCcc--cccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhh
Confidence 3221000 000000000 001112222222 467889999999999999999999988888888888887776666
Q ss_pred chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 001924 727 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806 (995)
Q Consensus 727 se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~ 806 (995)
.....+....+-+++....+|.++..+..+......+++++|..+++|...+++.++.+.+.++.++..+.++++|||..
T Consensus 844 ~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~ 923 (1205)
T KOG0606|consen 844 RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS 923 (1205)
T ss_pred ccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc
Confidence 66666667777777766778999988888888889999999999999999999988899889999999999999999999
Q ss_pred CceeeecCCCcEEeccCCcEEEEecC-CcccccccccccCCCCCCCCCCCCCCCC---CccccccccCCcCCCCCCcccC
Q 001924 807 GIVHRDLKPDNLLIAHDGHIKLTDFG-LSKIGLINNTIDLSGPETDGIMPSDAHY---PEYQQTDNRNRHSAVGTPDYLA 882 (995)
Q Consensus 807 GIIHRDLKPeNILLDenG~VKLsDFG-LArv~~~~~s~dlsg~~t~gi~~s~~~y---s~~~~~~~~~s~t~vGTp~YmA 882 (995)
.+.|+|++|.|+|+..+|+.++.||| +.++..+....+.+|+...+..-..... ......+........||+.|.+
T Consensus 924 ~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~la 1003 (1205)
T KOG0606|consen 924 LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLA 1003 (1205)
T ss_pred hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccC
Confidence 99999999999999999999999999 6666666666666555443332222111 1111122234556789999999
Q ss_pred hhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 883 PEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 883 PEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
||.+.+...+..+|+|++|++++|.++|.+||....++.++++|..+..+|+..+...++++++++...+..+|.+|..+
T Consensus 1004 Pe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1004 PEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred CcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCccccccccccccchh
Q 001924 963 NGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 963 ~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
....+.-.|+||+..+|..+..|-
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred ccccccccCCccCCCCcccccccc
Confidence 989999999999999999887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=452.96 Aligned_cols=272 Identities=48% Similarity=0.860 Sum_probs=252.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++++.||+|+||+||+++.++|++.||+|++++.......+.+...+|..||..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45579999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+|+||+.||.|+..|++.+.|++..++.++.+|+.||.|||+.|||||||||+|||+|.+|+++|+|||+|+..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~----- 175 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED----- 175 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999841
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
......+.++|||+.|||||++.+.+|+..+|+||||+++||||+|.+||.+.+...+
T Consensus 176 ----------------------~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 176 ----------------------LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred ----------------------ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 1223445668999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC-HHHHHHHHcCcccccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS-A~EIlEiL~HPfF~~~~~n~~s 983 (995)
+++|..++... .+..++.++.+|++++|..||++|.. ..++.++-+||||..+.|+.+.
T Consensus 234 ~~~I~~~k~~~--~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~ 293 (357)
T KOG0598|consen 234 YDKILKGKLPL--PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL 293 (357)
T ss_pred HHHHhcCcCCC--CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH
Confidence 99999887433 34569999999999999999999985 4568889999999999998763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=460.57 Aligned_cols=300 Identities=47% Similarity=0.806 Sum_probs=258.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
+...++|++++.||+|+||.||+|+.+.||..||+|++++..+......+.+..|.++|....+|+||++|..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44779999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||||||++||++..+|.+.+.|++..++.++.+++.||+.||+.|+|||||||+|+|||..|++||+|||||.-....+-
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999963322222
Q ss_pred ccCCC------CCCCCCCCCCC--------------CCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHH
Q 001924 843 IDLSG------PETDGIMPSDA--------------HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (995)
Q Consensus 843 ~dlsg------~~t~gi~~s~~--------------~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGV 902 (995)
.+..+ .......+.+. .+..+.........+.+|||.|||||++.+.+|+...|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 22100 00001011111 11112223333445679999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 903 ILFEFITGIPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 903 ILyELLTGr~PF~g~s~~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
||||||.|.+||.+.++.+.+.+|++... .+|. ...++++++|||.+||+ ||++|.....+.++..||||.+++|+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 99999999999999999999999998763 3342 24678999999999999 99999999999999999999999999
Q ss_pred cccc
Q 001924 981 CVSM 984 (995)
Q Consensus 981 ~~s~ 984 (995)
.+..
T Consensus 455 ~l~~ 458 (550)
T KOG0605|consen 455 HLRE 458 (550)
T ss_pred hhhc
Confidence 8743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=450.43 Aligned_cols=264 Identities=35% Similarity=0.583 Sum_probs=235.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----KNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s----e~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...+.|.+.+.||+|+||.|-+|..+.||+.||||++.+..... ......+.+|+++|++++|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 34577899999999999999999999999999999998755433 12334567999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC---CcEEEEecCCccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKI 836 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen---G~VKLsDFGLArv 836 (995)
+..||||||+.||+|++.+-.++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 6799999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC---CchHHHHHHHHHHHHHHcCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y---s~KSDIWSLGVILyELLTGr~P 913 (995)
.. ....+.+.||||.|.|||++.+..+ ..++|||||||+||-+|+|.+|
T Consensus 329 ~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 21 2345678999999999999987654 4588999999999999999999
Q ss_pred CCCCCHHH-HHHHHHccCCCCC-CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 914 FTAESPEI-IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 914 F~g~s~~e-i~qkIl~~~~~~p-~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
|.+..... +.++|..+.+.+. ..+..++.++.+||++||..||++||| +.++|+||||+...
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAP 444 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhccc
Confidence 99876655 8899999988764 456789999999999999999999999 88999999999765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=454.97 Aligned_cols=256 Identities=33% Similarity=0.628 Sum_probs=244.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|...+.||+|||+.||.+++..+|+.||+|++.+.........+.+.+|++|.+.|+|||||+++++|++..++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|+|..|+|..++++...+++.+++.+++||+.||.|||+++|||||||..|+|++++.+|||+|||||...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l--------- 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL--------- 168 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee---------
Confidence 99999999999998899999999999999999999999999999999999999999999999999999852
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
..+..+..+.||||.|.|||++....++..+||||+||+||.||.|++||...+-.+.+..|
T Consensus 169 ------------------e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 169 ------------------EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred ------------------cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 23345677899999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
....+.+| ..++.++.+||.+||..||.+||| +.++|.|+||.
T Consensus 231 k~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 231 KLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred HhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 99999877 589999999999999999999999 88899999993
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=427.17 Aligned_cols=268 Identities=42% Similarity=0.792 Sum_probs=252.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++++.||.|+||.|.+++.+.+|..||+|++.+....+-...+...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999988888888999999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999841
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
...+.+.||||.|+|||++...+|+.++|+|+|||++|||+.|.+||...++..++
T Consensus 195 ------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 195 ------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred ------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 12367889999999999999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC-H-HHHHHHHcCccccccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-A-NGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS-A-~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
++|+.++..+| ..+++++++||+++|+.|-.+|.. . +...++.+||||+...|..+.-
T Consensus 251 ~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~ 310 (355)
T KOG0616|consen 251 EKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQ 310 (355)
T ss_pred HHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhh
Confidence 99999999877 689999999999999999999955 3 3689999999999999976643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=442.46 Aligned_cols=281 Identities=37% Similarity=0.680 Sum_probs=254.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccC
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~ 760 (995)
......+|.+.+.||.|+|++|++|+.+.+++.||||++.+.....+.....+..|-++|.+| .||.|++||..|++..
T Consensus 68 ~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 68 EKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 356789999999999999999999999999999999999998888888888999999999999 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+|+|+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||+|.++++||+|||.|+++...
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999964322
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.... . .+...........+++||..|.+||+|.....++.+|||+||||||.|+.|.+||.+.+.-
T Consensus 228 ~~~~-------------~-~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 228 QKSQ-------------E-NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred hccc-------------c-CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 1110 0 0111111122246799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
.++++|+.-.+.|| .++++.+.+||+++|..||.+|+| +.++.+||||.+++|+.+
T Consensus 294 liFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 294 LIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENL 349 (604)
T ss_pred HHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhh
Confidence 99999999999877 688999999999999999999999 788999999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=423.35 Aligned_cols=267 Identities=31% Similarity=0.544 Sum_probs=239.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe-e
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-L 762 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~-l 762 (995)
...++.+.++.||+|..|+||+++++.|++.+|+|++.. ..++...+++.+|+++++.++|||||.+|+.|..+.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 455688899999999999999999999999999999943 3356678899999999999999999999999999994 9
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++|+|.+++...+.+++.....++.++++||.|||+ ++||||||||+|||++..|.|||||||.++...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv--- 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV--- 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh---
Confidence 9999999999999999988999999999999999999999995 899999999999999999999999999988421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC----
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---- 917 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~---- 917 (995)
+....+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||...
T Consensus 231 --------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~ 284 (364)
T KOG0581|consen 231 --------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY 284 (364)
T ss_pred --------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence 12345789999999999999999999999999999999999999999874
Q ss_pred -CHHHHHHHHHccCCCCCCCCCC-CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchh
Q 001924 918 -SPEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 918 -s~~ei~qkIl~~~~~~p~lps~-lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
+..+++..|+.+.. |.+|.. +++++.+||..||++||.+||+ +.++++|||+.+-....+.+..
T Consensus 285 ~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~~~~~vd~~~ 350 (364)
T KOG0581|consen 285 LDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKFEDPNVDMAS 350 (364)
T ss_pred CCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhcccccccHHH
Confidence 67788888887654 456676 9999999999999999999999 8899999999987666555543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=440.47 Aligned_cols=270 Identities=37% Similarity=0.736 Sum_probs=249.3
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccC
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~ 760 (995)
.....++|.++++||+|.||+|+++..+.+++.||||++++......++.+..+.|.+|+.... ||.++.++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4567899999999999999999999999999999999999999999999999999999998775 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
++|+||||+.||++..+ ...+.|++..++.|+..|+.||.|||++||||||||.+|||+|..|++||+||||++-.
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--- 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--- 518 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc---
Confidence 99999999999995444 34567999999999999999999999999999999999999999999999999999831
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
......+.++||||.|||||++.+..|+..+|+|||||+|||||.|..||.+.+.+
T Consensus 519 ------------------------m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 519 ------------------------MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred ------------------------CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 11234567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
++++.|+.....+| ..++.++.+||+++|.++|++|..+ +++.++..||||..+.|..+
T Consensus 575 e~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L 635 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL 635 (694)
T ss_pred HHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence 99999999887766 6899999999999999999999997 67899999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=414.89 Aligned_cols=262 Identities=33% Similarity=0.626 Sum_probs=240.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...+|.+.+.||.|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.++|||||++++++...+.+|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46889999999999999999999999999999999977543 45677888999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC------CcEEEEecCCccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD------GHIKLTDFGLSKIGL 838 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen------G~VKLsDFGLArv~~ 838 (995)
|||||.||+|.+|+++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999875 469999999999521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
+.....+.||+|.|||||++..++|+.|+|+||+|+|+|+|++|+.||...+
T Consensus 167 ----------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 ----------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ----------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2334567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
..+++..+..+....+.++..++....+|+...|+.+|..|.+ ..+.+.|+++....
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAANP 275 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhcccCc
Confidence 9999999888888888888888888899999999999999999 77888888887664
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=403.33 Aligned_cols=265 Identities=40% Similarity=0.785 Sum_probs=236.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.+++.++||||+++++++...+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34689999999999999999999999999999999998755444455677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~----- 169 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----- 169 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC-----
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+
T Consensus 170 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 224 (329)
T PTZ00263 170 -------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224 (329)
T ss_pred -------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH
Confidence 0112346999999999999999999999999999999999999999999888888
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCcccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~ 981 (995)
..+..+...++ ..++..+.+||.+||+.||.+||++ ..+.++++||||.+..|..
T Consensus 225 ~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 225 EKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred HHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 88887765543 5688999999999999999999984 3489999999999877664
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=393.93 Aligned_cols=263 Identities=40% Similarity=0.758 Sum_probs=233.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997644333345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999888889999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 153 ----------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred ----------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0112346999999999999999999999999999999999999999999988888888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
..+...++ ..++..+.+||++||+.||.+||+.. .+.++++||||....|...
T Consensus 211 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 265 (291)
T cd05612 211 LAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265 (291)
T ss_pred HhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHH
Confidence 88776544 56799999999999999999999622 4788999999998887643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=412.30 Aligned_cols=261 Identities=39% Similarity=0.668 Sum_probs=234.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcC-CCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se--~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~ 760 (995)
...+.|.+.+.||+|+||.|++|.+..+|..||+|++.+...... ...+.+.+|+.+++.+. ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456899999999999999999999999999999998776422111 23456678999999999 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLArv~~~ 839 (995)
.+|+||||+.||+|++++.+.+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999998899999999999999999999999999999999999999999 999999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-C-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-H-GYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-y-s~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.......+.|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...
T Consensus 173 --------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 173 --------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred --------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 1223456789999999999999987 8 58999999999999999999999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCC-CHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~l-S~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+...++..|..+.+.+| ..+ +.++.+|+.+||..||.+|++ +.+++.||||+..
T Consensus 227 ~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 227 NVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQKE 281 (370)
T ss_pred cHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhccC
Confidence 99999999999888776 456 999999999999999999999 7888899999973
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=394.36 Aligned_cols=255 Identities=40% Similarity=0.799 Sum_probs=228.3
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||+|+||.||+|.+..+++.||+|++++...........+.+|+.++.+++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865544555677889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001924 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (995)
Q Consensus 775 ~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~ 854 (995)
.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--------------- 145 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--------------- 145 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---------------
Confidence 99998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCC
Q 001924 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (995)
Q Consensus 855 ~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p 934 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 146 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~- 212 (312)
T cd05585 146 ------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF- 212 (312)
T ss_pred ------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC-
Confidence 0111234579999999999999999999999999999999999999999988888888887765544
Q ss_pred CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 935 ~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+..+++.+.+||.+||..||.+||++.++.++++||||.+..+
T Consensus 213 --~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 213 --PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred --CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 4678999999999999999999999888999999999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=396.90 Aligned_cols=260 Identities=42% Similarity=0.761 Sum_probs=228.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998755445556678889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCC
Q 001924 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (995)
Q Consensus 773 SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~g 852 (995)
+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~-------------- 146 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-------------- 146 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc--------------
Confidence 999999888889999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCC
Q 001924 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (995)
Q Consensus 853 i~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~ 932 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||...+....+..+......
T Consensus 147 -------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05571 147 -------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213 (323)
T ss_pred -------------cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 0011123457999999999999999999999999999999999999999998888888877766554
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 933 ~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
+ +..+++++.+||.+||+.||++||+.. .+.++++||||....|...
T Consensus 214 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~ 262 (323)
T cd05571 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262 (323)
T ss_pred C---CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 4 467899999999999999999999421 3888999999999876544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=395.89 Aligned_cols=294 Identities=40% Similarity=0.709 Sum_probs=235.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..+|+.||||++++...........+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998755444455677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCC---------C--CCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 847 GPETDGIMP---------S--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 847 g~~t~gi~~---------s--~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
......... . ......+...........+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 000000000 0 00000000000112234579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 916 AESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..+....+..+......... ....+++.+.+||.+||. +|.+|++...+.+++.||||...+|..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 99888888777765433221 112578999999999997 999999877789999999999987754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=395.69 Aligned_cols=293 Identities=41% Similarity=0.737 Sum_probs=232.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||+||+|.+..+++.||||++++...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444555677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211111100
Q ss_pred CCCCCCCCCCCCCCCc---------cccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 847 GPETDGIMPSDAHYPE---------YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~---------~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
...... .+.+..... +...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHS-LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccc-ccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 000000 000000000 0000111123568999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 918 SPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 s~~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
+....+..+..... .+|. ...+++++.+||.+|+. +|.+|++.-.+.++++||||.+.+|..+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~ 304 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHI 304 (363)
T ss_pred CHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence 98888888876432 2232 13478999999999875 5665532222888899999999987664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=422.76 Aligned_cols=262 Identities=33% Similarity=0.585 Sum_probs=243.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.+-|++.+.||.|+.|.|.+|++..||+.+|||++.+...........+.+|+-+|+.+.||||+++|+++.....+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46689999999999999999999999999999999886555666677889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
.||++||.|++++-+.+.+++..+..+++||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|.+-
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-------- 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-------- 162 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999999851
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.++.-..+-||+|.|.+||++.|.+| +.++||||.|||||.||+|+.||++.+...++.
T Consensus 163 --------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLl 222 (786)
T KOG0588|consen 163 --------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLL 222 (786)
T ss_pred --------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHH
Confidence 22334557799999999999999999 789999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
++..+.+.+| ..++.++++||.+||..||++|+| ..++++|||+.+...-.
T Consensus 223 KV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 223 KVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCCCCC
Confidence 9999999887 789999999999999999999999 88899999999875443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=404.84 Aligned_cols=298 Identities=39% Similarity=0.673 Sum_probs=255.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...+.|++++.||.|.-|+||++....++..+|+|++.+..........+...|.+||+.+.||.++.||..|..++..|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 45678999999999999999999999999999999999988888888899999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|||||+||+|+.+++++ ..|++..++.++.+++.||+|||-+|||+|||||+||||.++|+|.|+||.|+......-
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999876 479999999999999999999999999999999999999999999999999987532211
Q ss_pred cccCC-CCCC------------CCCCCCCC-C--------------CCcc-ccccccCCcCCCCCCcccChhhhcCCCCC
Q 001924 842 TIDLS-GPET------------DGIMPSDA-H--------------YPEY-QQTDNRNRHSAVGTPDYLAPEILLGTEHG 892 (995)
Q Consensus 842 s~dls-g~~t------------~gi~~s~~-~--------------ys~~-~~~~~~~s~t~vGTp~YmAPEvL~g~~ys 892 (995)
+...+ .+.. .-+.+... . .++. .........+++||-.|.|||++.|.+++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 11100 0000 00000000 0 0001 12334567789999999999999999999
Q ss_pred chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC-HHHHHHHHcC
Q 001924 893 YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVFHC 971 (995)
Q Consensus 893 ~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS-A~EIlEiL~H 971 (995)
..+|||+||+++||||.|..||.+.+..+.+.+|+.....+|..+ .++..++|||+++|.+||.+|.. ...+.++.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999999999999999999999888765 78899999999999999999998 6789999999
Q ss_pred ccccccccccc
Q 001924 972 KIFIKKTENCV 982 (995)
Q Consensus 972 PfF~~~~~n~~ 982 (995)
|||.+..|-.+
T Consensus 393 pFF~gVnWaLi 403 (459)
T KOG0610|consen 393 PFFEGVNWALI 403 (459)
T ss_pred ccccCCChhhe
Confidence 99999999743
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=395.19 Aligned_cols=267 Identities=39% Similarity=0.734 Sum_probs=234.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG-~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.....++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3456789999999999999999999876555 689999997655444556678899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+|+||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~-- 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999987410
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.++.
T Consensus 183 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 234 (340)
T PTZ00426 183 ----------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234 (340)
T ss_pred ----------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH
Confidence 0112356999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCcccccccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~ 981 (995)
..+..+..+...+ |..++..+.++|++||+.||.+|++. ..+.++++||||.+..|..
T Consensus 235 ~~~~~i~~~~~~~---p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 235 LIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred HHHHHHhcCCCCC---CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 8888888776554 46789999999999999999999631 1278889999999887653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=403.59 Aligned_cols=260 Identities=30% Similarity=0.507 Sum_probs=226.2
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~-VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
.+.....++.+.+.||.|+||+||+|.+. |.. ||+|++......... .+.|.+|+.+|.+++|||||+++|++...
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34445567777788999999999999997 666 999999875544443 78999999999999999999999999998
Q ss_pred C-eeEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeeecCCCcEEeccCC-cEEEEecCCc
Q 001924 760 D-NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAHDG-HIKLTDFGLS 834 (995)
Q Consensus 760 ~-~lyLVmEym~GGSL~d~L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs~G-IIHRDLKPeNILLDenG-~VKLsDFGLA 834 (995)
. .+++||||+++|+|.+++.. ...++...+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999987 578999999999999999999999999 99999999999999997 9999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc--CCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~--g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
+..... ........||+.|||||++. ...|+.|+||||||++||||+||+.
T Consensus 192 r~~~~~---------------------------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 192 REKVIS---------------------------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eeeccc---------------------------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 852110 01222367999999999999 5699999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||.+..+..+...+...... |.+|..+++.+..||.+||..||.+||+..++...|+.
T Consensus 245 Pf~~~~~~~~~~~v~~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 99999987777777655543 56677799999999999999999999999999988873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=379.57 Aligned_cols=264 Identities=32% Similarity=0.560 Sum_probs=221.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.++..+.|+||+++++++...+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999876544333445568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999999887543 3589999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI---- 921 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e---- 921 (995)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 155 ----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred ----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 011123469999999999999999999999999999999999999998765432
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
....+.... ...+..++..+.+||++||+.||.+||++ ..+.++++||||.+..|+.+
T Consensus 213 ~~~~~~~~~---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 213 VDRRVKEDQ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred HHHHhhccc---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 222222222 22346789999999999999999999985 34789999999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=387.34 Aligned_cols=262 Identities=40% Similarity=0.746 Sum_probs=229.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444445677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999888889999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 153 ----------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred ----------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 0123457999999999999999999999999999999999999999998888877776
Q ss_pred HccCC--CCCCCC---CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 927 LNRKI--PWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 927 l~~~~--~~p~lp---s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..... ..+... ..++.++.+||.+||..+|.+||+ +.++++||||.+..|..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHH
Confidence 54332 112111 256899999999999999999999 88899999999886644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=387.76 Aligned_cols=259 Identities=41% Similarity=0.755 Sum_probs=227.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||+|+||.||++.+..+|..||+|++++...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998755445556677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCC
Q 001924 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (995)
Q Consensus 773 SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~g 852 (995)
+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------- 147 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999998863100
Q ss_pred CCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCC
Q 001924 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (995)
Q Consensus 853 i~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~ 932 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05595 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213 (323)
T ss_pred --------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 001122356999999999999999999999999999999999999999998888888887766654
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCcccccccccc
Q 001924 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 933 ~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~ 981 (995)
+ +..+++.+.+||.+||+.||.+|++. ..+.++++||||.+..|..
T Consensus 214 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred C---CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 4 46789999999999999999999942 2488999999999887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=384.48 Aligned_cols=264 Identities=37% Similarity=0.733 Sum_probs=230.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeeccCeeEEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP-NIVkL~gvf~~~~~lyLVm 766 (995)
+|++.+.||+|+||.||+|.+..+++.||||++++.........+.+..|..++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999875444455667888999999999765 5888999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~-------- 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI-------- 152 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecC--------
Confidence 999999999999888889999999999999999999999999999999999999999999999999986210
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 153 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 153 -------------------FGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred -------------------CCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0001122457999999999999999999999999999999999999999999988888888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCcccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~ 981 (995)
......+ +..++..+.+|+.+||..||.+|+++ ....++++||||...+|..
T Consensus 214 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~ 267 (324)
T cd05587 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267 (324)
T ss_pred HcCCCCC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 7766544 46789999999999999999999985 2347899999999987743
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=383.88 Aligned_cols=265 Identities=37% Similarity=0.720 Sum_probs=231.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVm 766 (995)
+|++.+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999875444444556678888888777 5799999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~-------- 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM-------- 152 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC--------
Confidence 999999999999888889999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...++..+
T Consensus 153 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 153 -------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred -------------------CCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011123457999999999999999999999999999999999999999999998888888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
......+| ..++.++.+|+.+||+.||.+|++. ....++++||||...+|...
T Consensus 214 ~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 214 MEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred HhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 87765544 6789999999999999999999985 24578899999998876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=391.44 Aligned_cols=293 Identities=42% Similarity=0.751 Sum_probs=236.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444555678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.+...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..........+.
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCCCCCCCC---------ccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 847 GPETDGIMPSDAHYP---------EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 847 g~~t~gi~~s~~~ys---------~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
..... ..+....+. .+...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTH-NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccc-CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 00000 000000000 00001111223468999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 918 SPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 s~~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
++...+..+..... .++. ...++.++.+||.+|+. ||.+|+++..+.++++||||.+.+|..+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred CHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence 98888888776432 2221 12478999999999874 9999998778999999999999877553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=387.88 Aligned_cols=258 Identities=42% Similarity=0.777 Sum_probs=226.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||+|+||.||++.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998755555566778899999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCC
Q 001924 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (995)
Q Consensus 773 SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~g 852 (995)
+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------------- 147 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------------- 147 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCC
Q 001924 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932 (995)
Q Consensus 853 i~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~ 932 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 213 (328)
T cd05593 148 --------------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213 (328)
T ss_pred --------------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc
Confidence 001122357999999999999999999999999999999999999999988888877777665544
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccc
Q 001924 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 933 ~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n 980 (995)
+ +..++..+.+||.+||+.||.+|++. ..+.++++||||....|.
T Consensus 214 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred C---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 3 46789999999999999999999832 238889999999987664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=393.06 Aligned_cols=294 Identities=43% Similarity=0.698 Sum_probs=233.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998755444556678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++............
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999997532100000000
Q ss_pred CCC------CCCCC-----CCCCCC---------CccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHH
Q 001924 847 GPE------TDGIM-----PSDAHY---------PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 847 g~~------t~gi~-----~s~~~y---------s~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyE 906 (995)
... ..... +..... ..............+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000 00000 000000 0000001111234679999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 907 FITGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
|++|+.||.+.++.+....+......... ....+++++.++|.+|+ .+|.+|++...+.++++||||....+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 99999999998888777777654332221 12468999999999986 5999999866788999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=393.42 Aligned_cols=293 Identities=40% Similarity=0.714 Sum_probs=230.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||++.+..+++.||||++.+...........+.+|+++++.+.||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987654444555678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998632111000000
Q ss_pred C------CCCCC------CCCCCCC--------CCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHH
Q 001924 847 G------PETDG------IMPSDAH--------YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 847 g------~~t~g------i~~s~~~--------ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyE 906 (995)
. ..... ....... ...+...........+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 00000 0000000 00000000001123579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHccCCC--CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 907 FITGIPPFTAESPEIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~~~~~--~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
|++|..||.+.+..+.+..+...... ++. ...++.++.+||.+||. +|.+|+....+.++++||||.+..|..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~ 315 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDT 315 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 99999999998888887777654322 221 12578999999999998 888876333489999999999876643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=385.54 Aligned_cols=258 Identities=38% Similarity=0.754 Sum_probs=226.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.++.+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999865444445567788899988876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~------------ 148 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF------------ 148 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 149 ---------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred ---------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112345799999999999999999999999999999999999999999999888888887665
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHH---HHHHHcCccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVFHCKIFIKKTEN 980 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~E---IlEiL~HPfF~~~~~n 980 (995)
.+ +..++.++.+||.+||+.||.+||++.+ ..++++||||....|.
T Consensus 214 ~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 214 VY---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred CC---CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 43 3578999999999999999999999633 4889999999987764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=383.87 Aligned_cols=292 Identities=44% Similarity=0.767 Sum_probs=233.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|.+.+.||+|+||+||+|.+..+|+.||||++++...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998755444456678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.+...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743221100000
Q ss_pred CCCCC--CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 847 GPETD--GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 847 g~~t~--gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
..... ...+....................||+.|+|||++.+..++.++|||||||++|||++|+.||........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 00000 0000000000000011122335679999999999999999999999999999999999999999988888888
Q ss_pred HHHc--cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 925 NILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~--~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
.+.. .....+.. ..+++.+.+||.+||. ||.+||+. +.++++||||...+|...
T Consensus 241 ~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s--~~~ll~hp~~~~~~~~~~ 296 (350)
T cd05573 241 KIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWENL 296 (350)
T ss_pred HHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCC--HHHHhcCCCcCCCCHHHH
Confidence 8776 33333322 2379999999999997 99999993 556789999999877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=382.66 Aligned_cols=259 Identities=37% Similarity=0.741 Sum_probs=226.7
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999875544455667788899998865 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~------------ 148 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL------------ 148 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 149 ---------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred ---------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01112245699999999999999999999999999999999999999999999999988887765
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH----HHHHHHcCcccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN----GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~----EIlEiL~HPfF~~~~~n~ 981 (995)
.++ ..++.++.+||.+||+.||.+||+.. .+.++++||||...+|..
T Consensus 214 ~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~ 264 (321)
T cd05591 214 LYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264 (321)
T ss_pred CCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence 443 56899999999999999999999432 378899999999887764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=388.55 Aligned_cols=291 Identities=42% Similarity=0.666 Sum_probs=228.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998765555556778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998632111000000
Q ss_pred CCCC----CCCCCCC----------------CCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHH
Q 001924 847 GPET----DGIMPSD----------------AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 847 g~~t----~gi~~s~----------------~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyE 906 (995)
.... ....+.. ..-..............+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 0000 0000000 0000000000111235689999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhc--CccCCCCHHHHHHHHcCcccccccccc
Q 001924 907 FITGIPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIH--DPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~--DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
|++|..||...+.......+..... .++ ....+++++.+||.+|+.. +|..|++ +.++++||||.+.+|..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhH
Confidence 9999999998887776666654322 222 1235889999999996654 4555999 88889999999877653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=389.66 Aligned_cols=293 Identities=43% Similarity=0.711 Sum_probs=230.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.+.||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654444445677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998532100000000
Q ss_pred CC----CCCCCCCCCCCCC-------------ccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 001924 847 GP----ETDGIMPSDAHYP-------------EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 847 g~----~t~gi~~s~~~ys-------------~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT 909 (995)
.. ......+.. ... .............+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSE-EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccc-cccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00 000000000 000 000000111234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 910 GIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
|+.||.+.+..+....+......... ....++..+.+||.+|+ .+|.+|++...+.++++||||...++..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 99999998887776666554322211 12468899999999977 5999999544499999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=384.24 Aligned_cols=258 Identities=42% Similarity=0.764 Sum_probs=225.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||+|+||.||++.+..+|+.||+|++++...........+.+|+.++..++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998755444556677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 773 SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
+|.+++.....+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~------------ 148 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK------------ 148 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC------------
Confidence 999999888889999999999999999999997 7999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 149 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred ---------------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112235699999999999999999999999999999999999999999888888777766655
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n 980 (995)
.+ +..+++++.+||.+||+.||.+|++. ..+.++++||||.+..|.
T Consensus 214 ~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred CC---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 44 46789999999999999999999831 138888999999987655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=380.11 Aligned_cols=262 Identities=39% Similarity=0.712 Sum_probs=226.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH---HhcCCCceEEEeeeeeccCeeEEE
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL---ITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieIL---s~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
|++.+.||+|+||.||+|.+..+|+.||||++++.........+.+.+|.+++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865444445566777777665 466799999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~------- 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM------- 152 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC-------
Confidence 999999999988854 569999999999999999999999999999999999999999999999999886310
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 153 --------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~ 212 (324)
T cd05589 153 --------------------GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212 (324)
T ss_pred --------------------CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 001112346799999999999999999999999999999999999999999988888888
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCcccccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~ 981 (995)
+......+ +..++..+.+||.+||+.||.+||++. .+.++++||||.+..+..
T Consensus 213 i~~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~ 267 (324)
T cd05589 213 IVNDEVRY---PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267 (324)
T ss_pred HHhCCCCC---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence 87766543 467899999999999999999999643 488999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=383.24 Aligned_cols=259 Identities=40% Similarity=0.773 Sum_probs=224.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEie-ILs~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||+||+|.+..+|+.||+|++.+...........++.|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998654434444556666665 45789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~------------- 147 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI------------- 147 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+.....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 148 --------------EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred --------------cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 001122345799999999999999999999999999999999999999999988888888877654
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH-HHHHHHcCcccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~-EIlEiL~HPfF~~~~~n~ 981 (995)
.. +..++..+.+||.+||+.||.+||++. .+.++++||||....|..
T Consensus 214 ~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 214 RL---KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred CC---CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 43 357899999999999999999999964 567999999999877643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.33 Aligned_cols=258 Identities=33% Similarity=0.480 Sum_probs=213.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|++..+++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876432 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------ 153 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG------ 153 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc------
Confidence 99998777666555567999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 154 --------------------SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred --------------------ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001112356899999999999999999999999999999999999999887654443332
Q ss_pred HccC-------------------CCCCC----------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 927 LNRK-------------------IPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 927 l~~~-------------------~~~p~----------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.... ..++. ....++.++.+||++||+.||++||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 2210 00110 01236788999999999999999999 6788899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.25 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=221.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|+.+.++|+|+||+||+++++.||+.||||.|.... .++.-.+-.++|+++|++++|||+|.++.+|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56888999999999999999999999999999987533 33445567799999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+. ++.+-|++. ..++...++.+++|++.|+.|+|+++||||||||+||||+.+|.+||||||+|+...
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------- 152 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------- 152 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc-------
Confidence 99987 555555544 569999999999999999999999999999999999999999999999999999521
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.+....+..+.|.+|+|||++.| .+|+..+|||++||++.||++|.+.|++.+.-+.+.
T Consensus 153 --------------------~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 153 --------------------APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred --------------------CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 12334456788999999999998 789999999999999999999999999988766555
Q ss_pred HHHcc--------------C-----CCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 925 NILNR--------------K-----IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 925 kIl~~--------------~-----~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.|... . ..+|. ..+.++.-+.+|+++||..||++|++ +.++|.|+||.+
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~yFd~ 289 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcChHHHH
Confidence 44321 1 11111 12457778999999999999999999 999999999966
Q ss_pred cccc
Q 001924 977 KTEN 980 (995)
Q Consensus 977 ~~~n 980 (995)
..+.
T Consensus 290 ~~er 293 (396)
T KOG0593|consen 290 FIER 293 (396)
T ss_pred HHHH
Confidence 5443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=379.26 Aligned_cols=263 Identities=37% Similarity=0.737 Sum_probs=229.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVm 766 (995)
+|++.+.||+|+||.||+|.+..+|+.||+|++++.........+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998654444455677888999988886 577888999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 154 --------------------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred --------------------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011123456999999999999999999999999999999999999999999988888888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n 980 (995)
......+ +..++..+.+|+.+||+.+|.+|++.. ...++++||||....|.
T Consensus 214 ~~~~~~~---p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred HhCCCCC---CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 8766554 367899999999999999999999853 36789999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=377.74 Aligned_cols=257 Identities=39% Similarity=0.738 Sum_probs=221.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~-LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++.. .+||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999986544334455666777777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~------------ 148 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 149 ---------------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122345799999999999999999999999999999999999999999988888887765443
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..+..++.++.+||.+||+.||.+||++ ..++++||||....|..
T Consensus 214 ---~~~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~ 258 (316)
T cd05592 214 ---HFPRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWER 258 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHH
Confidence 3456789999999999999999999984 24678999999876643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=378.52 Aligned_cols=266 Identities=42% Similarity=0.756 Sum_probs=221.6
Q ss_pred CeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~-se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
+|++.+.||+|+||.||++.+. .+++.||+|++++.... .....+.+..|+.++..+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 47899999999764322 223456788899999999 589999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~--- 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--- 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC----
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---- 917 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~---- 917 (995)
.........+||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 158 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 158 -----------------------EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred -----------------------cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 001112245799999999999875 4788999999999999999999999643
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
....+...+..... .++..++..+.+||.+||+.||.+||++. .+.++++||||.+..|...
T Consensus 215 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 278 (332)
T cd05614 215 TQSEVSRRILKCDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEAL 278 (332)
T ss_pred CHHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 23344444444333 34467899999999999999999999765 6999999999998766443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=376.82 Aligned_cols=257 Identities=39% Similarity=0.769 Sum_probs=224.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||+||+|.+..++..||+|++++...........+..|..++..+ .||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999875544455667788899999887 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.+...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------------ 148 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL------------ 148 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 149 ---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 149 ---------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred ---------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01112235689999999999999999999999999999999999999999888888888776655
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCcccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~ 979 (995)
.+ +..++..+.+||.+||+.||.+||++ ....+++.||||....|
T Consensus 214 ~~---~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CC---CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 43 46789999999999999999999994 22388999999998766
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=388.32 Aligned_cols=250 Identities=30% Similarity=0.551 Sum_probs=222.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee-eeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~g-vf~~~~~ 761 (995)
.....+|+++++||.|+||+||++.+..+|..||.|.++ -...+......+..|+.+|++|+|||||++|+ .|..+..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 345678999999999999999999999999999999988 56667788899999999999999999999998 5555544
Q ss_pred -eEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeeecCCCcEEeccCCcEEEEecC
Q 001924 762 -LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS--LG--IVHRDLKPDNLLIAHDGHIKLTDFG 832 (995)
Q Consensus 762 -lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs--~G--IIHRDLKPeNILLDenG~VKLsDFG 832 (995)
++||||||.+|+|...++. ...+++..++.++.|++.||.++|+ .. |+||||||.||+++.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 8999999999999998863 3579999999999999999999999 44 9999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
++++.. .......+.+|||+||+||.+...+|+.++||||+||++|||+.-.+
T Consensus 174 L~r~l~---------------------------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 174 LGRFLS---------------------------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred hHhHhc---------------------------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 999632 12233456899999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCC-CCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 913 PFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~lp-s~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
||.+.+..++..+|.++.++ .+| ...|..+..||..|+..||+.||+.
T Consensus 227 PF~g~n~~~L~~KI~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 227 PFYGDNLLSLCKKIEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CcccccHHHHHHHHHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999988654 344 6788999999999999999999983
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=388.89 Aligned_cols=263 Identities=33% Similarity=0.580 Sum_probs=223.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC--eeE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NLY 763 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--~ly 763 (995)
..+|...+.||+|+||.||++.+..+|..+|||.+.... ....+.+.+|+.+|++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 466888999999999999999999999999999886542 222677899999999999999999999855555 699
Q ss_pred EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~~~ 841 (995)
++|||+++|+|.+++.+.+ .+++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999877 7999999999999999999999999999999999999999 79999999999874110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCC-CCH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA-ESP 919 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g-~s~ 919 (995)
............||+.|||||++.++. ...++|||||||++.||+||+.||.. ...
T Consensus 171 ----------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 171 ----------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred ----------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 001112234578999999999999632 34599999999999999999999998 455
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
......+.... ..|.+|..++.++.+||.+|+.+||++||| +.++|+|||..+...
T Consensus 229 ~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 229 AEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcccc
Confidence 55555555444 446788999999999999999999999999 889999999988765
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=380.39 Aligned_cols=258 Identities=36% Similarity=0.727 Sum_probs=220.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875444445567788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~------------- 147 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI------------- 147 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986210
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---------CHHHH
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 922 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~---------s~~ei 922 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 148 --------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred --------------cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 0011223457999999999999999999999999999999999999999632 12234
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH---HHHHHHcCccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~---EIlEiL~HPfF~~~~~n 980 (995)
...+...... +|..++..+.+||.+||+.||.+|+++. .+.++++||||...+|.
T Consensus 214 ~~~~~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 214 FQVILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHHHcCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 4445544433 3467899999999999999999999853 47899999999987664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=377.76 Aligned_cols=257 Identities=35% Similarity=0.702 Sum_probs=221.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~-LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.++.+|..||+|++++...........+..|..++.. .+||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999986443333445667778888875 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~------------- 147 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV------------- 147 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986210
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+.....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 148 --------------FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred --------------cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 001112345799999999999999999999999999999999999999999888888877765543
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..+..++.++.+||.+||+.||.+||++ ..++++||||....|..
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 214 ---HYPRWITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTA 258 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHH
Confidence 3446789999999999999999999994 23688899999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=380.87 Aligned_cols=258 Identities=42% Similarity=0.742 Sum_probs=225.8
Q ss_pred EeeccCCCeEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeec
Q 001924 693 KPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 693 k~LG~GgFGtVYka~~---k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
+.||+|+||.||++.+ ..+|+.||+|++++... .......+.+|++++++++||||+++++++...+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999886 35789999999986432 2233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCC
Q 001924 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (995)
Q Consensus 770 ~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~ 849 (995)
++|+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~---------- 150 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID---------- 150 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC----------
Confidence 9999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcc
Q 001924 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 850 t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~ 929 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...
T Consensus 151 -----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 151 -----------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred -----------------CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 001122457999999999999989999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHH--HHHHHcCcccccccccc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVFHCKIFIKKTENC 981 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~E--IlEiL~HPfF~~~~~n~ 981 (995)
...+ +..++..+.+||.+||+.||.+||++.+ +.+++.||||....|+.
T Consensus 214 ~~~~---p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T cd05582 214 KLGM---PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK 264 (318)
T ss_pred CCCC---CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence 6543 4678999999999999999999999888 99999999999887654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=379.09 Aligned_cols=265 Identities=40% Similarity=0.712 Sum_probs=227.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444455677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++|+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----- 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-----
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~------g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 156 ---------------------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ---------------------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 001122346899999999987 45678999999999999999999999998888
Q ss_pred HHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 920 EIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 920 ~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
...+..+..... .++. ...++..+.+||.+||. +|.+||+ +.+++.||||....|...
T Consensus 215 ~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHH
Confidence 888877766432 2222 23578999999999998 9999999 778899999998877643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=377.69 Aligned_cols=258 Identities=44% Similarity=0.815 Sum_probs=221.8
Q ss_pred EeeccCCCeEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 693 KPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~-se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
+.||+|+||.||++.+. .+++.||+|++++.... .......+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 47889999999864332 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCC
Q 001924 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (995)
Q Consensus 769 m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~ 848 (995)
+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--------- 152 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--------- 152 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc---------
Confidence 99999999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 001924 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928 (995)
Q Consensus 849 ~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~ 928 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..
T Consensus 153 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 153 ------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred ------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 01112235699999999999998999999999999999999999999999888888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC--HHHHHHHHcCccccccccc
Q 001924 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 929 ~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS--A~EIlEiL~HPfF~~~~~n 980 (995)
+... ++..+++.+.+||.+||+.||++||+ ...+.++++||||....|+
T Consensus 215 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 215 GKLN---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 6654 34678999999999999999999992 1228889999999887654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=379.27 Aligned_cols=258 Identities=38% Similarity=0.737 Sum_probs=223.5
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieI-Ls~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999986544344455566677654 6779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~------------- 147 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI------------- 147 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCC-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...++..+.....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 148 --------------AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred --------------CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 001112345799999999999999999999999999999999999999999988888888877654
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH-HHHHHHcCccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~-EIlEiL~HPfF~~~~~n 980 (995)
.. +...+..+.++|.+||+.||.+||++. .+.+++.||||....|.
T Consensus 214 ~~---~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~ 260 (325)
T cd05604 214 VL---RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT 260 (325)
T ss_pred cC---CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence 33 356889999999999999999999974 57789999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=386.20 Aligned_cols=268 Identities=39% Similarity=0.700 Sum_probs=228.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||++.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.....+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34568999999999999999999999999999999999765444444556678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~-- 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-- 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC--
Confidence 9999999999999998654 5889999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~----~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 196 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 196 ------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred ------------------------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 00112245799999999998754 37899999999999999999999999998
Q ss_pred HHHHHHHHHccCCC--CCCCCCCCCHHHHHHHHHHhhcCccC--CCCHHHHHHHHcCcccccccccc
Q 001924 919 PEIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 919 ~~ei~qkIl~~~~~--~p~lps~lS~eL~dLIkkCLq~DPeK--RPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
....+..+...... ++. ...++.++.+||.+||..+|.+ |++ +.++++||||.+..|..
T Consensus 252 ~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~ 314 (370)
T cd05596 252 LVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTF 314 (370)
T ss_pred HHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhh
Confidence 88888888765432 222 2357999999999999999988 999 88899999999877653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=376.15 Aligned_cols=258 Identities=40% Similarity=0.775 Sum_probs=222.8
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEie-ILs~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999998654434444556666665 57889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE------------ 148 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC------------
Confidence 99999998878899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
........+||+.|+|||++.+..++.++|||||||++|||++|..||...+....+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 149 ---------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred ---------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 00112245799999999999999999999999999999999999999999888888888876654
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCH-HHHHHHHcCccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA-~EIlEiL~HPfF~~~~~n 980 (995)
. ++...+..+.++|.+||+.||.+||++ .++.++++|+||....|.
T Consensus 214 ~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred C---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 4 346788999999999999999999985 467899999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=370.61 Aligned_cols=263 Identities=29% Similarity=0.445 Sum_probs=212.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----ee
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~-----~l 762 (995)
+|++.+.||+|+||.||+|.+..+|..||||.++... ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987432 22234567889999999999999999999876432 48
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987411000
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 158 -----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 158 -----------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred -----------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 00011123579999999999876 67899999999999999999999999876543
Q ss_pred HHHHHHHc--------------------------cCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 921 IIFDNILN--------------------------RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 921 ei~qkIl~--------------------------~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.....+.. ... ++....+.+++.+.+||.+||+.||++||+ +.++++||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l~hp 291 (338)
T cd07859 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEALADP 291 (338)
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHhcCc
Confidence 32221111 000 011112356788999999999999999999 78889999
Q ss_pred ccccccc
Q 001924 973 IFIKKTE 979 (995)
Q Consensus 973 fF~~~~~ 979 (995)
||++...
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9987655
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=365.94 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=212.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||.|+||.||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4789999999999999999999999999999999875332 22345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++ +|.+++...+ .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~----- 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV----- 155 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC-----
Confidence 999975 9999887544 578999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 156 ----------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred ----------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0011123468999999999876 56899999999999999999999999988776655
Q ss_pred HHHHccCC-------------------CCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRKI-------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~~-------------------~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+..... .++. ....++.++.+||.+||++||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~f 288 (288)
T cd07871 214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSYF 288 (288)
T ss_pred HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCCC
Confidence 54432110 0010 11356789999999999999999999 8888999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=375.12 Aligned_cols=256 Identities=38% Similarity=0.719 Sum_probs=220.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~-LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||||+++............+..|..++.. ++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999986543333445667778888876 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC------------
Confidence 99999998877899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 149 ---------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred ---------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 00112345699999999999999999999999999999999999999999888888877765543
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
. .+..++..+.+||.+||+.||.+||++. .++++||||....|.
T Consensus 214 ~---~~~~~~~~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~ 257 (316)
T cd05619 214 C---YPRWLTREAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWS 257 (316)
T ss_pred C---CCccCCHHHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHH
Confidence 3 3456889999999999999999999943 378999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=376.49 Aligned_cols=259 Identities=40% Similarity=0.762 Sum_probs=222.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEie-ILs~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||+||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999998644333334445555554 46789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~------------ 148 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE------------ 148 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05602 149 ---------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213 (325)
T ss_pred ---------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc
Confidence 01112345799999999999999999999999999999999999999999988888888776654
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH-HHHHHHcCcccccccccc
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~-EIlEiL~HPfF~~~~~n~ 981 (995)
. .+..++..+.++|.+||+.||.+|+++. .+.++++|+||...+|..
T Consensus 214 ~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 214 Q---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred C---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 3 3357899999999999999999999965 566899999998877643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=378.54 Aligned_cols=258 Identities=38% Similarity=0.746 Sum_probs=219.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875444445566788899988776 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|..++.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~------------- 147 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL------------- 147 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCcccccc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---------CHHHH
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 922 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~---------s~~ei 922 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 148 --------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred --------------CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 0011123457999999999999999999999999999999999999999521 12234
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH---HHHHHHcCccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~---EIlEiL~HPfF~~~~~n 980 (995)
...+...... +|..++..+.+||.+||+.||.+||++. .+.++++||||....|.
T Consensus 214 ~~~i~~~~~~---~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 214 FQVILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHhcCCCC---CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 4445554443 4467899999999999999999999852 35789999999988764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=402.32 Aligned_cols=256 Identities=35% Similarity=0.590 Sum_probs=235.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|-+.+.||+|+||.||+|+.+.|.+.||+|.+.+... .+.+...+.+|++|++.++|||||.++++|+...++++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 678899999999999999999999999999999987553 4557888999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+.| +|+.++...+.++++.++.++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+..+.
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99966 999999999999999999999999999999999999999999999999999999999999999643211
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.......|||.|||||++.+..|+..+|+||||||+|||++|++||...+..++...|
T Consensus 155 ----------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I 212 (808)
T KOG0597|consen 155 ----------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI 212 (808)
T ss_pred ----------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 2234567999999999999999999999999999999999999999999999999999
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
......|| ...+..+.+|+..+|.+||.+|++ .-+++.|||.++.
T Consensus 213 ~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 213 LKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKGK 257 (808)
T ss_pred hcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhhh
Confidence 88887776 589999999999999999999999 7788999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=401.79 Aligned_cols=256 Identities=33% Similarity=0.552 Sum_probs=232.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
...|....+||+|..|.||.+....+++.||||.+..... ...+-+++|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 3568888899999999999999999999999999876443 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||||+||+|.|++... .+++.++..+++++++||+|||.+||||||||.+|||++.+|.+||+|||+|..+.
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~------- 420 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS------- 420 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc-------
Confidence 9999999999998654 59999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.......+.+|||+|||||++....|++++||||||++++||+-|.+||-..++...+..
T Consensus 421 --------------------~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL 480 (550)
T KOG0578|consen 421 --------------------EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 480 (550)
T ss_pred --------------------cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH
Confidence 122356678999999999999999999999999999999999999999999999888888
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
|..++.+-...+..+++.+++|+.+||+.||++|++ +.++|+||||+
T Consensus 481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~ 527 (550)
T KOG0578|consen 481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLK 527 (550)
T ss_pred HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhh
Confidence 888877766678899999999999999999999999 88999999994
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=375.02 Aligned_cols=259 Identities=38% Similarity=0.733 Sum_probs=221.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|..++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875544455667788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~------------- 147 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL------------- 147 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceecc-------------
Confidence 9999999887889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-------CHHHHHH
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEIIFD 924 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~-------s~~ei~q 924 (995)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||... .....+.
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 148 --------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred --------------CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 0011123457999999999999999999999999999999999999999532 2233444
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH---HHHHHHcCcccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~---EIlEiL~HPfF~~~~~n~ 981 (995)
.+...... .|..++..+.++|.+||..||.+|+++. .+.++++||||..+.|..
T Consensus 214 ~~~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 214 VILEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HHHhCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 44444333 3467899999999999999999999853 578999999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=363.65 Aligned_cols=283 Identities=48% Similarity=0.837 Sum_probs=239.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||++.+..+++.||+|.+.............+.+|+++++.++||||+++++.+...+.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987654433445667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998742211111000
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.. ... ............|+..|+|||.+.+..++.++||||||+++|||++|..||.+....+....+
T Consensus 161 ~~----~~~--------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 161 EG----HIE--------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred cc----ccc--------cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 00 000 000011112346889999999999989999999999999999999999999998888888888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
......++.....++..+.+||.+||+.||++||++.++.++++||||...++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 7776666655557899999999999999999999999999999999999888776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=378.43 Aligned_cols=258 Identities=41% Similarity=0.744 Sum_probs=221.6
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L---kHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
||+|+||+||+|.+..+++.||+|++.+...........+..|..++... .||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765444444556667788887765 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~------------ 148 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT------------ 148 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 930 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~ 930 (995)
........+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+..+.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 149 ---------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred ---------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 01112345799999999999765 47999999999999999999999999988888888887776
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH-HHHHHHcCcccccccccc
Q 001924 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 931 ~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~-EIlEiL~HPfF~~~~~n~ 981 (995)
..++. ..++..+.+||.+||+.||.+||++. .+.++++||||....|..
T Consensus 214 ~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 214 VRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred CCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 55542 45789999999999999999999643 588999999998876543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=366.11 Aligned_cols=261 Identities=28% Similarity=0.505 Sum_probs=210.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||.|+||.||+|.+..+++.||+|+++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875432 22234678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||++ ++|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 99995 6888877654 5689999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~-~ei 922 (995)
.........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 156 ----------------------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred ----------------------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 00111234689999999998764 578999999999999999999999987533 222
Q ss_pred HHHHHcc--C---CCCCC------------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 923 FDNILNR--K---IPWPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 923 ~qkIl~~--~---~~~p~------------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
...+... . ..|+. .....+..+.+|+.+||+.||.+||| +.++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~h~~ 290 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALSHEY 290 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhcCcc
Confidence 2222110 0 00000 00124567899999999999999999 788899999
Q ss_pred cccccc
Q 001924 974 FIKKTE 979 (995)
Q Consensus 974 F~~~~~ 979 (995)
|.+...
T Consensus 291 f~~~~~ 296 (303)
T cd07869 291 FSDLPP 296 (303)
T ss_pred cccCCh
Confidence 988754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=383.56 Aligned_cols=267 Identities=39% Similarity=0.701 Sum_probs=225.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997654444445567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~---- 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---- 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc----
Confidence 999999999999999654 589999999999999999999999999999999999999999999999999874110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~----ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
.........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.
T Consensus 195 ----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 195 ----------------------TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ----------------------CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 0011123567999999999997643 78899999999999999999999999888
Q ss_pred HHHHHHHHccCCC--CCCCCCCCCHHHHHHHHHHhhcCccC--CCCHHHHHHHHcCcccccccccc
Q 001924 920 EIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 920 ~ei~qkIl~~~~~--~p~lps~lS~eL~dLIkkCLq~DPeK--RPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
...+..+...... ++. ...++..+.+++.+||..+|.+ |++ +.++++||||....|+.
T Consensus 253 ~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~---~~e~l~hp~~~~~~~~~ 314 (370)
T cd05621 253 VGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNG---VEEIKQHPFFKNDQWNW 314 (370)
T ss_pred HHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCC---HHHHhcCcccCCCCcCh
Confidence 8888888765432 221 1357899999999999855543 777 78899999999876643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=373.19 Aligned_cols=270 Identities=42% Similarity=0.749 Sum_probs=225.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444555677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD----- 155 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-----
Confidence 99999999999976 457899999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 156 ---------------------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 0011123469999999999963 45788999999999999999999999998888
Q ss_pred HHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 921 IIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 921 ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
+.+..+..... .++.....++..+.+||.+||.. |.+|++.-.+.++++||||.+.+|....
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~ 278 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIR 278 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHh
Confidence 88777765432 33333346899999999999975 4444332239999999999988775543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=372.45 Aligned_cols=267 Identities=39% Similarity=0.707 Sum_probs=226.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997644444445566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++|+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----- 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-----
Confidence 99999999999976 357899999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
........+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ---------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 001122357999999999986 346789999999999999999999999999888
Q ss_pred HHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccC--CCCHHHHHHHHcCccccccccccc
Q 001924 921 IIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 921 ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeK--RPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
..+..+..... .++.....++..+.+||.+||..+|.+ |++ +.++++||||.+.+|..+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~---~~~~~~h~~f~~~~~~~~ 277 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG---IEDFKQHPFFTGIDWDNI 277 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCC---HHHHhCCCCcCCCCHHHH
Confidence 88888876543 334444578999999999999765544 456 899999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.08 Aligned_cols=265 Identities=27% Similarity=0.434 Sum_probs=221.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||++.+..+|..||+|++.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999987532 23445779999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc-----
Confidence 999999999999998888899999999999999999999986 69999999999999999999999999986311
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......++.
T Consensus 156 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 156 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred ------------------------ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 00112346899999999999999999999999999999999999999776554432
Q ss_pred HHHHccC--------------------------------------------CCCCCC-CCCCCHHHHHHHHHHhhcCccC
Q 001924 924 DNILNRK--------------------------------------------IPWPCV-PSDMSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 924 qkIl~~~--------------------------------------------~~~p~l-ps~lS~eL~dLIkkCLq~DPeK 958 (995)
..+.... ...+.. ...++.++.+||.+||++||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCccc
Confidence 2111000 000111 1246789999999999999999
Q ss_pred CCCHHHHHHHHcCcccccccccccc
Q 001924 959 RLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
||| +.++++||||+.......-
T Consensus 292 Rpt---~~ell~h~~~~~~~~~~~~ 313 (331)
T cd06649 292 RAD---LKMLMNHTFIKRSEVEEVD 313 (331)
T ss_pred CCC---HHHHhcChHHhhccccccc
Confidence 999 7788899999876655443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=382.78 Aligned_cols=271 Identities=31% Similarity=0.506 Sum_probs=233.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
......+.|++...||.|..++||+|+...++..||||++.-.... ...+.+.+|+..|+.++||||++++.+|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 3445678999999999999999999999999999999999764432 34788999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||+||.+|++.+++... ..+++..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999764 359999999999999999999999999999999999999999999999999876321
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
. + | ........+.+||+.|||||+++. .+|+.|+||||||++..||.+|..||..
T Consensus 178 ~------~-----G------------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 178 D------S-----G------------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred c------c-----C------------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 1 0 0 001111167899999999999755 5799999999999999999999999999
Q ss_pred CCHHHHHHHHHccCCCCCC-------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 917 ESPEIIFDNILNRKIPWPC-------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~-------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..+..++-..+++..+.+. ....++..+..+|..||++||.+||| +.++|+|+||+...-
T Consensus 235 ~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 235 YPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhccc
Confidence 9999998888888765332 12346678999999999999999999 889999999998643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=362.66 Aligned_cols=258 Identities=31% Similarity=0.556 Sum_probs=215.4
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998765443444456788999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 775 YSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 775 ~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~----------- 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD----------- 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC-----------
Confidence 988743 34689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHH
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNI 926 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~----~ei~qkI 926 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+
T Consensus 150 ----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 150 ----------------GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ----------------CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 00112234689999999999999999999999999999999999999976543 2233333
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
..... ..+..++..+.+|+.+||+.||++||++. .+.++++||||++..|..+
T Consensus 214 ~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 214 LNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred cccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 33222 23467899999999999999999999643 3889999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=361.71 Aligned_cols=266 Identities=32% Similarity=0.541 Sum_probs=220.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999876443333344567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999888653 3589999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........|++.|+|||++.+..++.++||||||+++|||++|..||.+.........
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 155 ----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 0011234689999999999998999999999999999999999999988655433322
Q ss_pred HHccCC-CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCcccccccccc
Q 001924 926 ILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 926 Il~~~~-~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~ 981 (995)
+..... .....+..++..+.+||.+||..||.+||+.. .+.++++||||....|..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 213 VERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 221110 11223456899999999999999999999433 488899999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=380.42 Aligned_cols=269 Identities=42% Similarity=0.737 Sum_probs=227.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34556899999999999999999999999999999999976544444455678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~-- 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-- 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc--
Confidence 99999999999999998654 589999999999999999999999999999999999999999999999999874110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~----ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.........+||+.|+|||++.+.. ++.++|||||||++|||++|..||...
T Consensus 195 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 ------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred ------------------------CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 0011123467999999999997643 788999999999999999999999999
Q ss_pred CHHHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 918 SPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 918 s~~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+....+..+..... .++. +..++..+.+||..||. +|..|++...+.++++|+||.+..|
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 251 SLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCCh
Confidence 88888888876543 2332 24689999999999998 6666554444899999999988654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.44 Aligned_cols=273 Identities=41% Similarity=0.752 Sum_probs=255.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
.......++|..+++||+|.||.|.+++.+.+|+.||||++++.....+.+....+.|-++|+..+||.+..+-..|+..
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 44456789999999999999999999999999999999999999888999999999999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
+++++||||..||.|+-.|.+...|++..++.+...|+.||.|||+++||+||||.+|.|+|.+|++||+|||+++-.
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999999831
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........++||||.|+|||++....|+..+|+|.+||++|||++|+.||...+.
T Consensus 319 -------------------------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 319 -------------------------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred -------------------------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 1234556789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC--HHHHHHHHcCccccccccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS--A~EIlEiL~HPfF~~~~~n~~ 982 (995)
..++.-|+.....+| ..++++++.|+..+|.+||.+|.. ..++.++.+|+||..+.|..+
T Consensus 374 ~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 374 EKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred hHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 999999999988776 789999999999999999999987 689999999999999998753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=375.44 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=235.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|.|+.||++.+..||+.+|+|++....+. ....+.+.+|+.|-+.|+||||+++.+.+......||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 457899999999999999999999999999999998754443 3377889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC---CcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen---G~VKLsDFGLArv~~~~~ 841 (995)
|+|+|.||+|..-+-....+++..+..+++||+.||.|+|.+||||||+||+|+|+... ..+||+|||+|.-.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l---- 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV---- 163 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe----
Confidence 99999999997655555668999999999999999999999999999999999999643 46999999999731
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.+......++|||+|||||++...+|+..+|||+.|||||-||.|++||.+.+...
T Consensus 164 ------------------------~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 164 ------------------------NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred ------------------------CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 12233445789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
++++|..+.++++. ..+.+++++++|+++||..||.+|+| +.+.|+|||..+..
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNRE 274 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcchH
Confidence 99999999998876 56789999999999999999999999 88899999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=397.64 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=224.7
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..+....+.+++++.||+|.||.||.|.+.. ...||+|.++...+ ..+.|.+|+++|++|+|+|||+++++|...
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 4445556678888999999999999999973 34899999986433 346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
+.+|||||||+.|+|.++|+. ...+.......++.|||+||+||+++++|||||...||||++++.+||+|||||+..
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999999986 457899999999999999999999999999999999999999999999999999953
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g 916 (995)
..+.+..- ....-+..|+|||.+....++.+||||||||+||||+| |+.||.+
T Consensus 354 ~d~~Y~~~--------------------------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 354 GDDEYTAS--------------------------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred CCCceeec--------------------------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 33222111 11123568999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
.+..++...+..+ +.+| .|..+|+++.++|..||..+|++|||.......+...+
T Consensus 408 msn~ev~~~le~G-yRlp-~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 408 MSNEEVLELLERG-YRLP-RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCHHHHHHHHhcc-CcCC-CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 9999999887655 4445 36789999999999999999999999887777776544
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=371.69 Aligned_cols=268 Identities=41% Similarity=0.706 Sum_probs=226.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997644444455667888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----- 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 99999999999976 457899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 0011123569999999999876 46788999999999999999999999998888
Q ss_pred HHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 921 IIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 921 ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
+.+..+..... +++.....++..+.+||.+||..++ +|+....+.++++||||...+|..
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcCCCcCCCCHHH
Confidence 88887776542 3343335678999999999999655 555444589999999999877643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=368.20 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=210.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf 756 (995)
....++|++.+.||.|+||.||+|.+ ..++..||||+++... .......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 34567899999999999999999975 2345789999987432 233456789999999999 899999999988
Q ss_pred eccC-eeEEEEeecCCCCHHHHHHhc------------------------------------------------------
Q 001924 757 TCRD-NLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 781 (995)
Q Consensus 757 ~~~~-~lyLVmEym~GGSL~d~L~k~------------------------------------------------------ 781 (995)
.... .+++||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 589999999999999999642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001924 782 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853 (995)
Q Consensus 782 --------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi 853 (995)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------ 228 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 228 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc------------
Confidence 236777888899999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCC
Q 001924 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 932 (995)
Q Consensus 854 ~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~ 932 (995)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||.+......+...+.....
T Consensus 229 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 229 -------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred -------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 0011123346788999999999999999999999999999997 99999876544333333333322
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 933 ~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+..+..+++.+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 23456789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.10 Aligned_cols=262 Identities=46% Similarity=0.813 Sum_probs=231.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||++.+..+++.||+|++.............+.+|+++++++.||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998655444455678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|.+++.....++...+..++.|++.||+|||++||+|+||+|.||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~------- 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------- 153 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+
T Consensus 154 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 154 -----------------------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred -----------------------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 022346899999999998888899999999999999999999999988877777777
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCcccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~ 981 (995)
..+... ++..++..+.++|.+||+.||.+|++.. .+.++++||||....|-.
T Consensus 211 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred hcCCcc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 765544 3467799999999999999999999432 488999999999887543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.25 Aligned_cols=255 Identities=33% Similarity=0.495 Sum_probs=207.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeec----
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC---- 758 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~-TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L---kHPNIVkL~gvf~~---- 758 (995)
.+|++.+.||+|+||.||+|.+.. ++..||+|+++.... .......+.+|+.+++.+ .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 568899999875332 222334566777777665 69999999998853
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
...+++||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 346899999996 6999998753 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.... ........||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccC----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 4110 011234568999999999999899999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCC-----CCC-------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 916 AESPEIIFDNILNRKI-----PWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~-----~~p-------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+....+.+..+..... .++ ...+.++..+.+|+.+||+.||++||| +.++|+|
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~l~h 287 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 287 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHHhcC
Confidence 8887776666654211 011 012357888999999999999999999 8888899
Q ss_pred ccc
Q 001924 972 KIF 974 (995)
Q Consensus 972 PfF 974 (995)
|||
T Consensus 288 p~f 290 (290)
T cd07862 288 PYF 290 (290)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=389.84 Aligned_cols=263 Identities=32% Similarity=0.514 Sum_probs=225.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--Ce
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DN 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~ 761 (995)
...+.|+.+++||+|+||.||++++..||+.||+|.++... ..+....-..+|+.||++|.||||++|.+..... ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 34578999999999999999999999999999999987533 2344566778999999999999999999998887 68
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+|||+|||+. +|.-++... -.|++.+++.|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||||++..
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~-- 269 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT-- 269 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc--
Confidence 9999999987 999988764 369999999999999999999999999999999999999999999999999999622
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
.......+..+.|.+|+|||+|.|. .|+..+|+||.||||.||+.|++.|.+.+.
T Consensus 270 ------------------------~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 270 ------------------------PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred ------------------------CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 1122335567899999999999885 699999999999999999999999999998
Q ss_pred HHHHHHHHccC-----CCCC--C-------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 920 EIIFDNILNRK-----IPWP--C-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 920 ~ei~qkIl~~~-----~~~p--~-------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
.+.+..|..-- -.|+ . ....++..+.+|+..||..||.+|.| +.+.|+++|
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL~sey 402 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSALQSEY 402 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHhcCcc
Confidence 88887776521 1122 1 12357889999999999999999999 888899999
Q ss_pred cccc
Q 001924 974 FIKK 977 (995)
Q Consensus 974 F~~~ 977 (995)
|...
T Consensus 403 F~t~ 406 (560)
T KOG0600|consen 403 FTTE 406 (560)
T ss_pred cccC
Confidence 9444
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=381.97 Aligned_cols=264 Identities=39% Similarity=0.631 Sum_probs=238.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ly 763 (995)
....|++.+.||.|.||.||+++.+.||+.+|+|++.+.........+.+.+|+.+|+++. |||||.+++.|.+...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4568999999999999999999999999999999999877666666788999999999999 999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC----CcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen----G~VKLsDFGLArv~~~ 839 (995)
+|||++.||.|++.+... .+++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~- 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK- 190 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc-
Confidence 999999999999999876 49999999999999999999999999999999999999643 479999999998521
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+.
T Consensus 191 ---------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 191 ---------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ---------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 12345568999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
...+..+..+.+.++. .+..++..+.+||++||..||.+|+| +.+.|+|||+......
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSIGEA 302 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCCccc
Confidence 9999999999887654 34678999999999999999999999 6677779999987443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=356.33 Aligned_cols=256 Identities=31% Similarity=0.550 Sum_probs=212.0
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||+|+||.||++.+..+|+.||+|.+.............+..|+++++.++||||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998754433333345567799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCC
Q 001924 775 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (995)
Q Consensus 775 ~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~g 852 (995)
.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 98886543 488888899999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHc
Q 001924 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 928 (995)
Q Consensus 853 i~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~----~ei~qkIl~ 928 (995)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+......
T Consensus 148 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 148 ---------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ---------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 0011234689999999999998999999999999999999999999976432 233333333
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHH-HHHHHcCccccccccc
Q 001924 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG-AAEVFHCKIFIKKTEN 980 (995)
Q Consensus 929 ~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~E-IlEiL~HPfF~~~~~n 980 (995)
..... ....++.++.+||.+||+.||.+||++.+ +.+.++||||+...|.
T Consensus 213 ~~~~~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 213 DEVKF--EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred ccccc--ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 33322 22468999999999999999999999755 4579999999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=356.65 Aligned_cols=300 Identities=40% Similarity=0.728 Sum_probs=239.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..+++.||+|.+.............+.+|+++++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998755444456678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 767 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 767 Eym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||+.+++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 468999999999999999999999999999999999999999999999999987422111100
Q ss_pred CCCCCCCCCCC--CCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 845 LSGPETDGIMP--SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 845 lsg~~t~gi~~--s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........... ....................||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000011122233456799999999999998899999999999999999999999998888887
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC-HHHHHHHHcCccccccccccccchhH
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVFHCKIFIKKTENCVSMQSK 987 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS-A~EIlEiL~HPfF~~~~~n~~s~q~~ 987 (995)
+..+......++.. ...+..+.+||.+||+.||++||+ +..+.++|+||||++.+|-..+..+.
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~ 305 (316)
T cd05574 241 FSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTP 305 (316)
T ss_pred HHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCC
Confidence 77777665554432 237899999999999999999999 56678899999999998877776543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=391.36 Aligned_cols=267 Identities=30% Similarity=0.456 Sum_probs=224.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccC-e
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-N 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~-~ 761 (995)
...++|.++++||.|+||.||+|+.+.+|..||||.+++.. .. .+.-.-++|+..|+++. |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-cc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 34578999999999999999999999999999999987633 22 23344578999999998 999999999999988 8
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+|+|||||+ .+|+++++.. ..|++..++.|+.||++||+|+|.+|++|||+||+|||+..+..+||+|||+|+-.
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev--- 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV--- 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc---
Confidence 999999995 5999999754 56999999999999999999999999999999999999998999999999999831
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
......+..+.|.+|+|||+|.. .-|+.++|+|++|||++|+.+-++.|+|.+.
T Consensus 161 -------------------------~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 161 -------------------------RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred -------------------------ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 12233445678999999999865 5679999999999999999999999999988
Q ss_pred HHHHHHHHcc-------------------CCCCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 920 EIIFDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 920 ~ei~qkIl~~-------------------~~~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.+.+.+|..- ++.+|. +-+..+.++.+||.+||++||.+||| +.+.|+||
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al~~p 292 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQALQHP 292 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHhcCc
Confidence 7766666431 122222 22458899999999999999999999 77889999
Q ss_pred cccccccccccc
Q 001924 973 IFIKKTENCVSM 984 (995)
Q Consensus 973 fF~~~~~n~~s~ 984 (995)
||+.-..-..+.
T Consensus 293 ffq~~~~~~~~a 304 (538)
T KOG0661|consen 293 FFQVGRASGSSA 304 (538)
T ss_pred cccccccccccc
Confidence 999776554433
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=344.37 Aligned_cols=260 Identities=30% Similarity=0.493 Sum_probs=221.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~--se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
++|++.+.||.|++|.||+|.+..+++.||+|.+...... .......+.+|++++++++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754321 12234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++++|.+++...+.++...+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
..........|+..|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 159 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 159 ---------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ---------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 00011123458889999999999899999999999999999999999998876665555
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+...... +..+..++..+.++|.+||..+|.+||+ +.++++||||
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 55444333 3456788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.59 Aligned_cols=255 Identities=30% Similarity=0.558 Sum_probs=234.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
-.+|++.+.||+|.||.|-++.....|+.||||.|++....++.+.-.+.+|++||+.|+||||+.+|.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 47899999999999999999999999999999999999888888889999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||..+|.|+||+.+.+.+++..++.+++||+.|+.|+|.++++|||||.+|||+|.|+++||+|||++.+..
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~------- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA------- 204 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
......++||+|.|.+||++.|.+| +..+|-|||||+||.|+.|.+||++.+...+..
T Consensus 205 ---------------------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 205 ---------------------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred ---------------------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 2334567999999999999999998 789999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
+|..+.+.-|. .+..+.-||++||..||++|-| +.++-.|=|.+
T Consensus 264 QIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWvN 307 (668)
T KOG0611|consen 264 QISRGAYREPE----TPSDASGLIRWMLMVNPERRAT---IEDIASHWWVN 307 (668)
T ss_pred HhhcccccCCC----CCchHHHHHHHHHhcCcccchh---HHHHhhhheee
Confidence 99999887553 4567789999999999999999 55555665554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=384.18 Aligned_cols=272 Identities=35% Similarity=0.631 Sum_probs=229.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----------chhHHHHHHHHHHHHHhcCCCc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----------RKNDIERILAERNILITVRNPF 748 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----------se~e~e~flrEieILs~LkHPN 748 (995)
...+..+++|++.+.||+|.||.|-+|++..+++.||||++.+.... .....+.+.+|+.+|+++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 34456789999999999999999999999999999999999753321 1223468999999999999999
Q ss_pred eEEEeeeeecc--CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcE
Q 001924 749 VVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 749 IVkL~gvf~~~--~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~V 826 (995)
||+|+.+..+. +.+|||+|||..|.+...=.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.+|+|
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999998775 4699999999998875433222238999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC----CCchHHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGI 902 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~----ys~KSDIWSLGV 902 (995)
||+|||.+.....+. ...........+|||.|+|||++.+.. .+++.||||+||
T Consensus 250 KIsDFGVs~~~~~~~----------------------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGS----------------------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred EeeccceeeecccCC----------------------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 999999887422110 000111122368999999999997732 267899999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 903 ILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+||.|+.|+.||-+....+++.+|++....+|..+ .+...+++||.+||++||++|++ +.++..|||....
T Consensus 308 TLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVTRD 378 (576)
T ss_pred hHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheee---hhhheecceeccC
Confidence 99999999999999999999999999998888643 68899999999999999999999 8899999998876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.77 Aligned_cols=262 Identities=35% Similarity=0.648 Sum_probs=242.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
.....++++|++.+.||+|-||.||+|+.+.++-.||+|++.+..........++.+|++|-+.|+||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 44556789999999999999999999999999999999999988777777778899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~--k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
..+|+++||.+.|+|+..|. ....+++..+..++.|++.||.|+|..+||||||||+|+|++..|.+|++|||-+..
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~- 173 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH- 173 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-
Confidence 99999999999999999998 556799999999999999999999999999999999999999999999999998763
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.+.....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...
T Consensus 174 ----------------------------~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 174 ----------------------------APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred ----------------------------cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 1234556789999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
+..+.+.+|....+.+| ..++..+.+||.+||.++|.+|.+ ..+++.|||-..
T Consensus 226 ~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 99999999998887766 789999999999999999999999 888889999654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=362.86 Aligned_cols=268 Identities=29% Similarity=0.470 Sum_probs=222.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||.|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3478999999999999999999999999999999887532 23445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999998888899999999999999999999985 799999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 157 -------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred -------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 0112346899999999999989999999999999999999999999765543332
Q ss_pred HHH--------------------------------------------HccCCCCCCCC-CCCCHHHHHHHHHHhhcCccC
Q 001924 924 DNI--------------------------------------------LNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 924 qkI--------------------------------------------l~~~~~~p~lp-s~lS~eL~dLIkkCLq~DPeK 958 (995)
..+ ..... +..+ ...+.++.+||.+||++||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~ 289 (333)
T cd06650 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAE 289 (333)
T ss_pred HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCccc
Confidence 111 11110 1111 235788999999999999999
Q ss_pred CCCHHHHHHHHcCccccccccccccchhHh
Q 001924 959 RLGANGAAEVFHCKIFIKKTENCVSMQSKL 988 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~~~~~n~~s~q~~l 988 (995)
||| +.+++.||||+....+......-+
T Consensus 290 Rpt---~~ell~h~~~~~~~~~~~~~~~~~ 316 (333)
T cd06650 290 RAD---LKQLMVHAFIKRSEAEEVDFAGWL 316 (333)
T ss_pred CcC---HHHHhhCHHHhcCccccccHHHHH
Confidence 999 778889999998766555444433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.05 Aligned_cols=257 Identities=57% Similarity=0.971 Sum_probs=221.2
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieIL-s~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
+.||.|+||.||+|.+..+|+.||+|++++...........+..|..++ ....|||++++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998764433333344455565544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999887889999999999999999999999999999999999999999999999999886310
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....+..+.....
T Consensus 149 ------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 149 ------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred ------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 01234588899999999988899999999999999999999999998888888877766655
Q ss_pred CCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 932 PWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 932 ~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
.++. ....++..+.++|.+||+.+|++||++.++.+++.||||.+..|.
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 4432 334688999999999999999999999999999999999988773
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=355.76 Aligned_cols=265 Identities=32% Similarity=0.569 Sum_probs=220.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.++++++|+||+.+++.+...+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876544444445667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 99999999988644 3588999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---II 922 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~---ei 922 (995)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 155 ----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 00112346899999999999999999999999999999999999999865322 12
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
......... ...+..+++.+.+|+.+||+.||.+|||.. .+.++++||||.+..+..+
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05630 213 VERLVKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272 (285)
T ss_pred HHhhhhhhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHH
Confidence 222221111 123467889999999999999999999843 4889999999998766643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=355.11 Aligned_cols=246 Identities=20% Similarity=0.217 Sum_probs=213.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec----cCeeEEEEee
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYLVMEY 768 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~----~~~lyLVmEy 768 (995)
..||+|++|.||+|.. +|+.||||.++..........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 589999999986544444446788899999999999999999999876 3468999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+++|+|.+++.+...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-------- 175 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-------- 175 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc--------
Confidence 99999999998888899999999999999999999984 999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+++..
T Consensus 176 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 176 ----------------------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred ----------------------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0113468899999999976 6789999999999999999999999999988888888
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+......+ ..+..++..+.+||.+||+.||++|||+.++++.|+-
T Consensus 234 i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 234 IINKNNSL-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHhcCCCC-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 77665443 3455789999999999999999999999999988764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=356.27 Aligned_cols=269 Identities=26% Similarity=0.458 Sum_probs=219.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999875432 22334677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++ +|.+++... ..++...++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV----- 156 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC-----
Confidence 999975 888888654 4588999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 157 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 157 ----------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred ----------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0011123457899999999865 45799999999999999999999999887765554
Q ss_pred HHHHccC-------------------CCCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 924 DNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 924 qkIl~~~-------------------~~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
..+.... ...+. ....++.++.+||.+||+.||.+||| +.++++||||..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 291 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHAYFRS 291 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcChhhhh
Confidence 4433210 00010 11357889999999999999999999 888899999998
Q ss_pred cccccccchhH
Q 001924 977 KTENCVSMQSK 987 (995)
Q Consensus 977 ~~~n~~s~q~~ 987 (995)
......++.+.
T Consensus 292 ~~~~~~~~~~~ 302 (309)
T cd07872 292 LGTRIHSLPES 302 (309)
T ss_pred cccccccCCcc
Confidence 76665555543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=341.85 Aligned_cols=265 Identities=59% Similarity=1.037 Sum_probs=227.8
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||.|+||.||++.+..+|+.|++|++.............+.+|++++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999765544455677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001924 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (995)
Q Consensus 775 ~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~ 854 (995)
.+++.+.+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------- 150 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN---------- 150 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc----------
Confidence 9999887789999999999999999999999999999999999999999999999999987421110000
Q ss_pred CCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCC
Q 001924 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (995)
Q Consensus 855 ~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p 934 (995)
............++..|+|||.+.+..++.++||||||+++|+|++|..||........+..+..+...++
T Consensus 151 ---------~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 151 ---------LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred ---------cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 00011122345688899999999888899999999999999999999999999888888888877665554
Q ss_pred CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 935 ~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
.. ..++..+.+|+.+||+.+|.+|||+..+.++|+||||+++.|
T Consensus 222 ~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 32 224899999999999999999999988899999999998876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=349.04 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=205.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeecc-----
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCR----- 759 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L---kHPNIVkL~gvf~~~----- 759 (995)
+|++.+.||+|+||+||+|.+..+|+.||+|.++..... ......+.+|+.+++.+ .||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998753221 12223456677776655 799999999987653
Q ss_pred CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
..+++||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 35899999997 4899988754 34899999999999999999999999999999999999999999999999998741
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 159 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SC----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cC----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 10 01112346899999999999999999999999999999999999999887
Q ss_pred CHHHHHHHHHccC-----CCCC-------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 918 SPEIIFDNILNRK-----IPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 918 s~~ei~qkIl~~~-----~~~p-------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
........+.... ..|+ ...+.++..+.+||.+||+.||.+||| +.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~hp~ 287 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQHPF 287 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhcCCC
Confidence 7665555543310 0010 012356788999999999999999999 788899999
Q ss_pred c
Q 001924 974 F 974 (995)
Q Consensus 974 F 974 (995)
|
T Consensus 288 f 288 (288)
T cd07863 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.17 Aligned_cols=260 Identities=31% Similarity=0.513 Sum_probs=221.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
.+|...+.||+|.||.||+|++..||+.||||.++.... .+.-....++|+..|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 578889999999999999999999999999999986532 2233456799999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+. +|...++.. ..++...++.++.++++||+|||+++|+||||||.|+|++.+|.+||+|||+|+...
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~------- 152 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG------- 152 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC-------
Confidence 99965 999999754 468999999999999999999999999999999999999999999999999999522
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........+.|.+|+|||++.|. .|+..+|+||.|||+.||+.|.+-|.+.+.-+.+.
T Consensus 153 --------------------~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 153 --------------------SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred --------------------CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 111222233789999999999885 68999999999999999999999999998877777
Q ss_pred HHHccC-----CCCCC--------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 925 NILNRK-----IPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 925 kIl~~~-----~~~p~--------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.|...- ..||. +.+..+.++.+|+.+||.+||.+|++ +.+.|+|+||..-.
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKSLP 288 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhcCC
Confidence 766521 11222 22346778899999999999999999 88889999999743
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=366.84 Aligned_cols=260 Identities=30% Similarity=0.485 Sum_probs=215.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----ee
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~-----~l 762 (995)
+|++.+.||+|+||.||++.+..+|+.||||.+... .........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 578999999999999999999999999999988643 223344567899999999999999999999998776 78
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999996 689998887778999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.++..
T Consensus 157 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 157 ------------------------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred ------------------------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 00111234688999999999875 47899999999999999999999998887665
Q ss_pred HHHHHHcc-----------------------CCCCC------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 922 IFDNILNR-----------------------KIPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 922 i~qkIl~~-----------------------~~~~p------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
....+... ....+ ......+.++.+||.+||+.||.+||| +.++++||
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l~hp 289 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADALAHP 289 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHhcCH
Confidence 55444321 11111 122456889999999999999999999 77889999
Q ss_pred cccccc
Q 001924 973 IFIKKT 978 (995)
Q Consensus 973 fF~~~~ 978 (995)
||.+.+
T Consensus 290 ~~~~~~ 295 (372)
T cd07853 290 YLDEGR 295 (372)
T ss_pred hhCCCc
Confidence 999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=378.70 Aligned_cols=259 Identities=29% Similarity=0.400 Sum_probs=209.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~---- 759 (995)
....+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34578999999999999999999999999999999875421 2245799999999999999998876432
Q ss_pred ----CeeEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEe
Q 001924 760 ----DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTD 830 (995)
Q Consensus 760 ----~~lyLVmEym~GGSL~d~L~----k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsD 830 (995)
..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999975 7777764 345689999999999999999999999999999999999998665 799999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHc
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLT 909 (995)
||+|+.... ........||+.|+|||++.+. .|+.++|||||||++|||++
T Consensus 215 FGla~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 215 FGSAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred cccchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999974210 0111235689999999998764 68999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccC-----------------CCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 910 GIPPFTAESPEIIFDNILNRK-----------------IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~~~-----------------~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
|.+||.+.+..+.+..+.... ..++. +|...+.++.+||.+||++||.+|||
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t-- 344 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN-- 344 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC--
Confidence 999999887665555543311 11111 23457889999999999999999999
Q ss_pred HHHHHHcCcccccccccc
Q 001924 964 GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 964 EIlEiL~HPfF~~~~~n~ 981 (995)
+.++|+||||...+...
T Consensus 345 -a~e~l~hp~f~~~~~~~ 361 (440)
T PTZ00036 345 -PIEALADPFFDDLRDPC 361 (440)
T ss_pred -HHHHhCChhHHhhhccc
Confidence 78889999998876543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=365.24 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=210.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|+..+.||.|+||.||+|.+..+++.||||++.... .......+.+|+++++.++|+||+++++++...+.++
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 44678999999999999999999999999999999986432 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++|+|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~---- 220 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ---- 220 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc----
Confidence 99999999998653 2356778888999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........||..|+|||++.. ...+.++|||||||++|||++|+.||....
T Consensus 221 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 221 -----------------------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred -----------------------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0011123569999999999843 234578999999999999999999997433
Q ss_pred HHH---HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 919 PEI---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 919 ~~e---i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
... ....+... ..+..+..++.++.+||.+||+.||++||+ +.++++||||.+..
T Consensus 278 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~~ 335 (353)
T PLN00034 278 QGDWASLMCAICMS--QPPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRAQ 335 (353)
T ss_pred CccHHHHHHHHhcc--CCCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccCC
Confidence 222 22222221 123345678999999999999999999999 77889999999863
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.77 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=207.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...+|++.+.||+|+||.||++.+..+++.||+|.... ..+.+|++++++++||||++++++|......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 45789999999999999999999999999999996432 346789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~----- 234 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD----- 234 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc-----
Confidence 999994 69999998777899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC------
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES------ 918 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s------ 918 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 235 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~ 293 (391)
T PHA03212 235 ---------------------INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293 (391)
T ss_pred ---------------------ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC
Confidence 00111224579999999999999999999999999999999999998874321
Q ss_pred -HHHHHHHHHcc--------------------------CCCCCC-C-----CCCCCHHHHHHHHHHhhcCccCCCCHHHH
Q 001924 919 -PEIIFDNILNR--------------------------KIPWPC-V-----PSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (995)
Q Consensus 919 -~~ei~qkIl~~--------------------------~~~~p~-l-----ps~lS~eL~dLIkkCLq~DPeKRPSA~EI 965 (995)
....+..+... ....+. . ...++.++.+||.+||+.||.+||| +
T Consensus 294 ~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt---a 370 (391)
T PHA03212 294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS---A 370 (391)
T ss_pred chhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC---H
Confidence 11111111110 000000 0 0134678999999999999999999 7
Q ss_pred HHHHcCccccccc
Q 001924 966 AEVFHCKIFIKKT 978 (995)
Q Consensus 966 lEiL~HPfF~~~~ 978 (995)
.++|+||||....
T Consensus 371 ~elL~hp~f~~~~ 383 (391)
T PHA03212 371 EALLDFAAFQDIP 383 (391)
T ss_pred HHHhcChhhccCC
Confidence 7888999998753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.41 Aligned_cols=266 Identities=32% Similarity=0.545 Sum_probs=221.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|+..+.||.|+||+||+|.+..+++.||+|.+.............+.+|+++++.++|+||+.+++.+...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544334445667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 99999999888643 3689999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........|++.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 155 ----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 155 ----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred ----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011234689999999999999999999999999999999999999987765443333
Q ss_pred HHccCCC-CCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCcccccccccc
Q 001924 926 ILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 926 Il~~~~~-~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~ 981 (995)
+...... ....+..++..+.+|+.+||+.||.+||++. .+.++++|+||....+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence 3221111 1223457889999999999999999999953 367899999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=342.77 Aligned_cols=255 Identities=38% Similarity=0.647 Sum_probs=213.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|++.+.||+|+||+||++.+..+++.||+|++...... ........+|+.++++++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999875432 22233445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCC
Q 001924 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (995)
Q Consensus 769 m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~ 848 (995)
+++++|.+++.....++...+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~----------- 148 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL----------- 148 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------
Confidence 999999999997788999999999999999999999999999999999999999999999999998631
Q ss_pred CCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---HHHHHH
Q 001924 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAES---PEIIFD 924 (995)
Q Consensus 849 ~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-g~~ys~KSDIWSLGVILyELLTGr~PF~g~s---~~ei~q 924 (995)
...........+++.|+|||++. +..++.++||||||+++|+|++|..||.... ......
T Consensus 149 ----------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 149 ----------------SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp ----------------TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred ----------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 01112334567899999999998 7889999999999999999999999999873 333333
Q ss_pred HHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
........... .....+..+.+||.+||+.||++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 33322111110 01123489999999999999999999 8999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=335.22 Aligned_cols=254 Identities=30% Similarity=0.523 Sum_probs=221.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58899999999999999999999999999999875332 34566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++++|.+++... ..++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~------ 153 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD------ 153 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC------
Confidence 99999999999764 5688999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......
T Consensus 154 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 154 ---------------------NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ---------------------ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00111234688999999999999999999999999999999999999998887777777
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..+.. +..+..++..+.+++.+||+.+|++||+ +.++++|||+
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHcCCC--CCCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 666543 3344578899999999999999999999 7888889985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=414.10 Aligned_cols=276 Identities=41% Similarity=0.724 Sum_probs=248.1
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...+...++|.+++.||+|+||.|.+++++.|++.||+|++.+-.+....+..-|..|..+|.....+=|++++..|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34466789999999999999999999999999999999999987777777788899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.++|+|||||+||+|..++.+...+++.++++|+..|+.||..||+.|+|||||||+|||||.+|++||+|||.|--+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999998753221
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
.+.......+|||.|.+||+|.. +.|+...|+||+||++||||.|..||
T Consensus 228 --------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 228 --------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred --------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 12233456789999999999942 56899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcc--CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 915 TAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~--~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
...+-.+.|.+|++. .+.||. ...+|.++++||.+++. +|+.|.+-+.+.++.+||||.+++|..+.
T Consensus 282 YadslveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 282 YADSLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR 350 (1317)
T ss_pred hHHHHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh
Confidence 999999999999987 444552 25699999999999987 89999999999999999999999997654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=360.48 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=208.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||+|+||.||++.+..+|..||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4689999999999999999999999999999999987532 23344567889999999999999999999886543
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||||+++ +|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 47999999965 67766643 48889999999999999999999999999999999999999999999999987311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 175 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 175 T----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred c----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 0 011223568999999999999999999999999999999999999998766
Q ss_pred HHHHHHHHHc----------------------cCCCCCC-----------------CCCCCCHHHHHHHHHHhhcCccCC
Q 001924 919 PEIIFDNILN----------------------RKIPWPC-----------------VPSDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 919 ~~ei~qkIl~----------------------~~~~~p~-----------------lps~lS~eL~dLIkkCLq~DPeKR 959 (995)
....+..+.. ....++. .....+..+.+||.+||+.||.+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 5433322211 1111100 111246788999999999999999
Q ss_pred CCHHHHHHHHcCccccc
Q 001924 960 LGANGAAEVFHCKIFIK 976 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~ 976 (995)
|| +.++|+||||..
T Consensus 307 ~t---~~e~l~hp~~~~ 320 (359)
T cd07876 307 IS---VDEALRHPYITV 320 (359)
T ss_pred CC---HHHHhcCchhhh
Confidence 99 778899999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.38 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=217.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-CeeEEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVM 766 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-~~lyLVm 766 (995)
+|++.+.||.|++|.||++.+..+++.||+|.+.... ........+.+|+++++.++|||++++++.+... ..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986533 2334566788999999999999999999887644 4689999
Q ss_pred eecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 767 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 767 Eym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~----- 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN----- 154 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc-----
Confidence 999999999999753 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 155 ----------------------QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ----------------------cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0011223468899999999999999999999999999999999999999887777666
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..+.. +..+...+..+.+|+.+||+.||.+||+ +.++++||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 6665543 2345678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=365.58 Aligned_cols=267 Identities=32% Similarity=0.482 Sum_probs=224.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 758 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~- 758 (995)
.....++++|+.++.|++|+||.||+|+++.|++.||+|.++... ......-.-++|+++|.+++|||||.+-.+...
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 344567899999999999999999999999999999999987543 222223356899999999999999999776554
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
-+.+|||||||+. +|..++.+.+ .|....++.++.|++.|++|||.++|+||||||+|+|++..|.+||+|||+|+.
T Consensus 148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 4569999999977 9999998765 799999999999999999999999999999999999999999999999999994
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.. ......+..+.|.+|+|||++.+. .|+..+|+||+|||+.||+++++-|.
T Consensus 227 yg---------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 227 YG---------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred hc---------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 11 122334567889999999999885 58999999999999999999999999
Q ss_pred CCCHHHHHHHHHccC-----CCCCC-----------------------CCC-CCCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 916 AESPEIIFDNILNRK-----IPWPC-----------------------VPS-DMSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 916 g~s~~ei~qkIl~~~-----~~~p~-----------------------lps-~lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
+.+..+.+++|+.-- ..||. ++. .++....+|++.+|.+||.+|.| +.
T Consensus 280 G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t---A~ 356 (419)
T KOG0663|consen 280 GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT---AE 356 (419)
T ss_pred CCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---HH
Confidence 999888888776521 11221 111 25688999999999999999999 77
Q ss_pred HHHcCccccccc
Q 001924 967 EVFHCKIFIKKT 978 (995)
Q Consensus 967 EiL~HPfF~~~~ 978 (995)
+.|.|.||....
T Consensus 357 ~~L~h~~F~e~P 368 (419)
T KOG0663|consen 357 DGLKHEYFRETP 368 (419)
T ss_pred HhhcccccccCC
Confidence 889999999853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.98 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=210.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~----------------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI 749 (995)
.++|.+.+.||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998643 34479999987532 23456679999999999999999
Q ss_pred EEEeeeeeccCeeEEEEeecCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 001924 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-------------------CLEEDVARIYIAELVLALEYLHSLGIVH 810 (995)
Q Consensus 750 VkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~-------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIH 810 (995)
+++++++...+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986431 3567788899999999999999999999
Q ss_pred eecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC
Q 001924 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (995)
Q Consensus 811 RDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ 890 (995)
|||||+|||++.++.+||+|||+++....... ........++..|+|||++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-------------------------YRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce-------------------------eEecCcCCCCccccCHHHHhcCC
Confidence 99999999999999999999999873211000 01112345678999999999889
Q ss_pred CCchHHHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHcc-----CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 891 HGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 891 ys~KSDIWSLGVILyELLT--Gr~PF~g~s~~ei~qkIl~~-----~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
++.++||||||+++|||++ +..||...+.......+... ...+...+..++..+.+|+.+||+.||.+|||+.
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 9999999999999999986 67889887766655443221 1112233467889999999999999999999999
Q ss_pred HHHHHHc
Q 001924 964 GAAEVFH 970 (995)
Q Consensus 964 EIlEiL~ 970 (995)
++..+|+
T Consensus 297 ~i~~~l~ 303 (304)
T cd05096 297 DIHAFLT 303 (304)
T ss_pred HHHHHHh
Confidence 9988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=343.33 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=219.7
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|++.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 688899999999999999999999999999886432 34567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-------- 155 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-------- 155 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--------
Confidence 999999988764 45689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........|++.|+|||++. +..++.++|||||||++|+|++|.+||...+....
T Consensus 156 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 156 -------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred -------------------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 001122346899999999984 34578899999999999999999999998877776
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
...+..........+..++..+.+||.+||+.||.+||+ +.++++||||.....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 270 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEeccCC
Confidence 666655544333345678899999999999999999999 778899999997644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=341.62 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=216.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3568999999999999999999875 345699999987532 23445678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999764 46899999999999999999999999999999999999999999999999986531000
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 161 --------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred --------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 0001112335678999999999999999999999999999875 9999999888
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
......+..+. ..+ .+..++..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 215 ~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 215 QDVIKAVEDGF-RLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 87777765543 222 457789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=345.72 Aligned_cols=265 Identities=33% Similarity=0.559 Sum_probs=224.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..+.|++++.||.|+||.||+|.+..++..|++|++... .......+.+|+.+++.++||||+++++++.....+++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 347799999999999999999999999999999998653 34456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++++|..++.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---- 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---- 162 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc----
Confidence 9999999999888754 35689999999999999999999999999999999999999999999999998763100
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........+++.|+|||++. ...++.++|||||||++|+|++|..||...+
T Consensus 163 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 163 -----------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -----------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 001112345888999999985 3456889999999999999999999998877
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
.......+.....+....+..++..+.+||.+||..||++||+ +.++++||||....++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchh
Confidence 7666666655443333345678899999999999999999999 678899999999888873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.39 Aligned_cols=262 Identities=32% Similarity=0.566 Sum_probs=224.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||.|+||.||+|.+..++..||+|+++.. .......+.+|+.++++++||||+++++.+......|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999889999999998643 334567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~------ 154 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK------ 154 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc------
Confidence 9999999999998764 468999999999999999999999999999999999999999999999999876311
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
..........|++.|+|||++. +..++.++||||||+++|+|++|+.||...+.
T Consensus 155 ---------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 155 ---------------------STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ---------------------ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 0011122346899999999985 34467899999999999999999999998887
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
......+.....+....+..++..+.++|.+||+.+|.+||+ +.++++||||.+..++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~~~ 271 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQSDN 271 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccchh
Confidence 777777766544333345678899999999999999999999 7788999999988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=337.92 Aligned_cols=261 Identities=30% Similarity=0.503 Sum_probs=219.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s------e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
+|.+...||.|+||.||+|.+..++..||+|.+....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999999899999999886543221 1234678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
.++||||+++++|.+++...+.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
. ............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 161 ~---------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 161 L---------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred c---------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 0 0001112233568899999999999889999999999999999999999998876655
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
....+... ..+..+..++..+.++|.+||+.||.+||+ +.++++||||
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 54444332 234456778999999999999999999999 7888999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=375.64 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=205.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC------CceEEEeeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFT 757 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH------PNIVkL~gvf~ 757 (995)
...++|++.+.||+|+||+||+|.+..+++.||||+++... .....+..|+.++..+.| ++++.+++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34688999999999999999999999999999999987532 123345567777776654 45888988887
Q ss_pred cc-CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCC-----------
Q 001924 758 CR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG----------- 824 (995)
Q Consensus 758 ~~-~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG----------- 824 (995)
.. ..+++||+++ +++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 4689999988 77999999888889999999999999999999998 5999999999999998765
Q ss_pred -----cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHH
Q 001924 825 -----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (995)
Q Consensus 825 -----~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (995)
.+||+|||++... .......+||+.|+|||++.+..|+.++||||
T Consensus 281 ~~~~~~vkl~DfG~~~~~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCceEEECCCCccccC------------------------------ccccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 4999999987520 01123467999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCC------------------------CC---------------CCCC
Q 001924 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP------------------------CV---------------PSDM 940 (995)
Q Consensus 900 LGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p------------------------~l---------------ps~l 940 (995)
|||++|||++|+.||.+.+..+....+......+| .. ....
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 99999999999999988776554443322110000 00 0011
Q ss_pred CHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 941 SFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 941 S~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
++.+.+||.+||++||.+||| +.++|+||||.+...
T Consensus 411 ~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLKYYP 446 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCC---HHHHhcCccccccCC
Confidence 356789999999999999999 788889999998543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=363.06 Aligned_cols=268 Identities=28% Similarity=0.475 Sum_probs=236.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-----~se~e~e~flrEieILs~L-kHPNIVkL~gvf 756 (995)
......|...+.||.|..++|.++.++.+|..+|+|++..... ....-.+...+|+.||+++ .||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3456778888999999999999999999999999999864221 1222345667899999987 599999999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+.+..+++|+|.|+.|.|+|+|...-.+++...+.+++|++.|+.|||.++|+||||||+|||++++.++||+|||+|+.
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999999999988999999999999999999999999999999999999999999999999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC------CCCCchHHHHHHHHHHHHHHcC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g------~~ys~KSDIWSLGVILyELLTG 910 (995)
. .........||||+|+|||.+.. .+|+..+|+|++|||||.||.|
T Consensus 173 l----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 173 L----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred c----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 2 23345567899999999999843 3578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
.+||.......++..|+.+++.+.. .+.+++..+++||.+||+.||.+|.| +.+.|.||||+++....
T Consensus 225 cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQIAQQQ 293 (411)
T ss_pred CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHHHHhc
Confidence 9999999889999999999987754 34689999999999999999999999 77889999998875544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=342.84 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=218.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG-----~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..++|++.+.||+|+||.||+|.....+ ..||+|.++... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3468999999999999999999976555 689999886432 234456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen 823 (995)
...+++|||+++|+|.+++... ..++...+..++.|++.||+|||++||+|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999754 347888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHH
Q 001924 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (995)
Q Consensus 824 G~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (995)
+.+||+|||+++...... .........+++.|+|||.+.+..++.++|||||||+
T Consensus 161 ~~~~L~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~i 215 (283)
T cd05048 161 LTVKISDFGLSRDIYSAD-------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215 (283)
T ss_pred CcEEECCCcceeeccccc-------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHH
Confidence 999999999987421000 0011123356889999999998899999999999999
Q ss_pred HHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 904 LyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+|||++ |..||.+.+..++...+..... +..+..++.++.+|+.+||+.||.+||++.++.+.|+
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 216 LWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 999998 9999999888888777765543 2345789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=338.09 Aligned_cols=262 Identities=26% Similarity=0.456 Sum_probs=219.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM---IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~---~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
+|++.+.||.|+||.||+|... +++.+|+|.++.... ........+.+|+++++.++|+||+++++++.....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5788999999999999999864 788999998864321 122334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++++|.+++.+...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-- 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc--
Confidence 999999999999998877899999999999999999999999999999999999999999999999998874210000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
............|+..|+|||++.+..++.++||||||+++|+|++|..||...+......
T Consensus 158 -------------------~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 218 (265)
T cd06631 158 -------------------HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218 (265)
T ss_pred -------------------cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence 0000111223468999999999999889999999999999999999999998776655554
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+.......+..+..++..+.++|.+||..+|.+||+ +.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5444434445566788999999999999999999999 7889999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=358.13 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=210.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~----- 759 (995)
..++|++.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4689999999999999999999999999999999987532 2334456788999999999999999999887653
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..+|+||||+++ +|.+++.. .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999965 78777753 47888999999999999999999999999999999999999999999999987411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 178 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 178 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred C----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0 011123568999999999999999999999999999999999999999887
Q ss_pred HHHHHHHHHccCCC----------------------CC-----------------CCCCCCCHHHHHHHHHHhhcCccCC
Q 001924 919 PEIIFDNILNRKIP----------------------WP-----------------CVPSDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 919 ~~ei~qkIl~~~~~----------------------~p-----------------~lps~lS~eL~dLIkkCLq~DPeKR 959 (995)
....+..++..... +. ..+...+..+.+||.+||+.||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 76665554431100 00 0011234678999999999999999
Q ss_pred CCHHHHHHHHcCccccc
Q 001924 960 LGANGAAEVFHCKIFIK 976 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~ 976 (995)
|| +.++|+||||..
T Consensus 310 ~t---~~e~L~hp~~~~ 323 (364)
T cd07875 310 IS---VDEALQHPYINV 323 (364)
T ss_pred CC---HHHHhcCccccc
Confidence 99 778899999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.97 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=221.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
+...++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4566899999999999999999997652 34589999876432 2223456788999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~----------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
.....|+||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999999753 2245677888999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
|+|||+++...... .........++..|+|||.+.+..++.++|||||||++|||
T Consensus 160 L~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCccccccccc-------------------------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 99999987421000 00011123457789999999998999999999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc---Ccccccccc
Q 001924 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH---CKIFIKKTE 979 (995)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~---HPfF~~~~~ 979 (995)
++ |..||.+....+....+..+.. +..+..+++.+.+++.+||+.||.+|||+.++++.++ ||||..++|
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 98 8999998888887777665543 2334677899999999999999999999999998877 899999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=338.13 Aligned_cols=257 Identities=38% Similarity=0.717 Sum_probs=222.2
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.....+++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999875554445667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001924 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (995)
Q Consensus 775 ~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~ 854 (995)
.+++.+...++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~--------------- 145 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--------------- 145 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc---------------
Confidence 99998877899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHccCCC
Q 001924 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PEIIFDNILNRKIP 932 (995)
Q Consensus 855 ~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s--~~ei~qkIl~~~~~ 932 (995)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ....+..+..+..
T Consensus 146 -------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 211 (262)
T cd05572 146 -------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG- 211 (262)
T ss_pred -------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-
Confidence 001123468899999999988889999999999999999999999998776 6666666664322
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccc
Q 001924 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 933 ~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n 980 (995)
.+..+...+.++.++|.+||+.+|.+||+. ..+.++++||||++.+|+
T Consensus 212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 233445668999999999999999999993 347889999999998775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.57 Aligned_cols=260 Identities=32% Similarity=0.534 Sum_probs=219.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||+||+|.+..++..+|+|++...... .....+.+|+.+++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4799999999999999999999989999999998653322 25678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 767 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 767 Eym~GGSL~d~L~k~---~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999874211000
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
..........|+..|+|||++... .++.++|+||||+++|+|++|+.||...+....
T Consensus 158 ----------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 158 ----------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred ----------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 000112345689999999999877 789999999999999999999999988877666
Q ss_pred HHHHHccCCCC-CCC--CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 923 FDNILNRKIPW-PCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 923 ~qkIl~~~~~~-p~l--ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..+....... +.. ...++..+.+|+.+||+.||++||+ +.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 66665543221 111 1367889999999999999999999 8888999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=357.54 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC---
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--- 760 (995)
...++|++.+.||+|+||.||++.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 34689999999999999999999999999999999987532 23344567889999999999999999999886543
Q ss_pred ---eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 761 ---~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
..|+||||+++ +|.+.+.. .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999965 77777653 4888899999999999999999999999999999999999999999999998731
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 170 GT----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CC----------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 10 01112356899999999999999999999999999999999999999887
Q ss_pred CHHHHHHHHHccC----------------------CC-----CC------------CCCCCCCHHHHHHHHHHhhcCccC
Q 001924 918 SPEIIFDNILNRK----------------------IP-----WP------------CVPSDMSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 918 s~~ei~qkIl~~~----------------------~~-----~p------------~lps~lS~eL~dLIkkCLq~DPeK 958 (995)
+....+..+.... .. ++ ..+...+..+.+||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 6544433322110 00 00 011224567899999999999999
Q ss_pred CCCHHHHHHHHcCccccc
Q 001924 959 RLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~~ 976 (995)
||| +.++|+||||+.
T Consensus 302 Rps---~~ell~hp~~~~ 316 (355)
T cd07874 302 RIS---VDEALQHPYINV 316 (355)
T ss_pred cCC---HHHHhcCcchhc
Confidence 999 788899999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=343.67 Aligned_cols=273 Identities=29% Similarity=0.496 Sum_probs=227.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++++.||+|+||.||+|.+..+|..||+|.++.. ........+.+|+.++++++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4789999999999999999999999999999988642 23344578899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 767 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 767 Eym~GGSL~d~L~k~---~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||+++++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999998763 368999999999999999999997 599999999999999999999999999886310
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC------CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~------~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
........|++.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 155 -------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0011234588899999998554 357899999999999999999999977
Q ss_pred CCHHHHHHHHHcc-CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhhc
Q 001924 917 ESPEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIELK 993 (995)
Q Consensus 917 ~s~~ei~qkIl~~-~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~~ 993 (995)
......+..+... ....+..+..++.++.+||.+||+.+|.+||+ +.++++||||...+....++.+.+...++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (286)
T cd06622 210 ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKYKNADVDMAEWVTGALK 284 (286)
T ss_pred cchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhccCCccchHHHHHHHHh
Confidence 6555444432221 11233455678999999999999999999999 67888999999999888888877655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.10 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=215.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..+++.||||.++............+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999887655555556677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 767 Eym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~--- 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--- 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc---
Confidence 99999999988853 34578899999999999999999999999999999999999999999999998874210
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 920 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s--~~ 920 (995)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..
T Consensus 159 ------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 159 ------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred ------------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 0011123468899999999999889999999999999999999999996543 33
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+..... .+..+...+..+.+||.+||+.+|++||++.++++.++
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 215 SLCQKIEQCDY-PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred HHHHHHhcCCC-CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 44444433332 22223467889999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=339.44 Aligned_cols=255 Identities=39% Similarity=0.703 Sum_probs=220.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..++..||+|++.+.........+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999986554444567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+.+++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~-------- 152 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-------- 152 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC--------
Confidence 999999999998777899999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---HHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFD 924 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~---~ei~q 924 (995)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. .....
T Consensus 153 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 153 --------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred --------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 0011234588899999999988899999999999999999999999987763 33332
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
. ... ..+..+..++..+.++|.+||..||.+||+.. +.++++||||
T Consensus 213 ~-~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 213 K-QET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred H-hcc--ccccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 2 221 22334567889999999999999999999954 5899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=376.13 Aligned_cols=264 Identities=29% Similarity=0.470 Sum_probs=224.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC--
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 760 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~-- 760 (995)
....++|.+.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445799999999999999999999999999999999876432 3455677889999999999999999987765432
Q ss_pred ------eeEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEe
Q 001924 761 ------NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (995)
Q Consensus 761 ------~lyLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsD 830 (995)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999998643 4689999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG 910 (995)
||+++..... .........+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 187 FGls~~~~~~-------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 187 FGFSKMYAAT-------------------------VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred cccCeecccc-------------------------ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9998742100 001112346799999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+.||.+.+....+..+..+... .++..+++++.+|+.+||+.||.+||+ +.++++|||+...
T Consensus 242 ~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 242 KRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 9999999888888887766543 346789999999999999999999999 6677888887653
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.36 Aligned_cols=254 Identities=30% Similarity=0.547 Sum_probs=217.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||.|+||.||+|.+..++..|++|.+.... ....+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999889999999986532 267899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~----- 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----- 151 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc-----
Confidence 999999999999975 45689999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.....
T Consensus 152 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 152 ----------------------TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ----------------------CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 0001223457889999999999999999999999999999999999998876655544
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..........+..++..+.++|.+||+.||.+||| +.++|.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 4433332222234567889999999999999999999 7888999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=338.29 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=211.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeecc----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR---- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~---- 759 (995)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4577999999999999999999999999999999986532 2345688899999998 699999999998753
Q ss_pred --CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 760 --DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 760 --~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4589999999999999999763 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTG 910 (995)
.... .........|++.|+|||++. +..++.++|||||||++|||++|
T Consensus 160 ~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 160 QLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred eccc---------------------------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 4110 001123456899999999986 34578899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..||...........+...... ...+..++..+.+||.+||..||.+||| +.+++.||||
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 213 APPLCDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCCccccCHHHHHHHHhcCCCC-CCCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 9999876665555444333222 2223567899999999999999999999 7889999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.81 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=211.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~----- 759 (995)
..++|++.+.||.|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3578999999999999999999999999999999987532 2223456678999999999999999999887643
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
...|++++++ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3478999988 7899888754 469999999999999999999999999999999999999999999999999987310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 170 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ------------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 01123468999999999977 56899999999999999999999999877
Q ss_pred CHHHHHHHHHccCC--------------------CCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRKI--------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~~--------------------~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+....+..+..... .++. .....++.+.+||.+||..||.+||| +.++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~ell 296 (343)
T cd07878 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASEAL 296 (343)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 65544443322100 0000 11245677899999999999999999 78889
Q ss_pred cCccccccccc
Q 001924 970 HCKIFIKKTEN 980 (995)
Q Consensus 970 ~HPfF~~~~~n 980 (995)
.||||......
T Consensus 297 ~hp~~~~~~~~ 307 (343)
T cd07878 297 AHPYFSQYHDP 307 (343)
T ss_pred cCcchhccCCC
Confidence 99999886543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=372.33 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=220.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~T-G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+++.++|||||++++++...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976432 23445677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 765 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 765 VmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346889999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 223 ~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 V-------------------------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred c-------------------------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0 001123467999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.++..+..+... ..+..++..+.+||.+||+.||++||+ +.+++.|+|+..
T Consensus 278 ~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~ 328 (478)
T PTZ00267 278 EIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHH
Confidence 888887766543 234678999999999999999999999 556677888764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=339.57 Aligned_cols=256 Identities=30% Similarity=0.481 Sum_probs=214.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||.|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999987532 2344567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA----- 158 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........|++.|+|||++. ...++.++|||||||++|+|++|..||....+..
T Consensus 159 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~ 216 (267)
T cd06645 159 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred ----------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh
Confidence 001122346899999999984 4568899999999999999999999997665444
Q ss_pred HHHHHHccCCCCCCC--CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 922 IFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 922 i~qkIl~~~~~~p~l--ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
............+.. ...++..+.++|.+||+.+|++||+ +.+++.|||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 217 ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 333333333322221 1246788999999999999999999 778899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.57 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=207.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..++..||+|.++... ........+.+|+.+++.+.||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986532 222334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 768 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 768 ym~GGSL~d~L~k~---~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|++ ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 997 6898888643 4589999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+.......
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 154 ----------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ----------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 00111223578999999998764 4789999999999999999999999876554333
Q ss_pred HHHHccCC------------------CC--------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRKI------------------PW--------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~~------------------~~--------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+..... .+ ......+++++.+||.+||+.||.+||| +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 22211000 00 0012357889999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.25 Aligned_cols=262 Identities=26% Similarity=0.469 Sum_probs=214.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||.|+||.||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++++.....+++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875332 2234467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---- 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 156 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC----
Confidence 999996 5899888654 4688999999999999999999999999999999999999999999999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........+++.|+|||++.+. .++.++||||||+++|+|++|++||...+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 157 -----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -----------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00111223578899999998764 578899999999999999999999988776554
Q ss_pred HHHHHccC-------------------CCCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 923 FDNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 923 ~qkIl~~~-------------------~~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
...+.... ..++. ....+++.+.+||.+||+.||.+||| +.++++||||.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~~f~ 290 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHPYFH 290 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCcccc
Confidence 44332210 00111 11357889999999999999999999 88999999998
Q ss_pred cccc
Q 001924 976 KKTE 979 (995)
Q Consensus 976 ~~~~ 979 (995)
...+
T Consensus 291 ~~~~ 294 (301)
T cd07873 291 CLGE 294 (301)
T ss_pred cccc
Confidence 7654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.19 Aligned_cols=257 Identities=29% Similarity=0.457 Sum_probs=211.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++|||++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999865321 2223456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|..++.....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG------- 152 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC-------
Confidence 9999988888877666799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....
T Consensus 153 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 153 --------------------PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred --------------------CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 0001123457889999999876 4578999999999999999999999988765444333
Q ss_pred HHccC-------------------CCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRK-------------------IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~-------------------~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+.... ...+. ....++..+.+||.+||+.||++||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 22110 00000 01356788999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.84 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=213.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+++++++.||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999986532 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|..+ ..+++..+..++.|++.||+|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-------- 146 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------- 146 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc--------
Confidence 99999998654 347888999999999999999999999999999999999999999999999986311
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------- 919 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~------- 919 (995)
.......+||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 147 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 147 ---------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred ---------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 0011235689999999999998999999999999999999999999965321
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
......+...... .......++.+.+||.+||+.+|.+||+ +.+++.||||.....+..
T Consensus 206 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 206 LQLLQCIVDEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYNDGNA 264 (279)
T ss_pred HHHHHHHhccCCC-CCCCCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCcccccccCccH
Confidence 1222222222211 1112457889999999999999999999 788889999998865554
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.33 Aligned_cols=264 Identities=31% Similarity=0.490 Sum_probs=221.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-----c
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----R 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-----~ 759 (995)
....|...+.||.|+||.|+.+.++.||+.||||.+.. .+......++.++|+.+|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566778999999999999999999999999998753 34556678899999999999999999999999876 2
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..+|+|+|+| +.+|...++....++...++.+++|+++||+|+|+.||+||||||.|+|++.+..+||||||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 3589999999 569999998888899999999999999999999999999999999999999999999999999995211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
. ......+..+.|.+|+|||++.. ..|+..+||||+||||.|||+|++-|.|.+
T Consensus 178 ~-------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 178 F-------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred c-------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 0 11223345678999999999855 579999999999999999999999999887
Q ss_pred HHHHHHHHHcc-----------------------C-----CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNR-----------------------K-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~-----------------------~-----~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
....+..|+.- . .+|..+.++.++.+.+|+.+||..||.+|+| +.+.|+
T Consensus 233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL~ 309 (359)
T KOG0660|consen 233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEALA 309 (359)
T ss_pred hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHhc
Confidence 65444433221 1 1122234688999999999999999999999 888999
Q ss_pred Cccccccc
Q 001924 971 CKIFIKKT 978 (995)
Q Consensus 971 HPfF~~~~ 978 (995)
||||....
T Consensus 310 hPYl~~~h 317 (359)
T KOG0660|consen 310 HPYLAPYH 317 (359)
T ss_pred Chhhhhhc
Confidence 99998763
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=371.36 Aligned_cols=273 Identities=37% Similarity=0.730 Sum_probs=249.2
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeec
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 758 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~ 758 (995)
....+...+|..+.+||+|+||.|.++..+.|.+.||||++++...+..++.+-.+.|-++|... +-|.++++..+|+.
T Consensus 342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 33456778999999999999999999999999999999999998888788888888899998877 46899999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+++|+||||+.||+|...++..+.+.+..+..++..|+-||-+||++|||+||||.+|||+|..|++||+|||+++-.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn- 500 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN- 500 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999831
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
..+...+.++||||.|+|||++.+++|+.++|+||+||+|||||.|.+||++.+
T Consensus 501 --------------------------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 501 --------------------------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred --------------------------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 123345668999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
..++++.|......+| ..+|.++.++++..|.+.|.+|... ..-.++-.||||..++|..+
T Consensus 555 E~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 555 EDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred HHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 9999999999987766 7899999999999999999999873 34478899999999998653
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.15 Aligned_cols=260 Identities=32% Similarity=0.523 Sum_probs=220.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
..+|++.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.+.||||+++++.+......|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999998875332 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.. ..++...+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~------ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc------
Confidence 999999999999865 4588999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......
T Consensus 169 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred ---------------------cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 00111234688999999999998899999999999999999999999988776544444
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+.....+....+..++..+.+||.+||..||++||+ +.++++||||...+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~~ 278 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKIAKP 278 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhccCC
Confidence 433332222334568899999999999999999999 788889999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=335.54 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=215.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--Cee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~--~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~l 762 (995)
.+|+..+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998865322 1223456788999999999999999999988753 568
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+++|||+++++|.+++.....++......++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 8999999999999999887789999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
..........|+..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 161 -----------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred -----------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 000111234588999999999998899999999999999999999999987765554
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
...+.... ..+.++..++..+.+|+ .||..+|++||+ +.++++||||+
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 44443322 23445667888999999 677789999999 88889999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.68 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=215.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||++.+..++..+|+|.++... .......+.+|++++.+++||||+++++++...+.+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999886422 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++++|.+++.+...+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999888889999999999999999999997 599999999999999999999999999876310
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 209 (308)
T cd06615 152 ----------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209 (308)
T ss_pred ----------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence 0011235689999999999888899999999999999999999999976554333222
Q ss_pred HHccC----------------------------------CCCCCCC-CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 926 ILNRK----------------------------------IPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 926 Il~~~----------------------------------~~~p~lp-s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+.... ...+..+ ..++.++.+|+.+||..||++||+ +.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~ 286 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKELTK 286 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHHHhc
Confidence 11100 0001111 236788999999999999999999 889999
Q ss_pred Ccccccccc
Q 001924 971 CKIFIKKTE 979 (995)
Q Consensus 971 HPfF~~~~~ 979 (995)
||||.+..-
T Consensus 287 ~~~~~~~~~ 295 (308)
T cd06615 287 HPFIKRAEL 295 (308)
T ss_pred Chhhhhccc
Confidence 999987433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.65 Aligned_cols=259 Identities=32% Similarity=0.569 Sum_probs=222.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47889999999999999999999999999999987532 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~------ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST------ 151 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc------
Confidence 999999999999765 7899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
........|++.|+|||++.+..++.++||||||+++|+|++|..||...++......+
T Consensus 152 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 152 ---------------------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred ---------------------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 01122346889999999999988999999999999999999999999887766665555
Q ss_pred HccCCCCCCCCCC-CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 927 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 927 l~~~~~~p~lps~-lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
..... +..+.. ++..+.+++.+||..+|++||+ +.++++||||.+...+
T Consensus 211 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~ 260 (274)
T cd06609 211 PKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAKKT 260 (274)
T ss_pred hhcCC--CCCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCCcc
Confidence 54432 222333 8899999999999999999999 7788899999998877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=334.38 Aligned_cols=256 Identities=21% Similarity=0.373 Sum_probs=218.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
....+|.+.+.||.|+||.||+|.+..++..||+|++... ......+.+|+++++.++||||+++++++.....++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 3456799999999999999999999999999999988643 234567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999999653 358889999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
........+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus 159 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 --------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred --------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 000111234678999999999999999999999999999998 99999988887
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
..+..+.... . +..+..++.++.+++.+||..||++||++.++.+.|+.
T Consensus 213 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 213 QVYELLEKGY-R-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HHHHHHHCCC-C-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 7777765432 2 23456789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=331.15 Aligned_cols=255 Identities=34% Similarity=0.527 Sum_probs=217.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||.|+||.||+|.+..+++.+++|++.... ......+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999987533 23567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~----- 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----- 153 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh-----
Confidence 9999999999999776 6799999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........++..|+|||.+.+. .++.++||||||+++|+|++|..||...++..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 154 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ----------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112234688899999999877 78999999999999999999999998877666
Q ss_pred HHHHHHccCCCCCC--CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 922 IFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 922 i~qkIl~~~~~~p~--lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
....+.......+. .+...+.++.+|+.+||..+|..||+ +.+++.|+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 55555444333222 23446788999999999999999999 788888987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.33 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=211.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986432 2234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA----- 158 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc-----
Confidence 999999999999998777899999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........|++.|+|||.+. ...++.++|||||||++|||++|..||....+..
T Consensus 159 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 159 ----------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred ----------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 001112346889999999985 3457889999999999999999999997665544
Q ss_pred HHHHHHccCCCCCCC--CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 922 IFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 922 i~qkIl~~~~~~p~l--ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
....+.......+.. ...++..+.+||.+||+.+|++||+ +.++++|+|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 333332332222221 2357889999999999999999999 666777776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=332.31 Aligned_cols=260 Identities=28% Similarity=0.469 Sum_probs=216.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--Cee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~--~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~l 762 (995)
.+|++.+.||+|+||.||+|.+..+|..||||.+.... .........+.+|+.+++++.||||+++++++... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 68999999999999999999999999999999886422 11223457888999999999999999999988764 468
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+++++|.+++.....+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~-- 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI-- 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc--
Confidence 899999999999999988777899999999999999999999999999999999999999999999999988731100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
...........|+..|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 160 ----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 160 ----------------------CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred ----------------------cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 0000112234688999999999988899999999999999999999999987766555
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
...+.... ..+..+..++..+.++|.+||. +|.+||+ +.++++|||+.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 55544332 2344566788899999999995 9999999 88999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.66 Aligned_cols=272 Identities=21% Similarity=0.336 Sum_probs=211.9
Q ss_pred EEEeeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 691 IIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 691 Ilk~LG~G--gFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
++++||+| +|++||++.++.+|+.||+|.++.... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 788999999999999999999865322 233456677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 769 LNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 769 m~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+.... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~-~~~---- 155 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI-NHG---- 155 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccc-ccc----
Confidence 9999999999653 458999999999999999999999999999999999999999999999998654210 000
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
. . . ...........++..|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 156 ~-~----------~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 156 Q-R----------L----RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred c-c----------c----cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 0 0 0 000001122357788999999976 468999999999999999999999998765544433
Q ss_pred HHHccCCCC-------------------------------------------CCCCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 925 NILNRKIPW-------------------------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 925 kIl~~~~~~-------------------------------------------p~lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
....+..+. ......+++.+.+||.+||+.||++|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 333221110 0011235678999999999999999999
Q ss_pred HHHHHHHHcCccccccccccccchh
Q 001924 962 ANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 962 A~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
+.++++||||++......-..+
T Consensus 301 ---~~ell~~p~f~~~~~~~~~~~~ 322 (327)
T cd08227 301 ---ASTLLNHSFFKQIKRRASEALP 322 (327)
T ss_pred ---HHHHhcChhhhhcchhhhhhhh
Confidence 7788999999987655544333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=358.98 Aligned_cols=263 Identities=30% Similarity=0.495 Sum_probs=222.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeeccC----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRD---- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~~---- 760 (995)
...|..+++||+|+||+||+|+.+.+|+.||+|.++.... .+.......+|+.+++.++|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4568888899999999999999999999999999875432 1334556789999999999999 999999999877
Q ss_pred --eeEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
.+++|+||++. +|..++...+ .++...++.+++||+.||+|||+++|+||||||+||||+..|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 79999999954 9999998655 5788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~P 913 (995)
+... -+.......++|.+|+|||++.+. .|+..+||||+|||++||++++.-
T Consensus 168 ra~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 8311 112224567899999999999997 789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcc-----CCCCCC-------------C---------CCCCCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 914 FTAESPEIIFDNILNR-----KIPWPC-------------V---------PSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~-----~~~~p~-------------l---------ps~lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
|.+.+..+....|..- ...||. . .+..++...+++.+||+++|.+|.| +.
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S---a~ 297 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS---AK 297 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC---HH
Confidence 9999887777776541 122322 1 1223458999999999999999999 88
Q ss_pred HHHcCccccccccc
Q 001924 967 EVFHCKIFIKKTEN 980 (995)
Q Consensus 967 EiL~HPfF~~~~~n 980 (995)
.+|.||||......
T Consensus 298 ~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 298 GALTHPYFSELPEK 311 (323)
T ss_pred HHhcChhhcccccc
Confidence 88999999988554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.97 Aligned_cols=257 Identities=29% Similarity=0.497 Sum_probs=230.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
...|+....||+|.||.||+|.+..+++.||+|++.... .+.+++.+.+|+.++..++++||.++|+.+.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 356888899999999999999999999999999998644 456788999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||||.||++.+.++....+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.|||+|||++....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------- 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------- 162 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee-------
Confidence 9999999999999888777999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.......+++|||.|||||++.+..|+.++||||||++.+||++|.+||....+..++..
T Consensus 163 --------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 163 --------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred --------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 122334788999999999999999999999999999999999999999999988666555
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
|.... .|.+...+++.+++||..||.+||+.||+ +.++|.|+|.+.
T Consensus 223 Ipk~~--PP~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~ 268 (467)
T KOG0201|consen 223 IPKSA--PPRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKR 268 (467)
T ss_pred ccCCC--CCccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHh
Confidence 54443 35556789999999999999999999999 889999999988
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.27 Aligned_cols=261 Identities=28% Similarity=0.487 Sum_probs=215.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~---se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
+|+..+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998743311 12235678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++++|.+++.+.+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~--- 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK--- 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc---
Confidence 999999999999998888899999999999999999999999999999999999998776 6999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
............|+..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 158 --------------------~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 158 --------------------GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred --------------------cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 000011122346899999999999888999999999999999999999999754432222
Q ss_pred H---HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 924 D---NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 924 q---kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
. .+.... ..+..+..+++.+.+++.+||..+|.+||+ +.++++||||.
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 218 ALIFKIASAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred HHHHHHhccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 2 222222 224455678899999999999999999999 88999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.15 Aligned_cols=255 Identities=35% Similarity=0.593 Sum_probs=213.0
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||+|+||+||+|.+..+|+.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998764443344456778899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCC
Q 001924 775 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (995)
Q Consensus 775 ~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~g 852 (995)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99997655 689999999999999999999999999999999999999999999999998864210
Q ss_pred CCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHc
Q 001924 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 928 (995)
Q Consensus 853 i~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~----~ei~qkIl~ 928 (995)
........++..|+|||++.+..++.++||||||+++|+|++|+.||..... ..+...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 148 ---------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ---------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 0111234578899999999988899999999999999999999999977543 222222222
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccc
Q 001924 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 929 ~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n 980 (995)
.. ...+..+++.+.++|.+||+.||.+||+.. .+.++++||||.+.+|.
T Consensus 213 ~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 213 MA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred cc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 11 223466899999999999999999999432 27788999999988873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.99 Aligned_cols=263 Identities=32% Similarity=0.507 Sum_probs=221.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
..+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 4789999999999999999999999999999998865332 2346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~----- 168 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 168 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-----
Confidence 999999999999865 45888999999999999999999999999999999999999999999999988631100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||...++......
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 169 ----------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred ----------------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 0111234688999999999998899999999999999999999999987665443333
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
+.....+....+..++..+.+|+.+||..+|++||+ +.+++.||||..-+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLAKPLSS 280 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhcccccccc
Confidence 333222222345668899999999999999999999 889999999987665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.57 Aligned_cols=258 Identities=35% Similarity=0.583 Sum_probs=206.3
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCceEEEeeeeeccCeeEEEEeecC
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs---~LkHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
.||+|+||.||++.+..+++.||+|++.+...........+.+|..++. ...||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987644332333334445554443 4479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 771 GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
+|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~------------ 148 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999886210
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNIL 927 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~--ei~qkIl 927 (995)
........||+.|+|||.+.+ ..++.++|||||||++|+|++|..||...... .......
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 211 (279)
T cd05633 149 -----------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (279)
T ss_pred -----------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh
Confidence 001112358999999999864 56899999999999999999999999754321 1122211
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC--HHHHHHHHcCccccccccccc
Q 001924 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 928 ~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS--A~EIlEiL~HPfF~~~~~n~~ 982 (995)
. ... ..++..++..+.++|.+||..||.+||+ ...+.++++||||.+..+...
T Consensus 212 ~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 212 L-TVN-VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred h-cCC-cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 1 111 2345678999999999999999999994 112778899999999876654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.48 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=212.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||++.+.. +..+|+|.++... .....+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4679999999999999999998864 5679999876432 2345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~---- 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC----
Confidence 9999999999998753 46899999999999999999999999999999999999999999999999988731100
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
.........++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05114 154 ----------------------EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV 211 (256)
T ss_pred ----------------------ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 0001112235678999999998899999999999999999999 99999998888888
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
..+..+... ..+...+..+.+|+.+||+.+|.+||++.+++..|
T Consensus 212 ~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 212 EMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 777665432 23456788999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.58 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=216.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+++++.+.||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4678999999999999999998753 46789999987532 2334578999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcE
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~--------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~V 826 (995)
..++||||+++|+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997542 37788899999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyE 906 (995)
||+|||++........ ........+++.|+|||++.+..++.++||||||+++||
T Consensus 162 kl~d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216 (280)
T ss_pred EECCcccceecccCcc-------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHH
Confidence 9999999863110000 011123346789999999999999999999999999999
Q ss_pred HHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 907 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 907 LLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|++ |..||...+.......+..+... ..+..++..+.+|+.+||+.||.+||++.++++.|+
T Consensus 217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 217 IFTYGKQPWYGLSNEEVIECITQGRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 998 99999988888877777655433 234678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.97 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=214.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG-----~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
..+....++|++.+.||+|+||.||+|.+..+| ..||+|+++... .......+.+|+.+++.+ .||||++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 344455678999999999999999999865433 579999987533 223456788999999999 899999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhc----------------------------------------------------
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV---------------------------------------------------- 781 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~---------------------------------------------------- 781 (995)
+++...+..++||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999998542
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 782 ------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 782 ------------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~-- 266 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-- 266 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc--
Confidence 136778889999999999999999999999999999999999999999999987321000
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei 922 (995)
.........+++.|+|||++.+..++.++|||||||++|+|++ |+.||........
T Consensus 267 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 267 -----------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred -----------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 0001112235678999999999999999999999999999997 9999987665544
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+..+....... ..+...++++.+++.+||+.||.+||++.++.++|+.
T Consensus 324 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 324 FYKMVKRGYQM-SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHHHHHcccCc-cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 44444443332 2345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=341.86 Aligned_cols=259 Identities=33% Similarity=0.534 Sum_probs=221.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 367999999999999999999999999999999886432 23356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|..++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~------ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP------ 167 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc------
Confidence 9999999999988654 589999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred ---------------------ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00111234688999999999998899999999999999999999999998877665555
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
+.....+....+..+++.+.+||.+||..||.+||+ +.+++.||||+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~~ 276 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLAK 276 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhcc
Confidence 544433333345678999999999999999999999 78889999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=359.12 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=213.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
.+....++|++.+.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+.++..+ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 3344567899999999999999999974 34567899999874332 23456788999999999 8999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcC----------------------------------------------------
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 782 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~---------------------------------------------------- 782 (995)
++...+..++||||+++|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 783 -----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 783 -----------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 367788889999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
... ........++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 267 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 267 DSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ccc-------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 000 001112335678999999999999999999999999999998 899998766
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+...+..... +..+...+.++.+|+.+||+.||++||++.++++.|+.
T Consensus 322 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 322 VDSKFYKMIKEGYR-MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred chHHHHHHHHhCcc-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 54444444444332 22345678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.38 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=213.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccC---
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD--- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~--- 760 (995)
..++|++.+.||.|+||.||+|.+..+++.+++|++.... .....+.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4689999999999999999999999899999999987532 2456788999999998 6999999999997644
Q ss_pred ---eeEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 761 ---NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 761 ---~lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999865 34789999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHHH
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyELL 908 (995)
+..... .........|++.|+|||++.. ..++.++||||||+++|+|+
T Consensus 160 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 160 SAQLDS---------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ceeccc---------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 864110 0011223468999999999854 34678999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+|..||...........+..........+..++..+.+||.+||..||++||| +.+++.|||+
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred hCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 99999987766665555555433222223347789999999999999999999 8888999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.86 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=215.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k--~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
...+|.+.+.||.|+||.||++... .++..||+|.+... ....+|+++++.++||||+++++++......
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3467999999999999999999764 35678999987642 2346799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++|||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~-- 238 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH-- 238 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc--
Confidence 99999995 689999977788999999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH---
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 919 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~--- 919 (995)
..........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus 239 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 295 (392)
T PHA03207 239 -----------------------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295 (392)
T ss_pred -----------------------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence 001112245799999999999999999999999999999999999999976432
Q ss_pred HHHHHHHHcc----CC-------------------------CCCC--CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 920 EIIFDNILNR----KI-------------------------PWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 920 ~ei~qkIl~~----~~-------------------------~~p~--lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
...+..+... .. ..+. ....++.++.+||.+||..||++||+ +.++
T Consensus 296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps---a~e~ 372 (392)
T PHA03207 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS---AQDI 372 (392)
T ss_pred HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---HHHH
Confidence 1111221110 00 0000 01235678899999999999999999 8899
Q ss_pred HcCccccccccccccchh
Q 001924 969 FHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 969 L~HPfF~~~~~n~~s~q~ 986 (995)
|.||||.+..++.+-|.+
T Consensus 373 l~~p~f~~~~~~~~~~~~ 390 (392)
T PHA03207 373 LSLPLFTKEPINLLNITP 390 (392)
T ss_pred hhCchhhccchhhhcCcc
Confidence 999999999999887754
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=328.82 Aligned_cols=254 Identities=28% Similarity=0.532 Sum_probs=220.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||++....+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875332 23455688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~------ 153 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS------ 153 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc------
Confidence 999999999987543 578899999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||......+....
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 154 ---------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ---------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 00111234588999999999998899999999999999999999999998888888777
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..+..+ ..+..++..+.++|.+||+.+|.+||+ +.++++||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYP--PVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HhcCCCC--CCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 7666543 345678999999999999999999999 8888899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.08 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=206.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.....+++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999875322 22234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 768 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 768 ym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------- 151 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------- 151 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC-------
Confidence 996 588887764 45689999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIFD 924 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF-~g~s~~ei~q 924 (995)
.........+++.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+....+.
T Consensus 152 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 152 --------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred --------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 001112345788999999987754 689999999999999999988885 4444444433
Q ss_pred HHHccC-----------------CCCC---------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRK-----------------IPWP---------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~-----------------~~~p---------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+.... ..++ ...+.+++.+.+||.+||+.||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 332110 0001 112357889999999999999999999 7788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=326.90 Aligned_cols=255 Identities=33% Similarity=0.544 Sum_probs=218.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~--~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
+|+..+.||.|+||.||+|.+..++..|++|.+..... ........+.+|+.+++.++||||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788899999999999999998999999999865332 2234567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.+...+++..+..++.|++.||+|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998877799999999999999999999999999999999999999999999999998874110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
........|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 155 ----------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred ----------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 00122356889999999998776 8999999999999999999999998776555544
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+... ...+..+..++..+.+|+.+||+.+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 44332 2334456778999999999999999999999 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=334.60 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=214.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 356789999999999999999998642 45689999886432 22344578899999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEE
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~----------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKL 828 (995)
....++||||+++|+|.+++.... .++...+..++.|++.||+|||+.|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999996532 3567788889999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELL 908 (995)
+|||+++....... ........+++.|+|||++.+..++.++||||||+++|||+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999873210000 00111234678899999999989999999999999999999
Q ss_pred c-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 909 T-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+ |..||.+.........+..... +..+..++..+.+++.+||+.||.+|||+.++++.++
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 9 7999998888877777665543 3345678899999999999999999999999888775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=328.55 Aligned_cols=257 Identities=30% Similarity=0.491 Sum_probs=216.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987655544555678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 767 Eym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||+++|+|.+++.. ...++...+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999999864 245889999999999999999999999999999999999999999999999998631100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 920 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s--~~ 920 (995)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..
T Consensus 160 -------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 001123458889999999999899999999999999999999999996543 33
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+..+... +......+..+.++|.+||..+|++||++.++++.++.
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 215 SLCKKIEKCDYP-PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred HHHhhhhcCCCC-CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 444444433221 22223678899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.13 Aligned_cols=278 Identities=38% Similarity=0.721 Sum_probs=227.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLV 765 (995)
++|.+.+.||.|+||.||+|.+..+|..||+|++.+...........+.+|+.+++++. ||||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998755545555678899999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~- 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE- 159 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987422111000
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
... .... .-...............|+..|+|||++.+..++.++||||||+++|+|++|+.||...+....+..
T Consensus 160 ~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 160 SNK-GDAT-----NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cCC-CCCc-----cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 000 0000 0000000111233455689999999999988899999999999999999999999998887777777
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH-HHHHHHcCccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~-EIlEiL~HPfF 974 (995)
+......+ +..+++.+.+||.+||+.+|.+||++. ...++++||||
T Consensus 234 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCC---CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 66544443 357799999999999999999999931 11899999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.16 Aligned_cols=258 Identities=31% Similarity=0.492 Sum_probs=213.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeecc---
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--- 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~--- 759 (995)
...++|.+.+.||.|+||.||+|....+++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35688999999999999999999999999999999986532 2345677899999988 799999999998754
Q ss_pred --CeeEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 760 --DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 760 --~~lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
..+++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998853 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-----CCCchHHHHHHHHHHHHHH
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-----~ys~KSDIWSLGVILyELL 908 (995)
+...... ........|+..|+|||++... .++.++|||||||++|+|+
T Consensus 175 ~~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 175 SAQLTST---------------------------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred chhcccc---------------------------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 8742100 0011234688999999998653 3688999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 909 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
+|+.||...........+..........+...+..+.+||.+||+.+|++||+ +.++++||||+
T Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 99999988776655555544433222224457788999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.62 Aligned_cols=254 Identities=31% Similarity=0.528 Sum_probs=220.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|+..+.||.|+||.||.+....++..+++|.+..... .......+.+|+.++++++|+||+++++++...+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999998865332 33456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~----- 154 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE----- 154 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc-----
Confidence 99999999999764 45899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........|++.|+|||++.+..++.++||||||+++|+|++|..||......+....
T Consensus 155 ----------------------~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 155 ----------------------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred ----------------------cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0011234689999999999988899999999999999999999999998888888777
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..+... ..+..++..+.++|.+||..+|.+||+ +.++++|+|+
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 7765543 234678899999999999999999999 7788888885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.15 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=215.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..++..||||.+.............+.+|+.+++.+.||||+++++++...+.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999887655445556678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 767 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 767 Eym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998863 345899999999999999999999999999999999999999999999999988742100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--H
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--E 920 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~--~ 920 (995)
........|+..|+|||++.+..++.++||||||+++|+|++|..||.+... .
T Consensus 160 -------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 160 -------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred -------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 0011234688999999999998999999999999999999999999976533 3
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+.....+ +..+...+..+.+++.+||..||.+|||+.++.+.++
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 215 SLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred HHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 333444333221 2223468889999999999999999999999888775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.45 Aligned_cols=258 Identities=31% Similarity=0.494 Sum_probs=210.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeee----
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT---- 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~---- 757 (995)
....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345689999999999999999999999999999999876422 2235677899999999 6999999999874
Q ss_pred -ccCeeEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecC
Q 001924 758 -CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (995)
Q Consensus 758 -~~~~lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFG 832 (995)
....+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 34568999999999999998753 2458888999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHH
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyEL 907 (995)
++..... .........|++.|+|||++.. ..++.++|||||||++|+|
T Consensus 170 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 170 VSAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ceeeccc---------------------------CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9873110 0011223468999999999853 4578899999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 908 LTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
++|+.||...........+..........+..++..+.+||.+||+.||++||| +.++++|+||
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred hcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 999999987765444443333222212234456789999999999999999999 8888899997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=329.76 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=215.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999865 56789999876422 23567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++|||+++|+|.+++... ..++...+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999753 457888899999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
........++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 158 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 158 --------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred --------------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 001112345678999999998889999999999999999998 99999988877
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+... ..++ .+..++..+.+|+.+||..+|++||+++++.++|+.
T Consensus 212 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 212 DVMSALQRG-YRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 777666544 2333 235688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.45 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=191.6
Q ss_pred EEeeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec--cCeeEEEEe
Q 001924 692 IKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 767 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k--~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~--~~~lyLVmE 767 (995)
.++||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999976 367899999886532 22457789999999999999999998854 456899999
Q ss_pred ecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe----ccCCcEEEEecCCc
Q 001924 768 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 834 (995)
Q Consensus 768 ym~GGSL~d~L~k~---------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL----DenG~VKLsDFGLA 834 (995)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 985 5898887532 248899999999999999999999999999999999999 45678999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~P 913 (995)
+..... ...........||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 160 ~~~~~~------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSP------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCC------------------------CccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 742100 0001122345789999999999874 589999999999999999999999
Q ss_pred CCCCCH---------HHHHHHHHccC-CC----------CC------------------------CCCCCCCHHHHHHHH
Q 001924 914 FTAESP---------EIIFDNILNRK-IP----------WP------------------------CVPSDMSFEAQDLIN 949 (995)
Q Consensus 914 F~g~s~---------~ei~qkIl~~~-~~----------~p------------------------~lps~lS~eL~dLIk 949 (995)
|..... ...+..+.... .+ ++ ......+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 964321 11111111100 00 00 001123567889999
Q ss_pred HHhhcCccCCCCHHHHHHHHcCccc
Q 001924 950 RFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 950 kCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+||++||.+||| +.++|+||||
T Consensus 296 ~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC---HHHHhcCCCC
Confidence 999999999999 7788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.06 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=211.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+++++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999998999999998865332 2234566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|..+......+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA------- 152 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC-------
Confidence 9999999988877666799999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........++..|+|||++.+ ..++.++||||||+++|||++|++||......+....
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 153 --------------------PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred --------------------CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 0011123457899999999876 3478899999999999999999999987665443333
Q ss_pred HHccCC-------------------CCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRKI-------------------PWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~~-------------------~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..... ..+. ..+.++..+.+|+.+||..+|.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 321100 0010 12467889999999999999999999 6789999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=333.89 Aligned_cols=269 Identities=28% Similarity=0.479 Sum_probs=214.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeeccCeeEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieI-Ls~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... ......+..|+.+ ++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999875322 1233455666665 6677899999999999999999999
Q ss_pred EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 766 mEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
|||++ |+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99996 688888754 24689999999999999999999998 999999999999999999999999999873110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g----~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
........|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 ---------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ---------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 001122458889999999865 4568899999999999999999999975
Q ss_pred C-CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHH
Q 001924 917 E-SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEI 990 (995)
Q Consensus 917 ~-s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~ 990 (995)
. ...+....+...... ......++.++.+||.+||..+|.+||+ +.+++.||||....+....+.+.++.
T Consensus 210 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~~~~~~~ 280 (283)
T cd06617 210 WKTPFQQLKQVVEEPSP-QLPAEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSKNTDVASFVSL 280 (283)
T ss_pred cccCHHHHHHHHhcCCC-CCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccccHHHHHHHHh
Confidence 3 222333333332211 1112457899999999999999999999 78889999999998777666665543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.51 Aligned_cols=254 Identities=32% Similarity=0.572 Sum_probs=217.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec--cCeeEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLV 765 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~--~~~lyLV 765 (995)
+|++.+.||.|+||.||++.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999875432 34556788999999999999999999997764 3468999
Q ss_pred EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLH-----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 766 mEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLH-----s~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
|||+++++|.+++.. ...+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999965 356899999999999999999999 99999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
... .........|++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 160 ~~~---------------------------~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGH---------------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccC---------------------------CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 210 00111234689999999999998899999999999999999999999998
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+.......+..+.. +.++...+..+.+++.+||+.+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 887777666655443 4456788999999999999999999999 8888999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.67 Aligned_cols=249 Identities=28% Similarity=0.516 Sum_probs=214.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999987533 23356778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~------ 152 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS------ 152 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc------
Confidence 99999999988643 4588999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 153 ---------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ---------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 00111234688999999999998999999999999999999999999998888777777
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
+..+... ..+..++..+.+||.+||+.||.+||++.+++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 212 VCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 6655432 345678899999999999999999999777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.12 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=216.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~T-----G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
...++|++.+.||.|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3457899999999999999999998643 4789999876432 22345678899999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEE
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~----------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKL 828 (995)
....++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999996432 3677888999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELL 908 (995)
+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred CCcccchhhccCcc-------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence 99999874211000 01112345678999999999888999999999999999999
Q ss_pred c-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 909 T-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+ |..||...+.......+.... .+..+..++..+.+|+.+||+.+|++|||+.++.+.|+
T Consensus 216 t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 216 TLAEQPYQGLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ccCCCCCccCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 8 999999888888877776433 23345678999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.43 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=218.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999875432 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCccccccccccc
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLArv~~~~~s~d 844 (995)
|+++++|.+++... ..+++..+..++.|++.||+|||++||+|+||+|+||+++.+ +.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 358899999999999999999999999999999999999865 4689999999874210
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 155 -----------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred -----------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 011123468899999999998889999999999999999999999999887777776
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..... ...+..++..+.+++.+||..+|.+||| +.++++||||
T Consensus 212 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 6665443 2344678999999999999999999999 8889999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=333.19 Aligned_cols=270 Identities=29% Similarity=0.539 Sum_probs=225.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeeccCeeEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk---HPNIVkL~gvf~~~~~lyL 764 (995)
.|++.+.||.|+||.||+|.+..+++.||+|+++... .......+.+|+.+++.+. |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999986532 2334567889999999986 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~----- 153 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----- 153 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC-----
Confidence 9999999999999865 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.........
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 154 ----------------------NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred ----------------------CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 0011223468899999999865 44688999999999999999999999887665544
Q ss_pred HHHHccCCCCCCCCC-CCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhh
Q 001924 924 DNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIEL 992 (995)
Q Consensus 924 qkIl~~~~~~p~lps-~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~ 992 (995)
..+... ..+.++. ..+.++.+++.+||..||.+||+ +.++++|+||.+...+..+.+.++...+
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06917 212 MLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHSKTPVSILKELISRY 276 (277)
T ss_pred hccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccccCchhhHHHHHHhh
Confidence 333222 1223333 37889999999999999999999 7777889999999988888887776543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.75 Aligned_cols=271 Identities=24% Similarity=0.350 Sum_probs=219.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~--VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~ 760 (995)
...++|++.+.||+|+||.||+|.+..++.. +|+|.++. .........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3457999999999999999999999887765 46665543 22344566788999999999 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
.+|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997542 478889999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.+||+|||++.... . ........++..|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~---~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQE---V-------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccc---h-------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 99999999876200 0 0001112346789999999888899999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 905 yELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
|||++ |..||...+..+.+..+.... . +..+..++..+.+|+.+||+.+|.+||++.+++..+...+..........
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~ 291 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 291 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcCC-c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhh
Confidence 99998 999998887777776654331 1 22345678999999999999999999999999988876655555444444
Q ss_pred chh
Q 001924 984 MQS 986 (995)
Q Consensus 984 ~q~ 986 (995)
+-+
T Consensus 292 ~~~ 294 (303)
T cd05088 292 LYE 294 (303)
T ss_pred hhc
Confidence 333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=337.33 Aligned_cols=260 Identities=36% Similarity=0.569 Sum_probs=209.9
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH---HHHhcCCCceEEEeeeeeccCeeEEEEeecC
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN---ILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEie---ILs~LkHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
.||+|+||.||++.+..+++.||+|++.+...........+..|.. +++...||||+.+++++...+.+++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987643322222223444443 3445679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 771 GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
||+|.+++...+.+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~------------ 148 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHH
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNI 926 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~---s~~ei~qkI 926 (995)
........|+..|+|||++.+. .++.++||||||+++|+|++|+.||... ........+
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 211 (278)
T cd05606 149 -----------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (278)
T ss_pred -----------------ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh
Confidence 0011234689999999999754 6899999999999999999999999876 333333333
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccccch
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~s~q 985 (995)
.... +..+..++..+.+++.+||..+|.+||... .+.++++||||....|+.+..+
T Consensus 212 ~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 212 LTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred hccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 2222 234456799999999999999999999222 2778889999999998877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.44 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=207.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..+++.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+.+++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455556678999999999999999999999999876432 3345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~-~~L--see~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~~ 840 (995)
|+||+++++|.+++... ..+ +...+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG- 161 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc-
Confidence 99999999999999764 445 77888889999999999999999999999999999976 67999999998863110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~--ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||....
T Consensus 162 --------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 --------------------------INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred --------------------------CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 001112235789999999986643 7889999999999999999999997643
Q ss_pred HHH-HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 919 PEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 919 ~~e-i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
... ....+. .....+.++..++.++.+|+.+||+.+|.+||| +.+++.||||
T Consensus 216 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 216 EPQAAMFKVG-MFKIHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred ChhhhHhhhh-hhccCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 221 111111 111123455678899999999999999999999 7889999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.54 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=213.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.++|++.+.||+|+||.||+|.+. .++..||+|.++... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 478999999999999999999863 356789999887432 23345678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
.|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998532 2367888889999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.+||+|||+++...... .........++..|+|||++.+..++.++||||||+++
T Consensus 162 ~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 162 HVKISDLGLSREIYSAD-------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred cEEeccccccccccCCc-------------------------ceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999999987421100 00111233467789999999988899999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 905 yELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||++ |..||.+.....+...+..... +..+..++..+.+++.+||+.||.+||++.++.+.|+
T Consensus 217 ~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 99998 9999988877766666554432 2345678999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.09 Aligned_cols=264 Identities=32% Similarity=0.480 Sum_probs=216.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~--se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
+|++.+.||.|+||.||+|.+..+|+.||+|.++..... .......+.+|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999764432 122345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----- 154 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC-----
Confidence 9999 899999998765 799999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....+
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 155 ----------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred ----------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 0011122356889999999865 45789999999999999999998888877665554
Q ss_pred HHHHccCCC-----C--------------------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 924 DNILNRKIP-----W--------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 924 qkIl~~~~~-----~--------------------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
..+...... + .......+..+.+||.+||..||.+||| +.++++|+||.+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~~~~ 289 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFSNDP 289 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCccccCCC
Confidence 444321000 0 0012345788999999999999999999 88888899999987
Q ss_pred cccc
Q 001924 979 ENCV 982 (995)
Q Consensus 979 ~n~~ 982 (995)
..+-
T Consensus 290 ~~~~ 293 (298)
T cd07841 290 APTP 293 (298)
T ss_pred CCCC
Confidence 6654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.88 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=217.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
-.+|.+.+.||.|+||.||++... .++..+|+|.+... .......+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 467999999999999999999852 34567999987643 2345667899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~-------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
.+++||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 389999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
|+|||+++...... .........+++.|+|||++.+..++.++||||||+++|+|
T Consensus 161 l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l 215 (288)
T cd05093 161 IGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215 (288)
T ss_pred eccCCccccccCCc-------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 99999987321000 00111223467889999999999999999999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
++ |..||...........+..+... ..+..++..+.+|+.+||+.||.+|||+.++.+.|+..
T Consensus 216 ~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 216 FTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 98 99999988888887777765532 23456889999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.22 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=210.6
Q ss_pred eeccCCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 694 PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 694 ~LG~GgFGtVYka~~--k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
.||+|+||.||+|.+ ..++..+|+|+++... ......+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4567899999986432 23445678899999999999999999999875 4567999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
|+|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~--------- 150 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN--------- 150 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC---------
Confidence 99999998877899999999999999999999999999999999999999999999999999874210000
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~ 930 (995)
.........+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+..+.
T Consensus 151 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~ 215 (257)
T cd05116 151 ---------------YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215 (257)
T ss_pred ---------------eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 0001112235678999999988889999999999999999998 999999888777777765543
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 931 ~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
. +..+..++.++.+||.+||+.||.+||++.++.+.|+.=|
T Consensus 216 ~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 216 R--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 2 3356789999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=359.54 Aligned_cols=257 Identities=31% Similarity=0.498 Sum_probs=214.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----- 760 (995)
.-.|...+.+|.|+||.||+|....+++.||||.+-... +.-.+|+++|+.+.|||||++..+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 345888999999999999999999999999999764422 12346999999999999999988886532
Q ss_pred eeEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCcc
Q 001924 761 NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSK 835 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLAr 835 (995)
...+||||||. +|+++++. +..++.-.++.+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 35689999976 99998874 4678999999999999999999999999999999999999976 999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
+... +....+...|..|+|||++.|. .|+.+.||||.||++.||+-|++-|
T Consensus 175 ~L~~----------------------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 175 VLVK----------------------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred eecc----------------------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 6321 2223456789999999999885 6899999999999999999999999
Q ss_pred CCCCHHHHHHHHHccC-----------------CCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 915 TAESPEIIFDNILNRK-----------------IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~-----------------~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
.|.+..+.+..|+.-- ..+|. +....++++.+|+.++|+++|.+|.+ +.++
T Consensus 227 pG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~~~ 303 (364)
T KOG0658|consen 227 PGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---ALEA 303 (364)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HHHH
Confidence 9998877666654310 01111 34568999999999999999999999 8999
Q ss_pred HcCcccccccccc
Q 001924 969 FHCKIFIKKTENC 981 (995)
Q Consensus 969 L~HPfF~~~~~n~ 981 (995)
+.||||+..+.-.
T Consensus 304 l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 304 LAHPFFDELRDPN 316 (364)
T ss_pred hcchhhHHhhCcC
Confidence 9999999887653
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.82 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=214.3
Q ss_pred EeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeec
Q 001924 693 KPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
+.||+|+||.||+|.+... +..|++|+++..... .....+.+|+.+++.++|+||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 889999998764322 24678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 770 NGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 770 ~GGSL~d~L~k~---------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
++++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999998742111
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 011223457889999999998899999999999999999999 6999999988
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
......+.... ....+..++.++.+++.+||..+|.+|||+.++++.|+
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 214 EEVLEYLRKGY--RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHcCC--CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 88888777532 23345678999999999999999999999988888763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.95 Aligned_cols=258 Identities=34% Similarity=0.573 Sum_probs=221.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|++|.||+|.+..+++.|++|++..... ......+.+|+..+..++|||++++++++.....+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 478999999999999999999999999999999875432 144678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++++|.+++.....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~----- 153 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT----- 153 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC-----
Confidence 999999999999887889999999999999999999999 99999999999999999999999999988742100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---CHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEII 922 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~---s~~ei 922 (995)
........++..|+|||.+.+..++.++||||||+++|+|++|..||... ...+.
T Consensus 154 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 154 ----------------------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred ----------------------CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 00112345789999999999989999999999999999999999999776 44455
Q ss_pred HHHHHccCCCCCCCCCC-CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 923 FDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~-lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
...+..... +..+.. ++..+.++|.+||..+|++||+ +.++++||||+..+
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 212 MQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 555543322 333455 8899999999999999999999 78888999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.77 Aligned_cols=257 Identities=37% Similarity=0.593 Sum_probs=219.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--CeeEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLV 765 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~lyLV 765 (995)
+|.+.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.++++++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 48889999999999999999999999999999876432 245577899999999999999999999999988 889999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998877899999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s-~~ei~q 924 (995)
........++..|+|||.+.+..++.++||||||+++|+|++|..||.... ......
T Consensus 157 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (260)
T cd06606 157 ----------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214 (260)
T ss_pred ----------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 001223568899999999998889999999999999999999999998765 222222
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+.. ....+..+..++..+.+|+.+||+.||.+||+ +.+++.||||
T Consensus 215 ~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 215 KIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred hccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 2222 22334556778999999999999999999999 8999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.92 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=210.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeec----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC---- 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~---- 758 (995)
...+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.++.++ .||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 4567899999999999999999999999999999988642 23446688899999988 69999999999853
Q ss_pred --cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 759 --RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 759 --~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
...+|++|||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45689999999999999999753 35788889999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHc
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLT 909 (995)
..... .........|++.|+|||++. +..++.++|||||||++|||++
T Consensus 169 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 169 AQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred hhhhc---------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 63110 001123456899999999986 3467889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
|..||....+......+.... ........++..+.+||.+||..||.+||+ +.++++||||
T Consensus 222 g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 222 GAPPLCDMHPMRALFLIPRNP-PPKLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred CCCCccccCHHhhhhhHhhCC-CCCCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 999998766554444333322 112223468899999999999999999999 7888999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.49 Aligned_cols=258 Identities=36% Similarity=0.607 Sum_probs=214.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..+++.||+|+++.... .......+.+|+.+++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58999999999999999999998999999999876443 24567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+++++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~----- 154 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT----- 154 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC-----
Confidence 999999999998877789999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 923 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~---ys~KSDIWSLGVILyELLTGr~PF~g~s~-~ei~ 923 (995)
..........+++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ....
T Consensus 155 ------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~ 216 (264)
T cd06626 155 ------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216 (264)
T ss_pred ------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH
Confidence 0000012346889999999998766 88999999999999999999999976533 2222
Q ss_pred HHHHccCCCCCCCCC--CCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRKIPWPCVPS--DMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~~~~p~lps--~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+.... .+.++. .++..+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 217 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGAGH--KPPIPDSLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHhcCC--CCCCCcccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 2222221 122333 34899999999999999999999 7889999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.11 Aligned_cols=258 Identities=32% Similarity=0.522 Sum_probs=213.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||+|.+..+++.||+|.++... ........+.+|+++++.++|+||+++++++...+.+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999886532 22334577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||++++.+..+......++...+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~------ 153 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR------ 153 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC------
Confidence 99998777777766667999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........++..|+|||++.+. .++.++||||||+++|+|++|++||.+....+....
T Consensus 154 --------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 154 --------------------PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred --------------------ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00112234678999999999888 789999999999999999999999987655443332
Q ss_pred HHccC-------------------CCCC----------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRK-------------------IPWP----------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~-------------------~~~p----------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+.... ..++ ..+..++..+.+||++||..+|++||+ +.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~f 288 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPYF 288 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCCC
Confidence 22100 0000 012335889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.47 Aligned_cols=257 Identities=35% Similarity=0.547 Sum_probs=213.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999876432 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 768 ym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|+ +++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 152 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE------ 152 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC------
Confidence 99 99999998653 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+......+..
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 153 --------------------EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred --------------------CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 00112234689999999998764 468999999999999999999999987766555544
Q ss_pred HHccCC-------------------CCC--------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 926 ILNRKI-------------------PWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 926 Il~~~~-------------------~~p--------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
+..... .++ ......+..+.+||.+||..||.+||+ +.++++||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 433110 000 112356789999999999999999999 78999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.67 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=208.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+++++.++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3699999999999999999999999987642 23345577999999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 773 SL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---------- 148 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV---------- 148 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc----------
Confidence 999999754 458999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~ 930 (995)
+ ........++..|+|||.+.+..++.++||||||+++|||++ |..||...........+....
T Consensus 149 --------~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 149 --------Y-------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred --------c-------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 0 000011123567999999999899999999999999999997 999998877766665554432
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 931 ~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
. ...+..++..+.+|+.+||+.+|++|||+.++.+.|+
T Consensus 214 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 R--LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred C--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2 2235677899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.18 Aligned_cols=265 Identities=30% Similarity=0.530 Sum_probs=224.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|+..+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.+.||||+++++++......++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888899999999999999999999999999987532 2345678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC-------
Confidence 99999999999865 4688899999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........++..|+|||++.+..++.++|+||||+++|||++|..||....+......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 154 --------------------TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred --------------------CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 001112345888999999999888999999999999999999999999887766655544
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchh
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
.... .+..+..++..+.+|+.+||+.+|.+||+ +.+++.|+||.....+..-+..
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~~~ 268 (277)
T cd06640 214 PKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAKKTSYLTE 268 (277)
T ss_pred hcCC--CCCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcchhhhHHHH
Confidence 3332 23445667889999999999999999999 7888999999998877544443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.42 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=214.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTG----------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG----------------~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI 749 (995)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+++++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 468999887532 23456788999999999999999
Q ss_pred EEEeeeeeccCeeEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 750 VkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~-----------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
+++++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997655 689999999999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIW 898 (995)
+++.++.++|+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDY-------------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216 (296)
T ss_pred eecCCCceEEccccceeecccCcc-------------------------eeecCcCCCCceecCHHHhhcCCCCccchhh
Confidence 999999999999999874211000 0112234567899999999988899999999
Q ss_pred HHHHHHHHHHc--CCCCCCCCCHHHHHHHHHcc-----CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 899 SVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 899 SLGVILyELLT--Gr~PF~g~s~~ei~qkIl~~-----~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||+++|||++ |..||...+....+..+... .......+..++.++.+|+.+||+.||.+|||+.++.+.|+
T Consensus 217 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 99999999998 78899887777766655432 11112234567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.86 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=211.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe----
Q 001924 689 FEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 761 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~---- 761 (995)
|++.+.||+|+||.||+|....+ +..||+|.++.. .........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999997653 478999998753 2234456789999999999999999999998876554
Q ss_pred --eEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 762 --LYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 762 --lyLVmEym~GGSL~d~L~k~------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.+++|||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988532 3588899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~ 912 (995)
++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 874211100 000112234678999999988889999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||.+......+..+..+.. +..+..++..+.+++.+||+.||.+||++.++.+.|+.
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 9998888887777665432 33457889999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.33 Aligned_cols=259 Identities=31% Similarity=0.500 Sum_probs=213.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-------se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... .....+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999999989999999988642111 1112456788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
..++||||+++|+|.+++.+.+.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998731100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~--ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
..........|+..|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 162 -------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 162 -------------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred -------------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 0001122345889999999997755 7899999999999999999999997665
Q ss_pred HHHHHHHHHccCCC--CC-CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 919 PEIIFDNILNRKIP--WP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 919 ~~ei~qkIl~~~~~--~p-~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.......+...... ++ .....++..+.++|.+||..+|.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 54444333322211 11 122356899999999999999999999 8889999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=352.34 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=201.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...+|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.++++++||||+++++++......++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999999999999999975432 23568999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 209 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---- 209 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc----
Confidence 999995 688888864 45689999999999999999999999999999999999999999999999999873110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC-CCCCCH---
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAESP--- 919 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P-F~g~s~--- 919 (995)
........||+.|+|||++.+..++.++|||||||++|||+++..| |.....
T Consensus 210 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~ 265 (357)
T PHA03209 210 ------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265 (357)
T ss_pred ------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHH
Confidence 0111234689999999999999999999999999999999985544 433211
Q ss_pred ------HHHHHHHHcc-CC---CCC-----------------------C----CCCCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 920 ------EIIFDNILNR-KI---PWP-----------------------C----VPSDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 920 ------~ei~qkIl~~-~~---~~p-----------------------~----lps~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
...+..++.. .. .++ . ....++..+.+||.+||+.||.+|||
T Consensus 266 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt- 344 (357)
T PHA03209 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS- 344 (357)
T ss_pred HHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC-
Confidence 0111111110 00 011 0 01245667888999999999999999
Q ss_pred HHHHHHHcCcccccc
Q 001924 963 NGAAEVFHCKIFIKK 977 (995)
Q Consensus 963 ~EIlEiL~HPfF~~~ 977 (995)
+.++|+||||++.
T Consensus 345 --a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 --AEEILNYPMFAQL 357 (357)
T ss_pred --HHHHhcCchhccC
Confidence 7889999999863
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.77 Aligned_cols=265 Identities=43% Similarity=0.756 Sum_probs=220.2
Q ss_pred CeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~s-e~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
+|++.+.||.|+||.||++.+. .++..||||++++..... ......+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999987543322 23346788999999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999987777999999999999999999999999999999999999999999999999998631100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCC--
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES-- 918 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~--ys~KSDIWSLGVILyELLTGr~PF~g~s-- 918 (995)
.........|++.|+|||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 159 ------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 001112346889999999987765 7889999999999999999999996432
Q ss_pred --HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 919 --~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
.......+..... ..+..++..+.++|.+||+.||++|||+.++.++|+||||+...|+.
T Consensus 215 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 215 NSQSEISRRILKSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred chHHHHHHHHHccCC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 2333344443332 23466889999999999999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=319.60 Aligned_cols=254 Identities=35% Similarity=0.647 Sum_probs=222.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|.+.+.||.|+||.||++.+..++..||+|++..... .......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999998999999999875432 33556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 768 YLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 768 ym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|+++++|.+++... ..++...+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~---- 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---- 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc----
Confidence 99999999999764 6799999999999999999999999999999999999999999999999998874110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 156 -----------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 156 -----------------------TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -----------------------CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 001122346889999999999988999999999999999999999999988887777
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
....... .+.++..++..+.+++.+||..+|++||+ +.++|+||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 7776554 34456688999999999999999999999 8889999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.96 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=213.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45789999999999999999999987 77899999876422 233456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEE
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLT 829 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~-------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLs 829 (995)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997653 488899999999999999999999999999999999998765 59999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 001924 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 830 DFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT 909 (995)
|||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 162 dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASY-------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccc-------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999874210000 001112234568999999999999999999999999999997
Q ss_pred -CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 910 -GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 910 -Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|..||...+.......+..... +..+..++..+.+|+.+||+.+|++||++.++++.|+
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9999998887777666554322 2345678999999999999999999999988888764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=333.66 Aligned_cols=251 Identities=31% Similarity=0.496 Sum_probs=207.6
Q ss_pred EEEEeeccCCCeEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 690 EIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
++.+.||.|.||.||+|.+. ..+..|+||+++. .......+.+.+|++.+++++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999998 4567899999854 22344578999999999999999999999999988889999
Q ss_pred EeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 766 mEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+|+||+++||+++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999876 67999999999999999999999999999999999999999999999999998742000
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei 922 (995)
..........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++
T Consensus 157 ----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 157 ----------------------SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ----------------------SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ----------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00011223446788999999998889999999999999999999 7899999988888
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
...+..+.. +..+..++..+.++|..||..||.+||++.++.+.|
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 IEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 888755443 234567899999999999999999999999988765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.79 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=210.2
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc------C
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------D 760 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~--~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~------~ 760 (995)
|.+.+.||+|+||.||+|.+..++. .||+|.++.. .......+.+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999887775 6999988653 23445577889999999999999999999876432 2
Q ss_pred eeEEEEeecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 761 NLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k------~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
..+++|||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 47899999999999988742 134789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~P 913 (995)
+....... ........+++.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 74211000 001122346778999999999999999999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|.+.........+..+.. +..+..++..+.++|.+||+.||.+|||+.++.+.|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 215 YPGVENSEIYDYLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 998888777777765543 22346788999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=329.22 Aligned_cols=255 Identities=33% Similarity=0.548 Sum_probs=216.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|+||.||++.+..+++.||+|.+.... .......+.+|+++++.+.||||+++++.+.....+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 46888899999999999999999999999999987643 2345577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~----- 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----- 153 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH-----
Confidence 999999999999876 678999999999999999999999 9999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-----CH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-----SP 919 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~-----s~ 919 (995)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||... ..
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred ------------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 0011156889999999999999999999999999999999999999754 23
Q ss_pred HHHHHHHHccCCCCCCCCCC-CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~-lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.+....+.... .+..+.. ++..+.+||.+||..||.+||| +.+++.||||++.
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~~ 263 (265)
T cd06605 210 FELLQYIVNEP--PPRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhcc
Confidence 34444444332 2333333 8899999999999999999999 8888999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=375.69 Aligned_cols=269 Identities=35% Similarity=0.668 Sum_probs=251.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...+++++..||-||||.|=++........+|+|++++....+....+.+..|.+||..++.|.||++|-.|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 35678888999999999999998876666799999999999999999999999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
+||-|-||.|+..+...+.|....+++++..+++|++|||++|||+|||||+|.+++.+|.+||.|||+|+..
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki------- 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI------- 570 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999852
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
..+..++++||||.|.|||++.+..++.++|.||||+++||||+|.+||.+.++...++
T Consensus 571 ---------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn 629 (732)
T KOG0614|consen 571 ---------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN 629 (732)
T ss_pred ---------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 34567889999999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC--HHHHHHHHcCccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS--A~EIlEiL~HPfF~~~~~n~~ 982 (995)
.|+.+--. -.+|..++..+.+||+++...+|.+|.. ...|.++.+|.||.+.+|..+
T Consensus 630 ~ILkGid~-i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 630 LILKGIDK-IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred HHHhhhhh-hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 99887533 3456889999999999999999999999 689999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=325.61 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=214.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||.|+||.||+|.+.. +..||+|.++... .....+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 345789999999999999999999754 5789999987533 23456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 68999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
........++..|+|||++.+..++.++||||||+++|||++ |+.||.+....
T Consensus 158 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 --------------------------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred --------------------------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 000011223468999999999899999999999999999999 99999988887
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+.... .. ..+...+..+.+++.+||+.+|.+||++.++...|+.
T Consensus 212 ~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 212 EVLQQVDQGY-RM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 7777665442 22 2345788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.29 Aligned_cols=257 Identities=23% Similarity=0.292 Sum_probs=216.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999998654 4589999886532 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999988421000
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 161 -------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 161 -------------------------ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred -------------------------cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 0001112235678999999999899999999999999999998 99999888877
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+...... ..+...+..+.+|+.+||+.+|++||++.++.+.|..
T Consensus 216 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 216 DVIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 777776554221 2245788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.80 Aligned_cols=261 Identities=34% Similarity=0.580 Sum_probs=236.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...=|.+.+.||+|-|.+|-++++-.||..||||++.+..+ +......+++|+++|+.++|||||++|.+......+|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 44679999999999999999999999999999999998654 44556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec-cCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD-enG~VKLsDFGLArv~~~~~s 842 (995)
|+|+=++|+|+||+.++ ..+.+..+++|+.||+.|+.|+|+..++||||||+|+.+. ..|-|||.|||++.-.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf----- 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF----- 169 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-----
Confidence 99999999999999765 4699999999999999999999999999999999999775 5689999999987521
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys-~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.+.....+.||+..|-|||++.|..|+ +.+||||||||||.|++|++||...+..+
T Consensus 170 -----------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 170 -----------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred -----------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 234556788999999999999999996 68999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
.+-.|+..++..| ..++.+..+||..||..||.+|.+ +.++..++|++.++.-
T Consensus 227 TLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 227 TLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 9999999998765 789999999999999999999999 8888999999988754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.46 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=210.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~----VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...+|++.+.||+|+||.||+|.+..++.. ||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346899999999999999999998766664 8999886422 234456788999999999999999999998764
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++|++|+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999999764 4588889999999999999999999999999999999999999999999999984211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
... ........++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 162 ~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 162 DEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCc-------------------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 000 000112234678999999999999999999999999999998 999999887
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
..+....+ .....++ .+..++..+.+++.+||..+|.+||++.+++..+..
T Consensus 217 ~~~~~~~~-~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 217 ASEISSIL-EKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred HHHHHHHH-hCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 76655443 3333333 345688899999999999999999999888887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.14 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=215.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~T-----G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..+|.+.+.||.|+||.||+|.+..+ +..||+|+++... .......+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45688899999999999999987543 5789999987432 2234567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
..++++||+++++|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998532 2477888899999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.+||+|||+++....... ........+++.|+|||++.+..++.++||||||+++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 216 (283)
T cd05091 162 NVKISDLGLFREVYAADY-------------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216 (283)
T ss_pred ceEecccccccccccchh-------------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHH
Confidence 999999999874211000 0111233467899999999988899999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 905 yELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||++ |..||.+....+....+...... ..+..++..+.+|+..||+.+|.+||++.++...|+
T Consensus 217 ~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 217 WEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 99998 89999998888888887766543 245689999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.93 Aligned_cols=259 Identities=30% Similarity=0.530 Sum_probs=232.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe-eEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYL 764 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~-lyL 764 (995)
.++|..++++|+|+||.+++++++.++..|++|.+..... ...+.....+|+.++++++|||||.+.+.|..+++ ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4789999999999999999999999999999999986544 34455688999999999999999999999999998 999
Q ss_pred EEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||+||+||+|.+.+.+. ..|+++.+..++.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~---- 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN---- 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC----
Confidence 99999999999999755 369999999999999999999999999999999999999999999999999999631
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.......+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+...+
T Consensus 158 -----------------------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 158 -----------------------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred -----------------------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 111244578899999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..+|....+ ..+|...+.++..||+.||..+|..||+ +.++|.+|.....
T Consensus 215 i~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 215 ILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLLRY 264 (426)
T ss_pred HHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhhhH
Confidence 999988873 3456889999999999999999999999 7777777776633
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.00 Aligned_cols=255 Identities=31% Similarity=0.505 Sum_probs=208.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..+|..||||.++... ........+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999886432 222334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+. ++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~------ 152 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV------ 152 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc------
Confidence 995 6899888653 4689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+......
T Consensus 153 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 153 ---------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ---------------------CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 001112235788999999987654 5889999999999999999999998776554443
Q ss_pred HHHccCC------------------CCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKI------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~------------------~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
++..... .++. ....+++.+.++|.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 3332110 0000 12357788999999999999999999 7889999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=322.29 Aligned_cols=250 Identities=50% Similarity=0.913 Sum_probs=220.5
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||.|+||.||++.+..+++.||+|++++...........+..|+.+++.++||||+++++.+.....+++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999876555555677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 001924 775 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854 (995)
Q Consensus 775 ~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~ 854 (995)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-------------- 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-------------- 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--------------
Confidence 999988878999999999999999999999999999999999999999999999999988741100
Q ss_pred CCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCC
Q 001924 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 934 (995)
Q Consensus 855 ~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p 934 (995)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......
T Consensus 147 -------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 211 (250)
T cd05123 147 -------------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR-- 211 (250)
T ss_pred -------------CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC--
Confidence 01123456888999999999888899999999999999999999999888877777777664433
Q ss_pred CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 935 ~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+...+..+.++|.+||..||.+||++.++.++++||||
T Consensus 212 -~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 -FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 346678999999999999999999997667999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.50 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=216.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...+|++.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++||||+++++++.....+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 44679999999999999999999987 8899999987533 2235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-- 157 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-- 157 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence 99999999999999753 45889999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 158 -------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 158 -------------------------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred -------------------------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 000112335778999999998899999999999999999998 899999888888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.+..+.... . +..+..++..+.+++.+||+.||.+|||+.++.+.|+
T Consensus 213 ~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 213 VYDQITAGY-R-MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHHHHHhCC-c-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 877776442 2 2234678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=334.03 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=211.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~--~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ly 763 (995)
++|++.+.||.|+||.||+|....++. .+++|.++.. ........+.+|+.++.++ +||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999887765 4688877632 2334456789999999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 764 LVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478889999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
|+|||++.... . ........++..|+|||++.+..++.++|||||||++|||
T Consensus 160 l~dfg~~~~~~--~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEE--V--------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCcccc--c--------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 99999876210 0 0001111235679999999998999999999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
++ |..||...........+..+. . +..+..++..+.+|+.+||+.+|.+||++.++...|.
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 97 999999988888877765542 2 2245678999999999999999999999999977764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=332.36 Aligned_cols=258 Identities=30% Similarity=0.526 Sum_probs=219.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|...+.||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.+.||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3555679999999999999999899999999876422 2345668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+++++|.+++.. ..++...+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-------- 167 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------- 167 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--------
Confidence 9999999999977 5689999999999999999999999999999999999999999999999998763110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...++......+.
T Consensus 168 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 168 -------------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred -------------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 0011123468999999999998889999999999999999999999998888777776666
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 928 ~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
....+....+..++..+.+||.+||+.+|++||+ +.++++||||...+.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~ 277 (285)
T cd06648 229 DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKAGP 277 (285)
T ss_pred hcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccCCC
Confidence 5533322223447899999999999999999999 788899999988663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.75 Aligned_cols=257 Identities=31% Similarity=0.486 Sum_probs=207.2
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCe----
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN---- 761 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~---- 761 (995)
++|++.+.||.|+||.||+|.+..+++.||+|.++... ........+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999876532 22233457888999999995 6999999999887665
Q ss_pred -eEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCc
Q 001924 762 -LYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLS 834 (995)
Q Consensus 762 -lyLVmEym~GGSL~d~L~k~-----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLA 834 (995)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 898888643 34799999999999999999999999999999999999998 889999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
..... .........+++.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 159 ~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCC---------------------------CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 73110 0001112356889999999865 4578999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCC-----CC------------C--------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 914 FTAESPEIIFDNILNRKI-----PW------------P--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~-----~~------------p--------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
|.+.+.......+..... .+ + .....++..+.+||.+||..||.+||+ +.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~~ei 288 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---AKAA 288 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---HHHH
Confidence 988766554444332100 00 0 011357889999999999999999999 7899
Q ss_pred HcCcccc
Q 001924 969 FHCKIFI 975 (995)
Q Consensus 969 L~HPfF~ 975 (995)
+.||||+
T Consensus 289 l~~~~~~ 295 (295)
T cd07837 289 LTHPYFD 295 (295)
T ss_pred hcCCCcC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.33 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=216.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.....+++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999875432 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCccccccccccc
Q 001924 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 768 ym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~~~s~d 844 (995)
|+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----- 154 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC-----
Confidence 999999999997543 478999999999999999999999999999999999999886 479999998864110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 155 ----------------------SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ----------------------CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0011123458899999999988889999999999999999999999998877766666
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..... +..+...+..+.++|.+||..+|++||| +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 6555443 3334578899999999999999999999 8888999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.32 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=216.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||+||++.+..+|..||+|++.... .......+.+|+++++.++||||+++++++.....+++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 468999999999999999999999999999999886432 233457889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++++|.+++.+.+.+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~------ 155 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI------ 155 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh------
Confidence 9999999999999887889999999999999999999997 599999999999999999999999999876310
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---- 920 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~---- 920 (995)
........|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 -----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~ 212 (284)
T cd06620 156 -----------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212 (284)
T ss_pred -----------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence 00112346899999999998888999999999999999999999999865432
Q ss_pred -------HHHHHHHccCCCCCCCC-CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 921 -------IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 921 -------ei~qkIl~~~~~~p~lp-s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.....+..... +.++ ..++..+.+|+.+||..||.+||+ +.++++|+||.+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~~~ 273 (284)
T cd06620 213 DDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQAL 273 (284)
T ss_pred hhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccc
Confidence 22333332221 2222 237889999999999999999999 78899999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=374.69 Aligned_cols=151 Identities=57% Similarity=1.009 Sum_probs=141.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|.+.+.||+|+||.||+|.+..+++.||||+++............+..|+.++..++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876655566667889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=323.63 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=210.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee-ccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~-~~~~ly 763 (995)
...+|++.+.||+|+||.||++... |..||+|.++.. .....+.+|+.++++++|+|++++++++. .....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4568999999999999999999765 788999988642 23467889999999999999999998764 456789
Q ss_pred EEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-- 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc--
Confidence 9999999999999997643 478899999999999999999999999999999999999999999999998873110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 155 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~ 206 (256)
T cd05082 155 ----------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred ----------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 0112234568999999999899999999999999999997 99999988777
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+..+. . +..+..+++.+.+++.+||+.+|.+|||+.++.+.|++
T Consensus 207 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 207 DVVPRVEKGY-K-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 7766665432 2 23456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.74 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=211.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+.. +..+|+|.++.... ....+.+|+.++++++||||+++++++......++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998764 45699998864322 245689999999999999999999999998899999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc---
Confidence 9999999999999764 468999999999999999999999999999999999999999999999999887421000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 155 -----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05113 155 -----------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211 (256)
T ss_pred -----------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 001112235678999999998889999999999999999998 99999988887777
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
..+...... ..+...+..+.+++.+||..||.+||++.+++..+
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 212 EKVSQGLRL--YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHhcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 777665433 23456789999999999999999999988887765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.70 Aligned_cols=268 Identities=29% Similarity=0.463 Sum_probs=218.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--CeeEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYL 764 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~lyL 764 (995)
++|...+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||+++++++... ..+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 478999999999999999999999999999999875322 24457789999999999999999999988654 36899
Q ss_pred EEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 765 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 765 VmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
||||+++++|.+++.. ...++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34588899999999999999999999999999999999999999999999999863110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~--- 917 (995)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 158 ----------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 158 ----------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred ----------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 0011235788999999999999999999999999999999999999765
Q ss_pred --CHHHHHHHHHccCCC-CCCCC---CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHh
Q 001924 918 --SPEIIFDNILNRKIP-WPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKL 988 (995)
Q Consensus 918 --s~~ei~qkIl~~~~~-~p~lp---s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l 988 (995)
...+....+...... .+..+ ...++.+.+||.+||..+|.+||| +.+++.||||.+.......+....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~~~~~~~~~~~ 283 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQMKKKVNMAKFV 283 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccccccchhhHHHHH
Confidence 233444444332211 11111 234678999999999999999999 789999999988877766555443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.28 Aligned_cols=263 Identities=33% Similarity=0.553 Sum_probs=224.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..+.|++.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45678999999999999999999998899999999875332 45678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|+||+++++|.+++.... .++...+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~---- 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK---- 168 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc----
Confidence 999999999999998776 799999999999999999999999999999999999999999999999998763110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+++.|+|||++.+..++.++||||||+++|+|++|..||....+....
T Consensus 169 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 169 -----------------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -----------------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 001112345788999999999888999999999999999999999999988776666
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..+..........+..++..+.+||.+||+.+|.+||+ +.++++|+||.+..++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCchH
Confidence 55554443322223448899999999999999999999 77889999999966553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=321.63 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=214.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||.|+||.||+|... |+.||+|.++.... ....+.+|+.+++.++|+||+++++++......++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4578999999999999999999875 88999999875321 46789999999999999999999999999899999
Q ss_pred EEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~--- 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ--- 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc---
Confidence 999999999999997665 689999999999999999999999999999999999999999999999999874100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 155 ---------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 155 ---------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred ---------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 0001234567999999998889999999999999999997 999999888777
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+.... . +..+..+++.+.+||.+||..+|.+||++.++++.|+.
T Consensus 208 ~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 208 VVPHVEKGY-R-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHhcCC-C-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 766655432 2 23456788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.31 Aligned_cols=251 Identities=23% Similarity=0.391 Sum_probs=210.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+++++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 356899999999999999999886 467899998864322 235688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 9999999999999753 468999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 155 -----------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 000111124567999999999999999999999999999999 89999888877777
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
..+.... . +..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 212 ~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 ESVSAGY-R-LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHcCC-c-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 6665442 2 223456899999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.80 Aligned_cols=265 Identities=33% Similarity=0.482 Sum_probs=214.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--Cee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~l 762 (995)
..++|++.+.||.|+||.||+|.+..+|+.||+|.++.... .......+.+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 56899999999999999999999999999999999875332 122233567899999999999999999998765 468
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 99999996 5898888753 56899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
........+++.|+|||++.+ ..++.++||||||+++|+|++|++||...+..
T Consensus 162 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 162 --------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred --------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 001112345788999999876 45789999999999999999999999988887
Q ss_pred HHHHHHHccCC-------------------CCCCC--------CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 921 IIFDNILNRKI-------------------PWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 921 ei~qkIl~~~~-------------------~~p~l--------ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
+.+..+..... ..+.. ....++.+.+||.+||+.||++||| +.++++|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~h~~ 292 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhcChh
Confidence 77666554211 00000 1235788999999999999999999 778889999
Q ss_pred cccccccc
Q 001924 974 FIKKTENC 981 (995)
Q Consensus 974 F~~~~~n~ 981 (995)
|.+.....
T Consensus 293 f~~~~~~~ 300 (309)
T cd07845 293 FKEKPLPC 300 (309)
T ss_pred hccCCCCC
Confidence 98766543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.26 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=216.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG-----~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
.+....++|++.+.||+|+||.||++.+...+ ..+|+|.+.... .......+.+|+.++.++ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34456688999999999999999999986443 689999887532 233456788999999999 8999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
++...+.++++|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 3578889999999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIW 898 (995)
+++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999999999874211000 0001112356789999999998999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 899 SLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
||||++|||++ |..||......+.+..+..... +..+...+..+.+|+.+||..||.+|||+.++++.|.
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 99999999997 9999998888887777655432 2345678899999999999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=334.80 Aligned_cols=263 Identities=30% Similarity=0.532 Sum_probs=220.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|+..+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 34677788999999999999999999999999886432 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC-------
Confidence 99999999998864 4689999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........|+..|+|||++.+..++.++||||||+++|||++|..||....+......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 154 --------------------TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred --------------------cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 000112345889999999999988999999999999999999999999876665555444
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
.... .+..+...+..+.+++.+||+.+|.+||+ +.++++||||....++...+
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~ 266 (277)
T cd06642 214 PKNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYTKKTSFL 266 (277)
T ss_pred hcCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHhhhHHHH
Confidence 3332 23345568889999999999999999999 77778899998877655443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.69 Aligned_cols=254 Identities=31% Similarity=0.590 Sum_probs=220.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|++|.||++.+..+++.|++|.+..... .......+.+|+++++++.|||++++++++......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999976543 23456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------- 152 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------- 152 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC-------
Confidence 9999999999988788999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
........|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+.
T Consensus 153 --------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 153 --------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred --------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 001223468899999999988888999999999999999999999998776655554444
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 928 ~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.. ..+..+..++..+.+++.+||..+|++||+ +.+++.||||
T Consensus 213 ~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred cc--CCCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 33 234456788999999999999999999999 7888999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.28 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=212.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..++|++.+.||.|+||+||+|.+..++. .||+|+++... .......+.+|+.++..+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45789999999999999999999877776 48999886432 33445678899999999999999999998875 4
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..+++|+|+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 578999999999999999764 5689999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 162 ~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 162 DET-------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred ccc-------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 000 000111235678999999999999999999999999999998 999998877
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.......+..... +..+..++..+.+++.+||+.||++||++.++.+.|..-
T Consensus 217 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 217 AREIPDLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHHHHHHHCCCc--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 7666655544332 223467889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.01 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=214.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..++|+..+.||+|+||.||+|....++. .+|+|.++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45689999999999999999999876665 79999876432 23345678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.++||||+++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999754 56899999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
.. ..........++.|+|||++.+..++.++||||||+++|||++ |..||...+.
T Consensus 161 ~~------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 161 PE------------------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cc------------------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 00 0000111223567999999998889999999999999999997 9999988887
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
......+.... ..+ .+..++..+.+|+.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 217 HEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred HHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 77777765542 222 23467899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.82 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=215.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..+|.+.+.||+|+||.||+|.+.. ++..+++|.++... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4679999999999999999998643 45578888876432 233467889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
..++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997542 378899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.++|+|||++....... .........|+..|+|||++.+..++.++||||||+++
T Consensus 161 ~~~l~dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 161 LVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred cEEECCCCcccccCCCc-------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 99999999987321000 00111234578899999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 905 yELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
|||++ |..||...+.......+..+.. +..+..++..+.+|+.+||+.||.+||++.++.+.|+..
T Consensus 216 ~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 216 WEIFTYGKQPWFQLSNTEVIECITQGRV--LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhCCCC--CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 99998 9999988888777776655443 234466889999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=324.31 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=211.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+. ++..+|+|.++.... ....+.+|+.++++++|||++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34578999999999999999999876 567799999875332 2356889999999999999999999875 45689
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999753 358999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred --------------------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001112235678999999998889999999999999999999 99999988887
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+....+.... . +..+...+..+.+|+.+||..+|.+|||+.++.++|+
T Consensus 211 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 211 EVLEQVERGY-R-MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred HHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 7777765432 2 2234678899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=333.84 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=190.4
Q ss_pred EEeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec--cCeeEEEEe
Q 001924 692 IKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 767 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~--TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~--~~~lyLVmE 767 (995)
..+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3579999999999999754 56899999886532 23457789999999999999999998854 457899999
Q ss_pred ecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe----ccCCcEEEEecCCc
Q 001924 768 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 834 (995)
Q Consensus 768 ym~GGSL~d~L~k~---------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL----DenG~VKLsDFGLA 834 (995)
|+. ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 986 5888877522 247888999999999999999999999999999999999 45679999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~P 913 (995)
+...... ..........||+.|+|||++.+. .++.++|||||||++|||++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~ 215 (317)
T cd07867 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCc------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence 7421000 001112345689999999999774 579999999999999999999999
Q ss_pred CCCCCHH---------HHHHHHHcc-C-------------CCC---------------------CCCCCCCCHHHHHHHH
Q 001924 914 FTAESPE---------IIFDNILNR-K-------------IPW---------------------PCVPSDMSFEAQDLIN 949 (995)
Q Consensus 914 F~g~s~~---------ei~qkIl~~-~-------------~~~---------------------p~lps~lS~eL~dLIk 949 (995)
|...... .....+... . ..+ .......+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 295 (317)
T cd07867 216 FHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295 (317)
T ss_pred cccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHH
Confidence 9653211 111111100 0 000 0011123567889999
Q ss_pred HHhhcCccCCCCHHHHHHHHcCccc
Q 001924 950 RFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 950 kCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+||+.||.+||| +.++|+||||
T Consensus 296 ~~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 296 KLLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HHhccCcccccC---HHHHhcCCCC
Confidence 999999999999 7889999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=322.52 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=208.7
Q ss_pred EeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeec
Q 001924 693 KPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG---~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876555 78999998764432 34567899999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCC
Q 001924 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (995)
Q Consensus 770 ~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~ 849 (995)
++|+|.+++.....+++..+..++.|++.||+|||+.+++|+||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------- 150 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------- 150 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-------
Confidence 9999999998877899999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 001924 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928 (995)
Q Consensus 850 t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~ 928 (995)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+..
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 151 -----------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred -----------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 0000111224568999999999999999999999999999998 9999998887777666654
Q ss_pred cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 929 ~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
... ...+..++..+.++|.+||..+|.+||++.++.+.|+.
T Consensus 214 ~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 214 GER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred CCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 432 23456788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.41 Aligned_cols=256 Identities=29% Similarity=0.528 Sum_probs=204.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875321 12234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV----- 155 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC-----
Confidence 999974 999988754 4689999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES-PEII 922 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s-~~ei 922 (995)
.........++..|+|||++.+ ..++.++||||||+++|+|++|+.||.... ..+.
T Consensus 156 ----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 213 (291)
T cd07844 156 ----------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213 (291)
T ss_pred ----------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 0001112346889999999876 457899999999999999999999997654 2222
Q ss_pred HHHHHccC-------------------CCCCC--------CCCCCC--HHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 923 FDNILNRK-------------------IPWPC--------VPSDMS--FEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 923 ~qkIl~~~-------------------~~~p~--------lps~lS--~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
...+.... ..++. ....++ ..+.+++.+||+.+|.+||| +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~~~~ 290 (291)
T cd07844 214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMKHPY 290 (291)
T ss_pred HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhcCCC
Confidence 22221100 00000 001234 78899999999999999999 778999999
Q ss_pred c
Q 001924 974 F 974 (995)
Q Consensus 974 F 974 (995)
|
T Consensus 291 f 291 (291)
T cd07844 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.08 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=216.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666678999999999999999999999999886432 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~------- 170 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK------- 170 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc-------
Confidence 99999999998854 4689999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||...+....+..+
T Consensus 171 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 171 --------------------EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred --------------------ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001112346899999999999888999999999999999999999999887776665554
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..............+..+.+++.+||..||.+||| +.++++||||.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~~~ 280 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLAGP 280 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhccCC
Confidence 43322211222357889999999999999999999 778888999986644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.98 Aligned_cols=259 Identities=28% Similarity=0.468 Sum_probs=216.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--Cee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~--~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~l 762 (995)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|++++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875321 12234556889999999999999999999998764 458
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+++|||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 899999999999999987777899999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
...........|+..|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 160 ----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 160 ----------------------CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred ----------------------cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 0001111234689999999999998899999999999999999999999988766665
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..++.... ..+.+|..++..+.++|.+||. +|.+||+ +.++++|||.
T Consensus 218 ~~~~~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 55544332 2245677899999999999999 5799999 6688999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.11 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=208.7
Q ss_pred eeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 694 PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k--~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 445679999886532 2344567899999999999999999999875 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 772 GDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 772 GSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 150 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-------- 150 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc--------
Confidence 999999874 45689999999999999999999999999999999999999999999999999873211000
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcc
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~ 929 (995)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+..+
T Consensus 151 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 151 ----------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred ----------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 0001111234678999999998889999999999999999996 99999988887776666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.. +..+...++++.++|.+||..+|++||++.++.+.|+.-||
T Consensus 215 ~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 215 KR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 32 23456789999999999999999999999999999988776
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.91 Aligned_cols=252 Identities=37% Similarity=0.619 Sum_probs=214.3
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|++|.||++.+..++..+++|++..... .....+.+|+++++.+.|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999876432 356788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 768 ym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------ 151 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT------ 151 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc------
Confidence 99999999999776 57899999999999999999999999999999999999999999999999988741100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+........
T Consensus 152 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 152 ----------------------KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ----------------------ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 0023456889999999999888999999999999999999999999887655554444
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
.....+....+..++..+.++|.+||+.||.+||| +.+++.|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 210 ATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 33222211112234889999999999999999999 788899998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.48 Aligned_cols=254 Identities=29% Similarity=0.487 Sum_probs=209.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|++|.||+|.+..+|..||+|+++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 768 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 768 ym~GGSL~d~L~k~---~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~----- 152 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI----- 152 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC-----
Confidence 9975 898888654 3589999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+++.|++||++.+. .++.++||||||+++|+|++|+.||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 153 ----------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ----------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 00111234578899999998664 5689999999999999999999999887766555
Q ss_pred HHHHccCC------------------CCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRKI------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~~------------------~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+..... ..+. ..+..+..+.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 54432100 0000 11345788999999999999999999 7889999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.23 Aligned_cols=268 Identities=34% Similarity=0.598 Sum_probs=236.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...+.|+.-++||+||||.||-++.+.||+.||.|.+.+.....+......++|..+|.+++.+.||.+-..|...+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 45578899999999999999999999999999999988766666677788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+..|.||+|.-+|.+.+ .|++..++.++.+|+.||++||+.+|++||+||+|||+|+.|+|+|+|+|||.-+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~--- 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP--- 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC---
Confidence 9999999999998887665 79999999999999999999999999999999999999999999999999997422
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--- 918 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s--- 918 (995)
........+||.+|||||++.+..|+.+.|+|||||+||||+.|+.||....
T Consensus 339 -------------------------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv 393 (591)
T KOG0986|consen 339 -------------------------EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV 393 (591)
T ss_pred -------------------------CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh
Confidence 1222334589999999999999999999999999999999999999997643
Q ss_pred -HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 919 -PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 919 -~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
.+++-+.+......++ ..+++++++|+..+|++||.+|..- +.+.++.+||||+++.|..+
T Consensus 394 k~eEvdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 394 KREEVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred hHHHHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 3355555655554444 7899999999999999999999984 46788999999999999865
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=328.76 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=204.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
+.++|.+.+.||+|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++|+||+++++++......|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999865332 2233467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---- 155 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI---- 155 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC----
Confidence 999995 677777654 34578888899999999999999999999999999999999999999999999873110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-H
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPE-I 921 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~-e 921 (995)
.........+++.|+|||++.+. .++.++||||||+++|+|++|..||...... +
T Consensus 156 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~ 212 (291)
T cd07870 156 -----------------------PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212 (291)
T ss_pred -----------------------CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH
Confidence 00011223578999999998764 5788999999999999999999999765432 2
Q ss_pred HHHHHHcc-CC-----------------CC-CC--------C--CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 922 IFDNILNR-KI-----------------PW-PC--------V--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 922 i~qkIl~~-~~-----------------~~-p~--------l--ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.+..+... .. .+ +. . ....+..+.+|+.+||+.||.+||| +.+++.||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~h~ 289 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALLHP 289 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhcCC
Confidence 22221110 00 00 00 0 0123578999999999999999999 78899999
Q ss_pred cc
Q 001924 973 IF 974 (995)
Q Consensus 973 fF 974 (995)
||
T Consensus 290 ~~ 291 (291)
T cd07870 290 YF 291 (291)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.90 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=217.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|.....||.|+||.||++.+..+++.||+|++.... ....+.+.+|+.++..+.||||+++++++...+..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3445567999999999999999899999999986532 2234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+++++|..++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-------- 169 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 169 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--------
Confidence 9999999998754 5689999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
.........|++.|+|||++.+..++.++||||||+++|||++|+.||...........+.
T Consensus 170 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 170 -------------------DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred -------------------ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0011223568999999999999889999999999999999999999998877776666655
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 928 ~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.........+..++..+.++|.+||+.+|.+||+ +.++++||||.+-.
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~~ 278 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQTG 278 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccCC
Confidence 4443333344567889999999999999999999 77888999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=334.22 Aligned_cols=259 Identities=32% Similarity=0.524 Sum_probs=217.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|.+.+.||.|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 478999999999999999999998899999999885422 23456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
+||+++++|.+++.+. .++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~------ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 167 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc------
Confidence 9999999999998654 578889999999999999999999999999999999999999999999998763110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred ---------------------cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 00111234688999999999888899999999999999999999999987765444333
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
+.....+....+..++..+.++|.+||+.+|.+||+ +.+++.|+||...+
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~~ 276 (293)
T cd06647 227 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIAK 276 (293)
T ss_pred hhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcCc
Confidence 332222212223457889999999999999999999 78899999998776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=331.74 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=210.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTG--------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG--------------~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVk 751 (995)
.++|++.+.||+|+||.||++.+..++ ..||+|.++.. ........+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 35899988643 22345567899999999999999999
Q ss_pred EeeeeeccCeeEEEEeecCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEE
Q 001924 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (995)
Q Consensus 752 L~gvf~~~~~lyLVmEym~GGSL~d~L~k~~------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNIL 819 (995)
+++++......++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986432 3677888899999999999999999999999999999
Q ss_pred eccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHH
Q 001924 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (995)
Q Consensus 820 LDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (995)
++.++.+||+|||++....... .........++..|+|||++.+..++.++||||
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred EcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 9999999999999987321000 001112234678899999999999999999999
Q ss_pred HHHHHHHHHc--CCCCCCCCCHHHHHHHHHc-----cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 900 VGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 900 LGVILyELLT--Gr~PF~g~s~~ei~qkIl~-----~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
||+++|+|++ |..||...+.......+.. ....+...+..+++.+.+|+.+||+.||++||++.++.+.|+
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 9999999988 6789988776666554432 111222345568899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=329.40 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=210.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||.|++|.||+|.+..+|+.||+|.++.... .......+.+|+++++.++||||+++++++.....+|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999998865332 2233466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCcccccccccc
Q 001924 767 EYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~~~s~ 843 (995)
||++ ++|.+++..... +++..+..++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~---- 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI---- 155 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC----
Confidence 9995 588888765433 578888899999999999999999999999999999985 55799999999863110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........|++.|+|||++.+. .++.++||||||+++|+|++|..||...+....
T Consensus 156 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 156 -----------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred -----------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00111224578899999998764 578999999999999999999999988766555
Q ss_pred HHHHHccC-C--------------------CCCC-----CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 923 FDNILNRK-I--------------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 923 ~qkIl~~~-~--------------------~~p~-----lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
...+.... . .++. ....+++.+.+++.+||+.+|++||+ +.++++||||.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~~~~~ 289 (294)
T PLN00009 213 LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHEYFKD 289 (294)
T ss_pred HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCchHhH
Confidence 44433210 0 0000 12357888999999999999999999 778888999998
Q ss_pred ccc
Q 001924 977 KTE 979 (995)
Q Consensus 977 ~~~ 979 (995)
.+.
T Consensus 290 ~~~ 292 (294)
T PLN00009 290 LGD 292 (294)
T ss_pred Hhc
Confidence 765
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=333.77 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=215.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
...|++.+.||.|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999989999999998755444445567789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------ 166 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------ 166 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC------
Confidence 99996 577777753 4568999999999999999999999999999999999999999999999999886310
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
......|++.|+|||++. ...++.++||||||+++|||++|..||...+...
T Consensus 167 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 167 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred -------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 011245788999999984 3567889999999999999999999998877666
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
....+.....+ ...+..++..+.+||.+||..||.+||+ +.+++.||||....
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~ 274 (307)
T cd06607 222 ALYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLRER 274 (307)
T ss_pred HHHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcccC
Confidence 55544433221 1123457889999999999999999999 77778999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=324.91 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=210.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+ ..||+|+++.... ..+.+.+|+++++.++||||+++++.+. ....++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 457899999999999999999988765 4699999875332 2356889999999999999999999875 456899
Q ss_pred EEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 99999999999999753 357889999999999999999999999999999999999999999999999987421100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 157 -------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~ 211 (262)
T cd05071 157 -------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211 (262)
T ss_pred -------------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence 001112346778999999998899999999999999999999 899999887777
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+.... ..+ .+..++..+.+|+.+||+.||.+||++.++.++|+.
T Consensus 212 ~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 212 VLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred HHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 776665432 222 245788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.81 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=214.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~-------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
....++|.+.+.||+|+||.||++.+.. ++..+|+|.++... .......+.+|+++++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998643 23579999987532 234556788999999999 7999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
++...+..|+||||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997532 478888999999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIW 898 (995)
+++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred EEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 999999999999999873210000 0001112345789999999998999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 899 SLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||||++|+|++ |..||.+....+....+..... ...+..++.++.+|+.+||..+|.+||++.++++.|.-
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 99999999998 8999988887777766654432 23456789999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.69 Aligned_cols=258 Identities=22% Similarity=0.382 Sum_probs=215.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..++|++.+.||.|+||.||+|.+. .++..||+|+++... .......+.+|+.+++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3578999999999999999999874 367899999886432 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVG----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~----------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeN 817 (995)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36778889999999999999999999999999999
Q ss_pred EEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHH
Q 001924 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (995)
Q Consensus 818 ILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDI 897 (995)
|+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------------YKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------------ccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999999999998863110000 001112234667999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 898 WSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|||||++|||++ |..||.+....+....+..+... ..+..++..+.+||.+||+.||.+|||+.++...|++
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 999999999997 88999888887777776655432 2346788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=352.64 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=213.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF 756 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~T-----G~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf 756 (995)
....++|.+.+.||+|+||.||+|.+... +..||||+++... .....+.+.+|+++++++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 44567899999999999999999987433 3479999986532 2344578999999999996 99999999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhc-------------------------------------------------------
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------- 781 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~------------------------------------------------------- 781 (995)
...+.+|+||||+++|+|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999988642
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe
Q 001924 782 -----------------------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820 (995)
Q Consensus 782 -----------------------------------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL 820 (995)
..+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136777788899999999999999999999999999999
Q ss_pred ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHH
Q 001924 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900 (995)
Q Consensus 821 DenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSL 900 (995)
+.++.+||+|||+++...... .........+++.|+|||++.+..++.++|||||
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDS-------------------------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred eCCCEEEEEeCCcceeccccc-------------------------cccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 999999999999987421000 0011123457789999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 901 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 901 GVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||++|||++ |..||............+.....+ ..+..++..+.+++.+||+.||++||++.++.++|+.
T Consensus 326 Gvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 999999997 999998765544444444444332 2456789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.93 Aligned_cols=262 Identities=32% Similarity=0.563 Sum_probs=234.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+-|.|+..||-|+||.||++.++.++-..|-|+|.. ....+.+.++-|++||..+.||+||++++.|...+.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 446788899999999999999999998889998753 45678899999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||.||-+..++-.- ..+.+.++..+++|++.||+|||+++|||||||..|||++.+|.++|+|||.+.-.
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn-------- 180 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN-------- 180 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc--------
Confidence 999999998877554 46999999999999999999999999999999999999999999999999986521
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
........++.|||+|||||+.+ ..+|++++||||||++|.||..+.+|....++.
T Consensus 181 -------------------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 181 -------------------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred -------------------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 11233456789999999999974 457999999999999999999999999999999
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
.++-+|.....+-...|..++..+.||+++||.+||..||+ +.++|.||||.+.+-|.
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcch
Confidence 99999888777666678899999999999999999999999 88899999999888773
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=344.66 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=211.6
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 755 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gv 755 (995)
|....++|++.+.||.|+||.||+|.+.. +++.||+|+++... .......+..|+.++.++ +||||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 34455789999999999999999997543 45789999886432 233456788999999999 89999999998
Q ss_pred eecc-CeeEEEEeecCCCCHHHHHHhc-----------------------------------------------------
Q 001924 756 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 781 (995)
Q Consensus 756 f~~~-~~lyLVmEym~GGSL~d~L~k~----------------------------------------------------- 781 (995)
+... ..++++|||+++|+|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 7654 5688999999999999998532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCC
Q 001924 782 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853 (995)
Q Consensus 782 --------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi 853 (995)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------ 227 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 227 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc------------
Confidence 257888899999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCC
Q 001924 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 932 (995)
Q Consensus 854 ~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~ 932 (995)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.........
T Consensus 228 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 228 -------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred -------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 0011123456778999999999999999999999999999998 99999876554444444433322
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 933 ~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+..+...++++.+++.+||+.+|++||++.++++.|+.
T Consensus 295 -~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 23356788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.80 Aligned_cols=258 Identities=30% Similarity=0.532 Sum_probs=219.9
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
-|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999998999999998764322 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------- 153 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc--------
Confidence 9999999999864 4689999999999999999999999999999999999999999999999998863110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
.........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 154 -------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred -------------------chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 0011123468889999999998888999999999999999999999998877766666554
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 928 ~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
... .+..+..++..+.+++.+||+.+|.+||+ +.++++||||.+....
T Consensus 215 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 215 KNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRFAKK 262 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhhhhc
Confidence 433 23445678899999999999999999999 7778889999986554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.99 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=205.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||.|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 45789999999999999999999999999999998864322 2222345678999999999999999999887654
Q ss_pred ----eeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 761 ----NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 761 ----~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
..++||||+. ++|.+++.... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999996 58888876543 68999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
....... ..........++..|+|||++.+. .++.++||||||+++|+|++|+.||
T Consensus 168 ~~~~~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 168 AFSLSKN-----------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cccCCcc-----------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 4211000 000111234578899999998765 4688999999999999999999999
Q ss_pred CCCCHHHHHHHHHcc--CCC-----------------CCC----------CCCCCCHHHHHHHHHHhhcCccCCCCHHHH
Q 001924 915 TAESPEIIFDNILNR--KIP-----------------WPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~--~~~-----------------~p~----------lps~lS~eL~dLIkkCLq~DPeKRPSA~EI 965 (995)
.+.+.......+... ..+ .+. .+...+..+.+||.+||..||.+||| +
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t---~ 301 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID---A 301 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC---H
Confidence 887655443332221 000 000 01123567889999999999999999 7
Q ss_pred HHHHcCccc
Q 001924 966 AEVFHCKIF 974 (995)
Q Consensus 966 lEiL~HPfF 974 (995)
.++++||||
T Consensus 302 ~e~l~h~~f 310 (310)
T cd07865 302 DTALNHDFF 310 (310)
T ss_pred HHHhcCCCC
Confidence 788999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.10 Aligned_cols=257 Identities=32% Similarity=0.477 Sum_probs=210.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--CeeE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 763 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~ly 763 (995)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999998754322 22334577899999999999999999998877 7899
Q ss_pred EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 9999996 59999887643 5899999999999999999999999999999999999999999999999988731100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+...
T Consensus 160 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 160 -------------------------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred -------------------------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 01112345788999999987654 6899999999999999999999998877666
Q ss_pred HHHHHHccCC-------------------CC---------CCCCCC-CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 922 IFDNILNRKI-------------------PW---------PCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 922 i~qkIl~~~~-------------------~~---------p~lps~-lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
....+..... .+ ..++.. +++.+.+||.+||+.||++||| +.+++.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell~~~ 291 (293)
T cd07843 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDALKHP 291 (293)
T ss_pred HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHhcCC
Confidence 5554432100 00 001222 5888999999999999999999 88999999
Q ss_pred cc
Q 001924 973 IF 974 (995)
Q Consensus 973 fF 974 (995)
||
T Consensus 292 ~f 293 (293)
T cd07843 292 YF 293 (293)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.55 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=214.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..+|.+.++||+|+||.||+|... .++..+|+|.++.. .......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 467899999999999999999743 35678999987643 2345678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG---------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~---------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~ 825 (995)
..+++|||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997542 4788899999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHH
Q 001924 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905 (995)
Q Consensus 826 VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILy 905 (995)
+||+|||++....... .........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kL~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05092 161 VKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215 (280)
T ss_pred EEECCCCceeEcCCCc-------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHH
Confidence 9999999987321000 000112234578899999999999999999999999999
Q ss_pred HHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 906 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 906 ELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
||++ |.+||...........+..+.. +..+..+++.+.+||.+||+.||.+||++.++.+.|+
T Consensus 216 el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 216 EIFTYGKQPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCCCCCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 9998 9999988877777777655532 2234678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.24 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=214.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
..+|++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 79999886432 233456889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
..........++..|+|||++.+..++.++||||||+++|++++ |..||......
T Consensus 161 ------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 161 ------------------------EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred ------------------------ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 00001111234568999999999899999999999999999887 99999888777
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+.... ..+ .+..++..+.+++.+||+.+|.+||++.++.+.|..
T Consensus 217 ~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 217 DVIKAIEEGY-RLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HHHHHHhCCC-cCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 7776665542 222 345688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.17 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=211.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 688 DFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.+.||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23578999876432 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 763 YLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~------------------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
+++|||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2367888899999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIW 898 (995)
|++.++.+||+|||+++...... .........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCcc-------------------------chhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999999987421100 00111223456789999999988899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 899 SLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|||+++|||++ |..||.+..+..+...+... ..+ ..+..++..+.+|+..||+.+|.+||++.++.+.|+.
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 99999999998 99999988887777665433 222 2356788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.01 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=214.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|.+.+.||.|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45688999999999999999999976 45789999887533 23467889999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+||||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997643 68999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....
T Consensus 158 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 158 --------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred --------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 000111224568999999999899999999999999999998 99999988887
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+.... . ...+...+..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 212 ~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 212 EVLEQVERGY-R-MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 7777765542 2 1234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=358.98 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=204.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
...|.+.+.||.|+||.||++.+..+++.||||... ...+.+|++++++++|||||++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 457999999999999999999999999999999532 12357899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|+++ .++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~--- 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW--- 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc---
Confidence 9999 46898888654 469999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-------
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE------- 917 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~------- 917 (995)
.........||+.|+|||++.+..++.++|||||||+||||++|..|+...
T Consensus 315 ----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~ 372 (461)
T PHA03211 315 ----------------------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372 (461)
T ss_pred ----------------------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC
Confidence 001112357999999999999999999999999999999999987654321
Q ss_pred -CHHHHHHHHHccCCC---CCC----------------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHH
Q 001924 918 -SPEIIFDNILNRKIP---WPC----------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (995)
Q Consensus 918 -s~~ei~qkIl~~~~~---~p~----------------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EI 965 (995)
....+...+...... ++. ....++..+.+||.+||+.||.+||| +
T Consensus 373 ~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs---a 449 (461)
T PHA03211 373 PYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS---A 449 (461)
T ss_pred CcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC---H
Confidence 122233222221111 100 00134568899999999999999999 8
Q ss_pred HHHHcCcccccc
Q 001924 966 AEVFHCKIFIKK 977 (995)
Q Consensus 966 lEiL~HPfF~~~ 977 (995)
.++|+||||+.+
T Consensus 450 ~elL~hp~f~~~ 461 (461)
T PHA03211 450 AELLRLPLFQSK 461 (461)
T ss_pred HHHhhCcccCCC
Confidence 999999999764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.37 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=208.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~----VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..+|++.+.||+|+||+||+|.+..++.. +++|.+... ........+..|+.+++.+.||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 46899999999999999999999877774 666665421 12334567788888999999999999999875 456
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.++++||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 78999999999999999754 56899999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
. .........++..|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 163 ~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 163 D-------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred C-------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 0 0011123457788999999999899999999999999999998 9999998877
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
......+..+.. +..+..++..+.+++.+||..||++|||+.++.+.|.
T Consensus 218 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 218 HEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred HHHHHHHHCCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 666555543332 2234567889999999999999999999998888664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=328.10 Aligned_cols=266 Identities=40% Similarity=0.741 Sum_probs=218.2
Q ss_pred CeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 688 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIR-KNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~s-e~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
+|++.+.||.|+||.||+|.+. .+|..||+|+++...... ....+.+.+|+.++..+ +|+||+.+++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 478999999987543322 22346678899999999 589999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCC--
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAES-- 918 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILyELLTGr~PF~g~s-- 918 (995)
.........|+..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 159 ------------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred ------------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 00112235689999999998753 46789999999999999999999997432
Q ss_pred --HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 919 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 919 --~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
...+...+.....+ .+..+++.+.+|+.+||+.||.+||+. ..+.+++.||||+...|...
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 215 NSQAEISRRILKSEPP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred ccHHHHHHHhhccCCC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 23344444433332 346688999999999999999999842 35899999999999987443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=366.08 Aligned_cols=300 Identities=42% Similarity=0.674 Sum_probs=245.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
.+.-+-|..++.||-|+||.|.+++..+|...||+|.+++.+...+.....+..|..||....++-||+||..|++.+++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 34556799999999999999999999999999999999999988888899999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||+|++||++..+|.+.+.|++..+++++.++..|+++.|.+|+|||||||+|||||.+|++||.|||||.-..=.+.
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999862211111
Q ss_pred ccCCCCCCCCCCCCCCCCCcccc---------------ccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQ---------------TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~---------------~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
..+++...+.--.+-....+|.. .........+||+.|+|||++....|+...|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 11222111100000000011111 011123356899999999999999999999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHccCCCCCCC--CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 908 ITGIPPFTAESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 908 LTGr~PF~g~s~~ei~qkIl~~~~~~p~l--ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
+.|++||-..++.+...++++.... ..+ ..+++.++.+||.++++ +++.|+.-..+-++..||||+.++|..+.-
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~-l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRk 941 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNF-LHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRK 941 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhc-cccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhh
Confidence 9999999888877766665543322 111 25789999999998765 889999988888999999999999876443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.16 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=211.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
+..++|++.+.||.|+||.||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++. .+.++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 44578999999999999999999865 57889999887533 23467889999999999999999998864 45689
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++|||+++|+|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-
Confidence 999999999999998653 35888999999999999999999999999999999999999999999999998641100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 156 -------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred -------------------------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 0001112345778999999998889999999999999999998 99999988877
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+.... . +..+...+.++.+++.+||..+|++||++.++..+|+
T Consensus 211 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 211 EVIQNLERGY-R-MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 7766654432 2 2244678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.42 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=209.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|.+...||.|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. ....++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 346799999999999999999988754 469999876432 23456889999999999999999998875 456899
Q ss_pred EEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 99999999999999754 347888999999999999999999999999999999999999999999999987421100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 157 -------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 157 -------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred -------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 001112235678999999998899999999999999999999 999999888777
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
....+.... . +..+...+..+.+|+.+||..||.+||++.++.+.|+
T Consensus 212 ~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 212 VLEQVERGY-R-MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HHHHHHcCC-C-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 776665432 2 2234678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.29 Aligned_cols=266 Identities=28% Similarity=0.446 Sum_probs=230.9
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---L-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 755 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~-VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gv 755 (995)
..|....++..+.++||+|+||.||+|..+..+. . ||+|..+...........++++|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456667888888999999999999999876433 3 89998886555667889999999999999999999999999
Q ss_pred eeccCeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 756 FTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 756 f~~~~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
+.....+++|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999999876 4999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~P 913 (995)
+... .+... .....-+..|+|||.+....|++++|||||||++||+++ |..|
T Consensus 310 ~~~~-----------------------~~~~~----~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~P 362 (474)
T KOG0194|consen 310 RAGS-----------------------QYVMK----KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEP 362 (474)
T ss_pred cCCc-----------------------ceeec----cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCC
Confidence 8411 00110 101135678999999999999999999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
|.+....++...|....++++ .+...+..+..++.+||..||+.||++.++.+.++...
T Consensus 363 y~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 363 YPGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred CCCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 999999999999988777655 35578889999999999999999999999888776543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.66 Aligned_cols=251 Identities=30% Similarity=0.474 Sum_probs=203.5
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeecc--CeeEEE
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DNLYLV 765 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~--~~lyLV 765 (995)
|++.+.||.|+||.||+|.+..++..||+|.++.... ........+|+.++.++. |||++++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999875321 122234567888888885 99999999999987 889999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||++ |+|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 99996 5888888653 56899999999999999999999999999999999999999 9999999999873110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
........+++.|+|||++.. ..++.++|||||||++|||++|..||.+.+..+..
T Consensus 152 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 152 -----------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred -----------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 001112357889999998754 45688999999999999999999999887765554
Q ss_pred HHHHccC------------------CCCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~------------------~~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+.... ..++. ....++..+.+||.+||..+|.+||+ +.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 4433210 11111 11356889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.10 Aligned_cols=254 Identities=30% Similarity=0.504 Sum_probs=208.7
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|++.+.||.|++|.||+|.+..+|..||+|++.... ........+.+|+.+++.++|||++++++++...+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987533 2223345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 769 LNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 769 m~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
++ ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 95 69999997765 6899999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........+++.|+|||++.+. .++.++||||||+++|+|++|++||...+.......
T Consensus 153 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 153 ---------------------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ---------------------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011223568899999988664 568899999999999999999999987766444333
Q ss_pred HHccCC--------------------------CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 926 ILNRKI--------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 926 Il~~~~--------------------------~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..... ........++..+.++|.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 322100 001123467789999999999999999999 7888999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=328.26 Aligned_cols=263 Identities=25% Similarity=0.428 Sum_probs=210.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLV 765 (995)
++|...+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.++.++. ||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 467778899999999999999999999999998875332 245667889999999996 99999999999998899999
Q ss_pred EeecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 766 MEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 766 mEym~GGSL~d~L~-----k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
|||+. ++|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99985 46655432 235689999999999999999999975 999999999999999999999999999863110
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC---CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
........|++.|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 161 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 161 ----------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred ----------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 0111233588999999999776 689999999999999999999999976
Q ss_pred CCH-HHHHHHHHccCCCCC--CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 917 ESP-EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 917 ~s~-~ei~qkIl~~~~~~p--~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
... .+....+.....+.. ..+..++..+.+||.+||+.||.+||| +.+++.||||....+..+-
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~~ 279 (288)
T cd06616 213 WNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNVD 279 (288)
T ss_pred cchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcchh
Confidence 542 122223222221111 112357899999999999999999999 7899999999987765543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=340.69 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=208.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4588999999999999999999999999999999986432 22334567788999999999999999999886443
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..|+||||+. ++|.+.+... ++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 4799999995 5888888654 8999999999999999999999999999999999999999999999999987411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred C----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 0 001123468899999999999999999999999999999999999998776
Q ss_pred HHHHHHHHHccC----------------------C-----C---------CCC----CCCCCCHHHHHHHHHHhhcCccC
Q 001924 919 PEIIFDNILNRK----------------------I-----P---------WPC----VPSDMSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 919 ~~ei~qkIl~~~----------------------~-----~---------~p~----lps~lS~eL~dLIkkCLq~DPeK 958 (995)
....+..+.... . . ++. .+...+..+.+||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 544443332210 0 0 000 01234667899999999999999
Q ss_pred CCCHHHHHHHHcCccccc
Q 001924 959 RLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~~ 976 (995)
||| +.++|.||||..
T Consensus 302 R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 302 RIS---VDDALQHPYINV 316 (353)
T ss_pred CcC---HHHHhcChhHhh
Confidence 999 888899998873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.35 Aligned_cols=268 Identities=26% Similarity=0.348 Sum_probs=213.2
Q ss_pred CCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEE
Q 001924 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 752 (995)
Q Consensus 673 ~tp~~s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL 752 (995)
....++..+...++++|.....||+|+||.||+|.... |..||||.+....... ..+|.+|+.++.+++|||+|++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccE
Confidence 34456677788899999999999999999999999764 5899999776533211 4459999999999999999999
Q ss_pred eeeeeccC-eeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---ceeeecCCCcEEeccCCcE
Q 001924 753 FYSFTCRD-NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 753 ~gvf~~~~-~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~G---IIHRDLKPeNILLDenG~V 826 (995)
+|+|.+.+ ..+||+|||++|+|.++|.... .++|..+..|+.++|+||+|||+.. ||||||||+|||+|++.++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999998 5999999999999999998654 7999999999999999999999864 9999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCC-CCCCcccChhhhcCCCCCchHHHHHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILF 905 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~-vGTp~YmAPEvL~g~~ys~KSDIWSLGVILy 905 (995)
||+|||+|+..... .....+. .||.+|+|||++..+..+.|+|||||||+|+
T Consensus 217 KlsDFGLa~~~~~~---------------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvll 269 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEG---------------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLL 269 (361)
T ss_pred EccCccCcccCCcc---------------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHH
Confidence 99999999742210 0000111 7999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC---H---HHHHHHHHccC-CC---CCCCC-CCCC--HH---HHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 906 EFITGIPPFTAES---P---EIIFDNILNRK-IP---WPCVP-SDMS--FE---AQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 906 ELLTGr~PF~g~s---~---~ei~qkIl~~~-~~---~p~lp-s~lS--~e---L~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
||++|+.|.+... . .+.....+... .. -+.+. ...+ .. +..+..+|++.+|.+||++.++.+.|
T Consensus 270 Elitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 270 ELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 9999998887432 1 11111222221 11 01111 2222 22 55678899999999999999999988
Q ss_pred cC
Q 001924 970 HC 971 (995)
Q Consensus 970 ~H 971 (995)
+.
T Consensus 350 ~~ 351 (361)
T KOG1187|consen 350 EG 351 (361)
T ss_pred Hh
Confidence 44
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.78 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=200.1
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecC
Q 001924 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~--TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999997533 34578888765322 23445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 771 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 771 GGSL~d~L~k~~-----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
+|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 999999997643 245777889999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-------~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
........+++.|+|||++.. ..++.++|||||||++|||++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 001123346778999999743 356889999999999999999 88999888
Q ss_pred CHHHHHHHHHccC-CC--CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRK-IP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~-~~--~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+....+.... .. .+..+..++..+.+++..|| .||.+||++.++.++|.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLTY 269 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhcC
Confidence 7766665554432 22 23345578889999999999 599999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.84 Aligned_cols=252 Identities=29% Similarity=0.512 Sum_probs=219.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+|++.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999875433 33456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 768 YLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 768 ym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|+++++|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999865 356899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 112245788999999999999999999999999999999999999988887776
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+..... +..+...+.++.+++.+||..+|.+||+ +.++++||+.
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGKY--PPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHhcCCC--CCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 66655443 3445678899999999999999999999 7888999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=365.18 Aligned_cols=253 Identities=31% Similarity=0.491 Sum_probs=212.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-----CceEEEeeeeeccC
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N-----PFVVRFFYSFTCRD 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-H-----PNIVkL~gvf~~~~ 760 (995)
.+|.+.+.||+|+||.|.+|.+..|++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3899999999999999999999999999999999863 345667788999999987 4 38999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC--cEEEEecCCccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKI 836 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG--~VKLsDFGLArv 836 (995)
++|||+|.+ ..+|+++++.+ ..++...++.++.||+.||.+||+.||||+||||+||||...+ .|||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 55999999865 3589999999999999999999999999999999999997654 799999999984
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
.. ....+.+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+
T Consensus 341 ~~------------------------------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ES------------------------------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cC------------------------------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 11 111245567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHccCCC---------------------CCC----------------------------CC----------
Q 001924 917 ESPEIIFDNILNRKIP---------------------WPC----------------------------VP---------- 937 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~---------------------~p~----------------------------lp---------- 937 (995)
.+..+.+..|+.-... ++. .|
T Consensus 391 ~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~ 470 (586)
T KOG0667|consen 391 DNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGL 470 (586)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhc
Confidence 9887776665431100 000 11
Q ss_pred -CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 938 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 938 -s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..-...+.+||++||.+||.+|+| ..+.|+||||.+.
T Consensus 471 ~~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 471 PKADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGT 508 (586)
T ss_pred ccccHHHHHHHHHHHhccCchhcCC---HHHHhcCcccccc
Confidence 011235789999999999999999 8888999999954
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=322.59 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=204.5
Q ss_pred eeccCCCeEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecC
Q 001924 694 PISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~--~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 68999999999999988776 4688877632 2334556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 771 GGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 771 GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
+|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997532 4788899999999999999999999999999999999999999999999987
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~P 913 (995)
.... . .........+..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 160 ~~~~---~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 160 RGQE---V-------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccc---h-------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 5200 0 000111234567999999998899999999999999999997 9999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|.+.+....+..+.... . ...+..++..+.+|+.+||..||.+|||+.+++..|+
T Consensus 212 f~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 212 YCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred ccccCHHHHHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 98888777777665432 2 2234568899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.03 Aligned_cols=261 Identities=22% Similarity=0.363 Sum_probs=215.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 756 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf 756 (995)
....++|.+.+.||+|+||.||++.+ ..++..||+|+++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 44557899999999999999999975 3345689999887532 233456789999999999 799999999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
...+.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997543 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~P 913 (995)
+...... .........++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 189 ~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 189 RDIMNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred ccccCCC-------------------------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 7321000 0001112346788999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|........+.......... ..+...+..+.+|+.+||..+|++||++.+++..|..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 244 YPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 98877665555555444332 2345678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.27 Aligned_cols=250 Identities=31% Similarity=0.529 Sum_probs=202.5
Q ss_pred CCCeEEEEee--ccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeeccCee
Q 001924 686 IDDFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~L--G~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~-LkHPNIVkL~gvf~~~~~l 762 (995)
.++|++.+.+ |.|+||.||++..+.++..+|+|++...... . .|+.+... .+||||+++++++...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-A-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-h-------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3566676666 9999999999999999999999998753221 1 12222222 2799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~~~ 841 (995)
|+||||+++|+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~--- 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--- 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC---
Confidence 99999999999999998877899999999999999999999999999999999999999998 99999999886310
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 162 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 162 ----------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ----------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 0112358899999999999999999999999999999999999998654332
Q ss_pred H-HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 922 I-FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 922 i-~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
. ...+..........+..+++.+.+||.+||+.||.+||+. +.++|+||||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 2 1111111111222345789999999999999999999962 688999999974
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.41 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=209.5
Q ss_pred EeeccCCCeEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeec
Q 001924 693 KPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~-TG~--~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
+.||.|+||.||+|.+.. .+. .||+|.+...... .....+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999998764432 556789999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 770 NGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 770 ~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
++|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~------ 151 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE------ 151 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc------
Confidence 9999999997654 68999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkI 926 (995)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 152 ----------~~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 152 ----------DH--------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred ----------cc--------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 00 001113457789999999999999999999999999999998 99999888887777766
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
......+ ..+...+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 214 DKEGERL-ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HhcCCcC-CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 6433332 234568899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.36 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=215.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~-------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
....++|.+.+.||+|+||.||+|.+.. ....+|+|.++... .......+.+|+.+++.+ .||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4455789999999999999999998632 34579999887432 234466788999999999 6999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
++.....+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 2478888899999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIW 898 (995)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred EEcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchhh
Confidence 999999999999999874210000 0001112245679999999998999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 899 SLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|||+++|+|++ |..||........+..+..... ...+..++..+.+|+.+||..||++||++.++++.|..
T Consensus 221 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 99999999999 9999998888887777665432 23456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.76 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=214.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
..+|++.+.||+|+||.||+|.+..+++ .||||+++.. ........+..|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999887665 6999998653 2344567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++|+|.+++... +.++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999753 468999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
. ... ........++..|+|||++.+..++.++||||||+++|||++ |..||...+..
T Consensus 161 ~-----------------~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 161 S-----------------DPT-----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred c-----------------ccc-----cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 0 000 000001112467999999999999999999999999999886 99999988877
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+... ..++ .+..++..+.+++.+||+.+|.+||++.++...|+
T Consensus 219 ~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 219 DVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred HHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 777766433 2322 24578899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.35 Aligned_cols=269 Identities=26% Similarity=0.407 Sum_probs=226.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|+..+.||+|+||.||+|.+..++..||+|.+.............+.+|+++++.++|||++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44888999999999999999999999999999987654444455678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||++ |+|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 9996 588777754 4568999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
......|++.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 011245888999999984 45688999999999999999999999988777666
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHh
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIE 991 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e 991 (995)
...+........ .....+..+.+|+.+||+.+|.+||+ +.++++|+|+.....+.+.++...+++
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~~~~~~~~~~~ 297 (317)
T cd06635 233 LYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLRERPETVLIDLIQRTK 297 (317)
T ss_pred HHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhccCcccchhhHHHHHH
Confidence 666665543322 23467889999999999999999999 788899999998888887766555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=328.62 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=215.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k-------~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
.....+|.+.+.||+|+||.||+|.+. .++..||+|.++.. ........+.+|+.+++.+ .||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 345688999999999999999999753 23457999988643 2234567789999999999 8999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
++......|+||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999753 2367788889999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 898 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIW 898 (995)
+++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-------------------------cccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 999999999999999874210000 0011123466789999999998999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 899 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 899 SLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||+++|+|++ |..||.+.+..++...+..... ...+..++..+.+|+.+||..+|.+||++.++++.|+
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 99999999998 8999998888888777654432 2335678999999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=375.39 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=227.9
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~g 754 (995)
........+....+.||+|.||+||+|.... +...||||.++... +.....+|.+|++++..++|||||+++|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 4445667888999999999999999998532 34589999988643 3446789999999999999999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~--------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL 820 (995)
+|...+..++|+|||..|+|..||.... .++..+...|+.||+.||.||-++.++||||...|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9999999999999999999999996421 27788899999999999999999999999999999999
Q ss_pred ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHH
Q 001924 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900 (995)
Q Consensus 821 DenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSL 900 (995)
.++..|||+||||++-....+++.. .....-+.+|||||.+++++|+.+||||||
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~-------------------------~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKV-------------------------RGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcc-------------------------cCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 9999999999999984322222111 111234679999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 901 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 901 GVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||+|||+++ |+.||.+.+.+++.+.|.+++. + ..|.++|.++.+||..||+.+|.+||+..+|-.+|++
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-L-SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc-c-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 999999999 9999999999999999988887 3 3578999999999999999999999999999998875
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.65 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=211.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
..+|++.+.||.|+||.||+|.+. .+..+|+|.++.... ....+.+|+++++.+.|||++++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999886 477899998865322 235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++++|.+++... +.+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence 9999999999999754 468999999999999999999999999999999999999999999999999887311000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
........++..|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 155 -----------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 211 (256)
T cd05112 155 -----------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 000112235678999999998899999999999999999998 99999988877777
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
..+..+... ..+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 212 ETINAGFRL--YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHhCCCCC--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 776554322 22455789999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.07 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=215.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~T-----G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
++|++.+.||.|+||.||+|+.+.+ ...|++|.+.... .......+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 6899999999999999999997543 4689999875422 22345778999999999999999999999999899
Q ss_pred eEEEEeecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecC
Q 001924 762 LYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~---------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFG 832 (995)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999997655 68999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr 911 (995)
++...... .........+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 163 ~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 163 LSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred cccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 88631100 0011123356778999999988888999999999999999998 88
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.||...........+..+...++. +..++..+.+++.+||..+|.+||++.+++..|+
T Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 217 LPFYGLSDEEVLNRLQAGKLELPV-PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCccccchHHHHHHHHcCCcCCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 999887777777777666655442 4568899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=339.28 Aligned_cols=267 Identities=28% Similarity=0.411 Sum_probs=213.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec----cCee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~----~~~l 762 (995)
++|++.+.||.|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 78999999999999999999999999999999987532 222345677889999999999999999988763 3468
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+. |+|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 69999998777799999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
..........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+...
T Consensus 163 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 163 -----------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred -----------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 01111223468999999999866 458899999999999999999999998765443
Q ss_pred HHHHHHcc-----------------------C-----CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 922 IFDNILNR-----------------------K-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 922 i~qkIl~~-----------------------~-----~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
....+... . .++.......+..+.++|.+||+.+|.+||+ +.+++.|||
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~ 296 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQHPF 296 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHhChh
Confidence 32222110 0 0011112457899999999999999999999 778999999
Q ss_pred cccccccc
Q 001924 974 FIKKTENC 981 (995)
Q Consensus 974 F~~~~~n~ 981 (995)
|.+.....
T Consensus 297 ~~~~~~~~ 304 (334)
T cd07855 297 LAQYHDPD 304 (334)
T ss_pred hhhccCCc
Confidence 98665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.62 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=207.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 750 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~----------------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIV 750 (995)
++|++.+.||+|+||.||++.+.. ++..||+|+++... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986542 34479999886432 234456889999999999999999
Q ss_pred EEeeeeeccCeeEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEE
Q 001924 751 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (995)
Q Consensus 751 kL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~-----------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNIL 819 (995)
++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999997542 3567789999999999999999999999999999999
Q ss_pred eccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHH
Q 001924 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (995)
Q Consensus 820 LDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (995)
++.++.++|+|||+++....... ........+++.|+|||+..+..++.++||||
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS 217 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence 99999999999999873210000 00111234567899999998888999999999
Q ss_pred HHHHHHHHHc--CCCCCCCCCHHHHHHHHHc-----cCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 900 VGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 900 LGVILyELLT--Gr~PF~g~s~~ei~qkIl~-----~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||++|||++ |..||...+..+....... ........+..++..+.+|+.+||+.||.+||++.++.+.|+
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9999999998 7899987766555443321 111112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.45 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=204.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--CeeE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 763 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~--TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~ly 763 (995)
.|++.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999998864322233456778899999999999999999999988 7899
Q ss_pred EEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc----CCcEEEEecCCc
Q 001924 764 LVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLS 834 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~-----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe----nG~VKLsDFGLA 834 (995)
+||||+++ +|.+++... ..+++..++.++.|++.||+|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 777776432 26889999999999999999999999999999999999999 899999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~P 913 (995)
....... ..........+|+.|+|||++.+. .++.++||||||+++|+|++|+.|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPL------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCc------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 7421100 001122335688999999998764 578999999999999999999999
Q ss_pred CCCCCHHH---------HHHHHHc--------------------------cCCCCCC--------CCCCCCHHHHHHHHH
Q 001924 914 FTAESPEI---------IFDNILN--------------------------RKIPWPC--------VPSDMSFEAQDLINR 950 (995)
Q Consensus 914 F~g~s~~e---------i~qkIl~--------------------------~~~~~p~--------lps~lS~eL~dLIkk 950 (995)
|.+..... .+..++. ....++. .....+..+.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97654321 1111100 0000110 001566789999999
Q ss_pred HhhcCccCCCCHHHHHHHHcCccc
Q 001924 951 FLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 951 CLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
||+.||++||| +.+++.||||
T Consensus 296 ~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=378.60 Aligned_cols=263 Identities=30% Similarity=0.522 Sum_probs=215.3
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 759 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-- 759 (995)
.....++|.+++.||.|+||+||+|.+..++..||+|++.... ........+..|+.+++.++|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3456689999999999999999999999999999999987543 2344567889999999999999999999988653
Q ss_pred CeeEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-------CceeeecCCCcEEecc------
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL-------GIVHRDLKPDNLLIAH------ 822 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~-------GIIHRDLKPeNILLDe------ 822 (995)
..+||||||+++|+|.++|... ..+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998652 5699999999999999999999985 4999999999999964
Q ss_pred -----------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--C
Q 001924 823 -----------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--T 889 (995)
Q Consensus 823 -----------nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~ 889 (995)
.+.+||+|||++..... ........||+.|+|||++.+ .
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~----------------------------~s~~~s~vGTp~YmAPEvL~ge~~ 218 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI----------------------------ESMAHSCVGTPYYWSPELLLHETK 218 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc----------------------------cccccccCCCccccCHHHHhccCC
Confidence 23599999999873110 011123579999999999965 4
Q ss_pred CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 890 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 890 ~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
.++.++||||||||||+|++|..||........+...+......+ ....+..+.+||..||..+|.+||+ +.++|
T Consensus 219 ~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPS---a~QlL 293 (1021)
T PTZ00266 219 SYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPS---ALQCL 293 (1021)
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcC---HHHHh
Confidence 588999999999999999999999986654443333333333222 2457899999999999999999999 77888
Q ss_pred cCccccccc
Q 001924 970 HCKIFIKKT 978 (995)
Q Consensus 970 ~HPfF~~~~ 978 (995)
.|+||....
T Consensus 294 ~h~~ik~i~ 302 (1021)
T PTZ00266 294 GYQIIKNVG 302 (1021)
T ss_pred ccHHHhhcC
Confidence 999998654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.25 Aligned_cols=257 Identities=20% Similarity=0.326 Sum_probs=213.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-c
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-~ 759 (995)
..++|++.+.||+|+||.||+|.+.. ++..|++|.++.. ........+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 45789999999999999999999876 3578999987642 234556788999999999999999999998766 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~--------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
...+++++|+++|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 6789999999999999998653 35889999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-C
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-G 910 (995)
|+++....... + .......++..|+|||++.+..++.++||||||+++||+++ |
T Consensus 162 g~~~~~~~~~~----------------~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g 216 (280)
T cd05043 162 ALSRDLFPMDY----------------H---------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLG 216 (280)
T ss_pred CCcccccCCce----------------E---------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCC
Confidence 99873211100 0 00112245678999999999899999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+.||....+..+...+... ..++ .+..+++.+.+++.+||..||++|||+.++++.|+
T Consensus 217 ~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 217 QTPYVEIDPFEMAAYLKDG-YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred CCCcCcCCHHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 9999988877766655443 2222 34567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=364.02 Aligned_cols=262 Identities=19% Similarity=0.315 Sum_probs=220.0
Q ss_pred CccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 679 ~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
...|.+..+++.+...||+|.||+||+|.|.. .||||++..... ..+..+.|.+|+.++++-+|.||+-+.|++..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 36777888999999999999999999999973 599999987554 44578999999999999999999999999988
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
... .||+.+|+|.+|+.+|+-. ..|.....+.|++||++||.|||.++|||||||..||++.+++.|||+|||++.+.
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 776 9999999999999999743 45899999999999999999999999999999999999999999999999998751
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
. .+ ..........|...|||||+++- .+|++.+||||||+++|||++|..||
T Consensus 539 ~--------------~w-----------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 T--------------RW-----------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred e--------------ee-----------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 1 11 11122233458899999999964 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHccC--CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 915 TAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~--~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....++++-.+-.+. .+......+++.++++|+..||.+++++||...++++.|.
T Consensus 594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 9766666655544331 2222345678889999999999999999999998888443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.68 Aligned_cols=264 Identities=28% Similarity=0.471 Sum_probs=209.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----- 760 (995)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 478999999999999999999999999999999986422 2334567889999999999999999998765443
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+|+|+||+. ++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5799999996 588888754 46999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
. ..........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 160 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred c------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 00011223568999999998765 4689999999999999999999999977654
Q ss_pred HHHHHHHHc---------------cC-------C------CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILN---------------RK-------I------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~---------------~~-------~------~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
......+.. .. . ++....+..+.++.+||.+||+.||++||| +.++++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHhcC
Confidence 332222111 00 0 000012346788999999999999999999 7899999
Q ss_pred ccccccccc
Q 001924 972 KIFIKKTEN 980 (995)
Q Consensus 972 PfF~~~~~n 980 (995)
|||......
T Consensus 293 p~~~~~~~~ 301 (336)
T cd07849 293 PYLEQYHDP 301 (336)
T ss_pred ccccccCCC
Confidence 999887654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=313.68 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=213.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG----~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
+++.+.||.|+||.||++.+..++ ..||+|+++.... ......+.+|+.++..+.||||+++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 8999999865432 2256788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+|||+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 89999999999999999999999999999999999999999999999999874211100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
+ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+...
T Consensus 159 -----------------~---------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 -----------------Y---------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred -----------------c---------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0 0001226789999999988889999999999999999998 899999888888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
....+...... ..+...+..+.+++.+||..||.+|||+.++++.|
T Consensus 213 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 VLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 88777665432 33466899999999999999999999988887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.08 Aligned_cols=247 Identities=24% Similarity=0.349 Sum_probs=205.8
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||.|+||.||+|... ++..||+|+++... .......+.+|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999886532 2334457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 773 SL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---------- 147 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc----------
Confidence 999998753 457899999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~ 930 (995)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+....
T Consensus 148 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 148 ----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred ----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 000112234678999999998889999999999999999998 999999887777666655432
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 931 ~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
. ...+..++..+.+|+.+||+.+|++||++.++.+.|.
T Consensus 212 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 -R-MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2 2345678899999999999999999999999887663
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=319.98 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=214.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..+|++.+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4789999999999999999999877765 58999876543 23455778899999999999999999999887 78
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 89999999999999999764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
.. . .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 163 ~~----------------~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 163 EK----------------E---------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred cc----------------c---------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 00 0 00111224678999999988889999999999999999998 9999999888
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.++...+..+.. ...+...+..+.+++.+||..||.+||++.++.+.|..
T Consensus 218 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 218 VEIPDLLEKGER--LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred HHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 887777665432 22345678899999999999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.38 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=211.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
...+|.+.+.||.|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999997654 3478999876432 23455688999999999999999999998875 45
Q ss_pred eEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997643 5899999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
. ........+++.|+|||.+.+..++.++||||||+++|||++ |..||...+.
T Consensus 161 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 161 S--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred c--------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 0 000112234578999999988889999999999999999986 9999998887
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.+....+..+.. +..+..++..+.++|.+||..+|.+|||+.++.+.|..
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 215 NDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred HHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 777666654432 23456789999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.49 Aligned_cols=253 Identities=32% Similarity=0.502 Sum_probs=206.8
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeeccCe----
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDN---- 761 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L---kHPNIVkL~gvf~~~~~---- 761 (995)
|++.+.||.|+||.||+|.++.++..||+|+++.... .......+.+|+.+++++ .|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998999999999875332 222334566788777665 59999999999988776
Q ss_pred -eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 762 -LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 762 -lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
++++|||++ ++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 48999887643 58999999999999999999999999999999999999999999999999886411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
. ........++..|+|||++.+..++.++||||||+++|+|++|.+||.+.+
T Consensus 159 ~----------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 F----------------------------EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred C----------------------------CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 0 001112347889999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHccCC-----CCC-----------C--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 919 PEIIFDNILNRKI-----PWP-----------C--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 919 ~~ei~qkIl~~~~-----~~p-----------~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..+.+..+..... .++ . ....++..+.++|.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcCcCC
Confidence 7766665543110 000 0 11235678899999999999999999 7788999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.31 Aligned_cols=255 Identities=34% Similarity=0.567 Sum_probs=209.2
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--CeeEEEE
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLVM 766 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~lyLVm 766 (995)
|++.+.||.|+||.||+|.+..++..+|+|.++... ........+.+|+.+++.++|||++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998643 2233456788999999999999999999999988 7899999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99974 899888665 578999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 155 ----------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred ----------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 001122356789999998765 457899999999999999999999998877665555
Q ss_pred HHHccCC-----CCCC----------------------CCCC-CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKI-----PWPC----------------------VPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~-----~~p~----------------------lps~-lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..... .|+. .... ++..+.+++.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~~ 287 (287)
T cd07840 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEYF 287 (287)
T ss_pred HHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcCC
Confidence 5443110 0110 0012 3889999999999999999999 7889999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=330.65 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=216.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 752 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~T-------G~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL 752 (995)
.+.....+|++.+.||+|+||.||+|.+... +..||+|+++.. ........+.+|+++++++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3444556899999999999999999986432 237899987642 2334567889999999999 79999999
Q ss_pred eeeeeccCeeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCC
Q 001924 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (995)
Q Consensus 753 ~gvf~~~~~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPe 816 (995)
++++...+.++++|||+++|+|.+++.... .++...+..++.|++.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 3677888889999999999999999999999999
Q ss_pred cEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHH
Q 001924 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (995)
Q Consensus 817 NILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSD 896 (995)
|||++.++.+||+|||+++....... ........++..|+|||++.+..++.++|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchhh
Confidence 99999999999999999874210000 00111223456899999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 897 IWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
|||||+++|||++ |..||.+.+....+..+..... +..+..++..+.+|+.+||+.+|.+||++.++++.|+.-.
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 9999999999998 8999999888887777655432 2335678899999999999999999999999998886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.02 Aligned_cols=269 Identities=29% Similarity=0.439 Sum_probs=208.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.++||||+++++++....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999998865332 1222345678999999999999999998875433
Q ss_pred ----eeEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 761 ----NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 761 ----~lyLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
.+++||||+.+ +|...+.. ...+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 46999999964 77777754 3479999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
.......... ..............|++.|+|||++.+. .++.++||||||+++|+|++|++||
T Consensus 164 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPNPK----------------GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcccc----------------cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 4211110000 0000011122345688999999998664 5789999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCC-----CC---------------CC-------CCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 915 TAESPEIIFDNILNRKIP-----WP---------------CV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~-----~p---------------~l-------ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
.+.+.......+...... ++ .. ....+..+.+||.+||+.||.+||| +.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~e 304 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---ASD 304 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---HHH
Confidence 887776555544331100 00 00 1234567889999999999999999 889
Q ss_pred HHcCccc
Q 001924 968 VFHCKIF 974 (995)
Q Consensus 968 iL~HPfF 974 (995)
++.||||
T Consensus 305 ll~~~~f 311 (311)
T cd07866 305 ALEHPYF 311 (311)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.39 Aligned_cols=261 Identities=29% Similarity=0.429 Sum_probs=212.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----- 760 (995)
.++|.+.+.||.|+||.||+|.+..++..||||.++... ........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 468999999999999999999999999999999987532 22334567788999999999999999999876543
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 4799999995 699999988788999999999999999999999999999999999999999999999999998741100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.
T Consensus 162 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 162 ---------------------------GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred ---------------------------cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 011123457889999999865 4688999999999999999999999987654
Q ss_pred HHHHHHHHcc----------------------------CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~----------------------------~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
......+... ...+......+++.+.+||.+||+.+|++||| +.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell~h 291 (337)
T cd07858 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEALAH 291 (337)
T ss_pred HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHHcC
Confidence 3322222110 00001123467899999999999999999999 8999999
Q ss_pred ccccccc
Q 001924 972 KIFIKKT 978 (995)
Q Consensus 972 PfF~~~~ 978 (995)
|||....
T Consensus 292 ~~~~~~~ 298 (337)
T cd07858 292 PYLASLH 298 (337)
T ss_pred cchhhhc
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=315.95 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=208.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.+++.++|||++++++++... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346799999999999999999864 6889999988642 2345788999999999999999999998764 4799
Q ss_pred EEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997543 478889999999999999999999999999999999999999999999998873110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+...
T Consensus 153 ---------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 153 ---------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ---------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 0011223567999999998899999999999999999997 999999888877
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+..+. . +..+..++..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 206 ~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 VKECVEKGY-R-MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 766665442 2 22346788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=327.33 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=217.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|...+.||+|+||.||+|.+..+|..|++|++.............+.+|+.+++.++|||++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998765444445567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+. |+|.+++.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---------- 171 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---------- 171 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc----------
Confidence 95 578887764 356899999999999999999999999999999999999999999999999987520
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.......|+..|+|||++. +..++.++||||||+++|+|++|..||..........
T Consensus 172 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 172 ---------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred ---------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 0112346889999999984 3567889999999999999999999998877666555
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
.+.....+. .....++..+.+|+.+||+.+|.+||+ +.++++||||...+...+.
T Consensus 231 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~~~~~~ 285 (313)
T cd06633 231 HIAQNDSPT-LQSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDRPARVL 285 (313)
T ss_pred HHHhcCCCC-CCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCchhHHH
Confidence 554443221 123457788999999999999999999 8899999999987655544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=315.45 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=203.4
Q ss_pred EeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee-ccCeeEEEEee
Q 001924 693 KPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLYLVMEY 768 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~---TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~-~~~~lyLVmEy 768 (995)
+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 34579999875322 2345678889999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+++|+|.+++... ..++...+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~----- 153 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY----- 153 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc-----
Confidence 9999999999764 3467777888899999999999999999999999999999999999999999873211000
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkI 926 (995)
..........+++.|+|||.+.+..++.++||||||+++|||++ |.+||...+.......+
T Consensus 154 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 154 ------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred ------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 00011122346778999999998899999999999999999999 57788877777766666
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
..+.. +..+..++..+.+++.+||..+|++||++.+++..|+..|
T Consensus 216 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 LQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred hcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 55432 2234567899999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.32 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=211.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 44578999999999999999999865 4567999987642 2345678899999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++|||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999753 357888889999999999999999999999999999999999999999999886421000
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 157 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 157 --------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred --------------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001112235678999999998889999999999999999998 99999988777
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+..+. .. ..+...+.++.+++.+||+.+|++||++.++.++|+
T Consensus 211 ~~~~~~~~~~-~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 211 EVIRALERGY-RM-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred HHHHHHhCCC-CC-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 7666654432 22 234678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.68 Aligned_cols=264 Identities=29% Similarity=0.440 Sum_probs=219.3
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----ee
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~-----~l 762 (995)
+|++.+.||.|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999899999999987532 22345577899999999999999999999988875 78
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||++ ++|.+++.....+++..+..++.|++.||+|||++||+||||||.|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~- 157 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc-
Confidence 99999997 5899999877789999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
..........+++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+
T Consensus 158 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 158 -----------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred -----------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 000112234688999999999887 78999999999999999999999999887766
Q ss_pred HHHHHHccCCC----------------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 922 IFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 922 i~qkIl~~~~~----------------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
.+..+...... +......++..+.+||.+||+.+|.+||+ +.+++.|||
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~~~ 291 (330)
T cd07834 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALAHPY 291 (330)
T ss_pred HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCcc
Confidence 65555442111 01112347889999999999999999999 778999999
Q ss_pred ccccccc
Q 001924 974 FIKKTEN 980 (995)
Q Consensus 974 F~~~~~n 980 (995)
|.+....
T Consensus 292 ~~~~~~~ 298 (330)
T cd07834 292 LAQLHDP 298 (330)
T ss_pred HHhhccc
Confidence 9876554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=312.37 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=207.6
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
++||.|+||.||++.+.. ++.||+|.++.... ......+.+|+++++++.||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999887 99999998875432 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCC
Q 001924 773 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851 (995)
Q Consensus 773 SL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~ 851 (995)
+|.+++... ..++...+..++.+++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--------- 148 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--------- 148 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---------
Confidence 999999653 4678889999999999999999999999999999999999999999999999874210000
Q ss_pred CCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccC
Q 001924 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 930 (995)
Q Consensus 852 gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~ 930 (995)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+....
T Consensus 149 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 149 ----------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred ----------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 000111234667999999998899999999999999999998 899998887776666654432
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 931 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 931 ~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
. ...+..++.++.+|+.+||..+|.+||++.++++.|+
T Consensus 213 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 -R-MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -C-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2 2234678899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.38 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=206.6
Q ss_pred EeeccCCCeEEEEEEECCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 693 KPISRGAFGRVFLARKRTTG------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG------~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.||.|+||.||+|.+.... ..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999876432 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-----cEEEEecCCc
Q 001924 767 EYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLS 834 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-----~VKLsDFGLA 834 (995)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 3477888999999999999999999999999999999999887 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~P 913 (995)
+....... ........++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 73211000 001112346788999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|......+....+..... ...+..++..+.+||.+||..+|.+||++.++.+.|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 214 YPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 988877777666544332 22346788999999999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=372.05 Aligned_cols=273 Identities=25% Similarity=0.369 Sum_probs=210.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+..+|+.||+|+++...........++.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987543333445678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 767 EYLNGGDLYSLLRKV-----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-----------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 234556778899999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
........ .. ....................+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 162 ~i~~~~~~-~~--------~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 162 FKKLEEED-LL--------DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred eccccccc-cc--------ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 53111000 00 0000000000011122234679999999999999999999999999999999999999998
Q ss_pred CCCHHHHHHHH-HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH-HHHHHHH
Q 001924 916 AESPEIIFDNI-LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVF 969 (995)
Q Consensus 916 g~s~~ei~qkI-l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA-~EIlEiL 969 (995)
........... ......+ .....+++.+.+++.+||+.||.+||+. +++.+.|
T Consensus 233 ~~~~~ki~~~~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 233 RKKGRKISYRDVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred CcchhhhhhhhhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 76554433221 1111111 1124688999999999999999999874 3344433
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=317.71 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=198.5
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecC
Q 001924 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~--TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
+.||+|+||.||+|.+.. ++..+|+|.++.... ......+.+|+.+++.++||||+++++++......++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 456899998765332 2334578899999999999999999999999899999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 771 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 771 GGSL~d~L~k~~-----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
+|+|.+++.... ..+...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999996432 35667778899999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-------CCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-------~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.........|+..|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 155 ---------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ---------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 00111234578899999998642 35789999999999999996 99999887
Q ss_pred CHHHHHHHHHcc-CC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNR-KI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~-~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+........ .. ..+......+..+.+++..|| .+|++|||+.++...|.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~~ 269 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLSY 269 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhcC
Confidence 766654443332 12 222333457788999999999 689999999999988764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=334.84 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=206.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeec
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~ 758 (995)
..++|++.+.||.|+||.||+|.+ ..+++.||||+++... .......+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 457899999999999999999984 3467899999987532 233456788999999999 68999999998765
Q ss_pred c-CeeEEEEeecCCCCHHHHHHhc--------------------------------------------------------
Q 001924 759 R-DNLYLVMEYLNGGDLYSLLRKV-------------------------------------------------------- 781 (995)
Q Consensus 759 ~-~~lyLVmEym~GGSL~d~L~k~-------------------------------------------------------- 781 (995)
. ...++||||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4678999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 782 -----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 782 -----------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--------- 233 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--------- 233 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc---------
Confidence 135677788899999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcc
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~ 929 (995)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 234 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 297 (343)
T cd05103 234 ----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297 (343)
T ss_pred ----------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc
Confidence 0001112346678999999999999999999999999999997 99999876543333333332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
... +..+...++.+.+++.+||+.||.+||++.++++.|+..
T Consensus 298 ~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 298 GTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred cCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222 223456788999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=361.54 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=213.1
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
+.|++.++....++-||.|+-|.||+|+.+ ++.||||.++... ..++.-|++|+||||+.+.|+|...
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCC
Confidence 344555666677788999999999999876 8899999665321 2366779999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||||..|-|+.+|+....+.......+..+|+.||+|||.+.|||||||.-||||..+..|||+|||-++.
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e--- 261 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKE--- 261 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHh---
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999998873
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
..+......++||..|||||++.+.+.+.|+|||||||+|||||||..||.+.+.
T Consensus 262 -------------------------~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 262 -------------------------LSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred -------------------------hhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 1223456678999999999999999999999999999999999999999988765
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
..++-.+-.+-...| .|..++.-++-||+.||...|..||+..+++..|
T Consensus 317 sAIIwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 317 SAIIWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred heeEEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 554433333322222 4678999999999999999999999977776544
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.84 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=202.2
Q ss_pred CCe-EEEEeeccCCCeEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--
Q 001924 687 DDF-EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 759 (995)
Q Consensus 687 ~dY-eIlk~LG~GgFGtVYka~----~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-- 759 (995)
++| ++.+.||+|+||+||++. ...++..||+|+++... .......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 899999999999998765 34578899999987532 223456788999999999999999999987654
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 3589999999999999999764 599999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
... .........++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 160 ~~~------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 160 GHE------------------------YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred cch------------------------hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc
Confidence 000 00001123456779999999988899999999999999999999999865321
Q ss_pred H--HH------------HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 E--II------------FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~--ei------------~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
. .. .......... +..+..++..+.+|+.+||+.||++|||+.++++.|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 216 KFEEMIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhhhhhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 1 00 1111111111 1234678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.59 Aligned_cols=260 Identities=32% Similarity=0.490 Sum_probs=209.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC---
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--- 760 (995)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456889999999999999999999999999999999875332 2223456778999999999999999999887655
Q ss_pred -------eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecC
Q 001924 761 -------NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (995)
Q Consensus 761 -------~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFG 832 (995)
.+++|+||+++ +|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999976 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr 911 (995)
++....... ........++..|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEE--------------------------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCc--------------------------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 987421100 0011123467889999998654 5688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcc---CC--CCC----------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHHH
Q 001924 912 PPFTAESPEIIFDNILNR---KI--PWP----------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~---~~--~~p----------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~E 964 (995)
+||...+....+..+... .. .++ .....++..+.+||.+||..||.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 999877655544443321 10 000 012346889999999999999999999
Q ss_pred HHHHHcCccc
Q 001924 965 AAEVFHCKIF 974 (995)
Q Consensus 965 IlEiL~HPfF 974 (995)
+.+++.||||
T Consensus 293 ~~~il~~~~~ 302 (302)
T cd07864 293 AEEALNSPWL 302 (302)
T ss_pred HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.91 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=202.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--C
Q 001924 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~ 760 (995)
.+|++.+.||+|+||.||++.. ..++..||+|.+.... ......+.+|+++++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999974 4578899999886532 34456789999999999999999999987543 4
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999754 4589999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
... .........++..|+|||++.+..++.++||||||+++|||++|..|+.....
T Consensus 161 ~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 161 DKE------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred CCc------------------------ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 000 00000112245569999999998999999999999999999998777643221
Q ss_pred HH---------------HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 EI---------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~e---------------i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.. ....++.....+ ..+..++..+.+|+.+||..+|++|||+.++...|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 10 011122222222 234678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=329.60 Aligned_cols=284 Identities=27% Similarity=0.393 Sum_probs=220.1
Q ss_pred CCeE-EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhcCCCceEEEee
Q 001924 687 DDFE-IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----------DIERILAERNILITVRNPFVVRFFY 754 (995)
Q Consensus 687 ~dYe-Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~-----------e~e~flrEieILs~LkHPNIVkL~g 754 (995)
++|. +.+.||.|+||+||+|.+..+++.||+|+++........ ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 5665 457799999999999999999999999998754322100 0124778999999999999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
++...+..++||||+. |+|.+++.....++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988778999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~P 913 (995)
........... ..... ............+++.|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 167 ~~~~~~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 167 RRYGYPPYSDT--------LSKDE-----TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred eeccccccccc--------ccccc-----cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 74221110000 00000 00011122234578899999999764 468999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCC-----CCC--------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 914 FTAESPEIIFDNILNRKI-----PWP--------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~-----~~p--------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
|.+.+....+..+..... .|+ ......+..+.++|.+||..+|.+||+ +.++
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~ 310 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---AKEA 310 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---HHHH
Confidence 998877665554433110 011 012345788999999999999999999 7888
Q ss_pred HcCccccccccccccchhH
Q 001924 969 FHCKIFIKKTENCVSMQSK 987 (995)
Q Consensus 969 L~HPfF~~~~~n~~s~q~~ 987 (995)
|.||||+.......+.+..
T Consensus 311 l~~~~~~~~~~~~~~~~~~ 329 (335)
T PTZ00024 311 LKHEYFKSDPLPCDPSQLP 329 (335)
T ss_pred hcCcccCCCCCCCCcccCC
Confidence 8999999877666555543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.76 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=213.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||+|+||.||+|.+..+|..||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4678999999999999999999999999999999886432 23334567889999999999999999999987654
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..++||+|+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 358999999 7799888764 568999999999999999999999999999999999999999999999999886310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 ------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01112357889999999876 45789999999999999999999999877
Q ss_pred CHHHHHHHHHccCCC----------------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~~~----------------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+....+..+...... +......++..+.++|.+||+.||.+||| +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~~l 296 (343)
T cd07880 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAEAL 296 (343)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 655444443321111 01122467888999999999999999999 77888
Q ss_pred cCccccccccc
Q 001924 970 HCKIFIKKTEN 980 (995)
Q Consensus 970 ~HPfF~~~~~n 980 (995)
.||||+.....
T Consensus 297 ~~~~~~~~~~~ 307 (343)
T cd07880 297 AHPYFEEFHDP 307 (343)
T ss_pred cCccHhhhcCc
Confidence 99999987544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=343.82 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=214.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFY 754 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~g 754 (995)
.+....++|.+.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.++.++. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 35566788999999999999999999964 345689999997532 2333457889999999997 999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcC----------------------------------------------------
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 782 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~---------------------------------------------------- 782 (995)
++...+..++||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999996431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCC
Q 001924 783 ----------------------------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (995)
Q Consensus 783 ----------------------------------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPe 816 (995)
.++...+..++.|++.||+|||+.+|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2456677889999999999999999999999999
Q ss_pred cEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHH
Q 001924 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (995)
Q Consensus 817 NILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSD 896 (995)
|||++.++.+||+|||+++...... .........+++.|+|||++.+..++.++|
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 323 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDS-------------------------NYISKGSTFLPLKWMAPESIFNNLYTTLSD 323 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccc-------------------------ccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence 9999999999999999987421000 000112335788999999999988999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 897 IWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||||+++|||++ |..||......+.....+..... +..+..++..+.+|+.+||..+|.+||++.+++..|+
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999999999998 89999876655555454444433 2245678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=314.78 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=213.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~--~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
+|.+.+.||+|+||.||++.+..++..+++|+++.... ........+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999999988888888888765332 1223345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 766 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 766 mEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999998863 346899999999999999999999999999999999999975 67999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 159 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 159 --------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred --------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 011123457889999999988889999999999999999999999998877766
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
....+..+. .+..+..++.++.++|.+||..+|.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 666665443 33445678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.97 Aligned_cols=260 Identities=29% Similarity=0.435 Sum_probs=210.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~---- 759 (995)
...++|.+.+.||+|+||.||+|.+..+|..||+|.+.... ......+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 45689999999999999999999999999999999987532 2233456788999999999999999999987643
Q ss_pred --CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 --DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 --~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
...|++++++ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3468888887 7899888764 45899999999999999999999999999999999999999999999999998631
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
. .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 171 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 D------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred c------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0 01123457889999999876 5678999999999999999999999987
Q ss_pred CCHHHHHHHHHccCC-----------------------CCC-----CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 917 ESPEIIFDNILNRKI-----------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~-----------------------~~p-----~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
.+....+..+..... ..+ ......++.+.+||.+||+.||.+||+ +.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~ 297 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQA 297 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHHH
Confidence 665444333322110 000 011245788999999999999999999 7899
Q ss_pred HcCcccccccc
Q 001924 969 FHCKIFIKKTE 979 (995)
Q Consensus 969 L~HPfF~~~~~ 979 (995)
++||||.+...
T Consensus 298 l~h~~f~~~~~ 308 (345)
T cd07877 298 LAHAYFAQYHD 308 (345)
T ss_pred hcChhhhhcCC
Confidence 99999997544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.45 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=213.9
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeec
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
.....||+|+||.||++....+|..||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 3346799999999999999999999999987532 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCC
Q 001924 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (995)
Q Consensus 770 ~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~ 849 (995)
++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~---------- 168 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK---------- 168 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc----------
Confidence 99999998754 4689999999999999999999999999999999999999999999999998763110
Q ss_pred CCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcc
Q 001924 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 850 t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~ 929 (995)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+...
T Consensus 169 -----------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~ 231 (292)
T cd06657 169 -----------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231 (292)
T ss_pred -----------------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Confidence 001112345889999999998888899999999999999999999999887766655544333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..........++..+.+++.+||+.||.+||+ +.+++.||||.....
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~~~ 278 (292)
T cd06657 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhccCC
Confidence 22222223467899999999999999999999 777889999988764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=354.51 Aligned_cols=271 Identities=23% Similarity=0.316 Sum_probs=199.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEE--------------eecccccchhHHHHHHHHHHHHHhcCCCc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKV--------------LKKLDMIRKNDIERILAERNILITVRNPF 748 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG-~~VAVKV--------------Ikk~~~~se~e~e~flrEieILs~LkHPN 748 (995)
...++|++++.||+|+||+||++..+... ..++.|. +.+...........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998764322 2222221 11111112234556889999999999999
Q ss_pred eEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC
Q 001924 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (995)
Q Consensus 749 IVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~-----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen 823 (995)
|+++++++...+..|+|++++ +++|..++.... ......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999 458888775321 23456678899999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHH
Q 001924 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (995)
Q Consensus 824 G~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (995)
+.+||+|||+++..... ........+||+.|+|||++.+..++.++|||||||+
T Consensus 304 ~~vkL~DFGla~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 357 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE--------------------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357 (501)
T ss_pred CCEEEEeCCCceecCcc--------------------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHH
Confidence 99999999998742100 0111223579999999999999999999999999999
Q ss_pred HHHHHcCCCC-CCCC--CHHHHHHHHHccC----CCCCC-------------------------CCCCCCHHHHHHHHHH
Q 001924 904 LFEFITGIPP-FTAE--SPEIIFDNILNRK----IPWPC-------------------------VPSDMSFEAQDLINRF 951 (995)
Q Consensus 904 LyELLTGr~P-F~g~--s~~ei~qkIl~~~----~~~p~-------------------------lps~lS~eL~dLIkkC 951 (995)
+|||++|..+ |... .+...+..++... ..++. ....++..+.++|.+|
T Consensus 358 l~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~km 437 (501)
T PHA03210 358 LLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKM 437 (501)
T ss_pred HHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHH
Confidence 9999998754 4322 2222222221110 00000 0123567788899999
Q ss_pred hhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 952 LIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 952 Lq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
|++||.+||| +.++|.||||....+....+
T Consensus 438 L~~DP~~Rps---a~elL~hp~f~~~~~~~~~~ 467 (501)
T PHA03210 438 LTFDWHLRPG---AAELLALPLFSAEEEEEILF 467 (501)
T ss_pred hccCcccCcC---HHHHhhChhhhcCCchHHHH
Confidence 9999999999 77889999999876554433
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=331.84 Aligned_cols=257 Identities=30% Similarity=0.446 Sum_probs=208.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----- 760 (995)
.++|.+.+.||.|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.+.||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 478999999999999999999999999999999987532 22233456889999999999999999999887543
Q ss_pred -eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 -~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++|+||+. ++|..++. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~- 168 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD- 168 (342)
T ss_pred ceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC-
Confidence 4699999995 47777652 358999999999999999999999999999999999999999999999999986310
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 169 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 169 -----------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred -----------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112357889999999876 468899999999999999999999999877
Q ss_pred HHHHHHHHHccCC-----------------------C-----CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNRKI-----------------------P-----WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~~~-----------------------~-----~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
....+..+..... . +....+..+..+.+||.+||+.||.+||+ +.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~l~ 296 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEALE 296 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHHhc
Confidence 5554444332100 0 00011356788999999999999999999 788899
Q ss_pred Ccccccccc
Q 001924 971 CKIFIKKTE 979 (995)
Q Consensus 971 HPfF~~~~~ 979 (995)
||||.+.+.
T Consensus 297 h~~f~~~~~ 305 (342)
T cd07879 297 HPYFDSFRD 305 (342)
T ss_pred Ccchhhccc
Confidence 999998864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.36 Aligned_cols=268 Identities=26% Similarity=0.472 Sum_probs=214.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ 761 (995)
....++|++.+.||.|+||.||+|.+..++..||||.++.... ......+..|+.++.+.. ||||+++++++.....
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4456889999999999999999999999999999999875432 233456677887776665 9999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999984 578777765 3568999999999999999999997 5999999999999999999999999998863110
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~----ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
........+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.
T Consensus 168 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 168 ----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred ----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 00111234788999999987654 7889999999999999999999997
Q ss_pred CCCH-HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 916 AESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 916 g~s~-~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
.... .+.+..+.............++.++.+|+.+||..||.+||+ +.++++||||.........+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~ 286 (296)
T cd06618 220 NCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRRYETAEVDV 286 (296)
T ss_pred cchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhccchhHHHH
Confidence 6432 344445444432211122347889999999999999999999 78889999999766554433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=316.25 Aligned_cols=254 Identities=33% Similarity=0.542 Sum_probs=210.0
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|++.+.||.|++|.||+|.+..+|+.+++|.++.... .......+.+|+.+++.++||||+++++++.....+++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778899999999999999998999999999875432 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+++ +|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~------- 151 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP------- 151 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC-------
Confidence 965 888888663 57899999999999999999999999999999999999999999999999988642100
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+
T Consensus 152 --------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 152 --------------------VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred --------------------cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011123578899999999877 7899999999999999999999999887765554444
Q ss_pred HccCCC-----C----------------------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 927 LNRKIP-----W----------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 927 l~~~~~-----~----------------------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
...... + ......++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 321100 0 0112346789999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.78 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=212.6
Q ss_pred CeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeeccc-------ccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeec
Q 001924 688 DFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLD-------MIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC 758 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~-TG~~VAVKVIkk~~-------~~se~e~e~flrEieILs~-LkHPNIVkL~gvf~~ 758 (995)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 68899999886422 1233455677889988865 799999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 6899999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
+..... ........|+..|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 161 ~~~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQP----------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccc----------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 874110 0012234688999999999998899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|...........+...... +......++.+.+||.+||+.||++||++.++.+.+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9887777666666554433 2223367899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.10 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=195.1
Q ss_pred EeeccCCCeEEEEEEECCCCc-------EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 693 KPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~-------~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
+.||.|+||.||+|.+..++. .||+|.+.... ....+.+.+|+.+++.+.||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 369999999999999866554 38888765422 33456788999999999999999999999998999999
Q ss_pred EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc--------EEEEecCCccc
Q 001924 766 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSKI 836 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~--------VKLsDFGLArv 836 (995)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997643 5899999999999999999999999999999999999987764 68999998752
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcC-CCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITG-IPPF 914 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTG-r~PF 914 (995)
.. ......+++.|+|||++.+. .++.++||||||+++|+|++| ..||
T Consensus 158 ~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 158 VL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred cC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 10 11224578899999999874 579999999999999999998 5777
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.......... +..... ..+...+..+.+||.+||+.||.+|||+.++++.|+
T Consensus 207 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 207 SALDSQKKLQ-FYEDRH---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred hhccHHHHHH-HHHccc---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 6665554333 222222 234556788999999999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.52 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=206.0
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHHH
Q 001924 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778 (995)
Q Consensus 699 gFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L 778 (995)
++|.||.++...+++.||||++.... ........+.+|+.+++.++||||+++++++...+..+++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 45566666667789999999987642 23456678999999999999999999999999999999999999999999999
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCC
Q 001924 779 RKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856 (995)
Q Consensus 779 ~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s 856 (995)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~-------------- 156 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK-------------- 156 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc--------------
Confidence 753 4588999999999999999999999999999999999999999999999998863211000
Q ss_pred CCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCC-
Q 001924 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW- 933 (995)
Q Consensus 857 ~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~- 933 (995)
.............++..|+|||++.+ ..++.++|||||||++|||++|..||..............+....
T Consensus 157 ------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 157 ------RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred ------cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 00001111234457889999999976 358899999999999999999999998765544332222211100
Q ss_pred ------CC------------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 934 ------PC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 934 ------p~------------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
+. ....++..+.+|+.+||+.||++||| +.++|+||||+..+....+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~~~~~~~~~~~ 307 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSFFKQCKRRNTS 307 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCchHhhhcccchh
Confidence 00 11123467889999999999999999 7788999999988866665
Q ss_pred chhH
Q 001924 984 MQSK 987 (995)
Q Consensus 984 ~q~~ 987 (995)
+..-
T Consensus 308 ~~~~ 311 (314)
T cd08216 308 LLDL 311 (314)
T ss_pred HHHh
Confidence 5543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.23 Aligned_cols=237 Identities=24% Similarity=0.303 Sum_probs=194.3
Q ss_pred EeeccCCCeEEEEEEECCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 693 KPISRGAFGRVFLARKRTTG----------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG----------~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 357788765432 125788899999999999999999999888 778
Q ss_pred EEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-------cEEEEecCCc
Q 001924 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-------HIKLTDFGLS 834 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-------~VKLsDFGLA 834 (995)
++||||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999999887 7999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC--CCCchHHHHHHHHHHHHHHc-CC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFIT-GI 911 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILyELLT-Gr 911 (995)
..... .....++..|+|||++.+. .++.++||||||+++|+|++ |.
T Consensus 156 ~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 156 ITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred ccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 73110 1123467789999999876 78999999999999999999 68
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
.||...+......... .....+ ......+.+||.+||..+|.+||++.++++.|
T Consensus 205 ~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 205 EPLSTLSSSEKERFYQ-DQHRLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCcccCCchhHHHHHh-cCCCCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 8887765443333322 121111 22347899999999999999999998888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.17 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=203.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--C
Q 001924 687 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~ 760 (995)
.-|++++.||+|+||.||++.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3578999999999999999984 4578899999986432 233456789999999999999999999988775 5
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.+++||||+++++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 689999999999999999654 3589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s- 918 (995)
... .........|+..|+|||++.+..++.++||||||+++|+|+++..|+....
T Consensus 162 ~~~------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 162 DKE------------------------YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred Ccc------------------------ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 000 0011123457788999999998889999999999999999999877653210
Q ss_pred -------------HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 -------------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 -------------~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.............. ...+..++..+.+|+.+||+.||.+||++.++++.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 00111111222222 2234678999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.96 Aligned_cols=254 Identities=35% Similarity=0.539 Sum_probs=210.4
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|||++++++++...+.+++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999987643 2233456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
++ ++|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~-------- 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-------- 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC--------
Confidence 97 5999999876 5799999999999999999999999999999999999999999999999998873110
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.........++..|+|||.+.+. .++.++||||||+++|||++|..||........+..+
T Consensus 151 -------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 151 -------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred -------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 00011223467889999999776 7899999999999999999999999887665554443
Q ss_pred Hcc------------------CCCCCC--------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 927 LNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 927 l~~------------------~~~~p~--------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
... ...++. ..+..+..+.++|.+||..||++||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 321 000111 11235788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=356.75 Aligned_cols=264 Identities=33% Similarity=0.561 Sum_probs=237.8
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.......|.+.+.||+|.|++|.++++..|+..||||++.+.... ......+.+|+++|+.+.|||||++|.+......
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 345678999999999999999999999999999999999886543 3344559999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||+.+|.+++++.+.+.+.+..++.++.|++.|++|||+++|+|||||++|||++.+.++||+|||++.+..
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987521
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
......+.||++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++.+..
T Consensus 207 -------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 207 -------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred -------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 2234557899999999999999888 68999999999999999999999999988
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
++-..++.+++..+ ..++.+..+||+++|..+|.+|++ +.++.+|+|-+.....
T Consensus 262 ~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 262 ELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRNDLLEA 315 (596)
T ss_pred cccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccchhhhh
Confidence 88888888887755 578889999999999999999999 7788889888765443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.53 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=209.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34688999999999999999999987776 46888776432 233345688999999999999999999988754
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..+++++|+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999987643 588999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
.. .........++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 162 ~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DE-------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cc-------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00 0001112345778999999999999999999999999999997 999998877
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.......+..+. ..+ .+...+..+.+++.+||..+|++||++.++...++.
T Consensus 217 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 217 TREIPDLLEKGE-RLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred HHHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 666554443332 222 345678899999999999999999999998887664
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=372.41 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=222.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~-----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
....+.++.+.||+|.||.||.|....... .||||.+++. .+..+..+|++|..+|+.+.|||||+++|++..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 345678899999999999999999865433 3888887754 356778999999999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~-------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
....+|++|||.||+|..||++. ..++......++.|||+|++||+++++|||||...|+|++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999865 35888999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-C
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 910 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-G 910 (995)
|||+-+....++... . ...-...|||||.+..+.++.|+|||||||+|||+++ |
T Consensus 847 GlArDiy~~~yyr~~---------------------~----~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKH---------------------G----EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchheecc---------------------C----ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999943322222111 1 1223568999999999999999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
..||.+.++.+++..++.+. . ...|..++..+.++|..||+.+|++||+...+++.+.
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-R-L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-R-LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-c-cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 99999999999998777776 2 3356899999999999999999999999888877443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.93 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=219.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|+..+.||.|+||.||+|++..++..+|+|.+.............+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45888899999999999999999999999999987543334455667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9996 588877753 4468999999999999999999999999999999999999999999999999886310
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
......|++.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 167 ------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred ------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 011245888999999985 34578899999999999999999999987766555
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchh
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
...+.....+. .....++..+.+||.+||+.+|.+||+ +.++++||||...+.....++.
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~~~~~~~~~~ 282 (308)
T cd06634 223 LYHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRERPPTVIMDL 282 (308)
T ss_pred HHHHhhcCCCC-cCcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCccccccCChhHHHHH
Confidence 55554443322 123468889999999999999999999 7888999999998766555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.60 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=208.1
Q ss_pred EeeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecC
Q 001924 693 KPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 693 k~LG~G--gFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
..||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+..++||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875332 23445788899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCC
Q 001924 771 GGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (995)
Q Consensus 771 GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~ 848 (995)
+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 99999998764 3488999999999999999999999999999999999999999999999986542110000
Q ss_pred CCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 849 ~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.... .........++..|+|||++.+. .++.++|||||||++|+|++|..||............
T Consensus 157 ------~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 157 ------KAKV--------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ------cccc--------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 0000 00001122356789999999764 4789999999999999999999999877655544443
Q ss_pred HccCCCCC--------------------------------------------CCCCCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 927 LNRKIPWP--------------------------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 927 l~~~~~~p--------------------------------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
.......+ ..+..++..+.+||.+||+.||++|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 33211100 011235678999999999999999999
Q ss_pred HHHHHHHcCcccccccccc
Q 001924 963 NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 963 ~EIlEiL~HPfF~~~~~n~ 981 (995)
+.++|+||||..+.+..
T Consensus 302 --a~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 302 --ASSLLSHAFFKQVKEQT 318 (328)
T ss_pred --HHHHhhCHHHHHHHHhc
Confidence 88999999999887753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.35 Aligned_cols=262 Identities=30% Similarity=0.424 Sum_probs=207.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeecc----C
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR----D 760 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~T--G~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~----~ 760 (995)
+|++.+.||.|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++ .||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 8999999886422 2233456788899999999 599999999875432 4
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
..|++++|+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788999985 699999987788999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
. ...........||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...+.
T Consensus 159 ~-----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 159 P-----------------------GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred c-----------------------ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 0 001111234578999999998866 5689999999999999999999999987664
Q ss_pred HHHHHHHHcc----------------------------CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~----------------------------~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+..++.. ...+.......+..+.+|+.+||+.||.+||| +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcC
Confidence 4433322211 01111122346889999999999999999999 6778999
Q ss_pred cccccc
Q 001924 972 KIFIKK 977 (995)
Q Consensus 972 PfF~~~ 977 (995)
|||..-
T Consensus 293 ~~~~~~ 298 (332)
T cd07857 293 PYLAIW 298 (332)
T ss_pred hhhhhh
Confidence 999644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=311.86 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=208.3
Q ss_pred eEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----
Q 001924 689 FEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~---TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----- 760 (995)
|.+.+.||+|+||.||+|.+.. ++..||||++... .......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD-IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc-cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998653 5789999998653 333445678899999999999999999999886542
Q ss_pred -eeEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 761 -NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 761 -~lyLVmEym~GGSL~d~L~k~------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.++++++|+.+|+|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887532 2478888999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~ 912 (995)
++....... ........+++.|++||.+.+..++.++||||||+++|+|++ |..
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 874211000 001112345678999999999889999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||........+..+..... ...+...+..+.+++.+||+.+|.+||++.++...|+.
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 9988887777776665432 22335678999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.38 Aligned_cols=260 Identities=30% Similarity=0.454 Sum_probs=213.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe---
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~--- 761 (995)
..++|++.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+.+++.+.|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4678999999999999999999999999999999886532 223345667889999999999999999988876654
Q ss_pred ---eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 762 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 762 ---lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799999865 469999999999999999999999999999999999999999999999999986310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 00123457889999999865 36789999999999999999999999887
Q ss_pred CHHHHHHHHHccCCC----------------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~~~----------------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
.....+..+...... +.......+..+.+||.+||+.||.+||| +.+++
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~ell 296 (343)
T cd07851 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEAL 296 (343)
T ss_pred ChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHHHh
Confidence 766555544332110 00111346889999999999999999999 77889
Q ss_pred cCccccccccc
Q 001924 970 HCKIFIKKTEN 980 (995)
Q Consensus 970 ~HPfF~~~~~n 980 (995)
+||||.+....
T Consensus 297 ~h~~~~~~~~~ 307 (343)
T cd07851 297 AHPYLAEYHDP 307 (343)
T ss_pred cCCCccccCCC
Confidence 99999875433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.39 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=229.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
-|.-++.||.|+||.||.+++..+.+.||||.+.-......+.-..++.|+..|.++.|||+|.+-+||..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36677889999999999999999999999998876666666666789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 768 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 768 ym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|| -|+-.|++.-. .++.+..+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.++
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--------- 176 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--------- 176 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------
Confidence 99 56888888633 56899999999999999999999999999999999999999999999999988752
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
....+++|||+|||||++.. +.|+-++||||||+++.||.-.++|+...+....+
T Consensus 177 ----------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL 234 (948)
T KOG0577|consen 177 ----------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 234 (948)
T ss_pred ----------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence 23456899999999999854 67999999999999999999999999998888888
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
..|-.+..+... .+.++..+.+|+..||++-|.+||| ..++|+|+|....+-.++-|
T Consensus 235 YHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R~Rp~tvi~ 291 (948)
T KOG0577|consen 235 YHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLRERPPTVIM 291 (948)
T ss_pred HHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhccCCCchHHH
Confidence 888776544221 3568999999999999999999999 77889999998877655443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=329.36 Aligned_cols=265 Identities=32% Similarity=0.502 Sum_probs=211.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeecc--Ce
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--DN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~--~~ 761 (995)
..++|++.+.||.|+||.||+|.+..+|..+|+|.+.... ........+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4578999999999999999999999899999999885422 2223445677899999999 999999999988654 36
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++ ++|..++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999996 5999998765 78888999999999999999999999999999999999999999999999987421110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
. ...........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....
T Consensus 162 ~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~ 219 (337)
T cd07852 162 E----------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219 (337)
T ss_pred c----------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH
Confidence 0 000112223568999999998865 45788999999999999999999999876655
Q ss_pred HHHHHHHccCC----------------------------CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 921 IIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 921 ei~qkIl~~~~----------------------------~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.....+..... ........++.++.+||.+||+.||.+||| +.++++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il~~~ 296 (337)
T cd07852 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEALEHP 296 (337)
T ss_pred HHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHhhCh
Confidence 44333222110 011122347889999999999999999999 77888899
Q ss_pred ccccc
Q 001924 973 IFIKK 977 (995)
Q Consensus 973 fF~~~ 977 (995)
||.+.
T Consensus 297 ~~~~~ 301 (337)
T cd07852 297 YVAQF 301 (337)
T ss_pred hhhhh
Confidence 99776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.56 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=207.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec--cC
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RD 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~--~~ 760 (995)
..|++.+.||+|+||.||+|.+.. ++..||+|+++..... .....+.+|+++++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 568889999999999999998653 4789999998754321 346789999999999999999999998877 55
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7899999999999999997654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
... .........++..|+|||.+.+..++.++||||||+++|||++|..||.....
T Consensus 162 ~~~------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 162 DKD------------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred CCc------------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccc
Confidence 000 00001122355679999999988999999999999999999999999865422
Q ss_pred HH--------------HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~e--------------i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.. .....+......+ .+..++..+.+|+.+||..+|.+||++.++.+.|..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred hhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 11 1122222332222 245678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.48 Aligned_cols=238 Identities=25% Similarity=0.327 Sum_probs=192.1
Q ss_pred eeccCCCeEEEEEEECCCC------------------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 001924 694 PISRGAFGRVFLARKRTTG------------------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG------------------------~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI 749 (995)
.||+|+||.||+|....++ ..||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 5999999999999864322 368888876422 2334678889999999999999
Q ss_pred EEEeeeeeccCeeEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC----
Q 001924 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---- 824 (995)
Q Consensus 750 VkL~gvf~~~~~lyLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---- 824 (995)
+++++++......++||||+++|+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 45689999999999999999999999999999999999997644
Q ss_pred ---cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHH
Q 001924 825 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSV 900 (995)
Q Consensus 825 ---~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSL 900 (995)
.+|++|||++.... ......++..|+|||.+.+ ..++.++|||||
T Consensus 159 ~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 48999999875210 0112357788999999876 568999999999
Q ss_pred HHHHHHHH-cCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 901 GIILFEFI-TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 901 GVILyELL-TGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
|+++|||+ +|..||....+...... ...... .+...++.+.+||.+||+.+|.+||++.++++.|
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKERF-YEKKHR---LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHH-HHhccC---CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99999985 69999988766554332 222222 2234567899999999999999999988887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.69 Aligned_cols=240 Identities=22% Similarity=0.279 Sum_probs=192.7
Q ss_pred EeeccCCCeEEEEEEECCC------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 693 KPISRGAFGRVFLARKRTT------------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~T------------G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
+.||+|+||.||+|..... ...|++|++.... ......+.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986432 2368888875432 334557888999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc-------EEEEecC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------IKLTDFG 832 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~-------VKLsDFG 832 (995)
..++||||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999988753 56899999999999999999999999999999999999987664 8999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-CCCCCchHHHHHHHHHHHHHH-cC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFI-TG 910 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-g~~ys~KSDIWSLGVILyELL-TG 910 (995)
++.... ......|+..|+|||++. +..++.++|||||||++|||+ .|
T Consensus 158 ~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 158 IPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 876310 011245788999999987 466899999999999999998 58
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
..||......+... ....... .....+.++.+||.+||+.||.+||++.++++.++
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCM---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCcc---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 99998765544322 2222222 12335678999999999999999999888877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.60 Aligned_cols=252 Identities=35% Similarity=0.500 Sum_probs=205.2
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEEe
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVmE 767 (995)
|++.+.||.|+||.||+|....+++.|+||.+..... ........+|+..++++. ||||+++++++...+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998999999998865322 122334567899999999 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 768 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 768 ym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 889999887654 689999999999999999999999999999999999999999999999998873110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
........|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||........+.
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 152 ----------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ----------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 001122457889999998854 457899999999999999999999998776555444
Q ss_pred HHHccCC-------------------CCC--------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKI-------------------PWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~-------------------~~p--------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..... .++ ......+..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 3322100 000 011233678999999999999999999 7888999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.36 Aligned_cols=269 Identities=37% Similarity=0.735 Sum_probs=238.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
....++|.++++||+|+|..|.+++.+.|.+.||+|++++.-....+.+.-+..|-.+..+. +||.+|.+..+|+.+.+
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 34678999999999999999999999999999999999987777777788888888887765 68999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+++|.||++||+|.-.+++...++++.++.+...|+.||+|||+.|||+||||.+|+|+|..|++||.|+|+++-.
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~---- 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG---- 401 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC----
Confidence 9999999999999988988889999999999999999999999999999999999999999999999999999831
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC-----
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA----- 916 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g----- 916 (995)
+ .+...+.++||||.|.|||++.+..|++++|+|+|||+++||+.|+.||+-
T Consensus 402 -----------l------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 402 -----------L------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred -----------C------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 1 233456689999999999999999999999999999999999999999952
Q ss_pred ---CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC---HHHHHHHHcCcccccccccc
Q 001924 917 ---ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG---ANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 917 ---~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS---A~EIlEiL~HPfF~~~~~n~ 981 (995)
.+...+++-|+..++..| ..++-.+..+++..|.+||.+|.. -....++..|+||..++|..
T Consensus 459 ~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred cccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 234456777777776654 678888999999999999999976 24688999999999998864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.29 Aligned_cols=249 Identities=19% Similarity=0.291 Sum_probs=197.4
Q ss_pred eeccCCCeEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCC
Q 001924 694 PISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG--~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
.||+|+||.||+|....++ ..+++|.++... .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 6999999999999764332 345566554322 234567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 772 GDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 772 GSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+|.+++.+. ..++...+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~------ 153 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED------ 153 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch------
Confidence 9999999754 235667778899999999999999999999999999999999999999999876311000
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-------~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
.........|+..|+|||++.. ..++.++||||||+++|||++ |..||.....
T Consensus 154 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 154 -------------------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred -------------------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0011123568899999999853 245789999999999999997 6789988777
Q ss_pred HHHHHHHHccCC---CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 EIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~ei~qkIl~~~~---~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.+.+..+..... ..+..+...++.+.+++..|| .+|.+||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 215 REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 777666554432 123344567889999999999 68999999999988874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=326.59 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=207.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~------ 759 (995)
..+|.+.+.||.|+||.||+|.+..+|..||+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3789999999999999999999999999999998865432 3456788999999999999999999776654
Q ss_pred --------CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEe
Q 001924 760 --------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTD 830 (995)
Q Consensus 760 --------~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsD 830 (995)
..+|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999996 589888854 46899999999999999999999999999999999999974 56799999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHc
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLT 909 (995)
||++.... .... .........|+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 159 fg~~~~~~--~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 214 (342)
T cd07854 159 FGLARIVD--PHYS----------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214 (342)
T ss_pred cccceecC--Cccc----------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh
Confidence 99987411 0000 0001122357889999998754 567889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccCC----------------------CCC-----CCCCCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 910 GIPPFTAESPEIIFDNILNRKI----------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~~~~----------------------~~p-----~lps~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
|+.||...........+..... ..+ .....++.++.+||.+||+.||.+|||
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t- 293 (342)
T cd07854 215 GKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT- 293 (342)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC-
Confidence 9999987766555444332110 000 012357788999999999999999999
Q ss_pred HHHHHHHcCcccccc
Q 001924 963 NGAAEVFHCKIFIKK 977 (995)
Q Consensus 963 ~EIlEiL~HPfF~~~ 977 (995)
+.+++.||||+..
T Consensus 294 --~~ell~h~~~~~~ 306 (342)
T cd07854 294 --AEEALMHPYMSCY 306 (342)
T ss_pred --HHHHhCCCccccc
Confidence 7788999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.83 Aligned_cols=260 Identities=31% Similarity=0.490 Sum_probs=210.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-cCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-~~~ly 763 (995)
..++|++.+.||.|+||.||+|.+..++..||+|.+.+.. ........+.+|+.+++.++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 5688999999999999999999999999999999886532 223345678899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+ +++|.+++.. ..++...+..++.|++.||.|||++||+||||+|.||+++.++.+||+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999998 5689888864 458888899999999999999999999999999999999999999999999886310
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 160 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 160 -------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred -------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01112357889999999866 5689999999999999999999999987665332
Q ss_pred HHHHHcc----------------------------CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 923 FDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 923 ~qkIl~~----------------------------~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+..+.+. ..+.......++..+.++|.+||+.+|++||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~~~~ 291 (328)
T cd07856 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAHPYL 291 (328)
T ss_pred HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcCCcc
Confidence 2221110 00011112357789999999999999999999 7789999999
Q ss_pred cccccc
Q 001924 975 IKKTEN 980 (995)
Q Consensus 975 ~~~~~n 980 (995)
......
T Consensus 292 ~~~~~~ 297 (328)
T cd07856 292 APYHDP 297 (328)
T ss_pred ccccCC
Confidence 755443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.75 Aligned_cols=266 Identities=29% Similarity=0.514 Sum_probs=227.4
Q ss_pred eEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEE
Q 001924 689 FEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 689 YeIl-k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVm 766 (995)
|++. +.||+|+|+.|--+....||..||||++.+.. .....++++|++++.+++ |+||++++++|.++..+|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4433 57999999999999999999999999998753 345678999999999985 999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEEecCCcccccccccc
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLsDFGLArv~~~~~s~ 843 (995)
|-|.||+|...+.+...|++..+..+.++|+.||.|||.+||.||||||+|||..... -||||||.+..-+..++
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~-- 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN-- 233 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC--
Confidence 9999999999999999999999999999999999999999999999999999997654 59999999876322111
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
+.+ ........+.+|+..|||||+.. ...|+.+.|.||||||+|-||+|++||.+.-
T Consensus 234 ~~s------------------pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 234 DCS------------------PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CCC------------------CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 111 01123345689999999999963 2468999999999999999999999997642
Q ss_pred ---------------HHHHHHHHHccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 919 ---------------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 919 ---------------~~ei~qkIl~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
...++..|..+.+.||.. +..++.++++|+..+|..||..|.+ +..+++|||++.....
T Consensus 296 g~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 296 GADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPE 370 (463)
T ss_pred CCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchh
Confidence 457888999999998863 4678999999999999999999999 8899999999988643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.68 Aligned_cols=260 Identities=15% Similarity=0.236 Sum_probs=195.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCceEEEe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVVRFF 753 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e--------~e~flrEieILs~LkHPNIVkL~ 753 (995)
..++|++.+.||+|+||.||+|.+..+ +..+|+|+..........+ ......+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 447899999999999999999999877 6677888643221110000 01122334455677899999999
Q ss_pred eeeeccC----eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEE
Q 001924 754 YSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (995)
Q Consensus 754 gvf~~~~----~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLs 829 (995)
+++.... ..+++++++. .++.+.+......++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8776544 3477888774 4777777666567888899999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 001924 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 830 DFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT 909 (995)
|||+|+....+... . ...........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 169 DFGla~~~~~~~~~--------------~------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 169 DYGIASHFIIHGKH--------------I------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred EcCCceeeccCCcc--------------c------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999742211100 0 000111233469999999999999999999999999999999999
Q ss_pred CCCCCCCCCH-HH--------HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 910 GIPPFTAESP-EI--------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 910 Gr~PF~g~s~-~e--------i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
|..||.+... .. ....+...... ....+..+.+++..||..+|++||++.++.+.+
T Consensus 229 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 229 IKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCCccccchHHHHHhHHHHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999987632 22 12222222222 245688999999999999999999999998876
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=354.85 Aligned_cols=253 Identities=32% Similarity=0.496 Sum_probs=214.4
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCC
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 773 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGS 773 (995)
+||+|.||+||-|++..|....|||.+.... ......+..|+.+.+.++|.|||+++|++..++.+-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999999999999999886432 3456778999999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCcccccccccccCCCCC
Q 001924 774 LYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPE 849 (995)
Q Consensus 774 L~d~L~k~-~~L--see~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~~~s~dlsg~~ 849 (995)
|.++|+.. +++ ++...-.+.+||++||.|||++.|+|||||-+|+|++. .|.+||+|||-++...
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA----------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA----------- 727 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----------
Confidence 99999754 667 78888899999999999999999999999999999974 6899999999887421
Q ss_pred CCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH
Q 001924 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 926 (995)
Q Consensus 850 t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILyELLTGr~PF~g~s~-~ei~qkI 926 (995)
.-+.-+.++.||..|||||++..+ +|+..+|||||||++.||.||++||..... +..+.++
T Consensus 728 ----------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 728 ----------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred ----------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 112334567899999999999765 589999999999999999999999976543 3333232
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
-.-+ .-|.+|..++.+++.||.+|+..||.+||+ +.++|.+||++...+.
T Consensus 792 GmyK-vHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 792 GMYK-VHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHNNKK 841 (1226)
T ss_pred ccee-cCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccCCCC
Confidence 1111 235567889999999999999999999999 7889999999887443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=357.92 Aligned_cols=261 Identities=27% Similarity=0.443 Sum_probs=212.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeee-eec
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYS-FTC 758 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gv-f~~ 758 (995)
.......++++.+.|.+|||+.||+|.+...|..||+|.+-.. ++...+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 3345567899999999999999999999888799999976542 5778889999999999997 9999999993 322
Q ss_pred c------CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCcEEE
Q 001924 759 R------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 759 ~------~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~VKL 828 (995)
. -.++|+||||.||.|-|+++.. ..|++.++..|+.|+++|+++||... |||||||-+||||+.+|+.||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 2478999999999999999743 56999999999999999999999997 999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh---cCCCCCchHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILF 905 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL---~g~~ys~KSDIWSLGVILy 905 (995)
||||.|.-.. ..+...+-..+. ...-....|+.|+|||++ .+...++|+|||+|||+||
T Consensus 188 CDFGSatt~~--------------~~~~~~~e~~~v----e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 188 CDFGSATTKI--------------LSPTSAQEVNYV----EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred Cccccccccc--------------CCCccHHHHHHH----HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence 9999876210 001011000111 111123578999999997 5677899999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 906 ELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
-|+....||.+... -.|+++.+.+|.. +..+..+++||+.||+.||.+||++-++++
T Consensus 250 kLCy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 250 KLCYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred HHHHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 99999999987643 3567888888864 578899999999999999999999655554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.05 Aligned_cols=232 Identities=33% Similarity=0.500 Sum_probs=193.1
Q ss_pred CCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHH
Q 001924 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 777 (995)
Q Consensus 698 GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~ 777 (995)
|.||.||++.+..+++.||+|.++... .+.+|...+....||||+++++++...+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987532 223445555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 001924 778 LRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857 (995)
Q Consensus 778 L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~ 857 (995)
+.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9887789999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCC
Q 001924 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 937 (995)
Q Consensus 858 ~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lp 937 (995)
.......++..|+|||.+.+..++.++||||+|+++|||++|+.||....... ..... ..++
T Consensus 137 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~-~~~~ 198 (237)
T cd05576 137 -----------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTT-LNIP 198 (237)
T ss_pred -----------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccc-cCCc
Confidence 00112345677999999988889999999999999999999999876432210 11111 1244
Q ss_pred CCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccc
Q 001924 938 SDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974 (995)
Q Consensus 938 s~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF 974 (995)
..++..+.+||.+||+.||.+||++ ..+.++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 6788999999999999999999996 345899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.27 Aligned_cols=260 Identities=30% Similarity=0.485 Sum_probs=222.4
Q ss_pred ccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeec---
Q 001924 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC--- 758 (995)
Q Consensus 684 ~s~~dYeIl-k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~--- 758 (995)
..+++|++. ++||-|-.|.|..+.++.||+.+|+|++.. .....+|+++.-.. .|||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 356788876 478999999999999999999999998753 23466788875444 69999999998865
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecC
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFG 832 (995)
..++.+|||.|+||.|++.++..+. |++..+..|++||+.|+.|||+.+|.||||||+|+|... |..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 3578999999999999999987764 999999999999999999999999999999999999975 4579999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
+|+... ......+.|-||+|.|||++...+|+...|+||+||++|-||+|.+
T Consensus 210 FAK~t~----------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyP 261 (400)
T KOG0604|consen 210 FAKETQ----------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_pred cccccC----------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCC
Confidence 998411 1223456789999999999999999999999999999999999999
Q ss_pred CCCCCC----HHHHHHHHHccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 913 PFTAES----PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 913 PF~g~s----~~ei~qkIl~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
||.... ...+..+|..+.+.||.. +..+|..++++|+++|..+|++|.| |.++++|||.++......
T Consensus 262 PFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 262 PFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred cccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhcccccCCC
Confidence 997653 345677888899988863 4668999999999999999999999 889999999998765443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.45 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=225.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+-|.++.+||+|+||.||++.++.+|..+|||.+.. +.+..++..|+.+|++++.|+||++||.+.....+||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 458899999999999999999999999999997654 346788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||..|++.++++ +...+++..+..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 9999999999997 44679999999999999999999999999999999999999999999999999886311
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
......++..|||.|||||++..-.|+.++||||||+...||.-|++||.+..+......
T Consensus 181 --------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 181 --------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred --------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 123455678999999999999999999999999999999999999999998877665555
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
|-....+-...|...+.++.+|++.||.++|++|-| +.++++|||.++-
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA 289 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNA 289 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCC
Confidence 544443333345678899999999999999999999 8899999998764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=381.20 Aligned_cols=270 Identities=35% Similarity=0.531 Sum_probs=226.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
-+++-..+||.|.||.||-+.+..||...|+|-++-.... ......+.+|..++..++|||+|++||+-...+..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3566677899999999999999999999999988754433 566778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|||.+|+|.++++..+..++...+.+..|++.|++|||+.||+||||||+||+++.+|.+|++|||.|.-...+ +
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~--~--- 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN--A--- 1388 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc--h---
Confidence 99999999999988888888889999999999999999999999999999999999999999999998742211 0
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
..-.......+||+.|||||++.+. +...+.|||||||++.||+||+.||...+.+...
T Consensus 1389 ------------------~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI 1450 (1509)
T KOG4645|consen 1389 ------------------QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI 1450 (1509)
T ss_pred ------------------hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH
Confidence 0001223356899999999999764 4678999999999999999999999887655443
Q ss_pred -HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccch
Q 001924 924 -DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 924 -qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q 985 (995)
..+-.+.. |.+|..++.+..+||..||+.||.+|++ +.++++|.|-+..+...-+.|
T Consensus 1451 My~V~~gh~--Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~~~~d~~s~~~ 1508 (1509)
T KOG4645|consen 1451 MYHVAAGHK--PQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGKSCTDEDSSEQ 1508 (1509)
T ss_pred HhHHhccCC--CCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccccccccchhhc
Confidence 33333332 5667889999999999999999999999 668888888877766554443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=344.39 Aligned_cols=277 Identities=22% Similarity=0.363 Sum_probs=239.1
Q ss_pred CccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 679 ~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
.++|+..-.+..+-.+||.|.||.||.|.|+.-.-.||||.++.. ..+.++|+.|+.+|+.++|||+|+++|+|..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 367777778888999999999999999999998899999998753 3578899999999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+..+|||+|||..|+|.+||++.. .++.-....++.||..||.||..+++|||||...|+|+.++..|||+||||+++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999998653 367777788889999999999999999999999999999999999999999997
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 915 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~ 915 (995)
+..+.++-..| ..-...|.|||-|....++.|+|||+|||+|||+.| |-.||.
T Consensus 415 MtgDTYTAHAG--------------------------AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 415 MTGDTYTAHAG--------------------------AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred hcCCceecccC--------------------------ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 65443322111 123567999999999999999999999999999998 889999
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhhc
Q 001924 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIELK 993 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~~ 993 (995)
+.+..+++.-+ ...+.|. .|.+|++.+.+||+.||++.|..||+..++-+.++..|-. -||.++++.||.
T Consensus 469 GidlSqVY~LL-EkgyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~------sSisdEV~keLg 538 (1157)
T KOG4278|consen 469 GIDLSQVYGLL-EKGYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS------SSISDEVQKELG 538 (1157)
T ss_pred CccHHHHHHHH-hcccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc------ccccHHHHHHHh
Confidence 99988888664 4555554 4689999999999999999999999999999888876643 467777777663
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.64 Aligned_cols=269 Identities=26% Similarity=0.439 Sum_probs=213.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ 761 (995)
...-..|+++++||.||.+.||++...+ .+.||+|.+.. ...+......+.+|++.|.+++ |.+||++|++-..++.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 3456789999999999999999998764 45566665433 2345667889999999999996 8999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~-Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+||||||= ..+|..+|+.... ++...++.+..|++.|++++|+.||||-||||.|+|+ -.|.+||+|||+|..+..+
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 99999975 5599999987654 4446889999999999999999999999999999999 6789999999999864322
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-----------CCchHHHHHHHHHHHHHHc
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-----------ys~KSDIWSLGVILyELLT 909 (995)
.+ .....+.+||+.||+||.+.... .++++||||||||||+|+.
T Consensus 513 TT-------------------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 513 TT-------------------------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred cc-------------------------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 21 22345689999999999995432 4689999999999999999
Q ss_pred CCCCCCCCCHH-HHHHHHHcc--CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccch
Q 001924 910 GIPPFTAESPE-IIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 910 Gr~PF~g~s~~-ei~qkIl~~--~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q 985 (995)
|++||...... .-+..|..- .++||.++.+. ++.++++.||++||.+||+ |-++|+|||++-...-..+|-
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~~~i~~~~m~ 641 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWS---IPELLQHPFLQIQPIPVEQMA 641 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCC---cHHHhcCcccccccccchHHH
Confidence 99999765432 223333332 23555544333 3999999999999999999 999999999987655444443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.47 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=217.7
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe--eEEEE
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--LYLVM 766 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~-~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~--lyLVm 766 (995)
+....||+|+|-+||+|.+..+|-.||=-.++-.. .......++|..|+.+|+.|+|||||++|+++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999999999887743332211 2344566899999999999999999999999988765 88999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceeeecCCCcEEecc-CCcEEEEecCCcccccccccc
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~~~s~ 843 (995)
|.+..|+|+.|+.+.+.++...++.|++||+.||.|||++ .|||||||.+||+|+. .|.|||+|+|||.+..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----- 197 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh-----
Confidence 9999999999999999999999999999999999999998 5999999999999975 4899999999998632
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g-~s~~ei 922 (995)
.......+|||.|||||++. ..|+..+||||||++|+||.|+..||.. .++.++
T Consensus 198 ------------------------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 198 ------------------------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred ------------------------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 12233478999999999998 6899999999999999999999999975 678899
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
|.++..+..+ ..+..--.+++++||.+||.. ...||| +.++|.||||...
T Consensus 253 YKKV~SGiKP-~sl~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 253 YKKVTSGIKP-AALSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred HHHHHcCCCH-HHhhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 9998887654 223334578999999999999 899999 9999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.20 Aligned_cols=254 Identities=34% Similarity=0.541 Sum_probs=221.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
+.||.|.||+||-|+++.+|+.||||+|.+..+..+. ...+.+|+.||.++.||.||.+-..|+..+.+++|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 6899999999999999999999999999998876554 4789999999999999999999999999999999999995 5
Q ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC---CcEEEEecCCcccccccccccCCC
Q 001924 773 DLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 773 SL~d~L~--k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen---G~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+....+- +.+++++...++++.||+.||.|||-+||+|.||||+|||+... ..+||||||+|+++.
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--------- 718 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--------- 718 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---------
Confidence 6555553 55789999999999999999999999999999999999999654 479999999999742
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
......+.+|||.|+|||++.++.|+.+-|+||+|||+|.-|+|..||... +++-++|.
T Consensus 719 -------------------EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQ 777 (888)
T KOG4236|consen 719 -------------------EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQ 777 (888)
T ss_pred -------------------hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhh
Confidence 123345789999999999999999999999999999999999999999653 44556666
Q ss_pred ccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 928 NRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 928 ~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
+..+-+|. .+..+++++.+||+.+|+..-.+|.| +-..|.|||+++..-|.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~ 829 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWL 829 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHH
Confidence 66555443 34679999999999999999999999 88899999999886553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=356.47 Aligned_cols=273 Identities=31% Similarity=0.494 Sum_probs=210.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 758 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~------- 758 (995)
.++|+.++.||+||||.||+++++-+|+.||||.|.... +......+.+|+.++++|+|||||++|..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 578899999999999999999999999999999987543 45667889999999999999999998743300
Q ss_pred --------------------------------------------------------------------------------
Q 001924 759 -------------------------------------------------------------------------------- 758 (995)
Q Consensus 759 -------------------------------------------------------------------------------- 758 (995)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------c--------CeeEEEEeecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 001924 759 ------------------------R--------DNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 805 (995)
Q Consensus 759 ------------------------~--------~~lyLVmEym~GGSL~d~L~k~~~L-see~ir~Ia~QIa~GLaYLHs 805 (995)
+ ..+||-||||+..+|.+++..+... .....+.++++|+.||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1268899999987788887765544 467889999999999999999
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCccccccc-ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChh
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN-NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE 884 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~-~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPE 884 (995)
+|||||||||.||+++.++.|||+|||+|...... ...+... .........+....+..+||..|+|||
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~----------~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDL----------SFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhcc----------CccccccCCCCcccccccceeeeecHH
Confidence 99999999999999999999999999999841110 0111000 000011122233556789999999999
Q ss_pred hhcCCC---CCchHHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHccCCCCC-CCCCCCCHHHHHHHHHHhhcCccCC
Q 001924 885 ILLGTE---HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 885 vL~g~~---ys~KSDIWSLGVILyELLTGr~PF~g~-s~~ei~qkIl~~~~~~p-~lps~lS~eL~dLIkkCLq~DPeKR 959 (995)
++.+.. |+.|+|+||||+||+||+. ||... ....++.++..+.++.+ .++.+--+.-..+|++||+.||++|
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 997755 9999999999999999996 67543 33445555555554443 1233344567789999999999999
Q ss_pred CCHHHHHHHHcCccccc
Q 001924 960 LGANGAAEVFHCKIFIK 976 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~ 976 (995)
|| +.++|++.||..
T Consensus 863 Pt---A~eLL~s~llpp 876 (1351)
T KOG1035|consen 863 PT---ATELLNSELLPP 876 (1351)
T ss_pred CC---HHHHhhccCCCc
Confidence 99 889999999984
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.64 Aligned_cols=269 Identities=25% Similarity=0.340 Sum_probs=216.1
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....+..++|++.+.||+|||+.||++....++..||+|.+.-. ..++.+..++|++..++++||||++++++....
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 34456779999999999999999999999999999999987532 356788999999999999999999999877654
Q ss_pred C-----eeEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCcEEE
Q 001924 760 D-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 760 ~-----~lyLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~VKL 828 (995)
. ..||+++|+..|+|.+.++.. ..+++..+..|+.+|++||++||+.. ++||||||.|||+...+.+++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 4 499999999999999999743 47999999999999999999999998 999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILF 905 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILy 905 (995)
.|||.+...... +.+ .......+ .......|..|+|||++.- ...++++|||||||+||
T Consensus 171 ~D~GS~~~a~i~----i~~---------~~~a~~lQ-----e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 171 MDLGSATQAPIQ----IEG---------SRQALRLQ-----EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred EeccCccccceE----eec---------hHHHHHHH-----HHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 999987742211 100 00001111 1122347899999999854 45689999999999999
Q ss_pred HHHcCCCCCCCCC--HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 906 EFITGIPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 906 ELLTGr~PF~g~s--~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+|+.|..||...- ...+.-.+.++++.+|.-+ ..+..+.+||+.||+.||.+||++.+++..+.
T Consensus 233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred HHHHcCCcchHHhhcCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 9999999996421 1223334555677777543 48999999999999999999999888777654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=284.47 Aligned_cols=243 Identities=49% Similarity=0.829 Sum_probs=206.2
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHHH
Q 001924 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778 (995)
Q Consensus 699 gFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L 778 (995)
+||.||+|.+..+|..+|+|++........ ...+.+|+..+++++|+||+++++++......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999876433221 578899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001924 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (995)
Q Consensus 779 ~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~ 858 (995)
.....++...+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~------------------ 140 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG------------------ 140 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc------------------
Confidence 87666899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHccCCCCCCCC
Q 001924 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCVP 937 (995)
Q Consensus 859 ~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g-~s~~ei~qkIl~~~~~~p~lp 937 (995)
.......++..|++||.+.+..++.++||||||+++|+|++|..||.. .........+...........
T Consensus 141 ----------~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (244)
T smart00220 141 ----------GLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE 210 (244)
T ss_pred ----------cccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc
Confidence 022245688899999999988899999999999999999999999987 555666655554444433222
Q ss_pred CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 938 s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
..++..+.+++.+||..+|++||+ +.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 228899999999999999999999 7777789997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.11 Aligned_cols=274 Identities=27% Similarity=0.442 Sum_probs=214.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-c
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-~ 759 (995)
....|+.+..||+|+||.||++....++. .+|||.|+.... .........+|+.+++.++||||+.+..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45789999999999999999997665543 789998876432 22334567889999999999999999999988 7
Q ss_pred CeeEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC----CcEEEEe
Q 001924 760 DNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTD 830 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k-----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen----G~VKLsD 830 (995)
..+++++||.+. +|.++++- ...++..+++.++.||+.|+.|||++.|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999976 99998862 2468999999999999999999999999999999999999877 8999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHc
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLT 909 (995)
||++++.. .| ..+.......+.|.+|+|||++.|. .|+..+|||++|||+.|||+
T Consensus 180 lGlaR~~~--------~p----------------lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 180 LGLARLFN--------NP----------------LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccHHHHhh--------cc----------------ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 99999521 10 0111223456789999999999885 58999999999999999999
Q ss_pred CCCCCCCCCH---------HHHHHHHHcc-----CCCCCC-----------------------------CCCCCCHHHHH
Q 001924 910 GIPPFTAESP---------EIIFDNILNR-----KIPWPC-----------------------------VPSDMSFEAQD 946 (995)
Q Consensus 910 Gr~PF~g~s~---------~ei~qkIl~~-----~~~~p~-----------------------------lps~lS~eL~d 946 (995)
-.+.|.+... .+.+.+|+.- ...||. ....-++...+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 9888865321 1223333321 111221 01123556889
Q ss_pred HHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhH
Q 001924 947 LINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSK 987 (995)
Q Consensus 947 LIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~ 987 (995)
|+.+||++||.+|+| +.+.|+|+||........+.++-
T Consensus 316 LL~klL~yDP~kRIt---a~qAleh~yF~~d~lpp~pt~~~ 353 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRIT---AEQALEHPYFTEDPLPPLPTSDN 353 (438)
T ss_pred HHHHHhccCchhhcc---HHHHhcccccccCCCCCCcccce
Confidence 999999999999999 77889999999987776555543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=341.56 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=224.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
++..+..+|.++||.|.||.|++|+.+..|+ .||||.++... .+.....|+.|+.||-+..||||++|.|+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4556778999999999999999999987774 89999998644 456678899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
....||+|||++|+|..||+.+ +.|+..++..+++.|+.||+||-++|++||||...|||++.+..+||+|||++++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999754 569999999999999999999999999999999999999999999999999999632
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
++.. ..|.+ ..-.-+.+|.|||.+...+++..+||||+|++|||.++ |..||.+.
T Consensus 783 dd~~---------------~~ytt---------~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 783 DDPE---------------AAYTT---------LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred cCCC---------------ccccc---------cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 2110 01110 01113578999999999999999999999999999887 99999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+++++...|..+- ..| .|.++|..+.+|+..||++|-.+||...+++..|.
T Consensus 839 SNQdVIkaIe~gy-RLP-pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD 889 (996)
T KOG0196|consen 839 SNQDVIKAIEQGY-RLP-PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD 889 (996)
T ss_pred chHHHHHHHHhcc-CCC-CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence 9999999887653 333 25799999999999999999999999998888764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.73 Aligned_cols=257 Identities=28% Similarity=0.510 Sum_probs=215.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ly 763 (995)
.+++.+.+..||.|+.|.||+++.+.+|...|||.+.+.. +.++.++++..+.++.... +|+||+.||+|..+...+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 3466778888999999999999999999999999988644 5667788999999887775 899999999999999999
Q ss_pred EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+.||.|. ..+..++.+ .+++++..+-++...++.||.||.++ ||||||+||+|||+|+.|++||||||++....++
T Consensus 168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 9999983 355556654 35689988889999999999999965 8999999999999999999999999998753211
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCC-
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 917 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF~g~- 917 (995)
.......|.+.|||||.+.- ..|+.++||||||+.++||.||..||.+.
T Consensus 246 ---------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 246 ---------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred ---------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 12233469999999999954 46899999999999999999999999884
Q ss_pred CHHHHHHHHHccCCCCCCCC--CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 918 SPEIIFDNILNRKIPWPCVP--SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lp--s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
...+++..+++... |.++ ..+++.+.+|+..||++|+.+||. --++|+|||....
T Consensus 299 tdFe~ltkvln~eP--P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 299 TDFEVLTKVLNEEP--PLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKRY 355 (391)
T ss_pred ccHHHHHHHHhcCC--CCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceeec
Confidence 55677777777554 4443 358999999999999999999999 5567889987755
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=327.73 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=213.5
Q ss_pred EEEeeccCCCeEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 691 IIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~T----G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.+.||.|.||.||+|....- .--||||..+.... .+..+.|+.|.-+|+++.|||||+++|+|.+. ..||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 345799999999999997543 23789998876442 34478899999999999999999999999864 579999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+++-|.|..||+.. ..++......++.||+.||+|||+..++||||...|||+.....|||+|||+++.+....++.
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk- 548 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK- 548 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh-
Confidence 999999999999855 568999999999999999999999999999999999999999999999999999643332221
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~q 924 (995)
.....-+..|||||-+.-..++..+|||.|||++||+|+ |..||.+..+.++..
T Consensus 549 -------------------------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 549 -------------------------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred -------------------------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 112224568999999999999999999999999999998 999999988888777
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+.++.. +..|+++|+.+..|+.+||+++|.+||...++...|..-+-
T Consensus 604 ~iEnGeR--lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGER--LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCC--CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 7665542 33568999999999999999999999999888887765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=334.73 Aligned_cols=342 Identities=29% Similarity=0.416 Sum_probs=247.8
Q ss_pred hhhhccceeccccCCchhhhhHHHHhcchHHHHhhhccceEEecchhHHHHHHhhhhhhhhh----------hhccCCCC
Q 001924 580 ELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILAC----------ELLDEKSP 649 (995)
Q Consensus 580 ~~~~~~~~~~~~~~~k~~k~~~~a~~~~l~~vl~~~kl~~lvid~~g~Ri~kllr~k~il~~----------~lL~~ksp 649 (995)
+|..+|+=-+...+.+--+.|+++-..++.++++++-+..+ .|-.-..+..+..+.... ..+....|
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i---~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P 285 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI---DWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVP 285 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee---eHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCc
Confidence 35666666666777777788998888899999998888777 343211111111111000 00011111
Q ss_pred C---cccccccchhhhhhhcccCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc
Q 001924 650 T---SFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726 (995)
Q Consensus 650 ~---s~S~~~ensrllldslsqssg~~tp~~s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~ 726 (995)
. ..+....+.++..+- +......-...........|.+...+|.|+|+.|-.+.+..+++.+++|++.+..
T Consensus 286 ~dsp~~~~~~s~~~if~g~----sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-- 359 (612)
T KOG0603|consen 286 ADSPLLSASGSDHTIFSGP----SFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-- 359 (612)
T ss_pred ccCCCCCCCccccchhcCC----CccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc--
Confidence 0 000000000000000 0000000000111235788999999999999999999999999999999998652
Q ss_pred chhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 001924 727 RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805 (995)
Q Consensus 727 se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs 805 (995)
....+|+.++... +||||+++.+.+.+..+.|+|||++.||-|.+.+.....+. ..+..|+.+|+.|+.|||+
T Consensus 360 -----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~ 433 (612)
T KOG0603|consen 360 -----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE 433 (612)
T ss_pred -----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh
Confidence 2234566555444 79999999999999999999999999999988887766555 7778899999999999999
Q ss_pred cCceeeecCCCcEEe-ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChh
Q 001924 806 LGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE 884 (995)
Q Consensus 806 ~GIIHRDLKPeNILL-DenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPE 884 (995)
+|||||||||+|||+ +..|+++|+|||.++... ....+.+-|..|.|||
T Consensus 434 ~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~------------------------------~~~~tp~~t~~y~APE 483 (612)
T KOG0603|consen 434 QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE------------------------------RSCDTPALTLQYVAPE 483 (612)
T ss_pred cCeeecCCChhheeecCCCCcEEEEEechhhhCc------------------------------hhhcccchhhcccChh
Confidence 999999999999999 588999999999987311 0123456789999999
Q ss_pred hhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 885 ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 885 vL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~-ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
++....|+..+||||||++||+||+|+.||...... +++..+..+.+ ...+|..+++||+.||+.||.+||+
T Consensus 484 vl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~-----s~~vS~~AKdLl~~LL~~dP~~Rl~-- 556 (612)
T KOG0603|consen 484 VLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF-----SECVSDEAKDLLQQLLQVDPALRLG-- 556 (612)
T ss_pred hhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc-----ccccCHHHHHHHHHhccCChhhCcC--
Confidence 999999999999999999999999999999876555 55555443332 3689999999999999999999999
Q ss_pred HHHHHHcCccc
Q 001924 964 GAAEVFHCKIF 974 (995)
Q Consensus 964 EIlEiL~HPfF 974 (995)
+-+++.||||
T Consensus 557 -~~~i~~h~w~ 566 (612)
T KOG0603|consen 557 -ADEIGAHPWF 566 (612)
T ss_pred -hhhhccCcch
Confidence 6778889999
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=324.42 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=216.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
.-+...+.++||+|.||.|.++.... +..||||+++... .......|..|+++|.+++||||++++++|..++.+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34567788999999999999998653 6899999998644 34456899999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+|||++|+|.+|+.++ +.+.......|+.||+.||+||.+.+++||||.+.|+|++.++++||+|||+++-...+.+
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999999876 3344556667999999999999999999999999999999999999999999984322222
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPE 920 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT--Gr~PF~g~s~~ 920 (995)
+.. ....+-+.+|||||.+..++++.++|+|+||+++||+++ ...||...+.+
T Consensus 693 y~v-------------------------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 693 YRV-------------------------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred eee-------------------------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 221 123455789999999999999999999999999999866 88999998888
Q ss_pred HHHHHHHc---cC--CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILN---RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~---~~--~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
++.++... .+ ...+..|.-++..+.++|.+||.+|-.+||+.+++...|+
T Consensus 748 ~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 748 QVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred HHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 87766433 11 1234456789999999999999999999999888876654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=327.67 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=216.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
+..++..+.++||+|.||.|++|.|...+. .||||+++..... .....|++|+.+|.+|+|||+++|||+..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 445677888999999999999999975432 8999999865432 267899999999999999999999999987 6
Q ss_pred eeEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
...||||+++.|+|.+.|.+ ...|.....-.|+.||+.||.||.++++|||||...|+|+.....|||+||||.+-..
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78899999999999999986 3468888889999999999999999999999999999999999999999999988432
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.++ .+| .. .....-.+.|+|||.+....++.++|||+|||+||||++ |..||.+.
T Consensus 264 ~ne----------------d~Y---vm-----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 264 ENE----------------DMY---VM-----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred CCC----------------cce---Ee-----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 221 111 11 111234678999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
...+++.+|-.+. . ...|..++..+.++++.||+.+|++||+...+.
T Consensus 320 ~g~qIL~~iD~~e-r-LpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 320 RGIQILKNIDAGE-R-LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred CHHHHHHhccccc-c-CCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 9999999887433 2 335689999999999999999999999988775
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=288.87 Aligned_cols=260 Identities=29% Similarity=0.505 Sum_probs=217.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
.+|.-.++||+|.||+||++++..+++.||+|.++..+ .++......++|+-+++.++|.|||+++++...+..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35677789999999999999999999999999987533 34455678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||.. +|..+... ++.++.+.++.++.|+++||.++|++++.|||+||.|.||+.+|.+|++|||+++....
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99954 88888764 36689999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
+..-....+.|.+|++|.++.+.+ |+.+.|+||.|||+.|+.. |++.|++.+..+.+
T Consensus 154 ---------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred ---------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 011122346799999999998865 7899999999999999988 88999999888887
Q ss_pred HHHHcc-----CCCCCC---------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 924 DNILNR-----KIPWPC---------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 924 qkIl~~-----~~~~p~---------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.+|... .-.||. +-+.++..-.+|++++|.-+|..|++ +.+.++||||.+.
T Consensus 213 krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 213 KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCcccccc
Confidence 777642 112322 11234556789999999999999999 6778999999875
Q ss_pred c
Q 001924 978 T 978 (995)
Q Consensus 978 ~ 978 (995)
.
T Consensus 290 s 290 (292)
T KOG0662|consen 290 S 290 (292)
T ss_pred C
Confidence 3
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=326.20 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=183.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS---- 755 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~T----G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gv---- 755 (995)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ..+....+ .+....+.++..++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3568999999999999999999999988 8999999875422 11111111 1122222222222211
Q ss_pred --eeccCeeEEEEeecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCceeeec
Q 001924 756 --FTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------------LEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (995)
Q Consensus 756 --f~~~~~lyLVmEym~GGSL~d~L~k~~~--------------------Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDL 813 (995)
.......++||||+++++|.+++..... .....+..++.|++.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345678999999999999999865321 112345678999999999999999999999
Q ss_pred CCCcEEecc-CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC---
Q 001924 814 KPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--- 889 (995)
Q Consensus 814 KPeNILLDe-nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~--- 889 (995)
||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+...
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~--------------------------~~~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG--------------------------INYIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc--------------------------cccCCcccccCCCccChHHhhccCCC
Confidence 999999986 579999999999732100 01122346789999999976432
Q ss_pred -------------------CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-ccCCCC--------C----C--
Q 001924 890 -------------------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL-NRKIPW--------P----C-- 935 (995)
Q Consensus 890 -------------------~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl-~~~~~~--------p----~-- 935 (995)
.++.++|||||||+||||+++..|+... ...+...+ ...... + .
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 413 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLR 413 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhh
Confidence 2345679999999999999976665432 22222211 111110 0 0
Q ss_pred ----CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhH
Q 001924 936 ----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSK 987 (995)
Q Consensus 936 ----lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~ 987 (995)
..........+||.+||++||.+||| +.++|+||||.+.....+++...
T Consensus 414 ~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~~~~~~ 466 (566)
T PLN03225 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGLSVMQN 466 (566)
T ss_pred hhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCccccccccc
Confidence 00112334568999999999999999 88889999999988875554443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=326.09 Aligned_cols=257 Identities=32% Similarity=0.529 Sum_probs=225.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeec-----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC----- 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~----- 758 (995)
..+-|++...||.|.+|.||+++++.+++.+|+|+..... ...+++..|.++++.. .|||++.+|++|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3577999999999999999999999999999999986533 3456677899998877 58999999999865
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.+.+|||||||.||+..|++++. ..+.+..+..|++.++.|+.+||.+.+||||||-.|||++.+|.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 45799999999999999999754 5689999999999999999999999999999999999999999999999998863
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-----CCCchHHHHHHHHHHHHHHcCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-----~ys~KSDIWSLGVILyELLTGr 911 (995)
. .....+..+.+|||.|||||++... .|+..+|+||||++..||--|.
T Consensus 173 l---------------------------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~ 225 (953)
T KOG0587|consen 173 L---------------------------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA 225 (953)
T ss_pred e---------------------------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence 1 1233456788999999999998543 4778999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
+|+-+..+...+..|..+..+-...|...+.++.+||..||.+|-.+||+ +.++|+|||..
T Consensus 226 PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~ 286 (953)
T KOG0587|consen 226 PPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFIT 286 (953)
T ss_pred CCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCccc
Confidence 99999998888877776665544557889999999999999999999999 89999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=326.56 Aligned_cols=244 Identities=34% Similarity=0.491 Sum_probs=193.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC------
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD------ 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~------ 760 (995)
..|...+.||+|+||.||+|+++.+|+.||||.+++... ....+...+|+++|++++|||||+++++-....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 446677889999999999999999999999999987542 345678899999999999999999998765543
Q ss_pred eeEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc--CC--cEEEEecCC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DG--HIKLTDFGL 833 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~---~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe--nG--~VKLsDFGL 833 (995)
...+|||||.||+|+.++++. ..+++...+.++.+++.||.|||++||+||||||.||++.. +| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 578999999999999999743 46999999999999999999999999999999999999843 23 589999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
|+-.. ++..-.+.+||..|.+||++. ...|+..+|.|||||++|++.||..
T Consensus 171 Arel~----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 171 ARELD----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred cccCC----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 98421 223445688999999999998 4888999999999999999999999
Q ss_pred CCCCCCH----H-HHHHHHHc--------------cCCCCCC---CCCCCCH----HHHHHHHHHhhcCccCCC
Q 001924 913 PFTAESP----E-IIFDNILN--------------RKIPWPC---VPSDMSF----EAQDLINRFLIHDPNQRL 960 (995)
Q Consensus 913 PF~g~s~----~-ei~qkIl~--------------~~~~~p~---lps~lS~----eL~dLIkkCLq~DPeKRP 960 (995)
||..... . .++..+.. +...|.. .|..++. .+...+..+|..+|.+|.
T Consensus 223 PF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 223 PFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 9965321 1 23332221 1111111 1223333 344567788999999999
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=311.93 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=210.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--C----ceEEEeeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--P----FVVRFFYSFT 757 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--P----NIVkL~gvf~ 757 (995)
...++|.++..+|+|.||.|..+.+..++..||||+++.... ..+..+-|++++.++.+ | -+|++.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 447899999999999999999999999999999999986542 34556779999999842 3 3788899999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-------------
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------- 822 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe------------- 822 (995)
..++.+||+|.+ |-++++++.++. +++...++.+++|++.+++|||+++++|-||||+|||+..
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999998 669999998654 6899999999999999999999999999999999999842
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 823 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 823 -------nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
+-.|+|+|||.|.+.. ..-.+.+.|..|+|||++.+-+++.+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred ceeccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCcc
Confidence 2358999999987511 111356789999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc------------------cCCCCCCCC-----------------
Q 001924 896 DWWSVGIILFEFITGIPPFTAESPEI---IFDNILN------------------RKIPWPCVP----------------- 937 (995)
Q Consensus 896 DIWSLGVILyELLTGr~PF~g~s~~e---i~qkIl~------------------~~~~~p~lp----------------- 937 (995)
||||+||||+|+.+|...|...+..+ +++.|+. +..+|+...
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence 99999999999999999998766444 3333322 122222210
Q ss_pred -----CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 938 -----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 938 -----s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
......+.+||++||.+||.+|+| +.|+|.||||..-..
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARLTP 414 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcCCC
Confidence 011235889999999999999999 888999999987653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=336.56 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=190.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|...+.||+|+||.||+|.+..++..||||.++..... ...|++++++++|||||++++++...+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566778899999999999999989999999988643211 124588899999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLH---s~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 99999999999963 889999999999999999999 6699999999999999998888876 66543200
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---- 919 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~---- 919 (995)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 834 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~ 887 (968)
T PLN00113 834 --------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887 (968)
T ss_pred --------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence 01123688999999999999999999999999999999999999954211
Q ss_pred -HHHHHHHHccC-CC---CCCC------CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 -EIIFDNILNRK-IP---WPCV------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 -~ei~qkIl~~~-~~---~p~l------ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
........... .. .+.. +.....++.+++.+||+.||++||++.++++.|+.
T Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 11111110000 00 0111 11122356789999999999999999999998864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=301.82 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred cCCCCCCCCCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH--hcC
Q 001924 668 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVR 745 (995)
Q Consensus 668 qssg~~tp~~s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs--~Lk 745 (995)
+.+|...|. ...++...+..+.+.||+|.||.||+|.|+ |+.||||+|... +...+.+|.+|.+ .|+
T Consensus 195 SGSGSGlpl---LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLR 263 (513)
T KOG2052|consen 195 SGSGSGLPL---LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLR 263 (513)
T ss_pred CCCCCCchh---HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhc
Confidence 334444444 567788899999999999999999999998 999999999753 3456778888876 579
Q ss_pred CCceEEEeeeeeccC----eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------Cceeeec
Q 001924 746 NPFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 813 (995)
Q Consensus 746 HPNIVkL~gvf~~~~----~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--------GIIHRDL 813 (995)
|+||+.+++.-..+. ++|||++|++.|+|+|||.+ ..++.+...+++..++.||+|||.. .|.||||
T Consensus 264 HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 264 HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999999997655433 58999999999999999987 5688888899999999999999953 4999999
Q ss_pred CCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC---
Q 001924 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--- 890 (995)
Q Consensus 814 KPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~--- 890 (995)
|..|||+..+|.+.|+|+|||...... ...-....+..+||.+|||||+|...-
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~-----------------------t~~idi~~N~rVGTKRYMAPEvLdetin~~ 399 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSD-----------------------TDTIDIPPNPRVGTKRYMAPEVLDETINMK 399 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEeccc-----------------------CCcccCCCCCccceeeccChHHhhhhcChh
Confidence 999999999999999999999742111 011123345679999999999996532
Q ss_pred ---CCchHHHHHHHHHHHHHHcC----------CCCCCCC-----CHHHHHHHHHccCCCCCCCCCCCC-----HHHHHH
Q 001924 891 ---HGYAADWWSVGIILFEFITG----------IPPFTAE-----SPEIIFDNILNRKIPWPCVPSDMS-----FEAQDL 947 (995)
Q Consensus 891 ---ys~KSDIWSLGVILyELLTG----------r~PF~g~-----s~~ei~qkIl~~~~~~p~lps~lS-----~eL~dL 947 (995)
.-..+||||||.++||+... .+||.+. +.+++..-+...+.. |.+|.... ..+..|
T Consensus 400 ~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~kl 478 (513)
T KOG2052|consen 400 HFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAKL 478 (513)
T ss_pred hhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHHH
Confidence 13468999999999999642 4688653 334443333333332 33333322 246678
Q ss_pred HHHHhhcCccCCCCHHHHHHHH
Q 001924 948 INRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 948 IkkCLq~DPeKRPSA~EIlEiL 969 (995)
|+.||..+|.-|.||-.+...|
T Consensus 479 MkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 479 MKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred HHHhhcCCchhhhHHHHHHHHH
Confidence 9999999999999976555544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=309.18 Aligned_cols=269 Identities=29% Similarity=0.441 Sum_probs=217.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH----HHHHHHHHHHHHhcCCCceEEEeeeeec-c
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND----IERILAERNILITVRNPFVVRFFYSFTC-R 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e----~e~flrEieILs~LkHPNIVkL~gvf~~-~ 759 (995)
-.++|-++..||+|||+.||++.+...+++||+|+-.....+.++. .+...+|..|.+.|.||.||++|++|.. .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3478999999999999999999999999999999865443333322 3456789999999999999999999975 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceeeecCCCcEEecc---CCcEEEEecCCc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAH---DGHIKLTDFGLS 834 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--GIIHRDLKPeNILLDe---nG~VKLsDFGLA 834 (995)
+.++-|+|||+|.+|.-||+....+++..++.|+.||+.||.||.+. .|||-||||.|||+.. -|.+||.|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 67899999999999999999999999999999999999999999977 6999999999999954 368999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC----CCCchHHHHHHHHHHHHHHcC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~----~ys~KSDIWSLGVILyELLTG 910 (995)
+++..+.+-... ....+.-..||.+|++||++.-. +.+.++||||+|||+|.++.|
T Consensus 621 KIMdddSy~~vd--------------------GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 621 KIMDDDSYNSVD--------------------GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred hhccCCccCccc--------------------ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 976433321111 12223345799999999998543 458899999999999999999
Q ss_pred CCCCCCCC-HHHHHH--HHHcc-CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 911 IPPFTAES-PEIIFD--NILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 911 r~PF~g~s-~~ei~q--kIl~~-~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+.||.... ...+++ .|++. ...||. .+-++.++++||++||++--+.|.. +.++-.||||.-.
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyllPh 747 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLLPH 747 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhh---HHHHccCccccch
Confidence 99997653 333332 23332 333443 2468999999999999999999998 8899999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=297.73 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=214.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieIL-s~LkHPNIVkL~gvf~~~~~ly 763 (995)
..++.+-+..||.|.||+|++-.++.+|+..|||.|+... .+.+..+++.|.+.. +.-+.||||++||.+..++..|
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 3456677788999999999999999999999999998644 356778888888765 4557899999999999999999
Q ss_pred EEEeecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 764 LVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 764 LVmEym~GGSL~d~L~-----k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
|.||+|+ .+|..+.. ....+++..+-.|..-.+.||.||-.. .||||||||+|||++..|.|||||||++...
T Consensus 140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 9999994 46654442 335689998888888899999999965 8999999999999999999999999988631
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.+........|...|||||.+.. .+|+.++||||||++|||+.||+.||.
T Consensus 219 ----------------------------v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 219 ----------------------------VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred ----------------------------HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 11223344578999999999954 468999999999999999999999998
Q ss_pred CCC-HHHHHHHHHccCCCCCCCCCC---CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 916 AES-PEIIFDNILNRKIPWPCVPSD---MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 916 g~s-~~ei~qkIl~~~~~~p~lps~---lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
+.+ ..+...+++.+..+....+.. .+..+..+|..||.+|-..||. -.+++.+||.........
T Consensus 271 ~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 271 KWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred hHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhhhhhcCC
Confidence 754 344455566666654443333 7899999999999999999999 667888999887655443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=306.45 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=189.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC----------------CCCcEEEEEEeecccccch-----------hHHHHHH
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKR----------------TTGDLFAIKVLKKLDMIRK-----------NDIERIL 735 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k----------------~TG~~VAVKVIkk~~~~se-----------~e~e~fl 735 (995)
+...++|++.++||+|+||+||+|.+. ..++.||||.++....... ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999752 2356899998864221100 0112334
Q ss_pred HHHHHHHhcCCCce-----EEEeeeeec--------cCeeEEEEeecCCCCHHHHHHhcC--------------------
Q 001924 736 AERNILITVRNPFV-----VRFFYSFTC--------RDNLYLVMEYLNGGDLYSLLRKVG-------------------- 782 (995)
Q Consensus 736 rEieILs~LkHPNI-----VkL~gvf~~--------~~~lyLVmEym~GGSL~d~L~k~~-------------------- 782 (995)
.|+.++.+++|.++ ++++++|.. .+..++||||+++|+|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 56677777776554 566666643 346899999999999999886421
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001924 783 ----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (995)
Q Consensus 783 ----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~ 858 (995)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------------- 363 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------------- 363 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----------------
Confidence 23456788899999999999999999999999999999999999999999986311000
Q ss_pred CCCccccccccCCcCCCCCCcccChhhhcCCC--------------------C--CchHHHHHHHHHHHHHHcCCC-CCC
Q 001924 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--------------------H--GYAADWWSVGIILFEFITGIP-PFT 915 (995)
Q Consensus 859 ~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~--------------------y--s~KSDIWSLGVILyELLTGr~-PF~ 915 (995)
........+|+.|+|||.+.... | ..+.||||+||++|+|++|.. ||.
T Consensus 364 ---------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 364 ---------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ---------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 00111234588999999985432 1 234799999999999999875 775
Q ss_pred CCCHH-----------HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCc---cCCCCHHHHHHHHcCccccc
Q 001924 916 AESPE-----------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP---NQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 916 g~s~~-----------ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DP---eKRPSA~EIlEiL~HPfF~~ 976 (995)
+.... ..+..+....+.++ .....++..++|+.+||..+| .+|+| +.++|+||||..
T Consensus 435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred chhhhhhHHhhccchHHHHHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 42111 11122222333333 234678999999999999876 68999 889999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=314.81 Aligned_cols=261 Identities=28% Similarity=0.405 Sum_probs=216.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 752 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~-------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL 752 (995)
.++...++..+.+.||.|.||.|++|.-.. ....||||.++.... ..+...+..|+++|+.+ +||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455566677888899999999999987431 145899999876443 36678999999999998 59999999
Q ss_pred eeeeeccCeeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCC
Q 001924 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (995)
Q Consensus 753 ~gvf~~~~~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPe 816 (995)
+|++...+.+++|+||+..|+|.++++... .++......++.||+.||+||++.++|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997655 3888899999999999999999999999999999
Q ss_pred cEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCC--CCCcccChhhhcCCCCCch
Q 001924 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV--GTPDYLAPEILLGTEHGYA 894 (995)
Q Consensus 817 NILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~v--GTp~YmAPEvL~g~~ys~K 894 (995)
|||+..+..+||+|||+|+-.....++. ..... -+..|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~--------------------------~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYR--------------------------TKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceE--------------------------ecCCCCccceeecCHHHhccCccccc
Confidence 9999999999999999998321111100 00011 2456999999999999999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCC-HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 895 ADWWSVGIILFEFIT-GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 895 SDIWSLGVILyELLT-Gr~PF~g~s-~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+||||||++||||++ |..||.+.. ..+++..+.. +.. ...|..++.++.+||+.||+.+|++||+..++.+.+..
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNR-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCC-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 999999999999999 999999865 5666654444 333 33568899999999999999999999999999998876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=294.23 Aligned_cols=265 Identities=30% Similarity=0.438 Sum_probs=211.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~------ 759 (995)
.+.|.-..+||+|.||.||+++.+.+|+.||+|.+-.. ...+......++|+.+|..++|+|++.++..|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45677888999999999999999999999999854321 11223345678999999999999999999887643
Q ss_pred --CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 760 --DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 760 --~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..+|+||++|+. +|+.+|.+. ..++...++.++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 248999999976 999998655 5799999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
..... ..........+.|.+|++||.+.|. .|+.+.|||..|||+.||.+|.+-|.
T Consensus 174 fs~~~-----------------------n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSK-----------------------NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eeccc-----------------------ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 22111 1111223456789999999999874 68999999999999999999999999
Q ss_pred CCCHHHHHHHHHc--c---CCCCCC---------------------------CCCCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 916 AESPEIIFDNILN--R---KIPWPC---------------------------VPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 916 g~s~~ei~qkIl~--~---~~~~p~---------------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
+.+....+..|.. + ...||. .|-.-++++.+|+.++|.+||.+|++
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~-- 308 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID-- 308 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc--
Confidence 8887766555432 1 111222 01122457889999999999999999
Q ss_pred HHHHHHcCccccccc
Q 001924 964 GAAEVFHCKIFIKKT 978 (995)
Q Consensus 964 EIlEiL~HPfF~~~~ 978 (995)
+-+.|+|-||....
T Consensus 309 -ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 309 -ADQALNHDFFWKDP 322 (376)
T ss_pred -hHhhhchhhhhcCC
Confidence 66778999996543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=301.28 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=213.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC------CceEEEeeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFT 757 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH------PNIVkL~gvf~ 757 (995)
.--++|.+....|+|-|++|.+|.+..-|..||||+|+.... ..+.=+.|++||++|.. -|+++++-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 345789999999999999999999999999999999987543 33455789999999963 48999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCC
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGL 833 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGL 833 (995)
...++|||+|.+ ..+|.++|++.+ .|....++.|++|+..||..|-..||+|.||||.|||+++. ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999988 569999998765 47888999999999999999999999999999999999876 4799999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
|.....++ ......+..|.|||++.|..|++..|+||+||+||||.||+..
T Consensus 584 A~~~~ene-----------------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASENE-----------------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred cccccccc-----------------------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 87532211 1122345679999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCCCCCC---------------------------------------CC---------------CC
Q 001924 914 FTAESPEIIFDNILNRKIPWPC---------------------------------------VP---------------SD 939 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~---------------------------------------lp---------------s~ 939 (995)
|++.++..++.-.+.-+.+||. .| ..
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9999888877665543333322 01 00
Q ss_pred ---CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 940 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 940 ---lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+-..+.+|+.+||..||++|.| +.++|.||||..+
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITEK 752 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccCC
Confidence 1125789999999999999999 8889999999763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=284.62 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=210.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC---
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--- 760 (995)
+...+|.-++.+|.|.- .|.-+.+..+++.||+|.+... ........+..+|..++..+.|+||++++.+|.-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34578888999999998 7888888889999999987654 444555678899999999999999999999987654
Q ss_pred ---eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 761 ---~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
..|+|||||. ++|..++. -.++...+..++.|++.|+.|||++||+||||||+||++..++.+||.|||+|+..
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 4799999995 59998887 34788899999999999999999999999999999999999999999999999831
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.........+.|..|.|||++.+.+|...+||||+||++.||++|..-|.+.
T Consensus 169 ----------------------------~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 ----------------------------DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ----------------------------CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 0012334567899999999999999999999999999999999999999887
Q ss_pred CHHHHHHHHHccC---------------------------CCC----CC--------CCCCCCHHHHHHHHHHhhcCccC
Q 001924 918 SPEIIFDNILNRK---------------------------IPW----PC--------VPSDMSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 918 s~~ei~qkIl~~~---------------------------~~~----p~--------lps~lS~eL~dLIkkCLq~DPeK 958 (995)
+.-+.+.++...- ..+ |. .+..-+..+.+++.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 7655544443210 000 00 01123456889999999999999
Q ss_pred CCCHHHHHHHHcCcccc
Q 001924 959 RLGANGAAEVFHCKIFI 975 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~ 975 (995)
|.+ +.++|+||||+
T Consensus 301 Ris---v~daL~HPY~~ 314 (369)
T KOG0665|consen 301 RIS---VDDALRHPYIK 314 (369)
T ss_pred ccc---HHHHhcCCeee
Confidence 999 89999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=311.51 Aligned_cols=249 Identities=30% Similarity=0.404 Sum_probs=198.9
Q ss_pred EEeeccCCCeE-EEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEEEEeec
Q 001924 692 IKPISRGAFGR-VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 692 lk~LG~GgFGt-VYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
-+.+|.|+.|+ ||+|... |+.||||.+-. .......+|+..|+.. .|||||++|+.-.+....||+.|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35689999996 7999875 89999996542 3455678999999877 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---C--CcEEEEecCCccccccc
Q 001924 770 NGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---D--GHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 770 ~GGSL~d~L~k~~----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---n--G~VKLsDFGLArv~~~~ 840 (995)
. .+|.++++... .......+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++-...+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 5 59999998641 1111345678899999999999999999999999999976 3 37999999999842211
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
. ..-.......||-+|+|||++.....+..+|||||||++|+.++ |..||.....
T Consensus 665 ~------------------------sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 665 K------------------------SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred c------------------------chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 1 11122456679999999999999888889999999999999998 5999987644
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.+ .+|+.+......+.+....++.+||.+|+..+|..||+ +.++|.||||=...
T Consensus 721 R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 721 RQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLFWDSE 774 (903)
T ss_pred hh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCccCChH
Confidence 43 35677766544443333338999999999999999999 88999999996543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=289.59 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=194.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeeccC---
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD--- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~--LkHPNIVkL~gvf~~~~--- 760 (995)
....++.+.||+|+||.||+|... ++.||||+|.. .....+.+|.+|.+. ++|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 456678889999999999999875 79999999864 456778899988775 58999999998766554
Q ss_pred -eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeeecCCCcEEeccCCcEEEEe
Q 001924 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHIKLTD 830 (995)
Q Consensus 761 -~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~---------GIIHRDLKPeNILLDenG~VKLsD 830 (995)
.++||++|++.|+|.+||..+ .+++.....++..+++||+|||+. .|+|||||..|||+.++++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 789999999999999999764 599999999999999999999964 599999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC------CchHHHHHHHHHH
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIIL 904 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y------s~KSDIWSLGVIL 904 (995)
||+|..... ..........+||.+|||||+|.+.-. -.+.||||+|.+|
T Consensus 360 FGLAl~~~p-------------------------~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 360 FGLALRLEP-------------------------GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred cceeEEecC-------------------------CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 999985220 011222334789999999999977432 2478999999999
Q ss_pred HHHHcCCC------------CCCC-----CCHHHHHHHHHccCCCCCCCCC-----CCCHHHHHHHHHHhhcCccCCCCH
Q 001924 905 FEFITGIP------------PFTA-----ESPEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 905 yELLTGr~------------PF~g-----~s~~ei~qkIl~~~~~~p~lps-----~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
|||++... ||.. .+.+++...++..+. .|.++. .-...+.+.+..||..||+.|.|+
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~-RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQ-RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhcc-CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 99998543 3321 123344444444332 243332 233568899999999999999998
Q ss_pred HHHHHHH
Q 001924 963 NGAAEVF 969 (995)
Q Consensus 963 ~EIlEiL 969 (995)
.-+.+.+
T Consensus 494 ~Cv~eR~ 500 (534)
T KOG3653|consen 494 GCVEERM 500 (534)
T ss_pred HHHHHHH
Confidence 7776654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=302.06 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=211.0
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
..+..++||.|+||+||+|.|.-.|+ +||+|++.... ......+++.|+-+|.++.|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34556789999999999999976665 88999886533 3445678999999999999999999999998776 88
Q ss_pred EEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
||++|+++|+|.++++.. ..+-......|+.||++||.|||.++++||||-..|+|+.....+|+.|||+|+......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~- 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE- 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc-
Confidence 999999999999999754 568888899999999999999999999999999999999999999999999998522110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
..| ......-.+.|||=|.+....|+.++|||||||++||++| |..||.+....+
T Consensus 853 ---------------~ey---------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 853 ---------------KEY---------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred ---------------ccc---------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 011 1112224578999999999999999999999999999999 999999999888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
+-+.+..+.. ...|+.++.++.-++.+||..|+..||++++....
T Consensus 909 I~dlle~geR--LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 909 IPDLLEKGER--LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred hhHHHhcccc--CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHH
Confidence 8777655543 34568899999999999999999999997665553
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=286.10 Aligned_cols=262 Identities=29% Similarity=0.491 Sum_probs=212.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----e
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 761 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~-----~ 761 (995)
.+.+.-+.||.|+||+||-+.+..+|+.||+|.+.. .+.+-...+++.+|..+|...+|.|++..++...-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344556789999999999999999999999998764 3334456688999999999999999999888766543 4
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+++|+|. .+|..++-....++.+.++-+++||++||+|||+.||.||||||.|.|++.|..+||||||++++-
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve---- 206 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW---- 206 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc----
Confidence 788999994 589888887788999999999999999999999999999999999999999999999999999851
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.......+.-.+.|.+|+|||+++|. .|+..+||||+|||+.|||..+..|...++.
T Consensus 207 ----------------------e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 207 ----------------------DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred ----------------------chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 11223334445789999999999985 5899999999999999999999999877766
Q ss_pred HHHHHHHc-----------------------cCCCCCCC--------CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 921 IIFDNILN-----------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 921 ei~qkIl~-----------------------~~~~~p~l--------ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+.++.|.. +....|.. +..-..+...++..+|..||.+|.+ +.+.+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~A~ 341 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEEAL 341 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhhhc
Confidence 55544422 22222221 1233456788999999999999999 88889
Q ss_pred cCcccccccc
Q 001924 970 HCKIFIKKTE 979 (995)
Q Consensus 970 ~HPfF~~~~~ 979 (995)
.|+|+...+.
T Consensus 342 ~~~~~~e~R~ 351 (449)
T KOG0664|consen 342 QHRYLEEGRL 351 (449)
T ss_pred ccccccccce
Confidence 9999877654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=273.28 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=208.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccC-
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD- 760 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~- 760 (995)
....++|++.+++|+|.|+.||.|.+..+++.++||+++.. ..+.+.+|+.||..+. ||||++++++..+..
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 34678999999999999999999999999999999999853 3567899999999997 999999999988754
Q ss_pred -eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCccccc
Q 001924 761 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 -~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLArv~~ 838 (995)
.+.+|+||+.+.+...+. +.++...++.++.+++.||.|+|++||.|||+||.|++||.. ..++|+|||+|.+..
T Consensus 108 ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 588999999887665554 458888999999999999999999999999999999999965 579999999998622
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC-C
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT-A 916 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~-g 916 (995)
+....+..+.+..|--||++.. ..|+.+-|+|||||+|..|+..+.||- +
T Consensus 185 ----------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 ----------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred ----------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 1222344567888999999855 568999999999999999999888873 4
Q ss_pred CCHHHHHHHHH---------------------------ccC--CCCCC-----CCCCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 917 ESPEIIFDNIL---------------------------NRK--IPWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 917 ~s~~ei~qkIl---------------------------~~~--~~~p~-----lps~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
.++.+.+.+|. ... .+|.. ...-.++++.+|+.++|.+|-.+|+|
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT- 315 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT- 315 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc-
Confidence 44333222221 111 11111 11235699999999999999999999
Q ss_pred HHHHHHHcCcccccccccc
Q 001924 963 NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 963 ~EIlEiL~HPfF~~~~~n~ 981 (995)
+.+.+.||||..+.+..
T Consensus 316 --akEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 316 --AKEAMAHPYFAPVREAE 332 (338)
T ss_pred --hHHHhcCchHHHHHHHh
Confidence 77788999998876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-28 Score=237.27 Aligned_cols=210 Identities=44% Similarity=0.739 Sum_probs=181.6
Q ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCH
Q 001924 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 695 LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL 774 (995)
||.|++|.||++....+++.+++|++....... ....+.+|+.+++.+.|++++++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987643211 356799999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCcccccccccccCCCCCCCC
Q 001924 775 YSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDG 852 (995)
Q Consensus 775 ~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~~~s~dlsg~~t~g 852 (995)
.+++... ..++...+..++.+++.+|+|||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK----------- 147 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc-----------
Confidence 9999765 46899999999999999999999999999999999999999 8999999999987411000
Q ss_pred CCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCC
Q 001924 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931 (995)
Q Consensus 853 i~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~ 931 (995)
.......+...|++||.+... .++.++|+|+||+++++|
T Consensus 148 ----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 148 ----------------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred ----------------chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 012234578899999999887 788999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 932 ~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
..+.+++..|++.+|.+||++.+++.
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 57899999999999999999655543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=284.69 Aligned_cols=131 Identities=29% Similarity=0.494 Sum_probs=114.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----C---CceEEEeeeee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----N---PFVVRFFYSFT 757 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-----H---PNIVkL~gvf~ 757 (995)
..+|-+.++||.|-|++||++.+..+.+.||+|+.+... ...+..+.|+.+|+++. | .+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 379999999999999999999999999999999998643 33456788999998874 3 36999999997
Q ss_pred ccC----eeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEec
Q 001924 758 CRD----NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIA 821 (995)
Q Consensus 758 ~~~----~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLD 821 (995)
..+ +++||+|++ |-+|..+|... ..++...++.|++||+.||.|||.. ||||-||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 654 699999999 77999999754 5699999999999999999999976 999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=302.56 Aligned_cols=271 Identities=30% Similarity=0.492 Sum_probs=233.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|.++..+|.|+||.||+++++.+++..|+|+++... ...+.-+.+|+-+++.++|||||.+++.+...+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 45689999999999999999999999999999999997533 345667788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
++||||.||+|.+..+-.+.+++.++..+++..++||+|||+.|=+|||||-.|||++..|.+|++|||.+..+.
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh---cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL---~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
..-.+...+.||++|||||+. ..+.|+...|||++|+...|+---.+|.....+.
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 112344568899999999996 4567999999999999999998888888777777
Q ss_pred HHHHHHHccCCCCCCC--CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhhc
Q 001924 921 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIELK 993 (995)
Q Consensus 921 ei~qkIl~~~~~~p~l--ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~~ 993 (995)
....-+....+..|.+ +...++.+.+|++.+|.++|.+||+ +..+|.|||..+- +.--+.+||+
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~------l~~rl~~eLL 287 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT------LSRRLAIELL 287 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc------hhhHHHHHHH
Confidence 7777776776665654 3467899999999999999999999 7777889998765 4445555553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=242.89 Aligned_cols=214 Identities=45% Similarity=0.744 Sum_probs=182.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
|.+.+.||.|++|.||++....+++.+|+|.+...... .....+.+|++.+..++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67789999999999999999988999999998764322 2467888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 769 LNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 769 m~GGSL~d~L~k~~~-Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
+++++|.+++..... +++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987766 8999999999999999999999999999999999999999999999999887421100
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh-cCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCH-HHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITGIPPFTA-ESP-EIIFD 924 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL-~g~~ys~KSDIWSLGVILyELLTGr~PF~g-~s~-~ei~q 924 (995)
........++..|++||.+ ....++.++|||+||+++|+|++|+.||.. ..+ ..+.+
T Consensus 153 --------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 153 --------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred --------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 0012335678899999999 666778899999999999999999999987 444 46666
Q ss_pred HHHccC
Q 001924 925 NILNRK 930 (995)
Q Consensus 925 kIl~~~ 930 (995)
.+..+.
T Consensus 213 ~~~~~~ 218 (225)
T smart00221 213 VWSFGV 218 (225)
T ss_pred HHhcCC
Confidence 665554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=288.47 Aligned_cols=204 Identities=29% Similarity=0.518 Sum_probs=179.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhcC---CCceEEEeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVR---NPFVVRFFYS 755 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e-----~e~flrEieILs~Lk---HPNIVkL~gv 755 (995)
....+|..++.||.|+||.|+++.++.+...|+||.|.+....-... .-.+-.|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 45678999999999999999999999999999999998755432222 223457999999997 9999999999
Q ss_pred eeccCeeEEEEeecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 756 FTCRDNLYLVMEYLN-GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 756 f~~~~~lyLVmEym~-GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
|++++.+||+||-.. |-+|+++++..+.+++.+++.|++|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999999864 4589999999999999999999999999999999999999999999999999999999999988
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~P 913 (995)
... ....-..++||..|.|||++.|.+| +..-|||+||++||.++....|
T Consensus 718 a~~-----------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 718 AYT-----------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred hhh-----------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 641 1122346789999999999999988 7789999999999999999999
Q ss_pred CCC
Q 001924 914 FTA 916 (995)
Q Consensus 914 F~g 916 (995)
|..
T Consensus 769 yyn 771 (772)
T KOG1152|consen 769 YYN 771 (772)
T ss_pred CcC
Confidence 864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=251.87 Aligned_cols=217 Identities=29% Similarity=0.530 Sum_probs=181.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
...++..-+..||+|+||.|=+.++..+|...|+|.++.. ....+..+.++|+++..+. .+|.+|.+||........
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3445666778899999999999999999999999998753 3456678889999886654 689999999999999999
Q ss_pred EEEEeecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 763 YLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 763 yLVmEym~GGSL~d~L----~k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
+|.||.|+. +|..+. ...+.+++..+-+|+..++.||.|||++ .+||||+||+||||+..|.||+||||++...
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999954 776554 4557899999999999999999999986 8999999999999999999999999988642
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC----CCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g----~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
. +.-......|...|||||.+.. ..|+-++||||||+.+.||.+++.|
T Consensus 200 ~----------------------------dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 200 V----------------------------DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred h----------------------------hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence 1 1112233568899999999843 4789999999999999999999999
Q ss_pred CCC-CCHHHHHHHHHccCC
Q 001924 914 FTA-ESPEIIFDNILNRKI 931 (995)
Q Consensus 914 F~g-~s~~ei~qkIl~~~~ 931 (995)
|+. .++.+.+.+++....
T Consensus 252 Y~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 252 YESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred ccccCCHHHHHHHHhcCCC
Confidence 975 578888888877654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=269.55 Aligned_cols=289 Identities=25% Similarity=0.388 Sum_probs=208.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccC
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~---TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~ 760 (995)
..+.|..+++||.|.|++||++.+.. .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34678999999999999999999877 78899999876533 3567999999999885 899999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~ 839 (995)
...+|+||++...-.+++.. ++...++.+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|.-...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999888888754 678899999999999999999999999999999999975 46789999999872110
Q ss_pred c----ccccCCCCCCCCCCCCCCCCCcc-------------ccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHH
Q 001924 840 N----NTIDLSGPETDGIMPSDAHYPEY-------------QQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVG 901 (995)
Q Consensus 840 ~----~s~dlsg~~t~gi~~s~~~ys~~-------------~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLG 901 (995)
. ..-..+++..........++-.. ............||++|+|||++... ..+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 00010111000000000000000 11112223346799999999999765 458899999999
Q ss_pred HHHHHHHcCCCCCCCCCH-----H---------HHHHH-HHccC------C----------CCC----------------
Q 001924 902 IILFEFITGIPPFTAESP-----E---------IIFDN-ILNRK------I----------PWP---------------- 934 (995)
Q Consensus 902 VILyELLTGr~PF~g~s~-----~---------ei~qk-Il~~~------~----------~~p---------------- 934 (995)
||+.-+++++.||-.... . .+..- ...+. - .|.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 999999999999843211 0 00000 00000 0 000
Q ss_pred -C-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 935 -C-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 935 -~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
. .....+..+.+|+.+||..||.+|.| +.+.|.||||.......-..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~~~~~~~ 394 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEADRTERGL 394 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchhhhhhhh
Confidence 0 11224558999999999999999999 78889999999665544333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-25 Score=218.22 Aligned_cols=254 Identities=41% Similarity=0.720 Sum_probs=203.4
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeeccCeeEEEEe
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP-NIVkL~gvf~~~~~lyLVmE 767 (995)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|..++..+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 78999998875544433577899999999999988 79999999977777899999
Q ss_pred ecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCcccccccccc
Q 001924 768 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 768 ym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~~~s~ 843 (995)
|+.++++.+++.... .++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887664 799999999999999999999999999999999999999988 7999999998731110000
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP- 919 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF~g~s~- 919 (995)
...........||..|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 159 ---------------------~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 ---------------------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred ---------------------ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 000023456789999999999988 5788999999999999999999999877653
Q ss_pred ---HHHHHHHHccCCC-CCC-CCCCC----CHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 920 ---EIIFDNILNRKIP-WPC-VPSDM----SFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 920 ---~ei~qkIl~~~~~-~p~-lps~l----S~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
......+.....+ ... ..... ...+.+++..++..+|..|.+.....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 4455444444432 111 11111 25789999999999999999955444
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=255.52 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=209.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG-----~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...+++....+-+|.||.||+|.|+... +.|-+|.++.. .++.....++.|.-.+..+.|||+..+.+++...
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 3456778888999999999999886533 34556655532 2455677889999999999999999999887654
Q ss_pred -CeeEEEEeecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEe
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k--------~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsD 830 (995)
..++.++.++.-|+|..++.- ...++..+...++.|++.|++|||+.||||.||...|.+||+.-.|||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 568999999999999999971 12467778888999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT- 909 (995)
=.+++- ..|.+.++ .... . -.+..||+||.+.+..|+..+|||||||+||||+|
T Consensus 440 saLSRD----------------LFP~DYhc--LGDn--E-----nRPvkWMslEal~n~~yssasDvWsfGVllWELmtl 494 (563)
T KOG1024|consen 440 SALSRD----------------LFPGDYHC--LGDN--E-----NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTL 494 (563)
T ss_pred chhccc----------------cCcccccc--cCCC--C-----CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhc
Confidence 998872 12222221 1111 1 13568999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|+.||..-++.++...+..+.. ...|.++|+++..+|..||+.+|++||+..++...|.
T Consensus 495 g~~PyaeIDPfEm~~ylkdGyR--laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 495 GKLPYAEIDPFEMEHYLKDGYR--LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred CCCCccccCHHHHHHHHhccce--ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 9999999999999888766542 3346899999999999999999999999988877664
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=287.62 Aligned_cols=227 Identities=15% Similarity=0.192 Sum_probs=153.9
Q ss_pred hcCC-CceEEEeeee-------eccCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeec
Q 001924 743 TVRN-PFVVRFFYSF-------TCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (995)
Q Consensus 743 ~LkH-PNIVkL~gvf-------~~~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDL 813 (995)
.++| +||+.++++| ...+.++++|||+ +++|++++... ..+++..++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5777788777 2334678889988 66999999753 45999999999999999999999999999999
Q ss_pred CCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCC--------CCCcccc-ccccCCcCCCCCCcccChh
Q 001924 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA--------HYPEYQQ-TDNRNRHSAVGTPDYLAPE 884 (995)
Q Consensus 814 KPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~--------~ys~~~~-~~~~~s~t~vGTp~YmAPE 884 (995)
||+||||+..|.+|++|||++.....+......- ...|...... ....... .........+||+.|||||
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki-~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKS-REIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccc-cccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999887888888887765321111000000 0000000000 0000000 0001112357899999999
Q ss_pred hhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHH
Q 001924 885 ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964 (995)
Q Consensus 885 vL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~E 964 (995)
++.+..|+.++|||||||+||||++|.+|+.... .....+.....+ +. .....+...+++.+||+.+|.+||+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~L~~~P~~Rps--- 258 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP-PQ-ILLNWPKEASFCLWLLHPEPSCRPS--- 258 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC-hh-hhhcCHHHHHHHHHhCCCChhhCcC---
Confidence 9999999999999999999999999988876432 122222211111 11 1122456778999999999999999
Q ss_pred HHHHHcCccccccc
Q 001924 965 AAEVFHCKIFIKKT 978 (995)
Q Consensus 965 IlEiL~HPfF~~~~ 978 (995)
+.++++||||....
T Consensus 259 ~~eil~h~~~~~~~ 272 (793)
T PLN00181 259 MSELLQSEFINEPR 272 (793)
T ss_pred hHHHhhchhhhhhh
Confidence 67788999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=247.38 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=197.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee-eeccCee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS-FTCRDNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gv-f~~~~~l 762 (995)
..+.|.+.+.||+|.||.+.++.++.++..+++|.+.+.. ....+|.+|...--.| .|.||+..|++ |+..+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3578999999999999999999999999999999987643 3567899998875555 58999998865 6667788
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc--CCcEEEEecCCccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe--nG~VKLsDFGLArv~~~~ 840 (995)
++++||++.|+|..-+.. ..+-+...+.++.|++.||.|||+.+++|||||.+||||-. ...|||||||+++-..
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 899999999999998865 44888889999999999999999999999999999999953 3479999999987310
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-----CCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-----~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.+.++ .--+..|.+||++... ...+.+|||.||+++|.+|+|+.||.
T Consensus 175 ---------------~tV~~-------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 ---------------TTVKY-------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ---------------ceehh-------------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 11111 1124568899987443 23678999999999999999999997
Q ss_pred CCC----HHHHHHHHHccC-CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 916 AES----PEIIFDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 916 g~s----~~ei~qkIl~~~-~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
... +-.-+.+...+. ...|.....+++.+..+.++-|..+|++|--..++.+...+.|-
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred hhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 422 222233333332 23345556789999999999999999999554556655555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=221.08 Aligned_cols=162 Identities=24% Similarity=0.271 Sum_probs=127.0
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 772 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 772 GSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
|+|.+++... ..+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 7899999864 46999999999999999999999998 999999999999999 999874110
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcc
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNILNR 929 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~-~ei~qkIl~~ 929 (995)
....||+.|||||++.+..++.++|||||||++|||++|+.||..... ...+..+...
T Consensus 62 ---------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 120 (176)
T smart00750 62 ---------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120 (176)
T ss_pred ---------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH
Confidence 012589999999999999999999999999999999999999976543 2333333322
Q ss_pred CCCC-C---CCCCCCCH--HHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 930 KIPW-P---CVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 930 ~~~~-p---~lps~lS~--eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.... + ..+..++. .+.++|.+||..||.+||+ +.+++.|+|+..
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~~ 170 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRALF 170 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHHH
Confidence 2111 0 01122333 6899999999999999999 666677777653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-26 Score=261.59 Aligned_cols=247 Identities=42% Similarity=0.721 Sum_probs=215.5
Q ss_pred eeccCCCeEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEEeec
Q 001924 694 PISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 694 ~LG~GgFGtVYka~~---k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVmEym 769 (995)
.+|.|.||.|++++. .+.|..+|+|+.++......... ....|..++..++ ||.+|++...++.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999997653 45678999999887655443333 6677888888887 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCC
Q 001924 770 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (995)
Q Consensus 770 ~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~ 849 (995)
.||.|+..+.+...+.+...+.+...++.|++++|+.+|+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~---------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK---------- 149 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh----------
Confidence 9999999998888889999999999999999999999999999999999999999999999999985211
Q ss_pred CCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcc
Q 001924 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 850 t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~ 929 (995)
....|||..|||||++. .+...+|+||||++++||++|..||.+ ++...|...
T Consensus 150 ---------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 150 ---------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred ---------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 01128999999999998 567889999999999999999999988 677777777
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCcccccccccc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~ 981 (995)
...+| ..++..+.+++..++..+|.+|..+ ..+.++++|+||+.++|+.
T Consensus 203 ~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 203 ELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred ccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence 76655 6889999999999999999999986 6999999999999999983
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-23 Score=224.01 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=202.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCC----CceEEEeeee-eccCe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRN----PFVVRFFYSF-TCRDN 761 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG-~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH----PNIVkL~gvf-~~~~~ 761 (995)
+|++.+.||+|+||.||.|.+..++ ..+|+|+........ ...+..|..++..+.. +++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988764 688999876532211 1156778888888863 6899999999 47778
Q ss_pred eEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-----CcEEEEecCCc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-----GHIKLTDFGLS 834 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-----G~VKLsDFGLA 834 (995)
-|+||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||+|+++... ..++|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 89999998 78999988654 479999999999999999999999999999999999999865 36999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
+...... . .+. . ............||..|.++.+..+...+++.|+||++.++.+|+.|..||
T Consensus 175 r~~~~~~---~-----~~~----~-----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 175 RRFKYVG---D-----SGG----N-----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccccC---C-----CCc----c-----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 8211000 0 000 0 001111123466999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCCC--CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 915 TAESPEIIFDNILNRKIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~--p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
...........+....... .......+.++..+...+-..+...+|.+..+...++.-+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 7755322222222211111 1022345678888888888899999999999988876655544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=258.76 Aligned_cols=246 Identities=48% Similarity=0.810 Sum_probs=199.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|..++.|..|+||.||.++++.+.+.+|+|+ .+... +++- ++....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee--------------
Confidence 45789999999999999999999999999999964 32221 1111 33333444444
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|+=...++..+.++... +.+++|||+.||+|||+||+|.+|..-|++|+.|||+++.+.+..+..
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 56666676666677655 778999999999999999999999999999999999999765554432
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.. .+.+... .......-.||||.|.|||++.-..|+..+|||++|+|+||++.|..||.+.++++++.
T Consensus 201 l~----eg~I~k~--------t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 201 LK----EGHIEKD--------THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hh----hcchHHH--------HHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 11 1111111 11122334689999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
.++.....|+.-....++++.++|.++|+.+|..|.....+.++.+|+||+.-+|+.+
T Consensus 269 ~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~l 326 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSL 326 (1205)
T ss_pred hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchh
Confidence 9999999999877789999999999999999999999889999999999999999943
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-25 Score=258.38 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=203.6
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeec---ccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk---~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
.....+|.|.+|.|+.+........++.|.++. ...........+..|+-+-..++|||++..+..+......+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456689999999888888877777777776542 11111222223666777778899999999888887777766679
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|||++ +|+.++...+.+....+..++.|++.|++|||+.||.|||+|++|+++..+|.+||+|||.+.+.....
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~----- 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW----- 474 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc-----
Confidence 99999 999999887789999999999999999999999999999999999999999999999999987521100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEIIF-- 923 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys-~KSDIWSLGVILyELLTGr~PF~g~s~~ei~-- 923 (995)
..........+|+..|+|||++.+..|. +.+||||.|++++.|.+|+.||......+..
T Consensus 475 ------------------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 475 ------------------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred ------------------chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh
Confidence 0111334567899999999999999995 5689999999999999999999754332221
Q ss_pred HHHHccCCC----CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 924 DNILNRKIP----WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 924 qkIl~~~~~----~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
...-..... ...+...++...+.+|.+||+.||.+|.| +.++++.+||+.+.-
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIEC 593 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcce
Confidence 111111111 11123567888899999999999999999 889999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=226.81 Aligned_cols=177 Identities=23% Similarity=0.180 Sum_probs=132.7
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEE-Eeeeee
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVR-FFYSFT 757 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~-TG~~VAVKVIkk~~~--~se~e~e~flrEieILs~LkHPNIVk-L~gvf~ 757 (995)
.+...++|.+.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+++|+.+.|+|++. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34566889999999999999999999876 678889998653211 12334567899999999999999985 5442
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeec-CCCcEEeccCCcEEEEecCCccc
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDL-KPeNILLDenG~VKLsDFGLArv 836 (995)
+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999732 11 11 1457889999999999999999999 99999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 888 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g 888 (995)
..... .. +............+++.|+|||.+..
T Consensus 162 ~~~~~--------~~-----------~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRG--------AL-----------YRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCc--------ch-----------hhhhhhhhhhhhhccCccCCcccCCh
Confidence 32110 00 00001112235678999999999854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=213.65 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=212.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ly 763 (995)
.--.|++.++||+|+||+++.|.+.-++++||||.-.. +.+..++..|.+..+.|. .+.|...|.+..+..+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 34679999999999999999999999999999996432 234566788888888875 699999999999998899
Q ss_pred EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-----cEEEEecCCcccc
Q 001924 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIG 837 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-----~VKLsDFGLArv~ 837 (995)
||||++ |-+|.|+..- ...|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.++|||+|+.
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~- 178 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE- 178 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh-
Confidence 999998 7799988864 35699999999999999999999999999999999999997544 599999999995
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
+.+|.+.-++|+..+ .+..||..||+=....|...+.+.|+-|||-+++++|-|..||.+.
T Consensus 179 -------YrDp~TkqHIPYrE~------------KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 179 -------YRDPKTKQHIPYREH------------KSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred -------hcCccccccCccccc------------cccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 334555555554443 3467999999999999999999999999999999999999999875
Q ss_pred ---CHHHHHHHHHccCCCC--CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 ---SPEIIFDNILNRKIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 ---s~~ei~qkIl~~~~~~--p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+..+-+++|-..+..- ..+..++|.++..-+.-.-..+-.+-|+++-+..++.
T Consensus 240 KA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 240 KADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred cCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 4566677775544322 2234567888888888777788888888765554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=205.63 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=213.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH-PNIVkL~gvf~~~~~ 761 (995)
....+.|.++++||.|+||.+|+|....+|..||||+-.... ....+.-|..+...+++ ..|..+..++.+...
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 455689999999999999999999999999999999765422 23457788999988876 678888888888889
Q ss_pred eEEEEeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC---CcEEEEecCCcccc
Q 001924 762 LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIG 837 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen---G~VKLsDFGLArv~ 837 (995)
-.+||+.. |.+|.++++ -...++...+..++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.++|||+|+..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 779998886 33568999999999999999999999999999999999999754 46999999999842
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. |. .+..++| ........||..|.+-....+...+.+.|+-|+|.+|.++.-|..||.+.
T Consensus 165 ~-----d~---~t~~HIp------------yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 165 R-----DI---RTRQHIP------------YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred c-----cc---cccccCc------------cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 2 11 1111111 22233457999999988888888899999999999999999999999986
Q ss_pred CH---HHHHHHHHccCCCCC--CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 918 SP---EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 918 s~---~ei~qkIl~~~~~~p--~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.. .+-+.+|...+...+ .+..++|.++.-.+.-|-..--++-|++.-+.++++--|+.-
T Consensus 225 ka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 225 KAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred chhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 43 455666666554332 345788999999999999888889999776766665545443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=194.17 Aligned_cols=140 Identities=24% Similarity=0.203 Sum_probs=109.7
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH-----------------------HHHHHHHHHHHHhcCCCc
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----------------------IERILAERNILITVRNPF 748 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e-----------------------~e~flrEieILs~LkHPN 748 (995)
...||+|+||.||+|.+. +|+.||||+++......... ......|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 89999999997642211110 122345999999998776
Q ss_pred eEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceeeecCCCcEEeccCCcEE
Q 001924 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 749 IVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYL-Hs~GIIHRDLKPeNILLDenG~VK 827 (995)
+...+.... ...+|||||++|+++.........++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 643332222 22389999999888766544556789999999999999999999 799999999999999998 57899
Q ss_pred EEecCCcc
Q 001924 828 LTDFGLSK 835 (995)
Q Consensus 828 LsDFGLAr 835 (995)
|+|||+|.
T Consensus 158 LiDFG~a~ 165 (190)
T cd05147 158 IIDVSQSV 165 (190)
T ss_pred EEEccccc
Confidence 99999987
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-21 Score=204.21 Aligned_cols=249 Identities=21% Similarity=0.321 Sum_probs=201.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
+...+..+.-+|.+...|..|+|+|+ |..+++|++..... .......|..|+-.|+-..||||+.+++.|....++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34456667778999999999999997 66678888865433 3334567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCcEEEE--ecCCcccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLT--DFGLSKIG 837 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~VKLs--DFGLArv~ 837 (995)
++..||+.|+|+.+++.... .+..++..++.++++|++|||+.. |.---|....++||++-+.+|+ |--++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence 99999999999999987653 677889999999999999999874 3344578889999998877764 222111
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC---CchHHHHHHHHHHHHHHcCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y---s~KSDIWSLGVILyELLTGr~PF 914 (995)
. .....-.|.||+||.+...+- -...|+|||++++|||.|...||
T Consensus 342 --------q------------------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 342 --------Q------------------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred --------e------------------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 0 011234688999999987654 36789999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
...++.+.-.+|.-.+.. +.+|++++..+..|++-|+..||.+||....++-+|+
T Consensus 390 adlspmecgmkialeglr-v~ippgis~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLR-VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred ccCCchhhhhhhhhcccc-ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 999998877776555544 5678999999999999999999999999888877765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-20 Score=201.34 Aligned_cols=234 Identities=26% Similarity=0.352 Sum_probs=153.4
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---C-------ceEEEeeeee
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---P-------FVVRFFYSFT 757 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH---P-------NIVkL~gvf~ 757 (995)
.+.....||.|+++.||.+++..||+.+|||++...........+.+.+|.-....+.+ | .++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778899999999999999999999999999876655555567777777655544332 1 1222122111
Q ss_pred ---------cc---C-----eeEEEEeecCCCCHHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHHcCceeeec
Q 001924 758 ---------CR---D-----NLYLVMEYLNGGDLYSLLRK---VGCL----EEDVARIYIAELVLALEYLHSLGIVHRDL 813 (995)
Q Consensus 758 ---------~~---~-----~lyLVmEym~GGSL~d~L~k---~~~L----see~ir~Ia~QIa~GLaYLHs~GIIHRDL 813 (995)
.. . +.+++|+-+ .++|.+++.. .... .......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 246788877 5689887642 2222 12223345579999999999999999999
Q ss_pred CCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----
Q 001924 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----- 888 (995)
Q Consensus 814 KPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g----- 888 (995)
+|+|++++.+|.++|+||+..... +. .......+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~--g~----------------------------~~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA--GT----------------------------RYRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET--TE----------------------------EEEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec--Cc----------------------------eeeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999876521 00 0011234578999998743
Q ss_pred ---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCC
Q 001924 889 ---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 889 ---~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKR 959 (995)
..++.+.|.|+||+++|.|.+|..||....+...... .|.... ++|..++.||..+|++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2478999999999999999999999987644322111 233333 789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=185.63 Aligned_cols=141 Identities=25% Similarity=0.169 Sum_probs=111.0
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhcCCCc
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------------------NDIERILAERNILITVRNPF 748 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se-----------------------~e~e~flrEieILs~LkHPN 748 (995)
...||+|+||.||+|.+. +|+.||||+++....... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999986421100 00223457899999999988
Q ss_pred eEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEE
Q 001924 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 749 IVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VK 827 (995)
+.....+... ..|+||||++|+++.........++...+..++.|++.+|.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443333322 248999999988654443344568888899999999999999999 9999999999999998 89999
Q ss_pred EEecCCccc
Q 001924 828 LTDFGLSKI 836 (995)
Q Consensus 828 LsDFGLArv 836 (995)
|+|||++..
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=195.39 Aligned_cols=174 Identities=16% Similarity=0.181 Sum_probs=134.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcCCCceEEEeeeeec
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~------flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
..++|++.+.||.|+||.||+... ++..+|||+++......+..... +.+|++.+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 458899999999999999999654 47789999997644433333333 5789999999999999999888664
Q ss_pred c--------CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEe
Q 001924 759 R--------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 830 (995)
Q Consensus 759 ~--------~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsD 830 (995)
. ...++||||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 35899999999999988742 333 2355899999999999999999999999999988 99999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELL 908 (995)
||.......... -..++....|+.++||||||+.+.-+.
T Consensus 178 fg~~~~~~e~~a---------------------------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA---------------------------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh---------------------------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 998763110000 011445556778999999999986553
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-20 Score=222.24 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=185.5
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~-~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+|...+.||.+.|=.|.++++.. | .|+||+|-+.. ..+-....+-+.|++ ....+|||++.+.-+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78888999999999999998763 4 49999987654 333334445555666 66779999999998887778889999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc--cccccccc
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI--GLINNTID 844 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv--~~~~~s~d 844 (995)
+|+.+ +|+|.+...+.+..-+.+.|+.|++.||.-+|..||+|+|||.+||||+.-+=+.|+||..=+. .+.++..|
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99966 9999999888899999999999999999999999999999999999999988899999985442 11111110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC----------C-CCchHHHHHHHHHHHHHHc-CCC
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----------E-HGYAADWWSVGIILFEFIT-GIP 912 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~----------~-ys~KSDIWSLGVILyELLT-Gr~ 912 (995)
|.-|.. +...-..|.|||.+... . .+++.||||+||++.||++ |++
T Consensus 180 ---------------f~fFFD-------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 180 ---------------FTFFFD-------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred ---------------ceEEEe-------cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 000100 11122469999998542 1 5688999999999999998 899
Q ss_pred CCCC-----------CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 913 PFTA-----------ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 913 PF~g-----------~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
||.- .+++..+.+| -+..+..||..|++.||.+|.+|++.++-.+--.|
T Consensus 238 lF~LSQL~aYr~~~~~~~e~~Le~I-------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 238 LFTLSQLLAYRSGNADDPEQLLEKI-------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred cccHHHHHhHhccCccCHHHHHHhC-------------cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 9842 1122222221 12367899999999999999998887776444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-19 Score=197.37 Aligned_cols=270 Identities=27% Similarity=0.410 Sum_probs=184.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCc-----------------------------------EEEEEEeecccccch
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----------------------------------LFAIKVLKKLDMIRK 728 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~-----------------------------------~VAVKVIkk~~~~se 728 (995)
-.+++|++...||+|....||.++...+|. +.|||++-..+..+.
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 356889999999999999999887654221 445665543222211
Q ss_pred h--HHHHHHHHHH------HH--------Hh--------cCCCceEEEeeeeec--------------------------
Q 001924 729 N--DIERILAERN------IL--------IT--------VRNPFVVRFFYSFTC-------------------------- 758 (995)
Q Consensus 729 ~--e~e~flrEie------IL--------s~--------LkHPNIVkL~gvf~~-------------------------- 758 (995)
. ..+...+|.- .+ +. -+|||||+++..|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 1 1111112210 00 11 359999999987754
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec--cCC--cEEEEecCC
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDG--HIKLTDFGL 833 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD--enG--~VKLsDFGL 833 (995)
...+|+||..++. +|..++-.. ..+....+.++.|+++|+.|||++||.|||+|.+|||+. .++ .+.|+|||.
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 2247999999865 999999654 366677778889999999999999999999999999984 333 589999997
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC------CCchHHHHHHHHHHHHH
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEF 907 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~------ys~KSDIWSLGVILyEL 907 (995)
+-- ..+....+ ++.+ ..-...|.-.-||||+....+ ...++|.|+.|.+.||+
T Consensus 392 cLA-d~~hGlql---------py~S-----------~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEI 450 (598)
T KOG4158|consen 392 CLA-DDNHGLQL---------PYES-----------DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEI 450 (598)
T ss_pred eee-cccccccc---------cccc-----------ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHH
Confidence 641 11111111 1111 112345778899999986543 13589999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 908 LTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+....||.+.....+-... -..-..|.+|..+++.+.+++..+|+.||.+|++.+=+...++--.|...
T Consensus 451 fg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~ 519 (598)
T KOG4158|consen 451 FGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMG 519 (598)
T ss_pred hccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCc
Confidence 9999999874322111111 11223466778999999999999999999999998777776665444433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=180.33 Aligned_cols=201 Identities=21% Similarity=0.258 Sum_probs=141.8
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhH-HHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEEe
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e-~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVmE 767 (995)
.+...|+.|+||+||++.. .+.+++.+.+.......... ...+.+|+++|+++. |++|++++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999997765 57788877666543322211 225789999999995 4789999886 34699999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeec-CCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDL-KPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~---- 147 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR---- 147 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch----
Confidence 9999998765421 1 1346789999999999999999999 79999999999999999999974210000
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. ..+-......+........++.|++|+...- ..--...++++.|.-+|.++|+..|+.+.
T Consensus 148 ------~----~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 ------W----MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ------H----HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0000000000001112347888999987533 22236779999999999999999987654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=169.76 Aligned_cols=137 Identities=31% Similarity=0.373 Sum_probs=114.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s-----e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
+.||+|++|.||+|.+ +|..|++|+........ ......+.+|+.++..+.|++++....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 57889999865422211 1123467889999999999988777767767778899999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865332 7778899999999999999999999999999998 78999999998873
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=175.06 Aligned_cols=135 Identities=18% Similarity=0.210 Sum_probs=106.7
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCceEEEeeeeeccC---ee
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-----RNPFVVRFFYSFTCRD---NL 762 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-----kHPNIVkL~gvf~~~~---~l 762 (995)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ .||||+++|+++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346899999999995 6666666 689876532 22346789999999999 5799999999999874 33
Q ss_pred E-EEEee--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCceeeecCCCcEEeccC----CcEEEEecCCc
Q 001924 763 Y-LVMEY--LNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-EYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLS 834 (995)
Q Consensus 763 y-LVmEy--m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GL-aYLHs~GIIHRDLKPeNILLDen----G~VKLsDFGLA 834 (995)
+ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+-+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3 78999 5579999999764 46655 35577888787 99999999999999999999743 37999994433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=175.93 Aligned_cols=144 Identities=24% Similarity=0.139 Sum_probs=113.7
Q ss_pred CeEEEEeeccCCCeEEEEEE-ECCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q 001924 688 DFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIR---------------------KNDIERILAERNILITVR 745 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~-~k~TG~~VAVKVIkk~~~~s---------------------e~e~e~flrEieILs~Lk 745 (995)
-|.+.+.||+|+||.||+|. +..+|+.||+|+++...... ......+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 67789999999987532110 001134568999999997
Q ss_pred C--CceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeeecCCCcEEecc
Q 001924 746 N--PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAH 822 (995)
Q Consensus 746 H--PNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~G-IIHRDLKPeNILLDe 822 (995)
+ ..+.+++.. ...++||||++|++|..+......+....+..++.|++.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 5 334455543 235899999999888776544445666677889999999999999999 99999999999998
Q ss_pred CCcEEEEecCCccc
Q 001924 823 DGHIKLTDFGLSKI 836 (995)
Q Consensus 823 nG~VKLsDFGLArv 836 (995)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999873
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-17 Score=163.43 Aligned_cols=133 Identities=29% Similarity=0.322 Sum_probs=107.0
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
.||+|+||.||+|.+ +|..|++|+....... ......++.+|++++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 5788999986542211 112246678899999999988655444445556677999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 769 m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998754321 6788999999999999999999999999998 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.7e-17 Score=197.27 Aligned_cols=245 Identities=21% Similarity=0.322 Sum_probs=179.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk---HPNIVkL~gvf~~~ 759 (995)
......|.|.+.||+|+||.||+|.... |+.||||+=+....+ +|.--.+++.+|+ -+.|+.+..++...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce------eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4456779999999999999999999876 999999987654433 2333344555555 23455566666666
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-------CCcEEEEecC
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFG 832 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-------nG~VKLsDFG 832 (995)
+.-++|++|.+.|+|.++++..+.+++..+..+..|++.-+++||..+|||+||||+|+||.. +.-++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 778999999999999999998888999999999999999999999999999999999999953 2359999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
.+.=+ .+. .+...-...++|-.+-=+|+..|..+++.+|.|.|+.+++.||.|+.
T Consensus 847 ~siDm--------------~lf-----------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDM--------------KLF-----------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceee--------------eEc-----------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 77511 000 11122334678889999999999999999999999999999999854
Q ss_pred CCCCCCHHHHHHHHHccCCCCCC---CCCCCCHHHH-HHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 913 PFTAESPEIIFDNILNRKIPWPC---VPSDMSFEAQ-DLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~---lps~lS~eL~-dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
- + +.++..|.. ++..+..+++ +|+..+|..|-..=|...++...++.
T Consensus 902 ~----------q--~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 902 M----------E--VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred H----------H--hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHH
Confidence 1 1 222222211 1223333443 47777777444444555555555544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=161.80 Aligned_cols=136 Identities=21% Similarity=0.207 Sum_probs=107.1
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhcCCC--
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-------------------NDIERILAERNILITVRNP-- 747 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se-------------------~e~e~flrEieILs~LkHP-- 747 (995)
|.+.+.||.|+||.||++.+. +|+.||||+++....... ........|+.++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999875 799999998764321000 0112357788889888877
Q ss_pred ceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 748 NIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
.++..++. ...++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 44444442 346899999999998765431 34566788999999999999999999999999999999999
Q ss_pred EEecCCcc
Q 001924 828 LTDFGLSK 835 (995)
Q Consensus 828 LsDFGLAr 835 (995)
|+|||++.
T Consensus 166 liDfg~~~ 173 (198)
T cd05144 166 IIDWPQMV 173 (198)
T ss_pred EEECCccc
Confidence 99999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=182.46 Aligned_cols=140 Identities=26% Similarity=0.253 Sum_probs=113.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-----~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...|...+.||+|+||+||+|.+. +..+++|+...... ......+.+.+|++++..++|++++..+.++....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 445567889999999999999875 34455554322111 11123457889999999999999988877777777
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999999885 346788999999999999999999999999999 678999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-16 Score=180.94 Aligned_cols=210 Identities=24% Similarity=0.287 Sum_probs=163.2
Q ss_pred HHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCc-eeeecCCCcE
Q 001924 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGI-VHRDLKPDNL 818 (995)
Q Consensus 741 Ls~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GI-IHRDLKPeNI 818 (995)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+... -.+++.....++++|+.||+|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35688999999999999999999999999999999999863 457888888899999999999998866 9999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-------C
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------H 891 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-------y 891 (995)
++|....+||+|||+..+... . .. ........-...|.|||.+.+.. .
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--~---------------~~--------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--T---------------AE--------PEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred eeeeeEEEEechhhhcccccc--c---------------cc--------ccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999999999999875211 0 00 00000111345799999997742 3
Q ss_pred CchHHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHccCC--CCCCCC--CCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 892 GYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKI--PWPCVP--SDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 892 s~KSDIWSLGVILyELLTGr~PF~g~----s~~ei~qkIl~~~~--~~p~lp--s~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
+.+.||||||++++|+++...||... .+.++...+..+.. ..|.+. ...++++..++..||..+|.+||++.
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 56789999999999999999999752 33455555555222 223222 14566899999999999999999999
Q ss_pred HHHHHHcCcccc
Q 001924 964 GAAEVFHCKIFI 975 (995)
Q Consensus 964 EIlEiL~HPfF~ 975 (995)
++...++..+=.
T Consensus 216 ~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 216 QIRSKLLTINKG 227 (484)
T ss_pred HHHhhhhhhccc
Confidence 998887665543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.8e-17 Score=185.14 Aligned_cols=182 Identities=26% Similarity=0.412 Sum_probs=133.7
Q ss_pred eeEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
.+||.|++|...+|.+++.... ..+......++.|++.|+.| +|.+|||+||.||+...+..+||+|||+..-.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999997443 46677888899999999999 99999999999999999999999999987531
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.... .............||..||+||.+.+..|+.++||||||+||+||+. +|...
T Consensus 407 ~~~~---------------------~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~ 462 (516)
T KOG1033|consen 407 DKDE---------------------TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQ 462 (516)
T ss_pred ccCC---------------------cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccH
Confidence 1000 00112233455689999999999999999999999999999999997 33322
Q ss_pred CHH-HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 918 SPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 918 s~~-ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
... ..+..+-.+.++ |.. ..-.+.-..|+.+||...|.+||+ +.+.--|+|.
T Consensus 463 ~er~~t~~d~r~g~ip-~~~-~~d~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 463 FERIATLTDIRDGIIP-PEF-LQDYPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred HHHHHhhhhhhcCCCC-hHH-hhcCcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 111 122223333332 111 112245568999999999999995 5555555553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-17 Score=198.16 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=206.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k-~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ly 763 (995)
...|.+.+.||+|+|+.|-..... .+...+|+|.+.... ........+..|..+-..+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567888999999999999887764 344567777654432 23444556666887777777 999999999999999999
Q ss_pred EEEeecCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCceeeecCCCcEEeccCC-cEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLL-RKVG-CLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L-~k~~-~Lsee~ir~Ia~QIa~GLaYLH-s~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~ 839 (995)
++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ ..+++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 5554 6778888899999999999999 99999999999999999999 999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCC-CCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG-TPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vG-Tp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. ..........+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||...
T Consensus 178 -----~-------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 -----K-------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred -----c-------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 0 111222334567 99999999998854 477899999999999999999999765
Q ss_pred CHHHH-HHHHHccCCC-CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 918 SPEII-FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 918 s~~ei-~qkIl~~~~~-~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
..... +......... -...+..++....+++.+++..+|..|.+ +.++..+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 43321 1111222111 12234678889999999999999999999 888889999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=151.90 Aligned_cols=136 Identities=24% Similarity=0.283 Sum_probs=97.5
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHH---------------------HHHHHHHHHhcCCC--c
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER---------------------ILAERNILITVRNP--F 748 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~---------------------flrEieILs~LkHP--N 748 (995)
.+.||+|+||.||+|.+. +|+.||||+++............ ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 79999999987532211111111 13455666665443 2
Q ss_pred eEEEeeeeeccCeeEEEEeecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcE
Q 001924 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 749 IVkL~gvf~~~~~lyLVmEym~GGSL~d-~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~V 826 (995)
+.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 23589999999854321 121111 11 5677889999999999999 9999999999999999 8999
Q ss_pred EEEecCCcc
Q 001924 827 KLTDFGLSK 835 (995)
Q Consensus 827 KLsDFGLAr 835 (995)
+|+|||.+.
T Consensus 154 ~liDfg~a~ 162 (187)
T cd05119 154 YIIDVPQAV 162 (187)
T ss_pred EEEECcccc
Confidence 999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.6e-15 Score=136.25 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=111.6
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeeccCeeEEEEee
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--PNIVkL~gvf~~~~~lyLVmEy 768 (995)
+.+.||.|.++.||++... +..+++|.+..... ...+.+|+.++..+.| +++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999975 47899998765321 4568889999999976 5899999888887889999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 769 m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~---GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
++++.+..+ +......++.+++.+|++||.. +++|+|++|.||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877654 4556667788999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-14 Score=151.36 Aligned_cols=137 Identities=20% Similarity=0.346 Sum_probs=105.2
Q ss_pred Eeec-cCCCeEEEEEEECCCCcEEEEEEeecccc----------cchhHHHHHHHHHHHHHhcCCCce--EEEeeeeecc
Q 001924 693 KPIS-RGAFGRVFLARKRTTGDLFAIKVLKKLDM----------IRKNDIERILAERNILITVRNPFV--VRFFYSFTCR 759 (995)
Q Consensus 693 k~LG-~GgFGtVYka~~k~TG~~VAVKVIkk~~~----------~se~e~e~flrEieILs~LkHPNI--VkL~gvf~~~ 759 (995)
..|| .||.|+||.+... +..++||.+..... ........+.+|++++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 7888888888764 78899998864221 111234578889999999998774 6666654433
Q ss_pred C----eeEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 760 D----NLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 760 ~----~lyLVmEym~G-GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
. ..++||||++| .+|.+++.. ..++... +.+++.+|.+||++||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 689988865 3455443 568999999999999999999999999999999999999988
Q ss_pred cc
Q 001924 835 KI 836 (995)
Q Consensus 835 rv 836 (995)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-11 Score=142.02 Aligned_cols=140 Identities=24% Similarity=0.271 Sum_probs=95.1
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--------------------------ch-hH----------HHHHH
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--------------------------RK-ND----------IERIL 735 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~--------------------------se-~e----------~e~fl 735 (995)
+.||.|++|.||+|+.+ +|+.||||+.+..... +. .. .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999976 6999999998642100 00 00 00244
Q ss_pred HHHHHHHhcC----CCceEEEeeee-eccCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 001924 736 AERNILITVR----NPFVVRFFYSF-TCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL-ALEYLHSLGI 808 (995)
Q Consensus 736 rEieILs~Lk----HPNIVkL~gvf-~~~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~-GLaYLHs~GI 808 (995)
+|...+.++. |.+-+.+-.++ ......++||||++|++|.++.... .... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 5555555542 32222222222 2234569999999999998876532 1222 2345555555 4778999999
Q ss_pred eeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 809 IHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+|+|++|.||+++.+|.++++|||++..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 9999999999999999999999999874
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=120.39 Aligned_cols=128 Identities=18% Similarity=0.307 Sum_probs=95.4
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeeccCeeEEEEeecC
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI-VkL~gvf~~~~~lyLVmEym~ 770 (995)
++.|+.|.++.||++... +..|++|+...... ....+..|+.++..+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 78899998754321 12245678888888865443 34544432 34589999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI-----VHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 771 GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GI-----IHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
|.++.+. . . ....++.+++.+|+.||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 1 113356789999999999985 9999999999998 67899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.4e-12 Score=149.44 Aligned_cols=143 Identities=23% Similarity=0.376 Sum_probs=94.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--------------------------c-----hhHHHH-
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--------------------------R-----KNDIER- 733 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~--------------------------s-----e~e~e~- 733 (995)
..+|+. +.||.|++|.||+|+.+.+|+.||||++++.-.. + .+..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 7899999999999999988999999998743100 0 011112
Q ss_pred -----HHHHHHHHHhcC----CCceEEEeeeeec-cCeeEEEEeecCCCCHHHH--HHhcC----CCCHHHHHHHHHHHH
Q 001924 734 -----ILAERNILITVR----NPFVVRFFYSFTC-RDNLYLVMEYLNGGDLYSL--LRKVG----CLEEDVARIYIAELV 797 (995)
Q Consensus 734 -----flrEieILs~Lk----HPNIVkL~gvf~~-~~~lyLVmEym~GGSL~d~--L~k~~----~Lsee~ir~Ia~QIa 797 (995)
+.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.+.++ +...+ .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 334444444332 3333332222222 3346899999999999875 33322 12333333344444
Q ss_pred HHHHHHHHcCceeeecCCCcEEeccCC----cEEEEecCCccc
Q 001924 798 LALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 836 (995)
Q Consensus 798 ~GLaYLHs~GIIHRDLKPeNILLDenG----~VKLsDFGLArv 836 (995)
...|++|+|+||.||+++.+| .++++|||+...
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 468999999999999999888 999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=137.41 Aligned_cols=169 Identities=21% Similarity=0.358 Sum_probs=128.9
Q ss_pred EEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCC
Q 001924 705 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784 (995)
Q Consensus 705 ka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~L 784 (995)
.|..+.++.+|.|.+++.... .......+-+.-|+.++||||+++++.+...+.+|+|+|.+ ..|..++++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH--
Confidence 466778899999998876432 33456777888999999999999999999999999999998 47777887644
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcc
Q 001924 785 EEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863 (995)
Q Consensus 785 see~ir~Ia~QIa~GLaYLH-s~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~ 863 (995)
.......++||+.||.||| +.+++|++|.-+-|+++..|..||++|-++.-.. + ..
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~--------~-----~~--------- 159 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS--------G-----FN--------- 159 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc--------c-----CC---------
Confidence 5666667889999999998 5689999999999999999999999999875210 0 00
Q ss_pred ccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 001924 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 864 ~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG 910 (995)
. ......---.|..|+.+.... -..|.|.||++++|++.|
T Consensus 160 ----~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 ----A-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ----c-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 0 001111123466666553332 356999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-11 Score=143.87 Aligned_cols=266 Identities=25% Similarity=0.213 Sum_probs=187.8
Q ss_pred CCCeEEEEeecc--CCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISR--GAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~--GgFGtVYka~~--k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~ 760 (995)
...|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... .......+=++|+.-...+ .|+|.++.+..+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCC
Confidence 355677788999 99999999998 8889999999633211 1111222334555555555 4899999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLS 834 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~-Lsee~ir~Ia~QIa~----GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLA 834 (995)
..|+-+|++ +.+|..+...... ++...++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999999 4688888876554 888999999999999 9999999999999999999999999 88999999987
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
.-+...+-. ..........|...|++||.+.+ -++...|||+||.++.+-.+|-.++
T Consensus 271 ~~i~~~~~~----------------------~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 271 SKISDGNFS----------------------SVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred EEccCCccc----------------------cceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 632211100 00011112257778999999865 5788999999999999988766554
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
....... +..+- +.+....+....+..+...+..|+..+|-.|++ ....+++++-..+..+.
T Consensus 328 ~~g~~~~-W~~~r-~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~~~~ 389 (524)
T KOG0601|consen 328 SVGKNSS-WSQLR-QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKLFVH 389 (524)
T ss_pred cCCCCCC-ccccc-cccCchhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchhhhc
Confidence 3221100 00111 111111222345667777999999999999999 55566666665544433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=120.40 Aligned_cols=138 Identities=22% Similarity=0.174 Sum_probs=99.8
Q ss_pred EeeccCCCeEEEEEEECC------CCcEEEEEEeecccc-------------------cchhHHHHH----HHHHHHHHh
Q 001924 693 KPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDM-------------------IRKNDIERI----LAERNILIT 743 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~------TG~~VAVKVIkk~~~-------------------~se~e~e~f----lrEieILs~ 743 (995)
..||.|--+.||.|.... .+..+|||+++.... ........+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 357999999863110 001112233 379999988
Q ss_pred cCC--CceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCceeeecCCCcEEe
Q 001924 744 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLI 820 (995)
Q Consensus 744 LkH--PNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYL-Hs~GIIHRDLKPeNILL 820 (995)
+.. -+++..+++ ..-+|||||+.++.+..-.-+...++......+..+++.+|..| |+.||+|+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 466666654 34689999997654432221223455566677788999999999 89999999999999999
Q ss_pred ccCCcEEEEecCCcc
Q 001924 821 AHDGHIKLTDFGLSK 835 (995)
Q Consensus 821 DenG~VKLsDFGLAr 835 (995)
+ ++.++|+|||.+.
T Consensus 159 ~-~~~v~iIDF~qav 172 (197)
T cd05146 159 H-DGKVWFIDVSQSV 172 (197)
T ss_pred E-CCcEEEEECCCce
Confidence 6 5789999999886
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.7e-11 Score=131.03 Aligned_cols=208 Identities=23% Similarity=0.324 Sum_probs=146.7
Q ss_pred HHHHhcCCCceEEEeeeeeccC-----eeEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc--C
Q 001924 739 NILITVRNPFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL--G 807 (995)
Q Consensus 739 eILs~LkHPNIVkL~gvf~~~~-----~lyLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~--G 807 (995)
..+-.+.|.|+|+++.++.+.. +..+++|||..|+|..+|++. ..+....-++|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455667999999988876644 478999999999999999754 3577788889999999999999987 5
Q ss_pred ceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc
Q 001924 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887 (995)
Q Consensus 808 IIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~ 887 (995)
|+|+++...-|++..+|-+|++---... .+++. ............|-++|.|||.=.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s----------------------~h~s~-~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS----------------------THPSV-NSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc----------------------cchhh-hhhhHhhhhccccCCccccCCcCc
Confidence 9999999999999999999976322111 11111 011112223345788999999877
Q ss_pred CCCCCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 888 GTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 888 g~~ys~KSDIWSLGVILyELLTGr~PF-~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
....+..+|||+||+...+|..+..-- .+.+.-..-..+.+.-+. .-...-.+++.+|++-.|..||+ +.
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~------len~lqr~~i~kcl~~eP~~rp~---ar 326 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG------LENGLQRGSITKCLEGEPNGRPD---AR 326 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee------ccCccccCcCcccccCCCCCCcc---hh
Confidence 677788999999999999998876542 222211111111111110 01112246899999999999999 77
Q ss_pred HHHcCccccccc
Q 001924 967 EVFHCKIFIKKT 978 (995)
Q Consensus 967 EiL~HPfF~~~~ 978 (995)
+++.||.+-...
T Consensus 327 ~llfHpllfeVh 338 (458)
T KOG1266|consen 327 LLLFHPLLFEVH 338 (458)
T ss_pred hhhcCceeeecc
Confidence 889999876653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.6e-11 Score=138.11 Aligned_cols=251 Identities=26% Similarity=0.249 Sum_probs=180.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k-~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
-...+|..+..||.|.|+.|+.+... .++..|++|...+...... ....-+.|+.+...+ .|.++++++..+...++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34578999999999999999988766 6778999997765332222 222234555555544 68999999999998889
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLArv~~~~ 840 (995)
.|+-.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||......
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~-- 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA-- 418 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--
Confidence 99999999999988776545567888888899999999999999999999999999999876 788999999875200
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCccc--ChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL--APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~Ym--APEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
+ ........-+++ +|+......+..+.|+||||.-+.+.++|.+--....
T Consensus 419 ----~------------------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 419 ----F------------------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred ----e------------------------ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 0 000111223334 5555566678899999999999999998765322111
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
....+..+.. +..+ .....+..+.+.++..++..||. +.++..|.-|
T Consensus 471 ---~~~~i~~~~~--p~~~-~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 ---QSLTIRSGDT--PNLP-GLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred ---cceeeecccc--cCCC-chHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 1122223322 2222 33378889999999999999999 5555555444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.8e-10 Score=114.55 Aligned_cols=134 Identities=29% Similarity=0.313 Sum_probs=98.4
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEee-c----ccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLK-K----LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIk-k----~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
..+++|+-+.+|.+.+. |..+++|.=. + .....+-...+..+|+.++.++.--.|...+-+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999774 5567777522 1 122222234567889999998865433333333445566689999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
|++|-.|.+++... ...++..+-.-+.-||.+||+|+||.++||++... .+.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99998999898765 14456677778888999999999999999999654 499999999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-09 Score=110.72 Aligned_cols=140 Identities=20% Similarity=0.256 Sum_probs=104.0
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeecc---CeeEEEEe
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR---DNLYLVME 767 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--PNIVkL~gvf~~~---~~lyLVmE 767 (995)
+.|+.|.++.||++.... |..+++|+....... .....+.+|+.++..+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999998743 688999987643321 134567889999999875 3456666666554 36789999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------------ 805 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs------------------------------------------ 805 (995)
|++|.++.+.+.. ..++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765421 345666666667777777777763
Q ss_pred --------------cCceeeecCCCcEEecc--CCcEEEEecCCccc
Q 001924 806 --------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 836 (995)
Q Consensus 806 --------------~GIIHRDLKPeNILLDe--nG~VKLsDFGLArv 836 (995)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24799999999999998 67789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5e-09 Score=109.04 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=105.3
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEe-----ecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVI-----kk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.+..|-+|+-+.|+++.+. |+.+.||.- +.......-...+..+|++++.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5677889999999999775 888888842 223333344456788999999887643333323334445556789
Q ss_pred EeecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEEecCCccc
Q 001924 766 MEYLNG-GDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (995)
Q Consensus 766 mEym~G-GSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLsDFGLArv 836 (995)
|||++| .++.+++.... .........++.+|-+.+.-||.++|||+||..+||++..+| .+.++|||++.+
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 47888886542 223333367888999999999999999999999999997665 468999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=9.7e-10 Score=130.45 Aligned_cols=174 Identities=19% Similarity=0.285 Sum_probs=124.2
Q ss_pred HHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCc
Q 001924 794 AELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872 (995)
Q Consensus 794 ~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~ 872 (995)
.+++.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++........ |+. ...+.....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-----------------~p~-~~yd~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-----------------YPF-SEYDPPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-----------------ccc-ccCCCCCCh
Confidence 3566999999976 899999999999999999999999998763211111 111 111122222
Q ss_pred CCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH-HHccCCCCCCCCCCCCHHHHHHHHH
Q 001924 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN-ILNRKIPWPCVPSDMSFEAQDLINR 950 (995)
Q Consensus 873 t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qk-Il~~~~~~p~lps~lS~eL~dLIkk 950 (995)
...-...|.|||++.+...+.++|+||||+++|-+.. |+.-+........+.. ....+.........++.++.+-|.+
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH
Confidence 3345678999999999888999999999999999995 4444444322222211 1112222233447899999999999
Q ss_pred HhhcCccCCCCHHHHHHHHcCccccccccccccchhHh
Q 001924 951 FLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKL 988 (995)
Q Consensus 951 CLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l 988 (995)
++..++..||+ +..++..|||.+.....+.-.+.+
T Consensus 248 ~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLrfLD~l 282 (700)
T KOG2137|consen 248 LLNGDSAVRPT---LDLLLSIPFFSDPGLKALRFLDDL 282 (700)
T ss_pred HhcCCcccCcc---hhhhhcccccCCchhhhhhhcccc
Confidence 99999999997 888899999999887776655444
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.2e-07 Score=101.47 Aligned_cols=131 Identities=13% Similarity=0.100 Sum_probs=90.7
Q ss_pred EEEEEECCCCcEEEEEEeeccccc---ch-----hHHHHHHHHHHHHHhcCC--CceEEEeeeeec-----cCeeEEEEe
Q 001924 703 VFLARKRTTGDLFAIKVLKKLDMI---RK-----NDIERILAERNILITVRN--PFVVRFFYSFTC-----RDNLYLVME 767 (995)
Q Consensus 703 VYka~~k~TG~~VAVKVIkk~~~~---se-----~e~e~flrEieILs~LkH--PNIVkL~gvf~~-----~~~lyLVmE 767 (995)
|+++.. .|+.|.||........ .. .....+.+|...+.++.. -.++..+.++.. ...-++|||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 555543 3677888865322110 00 011147788888877742 223333333332 234689999
Q ss_pred ecCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-------CCcEEEEecCCcc
Q 001924 768 YLNGG-DLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 835 (995)
Q Consensus 768 ym~GG-SL~d~L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-------nG~VKLsDFGLAr 835 (995)
++++. +|.+++.. ....+......++.+++..+.-||.+||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 79998864 234566777889999999999999999999999999999975 4689999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.4e-07 Score=106.54 Aligned_cols=236 Identities=18% Similarity=0.199 Sum_probs=167.2
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc----CeeEEEEeecCC-CC
Q 001924 699 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----DNLYLVMEYLNG-GD 773 (995)
Q Consensus 699 gFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~----~~lyLVmEym~G-GS 773 (995)
.-.+.|++....+|..|++|.+....... ......-++.++++.|+|||++..+|... ..+++|++|+++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34578999999999999999884322222 22344567889999999999999988743 358999999986 57
Q ss_pred HHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 774 LYSLLRKV---------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 774 L~d~L~k~---------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
|.++.-.. ...++..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+..++|+..|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 77765321 246788999999999999999999999999999999999988889998777654311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC-CCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P-F~g~ 917 (995)
.+ . + |-+.+ -.+-|.=.||.+++.|.+|..- +...
T Consensus 445 ~d---------------------------~-------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d 480 (655)
T KOG3741|consen 445 ED---------------------------P-------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD 480 (655)
T ss_pred CC---------------------------C-------C-------cchhH---HhhhhHHHHHHHHHHHhhccccccccc
Confidence 00 0 0 11111 1256899999999999998542 3333
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhh
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIEL 992 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~ 992 (995)
.........+ ....+.++.++|.-+...++.+ -+..+++...-..||... +....+.+..++||
T Consensus 481 ~~~~s~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vm-es~q~~~d~mE~~L 544 (655)
T KOG3741|consen 481 STQSSHLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVM-ESVQLKTDVMETEL 544 (655)
T ss_pred chHHHHHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHH-HhHHHHHHHHHHHH
Confidence 3333311111 1356778889999999999887 676777777777777654 34445555555555
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-07 Score=98.78 Aligned_cols=126 Identities=25% Similarity=0.282 Sum_probs=82.2
Q ss_pred EEEEEEECCCCcEEEEEEeeccc-----------------------ccchhHHHHHHHHHHHHHhcCCC--ceEEEeeee
Q 001924 702 RVFLARKRTTGDLFAIKVLKKLD-----------------------MIRKNDIERILAERNILITVRNP--FVVRFFYSF 756 (995)
Q Consensus 702 tVYka~~k~TG~~VAVKVIkk~~-----------------------~~se~e~e~flrEieILs~LkHP--NIVkL~gvf 756 (995)
.||.|... +|..+|||+.+... ...........+|++.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 57899999875310 11112234667899999999765 567776543
Q ss_pred eccCeeEEEEeecC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 757 TCRDNLYLVMEYLN--GGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 757 ~~~~~lyLVmEym~--GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaY-LHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 65554443321 2234456677788886665 579999999999999999876 999999998
Q ss_pred cc
Q 001924 834 SK 835 (995)
Q Consensus 834 Ar 835 (995)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 76
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=99.58 Aligned_cols=237 Identities=16% Similarity=0.227 Sum_probs=152.1
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE--------EeeeeeccCe
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR--------FFYSFTCRDN 761 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVk--------L~gvf~~~~~ 761 (995)
..+.||+|+.+.+|-.-.- + ..+-|++.+...-.. .+.+..|... .||-+-. ++|- .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3467999999999954322 2 234688876442111 1122223332 4553322 1111 11223
Q ss_pred eEEEEeecCCCC-HHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 762 LYLVMEYLNGGD-LYSLLR------KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 762 lyLVmEym~GGS-L~d~L~------k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
+.++|+.++|.. +..++. ..+...+..+..+++.++.+.+.||..|.+-+|+.++|+|+.+++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 678888887652 333332 2235788999999999999999999999999999999999999999999874421
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHc
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLT 909 (995)
.+. .+.......+|...|.+||.-. +..-+...|-|.||++++++|.
T Consensus 165 qi~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 165 QIN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred eec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 110 1122233567999999999854 3345678899999999999998
Q ss_pred C-CCCCCCCC-------HHHHHHHHHccCC-----------CCCC--CCCCCCHHHHHHHHHHhhc--CccCCCCHHHHH
Q 001924 910 G-IPPFTAES-------PEIIFDNILNRKI-----------PWPC--VPSDMSFEAQDLINRFLIH--DPNQRLGANGAA 966 (995)
Q Consensus 910 G-r~PF~g~s-------~~ei~qkIl~~~~-----------~~p~--lps~lS~eL~dLIkkCLq~--DPeKRPSA~EIl 966 (995)
| +.||.+.. +.+ ..|-.+.+ +.|. ...-+++.+..|..+|+.. +|.-|||++.-.
T Consensus 217 ggrHPysGI~~~~~ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred cCCCCCCcccccCCCCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 5 99997632 111 11211111 1111 1134788999999999974 467899976443
Q ss_pred H
Q 001924 967 E 967 (995)
Q Consensus 967 E 967 (995)
.
T Consensus 295 a 295 (637)
T COG4248 295 A 295 (637)
T ss_pred H
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.3e-07 Score=92.91 Aligned_cols=106 Identities=28% Similarity=0.322 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHHhcCC--CceEEEeeeeecc----CeeEEEEeecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 001924 731 IERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYL 803 (995)
Q Consensus 731 ~e~flrEieILs~LkH--PNIVkL~gvf~~~----~~lyLVmEym~GG-SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYL 803 (995)
.....+|...+..+.. -.++..+.+.... ...++|||++++. +|.+++......+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4567788887777643 2344444444432 2458999999874 7999998755577778889999999999999
Q ss_pred HHcCceeeecCCCcEEeccCC---cEEEEecCCccc
Q 001924 804 HSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (995)
Q Consensus 804 Hs~GIIHRDLKPeNILLDenG---~VKLsDFGLArv 836 (995)
|++||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.4e-06 Score=93.74 Aligned_cols=137 Identities=23% Similarity=0.245 Sum_probs=101.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeec-------cc----------c--cchhHHHHHHHHHHHHHhcCCC--
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-------LD----------M--IRKNDIERILAERNILITVRNP-- 747 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk-------~~----------~--~se~e~e~flrEieILs~LkHP-- 747 (995)
+.+..+||-|--|.||.|... .|.++|||.=+. .. . +-........+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346688999999999999976 589999996321 00 0 0112234557899999998755
Q ss_pred ceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 748 NIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
.|.+.+++ ++-.+||||++|-.|...- ++.+....++..|++-+.-+-..||||+|+.+-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 66666554 3457999999987665432 23455556667777777777789999999999999999999999
Q ss_pred EEecCCcc
Q 001924 828 LTDFGLSK 835 (995)
Q Consensus 828 LsDFGLAr 835 (995)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=85.33 Aligned_cols=138 Identities=14% Similarity=0.205 Sum_probs=99.1
Q ss_pred ccCCCeEEEEEEECCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeec----cCeeEEEE
Q 001924 696 SRGAFGRVFLARKRTTGDLFAIKVLKKL---DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTC----RDNLYLVM 766 (995)
Q Consensus 696 G~GgFGtVYka~~k~TG~~VAVKVIkk~---~~~se~e~e~flrEieILs~LkH--PNIVkL~gvf~~----~~~lyLVm 766 (995)
|+||.+-|+..... |..+-+|.-... ...-......|.+|+..+.++.. -.+.+....... .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888888887654 446778854310 11113355779999999988853 224444422211 12368999
Q ss_pred eecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc--EEEEecCCcc
Q 001924 767 EYLNG-GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSK 835 (995)
Q Consensus 767 Eym~G-GSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~--VKLsDFGLAr 835 (995)
|-++| -+|.+++... ...+......++.+++..+.-||+.|+.|+|+.+.||+++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98854 4888888653 24577777889999999999999999999999999999987676 9999999766
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.1e-05 Score=77.56 Aligned_cols=138 Identities=28% Similarity=0.387 Sum_probs=82.1
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeeee---ccCeeEEEE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSFT---CRDNLYLVM 766 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP--NIVkL~gvf~---~~~~lyLVm 766 (995)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+... .+.+++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998764 58999986542 3456677888888877432 3556665332 233578999
Q ss_pred eecCCCCHHH----------------HHH---hc--C--CCCHHH------HHHH---------------HHHHHH-HHH
Q 001924 767 EYLNGGDLYS----------------LLR---KV--G--CLEEDV------ARIY---------------IAELVL-ALE 801 (995)
Q Consensus 767 Eym~GGSL~d----------------~L~---k~--~--~Lsee~------ir~I---------------a~QIa~-GLa 801 (995)
++++|..+.. .+. .. . .+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 11 0 011000 0000 111222 233
Q ss_pred HHHH-------cCceeeecCCCcEEec-cCCcEEEEecCCccc
Q 001924 802 YLHS-------LGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKI 836 (995)
Q Consensus 802 YLHs-------~GIIHRDLKPeNILLD-enG~VKLsDFGLArv 836 (995)
.+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 3599999999999999 667778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.9e-05 Score=97.45 Aligned_cols=213 Identities=23% Similarity=0.232 Sum_probs=151.1
Q ss_pred HHHHHHHHHHHHHhcCCCceEEEeeeeeccCee----EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 001924 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNL----YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805 (995)
Q Consensus 730 e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l----yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs 805 (995)
.+.....|...+.++.|+|++.++.+....... .+..+++..-++.+.+...+..+....+.+..++..||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344455677778899999999999988765443 3456788888999999998999999999999999999999999
Q ss_pred cCceeeecCCC---cEEeccCCcEEEE--ecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcc
Q 001924 806 LGIVHRDLKPD---NLLIAHDGHIKLT--DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880 (995)
Q Consensus 806 ~GIIHRDLKPe---NILLDenG~VKLs--DFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~Y 880 (995)
....|.-+... +...+..+.+..+ ||+.++.... ........-+..|
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d----------------------------~~~~~~~~~~~~~ 356 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD----------------------------NEKSFSDLLAEIR 356 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCC----------------------------cccchhhcCcccc
Confidence 96666555444 4444455566666 7777653211 1111223345678
Q ss_pred cChhhhcCCCCCc--hHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCcc
Q 001924 881 LAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 957 (995)
Q Consensus 881 mAPEvL~g~~ys~--KSDIWSLGVILyELLTGr~PF~g-~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPe 957 (995)
.+||......+.. ..|+|++|..+..+..|..+-.. ..+. +.++........+++.+|+..+++
T Consensus 357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~-------------~~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV-------------SLLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred ccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh-------------hhhccccchhhhhhhhhhcchhhh
Confidence 8999887766654 47999999999998886543211 1110 111122222678899999999999
Q ss_pred CCCCHHHHHHHHcCccccccccccccchh
Q 001924 958 QRLGANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 958 KRPSA~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
+|++ +.+++.|+|.+-...+..+...
T Consensus 424 ~Rl~---~~~ll~~~f~~~~~~~~~~~~~ 449 (1351)
T KOG1035|consen 424 ERLS---ALELLTHPFLRFPTDNESSEFA 449 (1351)
T ss_pred hccc---hhhhhhchhccccccccccccc
Confidence 9999 8888999998888777665443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.7e-05 Score=82.54 Aligned_cols=141 Identities=21% Similarity=0.312 Sum_probs=90.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHH------HHHHHHHHhcCC---CceEEEee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI------LAERNILITVRN---PFVVRFFY 754 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~f------lrEieILs~LkH---PNIVkL~g 754 (995)
....+|.+.+.+-......|.+.. .+|+.+++|..+......+.....| .+++..+..+.. -....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345788998988887777777654 4588999998765332211111111 233333333322 22222222
Q ss_pred ee-----eccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEE
Q 001924 755 SF-----TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 829 (995)
Q Consensus 755 vf-----~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLs 829 (995)
+. ......+++|||++|..|.++.. +++. +...+.+++.-||+.|++|+|..|.|++++.+ .++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 22 22234578999999988876642 3332 34567788999999999999999999999855 59999
Q ss_pred ecCCcc
Q 001924 830 DFGLSK 835 (995)
Q Consensus 830 DFGLAr 835 (995)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 999765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=6e-05 Score=80.20 Aligned_cols=134 Identities=16% Similarity=0.122 Sum_probs=83.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeeeeccCeeEEEEeecC
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP--NIVkL~gvf~~~~~lyLVmEym~ 770 (995)
..||.|..+.||+. .|..+++|...... ......+|.++++.+..- .+.+.+++....+...+||++++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999974 25567889875422 234568899999888643 35667777777777889999998
Q ss_pred CCC-HHHHH---------------------Hhc--CCCCHHH-HHHHHH----------HHHH-HHHHHHH----cCcee
Q 001924 771 GGD-LYSLL---------------------RKV--GCLEEDV-ARIYIA----------ELVL-ALEYLHS----LGIVH 810 (995)
Q Consensus 771 GGS-L~d~L---------------------~k~--~~Lsee~-ir~Ia~----------QIa~-GLaYLHs----~GIIH 810 (995)
|.+ +...+ +.. ....... ...+-. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11111 110 0111110 000100 0111 1222321 24789
Q ss_pred eecCCCcEEeccCCcEEEEecCCccc
Q 001924 811 RDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 811 RDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.2e-07 Score=107.78 Aligned_cols=243 Identities=22% Similarity=0.214 Sum_probs=161.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeeccCeeEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~~~lyLV 765 (995)
.-|...+.+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++.+..++..+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 44556677899999999998776555444 5544321 33455788999999999 88888888888899999
Q ss_pred EeecCCC-CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 766 MEYLNGG-DLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 766 mEym~GG-SL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
++++.+| +...... ..-.+..-....+++.-+++++|||+.-=+|+| ||+..+ +..+..||+...-..
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~----- 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT----- 382 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC-----
Confidence 9999887 2222111 111234444555667788899999998778998 887744 789999999765210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
......+..+|+.|+|||+.....+....|+|++|+--.+|--|-+|-.... ...
T Consensus 383 -----------------------~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~ 437 (829)
T KOG0576|consen 383 -----------------------RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVL 437 (829)
T ss_pred -----------------------cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--ccc
Confidence 0113456789999999999999999999999999987666666766643310 000
Q ss_pred HHHHccCCCCCCCCC--CCCHHHH-HHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 924 DNILNRKIPWPCVPS--DMSFEAQ-DLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 924 qkIl~~~~~~p~lps--~lS~eL~-dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..+-.+. ..+.+.. ..++... ++...|+...|..|+. ...++.|++|++=
T Consensus 438 ~~~g~~p-~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfngC 490 (829)
T KOG0576|consen 438 PMIGNGP-NSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNGC 490 (829)
T ss_pred CCCCCCC-CccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhccC
Confidence 0000000 0010000 0111112 3667788888888888 7778888888764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.6e-05 Score=92.52 Aligned_cols=138 Identities=25% Similarity=0.311 Sum_probs=88.7
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeeccc---------------------------ccchhHH----H------HHH
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---------------------------MIRKNDI----E------RIL 735 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~---------------------------~~se~e~----e------~fl 735 (995)
..|+.++-|.||+|+.++ |+.||||+.+..- ..-.... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999875 9999999975310 0000011 1 223
Q ss_pred HHHHHHHhcC-----CCceEEEeeeeeccCeeEEEEeecCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 001924 736 AERNILITVR-----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLA-LEYLHSLG 807 (995)
Q Consensus 736 rEieILs~Lk-----HPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L--~k~~~Lsee~ir~Ia~QIa~G-LaYLHs~G 807 (995)
+|...+.++. .|++.--.-+..-...-.++|||++|-.+.++. +. ..++...+.. .++++ +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~---~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAE---LLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHH---HHHHHHHHHHHhcC
Confidence 4444444432 233322222223344568999999999888874 44 3455333222 22222 23334479
Q ss_pred ceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 808 IIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
++|.|..|.||+++.+|.+.+.|||+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCccee
Confidence 9999999999999999999999999865
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.91 E-value=9e-05 Score=80.86 Aligned_cols=135 Identities=25% Similarity=0.225 Sum_probs=91.3
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchh---------------------HHHHHHHHHHHHHhcC--CCceE
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---------------------DIERILAERNILITVR--NPFVV 750 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~---------------------e~e~flrEieILs~Lk--HPNIV 750 (995)
.|..|--+.||+|.. .++..+|+|+++......+. .......|+..|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677888889999875 45889999998743211111 1112345666666653 34444
Q ss_pred EEeeeeeccCeeEEEEeecCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEE
Q 001924 751 RFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 751 kL~gvf~~~~~lyLVmEym~GGSL-~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKL 828 (995)
+.+.+.. -.|||||+...-+ .=.|.. -.+....+..+..++++.+.-|-. .+++|+||..=|||+. ++.+.+
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 5544432 3799999954311 111111 123334677788899999998887 8999999999999998 889999
Q ss_pred EecCCcc
Q 001924 829 TDFGLSK 835 (995)
Q Consensus 829 sDFGLAr 835 (995)
+|||-|.
T Consensus 208 ID~~QaV 214 (268)
T COG1718 208 IDVSQAV 214 (268)
T ss_pred EECcccc
Confidence 9999886
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00011 Score=77.49 Aligned_cols=134 Identities=12% Similarity=0.063 Sum_probs=82.5
Q ss_pred eccCCC-eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEEeecCCC
Q 001924 695 ISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 695 LG~GgF-GtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVmEym~GG 772 (995)
|..|.+ ..||+.... +..+.||+..... ...+.+|++++..+. +-.+.+++++....+..++||++++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 789988643 4678888765422 234667888887774 344667777777667789999999987
Q ss_pred CHHHHHH-------------------hcC----CCCHH---HHHHH---HH----------------HHHHHHHHHH---
Q 001924 773 DLYSLLR-------------------KVG----CLEED---VARIY---IA----------------ELVLALEYLH--- 804 (995)
Q Consensus 773 SL~d~L~-------------------k~~----~Lsee---~ir~I---a~----------------QIa~GLaYLH--- 804 (995)
+|..... ... .+... ..... +. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7754310 000 11100 00000 00 0111122221
Q ss_pred ----HcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 805 ----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 805 ----s~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
...++|+|+.|.|||+++++.+.|+||+.+.+
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12499999999999999988889999998863
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00033 Score=74.49 Aligned_cols=128 Identities=26% Similarity=0.374 Sum_probs=92.8
Q ss_pred CCeEEEEeeccCCC-eEEEEEEECCCCcEEEEEEeecccc----------cch--------hHHHHHHHHHHHHHhcC--
Q 001924 687 DDFEIIKPISRGAF-GRVFLARKRTTGDLFAIKVLKKLDM----------IRK--------NDIERILAERNILITVR-- 745 (995)
Q Consensus 687 ~dYeIlk~LG~GgF-GtVYka~~k~TG~~VAVKVIkk~~~----------~se--------~e~e~flrEieILs~Lk-- 745 (995)
.+++.++.||.|.. |.||++... |+.||+|+++.-.. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 999999764 88999999442110 000 12346788888877775
Q ss_pred -CCce--EEEeeeeeccC------------------eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001924 746 -NPFV--VRFFYSFTCRD------------------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804 (995)
Q Consensus 746 -HPNI--VkL~gvf~~~~------------------~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLH 804 (995)
+.++ |+.+|+..-.. ...||.||++... .+.... +.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 3455 99998874431 2467888876643 223222 457888899999
Q ss_pred HcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 805 s~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3489999964
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00043 Score=86.41 Aligned_cols=80 Identities=16% Similarity=0.282 Sum_probs=56.1
Q ss_pred EEeeccCCCeEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCce--EEEeeeeecc---CeeE
Q 001924 692 IKPISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFV--VRFFYSFTCR---DNLY 763 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG--~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNI--VkL~gvf~~~---~~ly 763 (995)
++.|+.|.++.+|+......+ ..+++|........ .....+.+|+.+++.+. |+++ .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567899999999998765432 36777765432211 12346789999999985 6554 7777777654 4689
Q ss_pred EEEeecCCCC
Q 001924 764 LVMEYLNGGD 773 (995)
Q Consensus 764 LVmEym~GGS 773 (995)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00031 Score=73.55 Aligned_cols=130 Identities=22% Similarity=0.323 Sum_probs=95.0
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceE-EEeeeeeccCeeEEEEe
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFTCRDNLYLVME 767 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIV-kL~gvf~~~~~lyLVmE 767 (995)
....+.||+|++|.||+|.+. |..+|+|+-+... ....+..|+++|..+.--++- ++|.+.. .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 456678999999999999986 7799999866432 346688899999988866554 3444433 346699
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecC-CCcEEeccCCcEEEEecCCccc
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK-PDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLK-PeNILLDenG~VKLsDFGLArv 836 (995)
|+.|-+|.++-... +. .-+..++..---|-..||-|..|. |..+++..++.+.|+||.-|++
T Consensus 93 ~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99988887765421 22 223356666555777899999997 7777776777999999998874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00033 Score=83.58 Aligned_cols=137 Identities=25% Similarity=0.376 Sum_probs=87.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeeccc----------------------------ccchhHHH------HHHHHH
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD----------------------------MIRKNDIE------RILAER 738 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~----------------------------~~se~e~e------~flrEi 738 (995)
+.||.-+.|.||+|+.+. |+.||||+-+..- ..-++..+ .|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 469999999999999886 9999999864310 00000111 234444
Q ss_pred HHHH----hcCCCc------eEEEeeeeeccCeeEEEEeecCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHH-HHHH
Q 001924 739 NILI----TVRNPF------VVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALE-YLHS 805 (995)
Q Consensus 739 eILs----~LkHPN------IVkL~gvf~~~~~lyLVmEym~GGSL~d~--L~k~~~Lsee~ir~Ia~QIa~GLa-YLHs 805 (995)
+... .+.|-+ |.++|..+. ..-.|+||||+|..+.|. +.+.+ ++...+ +..+.++.. -|-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i---~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDI---LNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-CCHHHH---HHHHHHHHHHHHHh
Confidence 4333 233444 555554443 346899999999877654 44443 554433 223333322 2335
Q ss_pred cCceeeecCCCcEEecc----CCcEEEEecCCccc
Q 001924 806 LGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKI 836 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDe----nG~VKLsDFGLArv 836 (995)
.|++|.|-.|.||++.. ++.+.+-|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 68999999999999984 56899999999764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00043 Score=73.08 Aligned_cols=72 Identities=15% Similarity=0.149 Sum_probs=45.3
Q ss_pred EeeccCCCe-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeeecc---CeeEEE
Q 001924 693 KPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFTCR---DNLYLV 765 (995)
Q Consensus 693 k~LG~GgFG-tVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP---NIVkL~gvf~~~---~~lyLV 765 (995)
+.|+.|+.. .||+. +..+++|+.+.. .....+.+|..++..+... .+..++...... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 467766666 58975 234778865431 1234688899998877532 344455444332 235889
Q ss_pred EeecCCCCH
Q 001924 766 MEYLNGGDL 774 (995)
Q Consensus 766 mEym~GGSL 774 (995)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.002 Score=68.10 Aligned_cols=134 Identities=22% Similarity=0.251 Sum_probs=93.9
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeeccc-------------ccchhHHHHHHHHHHHHHhcC------CCceEEEe
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-------------MIRKNDIERILAERNILITVR------NPFVVRFF 753 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~-------------~~se~e~e~flrEieILs~Lk------HPNIVkL~ 753 (995)
..||+|+.-.||. +.. .....||+..... ........+..+|+.....+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4699999999994 333 4456789887644 011123456667776665555 78899999
Q ss_pred eeeeccCeeEEEEeecCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---
Q 001924 754 YSFTCRDNLYLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 824 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~G------GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG--- 824 (995)
|+..++..+.+|+|.+.+ -+|.+++... .++. .. ...+-+-..||-+++|+.+|++|.||++..+.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 3688888543 4665 22 23344556788999999999999999997543
Q ss_pred -cEEEEe-cCCc
Q 001924 825 -HIKLTD-FGLS 834 (995)
Q Consensus 825 -~VKLsD-FGLA 834 (995)
.+.|+| ||-.
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 477777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=3.7e-05 Score=98.09 Aligned_cols=175 Identities=21% Similarity=0.174 Sum_probs=127.1
Q ss_pred EEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--CeeEEEEeecCCCCHHHHHHhc----CCCCH
Q 001924 715 FAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKV----GCLEE 786 (995)
Q Consensus 715 VAVKVIkk~~~--~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~~lyLVmEym~GGSL~d~L~k~----~~Lse 786 (995)
+-+|+.+..+. ..+...+..+.|.+.++...|+++...+.-.... ...|.+++|+.+|.+++.+-+. ..+..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45666554322 2233455666777777788999988876555433 3468999999999999999654 23344
Q ss_pred HHHHHHHHHHHHHHHHHHHc-----CceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCC
Q 001924 787 DVARIYIAELVLALEYLHSL-----GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861 (995)
Q Consensus 787 e~ir~Ia~QIa~GLaYLHs~-----GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys 861 (995)
..+.....+.+.+..-+|+. -.+|+++|+-|.+|..+.++|++++|+.++-
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk------------------------ 1390 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK------------------------ 1390 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccccccc------------------------
Confidence 44444444447777777754 2799999999999999999999999998830
Q ss_pred ccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 862 ~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
...........+++.|++|++...-.++.++|+|..|+-+|+...|..+|..
T Consensus 1391 ---np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1391 ---NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred ---CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 0111223345788899999999988999999999999999999888887743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0025 Score=66.62 Aligned_cols=75 Identities=16% Similarity=0.225 Sum_probs=47.1
Q ss_pred EEeeccCCCeEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeeccCeeEEEEeec
Q 001924 692 IKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~-TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH-PNIVkL~gvf~~~~~lyLVmEym 769 (995)
++.|..|-...+|++.... .+..|++|+...... ..-...+|+.++..+.. .-.++++..+. -.+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence 4678889999999987543 356888997654211 11123468888887743 22344444332 24799999
Q ss_pred CCCCH
Q 001924 770 NGGDL 774 (995)
Q Consensus 770 ~GGSL 774 (995)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.001 Score=69.31 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=79.8
Q ss_pred HHHHHHHHhcCC-CceEEEeeeeeccCeeEEEEeecCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 001924 735 LAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL---LRKVGCLEEDVARIYIAELVLALEYLHS---LG 807 (995)
Q Consensus 735 lrEieILs~LkH-PNIVkL~gvf~~~~~lyLVmEym~GGSL~d~---L~k~~~Lsee~ir~Ia~QIa~GLaYLHs---~G 807 (995)
.+|.-+++.+.+ +++++++|+|-. ++|+||.+.+++... +......++..+..++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 699999999843 679999987766421 1222346899999999999999999998 45
Q ss_pred ceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 808 IIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+.-.|++++|+-++.+|.+|++|.....+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0063 Score=67.46 Aligned_cols=78 Identities=12% Similarity=0.036 Sum_probs=55.3
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeeec---cCeeE
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC---RDNLY 763 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH---PNIVkL~gvf~~---~~~ly 763 (995)
.-.+.||.|..+.||+.... +..+.+|+.+.. .....+..|...|+.+.- ..+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC--CCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999988543 234677875421 123578889999988753 467778877654 36689
Q ss_pred EEEeecCCCCH
Q 001924 764 LVMEYLNGGDL 774 (995)
Q Consensus 764 LVmEym~GGSL 774 (995)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0088 Score=65.82 Aligned_cols=140 Identities=22% Similarity=0.239 Sum_probs=81.3
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee------eeccC
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS------FTCRD 760 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--PNIVkL~gv------f~~~~ 760 (995)
...++.++.|....+|++.. . +..+++|+..... ....+..|.+++..|.. -.+.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 34466778888889998864 2 4467789775421 12334556666666632 123343332 12245
Q ss_pred eeEEEEeecCCCCHH----H-------HH---Hh-cCCC----------CH-HH--HH----------HHHHHHHHHHHH
Q 001924 761 NLYLVMEYLNGGDLY----S-------LL---RK-VGCL----------EE-DV--AR----------IYIAELVLALEY 802 (995)
Q Consensus 761 ~lyLVmEym~GGSL~----d-------~L---~k-~~~L----------se-e~--ir----------~Ia~QIa~GLaY 802 (995)
..+++++|++|..+. . .+ +. ...+ +. .. .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885431 1 11 11 0011 00 00 00 001123345555
Q ss_pred HHH-------cCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 803 LHS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 803 LHs-------~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
+.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 543 589999999999999988878999999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.017 Score=67.23 Aligned_cols=80 Identities=18% Similarity=0.158 Sum_probs=54.4
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cc---hhHHHHHHHHHHHHHhcC---CCceEEEeeeeeccCeeEE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IR---KNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-~s---e~e~e~flrEieILs~Lk---HPNIVkL~gvf~~~~~lyL 764 (995)
.+.||.|.+..||++.....++.|+||.-..... .. ....++...|.+.|..+. ..++++++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 4679999999999999864335899997431100 00 124567778888887753 34677777763 355789
Q ss_pred EEeecCCCC
Q 001924 765 VMEYLNGGD 773 (995)
Q Consensus 765 VmEym~GGS 773 (995)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0055 Score=66.44 Aligned_cols=137 Identities=18% Similarity=0.152 Sum_probs=82.4
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeee------eeccCeeE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRDNLY 763 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP--NIVkL~gv------f~~~~~ly 763 (995)
.+.|..|....+|++.. ++..+++|++.. .....+..|+.++..+.+. .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56788888889998864 345788998753 1234566677777776432 24444332 12344578
Q ss_pred EEEeecCCCCHHH----HH----------Hhc-CCC----------CHHHH--H--------HHHHHHHHHHHHHHH---
Q 001924 764 LVMEYLNGGDLYS----LL----------RKV-GCL----------EEDVA--R--------IYIAELVLALEYLHS--- 805 (995)
Q Consensus 764 LVmEym~GGSL~d----~L----------~k~-~~L----------see~i--r--------~Ia~QIa~GLaYLHs--- 805 (995)
+|++|++|..+.. .. +.. ..+ .+... . .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998866421 11 100 000 00000 0 011123334555553
Q ss_pred ----cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 ----LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 ----~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.024 Score=62.31 Aligned_cols=31 Identities=32% Similarity=0.430 Sum_probs=26.8
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.++||+|+.|.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998666668999998863
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.007 Score=66.04 Aligned_cols=75 Identities=12% Similarity=0.087 Sum_probs=47.0
Q ss_pred EEeeccCCCeEEEEEEECC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeeccCeeEE
Q 001924 692 IKPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYL 764 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~~~lyL 764 (995)
++.|..|-...+|++.... +++.|++|+..... .......+|..++..+.... ..++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3567778888999887543 25789999876432 12234567877777765322 3344444432 36
Q ss_pred EEeecCCCCH
Q 001924 765 VMEYLNGGDL 774 (995)
Q Consensus 765 VmEym~GGSL 774 (995)
|++|++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0039 Score=66.59 Aligned_cols=133 Identities=20% Similarity=0.197 Sum_probs=75.4
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeeccCeeEEEEeecCCC
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI-VkL~gvf~~~~~lyLVmEym~GG 772 (995)
.+..|-.+.+|+.. .++..+++|+...... ...-...+|..+++.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35678888999886 4567888887543211 000124668888887754222 33333322 36899999886
Q ss_pred CHHH--------------HHH---hcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCceeeec
Q 001924 773 DLYS--------------LLR---KVG----CLEE-DVARIYIAEL---------VLALEYLHS--------LGIVHRDL 813 (995)
Q Consensus 773 SL~d--------------~L~---k~~----~Lse-e~ir~Ia~QI---------a~GLaYLHs--------~GIIHRDL 813 (995)
.+.. .+. ... .++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 111 111 1111 1111211111 111222222 24899999
Q ss_pred CCCcEEeccCCcEEEEecCCccc
Q 001924 814 KPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 814 KPeNILLDenG~VKLsDFGLArv 836 (995)
.|.||+++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0013 Score=74.39 Aligned_cols=136 Identities=15% Similarity=0.162 Sum_probs=94.0
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecc-----------------c--ccchhHHHHHHHHHHHHHhcCC--C
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-----------------D--MIRKNDIERILAERNILITVRN--P 747 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~-----------------~--~~se~e~e~flrEieILs~LkH--P 747 (995)
+.+.++||-|--+.||.|-+. .|.+.++|+=+.. . .+-.-..-...+|+..|+.+.. =
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999876 4888999952210 0 0111112234678888888753 2
Q ss_pred ceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 748 NIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
-|++.+++ .+-++|||++.|-.|...-+- .+ +..+...+..-+--|..+|+||+|..--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 24444443 346889999998887665321 12 223344555667778999999999999999999999999
Q ss_pred EEecCCcc
Q 001924 828 LTDFGLSK 835 (995)
Q Consensus 828 LsDFGLAr 835 (995)
++||--..
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.048 Score=63.08 Aligned_cols=138 Identities=29% Similarity=0.253 Sum_probs=88.3
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhcCCCce
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------------------NDIERILAERNILITVRNPFV 749 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se-----------------------~e~e~flrEieILs~LkHPNI 749 (995)
..|..|--+-||.+... +|..+|||+++..-+.-. .-......|++-|+++..-.|
T Consensus 150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 46778888899999854 688899999864221100 011122446666766654322
Q ss_pred EEEeeeeeccCeeEEEEeecCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEE
Q 001924 750 VRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 750 VkL~gvf~~~~~lyLVmEym~GGSL-~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VK 827 (995)
.-.--... ..-.|||+|+....- .-.| +...++...+..+-.+++.-|.-|-+ .+++|.||.--|+|+ .+|.+.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly 304 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY 304 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence 11100000 123789999943211 1122 23357777788877788887777654 589999999999999 678999
Q ss_pred EEecCCcc
Q 001924 828 LTDFGLSK 835 (995)
Q Consensus 828 LsDFGLAr 835 (995)
++|.+-+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99999765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.069 Score=60.63 Aligned_cols=142 Identities=18% Similarity=0.232 Sum_probs=82.1
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeeccC--eeEEEE
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRD--NLYLVM 766 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--PNIVkL~gvf~~~~--~lyLVm 766 (995)
+.+.+..|..-.+|..... ++.+++. ... ............+|+.+++.+.- .-+...+++|.... .+|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444434444445544433 7778777 221 12223345667788888887753 34555666666655 679999
Q ss_pred eecCCCCH------------------HHHHHh---c--------C---CCCHHHHHHHHH--------------HHHHHH
Q 001924 767 EYLNGGDL------------------YSLLRK---V--------G---CLEEDVARIYIA--------------ELVLAL 800 (995)
Q Consensus 767 Eym~GGSL------------------~d~L~k---~--------~---~Lsee~ir~Ia~--------------QIa~GL 800 (995)
+|+.|..+ .++|.. - + .+....+..+.. ....-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99988322 111210 0 0 000001111111 122234
Q ss_pred HHHHHc--------CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 801 EYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 801 aYLHs~--------GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.+|+.+ .++|+|+.+.||+++..+-+=|.||+++.+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 455543 499999999999999998999999999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.071 Score=58.73 Aligned_cols=30 Identities=37% Similarity=0.626 Sum_probs=25.6
Q ss_pred CceeeecCCCcEEeccCCc-EEEEecCCccc
Q 001924 807 GIVHRDLKPDNLLIAHDGH-IKLTDFGLSKI 836 (995)
Q Consensus 807 GIIHRDLKPeNILLDenG~-VKLsDFGLArv 836 (995)
.++|+|+.|.|||++.++. .-|.||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987454 67999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.1 Score=59.30 Aligned_cols=140 Identities=17% Similarity=0.226 Sum_probs=79.2
Q ss_pred CeEEEEeeccCCCeEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeeccCee
Q 001924 688 DFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNL 762 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI-VkL~gvf~~~~~l 762 (995)
..++ ..|..|-...+|++.... +++.|++|+..... ...++ -.+|..+++.+..-++ .++++.+.. +
T Consensus 38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g-- 109 (344)
T PLN02236 38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G-- 109 (344)
T ss_pred cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c--
Confidence 3444 456668888999987532 24689999875422 11222 2568888777753322 234454432 2
Q ss_pred EEEEeecCCCCHHHH-------H----------HhcC----C-C-CHHHHHHHHHH-----------------HHHHHHH
Q 001924 763 YLVMEYLNGGDLYSL-------L----------RKVG----C-L-EEDVARIYIAE-----------------LVLALEY 802 (995)
Q Consensus 763 yLVmEym~GGSL~d~-------L----------~k~~----~-L-see~ir~Ia~Q-----------------Ia~GLaY 802 (995)
.|++|+++.+|... + +... . . ....+..+..+ +...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 58999977665311 1 1101 0 1 11222222211 1111222
Q ss_pred HH--------HcCceeeecCCCcEEecc-CCcEEEEecCCccc
Q 001924 803 LH--------SLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 836 (995)
Q Consensus 803 LH--------s~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv 836 (995)
|. ...++|+|+++.|||+++ ++.+.++||..|..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 225899999999999986 47899999999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.12 Score=59.82 Aligned_cols=77 Identities=21% Similarity=0.184 Sum_probs=48.9
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeec----ccccchhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeeccCeeEEEE
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKK----LDMIRKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk----~~~~se~e~e~flrEieILs~Lk--HP-NIVkL~gvf~~~~~lyLVm 766 (995)
.||.|....||++.....++.|+||.-.. ....-+...++..-|...|+... -| .++++|.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999754336899995321 11111334566677888886653 24 45555543 445567899
Q ss_pred eecCCC
Q 001924 767 EYLNGG 772 (995)
Q Consensus 767 Eym~GG 772 (995)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.1 Score=58.74 Aligned_cols=141 Identities=15% Similarity=0.186 Sum_probs=77.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeeccCee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI-VkL~gvf~~~~~l 762 (995)
+..++ +.|..|-...+|++..... +..|++|+...... ..-.-.+|..+++.+..-++ +++++++. .+
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G-- 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG-- 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc--
Confidence 44444 4455588888998875432 23788998754221 11122467778777754333 34454442 22
Q ss_pred EEEEeecCCCCHHH-------HH----------HhcC-C----C-CHHHHHHHHHHH----------------------H
Q 001924 763 YLVMEYLNGGDLYS-------LL----------RKVG-C----L-EEDVARIYIAEL----------------------V 797 (995)
Q Consensus 763 yLVmEym~GGSL~d-------~L----------~k~~-~----L-see~ir~Ia~QI----------------------a 797 (995)
+|.+|++|-+|.. .+ +... . + ....+..+..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5889987765421 11 1111 0 1 112222222211 1
Q ss_pred HHHHHHH----Hc----CceeeecCCCcEEecc-CCcEEEEecCCccc
Q 001924 798 LALEYLH----SL----GIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 836 (995)
Q Consensus 798 ~GLaYLH----s~----GIIHRDLKPeNILLDe-nG~VKLsDFGLArv 836 (995)
.-+..+. .. -++|+|+.+.|||+++ ++.++++||..|..
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1122222 11 2899999999999975 57899999999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.35 Score=56.83 Aligned_cols=77 Identities=21% Similarity=0.168 Sum_probs=50.8
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcC---CCceEEEeeeeeccCeeE
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-~se---~e~e~flrEieILs~Lk---HPNIVkL~gvf~~~~~ly 763 (995)
..+.||.|....||++... +..|+||.-..... ... ....+...|.+.|+.+. ..+++++|.++. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999998863 45688986431111 111 13445555677666553 347888888777 4457
Q ss_pred EEEeecCC
Q 001924 764 LVMEYLNG 771 (995)
Q Consensus 764 LVmEym~G 771 (995)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.18 Score=58.96 Aligned_cols=78 Identities=22% Similarity=0.182 Sum_probs=51.3
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeec---ccccchhHHHHHHHHHHHHHhcC--CC-ceEEEeeeeeccCeeEEE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDMIRKNDIERILAERNILITVR--NP-FVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk---~~~~se~e~e~flrEieILs~Lk--HP-NIVkL~gvf~~~~~lyLV 765 (995)
.+.||.|.-..||++.+...++.|+||--.. ....-+-..++..-|.++|+... .| +++++|.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999854456799985221 11111345677778888887653 24 45666543 44456788
Q ss_pred EeecCC
Q 001924 766 MEYLNG 771 (995)
Q Consensus 766 mEym~G 771 (995)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.12 Score=61.90 Aligned_cols=164 Identities=20% Similarity=0.253 Sum_probs=103.1
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeeecc-CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 001924 732 ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 810 (995)
Q Consensus 732 e~flrEieILs~LkHPNIVkL~gvf~~~-~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIH 810 (995)
..++--+..++.+.|+|..+++++-... .+..+|||++ +.+|.+++.... +-... +. .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------ccccce
Confidence 4566678889999999999998876554 3578899999 679999987643 21111 11 223332
Q ss_pred eecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC
Q 001924 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (995)
Q Consensus 811 RDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ 890 (995)
- | .++.+| -++. ...+..|
T Consensus 91 ~-----~-------~~~~td-~~~t----------------------------------~~~~~~~-------------- 109 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLT----------------------------------KYPSPIG-------------- 109 (725)
T ss_pred e-----h-------hhhccc-cccc----------------------------------cCCCCCC--------------
Confidence 2 1 233333 1100 0011112
Q ss_pred CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 891 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 891 ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
+|+||||+|.++.++..|...|......+....+..-...-.. +.-.++.....+..+|+-..|..||.
T Consensus 110 --pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 110 --PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred --cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence 3899999999999999998887766665555544432211000 11234566778899999999999997
Q ss_pred HHHHHHHHcCcccccc
Q 001924 962 ANGAAEVFHCKIFIKK 977 (995)
Q Consensus 962 A~EIlEiL~HPfF~~~ 977 (995)
-.+...++-|...
T Consensus 188 ---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 ---PMELSKRCSFTEV 200 (725)
T ss_pred ---hhHHhcCccHHHH
Confidence 5566667776655
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.67 E-value=1.1 Score=49.83 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=28.0
Q ss_pred CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 807 GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.83 E-value=1 Score=50.53 Aligned_cols=75 Identities=21% Similarity=0.301 Sum_probs=48.3
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeeccCeeEEEE
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk---HPNIVkL~gvf~~~~~lyLVm 766 (995)
+-.+.|+.|....+|+.. .+++.+.||+-.. .....|..|.+-|+.|. .-.+++.+.+....+..||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445679999999999887 6688899997552 23356777888887773 456888888888877889999
Q ss_pred eecCCC
Q 001924 767 EYLNGG 772 (995)
Q Consensus 767 Eym~GG 772 (995)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.74 E-value=0.91 Score=52.76 Aligned_cols=79 Identities=18% Similarity=0.181 Sum_probs=45.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCC-CcE-----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeecc
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTT-GDL-----FAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCR 759 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~T-G~~-----VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~ 759 (995)
+.+.+ +.|..|-...+|++..... +.. |.+++... .....-.-.+|.++++.+...+ -.++++.+..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 34444 4666688899999975432 122 44433211 1111112356888888886543 4455665542
Q ss_pred CeeEEEEeecCCCCH
Q 001924 760 DNLYLVMEYLNGGDL 774 (995)
Q Consensus 760 ~~lyLVmEym~GGSL 774 (995)
++|+||++|-+|
T Consensus 125 ---g~l~efIeGr~l 136 (383)
T PTZ00384 125 ---FTIQEWVEGNTM 136 (383)
T ss_pred ---EEEEEEeccccC
Confidence 689999988765
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.74 E-value=2.4 Score=47.76 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.6
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3699999999999995 4 578999998763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.37 E-value=0.62 Score=54.29 Aligned_cols=72 Identities=26% Similarity=0.400 Sum_probs=55.6
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
....|++|++. |++|.-. ..-...++..++.+.+.-++-+..+ .+-|||+...||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34568888887 5555322 2245677778888888777777765 699999999999999 99999999999984
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=89.31 E-value=0.66 Score=50.55 Aligned_cols=29 Identities=24% Similarity=0.494 Sum_probs=25.8
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.19 E-value=5.8 Score=51.72 Aligned_cols=30 Identities=33% Similarity=0.560 Sum_probs=25.7
Q ss_pred cCceeeecCCCcEEeccCC--cEE-EEecCCcc
Q 001924 806 LGIVHRDLKPDNLLIAHDG--HIK-LTDFGLSK 835 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG--~VK-LsDFGLAr 835 (995)
.++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999998775 455 99999876
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=87.69 E-value=2 Score=47.42 Aligned_cols=115 Identities=15% Similarity=0.155 Sum_probs=71.4
Q ss_pred CCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHH
Q 001924 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 777 (995)
Q Consensus 698 GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~ 777 (995)
|+-++.-.+.-+. .+..+|.++.....- ...-+.++..++.++. .|+++..- ....+.++.|+|-...
T Consensus 73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~---- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK---- 140 (308)
T ss_pred CCceEEEEecccc--chhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----
Confidence 3444554444332 345567665544321 2345678889988876 47777622 3335678999883211
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CceeeecCCCcEEeccCCcEEEEecCC
Q 001924 778 LRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 778 L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.+.. .++.-=+.+|.-.|+. +.+|+|-.|+||+.|..|.+||.|=+.
T Consensus 141 -----i~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 141 -----INFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----cchh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 0111 1111124567778843 799999999999999999999999773
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.72 E-value=5.7 Score=47.22 Aligned_cols=79 Identities=16% Similarity=0.232 Sum_probs=45.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceE-EEeeeee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRT--------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFT 757 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~--------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIV-kL~gvf~ 757 (995)
++. -++.|..|-.-.+|++.... .++.|.+++..... + ..-.-.+|..+++.+....|- ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e-~lIdR~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---D-ELYNPISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---c-ceeCHHHHHHHHHHHHHCCCCCceEEEeC
Confidence 344 55677778888888887542 25678888875422 1 111234566666666533322 3444442
Q ss_pred ccCeeEEEEeecCCCCH
Q 001924 758 CRDNLYLVMEYLNGGDL 774 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL 774 (995)
-+.|.+|++|-+|
T Consensus 181 ----gg~I~efi~g~~l 193 (442)
T PTZ00296 181 ----GGRIEEWLYGDPL 193 (442)
T ss_pred ----CCEEEEeeCCccC
Confidence 2467899987643
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.46 E-value=1.3 Score=51.21 Aligned_cols=51 Identities=27% Similarity=0.444 Sum_probs=35.8
Q ss_pred HHHHHHHHHHHHHHHHHHH----HcCceeeecCCCcEEeccCC------------------cEEEEecCCccc
Q 001924 786 EDVARIYIAELVLALEYLH----SLGIVHRDLKPDNLLIAHDG------------------HIKLTDFGLSKI 836 (995)
Q Consensus 786 ee~ir~Ia~QIa~GLaYLH----s~GIIHRDLKPeNILLDenG------------------~VKLsDFGLArv 836 (995)
.+-++.++.|++.-.-.+- ..+++|-||||+|||+-... .++|.||.+|.+
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 3456777778876553443 34799999999999985432 357778888775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.21 E-value=3.7 Score=48.83 Aligned_cols=61 Identities=30% Similarity=0.299 Sum_probs=43.0
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCceeeecCCCcEEeccC
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHD 823 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaY-LHs~GIIHRDLKPeNILLDen 823 (995)
..++-+|..|-++..++... ..++...+.++.-.+.|+-- |--.+++|.|+.|.||++-.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 46677788888888888643 35555666666655555443 344589999999999999643
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=80.82 E-value=1.2 Score=47.33 Aligned_cols=29 Identities=24% Similarity=0.448 Sum_probs=25.8
Q ss_pred CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 807 GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
-.+|+|+.|.||+++.+| ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998877 88999998874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 995 | ||||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-55 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-54 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-54 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-54 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-53 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-53 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-53 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-53 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-53 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-53 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-53 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-53 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-53 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-53 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-53 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-53 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-53 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-53 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-53 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-53 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-53 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-53 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-53 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-53 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-53 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-53 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-53 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-53 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-53 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-53 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-52 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-52 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-52 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-52 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-52 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-52 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-52 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-52 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-52 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-52 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-52 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-52 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-52 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-52 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-52 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-52 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-52 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-52 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-52 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-52 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-52 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-52 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-52 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-52 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-52 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-52 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-52 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-52 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-52 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-51 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-51 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-51 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-51 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-51 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-51 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-51 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-51 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-51 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-51 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-51 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-51 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-51 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-51 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-51 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-50 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-50 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-50 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-50 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-49 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-48 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-48 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-48 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-47 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-47 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-46 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-46 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-46 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-45 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-45 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-45 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-45 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-45 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-45 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-45 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-44 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-44 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-44 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-44 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-44 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-44 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-44 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-44 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-44 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-44 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-44 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-44 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-44 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-44 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-44 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-44 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-44 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-44 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-40 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-39 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-39 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-39 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-39 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-39 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-39 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-39 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-38 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-38 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-38 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-38 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-38 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-38 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-38 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-38 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-38 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-37 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-37 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-36 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-36 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-35 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-35 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-34 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-34 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-33 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-33 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-33 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-32 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-32 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-32 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-31 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-31 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-31 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-31 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-31 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-30 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-30 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-30 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-30 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-30 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-30 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-30 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-29 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-29 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-29 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-29 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-29 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-29 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-29 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-29 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-29 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-29 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-29 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-29 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-29 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-29 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-28 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-28 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-28 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-28 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-26 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-26 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-26 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-25 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-25 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-25 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-24 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-24 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-24 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-24 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-24 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-24 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-24 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-24 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-22 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-21 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-20 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-17 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 |
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-122
Identities = 114/362 (31%), Positives = 179/362 (49%), Gaps = 48/362 (13%)
Query: 617 LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPL 676
++ LV+D +E LL L + E + ++ K + + +
Sbjct: 2 MQQLVLDPGFLGLEPLLD----LLLGVHQELGASELAQDKYVADFL-------QWAEPIV 50
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
+ R DDFEI+K I RGAF V + + + TG ++A+K++ K DM+++ ++
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAE 795
ER++L+ ++ + ++F + LYLVMEY GGDL +LL K G + ++AR Y+AE
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+V+A++ +H LG VHRD+KPDN+L+ GHI+L DFG + T+
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV------------ 218
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------HGYAADWWSVGIILFEFI 908
AVGTPDYL+PEIL +G DWW++G+ +E
Sbjct: 219 --------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 909 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G PF A+S + I++ K + P V + EA+D I R L P RLG GA
Sbjct: 265 YGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAG 323
Query: 967 EV 968
+
Sbjct: 324 DF 325
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-122
Identities = 92/314 (29%), Positives = 160/314 (50%), Gaps = 31/314 (9%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+ + + + +DF+ K + G+F V LAR+ T +AIK+L+K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+I++N + + ER+++ + +PF V+ +++F + LY + Y G+L +RK+G
Sbjct: 67 HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
+E R Y AE+V ALEYLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS----- 181
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
++ +S VGT Y++PE+L ++D W++G I
Sbjct: 182 --------------------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
+++ + G+PPF A + +IF I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCE 278
Query: 964 ---GAAEVFHCKIF 974
G + F
Sbjct: 279 EMEGYGPLKAHPFF 292
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-120
Identities = 116/364 (31%), Positives = 182/364 (50%), Gaps = 44/364 (12%)
Query: 615 SKLKALVIDTFGSRIEKLLREKYIL--ACELLDEKSPTSFSKYKENSRLILDSVSQSSGV 672
+L+ ++D + + +L L DE + + + K +
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYL-------EWA 59
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
+ R +DFEI+K I RGAFG V + + + +FA+K+L K +M+++ +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARI 791
ER++L+ + ++ Y+F +NLYLVM+Y GGDL +LL K L E++AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T+
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------- 232
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFE 906
AVGTPDY++PEIL E +G DWWS+G+ ++E
Sbjct: 233 -------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 907 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ G PF AES + I+N K +P +D+S A+DLI R LI RLG NG
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNG 332
Query: 965 AAEV 968
+
Sbjct: 333 IEDF 336
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-120
Identities = 104/294 (35%), Positives = 168/294 (57%), Gaps = 35/294 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS I++RDLKP+N+L+ +GHIK+TDFG +K + + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVT-------------------- 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
++ GTPDY+APE++ + + DWWS GI+++E + G PF +
Sbjct: 161 ---------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
++ ILN ++ + P + + +DL++R + D +QRLG NG +V + F
Sbjct: 212 YEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-115
Identities = 116/304 (38%), Positives = 172/304 (56%), Gaps = 36/304 (11%)
Query: 671 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR 727
G S + E+ + FE+++ + +G +G+VF RK T TG +FA+KVLKK ++R
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 728 K-NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 786
D AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L + G E
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 787 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846
D A Y+AE+ +AL +LH GI++RDLKP+N+++ H GH+KLTDFGL K +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-------- 172
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
D H+ GT +Y+APEIL+ + H A DWWS+G ++++
Sbjct: 173 -------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NG 964
+TG PPFT E+ + D IL K+ P ++ EA+DL+ + L + RLGA
Sbjct: 214 MLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGD 270
Query: 965 AAEV 968
A EV
Sbjct: 271 AGEV 274
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-114
Identities = 107/296 (36%), Positives = 168/296 (56%), Gaps = 35/296 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K + T
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRT------------------ 195
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
I++ I++ K+ + PS S + +DL+ L D +R G NG ++ + K F
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 357 bits (917), Expect = e-114
Identities = 112/302 (37%), Positives = 167/302 (55%), Gaps = 35/302 (11%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
++ R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFY 173
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
AE+VLAL+ +HS+G +HRD+KPDN+L+ GH+KL DFG
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------------- 216
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFI 908
+ + +AVGTPDY++PE+L +G DWWSVG+ L+E +
Sbjct: 217 ---------KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 909 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G PF A+S + I+N K + +P D+S EA++LI FL D RLG NG
Sbjct: 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFL-TDREVRLGRNGVE 325
Query: 967 EV 968
E+
Sbjct: 326 EI 327
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-114
Identities = 107/307 (34%), Positives = 166/307 (54%), Gaps = 32/307 (10%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
+ + L S DF +K I +G+FG+V LAR + +A+KVL+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74
Query: 724 DMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+++K + + I++ERN+L+ V++PF+V +SF D LY V++Y+NGG+L+ L++
Sbjct: 75 AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 134
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
C E AR Y AE+ AL YLHSL IV+RDLKP+N+L+ GHI LTDFGL K +
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---- 190
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
N + GTP+YLAPE+L + DWW +G
Sbjct: 191 -----------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+L+E + G+PPF + + ++DNILN+ + +++ A+ L+ L D +RLGA
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGA 284
Query: 963 -NGAAEV 968
+ E+
Sbjct: 285 KDDFMEI 291
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-113
Identities = 109/296 (36%), Positives = 165/296 (55%), Gaps = 36/296 (12%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERI 734
E+ FE++K + +G+FG+VFL +K + L+A+KVLKK ++ D R
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRT 73
Query: 735 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L K E+ + Y+A
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
EL LAL++LHSLGI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---------------- 177
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +S GT +Y+APE++ H +ADWWS G+++FE +TG PF
Sbjct: 178 -----------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
+ + IL K+ P +S EAQ L+ +P RLGA +G E+
Sbjct: 227 QGKDRKETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-112
Identities = 107/288 (37%), Positives = 165/288 (57%), Gaps = 32/288 (11%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS +V+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------------------------ 156
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 157 ---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-111
Identities = 114/337 (33%), Positives = 183/337 (54%), Gaps = 42/337 (12%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 704
S + + ++ + T + H E+ I++FE++K + GA+G+VF
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 705 LARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILITVRN-PFVVRFFYSFTCR 759
L RK + TG L+A+KVLKK +++K E ER +L +R PF+V Y+F
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
L+L+++Y+NGG+L++ L + E +IY+ E+VLALE+LH LGI++RD+K +N+L
Sbjct: 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ +GH+ LTDFGLSK + + + + GT +
Sbjct: 192 LDSNGHVVLTDFGLSKEFVAD--------------------------ETERAYDFCGTIE 225
Query: 880 YLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIPW 933
Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT + S I IL + P+
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
P +MS A+DLI R L+ DP +RLG A E+
Sbjct: 286 ---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-111
Identities = 96/303 (31%), Positives = 163/303 (53%), Gaps = 33/303 (10%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 728
++ VS ++ +++R + DF + + +G+FG+V L+ ++ T +L+A+K+LKK +I+
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 729 NDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
+D+E + E+ +L PF+ + F D LY VMEY+NGGDL +++VG +E
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
A Y AE+ + L +L S GI++RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--------- 172
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
D + GTPDY+APEI+ +G + DWW+ G++L+E
Sbjct: 173 ------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 908 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 965
+ G PF E + +F +I+ + + P MS EA + + P +RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271
Query: 966 AEV 968
++
Sbjct: 272 RDI 274
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-110
Identities = 111/306 (36%), Positives = 174/306 (56%), Gaps = 34/306 (11%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
+SS + + R ID+FE I+ + +G+FG+V LAR + TGDL+A+KVLKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
+ +D+E + E+ IL RN PF+ + F F D L+ VME++NGGDL ++K +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
E AR Y AE++ AL +LH GI++RDLK DN+L+ H+GH KL DFG+ K G+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------- 175
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
+ + GTPDY+APEIL +G A DWW++G++L+
Sbjct: 176 --------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--- 962
E + G PF AE+ + +F+ ILN ++ + P+ + +A ++ F+ +P RLG+
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQ 272
Query: 963 NGAAEV 968
G +
Sbjct: 273 GGEHAI 278
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-110
Identities = 103/288 (35%), Positives = 161/288 (55%), Gaps = 31/288 (10%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S + + I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 738 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
+ +L +PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE+
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+L L++LHS GIV+RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------------------ 169
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF
Sbjct: 170 ---------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 964
+ E +F +I + P + EA+DL+ + + +P +RLG G
Sbjct: 221 QDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG 265
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-108
Identities = 84/302 (27%), Positives = 153/302 (50%), Gaps = 39/302 (12%)
Query: 673 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 732
S P E + D FEI++ I +G+FG+V + +K T ++A+K + K + +N++
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
+ E I+ + +PF+V +YSF +++++V++ L GGDL L++ +E+ +++
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
I ELV+AL+YL + I+HRD+KPDN+L+ GH+ +TDF ++ +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--------------- 165
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT 909
+ GT Y+APE+ G + +A DWWS+G+ +E +
Sbjct: 166 -------------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 910 GIPPF---TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
G P+ ++ S + I + + PS S E L+ + L +P+QR +
Sbjct: 213 GRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QLS 267
Query: 967 EV 968
+V
Sbjct: 268 DV 269
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-107
Identities = 100/302 (33%), Positives = 161/302 (53%), Gaps = 43/302 (14%)
Query: 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
+ + DF++++ I RG++ +V L R + T ++A+KV+KK + DI+ + E++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 740 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ N PF+V F L+ V+EY+NGGDL +++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
AL YLH GI++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT--- 915
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF
Sbjct: 162 -------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 916 ------AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAA 966
+ + +F IL ++I P +S +A ++ FL DP +RLG G A
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 967 EV 968
++
Sbjct: 272 DI 273
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-106
Identities = 114/338 (33%), Positives = 179/338 (52%), Gaps = 34/338 (10%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIK 693
RE++ A + + + + + S + + L + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL-AKPKHRVTMNEFEYLK 154
Query: 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 753
+ +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRD 812
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 872
LK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATMK 307
Query: 873 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 932
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 933 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
+ P + EA+ L++ L DP QRLG A E+
Sbjct: 368 F---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI 402
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-105
Identities = 104/340 (30%), Positives = 173/340 (50%), Gaps = 44/340 (12%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
D PT+ + Y + + + + ++T + DF++++ I RG++
Sbjct: 8 HHHDYDIPTTENLYFQGA-MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 760
+V L R + T ++A++V+KK + DI+ + E+++ N PF+V F
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDLK DN+L+
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+GHIKLTD+G+ K GL + GTP+Y
Sbjct: 187 DSEGHIKLTDYGMCKEGL---------------------------RPGDTTSTFCGTPNY 219
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---------AESPEIIFDNILNRKI 931
+APEIL G ++G++ DWW++G+++FE + G PF + + +F IL ++I
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEV 968
P +S +A ++ FL DP +RLG G A++
Sbjct: 280 RIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADI 316
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-102
Identities = 98/330 (29%), Positives = 169/330 (51%), Gaps = 33/330 (10%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
+E+ F + K ++ +S ++ +++R + DF + + +G+FG
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFG 355
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 760
+V L+ ++ T +L+A+K+LKK +I+ +D+E + E+ +L PF+ + F D
Sbjct: 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
LY VMEY+NGGDL +++VG +E A Y AE+ + L +L S GI++RDLK DN+++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+GHIK+ DFG+ K + D + GTPDY
Sbjct: 476 DSEGHIKIADFGMCKENI---------------------------WDGVTTKTFCGTPDY 508
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDM 940
+APEI+ +G + DWW+ G++L+E + G PF E + +F +I+ + + P M
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSM 565
Query: 941 SFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
S EA + + P +RLG G ++
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDI 595
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-100
Identities = 90/290 (31%), Positives = 148/290 (51%), Gaps = 32/290 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
T L K + +IDDF+I +P+ +G FG V+LAR++ + A+KVL K + ++ +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
+ E I +R+P ++R + F R +YL++E+ G+LY L+K G +E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 794 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
EL AL Y H ++HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+ R + GT DYL PE++ G H D W G++ +EF+ G+PP
Sbjct: 163 -----------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
F + S I+N + + P +S ++DLI++ L + P QRL
Sbjct: 212 FDSPSHTETHRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRLPLK 258
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 324 bits (831), Expect = e-100
Identities = 82/298 (27%), Positives = 140/298 (46%), Gaps = 40/298 (13%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ D F + + RG FG VF + + TG L+A K L K + ++ + + E+ I
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAEL 796
L V + F+V Y+F + +L LVM +NGGD+ Y++ +E A Y A++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
V LE+LH I++RDLKP+N+L+ DG+++++D GL+
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK------------------ 340
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
GTP ++APE+LLG E+ ++ D++++G+ L+E I PF A
Sbjct: 341 ---------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 917 E----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
+ + +L + + + P S ++D L DP +RLG +
Sbjct: 392 RGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-100
Identities = 90/283 (31%), Positives = 145/283 (51%), Gaps = 32/283 (11%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
S K + +++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
I +R+P ++R + F +YL++EY G +Y L+K+ +E YI EL
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
AL Y HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------- 157
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
+ R GT DYL PE++ G H D WS+G++ +EF+ G PPF A +
Sbjct: 158 ------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
+ + I + + P ++ A+DLI+R L H+P+QR
Sbjct: 212 YQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRPM 251
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = 3e-97
Identities = 98/336 (29%), Positives = 152/336 (45%), Gaps = 49/336 (14%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 701
E+ F K+ E+ + + + +++DF + + I RG FG
Sbjct: 152 EICQNLRGDVFQKFIESDK--------FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFG 203
Query: 702 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC 758
V+ RK TG ++A+K L K + K L ER +L V PF+V Y+F
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818
D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+RDLKP N+
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP 878
L+ GH++++D GL+ H++VGT
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKKP-----------------------------HASVGTH 354
Query: 879 DYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNILNRKIPWP 934
Y+APE+L G + +ADW+S+G +LF+ + G PF I L +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL- 413
Query: 935 CVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
P S E + L+ L D N+RLG GA EV
Sbjct: 414 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = 2e-96
Identities = 98/354 (27%), Positives = 156/354 (44%), Gaps = 50/354 (14%)
Query: 633 LREKYILACELLDEKSPTSFSKYKENSRLILDSVSQ--------SSGVSTPLHSSHKERT 684
+ + + C E+ P ++E +RL + +S S + L ER
Sbjct: 121 VPRQLVTNCTQRLEQGPCK-DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ 179
Query: 685 --SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ + F + + +G FG V + R TG ++A K L+K + ++ L E+ IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLAL 800
V + FVV Y++ +D L LV+ +NGGDL + +G E A Y AE+ L
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
E LH IV+RDLKP+N+L+ GHI+++D GL+ TI
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----------------- 342
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 917
VGT Y+APE++ + ++ DWW++G +L+E I G PF
Sbjct: 343 -----------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEV 968
E + + + S +A+ L ++ L DP +RLG A EV
Sbjct: 392 IKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 7e-86
Identities = 86/293 (29%), Positives = 134/293 (45%), Gaps = 35/293 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DFE I + +GAFG+V AR +AIK ++ + + IL+E +L ++ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 747 PFVVRFFYSFTCRDN-------------LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+++ AL Y+HS GI+HRDLKP N+ I ++K+ DFGL+K
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV-------------HR 168
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911
+ + + N SA+GT Y+A E+L GT H D +S+GII FE I
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226
Query: 912 PPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
P T I + + I +P + + +I + HDPN+R GA
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 8e-84
Identities = 69/341 (20%), Positives = 135/341 (39%), Gaps = 73/341 (21%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
D +S S + ++ I+D+ II+ +++G F ++ L K +A+K +K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65
Query: 724 DMIRK--------------NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769
+ +K + + E I+ ++N + + T D +Y++ EY+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 770 NGGDLYSLLRKVGCLE--------EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLI 820
+ L+ V + I ++ + Y+H+ I HRD+KP N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+G +KL+DFG S+ ++ + GT ++
Sbjct: 186 DKNGRVKLSDFGESEY-----------------------------MVDKKIKGSRGTYEF 216
Query: 881 LAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWPCVP 937
+ PE +G D WS+GI L+ + PF+ + S +F+NI + I +P
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276
Query: 938 SD----------------MSFEAQDLINRFLIHDPNQRLGA 962
+ +S E D + FL +P +R+ +
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 1e-81
Identities = 84/324 (25%), Positives = 127/324 (39%), Gaps = 40/324 (12%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHS-SHKERTSIDDFEIIKPISRGAFGR 702
L ++ S ++ R + S + +P + S E F+ + + G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 703 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761
VF R + G L+A+K K D R LAE V ++P VR ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 762 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 820
LYL E G L G L E Y+ + +LAL +LHS G+VH D+KP N+ +
Sbjct: 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190
Query: 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
G KL DFGL L G P Y
Sbjct: 191 GPRGRCKLGDFGLLVE--------LGTAGA--------------------GEVQEGDPRY 222
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESPEIIFDNILNRKIPWPCVPSD 939
+APE+L G +G AAD +S+G+ + E + P E + + L P +
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAG 276
Query: 940 MSFEAQDLINRFLIHDPNQRLGAN 963
+S E + ++ L DP R A
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAE 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 2e-81
Identities = 77/283 (27%), Positives = 143/283 (50%), Gaps = 31/283 (10%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
+ I+DF++ + +G+F V+ A TG AIK++ K M + ++R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
I +++P ++ + F + +YLV+E + G++ L+ +V E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ YLHS GI+HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+ + ++ GTP+Y++PEI + HG +D WS+G + + + G PPF +
Sbjct: 160 TQL----KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+ + + ++ +PS +S EA+DLI++ L +P RL
Sbjct: 216 TVKNTLNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRL 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 3e-79
Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ S + + + +G F + F T ++FA K++ K +++ + E++ E +I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
++ + VV F F D +++V+E L L ++ L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV----------------- 165
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ D + GTP+Y+APE+L H + D WS+G I++ + G PPF +
Sbjct: 166 ----EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+ I + P ++ A LI + L DP R
Sbjct: 222 ETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP 258
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 3e-79
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 30/296 (10%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
++ + + + S + + + +G F + F T ++FA K++ K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 725 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784
+++ + E++ E +I ++ + VV F F D +++V+E L L ++ L
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 785 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844
E AR Y+ ++VL +YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV- 191
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
+ D + GTP+Y+APE+L H + D WS+G I+
Sbjct: 192 --------------------EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
Query: 905 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+ + G PPF + + I + P ++ A LI + L DP R
Sbjct: 232 YTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 3e-76
Identities = 78/298 (26%), Positives = 147/298 (49%), Gaps = 34/298 (11%)
Query: 668 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727
SSGV + + + S++ + ++ I G+FG+ L + G + IK + M
Sbjct: 7 HSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLE 785
K + E E +L +++P +V++ SF +LY+VM+Y GGDL+ + +K +
Sbjct: 65 K-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
ED + ++ LAL+++H I+HRD+K N+ + DG ++L DFG++++ +N+T++L
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL 181
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
+ + +GTP YL+PEI + +D W++G +L+
Sbjct: 182 A-------------------------RACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 906 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
E T F A S + + I++ P V S++ + L+++ +P R N
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-72
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 46/313 (14%)
Query: 667 SQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
SSGV + + + S+ + I+K I G +VF ++AIK + +
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-E 63
Query: 725 MIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
++ E L ++ + ++R + +Y+VME DL S L+K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
++ + Y ++ A+ +H GIVH DLKP N LI DG +KL DFG++
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIAN------- 174
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----------EH 891
M D T + + S VGT +Y+ PE + +
Sbjct: 175 ----------QMQPD--------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINR 950
+D WS+G IL+ G PF +I I++ P + QD++
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKC 275
Query: 951 FLIHDPNQRLGAN 963
L DP QR+
Sbjct: 276 CLKRDPKQRISIP 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 5e-72
Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 41/291 (14%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
+ +D+E++ I G++GR R+++ G + K L M + + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 744 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELV 797
+++P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 798 LALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
LAL+ H ++HRDLKP N+ + ++KL DFGL++I +N+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
+ VGTP Y++PE + + +D WS+G +L+E +P
Sbjct: 174 -------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
PFTA S + + I K +P S E ++I R L R
Sbjct: 215 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 8e-71
Identities = 92/284 (32%), Positives = 140/284 (49%), Gaps = 44/284 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ + GAF VFL ++R TG LFA+K +KK R + +E E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V + + YLVM+ ++GG+L+ + + G E A + I +++ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL + I +TDFGLSK+ E +GIM
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------EQNGIM--------- 164
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 165 --------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ I W + S A+D I L DPN+R
Sbjct: 217 EKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERYTC 256
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 4e-70
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 727 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---- 782
+ E ++L + +P V++++ SF + L +V+E + GDL +++
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ E Y +L ALE++HS ++HRD+KP N+ I G +KL D GL + ++
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSK 189
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
HS VGTP Y++PE + + + +D WS+G
Sbjct: 190 TTA-------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 903 ILFEFITGIPPFTAESPEI--IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQR 959
+L+E PF + + + I P +PSD S E + L+N + DP +R
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-69
Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 41/284 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++ + + +G+FG V L + + TG A+KV+ K + +K D E +L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + F + YLV E GG+L+ + E A I +++ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--------------------------- 178
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
++ +GT Y+APE+L G + D WS G+IL+ ++G PPF + I
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ K W V S A+DLI + L + P+ R+ A
Sbjct: 237 KKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRISA 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-69
Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 36/293 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+ DFE I+ + RG FG VF A+ + +AIK ++ + + E+++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 746 NPFVVRFFYSFTCRDN------------LYLVMEYLNGGDLYSLLRK---VGCLEEDVAR 790
+P +VR+F ++ ++ LY+ M+ +L + + E V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 791 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
++ A+E+LHS G++HRDLKP N+ D +K+ DFGL ++
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQD-------- 171
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
+ VGT Y++PE + G + + D +S+G+ILFE +
Sbjct: 172 -----EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225
Query: 911 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
P T ++ R + +P + + ++ L P +R A
Sbjct: 226 -PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-69
Identities = 78/332 (23%), Positives = 127/332 (38%), Gaps = 46/332 (13%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFL 705
S + + R +DS + SS E S+ + I+K I G +VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLY 763
++AIK + + ++ E L ++ + ++R + +Y
Sbjct: 75 VLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
+VME DL S L+K ++ + Y ++ A+ +H GIVH DLKP N LI D
Sbjct: 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VD 190
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 883
G +KL DFG++ M D T + + S VG +Y+ P
Sbjct: 191 GMLKLIDFGIAN-----------------QMQPD--------TTSVVKDSQVGAVNYMPP 225
Query: 884 EILLGT-----------EHGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKI 931
E + + +D WS+G IL+ G PF +I I++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
P + QD++ L DP QR+
Sbjct: 286 EIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP 316
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-69
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 44/290 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-- 745
+ I+K I G +VF ++AIK + + ++ E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ ++R + +Y+VME DL S L+K ++ + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
GIVH DLKP N LI DG +KL DFG++ M D
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIAN-----------------QMQPD-------- 160
Query: 866 TDNRNRHSAVGTPDYLAPEILLGT-----------EHGYAADWWSVGIILFEFITGIPPF 914
T + + S VGT +Y+ PE + + +D WS+G IL+ G PF
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 915 TAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
+I I++ P + QD++ L DP QR+
Sbjct: 221 QQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP 269
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 8e-69
Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 42/284 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I+ + +G+FG V + R T +A+KV+ K + D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDH 80
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
N +GT Y+APE+L GT + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ K W + S +A+DLI + L P+ R+ A
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRITA 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-68
Identities = 80/346 (23%), Positives = 135/346 (39%), Gaps = 71/346 (20%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KKLD 724
S L+ + + + I +G++G V +A + T + AIK++ K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 725 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 784
I D+ERI E ++ + +P + R + + + LVME +GG L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 785 E----------------------------------------EDVARIYIAELVLALEYLH 804
E + + ++ AL YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 805 SLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+ GI HRD+KP+N L + + IKL DFGLSK + +
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-----------------------FYK 222
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 920
+ + GTP ++APE+L T Y D WS G++L + G PF +
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 921 IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGA 965
+LN+K+ + + +S A+DL++ L + ++R A A
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 228 bits (585), Expect = 3e-68
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D++++ + + +GAF V +TTG FA K++ + D +++ E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHR+LKP+NLL+A +KL DFGL+ ++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN------------------- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
D+ H GTP YL+PE+L + D W+ G+IL+ + G PPF E ++
Sbjct: 160 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I W V + EA+ LI+ L +P +R+ A
Sbjct: 217 AQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRITA 256
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-68
Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 42/284 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I+ + +G+FG V + R T +A+KV+ K K D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
N +GT Y+APE+L G + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ K W + S +A+DLI + L P+ R+ A
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRITA 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 5e-68
Identities = 81/307 (26%), Positives = 134/307 (43%), Gaps = 42/307 (13%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 723
S++ + T D +++ + + +GAF V +TTG FA K++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT- 64
Query: 724 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+ D +++ E I +++P +VR S YLV + + GG+L+ +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 840
E A I +++ ++ Y HS GIVHR+LKP+NLL+A +KL DFGL+
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---- 180
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 900
++ D+ H GTP YL+PE+L + D W+
Sbjct: 181 --VN----------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216
Query: 901 GIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHD 955
G+IL+ + G PPF E ++ I W V + EA+ LI+ L +
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVN 272
Query: 956 PNQRLGA 962
P +R+ A
Sbjct: 273 PKKRITA 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-67
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D F + + GAFG V L +R++G IK + K + +E+I AE +L ++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLLRKVGCLEEDVARIYIAELVLALEY 802
P +++ F F N+Y+VME GG+L S + L E + +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 803 LHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL----------------------- 176
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ + +A GT Y+APE+ + + D WS G++++ +TG PFT S
Sbjct: 177 -----FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
E + ++ + ++ +A DL+ + L DP +R A
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSA 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-67
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 44/284 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I RG++G V +A ++ T A K + K + D++R E I+ ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P ++R + +F ++YLVME GG+L+ + E A + +++ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
+ HRDLKP+N L D +KL DFGL+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--------------------------- 158
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ + VGTP Y++P++L G +G D WS G++++ + G PPF+A + +
Sbjct: 159 -FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I W V S +A+ LI R L P QR+ +
Sbjct: 217 LKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRITS 256
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 7e-67
Identities = 85/308 (27%), Positives = 142/308 (46%), Gaps = 43/308 (13%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 722
+ Q +TP ++ + + ++ +K + GA+G V L R + T AIK+++K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 723 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+ + ++L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 73 -TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 839
E A + I +++ + YLH IVHRDLKP+NLL+ D IK+ DFGLS +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--- 188
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
+ + +GT Y+APE+L ++ D WS
Sbjct: 189 -------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWS 222
Query: 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 954
+G+ILF + G PPF ++ + I + K W V S A+DLI + L
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQF 278
Query: 955 DPNQRLGA 962
D +R+ A
Sbjct: 279 DSQRRISA 286
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 8e-67
Identities = 68/326 (20%), Positives = 119/326 (36%), Gaps = 73/326 (22%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEV 60
Query: 741 LITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAE 795
L + + +V+ F T + L+ME+ G LY++L + L E I + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
+V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------- 165
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGII 903
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 -------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVP 937
+ TG PF ++ + I +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 938 SDMSFEAQDLINRFLIHDPNQRLGAN 963
+ ++ L D + G +
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFD 298
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-66
Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 45/292 (15%)
Query: 684 TSIDDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERN 739
+ ++D E+ + + G F V R++ TG +A K +KK + E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
IL +R+P ++ F + ++ L++E ++GG+L+ L + L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 800 LEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YLHS I H DLKP+N+++ + IKL DFG++ I +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN-------- 170
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
GTP+++APEI+ G AD WS+G+I + ++G PF
Sbjct: 171 ------------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212
Query: 916 AESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
E+ + NI + S A+D I R L+ DP +R+
Sbjct: 213 GETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTI 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-66
Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 51/294 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----------KNDIERILA 736
+ + ++ + GA+G V L +++ AIKV+KK + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E ++L ++ +P +++ F F + YLV E+ GG+L+ + +E A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+ + YLH IVHRD+KP+N+L+ + +IK+ DFGLS
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----------------- 198
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
+ + +GT Y+APE+L ++ D WS G+I++ + G PP
Sbjct: 199 -----------FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 914 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
F ++ + I + K W + S EA++LI L +D N+R A
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRCTA 296
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-66
Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+++++ + + +GAF V K G +A ++ + D +++ E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
G+VHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------E 162
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ + + GTP YL+PE+L +G D W+ G+IL+ + G PPF E ++
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I W V + EA+DLIN+ L +P++R+ A
Sbjct: 223 QQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRITA 262
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-66
Identities = 82/315 (26%), Positives = 133/315 (42%), Gaps = 46/315 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 724
S S G L + + D +E+ + I +G F V R TG FA+K++
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 725 MIRKN--DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLL 778
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSK 835
E VA Y+ +++ AL Y H I+HRD+KP +L+A +KL FG++
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895
+ SG G VGTP ++APE++ +G
Sbjct: 182 Q------LGESGLVAGGR---------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINR 950
D W G+ILF ++G PF +F+ I+ K W + S A+DL+ R
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI----SESAKDLVRR 269
Query: 951 FLIHDPNQRLGANGA 965
L+ DP +R+ A
Sbjct: 270 MLMLDPAERITVYEA 284
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-66
Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 743
D ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
V + V+ + R ++ L++E ++GG+L+ L + L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 804 HSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
H+ I H DLKP+N+++ HIKL DFGL+ I
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----------------IEDGVEF 175
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 176 K------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ NI + + S A+D I + L+ + +RL
Sbjct: 224 QETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRLTI 267
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 4e-66
Identities = 62/300 (20%), Positives = 120/300 (40%), Gaps = 60/300 (20%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ DF+ I+ I G FG+VF A+ R G + IK ++ N+ E+ E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNN-EKAEREVKAL 58
Query: 742 ITVRNPFVVRFFYSF----------------TCRDNLYLVMEYLNGGDLYSLL--RKVGC 783
+ + +V + + + L++ ME+ + G L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L++ +A ++ ++Y+HS +++RDLKP N+ + +K+ DFGL + N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
R + GT Y++PE + ++G D +++G+I
Sbjct: 177 K--------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
L E + TA F ++ + I + + L+ + L P R +
Sbjct: 211 LAELLH--VCDTAFETSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNTS 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-66
Identities = 85/284 (29%), Positives = 142/284 (50%), Gaps = 33/284 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S E+ I ++ ++K I +G F +V LAR TG AIK++ K + ++++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFRE 64
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
I+ + +P +V+ F LYL+MEY +GG+++ L G ++E AR ++V
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
A++Y H IVHRDLK +NLL+ D +IK+ DFG S
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------------- 162
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+ T + G P Y APE+ G + G D WS+G+IL+ ++G PF
Sbjct: 163 ------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
++ + + + +L K +P MS + ++L+ RFL+ +P +R
Sbjct: 217 QNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG 257
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 8e-66
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 44/288 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 743
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 804 HSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HSL I H DLKP+N+++ IK+ DFGL+ I +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----------------IDFGNEF 174
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 175 ------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 920 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ N+ + S A+D I R L+ DP +R+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRMTI 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-65
Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 805
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 806 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I H D++P+N++ IK+ +FG ++ + P D
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDNF---- 160
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+NI+N + + + S EA D ++R L+ + R+ A+ A
Sbjct: 213 ENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEA 255
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-65
Identities = 85/292 (29%), Positives = 141/292 (48%), Gaps = 42/292 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 741
D++ + K + GA G V LA +R T AI+++ K + + E IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+ +P +++ F ++ Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 802 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 291
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 915
+ + GTP YLAPE+L+ A D WS+G+ILF ++G PPF+
Sbjct: 292 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 916 AES-PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ D I + K + +++S +A DL+ + L+ DP R A
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-65
Identities = 92/285 (32%), Positives = 138/285 (48%), Gaps = 46/285 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D FE+ + RGA V+ +++ T +A+KVLKK D + + E +L+ + +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSH 107
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ F + LV+E + GG+L+ + + G E A + +++ A+ YLH
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL A D +K+ DFGLSKI E +M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----------EHQVLM--------- 207
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 922
+ GTP Y APEIL G +G D WSVGII + + G PF E + +
Sbjct: 208 --------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
Query: 923 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
F ILN + W V S A+DL+ + ++ DP +RL
Sbjct: 260 FRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDPKKRLTT 300
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-65
Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 44/296 (14%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERIL 735
+ K++ D ++I + + G F V R+++TG +A K +KK E I
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 736 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 795
E +IL V +P ++ + R ++ L++E ++GG+L+ L + L E+ A +I +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETD 851
++ + YLH+ I H DLKP+N+++ HIKL DFGL+
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------- 168
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
I + GTP+++APEI+ G AD WS+G+I + ++G
Sbjct: 169 -IEDGVEFK------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 912 PPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
PF ++ + NI + S A+D I + L+ + +RL
Sbjct: 216 SPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRLTI 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-65
Identities = 72/358 (20%), Positives = 130/358 (36%), Gaps = 78/358 (21%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 742 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAEL 796
+ + +V+ F T + L+ME+ G LY++L + L E I + ++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---------------- 165
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGIIL 904
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 ------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 905 FEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVPS 938
+ TG PF ++ + I +
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC--KIFIKKTENCVSMQSKLEIELKL 994
+ ++ L D + G + + F I + + S+Q ++ +
Sbjct: 274 GLQVLLTPVLANILEADQEKCWGFD---QFFAETSDILHRMVIHVFSLQQMTAHKIYI 328
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-65
Identities = 88/311 (28%), Positives = 140/311 (45%), Gaps = 57/311 (18%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--------- 728
S + ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 729 --------------NDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGG 772
IE++ E IL + +P VV+ D+LY+V E +N G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 773 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
+ + L ED AR Y +L+ +EYLH I+HRD+KP NLL+ DGHIK+ DFG
Sbjct: 124 PVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
+S + + + VGTP ++APE L T
Sbjct: 183 VSNE---------------------------FKGSDALLSNTVGTPAFMAPESLSETRKI 215
Query: 893 Y---AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949
+ A D W++G+ L+ F+ G PF E + I ++ + +P P D++ + +DLI
Sbjct: 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLIT 274
Query: 950 RFLIHDPNQRL 960
R L +P R+
Sbjct: 275 RMLDKNPESRI 285
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 9e-65
Identities = 76/284 (26%), Positives = 132/284 (46%), Gaps = 32/284 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
L R+P +++ + + + ++VMEY++GG+L+ + K G +EE AR +++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
A++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 160
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 161 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
E +F I +P ++ L+ L DP +R
Sbjct: 214 EHVPTLFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA 254
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-64
Identities = 88/293 (30%), Positives = 138/293 (47%), Gaps = 50/293 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 741
D++ + K + GA G V LA +R T AIK++ K + + E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+ +P +++ F D Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 802 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 166
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFT 915
+ + GTP YLAPE+L+ + A D WS+G+ILF ++G PPF+
Sbjct: 167 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 916 AES-PEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ D I + K W V S +A DL+ + L+ DP R
Sbjct: 221 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARFTT 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 50/294 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDI----ERILAERNI 740
+++E + + RG V + T +A+K++ ++ E L E +I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----------------------- 173
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 913
GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 174 -----LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 914 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
F ++ I++ W S +DL++RFL+ P +R A
Sbjct: 229 FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQPQKRYTA 278
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-64
Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 45/308 (14%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
S + T + + + K + RG F V ++TG +A K LKK
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK-RR 66
Query: 726 IRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVG 782
++ IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 839
+ E+ I +++ + YLH IVH DLKP N+L++ G IK+ DFG+S+
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--- 183
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899
I +GTP+YLAPEIL A D W+
Sbjct: 184 ---IG----------------------HACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 900 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 954
+GII + +T PF E + + NI + + V S A D I L+
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLVK 274
Query: 955 DPNQRLGA 962
+P +R A
Sbjct: 275 NPEKRPTA 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-63
Identities = 84/334 (25%), Positives = 130/334 (38%), Gaps = 49/334 (14%)
Query: 646 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 705
+ + + QS G L + ++ I RG V
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 706 ARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVRN-PFVVRFFYSFTCR 759
R TG FA+K+++ + E E +IL V P ++ S+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
++LV + + G+L+ L + L E R + L+ A+ +LH+ IVHRDLKP+N+L
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879
+ + I+L+DFG S + P + GTP
Sbjct: 233 LDDNMQIRLSDFGFSCH----------------LEPGEKLR------------ELCGTPG 264
Query: 880 YLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-- 931
YLAPEIL + +G D W+ G+ILF + G PPF ++ I+ +
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 932 ---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
W S +DLI+R L DP RL A
Sbjct: 325 SSPEWDDR----SSTVKDLISRLLQVDPEARLTA 354
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-63
Identities = 80/312 (25%), Positives = 134/312 (42%), Gaps = 52/312 (16%)
Query: 668 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
Q+ GV + + H+ D +E+ + I G++ + T FA+K++ K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---- 57
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
K D E IL+ P ++ + +Y+V E + GG+L + +
Sbjct: 58 SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINN 841
E A + + +EYLH+ G+VHRDLKP N+L + I++ DFG +K
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---- 170
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 901
+ +N + T +++APE+L + A D WS+G
Sbjct: 171 -----------------------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 902 IILFEFITGIPPFTA---ESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 953
++L+ +TG PF ++PE I I + K W V S A+DL+++ L
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLH 263
Query: 954 HDPNQRLGANGA 965
DP+QRL A
Sbjct: 264 VDPHQRLTAALV 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-63
Identities = 64/287 (22%), Positives = 126/287 (43%), Gaps = 43/287 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++I++ + GAFG V ++ TG +F K + + K ++ E +I+ + +
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHH 107
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 805
P ++ +F + + L++E+L+GG+L+ + + + E Y+ + L+++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 806 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
IVH D+KP+N++ +K+ DFGL+ + P +
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATK----------------LNPDEIV---- 207
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
T ++ APEI+ G+ D W++G++ + ++G+ PF E
Sbjct: 208 --------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259
Query: 924 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
N+ + V S EA+D I L +P +RL + A
Sbjct: 260 QNVKRCDWEFDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 7e-63
Identities = 48/363 (13%), Positives = 102/363 (28%), Gaps = 88/363 (24%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
+G + S ER + + A + TG+ F + V + N
Sbjct: 58 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 730 DIE-------------------------RILAERNILITVRNPFVVRFFYSFTCRD--NL 762
I+ R + +++ + ++R +
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 763 YLVMEYLN------GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816
+ + + G L S L +++ L LH G+VH L+P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
++++ G + LT F + R +
Sbjct: 236 DIVLDQRGGVFLTGFEHLV-------------------------------RDGARVVSSV 264
Query: 877 TPDYLAPEILL-----------GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ + PE+ T ++ D W++G++++ P T ++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985
I ++ + L+ FL + RL A E ++ +S
Sbjct: 325 IFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME--TP--EYEQLRTELSAA 373
Query: 986 SKL 988
L
Sbjct: 374 LPL 376
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-62
Identities = 74/332 (22%), Positives = 138/332 (41%), Gaps = 44/332 (13%)
Query: 645 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRV 703
D + K D+ + + D ++I + + GAFG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
+R TG+ FA K + ++D E + E + +R+P +V +F + +
Sbjct: 174 HRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 764 LVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822
++ E+++GG+L+ + + + ED A Y+ ++ L ++H VH DLKP+N++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 823 --DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880
+KL DFGL+ ++ GT ++
Sbjct: 291 KRSNELKLIDFGLTA----------------------------HLDPKQSVKVTTGTAEF 322
Query: 881 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPC 935
APE+ G GY D WSVG++ + ++G+ PF E+ + N+ + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
+ S + +D I + L+ DPN R+ + A E
Sbjct: 383 I----SEDGKDFIRKLLLADPNTRMTIHQALE 410
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-62
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 33/284 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
++ R + + RG+FG V + + TG A+K ++ L++ R ++
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELV----- 102
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+ +P +V + + + + ME L GG L L++++GCL ED A Y+ + +
Sbjct: 103 --ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
LEYLH+ I+H D+K DN+L++ DG L DFG + L +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC--------LQPDGLGKSLL- 211
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
GT ++APE+++G D WS ++ + G P+T
Sbjct: 212 -------------TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 917 ESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ I + P +P + I L +P R
Sbjct: 259 YFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-62
Identities = 81/289 (28%), Positives = 124/289 (42%), Gaps = 53/289 (18%)
Query: 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 751
KP+ G+F + + FA+K+ I K E L P +V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 811
F + + +LVME LNGG+L+ ++K E A + +LV A+ ++H +G+VHR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 812 DLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
DLKP+NLL + IK+ DFG +++ + DN
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL---------------------------KPPDN 163
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEI 921
+ + T Y APE+L + + D WS+G+IL+ ++G PF + S
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 922 IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
I I W V S EA+DLI L DPN+RL +G
Sbjct: 224 IMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-62
Identities = 78/302 (25%), Positives = 121/302 (40%), Gaps = 48/302 (15%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDM 725
G TP ++ + + +G FG VF + T AIKV+ + L
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 726 IRKNDIERILAERNILITVRN----PFVVRFFYSFTCRDNLYLVMEY-LNGGDLYSLLRK 780
+D E +L V P V+R F ++ LV+E L DL+ + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 781 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 839
G L E +R + ++V A+++ HS G+VHRD+K +N+LI G KL DFG +
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--- 189
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 898
D Y GT Y PE + + H A W
Sbjct: 190 ---------------LHDEPY-----------TDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 899 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
S+GI+L++ + G PF + IL ++ P+ +S + LI R L P+
Sbjct: 224 SLGILLYDMVCGDIPFERD------QEILEAELH---FPAHVSPDCCALIRRCLAPKPSS 274
Query: 959 RL 960
R
Sbjct: 275 RP 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-62
Identities = 73/280 (26%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 923
+ GT Y+APE+L E H D WS GI+L + G P+ +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 924 DNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+ +K PW + L+++ L+ +P+ R+
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 8e-62
Identities = 66/286 (23%), Positives = 134/286 (46%), Gaps = 43/286 (15%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ + G FG+V + TG A K++K D E + E +++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+++ + +F ++++ LVMEY++GG+L+ ++ + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 807 GIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
I+H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR---------------------------- 238
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
GTP++LAPE++ + D WSVG+I + ++G+ PF ++ +
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 925 NILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
NIL + + + S EA++ I++ LI + + R+ A+ A
Sbjct: 299 NILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRISASEA 340
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-61
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
+F ++ I G FG VF KR G ++AIK KK D + L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQ 69
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 801
+ VVR+F ++ D++ + EY NGG L + R + +E + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPS 856
Y+HS+ +VH D+KP N+ I+ + +N + DL G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL------GHV-- 181
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 915
T + G +LA E+L H AD +++ + + P
Sbjct: 182 ---------TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ I R+ P +P +S E +L+ + DP +R
Sbjct: 233 NGDQ---WHEI--RQGRLPRIPQVLSQEFTELLKVMIHPDPERR 271
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-61
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 44/303 (14%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-- 722
++ + + E + + P+ GAFG V+ A + +K +KK
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 723 ---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME-YLNGGDLYSLL 778
I + ++ E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 779 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838
+ L+E +A +LV A+ YL I+HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADW 897
+ ++ GT +Y APE+L+G G +
Sbjct: 180 --------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 898 WSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 957
WS+G+ L+ + PF + + I P +S E L++ L P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIH---PPYLVSKELMSLVSGLLQPVPE 264
Query: 958 QRL 960
+R
Sbjct: 265 RRT 267
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 5e-61
Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 46/302 (15%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---L 723
+ +T L ++ +++ + G FG V+ + + AIK ++K
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 724 DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEYLNG-GDLYSLLRK 780
D + R+ E +L V + V+R F D+ L++E DL+ + +
Sbjct: 83 DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 781 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 839
G L+E++AR + +++ A+ + H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--- 199
Query: 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 898
D Y GT Y PE + HG +A W
Sbjct: 200 ---------------LKDTVY-----------TDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 899 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
S+GI+L++ + G PF E E I + +S E Q LI L P+
Sbjct: 234 SLGILLYDMVCGDIPF--EHDEEIIRGQVF-------FRQRVSSECQHLIRWCLALRPSD 284
Query: 959 RL 960
R
Sbjct: 285 RP 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-60
Identities = 57/285 (20%), Positives = 101/285 (35%), Gaps = 34/285 (11%)
Query: 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+ I+ + G F V L G +A+K + + D E E ++ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 748 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLA 799
++R +L++ + G L++ + ++ L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LE +H+ G HRDLKP N+L+ +G L D G + +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ---------------ACIHVEGS 191
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFTA 916
D + T Y APE+ H D WS+G +L+ + G P+
Sbjct: 192 RQALTLQDWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 917 ESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+ + ++ P S L+N + DP+QR
Sbjct: 249 VFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRP 292
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-60
Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 36/280 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF--TAESPEII 922
+ GT Y+APE+L E H D WS GI+L + G P+ ++S +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 923 FDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
D PW + L+++ L+ +P+ R+
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI 254
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-60
Identities = 80/281 (28%), Positives = 137/281 (48%), Gaps = 33/281 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ I + I + + G+FG+V LA T A+K + + + + + R+ E +
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L +R+P +++ + T ++ +V+EY GG+L+ + + + ED R + +++ A+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EY H IVHRDLKP+NLL+ + ++K+ DFGLS I
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------------------------ 157
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919
TD ++ G+P+Y APE++ G G D WS GI+L+ + G PF E
Sbjct: 158 ----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+F + + +P +S AQ LI R ++ DP QR+
Sbjct: 214 PNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-60
Identities = 88/304 (28%), Positives = 135/304 (44%), Gaps = 46/304 (15%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 725
+ ++ + PL D ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD--SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA 58
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 785
I +N ++R E ++R+P +VRF +L ++MEY +GG+LY + G
Sbjct: 59 IDEN-VQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTI 843
ED AR + +L+ + Y HS+ I HRDLK +N L+ + +K+ DFG SK
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------- 167
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGI 902
P S VGTP Y+APE+LL E G AD WS G+
Sbjct: 168 -----SVLHSQP----------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNR------KIPWPCVPSDMSFEAQDLINRFLIHDP 956
L+ + G PF + + R IP +S E LI+R + DP
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADP 263
Query: 957 NQRL 960
R+
Sbjct: 264 ATRI 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 5e-60
Identities = 72/284 (25%), Positives = 131/284 (46%), Gaps = 32/284 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
L R+P +++ + + ++++VMEY++GG+L+ + K G L+E +R +++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 165
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 166 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+ +F I + P ++ L+ L DP +R
Sbjct: 219 DHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-59
Identities = 62/370 (16%), Positives = 104/370 (28%), Gaps = 74/370 (20%)
Query: 642 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID----DFEIIKPISR 697
+LL + +E + V + P ++ + + ++++P+
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 698 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF---- 753
G VFL R + FA+KV ++++ER+ +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 754 ----------------------YSFTCRDNLYLVMEYLNG--GDLYSLLRKV----GCLE 785
N L+M + L+S L V G
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845
I A+L+ L S G+VH PDNL I DG + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------- 242
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGII 903
++ Y E L +A + W +G+
Sbjct: 243 --------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 904 LFEFITGIPPFTAESPEIIFDNILN-----RKIPWP-CVPSDMSFEAQDLINRFLIHDPN 957
++ PF +P I + + + LI RFL D
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 958 QRLGANGAAE 967
+RL A E
Sbjct: 343 RRLLPLEAME 352
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 209 bits (532), Expect = 1e-59
Identities = 50/336 (14%), Positives = 95/336 (28%), Gaps = 73/336 (21%)
Query: 670 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
+G + S ER + + A + TG+ F + V + N
Sbjct: 63 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 120
Query: 730 DIERILAERNI---LITVRNP------------------------FVVRFFYSFTCRDNL 762
I+++ E L ++N VR +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 763 YLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816
+ + + L S L +++ L LH G+VH L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
++++ G + LT F + P
Sbjct: 241 DIVLDQRGGVFLTGFEHLVR-----------DGASAVSPI---------------GRGFA 274
Query: 877 TPDYLAPEILLGTEHG-----YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 931
P+ A +L +H +A D W++G+ ++ P T ++ + I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-- 332
Query: 932 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967
++ + L+ FL + RL A E
Sbjct: 333 -----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-59
Identities = 76/316 (24%), Positives = 119/316 (37%), Gaps = 63/316 (19%)
Query: 677 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
S + +E+ + + G FG V + TG+ AIK ++ ++ KN ER
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCL 61
Query: 737 ERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEED 787
E I+ + +P VV D L MEY GGDL L + L+E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTID 844
R ++++ AL YLH I+HRDLKP+N+++ K+ D G +K
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-------- 173
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
VGT YLAPE+L ++ D+WS G +
Sbjct: 174 --------------------LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 905 FEFITGIPPFTAESPEIIFDNILNRK--------------------IPWPC-VPSDMSFE 943
FE ITG PF + + + K +P P + ++ +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
Query: 944 AQDLINRFLIHDPNQR 959
+ + L+ QR
Sbjct: 274 LERWLQCMLMWHQRQR 289
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-59
Identities = 77/306 (25%), Positives = 131/306 (42%), Gaps = 57/306 (18%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
D +++ + + GA RV T +A+K+++K ++ + R E +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 746 N-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
V+ F D YLV E + GG + S + K E A + + ++ AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 805 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+ GI HRDLKP+N+L H +K+ DF L I L+G +
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG------IKLNGDCSP---------- 172
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTA 916
+ G+ +Y+APE++ + + D WS+G+IL+ ++G PPF
Sbjct: 173 ----ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 917 E---------------SPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDP 956
++F++I K W + S A+DLI++ L+ D
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRDA 284
Query: 957 NQRLGA 962
QRL A
Sbjct: 285 KQRLSA 290
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-59
Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE-RILAERNILITV 744
I + + + G++G+V T A+K+LKK + R + E + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 745 RNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLAL 800
R+ V++ + +Y+VMEY G + +L V A Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHS GIVH+D+KP NLL+ G +K++ G++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALH---------------- 160
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 918
+ ++ G+P + PEI G + G+ D WS G+ L+ TG+ PF ++
Sbjct: 161 ---PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
+F+NI +P D DL+ L ++P +R
Sbjct: 218 IYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF 256
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-58
Identities = 47/317 (14%), Positives = 91/317 (28%), Gaps = 74/317 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + GAF +V+ A + F +KV K + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERL 121
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAEL 796
++F+ + ++ LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKIGLINNTIDL 845
+ +E +H I+H D+KPDN ++ + + L D G S ID+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDM 233
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905
I + T + E+L Y D++ V ++
Sbjct: 234 KLFPKGTIF-----------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 906 EFITGIPPFTAESPEI------------------IFDNILNRKIPWPCVPSDMSFEAQDL 947
+ G F +LN +P + DL
Sbjct: 277 CMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLPSLDL 329
Query: 948 INRFLIHDPNQRLGANG 964
+ + L Q
Sbjct: 330 LRQKLKKVFQQHYTNKI 346
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-58
Identities = 81/319 (25%), Positives = 132/319 (41%), Gaps = 64/319 (20%)
Query: 669 SSGVSTPLHSSHKERTSI-DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
SSG+ ++ ++ DD+++ K + G G+V R TG A+K+L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 727 RKNDIERILAERNILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLR 779
R+ E + P +V + + L ++ME + GG+L+S R
Sbjct: 69 RQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 780 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 836
E A + ++ A+++LHS I HRD+KP+NLL D +KLTDFG +K
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896
T + TP Y+APE+L ++ + D
Sbjct: 181 -----------------------------TTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI----------PWPCVPSDMSFEAQD 946
WS+G+I++ + G PPF + + + I + R+I W V S +A+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 947 LINRFLIHDPNQRLGANGA 965
LI L DP +RL
Sbjct: 267 LIRLLLKTDPTERLTITQF 285
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-58
Identities = 83/273 (30%), Positives = 129/273 (47%), Gaps = 40/273 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
+ +G +G V+ R + AIK + + D + + E + +++ +V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 755 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 811
SF+ + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 812 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 870
D+K DN+LI + G +K++DFG SK L+G N
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR--------LAG-------------------INPC 179
Query: 871 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT--AESPEIIFDNI 926
+ GT Y+APEI+ GY AAD WS+G + E TG PPF E +F +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV 238
Query: 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
K+ P +P MS EA+ I + DP++R
Sbjct: 239 GMFKVH-PEIPESMSAEAKAFILKCFEPDPDKR 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-56
Identities = 81/338 (23%), Positives = 134/338 (39%), Gaps = 60/338 (17%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLA 706
P + + ++ Q K+ IDD+++ + + G G+V
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF--FY--SFTCRDN 761
+ T + FA+K+L+ R+ E + P +VR Y + R
Sbjct: 82 FNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 762 LYLVMEYLNGGDLYS--LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
L +VME L+GG+L+S R E A + + A++YLHS+ I HRD+KP+NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 820 IAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 876
+ +KLTDFG +K + + +
Sbjct: 194 YTSKRPNAILKLTDFGFAKE-----------TTSHNSL-----------------TTPCY 225
Query: 877 TPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----IFDNILNRKI- 931
TP Y+APE+L ++ + D WS+G+I++ + G PPF + + I +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 932 ----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
W V S E + LI L +P QR+
Sbjct: 286 FPNPEWSEV----SEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-55
Identities = 56/275 (20%), Positives = 114/275 (41%), Gaps = 38/275 (13%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754
I RG+F V+ T A L+ + K++ +R E +L +++P +VRF+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 755 SFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--I 808
S+ + + LV E + G L + L++ ++ V R + +++ L++LH+ I
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 809 VHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
+HRDLK DN+ I G +K+ D GL+
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-----------------------------LKR 183
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+ +GTP+++APE + ++ + D ++ G+ + E T P++ +
Sbjct: 184 ASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ E +++I + + ++R
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSI 277
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 6e-55
Identities = 88/326 (26%), Positives = 144/326 (44%), Gaps = 44/326 (13%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
S+ + DD+E+ + I GA V A + AIK + L+ + ++ +L E
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQ-TSMDELLKE 63
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--------KVGCLEEDVA 789
+ +P +V ++ SF +D L+LVM+ L+GG + +++ K G L+E
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ E++ LEYLH G +HRD+K N+L+ DG +++ DFG+S + D
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGD----- 176
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFI 908
T N+ R + VGTP ++APE + + + AD WS GI E
Sbjct: 177 ---------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 909 TGIPPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
TG P+ P + L P + + +I+ L DP +R
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP- 280
Query: 962 ANGAAEVFHCKIFIKKTENCVSMQSK 987
AAE+ K F +K +N +Q K
Sbjct: 281 --TAAELLRHK-FFQKAKNKEFLQEK 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-54
Identities = 65/335 (19%), Positives = 117/335 (34%), Gaps = 77/335 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFA-------------------IKVLKKLD--- 724
DFE I+ + RG FG VF A+ + +A +K L KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 725 ---------------------------------MIRKNDIERILAERNILITVRNPFVVR 751
+ + ++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGI 808
+ + LY+ M+ +L + + + E V ++ A+E+LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRDLKP N+ D +K+ DFGL ++ + T
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP-------------MPAY 230
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
VGT Y++PE + G + + D +S+G+ILFE + T I ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-- 286
Query: 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963
R + +P + + + ++ L P +R A
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-53
Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ I G+ G V LAR++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
VV + S+ + L+++ME+L GG L ++ +V EE +A + ++ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV-CEAVLQALAYLHAQ 160
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
G++HRD+K D++L+ DG +KL+DFG Q +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA----------------------------QIS 192
Query: 867 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ R S VGTP ++APE++ + + D WS+GI++ E + G PP+ ++SP
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P +S +D + R L+ DP +R
Sbjct: 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 84/274 (30%), Positives = 133/274 (48%), Gaps = 33/274 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKN 76
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +V + S+ D L++VMEYL GG L ++ + E +A + E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSN 135
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K DN+L+ DG +KLTDFG Q T
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------------------------QIT 167
Query: 867 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
++ R + VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I P P +S +D +NR L D +R
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-53
Identities = 84/293 (28%), Positives = 143/293 (48%), Gaps = 38/293 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F ++ I +G+FG VF T + AIK++ L+ +++IE I E +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEA-EDEIEDIQQEITVLSQCDS 79
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 138
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
+HRD+K N+L++ G +KL DFG++ G + +T
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQI---------------------- 174
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 925
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 175 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-- 229
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978
L K P + + S ++ + L +P+ R A E+ K FI +
Sbjct: 230 -LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHK-FILRN 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 73/305 (23%), Positives = 130/305 (42%), Gaps = 40/305 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 722
S + +G T + + I+D E + + G G+V+ R R TG + A+K ++
Sbjct: 3 SGSSGKQTGYLTI--GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR- 59
Query: 723 LDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 781
K + +RIL + ++++ + P++V+ F +F ++++ ME + R
Sbjct: 60 RS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 782 GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
G + E + +V AL YL G++HRD+KP N+L+ G IKL DFG+S
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG----- 173
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 895
+ D++ + + G Y+APE + ++ A
Sbjct: 174 -----------------------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 896 DWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 954
D WS+GI L E TG P+ + + +L + P S + Q + L
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 955 DPNQR 959
D +R
Sbjct: 271 DHRKR 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-52
Identities = 62/296 (20%), Positives = 98/296 (33%), Gaps = 43/296 (14%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 737
+ F + GA G + A+K I E
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKR------ILPECFSFADRE 67
Query: 738 RNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAE 795
+L P V+R+F + R Y+ +E L + +K + +
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPET 850
L +LHSL IVHRDLKP N+LI+ ++DFGL K
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK--------------- 171
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEF 907
+ + +R R GT ++APE+L Y D +S G + +
Sbjct: 172 --------KLAVGRHSFSR-RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I+ G PF + + A++LI + + DP +R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-51
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 62/307 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ K + G+ G V G A+K + + + L E +L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKR------MLIDFCDIALMEIKLLTESDD 67
Query: 747 -PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-------ARIYIAELVL 798
P V+R++ S T LY+ +E +L L+ +E++ + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKIGLINNTIDL 845
+ +LHSL I+HRDLKP N+L++ + I ++DFGL K
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--------- 177
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-------GYAADWW 898
Q + N ++ GT + APE+L + + + D +
Sbjct: 178 --------------LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 899 SVGIILFEFIT-GIPPFTAESPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 955
S+G + + ++ G PF + I I + + EA DLI++ + HD
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 956 PNQRLGA 962
P +R A
Sbjct: 284 PLKRPTA 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 38/280 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ +EI+ + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P++V+ ++ L++++E+ GG + +++ ++ L E ++ +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L+ +G I+L DFG+S T+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQ--------------------- 172
Query: 866 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP- 919
R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 173 ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
++ I P PS S E +D + L +P R
Sbjct: 229 RVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-50
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 32/276 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
DDFE I + G G VF + +G + A K++ L+ I+ +I+ E +L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE-IKPAIRNQIIRELQVLHEC 88
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 805 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I+HRD+KP N+L+ G IKL DFG+S G + +++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSM-------------------- 186
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 187 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ +N+F +
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-50
Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 37/276 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ F++++ + G++G V+ A + TG + AIK + ++D++ I+ E +I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDS 83
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+ +HRD+K N+L+ +GH KL DFG++ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------QL 175
Query: 866 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 923
TD R++ +GTP ++APE++ + AD WS+GI E G PP+ P IF
Sbjct: 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I P P S D + + L+ P QR
Sbjct: 236 -MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 73/305 (23%), Positives = 116/305 (38%), Gaps = 81/305 (26%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 62
Query: 740 ILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLRKVGCLEEDVARIY 792
+ P +VR + R L +VME L+GG+L+S R E A
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
A E G ++ + D WS+G+I++ +
Sbjct: 166 -------------------------------FAKET-TGEKYDKSCDMWSLGVIMYILLC 193
Query: 910 GIPPFTAESPEI----IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
G PPF + + I + W V S E + LI L +P QR+
Sbjct: 194 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPTQRM 249
Query: 961 GANGA 965
Sbjct: 250 TITEF 254
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-50
Identities = 50/239 (20%), Positives = 99/239 (41%), Gaps = 27/239 (11%)
Query: 687 DDFEIIKPISRGA--FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+E++ I +G V LAR + TG+ ++ + L+ + + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEY 802
+P +V + +F + L++V ++ G L+ + + E + ++ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+H +G VHR +K ++LI+ DG + L+ + + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQ------------------ 183
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 919
Q+ + +V +L+PE+L GY +D +SVGI E G PF
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-50
Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 39/288 (13%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+ + ++ G F V+ A+ +G +A+K L + + I + E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHP 86
Query: 748 FVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 797
+V+F + + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 798 LALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
A++++H I+HRDLK +NLL+++ G IKL DFG + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT------------TISHYPDY 194
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIP 912
S + + R+ TP Y PEI+ G D W++G IL+
Sbjct: 195 SWSAQRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960
PF + I+N K P + LI L +P +RL
Sbjct: 252 PFEDGAKL----RIVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERL 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 43/286 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-T 743
DD E I + RGA+G V R +G + A+K ++ + + +R+L + +I + T
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-AT-VNSQEQKRLLMDLDISMRT 62
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLY-SLLRKVGCLEEDVARIYIAELVLAL 800
V PF V F+ + ++++ ME ++ Y ++ K + ED+ +V AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 801 EYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
E+LHS L ++HRD+KP N+LI G +K+ DFG+S
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------------------------ 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILFEFITGIPPFT 915
D+ + G Y+APE + + +D WS+GI + E P+
Sbjct: 159 ----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
Query: 916 A-ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 959
+ +P ++ P P +P+D S E D ++ L + +R
Sbjct: 215 SWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKER 258
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 63/297 (21%), Positives = 125/297 (42%), Gaps = 43/297 (14%)
Query: 676 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 735
+ + +D + + I RGA+G V + +G + A+K ++ + + + +++L
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-ST-VDEKEQKQLL 68
Query: 736 AERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKV--GCLEEDVAR 790
+ ++++ + P++V+F+ + + ++ ME ++ Y + V + E++
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 791 IYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
V AL +L L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG-------------- 174
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILF 905
Q D+ + G Y+APE + + +D WS+GI L+
Sbjct: 175 --------------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 906 EFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQR 959
E TG P+ + ++ P + F + +N L D ++R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 69/277 (24%), Positives = 107/277 (38%), Gaps = 37/277 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA-----------------------------SIM 204
Query: 867 DNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP-EII 922
N S VGTP ++APE IL E Y D WS+GI E PP + +
Sbjct: 205 APAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ +I + P S ++ ++ L P R
Sbjct: 263 Y-HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDR 297
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-47
Identities = 78/317 (24%), Positives = 138/317 (43%), Gaps = 52/317 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 745
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 746 NPFVVRFFYSF------TCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELV 797
+ + ++ +F D L+LVME+ G + L++ K L+E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
L +LH ++HRD+K N+L+ + +KL DFG+S ++ T+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG------------- 184
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-----GYAADWWSVGIILFEFITGIP 912
R++ +GTP ++APE++ E+ + +D WS+GI E G P
Sbjct: 185 ------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 913 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971
P P +F I P S + Q I L+ + +QR ++
Sbjct: 233 PLCDMHPMRALF-LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKH 287
Query: 972 KIFIKKTENCVSMQSKL 988
FI+ N ++ +L
Sbjct: 288 P-FIRDQPNERQVRIQL 303
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 17/274 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + +G FG+ R TG++ +K L + D + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALEYLHS 805
P V++F L + EY+ GG L +++ + R+ A+ + + YLHS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+ I+HRDL N L+ + ++ + DFGL+++ + + P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKP---------- 174
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
D + R++ VG P ++APE++ G + D +S GI+L E I + P +
Sbjct: 175 -DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ R P + + R DP +R
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 43/308 (13%)
Query: 664 DSVSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFA 716
+ T + + DD +I + I G+FG V A G A
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVA 64
Query: 717 IKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 776
+K+L + D + L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 65 VKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 777 LLRKVGCLEE--DVARIYIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 831
LL K G E+ + R+ +A ++ + YLH+ IVHR+LK NLL+ +K+ DF
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183
Query: 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891
GLS++ + + + SA GTP+++APE+L
Sbjct: 184 GLSRL---------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 951
+D +S G+IL+E T P+ +P + + + +P +++ + +I
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGC 275
Query: 952 LIHDPNQR 959
++P +R
Sbjct: 276 WTNEPWKR 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-44
Identities = 69/277 (24%), Positives = 105/277 (37%), Gaps = 52/277 (18%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 747
+E+ I+ G G ++LA + G +K L + +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 748 FVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS+G+V+ DLKP+N+++ + +KL D G I+ G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFG--------------- 235
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
GTP + APEI+ A D ++VG L +P +
Sbjct: 236 ----------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-- 282
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L P S+ L+ R + DP QR
Sbjct: 283 ---GLPEDDPVLKTYD--SYGR--LLRRAIDPDPRQR 312
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILI 742
++ E K I +G FG V R + AIK L D + ++ E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALE 801
+ +P +V+ + + +VME++ GDLY L + ++ + ++ L +E
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 802 YLHSLG--IVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
Y+ + IVHRDL+ N+ + K+ DFGLS+ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------SVHSVS 184
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIP 912
+G ++APE + E Y AD +S +IL+ +TG
Sbjct: 185 ------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 913 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PF S +I F N++ + P +P D +++I DP +R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 46/311 (14%)
Query: 666 VSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIK 718
+S S S P +S + + +++I + I +G FG+V+ R G++ AI+
Sbjct: 6 LSLLSARSFPRKAS-QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV-AIR 61
Query: 719 VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 778
++ ++ ++ E R+ VV F + +L ++ G LYS++
Sbjct: 62 LIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 779 RKVGCLEEDVARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
R + + IA E+V + YLH+ GI+H+DLK N+ +G + +TDFGL I
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSIS 179
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---- 893
+ G +LAPEI+
Sbjct: 180 GVLQAGRREDKLR----------------------IQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 894 -----AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 948
+D +++G I +E PF + E I + P M E D++
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISDIL 276
Query: 949 NRFLIHDPNQR 959
+ +R
Sbjct: 277 LFCWAFEQEER 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 70/292 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ E+ + + RGAFG V A+ R AIK ++ +++ + + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-----------DVARIYIAE 795
P +V+ + + C + + LVMEY GG LY++L L ++
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ----- 113
Query: 796 LVLALEYLHSL---GIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETD 851
+ YLHS+ ++HRDLKP NLL+ G +K+ DFG + +
Sbjct: 114 ---GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------DIQ 157
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
M + G+ ++APE+ G+ + D +S GIIL+E IT
Sbjct: 158 THMT-----------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 912 PPF--TAESPEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
PF I + N R P + ++ + L+ R DP+QR
Sbjct: 201 KPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 30/278 (10%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILI 742
T + + + + RG G V+ A + A+K++ + R+ E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ P VV LY+ M +NG DL ++LR+ G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H+ G HRD+KP+N+L++ D L DFG++ + + T
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKL------T------------ 190
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
Q + VGT Y+APE + Y AD +++ +L+E +TG PP+ + ++
Sbjct: 191 --QLG-----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
Query: 923 FDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 959
+ +N+ IP P V + +I R + +P R
Sbjct: 244 GAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 76/337 (22%), Positives = 134/337 (39%), Gaps = 72/337 (21%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 726
+Q+ G + S+ TSID + I + G +G V+ A T + AIK ++ L+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LE-- 70
Query: 727 RKNDIERI----LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
++ E + + E ++L +++ ++ L+L+ EY DL + K
Sbjct: 71 --HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 783 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIG 837
+ V + ++ +L+ + + HS +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-- 185
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 896
+ + H + T Y PEILLG+ H + D
Sbjct: 186 ------------------------AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVD 220
Query: 897 WWSVGIILFEFITGIPPFTAESPEI-----IFD-----------------NILNRKIPWP 934
WS+ I E + P F +S EI IF+ + +
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR 279
Query: 935 ------CVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ + + E DL+ L DP +R+ A A
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 44/297 (14%)
Query: 677 HSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 729
H H R + DD+EI + I G+FG V+ + GD+ A+K+L
Sbjct: 7 HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQ 62
Query: 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 789
++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 790 RIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
I IA + ++YLH+ I+HRDLK +N+ + D +K+ DFGL+
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------ 169
Query: 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILF 905
+ + + + G+ ++APE++ + + +D ++ GI+L+
Sbjct: 170 -------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 906 EFITGIPPFTAESP-EIIFDNIL--NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
E +TG P++ + + I + + + V S+ + L+ L ++R
Sbjct: 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-42
Identities = 77/313 (24%), Positives = 130/313 (41%), Gaps = 67/313 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITV 744
+ +E I I G++G VF R R TG + AIK K + + + +A R +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 803
++P +V F + L+LV EY + + L + + E + + + + A+ +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H +HRD+KP+N+LI IKL DFG +++ L+GP +Y +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGP--------SDYYDDE 162
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 921
V T Y +PE+L+G G D W++G + E ++G+P + +S ++
Sbjct: 163 -----------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-DVD 210
Query: 922 ----IFDNIL------------------NRKIPWPCVPSD-------MSFEAQDLINRFL 952
I L KIP P +S+ A L+ L
Sbjct: 211 QLYLIR-KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 953 IHDPNQRLGANGA 965
DP +RL
Sbjct: 270 HMDPTERLTCEQL 282
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-41
Identities = 78/325 (24%), Positives = 128/325 (39%), Gaps = 83/325 (25%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NI 740
++ +E + + G F V+ AR + T + AIK +K D A R +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 799
L + +P ++ +F + N+ LV +++ DL +++ L + Y+ +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
LEYLH I+HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------------------------ 160
Query: 860 YPEYQQTDNRNRHSAVGTPD-----------YLAPEILLGTEH-GYAADWWSVGIILFEF 907
+ G+P+ Y APE+L G G D W+VG IL E
Sbjct: 161 --------------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 908 ITGIPPFTAESPEI-----IFDNIL---NRKI--------------PWPCVP-----SDM 940
+ +P +S ++ IF+ L + +P +P S
Sbjct: 207 LLRVPFLPGDS-DLDQLTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264
Query: 941 SFEAQDLINRFLIHDPNQRLGANGA 965
+ DLI + +P R+ A A
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQA 289
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 747
++I+ + G V+LA AIK + + K + ++R E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+V D YLVMEY+ G L + G L D A + +++ +++ H +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
IVHRD+KP N+LI + +K+ DFG++K L ++ +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTN-------------------- 170
Query: 868 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927
+GT Y +PE G D +S+GI+L+E + G PPF E+ I +
Sbjct: 171 -----HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
Query: 928 NRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 959
+P V D+ ++I R D R
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 80/313 (25%), Positives = 133/313 (42%), Gaps = 68/313 (21%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 741
++ + ++ I G +G V+ A+ G+ FA+K ++ L+ + E I + E +IL
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LE----KEDEGIPSTTIREISIL 54
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 800
+++ +V+ + + L LV E+L+ DL LL LE A+ ++ +L+ +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y H ++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------------------------- 148
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
+ + H V T Y AP++L+G++ D WSVG I E + G P F S
Sbjct: 149 -AFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS- 205
Query: 920 EI-----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFL 952
E IF + +P + DL+++ L
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 953 IHDPNQRLGANGA 965
DPNQR+ A A
Sbjct: 266 KLDPNQRITAKQA 278
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 80/330 (24%), Positives = 129/330 (39%), Gaps = 88/330 (26%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERIL 735
+S F+ ++ + G + V+ +TTG A+K +K LD IR
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-------- 52
Query: 736 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------LEEDVA 789
E +++ +++ +VR + + L LV E+++ DL + LE ++
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + +L+ L + H I+HRDLKP NLLI G +KL DFGL++
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------------- 156
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFI 908
GI P + E V T Y AP++L+G+ + D WS G IL E I
Sbjct: 157 AFGI-PVNTFSSE------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 909 TGIPPFTAESPEI-----IFD----------------------------NILNRKIPWPC 935
TG P F + + IFD L + +
Sbjct: 204 TGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ D ++ L +P+ RL A A
Sbjct: 263 KEP-LDGNLMDFLHGLLQLNPDMRLSAKQA 291
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 79/322 (24%), Positives = 121/322 (37%), Gaps = 75/322 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL---AERNI- 740
+ +E + I GA+G V+ AR +G A LK + + L R +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVA 63
Query: 741 ----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVA 789
L +P VVR + LV E+++ DL + L K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 790 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + + + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMAL 176
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
T V T Y APE+LL + + D WSVG I E
Sbjct: 177 T----------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
Query: 910 GIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDMSFE 943
P F S E IFD ++ + +P P +M
Sbjct: 215 RKPLFCGNS-EADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 944 AQDLINRFLIHDPNQRLGANGA 965
L+ L +P++R+ A A
Sbjct: 273 GAQLLLEMLTFNPHKRISAFRA 294
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 79/317 (24%), Positives = 132/317 (41%), Gaps = 69/317 (21%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAER 738
+ ++ ++ ++ + G +G V+ A+ G + A+K ++ LD + E I + E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LD----AEDEGIPSTAIREI 70
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELV 797
++L + +P +V L LV E++ DL +L + L++ +IY+ +L+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ + H I+HRDLKP NLLI DG +KL DFGL++
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---------------------- 167
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 916
+ H V T Y AP++L+G++ + D WS+G I E ITG P F
Sbjct: 168 ----AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 917 ESPEI-----IFD-----------------NILNRKIP-WPCVP-----SDMSFEAQDLI 948
+ + IF R + P E DL+
Sbjct: 223 VT-DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 949 NRFLIHDPNQRLGANGA 965
+ L DPN+R+ A A
Sbjct: 282 SNMLCFDPNKRISARDA 298
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 72/315 (22%), Positives = 125/315 (39%), Gaps = 67/315 (21%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILI 742
S++ +E + + G++G V R + TG + A +KK + + + +A R +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLK 79
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALE 801
+R+ +V + YLV E+++ + L L+ V + Y+ +++ +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
+ HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAP-----GEVYDDE- 184
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920
V T Y APE+L+G G A D W++G ++ E G P F +S +
Sbjct: 185 -------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-D 230
Query: 921 I-----IFDNILNRKIP--WPCVPS-----------------------DMSFEAQDLINR 950
I I L IP +S DL +
Sbjct: 231 IDQLYHIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 951 FLIHDPNQRLGANGA 965
L DP++R
Sbjct: 290 CLHIDPDKRPFCAEL 304
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 72/316 (22%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 741
+ +E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLL 55
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 800
+++ +VR L LV E+ + DL L+ ++ + ++ +L+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ HS ++HRDLKP NLLI +G +KL +FGL++ GI P +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI-PVRCYS 159
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT-GIPPFTAES 918
E V T Y P++L G + + D WS G I E G P F
Sbjct: 160 AE------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 919 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 949
IF +L + WP + ++ +DL+
Sbjct: 208 -VDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264
Query: 950 RFLIHDPNQRLGANGA 965
L +P QR+ A A
Sbjct: 265 NLLKCNPVQRISAEEA 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 747
+E+ + + G V LAR A+KVL+ D+ R R E + +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 748 FVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
H GI+HRD+KP N++I+ +K+ DFG+++ + ++ ++
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVT----------------- 174
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 922
QT + +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 175 -QTA-----AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ ++ IP +S + ++ + L +P R
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 81/320 (25%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAE 737
++ + + + G + V+ + + T +L A+K ++ L+ IR E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR---------E 50
Query: 738 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 796
++L +++ +V +L LV EYL+ DL L G + ++++ +L
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L Y H ++HRDLKP NLLI G +KL DFGL++ S P
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIP-------- 153
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 915
+ + V T Y P+ILLG+ D W VG I +E TG P F
Sbjct: 154 -----------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 916 AESPEI-----IFDNIL---NRKIPWPCVPS----------------------DMSFEAQ 945
+ IF IL + WP + S + +
Sbjct: 203 GST-VEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 946 DLINRFLIHDPNQRLGANGA 965
DL+ + L + R+ A A
Sbjct: 260 DLLTKLLQFEGRNRISAEDA 279
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 81/323 (25%), Positives = 136/323 (42%), Gaps = 85/323 (26%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DD+++++ + RG + VF A T + +K+LK + ++I E IL +R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 89
Query: 747 -PFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
P ++ S LV E++N D L + L + R Y+ E++ A
Sbjct: 90 GPNIITLADIVKDPVSR----TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 142
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y HS+GI+HRD+KP N++I H+ ++L D+GL++ P +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQE------- 186
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF--- 914
Y V + + PE+L+ + Y+ D WS+G +L I PF
Sbjct: 187 -YNVR-----------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 915 ---------------TAESPEII----------FDNILNR--KIPW-PCVPSD----MSF 942
T + + I F++IL R + W V S+ +S
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 943 EAQDLINRFLIHDPNQRLGANGA 965
EA D +++ L +D RL A A
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREA 317
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 45/285 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LDMIRKNDIERILAERNILITVR 745
+ + + I G FG+V+ A GD A+K + D IE + E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+P ++ NL LVME+ GG L +L + D+ + ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 806 LG---IVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIGLINNTIDLSGPETDGIM 854
I+HRDLK N+LI +K+TDFGL++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------------------ 165
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ SA G ++APE++ + +D WS G++L+E +TG PF
Sbjct: 166 -----------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + K+ +PS L+ DP+ R
Sbjct: 215 RGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 83/325 (25%), Positives = 129/325 (39%), Gaps = 83/325 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIER----ILAERN 739
+ +E + I GA+G+VF AR + G A LK++ + + R
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRV----QTGEEGMPLSTIRE 61
Query: 740 I-----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEED 787
+ L T +P VVR F L LV E+++ DL + L KV + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ + +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSF 172
Query: 848 PETDGIMPSDAHY-PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
V T Y APE+LL + + D WSVG I E
Sbjct: 173 QMA---------LTSV------------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 907 FITGIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDM 940
P F S ++ I D ++ + +P +D+
Sbjct: 212 MFRRKPLFRGSS-DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 941 SFEAQDLINRFLIHDPNQRLGANGA 965
+DL+ + L +P +R+ A A
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSA 294
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 56/296 (18%)
Query: 678 SSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 735
+ H ID + ++ G ++ R + G+ +KVLK D
Sbjct: 2 NKHSG---IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFN 55
Query: 736 AERNILITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA-RIY 792
E L +P V+ + + L+ ++ G LY++L + D + +
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 793 IA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
A ++ + +LH+L I L +++I D +++ +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------------- 161
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFE 906
+Q + P ++APE L +AD WS ++L+E
Sbjct: 162 ------------SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
Query: 907 FITGIPPFTAESP-EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+T PF S EI L R P +P +S L+ + DP +R
Sbjct: 204 LVTREVPFADLSNMEIGMKVALEGLR----PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 86/327 (26%), Positives = 128/327 (39%), Gaps = 78/327 (23%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------IRKNDIER 733
+ +E + I +G FG VF AR R TG A LKK+ M +R+ I +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQ 71
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
+L N+ + + + C+ ++YLV ++ DL LL V +
Sbjct: 72 LLKHENV-VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETD 851
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL+ L
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL------------- 176
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 910
++ Y T NR V T Y PE+LLG G D W G I+ E T
Sbjct: 177 ---AKNSQPNRY--T-NR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 911 IPPFTAESPEI-----IFDNIL---NRKIPWPCVPS------------------------ 938
P + E I + ++ WP V +
Sbjct: 226 SPIMQGNT-EQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAY 282
Query: 939 DMSFEAQDLINRFLIHDPNQRLGANGA 965
A DLI++ L+ DP QR+ ++ A
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRIDSDDA 309
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-38
Identities = 81/330 (24%), Positives = 136/330 (41%), Gaps = 79/330 (23%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERN 739
+ R +D F++ + +G FG V L ++++TG AIK V+ D +N R L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRN---RELQIMQ 71
Query: 740 ILITVRNPFVVR---FFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC----LEEDV 788
L + +P +V+ +FY+ RD L +VMEY+ L+ R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 789 ARIYIAELVLALEYLH--SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDL 845
++++ +L+ ++ LH S+ + HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---------- 180
Query: 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 904
+ Y + + Y APE++ G + A D WSVG I
Sbjct: 181 -------KLSPSEPNVAY-----------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 905 FEFITGIPPFTAESP-----EII----------FDNILN----------RKIPW----PC 935
E + G P F ++ EI+ + + IPW
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 936 VPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ EA DL++ L + P +R+ A
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-38
Identities = 85/324 (26%), Positives = 128/324 (39%), Gaps = 78/324 (24%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+R + K I G+FG V+ A+ +G+L AIK K+ D E I+
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KV----LQDKRFKNRELQIM 101
Query: 742 ITVRNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGC----LEEDVARI 791
+ + +VR FFYS + + L LV++Y+ +Y + R L ++
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
Y+ +L +L Y+HS GI HRD+KP NLL+ +KL DFG +K
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------- 205
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 909
+ Y + + Y APE++ G T++ + D WS G +L E +
Sbjct: 206 --QLVRGEPNVSY-----------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 910 GIPPFTAESP-----EII----------------------FDNILNRKIPWP-CVPSDMS 941
G P F +S EII F I + PW
Sbjct: 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRTP 310
Query: 942 FEAQDLINRFLIHDPNQRLGANGA 965
EA L +R L + P RL A
Sbjct: 311 PEAIALCSRLLEYTPTARLTPLEA 334
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 58/315 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
DF++ + GA+G V A + TG++ AIK K++ K R L E IL +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFK 67
Query: 746 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
+ ++ F +N +Y++ E + DL+ ++ L +D + +I + + A+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAV 125
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ LH ++HRDLKP NLLI + +K+ DFGL++I + + M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM------ 179
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES- 918
E+ V T Y APE++L ++ A D WS G IL E P F
Sbjct: 180 VEF-----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 919 ---------------PEIIFDNILN-------------RKIPWPCVPSDMSFEAQDLINR 950
+ I + P + ++ + DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 951 FLIHDPNQRLGANGA 965
L+ DP +R+ A A
Sbjct: 289 MLVFDPAKRITAKEA 303
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 79/354 (22%), Positives = 127/354 (35%), Gaps = 74/354 (20%)
Query: 648 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 707
S T + LI S S SG PL +RT +++K I +G +G V++ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLV---QRTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 708 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFF----YSFTCRDN 761
R G+ A+KV + E I TV R+ ++ F
Sbjct: 58 WR--GEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 813
LYL+ +Y G LY L+ + + ++ V L +LH+ I HRDL
Sbjct: 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 873
K N+L+ +G + D GL+ E D ++
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVK------FISDTNEVDIPP-----------------NT 205
Query: 874 AVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGI----------PPFTAE 917
VGT Y+ PE+L + + AD +S G+IL+E P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 918 SP-----EIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
P E + + + +K P + + L+ H+P RL A
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-36
Identities = 89/317 (28%), Positives = 133/317 (41%), Gaps = 79/317 (24%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ K I G+FG VF A+ + + AIK K+ D E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KV----LQDKRFKNRELQIMRIVKHPN 93
Query: 749 VVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 798
VV FFYS + + L LV+EY+ +Y R + + ++Y+ +L+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 799 ALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+L Y+HS+GI HRD+KP NLL+ G +KL DFG +KI ++ +
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------------LIAGE 196
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 916
Y + + Y APE++ G T + D WS G ++ E + G P F
Sbjct: 197 P-NVSY-----------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 917 ESP-----EII----------------------FDNILNRKIPWP-CVPSDMSFEAQDLI 948
ES EII F I R P+ +A DLI
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPDAIDLI 302
Query: 949 NRFLIHDPNQRLGANGA 965
+R L + P+ RL A A
Sbjct: 303 SRLLEYTPSARLTAIEA 319
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 81/320 (25%), Positives = 126/320 (39%), Gaps = 72/320 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---------RN 739
+ +KP+ G G VF A AIK K+ + ++ L E N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 740 I-----LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
I ++ + S T +++Y+V EY+ DL ++L + G L E+ AR+++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMY 127
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+L+ L+Y+HS ++HRDLKP NL I D +K+ DFGL++I D
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------------MDPH 174
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 912
H E + T Y +P +LL + A D W+ G I E +TG
Sbjct: 175 YSHKGHLSEG-----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 913 PFTAESP----EIIFD-------------------NILN----RKIPWPCVPSDMSFEAQ 945
F ++I + I N P + +S EA
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 946 DLINRFLIHDPNQRLGANGA 965
D + + L P RL A A
Sbjct: 284 DFLEQILTFSPMDRLTAEEA 303
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 68/322 (21%)
Query: 644 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 703
LD + + K+ LI D + SG PL +RT + + I +G FG V
Sbjct: 5 LDRPFISEGTTLKD---LIYDMTTSGSGSGLPLLV---QRTIARTIVLQESIGKGRFGEV 58
Query: 704 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRDN 761
+ + R G+ A+K+ + E I T +R+ ++ F + +
Sbjct: 59 WRGKWR--GEEVAVKIF------SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 762 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIV 809
L+LV +Y G L+ L + E + ++ L +LH I
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDLK N+L+ +G + D GL+ + T +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVR-----------------------HDSATDTIDI 206
Query: 870 NRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ VGT Y+APE+L + E AD +++G++ +E
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--- 263
Query: 924 DNILNRKIPWP-CVPSDMSFEA 944
++P+ VPSD S E
Sbjct: 264 ------QLPYYDLVPSDPSVEE 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 62/283 (21%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+RT D +++ + +G +G V+ + G+ A+K+ D + E +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETELY 54
Query: 742 ITV--RNPFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 795
TV R+ ++ F S L+L+ Y G LY L+ RI +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLS 113
Query: 796 LVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ L +LH I HRDLK N+L+ +G + D GL+ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----------- 162
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVG 901
+ + + + VGT Y+APE+L T + D W+ G
Sbjct: 163 ------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
Query: 902 IILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
++L+E + + + K P+ VP+D SFE
Sbjct: 211 LVLWEVARRMVS---------NGIVEDYKPPFYDVVPNDPSFE 244
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
+E++K I +G+FG+V A A+K+++ + E IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQD 154
Query: 746 ---NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLAL 800
V+ +FT R+++ + E L +LY L++K + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+ LH I+H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQR 255
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
Y Y Q+ R Y APE++LG +G D WS+G IL E +TG P E
Sbjct: 256 VYT-YIQS----RF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-35
Identities = 74/342 (21%), Positives = 124/342 (36%), Gaps = 96/342 (28%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIK-----------------------VLKKLDM 725
+ + K + G+FG V +G FA+K ++K +D
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 726 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSL 777
E + + + L ++MEY+ L+ +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKV 127
Query: 778 LRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFG 832
L+ + ++ IYI +L A+ ++HSLGI HRD+KP NLL+ + D +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEH 891
+K + Y + + Y APE++LG TE+
Sbjct: 188 SAK-----------------KLIPSEPSVAY-----------ICSRFYRAPELMLGATEY 219
Query: 892 GYAADWWSVGIILFEFITGIPPFTAESP-----EII----------------------FD 924
+ D WS+G + E I G P F+ E+ II F
Sbjct: 220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279
Query: 925 NILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ + W + P A DL+ + L ++P+ R+ A
Sbjct: 280 TL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 77/316 (24%), Positives = 126/316 (39%), Gaps = 73/316 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ + GA+G V A + +G+ AIK KL +++I R E +L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 745 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ F + N YLVM ++ DL ++ E+ + + +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS G+VHRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADA 178
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 179 EMTGY-----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
I + + + + + S +A DL+
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 950 RFLIHDPNQRLGANGA 965
+ L D ++RL A A
Sbjct: 288 KMLELDVDKRLTAAQA 303
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 64/314 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 745
+ + I GA+G V A AIK K+ +R L E IL+ R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83
Query: 746 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
+ ++ + +Y+V + + DLY LL+ L D ++ +++ L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+Y+HS ++HRDLKP NLL+ +K+ DFGL+++ D
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFL 188
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 919
EY V T Y APEI+L ++ + D WSVG IL E ++ P F +
Sbjct: 189 TEY-----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 920 ----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRF 951
I I+N K+PW + + +A DL+++
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 952 LIHDPNQRLGANGA 965
L +P++R+ A
Sbjct: 298 LTFNPHKRIEVEQA 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 33/284 (11%), Positives = 69/284 (24%), Gaps = 60/284 (21%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 748
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 749 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 808
V R R +V E++ GG L + R + L A + H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 869 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 928
+ D +G L+ + P
Sbjct: 175 -----------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 929 RKIPWPCVPS----DMSFEAQDLINRFLIHDPNQRLGANGAAEV 968
P P+ D+ F+ + R + D R + +
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLM 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 72/316 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ ++ + P+ GA+G V A TG A+K KL ++ I R E +L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 745 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ V+ F + +YLV + G DL ++++ L +D + I +++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ T M
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTADEM---- 186
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 187 --TGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
++I I + K+ + V + A DL+
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 950 RFLIHDPNQRLGANGA 965
+ L+ D ++R+ A A
Sbjct: 294 KMLVLDSDKRITAAQA 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-34
Identities = 64/323 (19%), Positives = 109/323 (33%), Gaps = 74/323 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------DIERILAER 738
+ + + IS G++G V + G AIK + + +R+L E
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 739 NILITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIY 792
+L +P ++ F + LYLV E + DL ++ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ ++L L LH G+VHRDL P N+L+A + I + DF L++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADA 188
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911
Y V Y APE+++ + D WS G ++ E
Sbjct: 189 NK------THY-----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 912 PPFTAESP----EIIFD-----------NILN--------------RKIPWPCVPSDMSF 942
F + I + + W V
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 943 EAQDLINRFLIHDPNQRLGANGA 965
A DLI + L +P +R+ A
Sbjct: 292 VALDLIAKMLEFNPQRRISTEQA 314
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 72/316 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+ ++P+ GA+G V A TG AIK KL ++++ R E +L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 745 RNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
R+ V+ + + YLVM ++ G DL L++ L ED + + +++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++ +D+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QADS 180
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917
Y V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 181 EMTGY-----------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 918 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 949
+ I + + K + + ++ S A +L+
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 950 RFLIHDPNQRLGANGA 965
+ L+ D QR+ A A
Sbjct: 290 KMLVLDAEQRVTAGEA 305
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 70/242 (28%), Positives = 109/242 (45%), Gaps = 12/242 (4%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
D +EI I G++G V A + + AIK K+ + ++ I+ RIL E IL +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 745 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
+ VV+ D LY+V+E D L R L E + + L++
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++Y+HS GI+HRDLKP N L+ D +K+ DFGL++ + P + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 918
+ + R V T Y APE++L E+ A D WS+G I E + I A
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 919 PE 920
+
Sbjct: 289 AD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIE-RILAERNILITVRN 746
+EI I +G+FG+V A R + AIK++K K + + IE R+L N T
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLH 804
++V F R++L LV E L +LY LLR + ++ R + ++ AL +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 805 S--LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+ L I+H DLKP+N+L+ + IK+ DFG S Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------------CQLGQRIY 216
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918
Y Q+ R Y +PE+LLG + A D WS+G IL E TG P F+ +
Sbjct: 217 Q-YIQS----RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-32
Identities = 73/353 (20%), Positives = 133/353 (37%), Gaps = 98/353 (27%)
Query: 678 SSHKERTSIDDFEIIKP-ISRGAFGRVFLARKR--TTGDLFAIKVLKKLDM----IRKND 730
SS +ER D FE + RG +G V+ A+++ +A+K ++ + R+
Sbjct: 12 SSERER-VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70
Query: 731 IERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------- 783
+ R L N+ I+++ F+ ++L+ +Y DL+ +++
Sbjct: 71 LLRELKHPNV-ISLQKVFLSH------ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 784 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 837
L + + + +++ + YLH+ ++HRDLKP N+L+ + G +K+ D G +++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL- 181
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 896
+ P D V T Y APE+LLG H A D
Sbjct: 182 --------------------FNSPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAID 218
Query: 897 WWSVGIILFEFITGIPPFTAESPEIIFDNILNR----KI------P----WPCVPS---- 938
W++G I E +T P F +I N + +I P W +
Sbjct: 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH 278
Query: 939 --------------------------DMSFEAQDLINRFLIHDPNQRLGANGA 965
+A L+ + L DP +R+ + A
Sbjct: 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 72/326 (22%), Positives = 127/326 (38%), Gaps = 81/326 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 745 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ ++ FT + + +Y+VME + +L +++ L+ + + +++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 183
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y V T Y APE++LG + D WSVG I+ E I G F
Sbjct: 184 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 915 ---------------TAESPEIIFDNILN--------RKIPW------------PCVPSD 939
E + + + +
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGA 965
+ +A+DL+++ L+ D ++R+ + A
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEA 316
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 86/329 (26%), Positives = 147/329 (44%), Gaps = 61/329 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
+E++K + +GA+G V+ + R TG++ A+K K+ +N + R E IL +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 745 RN-PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
+V ++ +YLV +Y+ DL++++R LE + + +L+ ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIK 123
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YLHS G++HRD+KP N+L+ + H+K+ DFGLS+ + + + P + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP- 919
+ TD V T Y APEILLG T++ D WS+G IL E + G P F S
Sbjct: 184 QPILTD------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 920 ---EIIFD-------------------NILNRKIPWPCVP-------------------- 937
E I ++ +
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 938 -SDMSFEAQDLINRFLIHDPNQRLGANGA 965
+D + EA DL+++ L +PN+R+ AN A
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDA 326
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-32
Identities = 74/326 (22%), Positives = 129/326 (39%), Gaps = 81/326 (24%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 745 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ ++ FT + +YLVME + +L +++ L+ + + +++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 220
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 914
Y V T Y APE++LG + D WSVG I+ E + F
Sbjct: 221 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 915 ---------------TAESPEIIFDNILN--------RKIPWPCV------------PSD 939
E + + + N + +P +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 940 MSFEAQDLINRFLIHDPNQRLGANGA 965
+ +A+DL+++ L+ DP +R+ + A
Sbjct: 328 KASQARDLLSKMLVIDPAKRISVDDA 353
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-32
Identities = 81/344 (23%), Positives = 138/344 (40%), Gaps = 75/344 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 744
D++ I I RG++G V+LA + T AIK K++ + ++ I+ RIL E IL +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 745 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
++ +++R + D LY+V+E DL L + L E+ + + L+L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++H GI+HRDLKP N L+ D +K+ DFGL++ ++ + P +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 860 YPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917
+Q T + V T Y APE++L E+ + D WS G I E + + +
Sbjct: 202 KNLKKQLTSH------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 918 SP--------------------------------EIIFD-----------NILN------ 928
IIF+ NI
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 929 -------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ I +S + +L+ L +PN+R+ + A
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 58/282 (20%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-- 743
+D+ ++++ I RG +G V+ A+KV + + + E+NI
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 744 VRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+ + + RF + R LVMEY G L L R+ +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122
Query: 799 ALEYLHS---------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849
L YLH+ I HRDL N+L+ +DG ++DFGLS
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR------------- 169
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGI 902
+ ++ S VGT Y+APE+L G D +++G+
Sbjct: 170 ------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 903 ILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
I +E + +++ ++ + V + +FE
Sbjct: 224 IYWEIFMR------CTDLFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 60/246 (24%), Positives = 99/246 (40%), Gaps = 35/246 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 745
F +I+ + G FGRV L + +A+KV++ + E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKIQNDD 92
Query: 746 --NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
N +V++ F D++ L+ E L G LY ++ + + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI-------- 853
YL + + H DLKP+N+L+ K I + ++ GI
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD--GKKIQIYRTKSTGIKLIDFGCA 209
Query: 854 -MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
SD H T R Y APE++L ++D WS G +L E TG
Sbjct: 210 TFKSDYHGS-IINT----RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 913 PFTAES 918
F
Sbjct: 258 LFRTHE 263
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 59/261 (22%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP- 747
+ +++ + G F V+LA+ A+K+++ K E E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 76
Query: 748 ----------FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
+++ F + + +V E L G +L +L++K + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 792 YIAELVLALEYLHS-LGIVHRDLKPDNLLIAH------DGHIKLTDFGLSKIGLINNTID 844
+L+L L+Y+H GI+H D+KP+N+L+ IK+ D G +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185
Query: 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
D HY QT R Y +PE+LLG G AD WS ++
Sbjct: 186 ---------CWYDEHYTNSIQT----RE-------YRSPEVLLGAPWGCGADIWSTACLI 225
Query: 905 FEFITGIPPFTAESPEIIFDN 925
FE ITG F + +
Sbjct: 226 FELITGDFLFEPDEGHSYTKD 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 53/300 (17%), Positives = 107/300 (35%), Gaps = 69/300 (23%)
Query: 667 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-- 724
SSGV + ++ ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 7 HHSSGVDLGT-ENLYFQS--MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ 61
Query: 725 -MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLR 779
+ ++ L +++ +++F + + L+L+ + G L L+
Sbjct: 62 SWQNEYEVY-------SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 780 KVGCLEEDVARIYIAELVLALEYLHS----------LGIVHRDLKPDNLLIAHDGHIKLT 829
++ I + L YLH I HRD+K N+L+ ++ +
Sbjct: 115 ANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 886
DFGL+ + + H VGT Y+APE+L
Sbjct: 174 DFGLALKFEAGKSAG-------------------------DTHGQVGTRRYMAPEVLEGA 208
Query: 887 LGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 943
+ + D +++G++L+E + E +P+ + S E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--------YMLPFEEEIGQHPSLE 260
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 53/254 (20%), Positives = 89/254 (35%), Gaps = 55/254 (21%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 733
+EI+ + GAFG+V + G A+K++K L+ + D
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
V+ F ++ +V E L G Y +++ G D R
Sbjct: 76 ---TFRC---------VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 846
++ ++ +LHS + H DLKP+N+L + + + + + +D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF- 181
Query: 847 GPETDG--IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
G + H T RH Y APE++L D WS+G IL
Sbjct: 182 -----GSATYDDEHHST-LVST----RH-------YRAPEVILALGWSQPCDVWSIGCIL 224
Query: 905 FEFITGIPPFTAES 918
E+ G F
Sbjct: 225 IEYYLGFTVFPTHD 238
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-30
Identities = 66/340 (19%), Positives = 102/340 (30%), Gaps = 92/340 (27%)
Query: 689 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 733
+EI+ + G FG+V A+K+++ L I++ D E
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 791
+ V F ++ + E L G + + L++ R
Sbjct: 81 ---KFLC---------VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 846
+L AL +LH + H DLKP+N+L + L + S D
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906
+ H T RH Y PE++L D WS+G ILFE
Sbjct: 188 S----ATFDHEHHTT-IVAT----RH-------YRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 907 FITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSD------ 939
+ G F P + +K + W SD
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291
Query: 940 --------------MSFEAQDLINRFLIHDPNQRLGANGA 965
+ DL+ R L DP QR+ A
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 49/276 (17%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-- 746
+ +I+ + G F V+L+ A+KV+K ++ E L E +L +VRN
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSD 94
Query: 747 ------PFVVRFFYSFT---------CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVA 789
VV+ F C +V E L G L + K L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 790 RIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848
+ I +++ L+YLH+ I+H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 849 ETDGIM------------PSDAHYPEYQQTD-------NRNRHSAVGTPDYLAPEILLGT 889
P +A + + D +++ + T Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 890 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ AD WS + FE TG F S E +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
F + K I G FG + L + T + AIK+ K+ ++ E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + +Y C +V+E L G L L + V I I +L+ +EY+HS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAI-QLISRMEYVHS 123
Query: 806 LGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+++RD+KP+N LI G+ I + DF L+K ID + H
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-----YIDPETKK---------HI 169
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 917
P R S GT Y++ LG E D ++G + F+ G P A+
Sbjct: 170 PY------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223
Query: 918 SPEIIFDNILNRKI 931
+ + + I + K
Sbjct: 224 TLKERYQKIGDTKR 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 38/257 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ +Y + LV++ L G L LL G + VA +++ ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK-QMLARVQSIHE 124
Query: 806 LGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
+V+RD+KPDN LI + I + DFG+ K T H
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--------------KQHI 170
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 917
P R + + GT Y++ LG E D ++G + F+ G P A
Sbjct: 171 PY------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 918 SPEIIFDNILNRKIPWP 934
+ + ++ I +K P
Sbjct: 225 TNKQKYERIGEKKQSTP 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 58/252 (23%), Positives = 96/252 (38%), Gaps = 36/252 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+ + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + D +VME L G L L + V + +++ +EY+HS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-QMISRIEYIHS 123
Query: 806 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K D + H P
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-----KYRDARTHQ---------HIP- 168
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAESP 919
R + GT Y + LG E D S+G +L F G P A +
Sbjct: 169 -----YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223
Query: 920 EIIFDNILNRKI 931
++ I +K+
Sbjct: 224 RQKYERISEKKM 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D + + I RG FG VF R R L A+K ++ + + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 805
P +VR T + +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N L+ +K++DFG+S+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----------------EEADGVYAA---- 270
Query: 866 TDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
P + APE L + +D WS GI+L+E + G P+
Sbjct: 271 -----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 668 QSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLK 721
G L + T + I+ + G FG+V L T D + A+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 722 KLDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLR 779
E +IL T+ + ++++ +L LVMEY+ G L L
Sbjct: 70 --ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 780 KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
+ I +A+L+L + YLH+ +HRDL N+L+ +D +K+ DFG
Sbjct: 128 R--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 892
L+K + + DG P + APE L +
Sbjct: 180 LAK--AVPEGHEYYRVREDGDSPV----------------------FWYAPECLKEYKFY 215
Query: 893 YAADWWSVGIILFEFIT 909
YA+D WS G+ L+E +T
Sbjct: 216 YASDVWSFGVTLYELLT 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 66
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 120
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 163
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+P D + ++ + +P + APE L ++ A+D WS G++L+E T
Sbjct: 164 LPQDKEF--FKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 672 VSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDM 725
VS ++ + T + + I+ + G FG+V L R GD A+K LK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PE 61
Query: 726 IRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
N I + E IL + + +V++ + + + L+ME+L G L L K
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--- 118
Query: 784 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ +I + + + ++YL S VHRDL N+L+ + +K+ DFGL+K
Sbjct: 119 ---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK- 174
Query: 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAA 895
+ +D Y Y D+R+ +P + APE L+ ++ A+
Sbjct: 175 ----------------AIETDKEY--YTVKDDRD------SPVFWYAPECLMQSKFYIAS 210
Query: 896 DWWSVGIILFEFIT 909
D WS G+ L E +T
Sbjct: 211 DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 97
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQYT 151
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 194
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912
+P D Y Y+ + +P + APE L ++ A+D WS G++L+E T I
Sbjct: 195 LPQDKEY--YKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 913 PFTAESPEIIFDNILNRKIPWP 934
++SP F ++
Sbjct: 247 K--SKSPPAEFMRMIGN-DKQG 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 681 KERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK------------- 722
E +DD + + K I G FG ++LA + A V+K
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELK 85
Query: 723 -LDMIRKNDIERILAERNILITVRNPFVVRF-FYSFTCRDNLYLVMEYLNGGDLYSLLRK 780
+ K D + ER L + P F R ++VME L G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 781 VGCL-EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIG 837
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 145 NGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
N Y E R GT ++ + + G +D
Sbjct: 204 CPNGN--------------HKQYQE------NPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 898 WSVGIILFEFITG 910
+G + ++ G
Sbjct: 244 EILGYCMLRWLCG 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 49/265 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 742
+ I + +G FG V L R GD L A+K L+ ++ D E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF---QREIQILK 79
Query: 743 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 798
+ + F+V++ R +L LVMEYL G L L++ AR+ + L+L
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLYS 133
Query: 799 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 853
+EYL S VHRDL N+L+ + H+K+ DFGL+K +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK-----------------L 176
Query: 854 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 911
+P D Y Y + +P + APE L +D WS G++L+E T
Sbjct: 177 LPLDKDY--YVVREPG------QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 912 PPFTAESPEIIFDNILNRKIPWPCV 936
+ + + +
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRL 253
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 292
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 331
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY P + APE L +D WS GI+L E T G P+
Sbjct: 332 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 2e-21
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
F + + I G+FG ++L T + AIK+ K ++L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 805
+ + D LVM+ L G L L + V + +++ +E++HS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD-QMINRVEFVHS 121
Query: 806 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K D S + H P
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----KYRDTSTHQ---------HIPY 167
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---AESP 919
R + GT Y + LG E D S+G +L F+ G P+ A +
Sbjct: 168 ------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
Query: 920 EIIFDNILNRKIPWP 934
+ ++ I +K+
Sbjct: 222 KQKYEKISEKKVATS 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 48/241 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 798
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 914 F 914
+
Sbjct: 220 Y 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 33/231 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ E +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HR+L N L+ + +K+ DFGLS++ D Y
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-----------MTGD----------TY- 373
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
A + APE L + +D W+ G++L+E T G+ P+
Sbjct: 374 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 375
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 414
Query: 860 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
EY P + APE L +D WS GI+L E T G P+
Sbjct: 415 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 679 SHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRK 728
S + + ++D I + + +G FG V A+ + F A+K+LK D+I
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIAS 66
Query: 729 NDIERILAERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG 782
+DIE L E + +P V + + +++ ++ GDL++ L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 783 CLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
E + + LV +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 127 IGENP-FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN---RHSAVGTPDYLAPEILLGTEHG 892
I D Y+Q + +LA E L +
Sbjct: 186 ----------------KIYSGD----YYRQGCASKLPVK--------WLALESLADNLYT 217
Query: 893 YAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928
+D W+ G+ ++E +T G P+ I++ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 46/276 (16%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 665 SVSQSSGVSTPLHSSHKERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDL----- 714
+ S L I D +++ PI +G FG ++LA ++ +
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 715 FAIKVLKK-----------LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763
+KV K + + L + P Y
Sbjct: 68 CVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY-WGSGLHDKNGKSY 126
Query: 764 --LVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819
++M+ G DL + + V ++ + ++ LEY+H VH D+K NLL
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL-RILDILEYIHEHEYVHGDIKASNLL 184
Query: 820 I--AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 877
+ + + L D+GL+ Y + GT
Sbjct: 185 LNYKNPDQVYLVDYGLAYRYCPEGV--------------HKAYAA------DPKRCHDGT 224
Query: 878 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913
++ + + G D +G + +++TG P
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 48/242 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
D +++ + G+FG V +G A+K LK + + ++ + E N + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ + ++R Y + +V E G L LRK + L
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQV 130
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ YL S +HRDL NLL+A +K+ DFGL + + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQN 174
Query: 857 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D HY P + APE L +A+D W G+ L+E T G
Sbjct: 175 DDHY-----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 913 PF 914
P+
Sbjct: 224 PW 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ E + ++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL N L+ + +K+ DFGLS++
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ I G FG V L + AIK +++ M E + E +++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
P +V+ + + + LV E++ G L LR L+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEG 116
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ YL ++HRDL N L+ + IK++DFG+++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 687 DDFEI--------IKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILA 736
+ + K + G FG V + + A+K+LK + + +LA
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 67
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E N++ + NP++VR ++ LVME G L L++ +++ + ++
Sbjct: 68 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 38/151 (25%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
++ ++K + G FG V L + + D+ A+K++K+ M + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 805
P +V+F+ + +Y+V EY++ G L + LR G E + + ++ + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 48/253 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 742
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 798
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 799 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 856 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 914 FTAESPEIIFDNI 926
+ I +
Sbjct: 220 YDGIPASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 34/152 (22%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ + G FG V++ + A+K LK+ M + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 804
+VR + T ++ +Y++ EY+ G L L+ ++ + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +K + G FG V + R D+ AIK++K+ M + + E +++ + +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ + T + ++++ EY+ G L + LR++ R +L+ A
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEA 132
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+EYL S +HRDL N L+ G +K++DFGLS+
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 675 PLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKN 729
P + I+ I K I G G V R R G AIK LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ER 92
Query: 730 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 789
L+E +I+ +P ++R T +V EY+ G L + LR
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------G 146
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
+ I +LV + YL LG VHRDL N+L+ + K++DFGLS+ ++ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDD 204
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
D + T G +P + T APE + A+D WS G+
Sbjct: 205 PDAAYTTTGGKIP-------IRWT---------------APEAIAFRTFSSASDVWSFGV 242
Query: 903 ILFEFIT-GIPPF 914
+++E + G P+
Sbjct: 243 VMWEVLAYGERPY 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 34/165 (20%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 739
+D + + +G F ++F +R GD +KVL K +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 740 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVL 798
++ + + +V + C D LV E++ G L + L+K + ++ +A +L
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 835
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 51/271 (18%)
Query: 659 SRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--- 715
+ + + S + + E K I G FG V+ +T+
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEI-HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP 75
Query: 716 -AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 774
AIK LK + L E I+ + ++R + + ++ EY+ G L
Sbjct: 76 VAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 775 YSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827
LR+ + +LV ++YL ++ VHRDL N+L+ + K
Sbjct: 134 DKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK 187
Query: 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT--P-DYLAPE 884
++DFGLS++ D Y + G P + APE
Sbjct: 188 VSDFGLSRV------------------LEDDPEATY---------TTSGGKIPIRWTAPE 220
Query: 885 ILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
+ + A+D WS GI+++E +T G P+
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-19
Identities = 35/157 (22%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ K + G FG V++A + A+K +K M +E LAE N++ T+++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 799
+V+ T ++ +Y++ E++ G L L+ ++ ++ + +L+
Sbjct: 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEG 296
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
+ ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 53/255 (20%)
Query: 675 PLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRK 728
+ + T + +K + G FG V G+ IKV++ D +
Sbjct: 2 AMKVLARIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGR 56
Query: 729 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 788
+ + + ++ + +VR +L LV +YL G L +R+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQ------HR 109
Query: 789 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841
+ L+ + YL G+VHR+L N+L+ +++ DFG++
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD------ 163
Query: 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSV 900
++P D ++ + TP ++A E + ++ + +D WS
Sbjct: 164 -----------LLPPDDKQ--LLYSEAK-------TPIKWMALESIHFGKYTHQSDVWSY 203
Query: 901 GIILFEFIT-GIPPF 914
G+ ++E +T G P+
Sbjct: 204 GVTVWELMTFGAEPY 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 26/197 (13%)
Query: 663 LDSVSQSSGVSTPLHSSHKE--RTSIDDFEI-------IKPISRGAFGRVFLARKRTTGD 713
+ S S+ L E + ++D I K + G FG V +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 714 LF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-----YSFTCRDNLYLV 765
A+K +K D + +IE L+E + +P V+R S ++
Sbjct: 61 TSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNL 818
+ ++ GDL++ L LE I + L+ +EYL + +HRDL N
Sbjct: 120 LPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 819 LIAHDGHIKLTDFGLSK 835
++ D + + DFGLSK
Sbjct: 179 MLRDDMTVCVADFGLSK 195
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 673 STPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIR 727
+ +H KE T+I I K + G FG V R + AIK LK
Sbjct: 32 TQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-- 86
Query: 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 787
+ L E +I+ +P ++R T + +V EY+ G L S LRK
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 788 VARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840
A+ + +LV ++YL +G VHRDL N+LI + K++DFGL ++
Sbjct: 142 -AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV---- 196
Query: 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWS 899
D Y + P + +PE + + A+D WS
Sbjct: 197 --------------LEDDPEAAYTTRGGK-------IPIRWTSPEAIAYRKFTSASDVWS 235
Query: 900 VGIILFEFIT-GIPPF 914
GI+L+E ++ G P+
Sbjct: 236 YGIVLWEVMSYGERPY 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 57/266 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + + + +G+FG V+ K D AIK + + +R + L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVL 798
VVR + ++ME + GDL S LR +A +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 799 -------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---------------- 186
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYL-----APEILLGTEHGY--AADWWSVGIIL 904
D + +Y + + L +PE L + + +D WS G++L
Sbjct: 187 -----DIYETDYYRKGGKGL---------LPVRWMSPESLK--DGVFTTYSDVWSFGVVL 230
Query: 905 FEFIT-GIPPFTAESPEIIFDNILNR 929
+E T P+ S E + ++
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 46/273 (16%), Positives = 92/273 (33%), Gaps = 52/273 (19%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDL--------FAIKVLKK--------LDMIRKNDIE 732
+++ +R G ++ A +T F++K+ K R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 733 RILAERNILITVRNPFVVRFFYSFTCRDNL-YLVMEYLNGGDLYSLLRKVGCL---EEDV 788
++ + L + + +D +LV+ L G L S L E V
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 789 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDLS 846
++ L+ ALE+LH VH ++ +N+ + + L +G +
Sbjct: 162 LQVAC-RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR---------- 210
Query: 847 GPETDGIMPSDAH--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904
PS H Y E +R G ++++ ++ G +D S+G +
Sbjct: 211 ------YCPSGKHVAYVE------GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
Query: 905 FEFITGIPP---FTAESPEIIFDNILNRKIPWP 934
+++ G P + +I+ P P
Sbjct: 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 50/242 (20%)
Query: 687 DDFEIIK-PISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 743
D+ I + G FG V R AIKVLK+ K D E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ NP++VR + L LVME GG L+ L I ++ +
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQV 119
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
++YL VHRDL N+L+ + + K++DFGLSK +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA----------------LGAD 163
Query: 857 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 912
D++Y + P + APE + + +D WS G+ ++E ++ G
Sbjct: 164 DSYY-----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 913 PF 914
P+
Sbjct: 213 PY 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 743
+D + + + G FG V+ A+K KK + E+ ++E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 798
+ +P +V+ + +++ME G+L L + + + LVL
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQI 122
Query: 799 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 684 TSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIER 733
+S D+EI + I G FG V + + AIK K E+
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREK 62
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 793
L E + +P +V+ + ++++ME G+L S L+ + +
Sbjct: 63 FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK------YSLDL 115
Query: 794 AELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
A L+L AL YL S VHRD+ N+L++ + +KL DFGLS+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ I +G FG V L R A+K +K + LAE +++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73
Query: 747 PFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 803
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 60/302 (19%)
Query: 647 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
K+ + ++ + + +D + + + + S + I RG FG V+
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHG 108
Query: 707 RKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNL 762
A+K L ++ I ++ + L E I+ +P V+ +
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 763 YLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALEYLHSLGIVHRD 812
+V+ Y+ GDL + +R +G VA+ +++L S VHRD
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK--------GMKFLASKKFVHRD 217
Query: 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN---- 868
L N ++ +K+ DFGL++ + + +
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARD----------------MYDKE--FDSVHNKTGAKLP 259
Query: 869 -RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 926
+ ++A E L + +D WS G++L+E +T G PP+ + I +
Sbjct: 260 VK----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 927 LN 928
L
Sbjct: 310 LQ 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ I RG FG V+ A+K L ++ I ++ + L E I+ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 747 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAE 795
P V+ + +V+ Y+ GDL + +R +G VA+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK----- 139
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
++YL S VHRDL N ++ +K+ DFGL++ + + +T +P
Sbjct: 140 ---GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
++A E L + +D WS G++L+E +T G PP+
Sbjct: 196 V----------------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 915 TAESPEIIFDNILN 928
+ I +L
Sbjct: 234 PDVNTFDITVYLLQ 247
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-18
Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 36/246 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 743
+ E+ + I G FG V + + AIK K + E+ L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQ 447
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 802
+P +V+ + ++++ME G+L S L+ L+ +Y +L AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L S VHRD+ N+L++ + +KL DFGLS+ + ++
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDST------------------Y 546
Query: 863 YQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920
Y+ + + P ++APE + A+D W G+ ++E + G+ PF
Sbjct: 547 YKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 921 IIFDNI 926
+ I
Sbjct: 600 DVIGRI 605
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
D + + + GAFG+VFLA + L A+K LK + + D E +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELL 71
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVARIY 792
+++ +V+F+ D L +V EY+ GDL LR G + +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 793 IAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+++++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-17
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 634 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII- 692
+ + P + + + +D+ S S P K+ D +I
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 693 -KPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 749
+ G FG V R AIKVLK+ K D E ++ E I+ + NP++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYI 398
Query: 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEY 802
VR + L LVME GG L+ L I ++ + ++Y
Sbjct: 399 VRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKY 451
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
L VHR+L N+L+ + + K++DFGLSK + D++Y
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA----------------LGADDSYY-- 493
Query: 863 YQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 914
+ P + APE + + +D WS G+ ++E ++ G P+
Sbjct: 494 ---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 741
D + + GAFG+VFLA + L A+K LK+ + D E +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELL 97
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYI 793
+++ +VRFF T L +V EY+ GDL LR G + + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 794 AELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+L+ + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + K + G FG+V A R A+K+LK+ ++ +L+E N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 784
V +P V++ + + + L L++EY G L LR+
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 785 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
D + + +L+ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V AR + G AIK +K+ K+D E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 745 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--- 800
+P ++ + R LYL +EY G+L LRK LE D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 801 -------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 653 SKYKENSRLILDSVSQSSGVSTPLHS-SHKE-RTSIDDFEIIKPISRGAFGRVFLARKRT 710
SKY + + I D++S S V + + + ++F+ I G FG+V+ R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 711 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTC--RDNLYLVME 767
G A+K IE E L R+P +V + C R+ + L+ +
Sbjct: 63 -GAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGF---CDERNEMILIYK 115
Query: 768 YLNGGDLYSLLRKVGCLEED---VARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHD 823
Y+ G+L L R+ I L YLH+ I+HRD+K N+L+ +
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH--SAV-GTPDY 880
K+TDFG+SK G E QT H + V GT Y
Sbjct: 176 FVPKITDFGISKKG-----------------------TELDQT-----HLSTVVKGTLGY 207
Query: 881 LAPEILLGTEHGYA--------ADWWSVGIILFEFITGIPP 913
+ PE Y +D +S G++LFE +
Sbjct: 208 IDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER-ILAERNILITVRNPFVVRFF 753
+ G FG V+ + A+K L + I ++++ E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 754 -YSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEED-VARIYIAELVLA--LEYLHSLGI 808
+S D+L LV Y+ G L L G R IA A + +LH
Sbjct: 97 GFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA-QGAANGINFLHENHH 154
Query: 809 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 868
+HRD+K N+L+ K++DFGL++ ++ QT
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-----------------------EKFAQTVM 191
Query: 869 RNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+R VGT Y+APE L G T +D +S G++L E ITG+P
Sbjct: 192 TSR--IVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ I +G FG V L R G+ A+K +K + LAE +++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQLRH 245
Query: 747 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 803
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 804 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 51/259 (19%), Positives = 94/259 (36%), Gaps = 46/259 (17%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAER 738
ER + I +G FG V+ AIK L ++ ++ +E L E
Sbjct: 19 ERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREG 73
Query: 739 NILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
++ + +P V+ + ++++ Y+ GDL +R + +L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLI 127
Query: 798 L-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+EYL VHRDL N ++ +K+ DFGL++ +++
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHR 186
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 909
+P + A E L +D WS G++L+E +T
Sbjct: 187 HARLPV----------------------KWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 910 GIPPFTAESPEIIFDNILN 928
G PP+ P + +
Sbjct: 225 GAPPYRHIDPFDLTHFLAQ 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V +A A+K+LK + D+ +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 654 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLA----- 706
KY+ ++I S P + E+ ++ + K + GAFG+V A
Sbjct: 11 KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 765
K A+K+LK + E +++E I+ + +V + T + ++
Sbjct: 71 GKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--------------EYLHSLGIVHR 811
EY GDL + LR+ + E IA + +L S +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 812 DLKPDNLLIAHDGHIKLTDFGLS 834
D+ N+L+ + K+ DFGL+
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLA 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 23/169 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNIL 741
++ + FG+V+ AIK LK E E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLR 66
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL- 800
+++P VV T L ++ Y + GDL+ L + + + AL
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 801 ---------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
EYL S +VH+DL N+L+ ++K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ K + GAFG+V A K A+K+LK + + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------VGCLEEDVA 789
+ N +V + T ++ EY GDL + LR+ +E+D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
+ + +L+ + +L S +HRDL N+L+ H K+ DFGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 31/178 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 784
NP +V+ + L+ EY+ GDL LR
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 785 EEDVARIYIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ AE + + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ G FG+V +A K A+K+LK + D+ +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 789
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 790 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL--- 798
+ +VR +++ME + GGDL S LR+ + + + +L+
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 799 ----ALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 741
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV---- 797
+ +VR ++++E + GGDL S LR+ + + + +L+
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 798 ---LALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK+ + +++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 742 ITV-RNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK---------VGCLEEDVAR 790
I + + VV + T L +++E+ G+L + LR V +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 791 IYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
+ + L+ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 26/173 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V LA K A+K+LK + D+ +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 740 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
++ + ++ + T LY+++EY + G+L L+ + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 799 AL----------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
L EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E K + GAFG+V A K A+K+LK+ + E +++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 742 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCL 784
+ + +V + T +YL+ EY GDL + LR
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 785 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834
EED+ + +L+ +E+L VHRDL N+L+ H +K+ DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 7e-13
Identities = 45/219 (20%), Positives = 71/219 (32%), Gaps = 56/219 (25%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERN 739
+ + + I G FG VF AIK++ ++ + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 740 IL-----------------ITVRNPFVVRFFY----------------------SFTCRD 760
I I + + V+ Y F D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 761 NLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNL 818
L++V+E+ GG DL + K+ A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 819 LIAHDGHIKLTDFGLSKI------GLINNTIDLSGPETD 851
L+ KL K GL + ID + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 8e-13
Identities = 92/661 (13%), Positives = 174/661 (26%), Gaps = 213/661 (32%)
Query: 396 HEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKL--SEIL 453
H +D ++++ E A +C DV + + E +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS--VFED-------AFVDNFDCKDVQDMPKSILSKEEI 51
Query: 454 EQISESCNSSSHP------ILGSPENSRTQSMNSAITYDGYSPKISEWRNK-----GVEG 502
+ I S ++ S +L E + + + + Y +S + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTR 110
Query: 503 MFEDIHEM---DTACIDDSHLGS----LNLRGHLGLKLS-----------GYGASSSTGS 544
M+ + + D ++ L LR L L+L G G +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLIDGVLGSGKTWVALD 169
Query: 545 MTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLAC 604
S F FWL ++ C + + + L
Sbjct: 170 --VCLSYKVQCKMDFKIFWL------------------NLKNCNSPETVLEMLQKLLYQI 209
Query: 605 MHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILD 664
+ HS L I + + + +LL+ K Y+ N L+L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----------------PYE-NCLLVLL 251
Query: 665 SV------------------SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 706
+V ++ V+ L ++ S+D
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLT----- 299
Query: 707 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV----RFFYSFTCR--- 759
L K LD R D L + NP +
Sbjct: 300 -PDEVKSLLL----KYLDC-RPQD----LPREVLTT---NPRRLSIIAESIRDGLATWDN 346
Query: 760 ------DNLYLVME----YLNGGDLYSLLRKVGCLEEDVARIYIAELVLA---------- 799
D L ++E L + + ++ +I ++L+
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKSD 403
Query: 800 ----LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ LH +V + K + I +++L ++ L + +D
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVD----------- 451
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------T 909
HY + D+ D L P Y + I
Sbjct: 452 ---HYNIPKTFDS----------DDLIPP----YLDQY----------FYSHIGHHLKNI 484
Query: 910 GIPPFTAESPEIIFD-NILNRKI-----PWPCVPSDMSFEAQDLIN--RFLI-HDP-NQR 959
P + D L +KI W S ++ Q L ++ +DP +R
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKFYKPYICDNDPKYER 543
Query: 960 L 960
L
Sbjct: 544 L 544
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 7e-05
Identities = 68/541 (12%), Positives = 139/541 (25%), Gaps = 162/541 (29%)
Query: 38 YGVSRPPQKHKQKTVAQ--------------GHVK--LA----NSFTEEVRKGKKIAQWF 77
Y VSR K + G K +A S+ + + KI W
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WL 187
Query: 78 T--------SYISKFNIVSPNTENSGSEDKDVDVEDPRRT-----KLRHEGNHLNEKQSL 124
+ + + + + + D R +LR + L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 125 A--EHVSSSKVSKGLKSFSHELGPKGGIPSSYPRAHSYNDL--KELLDTLHSRFDAAKEV 180
+V ++K +F +L K LL T RF K+V
Sbjct: 248 LVLLNVQNAKA---WNAF---------------------NLSCKILLTT---RF---KQV 277
Query: 181 VNSELATFAKDVMNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLT 240
+ A + L+ + E+ +L + ++ QDL
Sbjct: 278 TDFLSAATTTHI--SLDHHSMTLTP-DEVKS---LLL-KYLDCR-----------PQDL- 318
Query: 241 EKRQQCQVG--LVKWLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVET 298
R+ + ++ + L +K + L +
Sbjct: 319 -PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC------DKLTTIIESSLNVL----- 366
Query: 299 SWVPSPGTAESDLDYASYQK-----ANAKKKISGQQKVSTVPEI----SDCSCSESLDHT 349
E + + +A I + + + S + +
Sbjct: 367 ---------EPAEYRKMFDRLSVFPPSA--HIP-----TILLSLIWFDVIKSDVMVVVNK 410
Query: 350 SENKSVFIEQNFPPQKSQH--YSRMQEQQSHIVE--GRIVEVTKSNCGSPHEQGQSLDGS 405
S+ +Q S Y ++ + + IV+ +
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD-DLIPPYL 469
Query: 406 DSVICRICEEVVPISHLESHSYICAYADKCEL-NCLDVDERLLKLSEILEQISESCNSSS 464
D SH+ H + ++ L + +D R L+ ++I
Sbjct: 470 DQYFY---------SHIGHHLKNIEHPERMTLFRMVFLDFRFLE-----QKIRHD----- 510
Query: 465 HPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGV-EGMFEDI----HEMDTACIDDSH 519
+ N+ +N+ Y P I + N E + I +++ I +
Sbjct: 511 ----STAWNASGSILNTLQQLKFYKPYICD--NDPKYERLVNAILDFLPKIEENLICSKY 564
Query: 520 L 520
Sbjct: 565 T 565
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D+F + RG FG+V+ R G L A+K LK+ + + +++ E ++ +
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKE-ERTQGGELQ-FQTEVEMISMAVH 86
Query: 747 PFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLA 799
++R F C LV Y+ G + S LR E R IA L A
Sbjct: 87 RNLLRL-RGF-CMTPTERLLVYPYMANGSVASCLR--ERPESQPPLDWPKRQRIA-LGSA 141
Query: 800 --LEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L YLH I+HRD+K N+L+ + + DFGL+K+ +T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------------ 189
Query: 855 PSDAHYPEYQQTDNRNRH--SAV-GTPDYLAPEILLGTEHGYA---ADWWSVGIILFEFI 908
H +AV GT ++APE L G + D + G++L E I
Sbjct: 190 -----------------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELI 229
Query: 909 TGIPPF 914
TG F
Sbjct: 230 TGQRAF 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK + ++ +++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 742 ITVRN-PFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
I + + VV + T L +++E+ G+L + LR + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDA 858
+ +G + DLK I + F K + + D +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 859 HYPEYQ 864
+Q
Sbjct: 196 ICYSFQ 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------------------- 241
Query: 861 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 913
+ + + R P ++APE + + +D WS G++L+E + G P
Sbjct: 242 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 21/149 (14%)
Query: 695 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRNPF 748
I +GA + + +V K +LD IRK R E L V++
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVKDFG 400
Query: 749 V-VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ + + DN ++M Y+NG ++ + + I + LH
Sbjct: 401 IPAPYIFDVD-LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEI--------VGKLHKND 451
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836
++H DL N + D + + DFGL KI
Sbjct: 452 VIHNDLTTSNFIF--DKDLYIIDFGLGKI 478
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 30/169 (17%)
Query: 679 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------------- 725
+D I K + G VF +K K
Sbjct: 84 RLVRSGKVDA--IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140
Query: 726 IRKNDIERILAER--NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 783
+ + + A L ++ V + + N ++ME ++ +LY +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYA---WEGNA-VLMELIDAKELYRVR----- 191
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 832
E+ + ++ + + GIVH DL N+L+ + I + DF
Sbjct: 192 -VENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 995 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.11 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.06 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.43 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.26 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=508.64 Aligned_cols=272 Identities=34% Similarity=0.667 Sum_probs=247.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++|||||+++++|.+.+.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765555566788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~--- 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 185 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC---
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999852110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++
T Consensus 186 ----------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 243 (311)
T 4aw0_A 186 ----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243 (311)
T ss_dssp ----------------------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1112345679999999999999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHH---HHHHcCcccccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA---AEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EI---lEiL~HPfF~~~~~n~~s 983 (995)
.+|....+.+| ..+++++.+||.+||+.||++|||+.++ ..+++||||++++|+.+.
T Consensus 244 ~~i~~~~~~~p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 244 AKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHHHHTCCCCC---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHcCCCCCC---cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 99999887655 6899999999999999999999998775 468999999999998763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=492.95 Aligned_cols=267 Identities=41% Similarity=0.739 Sum_probs=232.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..++|++++.||+|+||+||+|++. .+++.||||++++..... .....+.+|+.+|++++|||||++++++.+.+.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3478999999999999999999984 468899999998654322 233468889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~--- 177 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--- 177 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc---
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 178 ------------------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 178 ------------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp ---------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 01122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+......+| ..+|+++.+||.+||+.||++|||+. .+.++++||||++++|+.+
T Consensus 234 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l 293 (304)
T 3ubd_A 234 TMTMILKAKLGMP---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293 (304)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHcCCCCCC---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence 9999998876554 68999999999999999999999963 4789999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=476.97 Aligned_cols=257 Identities=34% Similarity=0.598 Sum_probs=218.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
.+++|++.+.||+|+||+||+|.++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35799999999999999999999999999999999987655555566789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+ +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~------ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT------ 163 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC------
Confidence 99999 68999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
......+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.+...++
T Consensus 164 ----------------------~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 164 ----------------------DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp ---------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 1112235689999999999999886 58999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
..+..+...+| ..+++++.+||.+||+.||++||| +.++++||||+.
T Consensus 222 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k~ 268 (275)
T 3hyh_A 222 KNISNGVYTLP---KFLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHHT
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHccCChhHCcC---HHHHHcCccccc
Confidence 99988876544 679999999999999999999999 777889999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=493.37 Aligned_cols=266 Identities=27% Similarity=0.513 Sum_probs=230.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45899999999999999999999999999999999986543 44567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~---- 176 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---- 176 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC----
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec----
Confidence 99999999999999754 357899999999999999999999999999999999999999999999999998421
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..++
T Consensus 177 -----------------------~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 233 (350)
T 4b9d_A 177 -----------------------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233 (350)
T ss_dssp -----------------------HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 011122356899999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
+.++..+.++ ..+..+++++.+||.+||+.||.+||| +.++|+||||.+.-+...+
T Consensus 234 ~~~i~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~~~~~ 289 (350)
T 4b9d_A 234 VLKIISGSFP--PVSLHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAKRIEKFLS 289 (350)
T ss_dssp HHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHTTGGGTSC
T ss_pred HHHHHcCCCC--CCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhcCCCcCCC
Confidence 9999887653 456789999999999999999999999 7778999999876554433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=490.51 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=230.9
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
..|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999764432 3456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|||+||+|.+++.+ +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-------- 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 221 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC--------
Confidence 99999999999975 569999999999999999999999999999999999999999999999999998421
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+
T Consensus 222 -------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 282 (346)
T 4fih_A 222 -------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282 (346)
T ss_dssp -------------------SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 1112234678999999999999999999999999999999999999999999999999888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.....+....+..+++++.+||.+||+.||++||| +.++|+||||.+..
T Consensus 283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKAG 331 (346)
T ss_dssp HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGCC
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcCCC
Confidence 77654444445679999999999999999999999 77889999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=473.10 Aligned_cols=256 Identities=23% Similarity=0.433 Sum_probs=219.6
Q ss_pred CCe-EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec----cCe
Q 001924 687 DDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDN 761 (995)
Q Consensus 687 ~dY-eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~----~~~ 761 (995)
.+| ++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|++++|||||+++++|.. ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 788899999999999999999999999999976443 44567789999999999999999999999875 356
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEecc-CCcEEEEecCCccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 838 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDe-nG~VKLsDFGLArv~~ 838 (995)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999999899999999999999999999999998 999999999999974 7999999999997411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+..
T Consensus 184 -----------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 184 -----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp -----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -----------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 112235689999999999875 69999999999999999999999998754
Q ss_pred H-HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 919 P-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 919 ~-~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
. ..++..+..+ ...+..+...++++.+||.+||+.||++||| +.++|+||||++.
T Consensus 234 ~~~~~~~~i~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 234 NAAQIYRRVTSG-VKPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQEE 289 (290)
T ss_dssp SHHHHHHHHTTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC--
T ss_pred cHHHHHHHHHcC-CCCCCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 4 4455555444 3334455678999999999999999999999 7788999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=484.39 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=233.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.++|||||++++++.+.+.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 346789999999999999999999999999999999976432 246999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~~~s 842 (995)
||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+....+..
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999999888999999999999999999999999999999999999999988 699999999985221100
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
..........+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+...+
T Consensus 207 ----------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 264 (336)
T 4g3f_A 207 ----------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264 (336)
T ss_dssp -----------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC
T ss_pred ----------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 0011122356899999999999999999999999999999999999999999888888
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH----------HcCcccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV----------FHCKIFIKKTE 979 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi----------L~HPfF~~~~~ 979 (995)
+..+.....++..++..+++.+.+||.+||+.||.+|||+.++++. |+|||+....+
T Consensus 265 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 265 CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 8888888776666788999999999999999999999999888764 68999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=491.56 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=231.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976443 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|||+||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~-------- 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 298 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC--------
Confidence 99999999999965 569999999999999999999999999999999999999999999999999998421
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus 299 -------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 359 (423)
T 4fie_A 299 -------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359 (423)
T ss_dssp -------------------SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 1112234678999999999999999999999999999999999999999999999999888
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.....+....+..+++++.+||.+||+.||++||| +.++|+||||.+..
T Consensus 360 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~~~ 408 (423)
T 4fie_A 360 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKAG 408 (423)
T ss_dssp HHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGCC
T ss_pred HcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcCCC
Confidence 87755444455689999999999999999999999 77889999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=455.71 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=223.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
+..++|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.|.+|+++|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 34478999999999999999999875 35789999999753 34556789999999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV-------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 825 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~-------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~ 825 (995)
.+.+|||||||++|+|.++|... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999754 35899999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHH
Q 001924 826 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 905 (995)
Q Consensus 826 VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILy 905 (995)
+||+|||+|+....... .......+||+.|||||++.+..|+.++|||||||+||
T Consensus 167 ~Ki~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 221 (299)
T ss_dssp EEECCCSCHHHHTGGGC-------------------------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEECCcccceecCCCCc-------------------------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHH
Confidence 99999999984221110 11223456999999999999999999999999999999
Q ss_pred HHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 906 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 906 ELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
||+| |+.||.+.+..+++..+..+.. +..|..+|+++.+||.+||+.||++|||+.++.+.|+
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9998 9999999999999998887654 3456789999999999999999999999999987765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=453.59 Aligned_cols=265 Identities=21% Similarity=0.315 Sum_probs=220.0
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..|+...++|++.+.||+|+||+||+|++. ..||||+++... ......+.|.+|+.+|++++|||||++++++..
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 345677899999999999999999999864 359999987543 345567889999999999999999999998764
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+.+|||||||+||+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 5689999999999999999754 579999999999999999999999999999999999999999999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.. .........+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.
T Consensus 184 ~~-------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 184 RW-------------------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp -----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cC-------------------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 10 01122345689999999999964 458999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCCCC---CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHH---HHHcCccc
Q 001924 916 AESPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAA---EVFHCKIF 974 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~~p---~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIl---EiL~HPfF 974 (995)
+.+.......++......| ..+..+++.+.+||.+||+.||++|||+.+++ +.|+|++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 239 HINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 8776665555555544333 45678999999999999999999999998876 45678763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=451.28 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=224.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
...+++++.+.||+|+||+||+|.+. .+++.||||+++... .....+.|.+|+.++++++|||||++++++..
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45578999999999999999999864 367899999987532 23445789999999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 822 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe 822 (995)
.+.++||||||++|+|.++|... ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999642 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHH
Q 001924 823 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902 (995)
Q Consensus 823 nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGV 902 (995)
++.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||
T Consensus 181 ~~~~Ki~DFGlar~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAAD-------------------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235 (308)
T ss_dssp GGCEEECCSCCBCGGGGGG-------------------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCCEEECCcccceeccCCC-------------------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHH
Confidence 9999999999998532111 112233567999999999999999999999999999
Q ss_pred HHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 903 ILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+||||+| |..||.+.+..++...+..+.. +..|..++..+.+||.+||+.||.+|||+.++.+.|+
T Consensus 236 vl~El~t~g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 236 VLWEVFSYGLQPYCGYSNQDVVEMIRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHHHHTTTCCTTTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999998 8999999999999888876653 3356789999999999999999999999999999987
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=453.72 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=219.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
...++|.+.++||+|+||+||+|+++ .++..||||+++.. .....+.|.+|+++|++++|||||+++++|.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44578999999999999999999875 36889999999753 34566789999999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV---------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 823 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~---------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen 823 (995)
.+.+|||||||++|+|.+++.+. +.+++..+..|+.||+.||+|||+++||||||||+|||++.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999999753 358999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHH
Q 001924 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (995)
Q Consensus 824 G~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (995)
+.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+
T Consensus 195 ~~~Ki~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvv 249 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249 (329)
T ss_dssp TEEEECCCC-----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CcEEEcccccceeccCCC-------------------------cceecCcccccccccChhhhcCCCCCccccccchHHH
Confidence 999999999998421110 0112234679999999999999999999999999999
Q ss_pred HHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 904 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 904 LyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
||||+| |+.||.+.+..+++..+..+.. +..|..+++++.+||.+||+.||++|||+.++.+.|+
T Consensus 250 l~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 250 LWEIFTYGKQPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHHHHTTSCCTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 999999 9999999999999888877642 3456789999999999999999999999999988775
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=464.95 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=225.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec------c
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------R 759 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~------~ 759 (995)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+++|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 368999999999999999999999999999999997643 334456788999999999999999999998764 3
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
+.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 57899999995 68999999888999999999999999999999999999999999999999999999999999984211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.. ........+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+
T Consensus 211 ~~-----------------------~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 211 SP-----------------------AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp ----------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred Cc-----------------------cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 00 0112234567899999999999886 46999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCCC----------------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNRKIPWP----------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p----------------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
..+.+..|.......+ ...+.+++++.+||.+||++||.+||| +.++|+
T Consensus 268 ~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~ 344 (398)
T 4b99_A 268 YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS---AAAALR 344 (398)
T ss_dssp HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC---HHHHTT
T ss_pred HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 8888887765322111 012457899999999999999999999 778899
Q ss_pred Cccccccc
Q 001924 971 CKIFIKKT 978 (995)
Q Consensus 971 HPfF~~~~ 978 (995)
||||.+..
T Consensus 345 Hp~f~~~~ 352 (398)
T 4b99_A 345 HPFLAKYH 352 (398)
T ss_dssp SGGGTTTC
T ss_pred CHhhCcCC
Confidence 99999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=449.76 Aligned_cols=270 Identities=26% Similarity=0.418 Sum_probs=205.1
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC------
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD------ 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~------ 760 (995)
++|++++.||+|+||+||+|+++.+|+.||||+++... .+...+.+.+|+.+|++++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 57999999999999999999999999999999997543 3445678999999999999999999999987654
Q ss_pred ------eeEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 761 ------NLYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 761 ------~lyLVmEym~GGSL~d~L~k~~~---Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
.+|+|||||++|+|.+++..... .+...++.++.||+.||+|||++|||||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 37999999999999999986654 455678899999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr 911 (995)
|+|+........... . ..........+.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 163 Gla~~~~~~~~~~~~------~---------~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV------L---------TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp CCC-----------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred ccceecCCCcccccc------c---------cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 999853221110000 0 00011123345789999999999999999999999999999999996
Q ss_pred CCCCCCCHH-HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 912 PPFTAESPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 912 ~PF~g~s~~-ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
||...... .....+... .+|..+...++.+.+||.+||+.||.+||| +.++|+||||++.+|..
T Consensus 226 -Pf~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVFEDLDFPG 290 (299)
T ss_dssp -CCSSHHHHHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGCCC----
T ss_pred -CCCCccHHHHHHHHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCCCCCCC
Confidence 88654322 223333332 233333456678899999999999999999 67789999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=491.00 Aligned_cols=267 Identities=35% Similarity=0.585 Sum_probs=232.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrE---ieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+| +.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 457899999999999999999999999999999999987554444444445555 45566778999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~-- 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-- 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC--
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE-- 917 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~-- 917 (995)
.....+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.
T Consensus 344 ---------------------------~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 344 ---------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp ---------------------------SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred ---------------------------CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 112345789999999999974 57999999999999999999999999763
Q ss_pred -CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 918 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 -s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
+...+...+......+ |..+++++.+||.+||+.||.+|++. ..+.++++||||++++|..+
T Consensus 397 ~~~~~i~~~i~~~~~~~---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 397 KDKHEIDRMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp CCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHHHHHHHhhcCCCCCC---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 4456666777666554 46899999999999999999999984 45889999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=467.94 Aligned_cols=263 Identities=27% Similarity=0.494 Sum_probs=234.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+...+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999987643 3345778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC--CcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen--G~VKLsDFGLArv~~~~~ 841 (995)
|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 4679999999999999999999999999999999999999854 899999999998421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+..+
T Consensus 309 -------------------------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~ 363 (573)
T 3uto_A 309 -------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363 (573)
T ss_dssp -------------------------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred -------------------------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 1112235689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
.+..+......++. .+..+++++.+||.+||+.||.+||| +.++|+||||+...+..
T Consensus 364 ~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 364 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTT
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCC
Confidence 99999888766543 34679999999999999999999999 66778999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=446.24 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=220.5
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG-----~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH-PNIVkL~ 753 (995)
.+|+...++|++.+.||+|+||+||+|.+..++ +.||||+++... .....+.+.+|+.+|+++.| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345677789999999999999999999986543 589999987543 33456789999999999976 8999999
Q ss_pred eeeecc-CeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCC
Q 001924 754 YSFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (995)
Q Consensus 754 gvf~~~-~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPe 816 (995)
++|... ..+|||||||++|+|.++|+.. ..+++..+..++.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998764 5689999999999999999753 34889999999999999999999999999999999
Q ss_pred cEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHH
Q 001924 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (995)
Q Consensus 817 NILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSD 896 (995)
|||++.++.+||+|||+|+....+ .........+||+.|||||++.+..|+.++|
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~-------------------------~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksD 269 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSD 269 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred ceeeCCCCCEEECcchhhhhcccC-------------------------CCceeeccccccccccCHHHHhcCCCCCccc
Confidence 999999999999999999842110 0111233567999999999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 897 IWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
||||||+||||+| |+.||.+....+.+..++..... +..|..+++++.+||.+||+.||++|||+.++++.|+
T Consensus 270 VwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 270 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred EeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 9999999999998 99999987655444444444333 3456789999999999999999999999998888764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=441.81 Aligned_cols=281 Identities=27% Similarity=0.377 Sum_probs=209.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
.++|++.+.||+|+||+||+|+++ .+++.||||.+.+.. ....+.+|+++|+.+ +|||||+++++|...+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 367999999999999999999875 467899999886532 345688999999988 69999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLArv~~~~ 840 (995)
+|+||||++||+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 49999999999999999999999999999999999999877 89999999999853211
Q ss_pred cccc--CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCC-
Q 001924 841 NTID--LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA- 916 (995)
Q Consensus 841 ~s~d--lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g- 916 (995)
.... +.............. ............+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNK-CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccc-ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1100 000000000000000 00001112234467899999999999876 589999999999999999999999954
Q ss_pred CCHHHHHHHHHcc--------------------------------------CCCC-------------CCCCCCCCHHHH
Q 001924 917 ESPEIIFDNILNR--------------------------------------KIPW-------------PCVPSDMSFEAQ 945 (995)
Q Consensus 917 ~s~~ei~qkIl~~--------------------------------------~~~~-------------p~lps~lS~eL~ 945 (995)
.+..+.+..|... .... ......+++++.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3444443333210 0000 012346889999
Q ss_pred HHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 946 DLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 946 dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
+||.+||++||.+||| +.++|+||||+++.
T Consensus 331 DLl~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 9999999999999999 77889999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=434.91 Aligned_cols=270 Identities=40% Similarity=0.767 Sum_probs=237.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
....++|++.+.||+|+||.||+|+++.+|+.||||++++...........+.+|..++..+ +||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876555555677889999999988 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~--- 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--- 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC---
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999987311
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 176 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 231 (353)
T 3txo_A 176 ------------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231 (353)
T ss_dssp ------------------------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH
Confidence 01122345689999999999999899999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH---HHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA---~EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+......+| ..++..+.+||.+||+.||.+||++ ..+.++++||||++++|..+
T Consensus 232 ~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 232 LFEAILNDEVVYP---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 9999998876654 6789999999999999999999996 23489999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=426.62 Aligned_cols=268 Identities=41% Similarity=0.766 Sum_probs=240.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46789999999999999999999999999999999987554445567789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~------ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------ 156 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC------
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc------
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987311
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...++.
T Consensus 157 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 215 (337)
T 1o6l_A 157 ---------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215 (337)
T ss_dssp ---------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ---------------------cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH
Confidence 01112345689999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
.+......+| ..+++++.+||.+||+.||.+||+. ..+.++++||||..++|..+
T Consensus 216 ~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~ 272 (337)
T 1o6l_A 216 LILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 8888776544 6799999999999999999999932 23889999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=416.48 Aligned_cols=262 Identities=31% Similarity=0.571 Sum_probs=235.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.++||||+++++++...+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 345689999999999999999999999999999999997643 3445677899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~---- 165 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---- 165 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS----
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC----
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys-~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...
T Consensus 166 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 166 ------------------------VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp ------------------------SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 01123456799999999999988875 89999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+...+..+...+| ..+++.+.+||.+||+.||.+||| +.++++||||+...+
T Consensus 222 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 222 LRERVLRGKYRIP---FYMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTCT
T ss_pred HHHHHHhCCCCCC---CCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCCc
Confidence 9999988876654 578999999999999999999999 888899999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=418.50 Aligned_cols=265 Identities=38% Similarity=0.729 Sum_probs=238.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|++..+|+.||+|++++.........+.+.+|..+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46789999999999999999999999999999999987544444456788899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~------ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 157 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC------
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987410
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+.
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 213 (318)
T 1fot_A 158 ------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 213 (318)
T ss_dssp ------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 11234679999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
.+......+| ..++.++.+||.+||+.||.+||+.. .+.++++||||+++.|..+
T Consensus 214 ~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 214 KILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 9988876554 67899999999999999999999421 3889999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=426.13 Aligned_cols=270 Identities=35% Similarity=0.706 Sum_probs=241.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
....++|++.+.||+|+||.||+|.++.+|+.||||++++.........+.+..|..++..+ +||||+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 35678999999999999999999999999999999999875544455667889999999887 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--- 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987311
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...
T Consensus 173 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 228 (353)
T 2i0e_A 173 ------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228 (353)
T ss_dssp ------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH
Confidence 01112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+......+| ..++.++.+||.+||+.||.+||++ ..+.++++||||..++|..+
T Consensus 229 ~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 229 LFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHhCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 9999998876654 6899999999999999999999985 46899999999999988654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=420.20 Aligned_cols=267 Identities=37% Similarity=0.747 Sum_probs=236.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ly 763 (995)
..++|++.+.||+|+||.||+|+++.+++.||||++++...........+.+|..++.++ +||||+++++++.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 467899999999999999999999999999999999876666666778899999999987 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~----- 161 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL----- 161 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC-----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc-----
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987311
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC-------
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 916 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g------- 916 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 219 (345)
T 3a8x_A 162 ----------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219 (345)
T ss_dssp ----------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----
T ss_pred ----------------------CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc
Confidence 011123456899999999999999999999999999999999999999975
Q ss_pred --CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH---HHHHHHHcCcccccccccc
Q 001924 917 --ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 917 --~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA---~EIlEiL~HPfF~~~~~n~ 981 (995)
.....++..+......+ |..++..+.+||.+||+.||.+||++ ..+.++++||||.+++|..
T Consensus 220 ~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 220 DQNTEDYLFQVILEKQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp ---CHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred ccccHHHHHHHHHcCCCCC---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 23445666777666554 46899999999999999999999996 3678999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=432.56 Aligned_cols=269 Identities=37% Similarity=0.738 Sum_probs=235.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
...++|++.+.||+|+||.||+|+++.+++.||||++++...........+.+|..++.++ +||||+++++++...+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4568999999999999999999999999999999999876555555566788999999877 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~---- 204 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL---- 204 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC----
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997311
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-----
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE----- 917 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~----- 917 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 205 -----------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~ 261 (396)
T 4dc2_A 205 -----------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261 (396)
T ss_dssp -----------------------CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---
T ss_pred -----------------------cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccc
Confidence 0112234578999999999999999999999999999999999999999642
Q ss_pred ----CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH---HHHHHHHcCccccccccccc
Q 001924 918 ----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 ----s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA---~EIlEiL~HPfF~~~~~n~~ 982 (995)
....++..+......+| ..++.++.+||.+||+.||.+||++ ..+.++++||||++++|..+
T Consensus 262 ~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l 330 (396)
T 4dc2_A 262 PDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330 (396)
T ss_dssp ---CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred cchhhHHHHHHHHhccccCCC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 33456677777665544 6799999999999999999999997 36899999999999988653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=424.06 Aligned_cols=268 Identities=38% Similarity=0.737 Sum_probs=237.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
....++|++.+.||+|+||.||+|+++.+|+.||||++++...........+..|..++..+ +||||+++++++...+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999875444445567788999999877 99999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM--- 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987311
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...
T Consensus 170 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (345)
T 1xjd_A 170 ------------------------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225 (345)
T ss_dssp ------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 01112345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+......+ +..++.++.+||.+||+.||.+||++.+ ++++||||..++|..+
T Consensus 226 ~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dp~~R~~~~~--~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 226 LFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFREINWEEL 281 (345)
T ss_dssp HHHHHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSBTTBS--CGGGSGGGTTCCHHHH
T ss_pred HHHHHHhCCCCC---CcccCHHHHHHHHHHhcCCHhHcCCChH--HHHcCccccCCCHHHH
Confidence 999988876554 4679999999999999999999999532 8899999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=426.66 Aligned_cols=270 Identities=39% Similarity=0.748 Sum_probs=232.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieI-Ls~LkHPNIVkL~gvf~~~~~ 761 (995)
....++|++.+.||+|+||.||+|+++.+++.||||++++...........+.+|..+ ++.++||||+++++++...+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4567899999999999999999999999999999999988666555566777888887 567899999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~--- 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--- 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB---
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987411
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+
T Consensus 191 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 246 (373)
T 2r5t_A 191 ------------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246 (373)
T ss_dssp ------------------------CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH
T ss_pred ------------------------cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 01122345689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH-HHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA-~EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+......+ +..++..+.+||.+||+.||.+||++ ..+.++++||||..++|..+
T Consensus 247 ~~~~i~~~~~~~---~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 247 MYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp HHHHHHHSCCCC---CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHhcccCC---CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 999998876554 36799999999999999999999997 45789999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=421.25 Aligned_cols=265 Identities=40% Similarity=0.774 Sum_probs=240.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++++.........+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 45899999999999999999999999999999999987554444556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~------ 192 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS------
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc------
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987410
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...++.
T Consensus 193 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 248 (350)
T 1rdq_E 193 ------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp ------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH
Confidence 11234679999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC--HHHHHHHHcCccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS--A~EIlEiL~HPfF~~~~~n~~ 982 (995)
.+..+...+| ..++..+.+||.+||+.||.+||+ ...+.++++||||...+|..+
T Consensus 249 ~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~ 305 (350)
T 1rdq_E 249 KIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp HHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred HHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence 9988876544 679999999999999999999998 345788999999999988643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=418.70 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=195.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----ee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----~l 762 (995)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999987 58999999986532 11122334555567889999999999998754 58
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--------GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
|||||||++|+|.++++.. .+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999999764 589999999999999999999987 9999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC------CCCchHHHHHHHHHHHHHH
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~------~ys~KSDIWSLGVILyELL 908 (995)
+....... .........+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 156 ~~~~~~~~-----------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 156 VRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp EEEETTTT-----------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCCCC-----------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 85221100 001122346899999999999764 3678999999999999999
Q ss_pred cCCCCCCC----------C-----CHHHHHHHHHccCCCCCCCCCC-----CCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 909 TGIPPFTA----------E-----SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 909 TGr~PF~g----------~-----s~~ei~qkIl~~~~~~p~lps~-----lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
+|.+||.. . ....+...+...... |.+|.. .+..+.+|+.+||+.||++|||+.++.+.
T Consensus 213 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HCCCCCCccccccccchhcccccchHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99776532 1 223444444444332 333322 33578899999999999999999999988
Q ss_pred Hc
Q 001924 969 FH 970 (995)
Q Consensus 969 L~ 970 (995)
|+
T Consensus 292 L~ 293 (303)
T 3hmm_A 292 LS 293 (303)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=408.66 Aligned_cols=269 Identities=42% Similarity=0.770 Sum_probs=227.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~-se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
....++|++.+.||+|+||.||+|++. .+|+.||+|++++.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345688999999999999999999985 68999999999864332 22345667899999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 173 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 173 ---------------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 01112234679999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCcccccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~ 981 (995)
.......+......+ +..++..+.+||.+||..||.+||++. .+.++++||||....|..
T Consensus 226 ~~~~~~~i~~~~~~~---p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 226 RKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp HHHHHHHHHHTCCCC---CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred HHHHHHHHHhCCCCC---CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 998888888876554 467899999999999999999999754 688999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=427.98 Aligned_cols=267 Identities=41% Similarity=0.762 Sum_probs=229.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..+|+.||||++++...........+.+|+.+++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34568899999999999999999999999999999999875544555667888999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
|+||||+++|+|.+++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~--- 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI--- 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC---
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc---
Confidence 9999999999999999988899999999999999999999998 999999999999999999999999999987311
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...
T Consensus 301 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 356 (446)
T 4ejn_A 301 ------------------------KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356 (446)
T ss_dssp ------------------------C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 01112335689999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCC-----CHHHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL-----GANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRP-----SA~EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+......++ ..+++.+.+||.+||+.||.+|| + +.++++||||.+..|..+
T Consensus 357 ~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t---~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 357 LFELILMEEIRFP---RTLGPEAKSLLSGLLKKDPKQRLGGGSED---AKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTT---HHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHhCCCCCC---ccCCHHHHHHHHHHcccCHHHhCCCCCCC---HHHHHhCccccCCCHHHH
Confidence 9999888776544 67899999999999999999999 6 888999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=429.12 Aligned_cols=273 Identities=38% Similarity=0.714 Sum_probs=235.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|+++.+|+.||||++++...........+.+|..++..++||||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 44568999999999999999999999999999999999875444444556688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~- 215 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD- 215 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC-
Confidence 99999999999999998754 7999999999999999999999999999999999999999999999999999742100
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-------CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-------GTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-------g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
........+||+.|+|||++. +..|+.++|||||||++|||++|+.||
T Consensus 216 -------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 216 -------------------------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp -------------------------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -------------------------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 011223468999999999997 456899999999999999999999999
Q ss_pred CCCCHHHHHHHHHccC--CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 915 TAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~--~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
.+.+..+.+..+.... ..+|..+..++.++.+||.+||+ +|.+|++...+.++++||||..++|..+
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 9999999988887643 44555557899999999999999 9999974445889999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=415.60 Aligned_cols=266 Identities=29% Similarity=0.466 Sum_probs=235.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...+.|++.+.||+|+||.||+|.+..+|+.||+|++++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 345789999999999999999999999999999999986543211 23567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC----cEEEEecCCccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 836 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG----~VKLsDFGLArv 836 (995)
.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999998888899999999999999999999999999999999999998877 799999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 169 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 169 IED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp CCT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCC----------------------------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 210 1112345799999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 917 ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
.+....+..+....+.++. .+..++..+.+||.+||..||.+||| +.++|+||||....+.
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQ 282 (361)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHH
T ss_pred CCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchh
Confidence 9999999999887766542 23578999999999999999999999 7788999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=400.23 Aligned_cols=260 Identities=32% Similarity=0.526 Sum_probs=229.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4689999999999999999999999999999999875432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 9999999999999764 699999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......
T Consensus 169 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp ---------------------TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ---------------------cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 11122346799999999999999999999999999999999999999999888777777
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+..........+..++..+.+||.+||+.||.+||| +.++++||||+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGCCC
T ss_pred HHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhcccCc
Confidence 666655444456789999999999999999999999 888899999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=431.26 Aligned_cols=271 Identities=37% Similarity=0.685 Sum_probs=237.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
+...++|++.+.||+|+||+||+|+++.+++.||||++++...........+.+|..++..++||||++++++|.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 45568999999999999999999999999999999999865443344445588999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
|+||||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~-- 227 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-- 227 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc--
Confidence 999999999999999987 46799999999999999999999999999999999999999999999999999974210
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
.........+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+
T Consensus 228 ------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 228 ------------------------DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp ------------------------TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------------------CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 0111223468999999999997 56789999999999999999999999999
Q ss_pred CCHHHHHHHHHcc--CCCCCCCCCCCCHHHHHHHHHHhhcCccC--CCCHHHHHHHHcCccccccccccc
Q 001924 917 ESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 917 ~s~~ei~qkIl~~--~~~~p~lps~lS~eL~dLIkkCLq~DPeK--RPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
.+..+.+..++.. ...+|.....+++++.+||.+||+.+|++ |++ +.++++||||++++|..+
T Consensus 284 ~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~---~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 284 ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNG---IEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT---THHHHTSGGGTTCCTTTG
T ss_pred CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCC---HHHHhCCCccCCCCHHHH
Confidence 9999999888764 34556555679999999999999998888 888 888999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=450.24 Aligned_cols=411 Identities=26% Similarity=0.391 Sum_probs=286.5
Q ss_pred CCCcccccccccccccCCccccCCCCccccCCCCCCCCCCCccccc-ccCCCCcchhHHHHHhhhhccceeccccCCchh
Q 001924 519 HLGSLNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDPFWL-ERNHPAELEDVQQMIELADIARCVADTDFSKEG 597 (995)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~ 597 (995)
...++-|+.|.| |..+.++.|.++|+++.+|..++...|.. +...+.++.+-|+|=.+-..+.|... .+-
T Consensus 7 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~p~~~~~~~l~~~~~~~~~~~~~~~~ig~~l~~~~~~~~----~~~ 77 (576)
T 2acx_A 7 VANTVLLKAREG-----GGGNRKGKSKKWRQMLQFPHISQCEELRLSLERDYHSLCERNPIGRLLFREFCATR----PEL 77 (576)
T ss_dssp -------CC------------CCCCCTTHHHHTCCCCSGGGHHHHHHSCCCHHHHHTTSHHHHHHHHHHHTTS----HHH
T ss_pred hhhHHHHHHHhc-----CCCCccccccccccccCCCCchHHHHHHhccccCHHHhhccCchhHHHHHHHHhcC----cch
Confidence 345778899987 67788899999999999999999987776 77788888888888888888877722 111
Q ss_pred h--hhHHHHhcchHHHHhh---------------hccce---EEecchhHHHHHHhhhhhhhhhhhccCCCCCccccccc
Q 001924 598 S--EFLLACMHDLQDVLQH---------------SKLKA---LVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKE 657 (995)
Q Consensus 598 k--~~~~a~~~~l~~vl~~---------------~kl~~---lvid~~g~Ri~kllr~k~il~~~lL~~ksp~s~S~~~e 657 (995)
+ -.|...+.+..-+... .+... .|.+.+.......+.. ......+....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~l~~~~~~~l~~----------~~~~~~~~~l~- 146 (576)
T 2acx_A 78 SRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQ----------GPCKDLFQELT- 146 (576)
T ss_dssp HHHHHHHHHHHHHHTSCTTTHHHHHHHHHHHHSCSSSCCSSTTCCHHHHHHHHHHHHH----------CCCTTTTHHHH-
T ss_pred hHHHHHHHHHHhhhcccchhHHHHHHHHHHHhcCcccccccccCCHHHHHHHHHHHhc----------CchHHHHHHHH-
Confidence 1 1222222222111000 00000 0000000000000000 00000000000
Q ss_pred chhhhhhhcccCC-C--CCCC-------CCCCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc
Q 001924 658 NSRLILDSVSQSS-G--VSTP-------LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 727 (995)
Q Consensus 658 nsrllldslsqss-g--~~tp-------~~s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s 727 (995)
......+.... . .... +..........++|++.+.||+|+||.||+|.+..+|+.||||++.+.....
T Consensus 147 --~~~~~~l~~~~~~~~~~s~~~~~~~~~~~l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~ 224 (576)
T 2acx_A 147 --RLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224 (576)
T ss_dssp --HHHHHHHTTHHHHHHHTSHHHHHHHHHHHHHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH
T ss_pred --HHHHHhhccCcchhhcchhhhhhhhhhhhhhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh
Confidence 00000000000 0 0000 0000112245688999999999999999999999999999999998755444
Q ss_pred hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH
Q 001924 728 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHS 805 (995)
Q Consensus 728 e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs 805 (995)
......+.+|+.+++.++||||+++++++...+.+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||+
T Consensus 225 ~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~ 304 (576)
T 2acx_A 225 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304 (576)
T ss_dssp TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556778999999999999999999999999999999999999999999997654 39999999999999999999999
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhh
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 885 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEv 885 (995)
+||+||||||+|||++.+|.+||+|||+++.... .......+||+.|+|||+
T Consensus 305 ~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~----------------------------~~~~~~~~GT~~Y~APEv 356 (576)
T 2acx_A 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE----------------------------GQTIKGRVGTVGYMAPEV 356 (576)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT----------------------------TCCEECCCSCGGGCCHHH
T ss_pred CCEeccCCchheEEEeCCCCeEEEecccceeccc----------------------------CccccccCCCccccCHHH
Confidence 9999999999999999999999999999974210 111234589999999999
Q ss_pred hcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 886 LLGTEHGYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 886 L~g~~ys~KSDIWSLGVILyELLTGr~PF~g~----s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
+.+..|+.++|||||||++|||++|..||.+. ....+...+......+ +..+++++.+||.+||+.||.+||+
T Consensus 357 l~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~---p~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp HTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred HcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC---CccCCHHHHHHHHHhccCCHHHcCC
Confidence 99999999999999999999999999999875 3455666666555443 4689999999999999999999996
Q ss_pred HH--HHHHHHcCccccccccccc
Q 001924 962 AN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 962 A~--EIlEiL~HPfF~~~~~n~~ 982 (995)
+. .+.++++||||++++|..+
T Consensus 434 ~~~~sa~eil~HpfF~~i~w~~l 456 (576)
T 2acx_A 434 CRGGSAREVKEHPLFKKLNFKRL 456 (576)
T ss_dssp CSSSHHHHHHTSGGGTTCCHHHH
T ss_pred CCCCCHHHHHhChhhccCCHHHH
Confidence 43 5899999999999887644
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=419.50 Aligned_cols=268 Identities=31% Similarity=0.649 Sum_probs=234.5
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999999999999999987655555567889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--- 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCC-
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 917 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF~g~- 917 (995)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...
T Consensus 167 -------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 167 -------------------------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp -------------------------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred -------------------------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 1112345689999999999974 45899999999999999999999999753
Q ss_pred --CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 918 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 --s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
........+......+ +..++..+.+||.+||+.||.+||++ +.++++||||.++.|..+
T Consensus 222 ~~~~~~~~~~~~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~s~--~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 222 STSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFSQ--LSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp TSCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSCCS--HHHHHTSGGGTTCCHHHH
T ss_pred CccHHHHHHHHhhcccCC---CCcCCHHHHHHHHHHhcCCHhHhccc--HHHHHcChhhhcCCHHHH
Confidence 4455555655555443 46889999999999999999999984 668899999999988654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=425.49 Aligned_cols=271 Identities=40% Similarity=0.707 Sum_probs=235.4
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.+...++|++.+.||+|+||.||+|+++.+++.||+|++++...........+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34567899999999999999999999999999999999987544333444568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~-- 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-- 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc--
Confidence 9999999999999999975 4699999999999999999999999999999999999999999999999999974210
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~----ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.......+.+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.
T Consensus 221 ------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 221 ------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp ------------------------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ------------------------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 0111234568999999999998765 789999999999999999999999999
Q ss_pred CHHHHHHHHHccC--CCCCCCCCCCCHHHHHHHHHHhhcCccC--CCCHHHHHHHHcCcccccccccccc
Q 001924 918 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 918 s~~ei~qkIl~~~--~~~p~lps~lS~eL~dLIkkCLq~DPeK--RPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
+....+..+.... ..+|. ...++.++.+||.+||+.+|.+ ||+ +.++++||||++++|..+.
T Consensus 277 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~---~~ei~~Hp~f~~~~w~~~~ 342 (410)
T 3v8s_A 277 SLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNG---VEEIKRHLFFKNDQWAWET 342 (410)
T ss_dssp SHHHHHHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSC---HHHHHTSGGGCCSSCCSTT
T ss_pred ChhhHHHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCC---HHHHhcCccccCCCHHHHh
Confidence 9999999988753 33332 2478999999999999999988 999 8889999999999886543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=389.40 Aligned_cols=265 Identities=34% Similarity=0.608 Sum_probs=233.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34678999999999999999999999999999999999765443344456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+++|+|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~---- 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC----
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999876310
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 161 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 215 (279)
T 3fdn_A 161 -------------------------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215 (279)
T ss_dssp --------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH
Confidence 0112235689999999999999999999999999999999999999999999888
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
...+......++ ..++..+.+||.+||+.||.+||| +.++++||||+......-
T Consensus 216 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~~~~~~~ 269 (279)
T 3fdn_A 216 YKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITANSSKPS 269 (279)
T ss_dssp HHHHHHTCCCCC---TTSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHHHCSSCC
T ss_pred HHHHHhCCCCCC---CcCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccCCccCcc
Confidence 888877665544 678999999999999999999999 788889999998765543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=445.36 Aligned_cols=270 Identities=35% Similarity=0.706 Sum_probs=242.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ 761 (995)
....++|++++.||+|+||.||+|.++.+++.||||++++.........+.+..|..++..+ +||||+++++++...+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999999875544455667889999999887 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+||||||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~--- 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--- 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC---
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997411
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+
T Consensus 494 ------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~ 549 (674)
T 3pfq_A 494 ------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549 (674)
T ss_dssp ------------------------CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH
Confidence 01122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
++..|......+| ..++.++.+||.+||+.||.+||++ ..+.++++||||..++|..+
T Consensus 550 ~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 550 LFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HHHHHHSSCCCCC---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HHHHHHhCCCCCC---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 9999998876655 6899999999999999999999996 56799999999999988754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=439.06 Aligned_cols=269 Identities=31% Similarity=0.570 Sum_probs=235.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34588999999999999999999999999999999998755444455678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999999764 3699999999999999999999999999999999999999999999999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC--
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-- 917 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~-- 917 (995)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 342 ---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 342 ---------------------------GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp ---------------------------TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred ---------------------------CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 011123458999999999999999999999999999999999999999875
Q ss_pred --CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 918 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 --s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
....+...+......+ |..++..+.+||.+||+.||.+||++. .+.++++||||..++|..+
T Consensus 395 ~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l 460 (543)
T 3c4z_A 395 KVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460 (543)
T ss_dssp CCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred chhHHHHHHHHhhcccCC---CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence 4567777777766554 468999999999999999999999865 3689999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=398.95 Aligned_cols=264 Identities=28% Similarity=0.489 Sum_probs=231.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..+.|++.+.||+|+||.||+|.+..+|+.||+|+++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34679999999999999999999999999999999986443211 235778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC----cEEEEecCCcccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 837 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG----~VKLsDFGLArv~ 837 (995)
+++||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888899999999999999999999999999999999999999887 8999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 169 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 169 DF----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CT----------------------------TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CC----------------------------CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 10 01122457999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 918 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
........+......++. .+..++..+.+||.+||+.||.+||| +.++|+||||....+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDT 280 (326)
T ss_dssp SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSH
T ss_pred CHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcc
Confidence 888888888776655432 23578999999999999999999999 778899999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=382.01 Aligned_cols=267 Identities=29% Similarity=0.512 Sum_probs=235.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++......++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35889999999999999999999999999999999976443 44556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc---EEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~---VKLsDFGLArv~~~~~ 841 (995)
||||+++|+|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~--- 159 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--- 159 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc---
Confidence 9999999999999988888999999999999999999999999999999999999987655 9999999987411
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.....
T Consensus 160 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 160 -------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp -------------------------SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 0111223569999999999999999999999999999999999999999999998
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
....+..+...++. ....+++.+.+||.+||+.||.+||| +.++++||||.+..+..-.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhHHhH
Confidence 88888877765543 23578999999999999999999999 7888999999988765543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=387.38 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=217.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.++++++||||+++++++...+.+++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 368999999999999999999999999999999997644 3344567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++ +|.+++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~------ 152 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG------ 152 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC------
Confidence 999976 5555554 45779999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCC-CCCCCHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPP-FTAESPEII 922 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~P-F~g~s~~ei 922 (995)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+....
T Consensus 153 ---------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~ 211 (292)
T 3o0g_A 153 ---------------------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp ---------------------SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred ---------------------CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 0111223457899999999998766 79999999999999999987776 566666666
Q ss_pred HHHHHccCCC--------------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 923 FDNILNRKIP--------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 923 ~qkIl~~~~~--------------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
...+...... .......++..+.+||.+||+.||.+||| +.++|+||||++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~ 288 (292)
T 3o0g_A 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTT
T ss_pred HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---HHHHhcCccccc
Confidence 6665432100 01122457899999999999999999999 788899999987
Q ss_pred c
Q 001924 977 K 977 (995)
Q Consensus 977 ~ 977 (995)
.
T Consensus 289 ~ 289 (292)
T 3o0g_A 289 F 289 (292)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=386.22 Aligned_cols=267 Identities=33% Similarity=0.611 Sum_probs=236.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999764433333456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~---- 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---- 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS----
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc----
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999986311
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 166 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 220 (284)
T 2vgo_A 166 -------------------------SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220 (284)
T ss_dssp -------------------------SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH
Confidence 0112245799999999999999999999999999999999999999999888888
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
...+......+ +..++..+.+||.+||+.||.+||+ +.++++||||+......++.
T Consensus 221 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 221 HRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp HHHHHTTCCCC---CTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHHHCCCCCCC
T ss_pred HHHHhccccCC---CCcCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHhhccccCCC
Confidence 88887766544 4678999999999999999999999 77889999999877665543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=401.13 Aligned_cols=260 Identities=26% Similarity=0.470 Sum_probs=230.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 357899999999999999999999999999999998643 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc--CCcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe--nG~VKLsDFGLArv~~~~~ 841 (995)
||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999999997653 6999999999999999999999999999999999999987 78999999999974210
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 157 --------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp --------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 111223579999999999999889999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
....+......++. .+..++.++.+||.+||..||.+||| +.++|+||||.+..+
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhccCcc
Confidence 99998888766542 22478999999999999999999999 777889999987644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=406.19 Aligned_cols=260 Identities=30% Similarity=0.529 Sum_probs=231.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999976443 345567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEEecCCccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLsDFGLArv~~~~~s 842 (995)
|||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~---- 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---- 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec----
Confidence 99999999999998888899999999999999999999999999999999999998654 59999999987411
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+
T Consensus 183 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 238 (362)
T 2bdw_A 183 ------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238 (362)
T ss_dssp ------------------------TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01112345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 923 ~qkIl~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+..+..+...++.. ...+++++.+||.+||+.||.+||+ +.++|+||||...
T Consensus 239 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHTH
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCCC
Confidence 99988887665532 2468999999999999999999999 7889999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=395.22 Aligned_cols=266 Identities=28% Similarity=0.469 Sum_probs=218.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.....++|++.+.||+|+||+||+|.+. +|+.||+|+++... ........+.+|+.+++.++||||+++++++.....
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3456789999999999999999999986 59999999987533 233345778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+++||||+++ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~- 171 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI- 171 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS-
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC-
Confidence 9999999975 888888654 4599999999999999999999999999999999999999999999999999974210
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 172 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 172 --------------------------PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp --------------------------CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred --------------------------CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 0111234578999999999977 5689999999999999999999999988776
Q ss_pred HHHHHHHHccCC--C---C----------------------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 920 EIIFDNILNRKI--P---W----------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 920 ~ei~qkIl~~~~--~---~----------------------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.+....+..... . + ......+++++.+||.+||+.||.+||| +.++|+||
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp 302 (311)
T 3niz_A 226 DDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS---ARDAMNHP 302 (311)
T ss_dssp TTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSG
T ss_pred HHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC---HHHHhcCc
Confidence 665555543110 0 0 0012457889999999999999999999 78889999
Q ss_pred cccccccc
Q 001924 973 IFIKKTEN 980 (995)
Q Consensus 973 fF~~~~~n 980 (995)
||++.+++
T Consensus 303 ~f~~~~~~ 310 (311)
T 3niz_A 303 YFKDLDPQ 310 (311)
T ss_dssp GGTTSCTT
T ss_pred ccccCCcc
Confidence 99987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=416.54 Aligned_cols=262 Identities=28% Similarity=0.517 Sum_probs=231.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976443 344567789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec---cCCcEEEEecCCccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD---enG~VKLsDFGLArv~~~~~s 842 (995)
|||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~--- 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--- 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT---
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC---
Confidence 99999999999999888999999999999999999999999999999999999998 457899999999974110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+....
T Consensus 166 ------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 166 ------------------------EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221 (444)
T ss_dssp ------------------------TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 01112346799999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 923 ~qkIl~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
+..+..+...++.. ...+++++.+||.+||+.||.+||| +.++|+||||....
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~~~ 275 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISHRS 275 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHHHH
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccCCc
Confidence 99998887765542 3578999999999999999999999 77889999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=389.27 Aligned_cols=261 Identities=34% Similarity=0.587 Sum_probs=219.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-----------------------hhHHHHHHHHHHH
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------------------KNDIERILAERNI 740 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s-----------------------e~e~e~flrEieI 740 (995)
...++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34689999999999999999999999999999999997643221 1224568999999
Q ss_pred HHhcCCCceEEEeeeeec--cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcE
Q 001924 741 LITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 818 (995)
Q Consensus 741 Ls~LkHPNIVkL~gvf~~--~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNI 818 (995)
++.++||||+++++++.. ...+|+||||+++|+|.+++. ...+++..++.++.|++.||+|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 567999999999999988653 45699999999999999999999999999999999999
Q ss_pred EeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC---CCchH
Q 001924 819 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAA 895 (995)
Q Consensus 819 LLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~---ys~KS 895 (995)
|++.++.+||+|||+++.... .........||+.|+|||++.+.. ++.++
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKG---------------------------SDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp EECTTSCEEECCCTTCEECSS---------------------------SSCEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred EECCCCCEEEecCCCcccccc---------------------------ccccccCCcCCccccChhhhccCCCCCCCchh
Confidence 999999999999999874210 001122457999999999998765 37899
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 896 DIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
||||||+++|+|++|+.||...........+......++. ...++..+.+||.+||+.||.+||| +.++++||||+
T Consensus 222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s---~~e~l~hp~~~ 297 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRIV---VPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTCHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCCC---HHHHhcCcccc
Confidence 9999999999999999999998888887777776655543 3578999999999999999999999 78889999996
Q ss_pred c
Q 001924 976 K 976 (995)
Q Consensus 976 ~ 976 (995)
+
T Consensus 298 ~ 298 (298)
T 2zv2_A 298 R 298 (298)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=402.63 Aligned_cols=273 Identities=21% Similarity=0.331 Sum_probs=221.9
Q ss_pred cCCCeEEEEeeccC--CCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 685 SIDDFEIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~G--gFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
..++|++.+.||+| +||.||+|.+..+|+.||||+++... ........+.+|+.+++.++||||+++++++...+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 45789999999999 99999999999999999999998643 3345667888999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999999865 67999999999999999999999999999999999999999999999999988642111
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
... ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 182 ~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 182 GQR--------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp TEE--------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccc--------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 000 0001112234579999999999988 678999999999999999999999998766
Q ss_pred HHHHHHHHHccCCC-------------------------------------------CCCCCCCCCHHHHHHHHHHhhcC
Q 001924 919 PEIIFDNILNRKIP-------------------------------------------WPCVPSDMSFEAQDLINRFLIHD 955 (995)
Q Consensus 919 ~~ei~qkIl~~~~~-------------------------------------------~p~lps~lS~eL~dLIkkCLq~D 955 (995)
.......+..+..+ ....+..+++.+.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp STTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 55444433322211 00123567899999999999999
Q ss_pred ccCCCCHHHHHHHHcCcccccccccc
Q 001924 956 PNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 956 PeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
|.+||| +.++|+||||++..+..
T Consensus 322 P~~Rpt---a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 322 PDARPS---ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp TTTSCC---HHHHTTSGGGGGC---C
T ss_pred cccCCC---HHHHhcCHHHHHHhhcc
Confidence 999999 77889999999887644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=385.85 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=230.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34578999999999999999999999999999999997665556667788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 163 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE---- 163 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc----
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.......
T Consensus 164 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 164 ----------------------TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221 (294)
T ss_dssp ---------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred ----------------------ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0111223457999999999999999999999999999999999999999998887776
Q ss_pred HHHHccCCCCC--CCCCCCCHHHHHHHHHHhhcCccCCC-CHHHHHHHHcCcccccccccc
Q 001924 924 DNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRL-GANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 924 qkIl~~~~~~p--~lps~lS~eL~dLIkkCLq~DPeKRP-SA~EIlEiL~HPfF~~~~~n~ 981 (995)
........+.. ..+..+++.+.++|.+||+.||.+|| ++.++.+.|..-.-.......
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 66666544321 23567899999999999999999999 788888888765544443333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=409.35 Aligned_cols=258 Identities=31% Similarity=0.547 Sum_probs=223.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45899999999999999999999999999999999976433333334678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+ +|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~------ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT------ 159 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT------
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc------
Confidence 99999 78999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+
T Consensus 160 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 217 (336)
T 3h4j_B 160 ----------------------DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217 (336)
T ss_dssp ----------------------TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB
T ss_pred ----------------------CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 1112234679999999999998876 78999999999999999999999876554444
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..+..... ..|..+++.+.+||.+||+.||.+||| +.++++||||+..
T Consensus 218 ~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 KKVNSCVY---VMPDFLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNVN 265 (336)
T ss_dssp CCCCSSCC---CCCTTSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHTT
T ss_pred HHHHcCCC---CCcccCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhccC
Confidence 33333322 245678999999999999999999999 8889999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=396.16 Aligned_cols=267 Identities=26% Similarity=0.387 Sum_probs=216.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.....++|++.+.||+|+||+||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++.....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3456789999999999999999999999999999999997543 233345677899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec-----cCCcEEEEecCCccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-----HDGHIKLTDFGLSKI 836 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD-----enG~VKLsDFGLArv 836 (995)
+++||||++ |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999999997 59999999888899999999999999999999999999999999999994 455699999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 187 ~~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 187 FGI---------------------------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp HC--------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCC---------------------------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 210 01122345689999999999875 48999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCC-----CCC----------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHH
Q 001924 916 AESPEIIFDNILNRKIP-----WPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 968 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~-----~p~----------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEi 968 (995)
+.........+...... ++. .+..++.++.+||.+||+.||.+||| +.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~ 316 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS---AKNA 316 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC---HHHH
Confidence 98887777766542110 000 00116789999999999999999999 7888
Q ss_pred HcCccccccccc
Q 001924 969 FHCKIFIKKTEN 980 (995)
Q Consensus 969 L~HPfF~~~~~n 980 (995)
|+||||++.+|+
T Consensus 317 l~hp~f~~~~~~ 328 (329)
T 3gbz_A 317 LEHPYFSHNDFD 328 (329)
T ss_dssp HTSGGGSSSCSC
T ss_pred hCCcccCCCCCC
Confidence 999999999886
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.00 Aligned_cols=258 Identities=29% Similarity=0.498 Sum_probs=214.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||.||+|.+ .+|+.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 5799999999875432 2233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+++ +|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 152 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI------ 152 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc------
Confidence 99975 999998754 6799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+......
T Consensus 153 ---------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 211 (288)
T 1ob3_A 153 ---------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (288)
T ss_dssp ------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01112235689999999999764 58999999999999999999999999988777666
Q ss_pred HHHccC--C---CC---------------------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 925 NILNRK--I---PW---------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 925 kIl~~~--~---~~---------------------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.+.... . .| ......++..+.+||.+||+.||.+||| +.++|+||||++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC-
T ss_pred HHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---HHHHhcCcchhhc
Confidence 654310 0 00 1122458899999999999999999999 7888999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=378.01 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=222.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 44568999999999999999999999999999999999764433334567889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~--- 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 164 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 164 -------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp --------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 011223468999999999988766 689999999999999999999999988888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
....+....... +..++..+.+||.+||+.||.+||| +.++++||||++.
T Consensus 219 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 219 LFKKIRGGVFYI---PEYLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHTT
T ss_pred HHHHhhcCcccC---chhcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhccC
Confidence 888877665443 4678999999999999999999999 7778889999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=385.61 Aligned_cols=265 Identities=28% Similarity=0.432 Sum_probs=219.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 478999999999999999999999999999999986543 3344467788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG------ 154 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (311)
T 4agu_A 155 ---------------------PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213 (311)
T ss_dssp --------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0111224578999999999976 568999999999999999999999999988766655
Q ss_pred HHHccC-------------------CCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 925 NILNRK-------------------IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 925 kIl~~~-------------------~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.+.... ...+. ....++..+.+||.+||+.||.+||| +.++++||||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~ 290 (311)
T 4agu_A 214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT---CEQLLHHPYFEN 290 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC---HHHHHTSGGGTT
T ss_pred HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC---HHHHhcChHHHh
Confidence 443210 11111 01468889999999999999999999 788899999999
Q ss_pred ccccc
Q 001924 977 KTENC 981 (995)
Q Consensus 977 ~~~n~ 981 (995)
.++..
T Consensus 291 ~~~~~ 295 (311)
T 4agu_A 291 IREIE 295 (311)
T ss_dssp CC---
T ss_pred ccCHH
Confidence 87654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=397.13 Aligned_cols=266 Identities=35% Similarity=0.564 Sum_probs=218.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+++.||||+++... ..+.+.+|+.++++++||||+++++++.....++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 44578999999999999999999999999999999997532 3456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecCCccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFGLArv~~~~ 840 (995)
+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~-- 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-- 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC--
Confidence 99999999999999988888999999999999999999999999999999999999975 8899999999987411
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 203 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 203 --------------------------HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp ------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred --------------------------cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 011123457999999999999999999999999999999999999999776544
Q ss_pred -HHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccch
Q 001924 921 -IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 921 -ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q 985 (995)
..+..+......++. ....++..+.+||.+||+.||.+||| +.++|+||||.+...+...+.
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~~~~ 320 (349)
T 2w4o_A 257 QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKAANFVHMD 320 (349)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTTCCCSCCH
T ss_pred HHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCccchhhhc
Confidence 466677666554332 33578999999999999999999999 778889999999988776553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=381.68 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=223.6
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.....++|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 3445688999999999999999999999999999999987643 23346788999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLS 834 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLA 834 (995)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999999988543 679999999999999999999999999999999999999 45678999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
..... ........||+.|+|||++. ..++.++||||||+++|+|++|+.||
T Consensus 175 ~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 175 ELFKS----------------------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp CC--------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eecCC----------------------------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCC
Confidence 74210 11123456999999999986 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.+.+.......+......++.....+++.+.+||.+||+.||.+||| +.++|+||||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 226 TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp CCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred CCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 99988888877776665555444568999999999999999999999 788899999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=390.24 Aligned_cols=266 Identities=29% Similarity=0.459 Sum_probs=232.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++....... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35779999999999999999999999999999999976433211 135778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC----cEEEEecCCcccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIG 837 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG----~VKLsDFGLArv~ 837 (995)
+++||||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999998888899999999999999999999999999999999999999888 7999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.. ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 170 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 170 ED----------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CT----------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred Cc----------------------------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 10 01122356999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 918 SPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
........+......++. .+..++..+.+||.+||+.||.+||| +.++++||||....+..
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQ 283 (321)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHH
T ss_pred CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCccc
Confidence 988888888776654432 23578899999999999999999999 77889999999876544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=401.85 Aligned_cols=264 Identities=29% Similarity=0.487 Sum_probs=224.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s--e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3468999999999999999999999999999999997533211 12356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc---EEEEecCCcc
Q 001924 763 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 835 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~---VKLsDFGLAr 835 (995)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888643 25899999999999999999999999999999999999987654 9999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 182 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 182 QLGE---------------------------SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp ECCT---------------------------TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecC---------------------------CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 4210 0111234579999999999999999999999999999999999999998
Q ss_pred CCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 916 AESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+. ....+..+..+...++. ....++..+.+||.+||+.||.+||| +.++|+||||+...+
T Consensus 235 ~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 235 GT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp SS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred Cc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 75 45666677766654321 22568999999999999999999999 778899999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=396.27 Aligned_cols=263 Identities=27% Similarity=0.462 Sum_probs=220.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45899999999999999999999999999999999875332 2234668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 158 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 158 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC----
Confidence 9999999999999988778999999999999999999999999999999999999999999999999999742111
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHH-HH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-II 922 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~-ei 922 (995)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ..
T Consensus 159 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 159 ---------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp ---------------------TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred ---------------------CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 01112235679999999999988776 78999999999999999999999876543 33
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
+......... ......++..+.+||.+||+.||.+||| +.++++||||++..
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 269 (323)
T 3tki_A 218 YSDWKEKKTY-LNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCCC
T ss_pred HHHHhccccc-CCccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhcccc
Confidence 3333333222 2223568999999999999999999999 78889999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=378.91 Aligned_cols=263 Identities=28% Similarity=0.483 Sum_probs=234.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+.||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998765555666788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---- 167 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---- 167 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.+
T Consensus 168 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 224 (294)
T 2rku_A 168 -----------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224 (294)
T ss_dssp -----------------------TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -----------------------CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 011123457999999999999999999999999999999999999999998888888
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..+....... +..++..+.+||.+||+.||.+||| +.++++||||.....
T Consensus 225 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 225 LRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHTTCCCC---CTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTSCC
T ss_pred HHHhhccCCC---ccccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecCCc
Confidence 7777665443 4678999999999999999999999 778899999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=395.22 Aligned_cols=275 Identities=28% Similarity=0.459 Sum_probs=227.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~--~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
...++|++.+.||+|+||.||+|.+..++..||+|++.+... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 345789999999999999999999999999999999976432 134456789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 001924 762 LYLVMEYLNGGDLYSLLRKV----------------------------------------GCLEEDVARIYIAELVLALE 801 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~----------------------------------------~~Lsee~ir~Ia~QIa~GLa 801 (995)
.++||||+++|+|.+++... ..+++..++.++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999998521 12356778889999999999
Q ss_pred HHHHcCceeeecCCCcEEeccCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCc
Q 001924 802 YLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 879 (995)
Q Consensus 802 YLHs~GIIHRDLKPeNILLDenG--~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~ 879 (995)
|||++||+||||||+|||++.++ .+||+|||+++....... ..........||+.
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~ 239 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-----------------------GEYYGMTTKAGTPY 239 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-----------------------C--------CCCGG
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc-----------------------cccccccccCCCcc
Confidence 99999999999999999998776 899999999974211000 01112334579999
Q ss_pred ccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCc
Q 001924 880 YLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDP 956 (995)
Q Consensus 880 YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DP 956 (995)
|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+......++. ....+++.+.+||.+||+.||
T Consensus 240 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp GCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred ccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCCh
Confidence 999999976 67899999999999999999999999999998888888877665432 123478999999999999999
Q ss_pred cCCCCHHHHHHHHcCccccccccccccc
Q 001924 957 NQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 957 eKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
.+||+ +.++|+||||++..+....|
T Consensus 320 ~~Rps---~~~~l~hp~~~~~~~~~~~~ 344 (345)
T 3hko_A 320 DERFD---AMRALQHPWISQFSDKIYKM 344 (345)
T ss_dssp TTSCC---HHHHHHSHHHHTTSSCSSCC
T ss_pred hHCCC---HHHHhcChhhccChHhhEec
Confidence 99999 77889999999988776554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=391.22 Aligned_cols=263 Identities=28% Similarity=0.463 Sum_probs=207.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 478999999999999999999999999999999997543 223346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 766 MEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 766 mEym~GGSL~d~L~k~------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999998754 3589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 161 ---------------------------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp ---------------------------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01112245789999999999874 68999999999999999999999999988
Q ss_pred HHHHHHHHHccCCC-----C--------------------------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 919 PEIIFDNILNRKIP-----W--------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 919 ~~ei~qkIl~~~~~-----~--------------------------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
..+....+...... | +..+..++..+.+||.+||+.||.+||| +.+
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e 290 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS---AKQ 290 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC---HHH
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC---HHH
Confidence 87777666542100 0 0012357889999999999999999999 788
Q ss_pred HHcCcccccccccc
Q 001924 968 VFHCKIFIKKTENC 981 (995)
Q Consensus 968 iL~HPfF~~~~~n~ 981 (995)
+|+||||.+..+..
T Consensus 291 ~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 291 ALHHPWFAEYYHHA 304 (317)
T ss_dssp HTTSGGGGGGCC--
T ss_pred HhCChhhhcccchh
Confidence 99999999876653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.45 Aligned_cols=262 Identities=29% Similarity=0.578 Sum_probs=201.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45789999999999999999999999999999999976443333445788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~---- 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM---- 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC----
Confidence 99999999999999865 5699999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 165 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 165 -----------------------PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp --------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred -----------------------CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 011122356899999999999989999999999999999999999999887665555
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..+...... .+..++..+.+||.+||+.||.+||| +.++++||||.+...
T Consensus 222 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 222 NKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRNSS 271 (278)
T ss_dssp --CCSSCCC---CCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC----
T ss_pred HHHhhcccC---CccccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCCCC
Confidence 554443333 34678999999999999999999999 888999999987653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=382.40 Aligned_cols=261 Identities=34% Similarity=0.562 Sum_probs=228.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|.+.+.||+|+||.||+|.+..+|+.||+|+++.... .....+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4689999999999999999999999999999999985432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLArv~~~~~s 842 (995)
|||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---- 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---- 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC----
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC----
Confidence 9999999999999888889999999999999999999999999999999999999 778899999999986310
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 161 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 215 (304)
T 2jam_A 161 -------------------------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215 (304)
T ss_dssp -------------------------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -------------------------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 0111234689999999999999999999999999999999999999999998888
Q ss_pred HHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 923 ~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
...+..+...++. .+..++..+.+||.+||+.||.+||| +.++++||||.......
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 272 (304)
T 2jam_A 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGNTALH 272 (304)
T ss_dssp HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSSCSCC
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCCCccc
Confidence 8888887665442 34678999999999999999999999 77889999998876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=377.22 Aligned_cols=258 Identities=30% Similarity=0.534 Sum_probs=227.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999876432 2356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLArv~~~~~s 842 (995)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~---- 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---- 160 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc----
Confidence 9999999999999888889999999999999999999999999999999999999 788999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........||+.|+|||++.+. ++.++||||||+++|+|++|..||........
T Consensus 161 ------------------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 215 (277)
T 3f3z_A 161 ------------------------PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215 (277)
T ss_dssp ------------------------TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ------------------------CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01122345699999999998764 89999999999999999999999999999888
Q ss_pred HHHHHccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 923 FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 923 ~qkIl~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
...+..+...++.. ...+++.+.+||.+||+.||.+||| +.++|+||||++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHHHH
T ss_pred HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhccc
Confidence 88888876654421 1368999999999999999999999 78889999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=388.56 Aligned_cols=257 Identities=29% Similarity=0.520 Sum_probs=225.1
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788889999999999999999999999999987543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
|+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-------- 193 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 193 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--------
Confidence 9999999999865 4699999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.
T Consensus 194 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 194 -------------------DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp -------------------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred -------------------CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0111234579999999999999999999999999999999999999999988888887777
Q ss_pred ccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 928 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 928 ~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
....+....+..+++.+.+||.+||+.||.+||| +.++++||||.+..
T Consensus 255 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQTG 302 (321)
T ss_dssp HSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGCC
T ss_pred cCCCCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccCC
Confidence 6654433334568999999999999999999999 77889999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=378.41 Aligned_cols=265 Identities=30% Similarity=0.515 Sum_probs=229.8
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
++|++.+.||+|+||.||+|.+..+|+.||+|+++....... ...+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999976433211 23578899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC----cEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG----~VKLsDFGLArv~~~ 839 (995)
+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998877 899999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 165 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 165 ----------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp -----------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 0111234689999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
......+......++. .+..++..+.+||.+||..||.+||| +.++++||||+..++...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHCCC
T ss_pred HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHHhh
Confidence 8888887766554331 23568899999999999999999999 778899999999876654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=395.92 Aligned_cols=258 Identities=33% Similarity=0.539 Sum_probs=214.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||+||++++..+++.||||++..... ..+.+.+|+.+++.++||||+++++++.....++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 346899999999999999999999999999999999976432 2356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc--EEEEecCCcccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINN 841 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~--VKLsDFGLArv~~~~~ 841 (995)
+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 99999999999999988888999999999999999999999999999999999999987765 9999999987310
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCCH-
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA-ADWWSVGIILFEFITGIPPFTAESP- 919 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~K-SDIWSLGVILyELLTGr~PF~g~s~- 919 (995)
........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 170 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 170 -------------------------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred -------------------------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 0111234579999999999998888655 8999999999999999999987543
Q ss_pred ---HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 920 ---EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 920 ---~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
......+......++. ...+++.+.+||.+||+.||.+||| +.++++||||.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~~ 281 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHHTT
T ss_pred HHHHHHHHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchhcC
Confidence 4555556555554442 2368999999999999999999999 7889999999654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=375.70 Aligned_cols=267 Identities=29% Similarity=0.461 Sum_probs=229.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc------cchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------IRKNDIERILAERNILITVR-NPFVVRFFYSF 756 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~------~se~e~e~flrEieILs~Lk-HPNIVkL~gvf 756 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||+++.... ......+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 356899999999999999999999999999999999975431 11233567889999999996 99999999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
......++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc------CCCCCchHHHHHHHHHHHHHHcC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~------g~~ys~KSDIWSLGVILyELLTG 910 (995)
.. .........||+.|+|||++. ...++.++||||||+++|+|++|
T Consensus 174 ~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 174 LD----------------------------PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CC----------------------------TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cC----------------------------CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 21 011123456899999999985 45688999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..||...+.......+......++. ....++..+.+||.+||+.||.+||| +.++++||||++..+..
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQYVVEE 294 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTTC---
T ss_pred CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhhccchh
Confidence 9999999888888888777665442 12468999999999999999999999 78889999999876654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=406.92 Aligned_cols=289 Identities=28% Similarity=0.390 Sum_probs=205.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~---- 759 (995)
...++|++.+.||+|+||+||+|.+..+|+.||||++.+. .........+.+|+.+|+.++||||+++++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 3458999999999999999999999999999999998653 33455677899999999999999999999998543
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..+|+||||+ +|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 5689999998 57999999888889999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCC--CCCcc--ccccccCCcCCCCCCcccChhhh-cCCCCCchHHHHHHHHHHHHHHc----
Q 001924 839 INNTIDLSGPETDGIMPSDA--HYPEY--QQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFIT---- 909 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~--~ys~~--~~~~~~~s~t~vGTp~YmAPEvL-~g~~ys~KSDIWSLGVILyELLT---- 909 (995)
........ ....+... ....+ ...........+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 208 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 208 YPENGNSQ----LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp SCTTCCCC----CC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred Cccccccc----cccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 11110000 00000000 00000 00111234456899999999986 45679999999999999999998
Q ss_pred -------CCCCCCCCCH--------------------HHHHHHHHcc----------------------------CCCCC
Q 001924 910 -------GIPPFTAESP--------------------EIIFDNILNR----------------------------KIPWP 934 (995)
Q Consensus 910 -------Gr~PF~g~s~--------------------~ei~qkIl~~----------------------------~~~~p 934 (995)
|+++|.+.+. ...+..+... ...+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 7777766541 1111111110 00111
Q ss_pred CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 935 ~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
...+..++++.+||.+||..||.+||| +.++|+||||.+..+..
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAE 407 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGG
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCc
Confidence 123467999999999999999999999 77889999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=383.73 Aligned_cols=265 Identities=29% Similarity=0.433 Sum_probs=213.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhc---CCCceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITV---RNPFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~--se~e~e~flrEieILs~L---kHPNIVkL~gvf~~ 758 (995)
...++|++.+.||+|+||+||+|.+..+|+.||||+++..... .......+.+|+.+++.+ .||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3468999999999999999999999999999999998753321 111123566777776665 59999999999987
Q ss_pred cC-----eeEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 759 RD-----NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 759 ~~-----~lyLVmEym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
.. .+++||||+. |+|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 4899999996 699999987654 999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr 911 (995)
|+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 165 g~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 165 GLARIYS----------------------------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp SCTTTST----------------------------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred ccccccC----------------------------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 9987411 011123457999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHccCCC-----CCC-------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 912 PPFTAESPEIIFDNILNRKIP-----WPC-------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~-----~p~-------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
.||.+.+.......+...... |+. ..+.++..+.+||.+||+.||.+||| +.+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e 293 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS---AFR 293 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC---HHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC---HHH
Confidence 999999888877776542111 110 12367899999999999999999999 778
Q ss_pred HHcCccccccccc
Q 001924 968 VFHCKIFIKKTEN 980 (995)
Q Consensus 968 iL~HPfF~~~~~n 980 (995)
+|+||||++...+
T Consensus 294 ~l~h~~~~~~~~~ 306 (308)
T 3g33_A 294 ALQHSYLHKDEGN 306 (308)
T ss_dssp HHTSTTC------
T ss_pred HhcCccccCCCCC
Confidence 8999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=377.21 Aligned_cols=258 Identities=22% Similarity=0.393 Sum_probs=218.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec----cCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~----~~~ 761 (995)
...|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3568999999999999999999999999999999976433 45567889999999999999999999998875 356
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEec-cCCcEEEEecCCccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLD-enG~VKLsDFGLArv~~ 838 (995)
+++||||+++|+|.+++.....+++..++.++.|++.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999998888999999999999999999999999 99999999999997 78999999999986311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
........||+.|+|||++.+ .++.++||||||+++|+|++|+.||....
T Consensus 184 -----------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 184 -----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp -----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -----------------------------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 011223569999999998875 58999999999999999999999998854
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..................+...++.+.+||.+||+.||.+||| +.++++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~~ 289 (290)
T 1t4h_A 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQEE 289 (290)
T ss_dssp SHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC--
T ss_pred cHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCC---HHHHhhCcccccC
Confidence 4444333334433334455678899999999999999999999 8889999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=416.46 Aligned_cols=265 Identities=30% Similarity=0.516 Sum_probs=234.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++++++||||+++++++.....+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987655445567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLArv~~~~~ 841 (995)
||||+.+|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--- 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc---
Confidence 99999999999999888889999999999999999999999999999999999999 467899999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 181 -------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 234 (484)
T 3nyv_A 181 -------------------------ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234 (484)
T ss_dssp -------------------------CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 0111233579999999999977 69999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
+...+..+...++. .+..+++.+.+||.+||+.||.+||| +.++|+||||+...+..
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC--
T ss_pred HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhccccccc
Confidence 99999888766442 22568999999999999999999999 88889999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=397.37 Aligned_cols=282 Identities=29% Similarity=0.456 Sum_probs=213.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccC--
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-- 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~-- 760 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3468999999999999999999999999999999998653 334556778899999999997 999999999997544
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 6899999997 599999876 56999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
..... .......................+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.
T Consensus 163 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 163 RRVTN------NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCC------CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccc------cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 10000 0000000000000111223445689999999999987 6789999999999999999999999999988
Q ss_pred HHHHHHHHccCCC-------------------------------CCC-------------CCCCCCHHHHHHHHHHhhcC
Q 001924 920 EIIFDNILNRKIP-------------------------------WPC-------------VPSDMSFEAQDLINRFLIHD 955 (995)
Q Consensus 920 ~ei~qkIl~~~~~-------------------------------~p~-------------lps~lS~eL~dLIkkCLq~D 955 (995)
...+..+...... +.. .+..+++++.+||.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 7777766532110 000 11267899999999999999
Q ss_pred ccCCCCHHHHHHHHcCcccccc
Q 001924 956 PNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 956 PeKRPSA~EIlEiL~HPfF~~~ 977 (995)
|.+||| +.++|+||||...
T Consensus 317 P~~R~t---~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 317 PNKRIS---ANDALKHPFVSIF 335 (388)
T ss_dssp GGGSCC---HHHHTTSTTTTTT
T ss_pred cccCCC---HHHHhCCHHHHHh
Confidence 999999 7889999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=386.36 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=219.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----CCceEEEee
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFFY 754 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-----HPNIVkL~g 754 (995)
.......++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+..|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44455678999999999999999999999999999999998742 334566788999999987 999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc----------
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---------- 822 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---------- 822 (995)
++...+..++||||+ +++|.+++.... .++...++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 899999998654 5999999999999999999999999999999999999975
Q ss_pred ---------------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc
Q 001924 823 ---------------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 887 (995)
Q Consensus 823 ---------------nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~ 887 (995)
++.+||+|||+++... .......||+.|+|||++.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~------------------------------~~~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKS------------------------------DYHGSIINTRQYRAPEVIL 232 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETT------------------------------SCCCSCCSCGGGCCHHHHT
T ss_pred hcccccccccccccCCCCEEEEeccCceecC------------------------------CCCcCccCcccccCcHHHc
Confidence 7899999999987410 1112457999999999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCC-----------------------CC-------
Q 001924 888 GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC-----------------------VP------- 937 (995)
Q Consensus 888 g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~-----------------------lp------- 937 (995)
+..++.++|||||||++|+|++|+.||.+.+..+....+.....+++. .+
T Consensus 233 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 999999999999999999999999999988877766665543322210 00
Q ss_pred -------------CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 938 -------------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 938 -------------s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
...++.+.+||.+||+.||.+||| +.++|+||||+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 112377889999999999999999 78889999995
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=387.57 Aligned_cols=264 Identities=28% Similarity=0.481 Sum_probs=235.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|.+.+.||+|+||.||++.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 34567899999999999999999999999999999999876555566778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--- 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--- 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS---
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.
T Consensus 194 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 194 ------------------------DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp ------------------------TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ------------------------CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 01112345799999999999999999999999999999999999999999888888
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
+..+......+ +..++..+.+||.+||+.||.+||| +.++++||||.....
T Consensus 250 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 250 YLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSGYI 300 (335)
T ss_dssp HHHHHHTCCCC---CTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTSCC
T ss_pred HHHHhcCCCCC---CccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCCCc
Confidence 87777766543 4678999999999999999999999 778899999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=416.45 Aligned_cols=261 Identities=27% Similarity=0.531 Sum_probs=233.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|.+.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34568999999999999999999999999999999999865443334567889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...
T Consensus 169 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 169 -------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp -------------------------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred -------------------------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 112234579999999999998776 789999999999999999999999998888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.+..+..+.... +..+++.+.+||.+||+.||.+||| +.++++||||.+.
T Consensus 224 ~~~~i~~~~~~~---p~~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~~ 273 (476)
T 2y94_A 224 LFKKICDGIFYT---PQYLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHTTCCCC---CTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHTT
T ss_pred HHHHHhcCCcCC---CccCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhhc
Confidence 888888776543 4678999999999999999999999 7788999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=400.13 Aligned_cols=263 Identities=24% Similarity=0.445 Sum_probs=229.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.....++
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999987543 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc--CCcEEEEecCCccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe--nG~VKLsDFGLArv~~~~ 840 (995)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 9999999999999997553 6999999999999999999999999999999999999974 46899999999974210
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 204 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 204 ---------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp ---------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ---------------------------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 01112346999999999999999999999999999999999999999999988
Q ss_pred HHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 921 ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
.....+......++. .+..+++++.+||.+||+.||.+||| +.++|+||||+....+
T Consensus 257 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 257 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHSN 314 (387)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCTT
T ss_pred HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCccc
Confidence 888888776654432 34578999999999999999999999 7788999999986554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=411.00 Aligned_cols=266 Identities=30% Similarity=0.527 Sum_probs=231.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.++++++||||+++++++.....+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 3456889999999999999999999999999999999976432 223467889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec---cCCcEEEEecCCcccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD---enG~VKLsDFGLArv~~~ 839 (995)
|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 175 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ- 175 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC-
Confidence 99999999999999998888899999999999999999999999999999999999995 45679999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.
T Consensus 176 ---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 176 ---------------------------QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp ---------------------------CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0112234579999999999986 599999999999999999999999999999
Q ss_pred HHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
.+++..+..+...++. .+..+++.+.+||.+||+.||.+||| +.++|+||||++.....
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSET 287 (486)
T ss_dssp HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTCCCC
T ss_pred HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCcccC
Confidence 9999998887765442 22468999999999999999999999 77888999999876554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=383.81 Aligned_cols=271 Identities=28% Similarity=0.494 Sum_probs=217.0
Q ss_pred cCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 685 SIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 685 s~~dYeIl-k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
..+.|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.++ +||||+++++++...+.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34789985 78999999999999999999999999997643 23456789999999885 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc---EEEEecCCcccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLI 839 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~---VKLsDFGLArv~~~ 839 (995)
|+||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999998888999999999999999999999999999999999999988775 99999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
.... ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 167 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 167 NGDC--------------------SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp -----------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcc--------------------ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 1000 0001112234579999999999975 45788999999999999999999999
Q ss_pred CCCC---------------HHHHHHHHHccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 915 TAES---------------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 915 ~g~s---------------~~ei~qkIl~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.+.. ...++..+......++.. ...++..+.+||.+||+.||.+||| +.++++||||++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS---AAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSTTCC---
T ss_pred cccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC---HHHHhcChhhcCCC
Confidence 8754 244566666666554421 1468899999999999999999999 77889999999876
Q ss_pred ccc
Q 001924 979 ENC 981 (995)
Q Consensus 979 ~n~ 981 (995)
+..
T Consensus 304 ~~~ 306 (316)
T 2ac3_A 304 PEN 306 (316)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=408.33 Aligned_cols=267 Identities=29% Similarity=0.490 Sum_probs=230.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc----------hhHHHHHHHHHHHHHhcCCCceEEEe
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----------KNDIERILAERNILITVRNPFVVRFF 753 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s----------e~e~e~flrEieILs~LkHPNIVkL~ 753 (995)
...++|++.+.||+|+||+||+|.+..++..||+|++++..... ....+.+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45688999999999999999999999999999999998644321 13356789999999999999999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEEe
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTD 830 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLsD 830 (995)
+++.....+|+||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999998888899999999999999999999999999999999999998876 699999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG 910 (995)
||++.... ........+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 193 fg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 193 FGLSSFFS----------------------------KDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp CTTCEECC----------------------------TTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCEEcC----------------------------CCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 99997421 0112234579999999999874 689999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
..||.+.+..++...+..+...++. .+..+++++.+||.+||+.||.+||| +.++|+||||++...+..
T Consensus 244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~~~~~~ 313 (504)
T 3q5i_A 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKKYANNIN 313 (504)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHHTCCCCC
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhhchhccc
Confidence 9999999999999999888765432 12578999999999999999999999 788899999998765543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=368.83 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=213.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyL 764 (995)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+..+..+ +||||+++++++...+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4789999999999999999999999999999999986432 334567788999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-----------------
Q 001924 765 VMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----------------- 823 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen----------------- 823 (995)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999765 669999999999999999999999999999999999999844
Q ss_pred --CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHH
Q 001924 824 --GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 900 (995)
Q Consensus 824 --G~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSL 900 (995)
..+||+|||++.... ......||+.|+|||++.+. .++.++|||||
T Consensus 169 ~~~~~kl~Dfg~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRIS-------------------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp -CCCEEECCCTTCEETT-------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CceEEEEcccccccccC-------------------------------CccccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 479999999987411 01123589999999999876 56789999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 901 GIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 901 GVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
|+++|+|++|.+|+.... ....+..+. .+..+..++..+.+||.+||+.||.+||| +.++++||||.+..
T Consensus 218 G~il~~l~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGD---QWHEIRQGR--LPRIPQVLSQEFTELLKVMIHPDPERRPS---AMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHHHTTCCCCCSSSH---HHHHHHTTC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTCTTC----
T ss_pred HHHHHHHhcCCCCCcchh---HHHHHHcCC--CCCCCcccCHHHHHHHHHHhCCCcccCCC---HHHHhhChHhhhhc
Confidence 999999999998775543 233444443 34456789999999999999999999999 88899999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=381.37 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=210.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----- 760 (995)
.++|++.+.||+|+||.||+|.+..+|+.||||+++... .....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999999999999999997543 3445678999999999999999999999886543
Q ss_pred ----------------------------------------------------eeEEEEeecCCCCHHHHHHhcC---CCC
Q 001924 761 ----------------------------------------------------NLYLVMEYLNGGDLYSLLRKVG---CLE 785 (995)
Q Consensus 761 ----------------------------------------------------~lyLVmEym~GGSL~d~L~k~~---~Ls 785 (995)
.+++||||+++|+|.+++.... ..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 3799999999999999998654 356
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccc
Q 001924 786 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865 (995)
Q Consensus 786 ee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~ 865 (995)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......... .. ...
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~-------------~~--~~~ 227 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT-------------VL--TPM 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcc-------------cc--ccc
Confidence 667889999999999999999999999999999999999999999999985321110000 00 000
Q ss_pred ccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHH
Q 001924 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQ 945 (995)
Q Consensus 866 ~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~ 945 (995)
.........+||+.|+|||++.+..++.++||||||+++|+|++|..|+.. .......+... .++..+...++.+.
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQEH 303 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHHH
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhHH
Confidence 011223456799999999999999999999999999999999998776532 22223333322 22322345678899
Q ss_pred HHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 946 DLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 946 dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+||.+||+.||.+||| +.++++||||+++
T Consensus 304 ~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred HHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 9999999999999999 7888999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=388.28 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=222.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe---
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~--- 761 (995)
..++|++.+.||+|+||.||+|.+..+++.||||+++............+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45889999999999999999999999999999999987555555666789999999999999999999999887654
Q ss_pred -eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 -LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 -lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+|+||||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 4999999999999999998888999999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
. .........+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....
T Consensus 170 ~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 225 (311)
T 3ork_A 170 G------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225 (311)
T ss_dssp ------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred c------------------------cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 0 0111223457999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHccCCCCC-CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 921 IIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 921 ei~qkIl~~~~~~p-~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.....+.......+ ..+..++..+.+||.+||+.||.+||+ ..+.+.|+|+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~~~ 280 (311)
T 3ork_A 226 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHHHh
Confidence 87777666544322 123568999999999999999999999 6677778887643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=389.51 Aligned_cols=270 Identities=29% Similarity=0.457 Sum_probs=229.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..++..||+|+++... .......+.+|+.+++.++||||+++++++...+.++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 34578999999999999999999999999999999987542 3455678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 183 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc----
Confidence 9999999999999999888899999999999999999999996 99999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 184 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 184 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp -------------------------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred -------------------------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112235799999999999999999999999999999999999999987665443
Q ss_pred HH------------------------------------------HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCC
Q 001924 923 FD------------------------------------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL 960 (995)
Q Consensus 923 ~q------------------------------------------kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRP 960 (995)
.. .+..... ....+..++.++.+||.+||+.||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp HHHHC------------------------------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCC
Confidence 22 1222211 1112345789999999999999999999
Q ss_pred CHHHHHHHHcCccccccccccccchhHh
Q 001924 961 GANGAAEVFHCKIFIKKTENCVSMQSKL 988 (995)
Q Consensus 961 SA~EIlEiL~HPfF~~~~~n~~s~q~~l 988 (995)
| +.++|+||||++..+..+....-+
T Consensus 318 t---~~ell~hp~~~~~~~~~~~~~~~~ 342 (360)
T 3eqc_A 318 D---LKQLMVHAFIKRSDAEEVDFAGWL 342 (360)
T ss_dssp C---HHHHHTSHHHHHHHHSCCCHHHHH
T ss_pred C---HHHHhhChHhhcchHhhhhHHHHH
Confidence 9 788899999999988887765544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.87 Aligned_cols=264 Identities=31% Similarity=0.538 Sum_probs=225.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++...+.+++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4578999999999999999999999999999999986532 3346788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 169 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK---- 169 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH----
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc----
Confidence 9999999999999875 45699999999999999999999999999999999999999999999999998753110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh-----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL-----~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........||+.|+|||++ .+..++.++||||||+++|+|++|..||...+
T Consensus 170 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 170 -----------------------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -----------------------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----------------------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 01112345699999999998 46678999999999999999999999999988
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
.......+.....+....+..++..+.+||.+||+.||.+||| +.++++||||....++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 227 PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSSITSNK 286 (302)
T ss_dssp HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTTCCCCH
T ss_pred HHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhhhccch
Confidence 8888777777665444445678999999999999999999999 78889999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.75 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=218.2
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
......++|++.+.||+|+||+||+|.+ +|+.||||++.... ......+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3445678999999999999999999987 58899999987643 34455678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGC---LEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~---Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
.+++||||+++|+|.+++..... +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999986543 899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
... ..........||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 188 ~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 188 LKA---------------------------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp -----------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred ccc---------------------------ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 411 01112234579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+.+.......+...... ...+..+++.+.+||.+||+.||.+|||+.++++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 241 NLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp TSCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99888877776544332 34567899999999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.95 Aligned_cols=264 Identities=27% Similarity=0.470 Sum_probs=222.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4689999999999999999999999999999999875432 23457889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---- 159 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT----
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc----
Confidence 9999999999999877789999999999999999999999999999999999999999999999999987421110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE-IIF 923 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~-ei~ 923 (995)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..+
T Consensus 160 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 160 ---------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp ---------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred ---------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 0112234579999999999988775 78999999999999999999999876543 333
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
..+...... ......++..+.+||.+||+.||.+||| +.++++||||++....
T Consensus 219 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 219 SDWKEKKTY-LNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKPLKK 271 (276)
T ss_dssp HHHHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCCCC-
T ss_pred HHhhhcccc-cCchhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccChhhc
Confidence 333333222 2223568999999999999999999999 7888999999877543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=396.53 Aligned_cols=255 Identities=29% Similarity=0.480 Sum_probs=221.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ly 763 (995)
..++|++.+.||+|+||.||+|.++.+|+.||||++++... ...+|++++.++ +||||+++++++.+...+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 35789999999999999999999999999999999976432 234688888877 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC----CcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen----G~VKLsDFGLArv~~~ 839 (995)
+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+... +.+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988889999999999999999999999999999999999998543 3599999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC---
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--- 916 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g--- 916 (995)
........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+
T Consensus 173 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 173 ---------------------------ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp ---------------------------TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred ---------------------------CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 11122356799999999999888899999999999999999999999986
Q ss_pred CCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 917 ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
....+++..+..+...++. .+..++..+.+||.+||..||.+||| +.++++||||.+
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~~ 283 (342)
T 2qr7_A 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWIVH 283 (342)
T ss_dssp SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHT
T ss_pred CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCeecC
Confidence 4667788888877766443 34678999999999999999999999 778999999965
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=389.96 Aligned_cols=265 Identities=26% Similarity=0.481 Sum_probs=216.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999865321 11122456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||++ |+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~----- 152 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 152 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC-----
Confidence 99997 5999988765 4589999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 210 (324)
T 3mtl_A 153 ----------------------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210 (324)
T ss_dssp --------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----------------------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1112234568999999999987 56899999999999999999999999999888777
Q ss_pred HHHHccCCC-----CCC----------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 924 DNILNRKIP-----WPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 924 qkIl~~~~~-----~p~----------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
..+...... |+. ....+++.+.+||.+||+.||.+||| +.++|+||||.+
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~ 287 (324)
T 3mtl_A 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS---AEDAMKHPFFLS 287 (324)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGGG
T ss_pred HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC---HHHHhcChhhhh
Confidence 666542111 110 12357889999999999999999999 888999999998
Q ss_pred ccccccc
Q 001924 977 KTENCVS 983 (995)
Q Consensus 977 ~~~n~~s 983 (995)
..+....
T Consensus 288 ~~~~~~~ 294 (324)
T 3mtl_A 288 LGERIHK 294 (324)
T ss_dssp GCSTTSS
T ss_pred ccccccc
Confidence 8765433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=392.85 Aligned_cols=259 Identities=30% Similarity=0.461 Sum_probs=216.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 457899999999999999999999999999999998653 234455678999999999999999999999998764
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999976 569999999999999999999999999999999999999999999999999997410
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 180 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 180 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01224578999999999987 67999999999999999999999999998
Q ss_pred CHHHHHHHHHccC----------------------------CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~----------------------------~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+....+..+.... ..+.......++.+.+||.+||+.||.+||| +.++|
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t---~~e~l 306 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 306 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC---HHHHh
Confidence 8777666654321 1122234578999999999999999999999 77889
Q ss_pred cCcccccccc
Q 001924 970 HCKIFIKKTE 979 (995)
Q Consensus 970 ~HPfF~~~~~ 979 (995)
+||||.....
T Consensus 307 ~hp~f~~~~~ 316 (367)
T 1cm8_A 307 AHPYFESLHD 316 (367)
T ss_dssp HSGGGTTTC-
T ss_pred cChHHHhhcC
Confidence 9999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.04 Aligned_cols=257 Identities=30% Similarity=0.500 Sum_probs=202.7
Q ss_pred CCeEEE---EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCee
Q 001924 687 DDFEII---KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 687 ~dYeIl---k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~l 762 (995)
++|++. +.||+|+||.||+|.+..+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++......
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 456665 7899999999999999999999999998652 3456788999999997 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEEecCCcccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLI 839 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLsDFGLArv~~~ 839 (995)
|+||||+++|+|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999888899999999999999999999999999999999999998765 899999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s- 918 (995)
........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 162 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 162 ---------------------------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ---------------------------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 1112234578999999999999999999999999999999999999997643
Q ss_pred ------HHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 919 ------PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 919 ------~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..+....+..+...++. .+..+++++.+||.+||+.||.+||| +.++++||||++...
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 215 SLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ---CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTTCC
T ss_pred ccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccCcc
Confidence 35666777666554332 11358999999999999999999999 777899999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=405.82 Aligned_cols=261 Identities=30% Similarity=0.530 Sum_probs=224.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|.+..++..||+|++++.... ......+.+|+.+++.++||||+++++++.....+|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 345799999999999999999999999999999999864422 2335678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC---CcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen---G~VKLsDFGLArv~~~~~ 841 (995)
||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.. +.+||+|||++....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~--- 190 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--- 190 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB---
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC---
Confidence 99999999999999888889999999999999999999999999999999999999764 459999999987421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 191 -------------------------~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 191 -------------------------NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp -------------------------TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 011223457999999999986 469999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
++..+..+...++. ....+++.+.+||.+||+.||.+||| +.++|+||||+...
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHHH
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccCc
Confidence 99999888766543 23578999999999999999999999 77889999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=375.41 Aligned_cols=262 Identities=28% Similarity=0.499 Sum_probs=221.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||.|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++.....+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4578999999999999999999999999999999987532 34678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++|+|.+++. ....+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD---- 177 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT----
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh----
Confidence 999999999999997 446799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 178 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 234 (314)
T 3com_A 178 -----------------------TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234 (314)
T ss_dssp -----------------------TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -----------------------hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 011123456999999999999999999999999999999999999999988777666
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
..+..........+..++..+.+||.+||..||.+||| +.++++||||.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGG
T ss_pred HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcch
Confidence 65555543333334568999999999999999999999 78889999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=395.20 Aligned_cols=259 Identities=26% Similarity=0.484 Sum_probs=220.6
Q ss_pred CeEE--EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 688 DFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 688 dYeI--lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.|.+ .+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|+.++++++||||+++++++...+.+++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4444 678999999999999999999999999997643 23557889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe--ccCCcEEEEecCCccccccccc
Q 001924 766 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 766 mEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL--DenG~VKLsDFGLArv~~~~~s 842 (995)
|||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--- 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--- 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT---
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC---
Confidence 9999999999988654 469999999999999999999999999999999999999 5678999999999974210
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....
T Consensus 242 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 296 (373)
T 2x4f_A 242 -------------------------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296 (373)
T ss_dssp -------------------------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1112235699999999999999999999999999999999999999999999888
Q ss_pred HHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 923 ~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
+..+......++. ....+++++.+||.+||+.||.+||| +.++|+||||.+.++.
T Consensus 297 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLH 352 (373)
T ss_dssp HHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHH
T ss_pred HHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchh
Confidence 8888877655432 23578999999999999999999999 7888999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=381.99 Aligned_cols=265 Identities=23% Similarity=0.393 Sum_probs=215.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 457899999999999999999999999999999988542 35567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999987 467999999999999999999999999999999999999999999999999999853211110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI-- 921 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e-- 921 (995)
.. ................+||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 165 ~~-------------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 165 PE-------------GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp ----------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cc-------------ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 00 000001111222335689999999999999999999999999999999999999987542211
Q ss_pred ---HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 922 ---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 922 ---i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
........ ..+..+++.+.+||.+||+.||.+|||+.++.+.|+
T Consensus 232 ~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 232 FGLNVRGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp SSBCHHHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Hhhhhhccccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 01111111 124678889999999999999999999999988765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=371.58 Aligned_cols=266 Identities=25% Similarity=0.405 Sum_probs=208.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+|+.||+|+++... ........+.++...++.+.||||+++++++...+..+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 45689999999999999999999999999999999987532 22233344455555678889999999999999999999
Q ss_pred EEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 764 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+||||++ |+|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999997 588877753 46799999999999999999999998 99999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh----cCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL----~g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
. ........||+.|+|||++ .+..++.++||||||+++|+|++|+.||
T Consensus 162 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 162 D----------------------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp ------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred c----------------------------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 0 1112234699999999996 5567899999999999999999999999
Q ss_pred CC-CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 915 TA-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 915 ~g-~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
.. ................ ...+..++..+.+||.+||+.||.+||| +.++++||||+........
T Consensus 214 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~~~~~~~~ 279 (290)
T 3fme_A 214 DSWGTPFQQLKQVVEEPSP-QLPADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTLHESKGTD 279 (290)
T ss_dssp CCCSCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHHHHHSCCC
T ss_pred cccCchHHHHHHHhccCCC-CcccccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCcccccCcccccC
Confidence 86 3444444444444332 2223578999999999999999999999 7788999999976655443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=390.84 Aligned_cols=271 Identities=41% Similarity=0.756 Sum_probs=224.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSFT 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~-se~e~e~flrEieILs~L-kHPNIVkL~gvf~ 757 (995)
....++|++.+.||+|+||.||+|++. .+++.||||++++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345689999999999999999999984 58999999998754321 122345577899999999 6999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
....+++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.. .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 210 ~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 210 VA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cc--------------------------CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 11 01112234579999999999986 347899999999999999999999997
Q ss_pred CC----CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 916 AE----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 916 g~----s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
.. ....+...+...... .+..++..+.+||.+||+.||.+||+.. .+.++++||||.+..|..+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 264 VDGEKNSQAEISRRILKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp CTTSCCCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred cCCccchHHHHHHHHhccCCC---CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 53 344555555554433 3468899999999999999999999322 3889999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=386.32 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=226.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 55999999999999999999999999999999998655444555678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
||+. |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------- 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 205 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-------
Confidence 9997 688888853 4679999999999999999999999999999999999999999999999999987410
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+....
T Consensus 206 ------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 206 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp ------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112357999999999985 56789999999999999999999999999888777
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
...+.....+ ...+..++..+.+||.+||+.||.+||| +.++++||||........
T Consensus 262 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~~~~~~ 317 (348)
T 1u5q_A 262 LYHIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRERPPTV 317 (348)
T ss_dssp HHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSCCCTTH
T ss_pred HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhccCCcch
Confidence 7777665543 2234678999999999999999999999 788899999988765443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=383.25 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=215.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeeccCe
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDN 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--PNIVkL~gvf~~~~~ 761 (995)
...++|++.+.||+|+||.||++.+. +++.||||++.... ........+.+|+.++..++| |||+++++++.....
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34578999999999999999999875 68999999987543 344556789999999999987 999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+|||+ .+|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~- 160 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 160 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc-
Confidence 9999994 5889999999888899999999999999999999999999999999999996 688999999999742110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----------CCCCchHHHHHHHHHHHHHHcC
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----------~~ys~KSDIWSLGVILyELLTG 910 (995)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 161 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 161 ------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp ---------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 00112234579999999999965 6789999999999999999999
Q ss_pred CCCCCCCCH-HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 911 IPPFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 911 r~PF~g~s~-~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
+.||..... ......+...... ...+...+..+.+||.+||+.||.+||| +.++|+||||+...
T Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 217 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQT 281 (343)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHSCC
T ss_pred CCcchhhhhHHHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCC---HHHHHhCccccccC
Confidence 999987533 3444444443332 3345677889999999999999999999 78889999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.19 Aligned_cols=266 Identities=29% Similarity=0.523 Sum_probs=232.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..+.|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.....+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 34679999999999999999999999999999999976432 3356789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~----- 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----- 171 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT-----
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc-----
Confidence 9999999999999865 5699999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 172 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 229 (303)
T 3a7i_A 172 ----------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229 (303)
T ss_dssp ----------------------TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence 0111234579999999999999999999999999999999999999999988877777
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccch
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q 985 (995)
.+..... +..+..++..+.+||.+||+.||.+||| +.++++||||.......-.++
T Consensus 230 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~~~~~~~ 285 (303)
T 3a7i_A 230 LIPKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILRNAKKTSYLT 285 (303)
T ss_dssp HHHHSCC--CCCCSSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHHHCCCGGGGH
T ss_pred HhhcCCC--CCCccccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhcCCCccHHHH
Confidence 6665543 3455788999999999999999999999 788899999988776654443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=407.43 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=213.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC---
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--- 760 (995)
...++|++++.||+|+||+||+|.+..+|+.||||++.+. .........+.+|+.+++.++||||+++++++....
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 3468999999999999999999999999999999999764 334556778999999999999999999999997653
Q ss_pred ---eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 761 ---NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 761 ---~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
.+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 57999999975 57777643 4899999999999999999999999999999999999999999999999999741
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 215 ~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 215 G----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----------------------------CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 011223467999999999999999999999999999999999999999998
Q ss_pred CHHHHHHHHHccCCC----------------------CCC------CCCC-----------CCHHHHHHHHHHhhcCccC
Q 001924 918 SPEIIFDNILNRKIP----------------------WPC------VPSD-----------MSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 918 s~~ei~qkIl~~~~~----------------------~p~------lps~-----------lS~eL~dLIkkCLq~DPeK 958 (995)
+..+.+..++..... +.. .+.. .++++.+||.+||++||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 887777766542110 000 0000 1567999999999999999
Q ss_pred CCCHHHHHHHHcCcccccc
Q 001924 959 RLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~~~ 977 (995)
||| +.++|+||||+..
T Consensus 347 R~t---a~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 347 RIS---VDDALQHPYINVW 362 (464)
T ss_dssp SCC---HHHHHTSTTTGGG
T ss_pred CCC---HHHHhcChhhhhc
Confidence 999 8889999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=380.27 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=208.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ly 763 (995)
..++|++.+.||+|+||+||+|.+..+|+.||||++..... .......+..|+..+..+ .||||+++++++...+.++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34789999999999999999999999999999998865332 233445556666665555 9999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+||||+ +++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~---- 208 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---- 208 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc----
Confidence 999999 67999888765 469999999999999999999999999999999999999999999999999987411
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........||+.|+|||++.+ .++.++|||||||++|||++|..||.+.. .
T Consensus 209 ------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~ 260 (311)
T 3p1a_A 209 ------------------------TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G 260 (311)
T ss_dssp ------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H
T ss_pred ------------------------cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H
Confidence 0111234569999999999886 79999999999999999999977665432 2
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
...+..... .+..+..++..+.+||.+||+.||.+||| +.++|+||||++
T Consensus 261 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 261 WQQLRQGYL-PPEFTAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp HHHHTTTCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred HHHHhccCC-CcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 333333322 22344678999999999999999999999 888999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=384.79 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=221.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 34688999999999999999999999999999999987543 33445567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 176 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA---- 176 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC----
Confidence 9999999999999887777899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.........||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 177 -----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 177 -----------------------PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233 (331)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----------------------CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 01122345689999999999875 789999999999999999999999998887666
Q ss_pred HHHHHcc-------------------CCCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 923 FDNILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 923 ~qkIl~~-------------------~~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
...+... ....+. ....++..+.+||.+||+.||.+||| +.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f 310 (331)
T 4aaa_A 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF---CAELLHHDFF 310 (331)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHH
T ss_pred HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC---HHHHhcCchh
Confidence 5554421 111111 12367899999999999999999999 7788999999
Q ss_pred cccc
Q 001924 975 IKKT 978 (995)
Q Consensus 975 ~~~~ 978 (995)
+...
T Consensus 311 ~~~~ 314 (331)
T 4aaa_A 311 QMDG 314 (331)
T ss_dssp HGGG
T ss_pred ccCC
Confidence 8753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=381.37 Aligned_cols=268 Identities=29% Similarity=0.430 Sum_probs=229.6
Q ss_pred ccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCe
Q 001924 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (995)
Q Consensus 684 ~s~~dYeIl-k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ 761 (995)
...+.|.+. +.||+|+||.||+|.+..+|+.||+|+++.... .......+.+|+.++..+. ||||+++++++.....
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 445678887 899999999999999999999999999986432 2334677899999999995 6999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecCCccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 836 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFGLArv 836 (995)
+++||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999998543 57999999999999999999999999999999999999987 78999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
.. .........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+
T Consensus 184 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 184 IG----------------------------HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp C-------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cC----------------------------CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 01112235799999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 917 ESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
.+....+..+......++. .+..++..+.+||.+||+.||.+||| +.++|+||||++..+....
T Consensus 236 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 236 EDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred CCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 9988888887776554432 34578999999999999999999999 7888999999998876653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=388.56 Aligned_cols=261 Identities=31% Similarity=0.502 Sum_probs=225.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhc-CCCceEEEeeeeec
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITV-RNPFVVRFFYSFTC 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----se~e~e~flrEieILs~L-kHPNIVkL~gvf~~ 758 (995)
..++|++.+.||.|+||.||+|.+..+|+.||||+++..... .....+.+.+|+.+++.+ .||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 346799999999999999999999999999999998754311 122245678999999999 79999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
....|+||||+++|+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC------CCCCchHHHHHHHHHHHHHHcCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g------~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 252 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 252 P----------------------------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp T----------------------------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred C----------------------------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 0 111234679999999999863 357899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 913 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
||...........+..+...++. .+..++..+.+||.+||+.||.+||| +.++|+||||++
T Consensus 304 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~r 365 (365)
T 2y7j_A 304 PFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFER 365 (365)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccCC
Confidence 99998888888888777655432 12468899999999999999999999 788899999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=387.11 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=223.4
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k-------~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
+....++|++.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+++.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3445689999999999999999999974 345689999987542 345677899999999999 899999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCc
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeN 817 (995)
+++...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 47889999999999999999999999999999999
Q ss_pred EEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHH
Q 001924 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (995)
Q Consensus 818 ILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDI 897 (995)
||++.++.+||+|||+++...... .........||+.|+|||++.+..++.++||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv 288 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCC-------------------------TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHH
T ss_pred EEECCCCCEEEccccCCcccCccc-------------------------ceecccCCCcccceECHhHhcCCCCCcHHHH
Confidence 999999999999999997421100 0011223457889999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 898 WSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|||||++|||++ |..||.+....+++..+..+.. +..+..++.++.+||.+||+.||.+||++.++++.|+.
T Consensus 289 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999 9999999888888777665542 34567899999999999999999999999999988764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=382.44 Aligned_cols=267 Identities=28% Similarity=0.415 Sum_probs=218.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~----- 759 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 35789999999999999999999999999999999865432 233345678999999999999999999998873
Q ss_pred ---CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 760 ---DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 760 ---~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
+.+|+||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999975 777777644 579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
...... ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 173 ~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 173 AFSLAK-----------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp ECCCCS-----------------------SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccc-----------------------cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 421100 011122334678999999999976 45799999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCCCC-CCCCC----------------------------CCHHHHHHHHHHhhcCccCCCCHHHH
Q 001924 915 TAESPEIIFDNILNRKIPWP-CVPSD----------------------------MSFEAQDLINRFLIHDPNQRLGANGA 965 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p-~lps~----------------------------lS~eL~dLIkkCLq~DPeKRPSA~EI 965 (995)
.+.+.......+.......+ ..... .++.+.+||.+||+.||.+||| +
T Consensus 230 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~ 306 (351)
T 3mi9_A 230 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---S 306 (351)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred CCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC---H
Confidence 99888777776654322111 11111 2678999999999999999999 7
Q ss_pred HHHHcCcccccccc
Q 001924 966 AEVFHCKIFIKKTE 979 (995)
Q Consensus 966 lEiL~HPfF~~~~~ 979 (995)
.++|+||||.....
T Consensus 307 ~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 307 DDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHTSGGGGSSSC
T ss_pred HHHhCCCCcCCCCC
Confidence 88999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=393.45 Aligned_cols=288 Identities=26% Similarity=0.405 Sum_probs=215.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~---- 759 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||+++.. .........+.+|+.+++.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 3468999999999999999999999999999999999753 33445667899999999999999999999999876
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 56999999995 6999999888889999999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh-cCCCCCchHHHHHHHHHHHHHHcC-------
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITG------- 910 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL-~g~~ys~KSDIWSLGVILyELLTG------- 910 (995)
.............. .................+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus 181 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 181 SEKDTNIVNDLEEN-----EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccc-----ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 21110000000000 00000000111234567899999999986 556799999999999999999984
Q ss_pred ----CCCCCCCCH-----------------HHHHHHHHc------------------------cCCCCC----CCCCCCC
Q 001924 911 ----IPPFTAESP-----------------EIIFDNILN------------------------RKIPWP----CVPSDMS 941 (995)
Q Consensus 911 ----r~PF~g~s~-----------------~ei~qkIl~------------------------~~~~~p----~lps~lS 941 (995)
.++|.+.+. ...+..+.. .....+ ...+.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 444544321 111111111 000000 0124689
Q ss_pred HHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 942 FEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 942 ~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
+.+.+||.+||+.||.+||| +.++|+||||.+.++..
T Consensus 336 ~~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTT
T ss_pred HHHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcc
Confidence 99999999999999999999 78889999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=368.56 Aligned_cols=262 Identities=31% Similarity=0.534 Sum_probs=225.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee--ccCee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT--CRDNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~--~~~~l 762 (995)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999976432 3455678999999999999999999999875 35679
Q ss_pred EEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeeecCCCcEEeccCCcEEEEecCC
Q 001924 763 YLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~----~~Lsee~ir~Ia~QIa~GLaYLHs~G-----IIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999754 24999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
+..... .........||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 163 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 163 ARILNH---------------------------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp HHHC------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred heeecc---------------------------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 874210 00111234689999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
|...+...+...+..+.. +.++..++..+.+||.+||+.||.+||| +.++++|+|+.+.+.
T Consensus 216 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 216 FTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLILEHHH 276 (279)
T ss_dssp SCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCGGGS
T ss_pred CcccCHHHHHHHHhhccc--ccCCcccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhhhcc
Confidence 999988888888777654 3455789999999999999999999999 888899999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=377.16 Aligned_cols=274 Identities=22% Similarity=0.335 Sum_probs=206.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....++|++.+.||+|+||.||+|.+..++. .||||+++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI-IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc-cCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4456889999999999999999999887765 89999987543 2344578899999999999999999999999887
Q ss_pred Cee------EEEEeecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEE
Q 001924 760 DNL------YLVMEYLNGGDLYSLLRKVG------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 760 ~~l------yLVmEym~GGSL~d~L~k~~------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VK 827 (995)
... ++||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 654 99999999999999996543 589999999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
|+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|+|
T Consensus 178 l~Dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (323)
T 3qup_A 178 VADFGLSRKIYSGD-------------------------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232 (323)
T ss_dssp ECCCCC------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred Eeeccccccccccc-------------------------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence 99999987421110 00112234578899999999999999999999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHH----HHHHHcCccccccccccc
Q 001924 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG----AAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~E----IlEiL~HPfF~~~~~n~~ 982 (995)
++ |..||.+.........+..... +..+..++..+.+||.+||+.||.+|||+.+ +.+++.|+|+....++.+
T Consensus 233 l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 233 MTRGQTPYAGIENAEIYNYLIGGNR--LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HhCCCCCccccChHHHHHHHhcCCC--CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 99 9999999888888888776543 2345789999999999999999999999765 556778999999887765
Q ss_pred cc
Q 001924 983 SM 984 (995)
Q Consensus 983 s~ 984 (995)
..
T Consensus 311 ~~ 312 (323)
T 3qup_A 311 YI 312 (323)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=374.13 Aligned_cols=265 Identities=27% Similarity=0.467 Sum_probs=220.5
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeec-
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC- 758 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~- 758 (995)
......++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33456789999999999999999999999999999999987532 2346788999999998 79999999999987
Q ss_pred -----cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 759 -----RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 759 -----~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999999764 56999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHH
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyE 906 (995)
|++..... .........||+.|+|||++. +..++.++||||||+++|+
T Consensus 174 g~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 174 GVSAQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp TTTC----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred cCceecCc---------------------------CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 99874110 001123457999999999997 5668999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
|++|..||.+.........+.....+ ...+..++..+.+||.+||..||.+||+ +.++++||||.+....
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRPA---TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHHTSHHHHCCTTH
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCccc-cCCccccCHHHHHHHHHHhccChhhCCC---HHHHhhChHHhhCccc
Confidence 99999999988877776666555433 2234678999999999999999999999 7788999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.64 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=211.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeec--cC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--RD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~--~~ 760 (995)
...++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+|+.+++.+. ||||+++++++.. ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 3458899999999999999999999999999999998742 2467889999999997 9999999999988 56
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~ 839 (995)
..++||||+++++|.+++.. +++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 78999999999999998853 89999999999999999999999999999999999999777 899999999974210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC-
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE- 917 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~- 917 (995)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 184 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 184 ----------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp ----------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ----------------------------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 111234578999999999987 67899999999999999999999999543
Q ss_pred CHHHHHHHH-------------HccCCCCC---------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 918 SPEIIFDNI-------------LNRKIPWP---------------------CVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 918 s~~ei~qkI-------------l~~~~~~p---------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
........+ ........ ..+..+++.+.+||.+||+.||.+|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-- 313 (330)
T 3nsz_A 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT-- 313 (330)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC--
T ss_pred chHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC--
Confidence 322222211 11111110 011237899999999999999999999
Q ss_pred HHHHHHcCccccccccc
Q 001924 964 GAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 964 EIlEiL~HPfF~~~~~n 980 (995)
+.++|+||||+++.++
T Consensus 314 -a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 -AREAMEHPYFYTVVKD 329 (330)
T ss_dssp -HHHHHTSGGGTTCC--
T ss_pred -HHHHhcCccHhhhccC
Confidence 8889999999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.08 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=224.4
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS 755 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gv 755 (995)
.+....++|.+.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 3445668999999999999999999998 3456899999987532 34566789999999999999999999999
Q ss_pred eeccCeeEEEEeecCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCceee
Q 001924 756 FTCRDNLYLVMEYLNGGDLYSLLRKVGC------------------------LEEDVARIYIAELVLALEYLHSLGIVHR 811 (995)
Q Consensus 756 f~~~~~lyLVmEym~GGSL~d~L~k~~~------------------------Lsee~ir~Ia~QIa~GLaYLHs~GIIHR 811 (995)
+...+..++||||+++|+|.+++..... +++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999986543 8899999999999999999999999999
Q ss_pred ecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC
Q 001924 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (995)
Q Consensus 812 DLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y 891 (995)
||||+|||++.++.+||+|||+++...... .........||+.|+|||++.+..+
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTS-------------------------CEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred ccchheEEEcCCCCEEEccccccccccccc-------------------------cceeccCCCCcccccChhhhcCCCc
Confidence 999999999999999999999987421100 0111223457889999999999889
Q ss_pred CchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 892 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 892 s~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+.++||||||+++|+|++ |..||.+.........+..... +..+..+++.+.+||.+||+.||.+||++.++++.|+
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999999999999999 9999999888887777665542 3345789999999999999999999999999988875
Q ss_pred C
Q 001924 971 C 971 (995)
Q Consensus 971 H 971 (995)
.
T Consensus 308 ~ 308 (314)
T 2ivs_A 308 K 308 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.16 Aligned_cols=261 Identities=24% Similarity=0.307 Sum_probs=223.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....++|++.+.||+|+||.||+|.+..++. .||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456889999999999999999999986665 59999987532 345567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999754 579999999999999999999999999999999999999999999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
... ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 203 ~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDP------------------------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----------------------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCc------------------------cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 110 00111223356889999999998899999999999999999999 99999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
........+..+.. +..+..++..+.+||.+||..||.+|||+.++++.|+.
T Consensus 259 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 259 TNRDVISSVEEGYR--LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99888888776532 22456899999999999999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=382.58 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=219.1
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~-----~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
..+....++|++.+.||+|+||.||+|. ...+++.||||+++... .......+.+|+.++.++ +||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445667899999999999999999999 45567899999997532 344567899999999999 789999999
Q ss_pred eeeeccCe-eEEEEeecCCCCHHHHHHhcCC-------------------------------------------------
Q 001924 754 YSFTCRDN-LYLVMEYLNGGDLYSLLRKVGC------------------------------------------------- 783 (995)
Q Consensus 754 gvf~~~~~-lyLVmEym~GGSL~d~L~k~~~------------------------------------------------- 783 (995)
+++...+. +++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99887654 8999999999999999976432
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 784 -----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 784 -----------------Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~------ 246 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD------ 246 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC------
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc------
Confidence 889999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDN 925 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qk 925 (995)
..........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.........
T Consensus 247 -------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 247 -------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp -------------------TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred -------------------ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 01112234568999999999999999999999999999999998 9999988765444444
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
....... +..+..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 308 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 308 RLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp HHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 4443332 3345779999999999999999999999999998875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=387.09 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=212.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-----
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----- 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~----- 758 (995)
...++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456899999999999999999999999999999999865322 12369999999999999999999844
Q ss_pred ---------------------------------cCeeEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 001924 759 ---------------------------------RDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALE 801 (995)
Q Consensus 759 ---------------------------------~~~lyLVmEym~GGSL~d~L~----k~~~Lsee~ir~Ia~QIa~GLa 801 (995)
...+++||||++ |+|.+.+. ....+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 334889999997 58777665 3467999999999999999999
Q ss_pred HHHHcCceeeecCCCcEEec-cCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcc
Q 001924 802 YLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 880 (995)
Q Consensus 802 YLHs~GIIHRDLKPeNILLD-enG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~Y 880 (995)
|||++||+||||||+|||++ .++.+||+|||+|+... .........||+.|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~----------------------------~~~~~~~~~~t~~y 207 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI----------------------------PSEPSVAYICSRFY 207 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECC----------------------------TTSCCCCCCCCSSC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccC----------------------------CCCCCcCcccCCCc
Confidence 99999999999999999998 68899999999997421 01112345689999
Q ss_pred cChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcc-----------------CCCCCC-------
Q 001924 881 LAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR-----------------KIPWPC------- 935 (995)
Q Consensus 881 mAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~-----------------~~~~p~------- 935 (995)
+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..++.. ...++.
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (383)
T 3eb0_A 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287 (383)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHH
T ss_pred cCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHH
Confidence 9999998754 899999999999999999999999998887777766541 111111
Q ss_pred --CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 936 --VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 936 --lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
.+..++..+.+||.+||++||.+||| +.++|+||||+..+.
T Consensus 288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 288 KILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHHHH
T ss_pred hhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHHHh
Confidence 34568999999999999999999999 788999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=375.83 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=225.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
....++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 455689999999999999999999987 355899999987533 3445678999999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeec
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~------------------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDL 813 (995)
..+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 46899999999999999999999999999999
Q ss_pred CCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCc
Q 001924 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 893 (995)
Q Consensus 814 KPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~ 893 (995)
||+|||++.++.+||+|||+++...... .........||+.|+|||++.+..++.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCc-------------------------cccccCCCcccceecChhhhccCCcCc
Confidence 9999999999999999999987421110 001122346899999999999999999
Q ss_pred hHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 894 AADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 894 KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
++||||||+++|+|++ |..||.+....+....+..+.. +..+..++..+.+||.+||+.||.+||++.++.+.|+.-
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9999999999999999 9999999998888888776654 334578999999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=363.86 Aligned_cols=255 Identities=21% Similarity=0.355 Sum_probs=221.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++......
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 445689999999999999999999987 477899999976432 235689999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc-
Confidence 9999999999999999654 45899999999999999999999999999999999999999999999999998742111
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 160 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 160 -------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp -------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -------------------------ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 1112233457889999999999999999999999999999999 99999999998
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.....+...... ..+...+..+.+|+.+||+.||.+||++.++++.|+
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 215 EVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp HHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhcCccC--CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 888887766332 235678999999999999999999999998888774
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=371.92 Aligned_cols=269 Identities=31% Similarity=0.444 Sum_probs=220.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeee---
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT--- 757 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k-~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L---kHPNIVkL~gvf~--- 757 (995)
..++|++.+.||+|+||.||+|.+. .+|+.||+|+++.... .......+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4578999999999999999999995 6789999999875432 112223456777777666 8999999999987
Q ss_pred --ccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 758 --CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 758 --~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
....+++||||++ |+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 5567899999997 69999997653 489999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
++... .........||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 167 ~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (326)
T 1blx_A 167 ARIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218 (326)
T ss_dssp CCCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccc----------------------------CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 87411 01122345789999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCC-----CC-------------------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 914 FTAESPEIIFDNILNRKI-----PW-------------------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~-----~~-------------------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
|.+.........+..... .| ......++..+.+||.+||+.||.+||| +.+++
T Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l 295 (326)
T 1blx_A 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSAL 295 (326)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC---HHHHh
Confidence 999888777776654210 01 1133568999999999999999999999 77888
Q ss_pred cCccccccccccccchh
Q 001924 970 HCKIFIKKTENCVSMQS 986 (995)
Q Consensus 970 ~HPfF~~~~~n~~s~q~ 986 (995)
+||||.+..+....+..
T Consensus 296 ~hp~~~~~~~~~~~~~~ 312 (326)
T 1blx_A 296 SHPYFQDLERCKENLDS 312 (326)
T ss_dssp TSGGGTTCCCCCCC---
T ss_pred cCccccccchhhhhhcc
Confidence 99999998776555443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=394.18 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=211.0
Q ss_pred ccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeeec---
Q 001924 684 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTC--- 758 (995)
Q Consensus 684 ~s~~dYeIl-k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieIL-s~LkHPNIVkL~gvf~~--- 758 (995)
...++|.+. +.||.|+||+||+|.+..+|+.||||+++.. ..+.+|+.++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 345788887 7899999999999999999999999998642 3466788886 45589999999998875
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecC
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFG 832 (995)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567999999999999999998653 5999999999999999999999999999999999999997 7899999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.
T Consensus 210 ~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 210 FAKETT----------------------------SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp TCEECC---------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred cccccC----------------------------CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 997411 0111235679999999999999999999999999999999999999
Q ss_pred CCCCCCHH----HHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 913 PFTAESPE----IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 913 PF~g~s~~----ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
||.+.... .....+..+.+.++. ....++.++.+||.+||+.||.+||| +.++++||||.+...
T Consensus 262 pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQSTK 330 (400)
T ss_dssp SCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHTTTT
T ss_pred CCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccCCCC
Confidence 99775432 244555556555443 22578999999999999999999999 788899999987544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.78 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=216.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEE-CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC------ceEEEeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARK-RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP------FVVRFFYSF 756 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~-k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP------NIVkL~gvf 756 (995)
...++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+.+++.++|+ +++++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3457999999999999999999998 568899999998753 23456788999999888765 499999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc------------
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------ 822 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe------------ 822 (995)
...+.+++||||+ +++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 889999998765 6889999999999999999999999999999999999987
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 823 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 823 -------nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
++.+||+|||+++... .......||+.|+|||++.+..++.++
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 215 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD------------------------------EHHSTLVSTRHYRAPEVILALGWSQPC 215 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHH
T ss_pred cccccccCCCceEeeCcccccCc------------------------------cccccccCCccccChHHhhCCCCCcch
Confidence 6689999999987410 112245799999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCC-----------------------------------------
Q 001924 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP----------------------------------------- 934 (995)
Q Consensus 896 DIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p----------------------------------------- 934 (995)
||||||+++|||++|..||...+..+....+.....+.+
T Consensus 216 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (339)
T 1z57_A 216 DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295 (339)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc
Confidence 999999999999999999998877665544432111111
Q ss_pred CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 935 ~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..+...++.+.+||.+||+.||.+||| +.++++||||+..++
T Consensus 296 ~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 296 LSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLLKK 337 (339)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGGGC
T ss_pred ccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHHhc
Confidence 011223567899999999999999999 888999999998765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=386.11 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=217.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----NDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se-----~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..++|++.+.||+|+||.||+|.+..+++.||||+++....... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34789999999999999999999999999999999986543221 1344677899999999999999999999999
Q ss_pred CeeEEEEeecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GG-SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+.+++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999777 999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. .......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 182 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 R----------------------------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp T----------------------------TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred C----------------------------CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 0 111223579999999999998877 88999999999999999999999763
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.. ..... ...+..++..+.+||.+||+.||.+||| +.++++||||.+.
T Consensus 234 ~~------~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~~ 281 (335)
T 3dls_A 234 EE------TVEAA---IHPPYLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQP 281 (335)
T ss_dssp GG------GTTTC---CCCSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTCC
T ss_pred HH------HHhhc---cCCCcccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccCC
Confidence 21 11222 2234568999999999999999999999 7888999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=401.47 Aligned_cols=253 Identities=15% Similarity=0.185 Sum_probs=206.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHH---HHHHhcCCCceEEEe-------e
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER---NILITVRNPFVVRFF-------Y 754 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEi---eILs~LkHPNIVkL~-------g 754 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+ .+++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999999999999999999865555556678899999 455566899999998 5
Q ss_pred eeeccC-----------------eeEEEEeecCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCcee
Q 001924 755 SFTCRD-----------------NLYLVMEYLNGGDLYSLLRKVGCLEE-------DVARIYIAELVLALEYLHSLGIVH 810 (995)
Q Consensus 755 vf~~~~-----------------~lyLVmEym~GGSL~d~L~k~~~Lse-------e~ir~Ia~QIa~GLaYLHs~GIIH 810 (995)
++...+ ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 554442 378999999 6899999987655555 777889999999999999999999
Q ss_pred eecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-
Q 001924 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT- 889 (995)
Q Consensus 811 RDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~- 889 (995)
|||||+|||++.++.+||+|||+|+.. .......+| +.|+|||++.+.
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~------------------------------~~~~~~~~g-~~y~aPE~~~~~~ 278 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRD------------------------------GARVVSSVS-RGFEPPELEARRA 278 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEET------------------------------TCEEECCCC-TTCCCHHHHHHHT
T ss_pred CCCCHHHEEEcCCCCEEEEechhheec------------------------------CCcccCCCC-cCccChhhhcccc
Confidence 999999999999999999999998731 011234567 999999999887
Q ss_pred ----------CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCC
Q 001924 890 ----------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 890 ----------~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKR 959 (995)
.++.++|||||||++|||++|+.||.+.........+.. .+..+++.+.+||.+||+.||.+|
T Consensus 279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-------SCKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-------SCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-------hccCCCHHHHHHHHHHcCCCchhC
Confidence 899999999999999999999999987654433332222 125789999999999999999999
Q ss_pred CCHHHHHHHHcCcccccccc
Q 001924 960 LGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~~~~ 979 (995)
|| +.++++||||++.+.
T Consensus 352 pt---~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 352 LL---PLQAMETPEYEQLRT 368 (377)
T ss_dssp CC---HHHHHTSHHHHHHHH
T ss_pred CC---HHHHhhChHHHHHHH
Confidence 99 788899999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=382.40 Aligned_cols=265 Identities=25% Similarity=0.492 Sum_probs=226.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh--------------HHHHHHHHHHHHHhcCCCce
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------------DIERILAERNILITVRNPFV 749 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~--------------e~e~flrEieILs~LkHPNI 749 (995)
...++|++.+.||+|+||.||+|.+ +|+.||||++......... ....+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4568999999999999999999998 8999999999764322211 12789999999999999999
Q ss_pred EEEeeeeeccCeeEEEEeecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEe
Q 001924 750 VRFFYSFTCRDNLYLVMEYLNGGDLYSL------LRK--VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLI 820 (995)
Q Consensus 750 VkL~gvf~~~~~lyLVmEym~GGSL~d~------L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILL 820 (995)
+++++++...+.+++||||+++|+|.++ +.. ...+++..++.++.|++.||.|||+ +||+||||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999998 655 5679999999999999999999999 999999999999999
Q ss_pred ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCc-hHHHH
Q 001924 821 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGY-AADWW 898 (995)
Q Consensus 821 DenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~-KSDIW 898 (995)
+.++.+||+|||++..... .......||+.|+|||++.+. .++. ++|||
T Consensus 186 ~~~~~~kl~dfg~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 236 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVD-----------------------------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236 (348)
T ss_dssp CTTSCEEECCCTTCEECBT-----------------------------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHH
T ss_pred cCCCcEEEecccccccccc-----------------------------ccccCCCCCcCccCchhhcCCCCCCcchhhHH
Confidence 9999999999999874210 012345699999999999887 6666 99999
Q ss_pred HHHHHHHHHHcCCCCCCCCCH-HHHHHHHHccCCCCCCC----------------CCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 899 SVGIILFEFITGIPPFTAESP-EIIFDNILNRKIPWPCV----------------PSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 899 SLGVILyELLTGr~PF~g~s~-~ei~qkIl~~~~~~p~l----------------ps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
|||+++|+|++|..||..... ......+......++.. ...++..+.+||.+||+.||.+|||
T Consensus 237 slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps 316 (348)
T 2pml_X 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316 (348)
T ss_dssp HHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC
Confidence 999999999999999998776 77777777665554421 1568999999999999999999999
Q ss_pred HHHHHHHHcCccccccccccc
Q 001924 962 ANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 962 A~EIlEiL~HPfF~~~~~n~~ 982 (995)
+.++++||||.+..+..+
T Consensus 317 ---~~e~l~hp~f~~~~~~~~ 334 (348)
T 2pml_X 317 ---SEDALKHEWLADTNIEDL 334 (348)
T ss_dssp ---HHHHHTSGGGTTCCHHHH
T ss_pred ---HHHHhcCccccCCCHHHH
Confidence 788899999999876554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=373.64 Aligned_cols=271 Identities=30% Similarity=0.508 Sum_probs=200.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 4556899999999999999999999988999999998865321 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 763 YLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k--------~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999974 345899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
........ ...........||+.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 169 ~~~~~~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 226 (303)
T 2vwi_A 169 AFLATGGD----------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226 (303)
T ss_dssp HHCC-------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred heeccCCC----------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 74211100 001112234579999999999976 5689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCCCC-------CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 914 FTAESPEIIFDNILNRKIPW-------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~-------p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
|................... +.....++..+.+||.+||+.||.+||+ +.++++||||.+..+.
T Consensus 227 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQKAKNK 297 (303)
T ss_dssp TTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSTTC------
T ss_pred CccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhChhhhcCCCC
Confidence 99877766655554443221 1233568899999999999999999999 7888999999876554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=382.51 Aligned_cols=265 Identities=29% Similarity=0.473 Sum_probs=215.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR--KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s--e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||+++...... ......+.+|+.+++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999999999999999987533211 11134678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~--- 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--- 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT---
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc---
Confidence 999999975 898888754 368899999999999999999999999999999999999999999999999987411
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 164 ------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 164 ------------------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp ------------------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ------------------------CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 011122345789999999999764 5899999999999999999999999999888
Q ss_pred HHHHHHHccCC-----CCCC--------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 921 IIFDNILNRKI-----PWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 921 ei~qkIl~~~~-----~~p~--------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
..+..+..... .|+. ....++..+.+||.+||+.||.+||| +.++|+||||.
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~h~~f~ 296 (346)
T 1ua2_A 220 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFS 296 (346)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGT
T ss_pred HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC---HHHHhcChhhh
Confidence 77777665311 1111 11456789999999999999999999 78899999998
Q ss_pred ccccc
Q 001924 976 KKTEN 980 (995)
Q Consensus 976 ~~~~n 980 (995)
+..+.
T Consensus 297 ~~~~~ 301 (346)
T 1ua2_A 297 NRPGP 301 (346)
T ss_dssp SSSCC
T ss_pred cCCCC
Confidence 86544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=364.96 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=220.1
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.+....++|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34566789999999999999999999887 577899999975432 2356889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999976 46799999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
. .........||+.|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus 173 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 173 D--------------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp H--------------------------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred c--------------------------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 1 1111223457889999999999899999999999999999998 999999999
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.......+...... ..+...++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 227 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 227 NSETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp HHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHHHhcccCC--CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 88888887766432 234678999999999999999999999999888775
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=360.19 Aligned_cols=252 Identities=19% Similarity=0.308 Sum_probs=219.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--C
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 760 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~--~ 760 (995)
....++|++.+.||+|+||.||+|.+. +..||||+++... ......+.+.+|+.++++++||||+++++++... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 345688999999999999999999985 8899999997643 3345567899999999999999999999999887 7
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8899999999999999998765 4899999999999999999999999 99999999999999999999999998652
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCC---chHHHHHHHHHHHHHHcCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys---~KSDIWSLGVILyELLTGr~P 913 (995)
. ......||+.|+|||++.+..++ .++||||||+++|+|++|..|
T Consensus 163 ~--------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 163 F--------------------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp T--------------------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred e--------------------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 0 11234689999999999876554 489999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 914 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|.+.+.......+...... +..+..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 211 FADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp TTTSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999888887777666544 4456789999999999999999999999999998875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=382.17 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=218.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----C
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-----~ 760 (995)
.++|++.+.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 468999999999999999999999999999999987532 344557889999999999999999999998765 3
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
..|+||||+. |+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999996 599999865 46999999999999999999999999999999999999999999999999999752111
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 182 ~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 182 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp G------------------------CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred C------------------------CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 0 01111234579999999998765 4589999999999999999999999998877
Q ss_pred HHHHHHHHccC----------------------------CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~~----------------------------~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.+....+.... .++......+++.+.+||.+||+.||.+||| +.++|+|
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~h 314 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAH 314 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTS
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcC
Confidence 66666554211 1111123567899999999999999999999 7888999
Q ss_pred cccccc
Q 001924 972 KIFIKK 977 (995)
Q Consensus 972 PfF~~~ 977 (995)
|||++.
T Consensus 315 p~~~~~ 320 (364)
T 3qyz_A 315 PYLEQY 320 (364)
T ss_dssp GGGTTT
T ss_pred cchhhc
Confidence 999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=361.66 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=220.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+. ++..||+|+++.... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45688999999999999999999876 577899999976432 3456899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-- 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT--
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh--
Confidence 9999999999999997654 5999999999999999999999999999999999999999999999999998742110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (268)
T 3sxs_A 158 ------------------------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213 (268)
T ss_dssp ------------------------CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred ------------------------hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence 0111223456788999999999889999999999999999999 999999998888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+...... ..+...++.+.+||.+||+.||.+|||+.++++.|+.
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 214 VVLKVSQGHRL--YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261 (268)
T ss_dssp HHHHHHTTCCC--CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred HHHHHHcCCCC--CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 88777665533 2346789999999999999999999999999998854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.17 Aligned_cols=265 Identities=29% Similarity=0.401 Sum_probs=212.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|.....||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34455666668999999999999999999999999987543 334577899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-CCcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-nG~VKLsDFGLArv~~~ 839 (995)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999997652 4678889999999999999999999999999999999987 89999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~--ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 176 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 176 ---------------------------INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ---------------------------CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 011123456999999999997643 889999999999999999999999764
Q ss_pred CHH-HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 918 SPE-IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 918 s~~-ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
... .......... ..+..+..++..+.+||.+||+.||.+||+ +.++++||||+...+...
T Consensus 229 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~~~~ 290 (295)
T 2clq_A 229 GEPQAAMFKVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVSSKKKK 290 (295)
T ss_dssp SSHHHHHHHHHHHC-CCCCCCTTSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC------
T ss_pred CchhHHHHhhcccc-ccccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhccccCC
Confidence 332 2222221111 123456789999999999999999999999 788899999998766543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=388.19 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=216.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeeccCeeE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk--HPNIVkL~gvf~~~~~ly 763 (995)
..+|++.+.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+++.+. ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4569999999999999999999865 89999999976432 4456788999999999996 599999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~-- 208 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-- 208 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC--
Confidence 9999 56889999999888899999999999999999999999999999999999995 6899999999997421100
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----------CCCCchHHHHHHHHHHHHHHcCCC
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----------~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 209 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~ 265 (390)
T 2zmd_A 209 -----------------------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265 (390)
T ss_dssp ----------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------------ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCC
Confidence 0111234679999999999975 368999999999999999999999
Q ss_pred CCCCCC-HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 913 PFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 913 PF~g~s-~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
||.... ....+..+...... ...+...+..+.+||.+||+.||.+||| +.++|+||||.....
T Consensus 266 Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 266 PFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQTH 329 (390)
T ss_dssp TTTTCCCHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHSCC-
T ss_pred cchhhhHHHHHHHHHhCcccc-CCCCccchHHHHHHHHHHcccChhhCCC---HHHHhhCcCccccCc
Confidence 998753 33455555554433 2234567899999999999999999999 778899999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=368.61 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=220.7
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeee--ccCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFT--CRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s-e~e~e~flrEieILs~LkHPNIVkL~gvf~--~~~~l 762 (995)
.++|++.+.||+|+||.||+|.+..++..||+|+++...... ......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999997643211 234578999999999999999999999984 45578
Q ss_pred EEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
++||||++++ |.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 7777765 356999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC--CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH--GYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y--s~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
..........||+.|+|||++.+... +.++||||||+++|+|++|..||.+.+
T Consensus 163 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 163 -------------------------AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp -------------------------CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -------------------------ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 00111234569999999999987544 789999999999999999999999998
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
.......+......+ +..++..+.+||.+||+.||.+||| +.++++||||.+...
T Consensus 218 ~~~~~~~i~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 218 IYKLFENIGKGSYAI---PGDCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHCCCCC---CSSSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCC
T ss_pred HHHHHHHHhcCCCCC---CCccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCC
Confidence 888888887776543 4678999999999999999999999 778889999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=368.44 Aligned_cols=264 Identities=30% Similarity=0.524 Sum_probs=228.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++......
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3445789999999999999999999999999999999976433 234567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC---CcEEEEecCCcccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLI 839 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen---G~VKLsDFGLArv~~~ 839 (995)
++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999888889999999999999999999999999999999999999764 4699999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.
T Consensus 177 ----------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 177 ----------------------------NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp ----------------------------CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 0111234588999999998764 89999999999999999999999999998
Q ss_pred HHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
......+..+...++. ....++..+.+||.+||+.||.+||| +.++++||||++..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 228 YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCC
T ss_pred HHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhcccc
Confidence 8888888777655432 12568999999999999999999999 778889999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=360.18 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=211.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc-hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s-e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
...++|++.+.||+|+||.||+|.+. |..||||+++...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45689999999999999999999975 8899999987543221 23357789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeeecCCCcEEecc--------CCcEEEEec
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAH--------DGHIKLTDF 831 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~G---IIHRDLKPeNILLDe--------nG~VKLsDF 831 (995)
++||||+++++|.+++. ...+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999985 457999999999999999999999999 999999999999986 678999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr 911 (995)
|++.... ........||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 161 g~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 161 GLAREWH-----------------------------RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp CC------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred Ccccccc-----------------------------cccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9987311 01112346899999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.||.+.+.......+....... ..+..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 212 VPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CTTTTSCHHHHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHhhhcCCCCC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 9999988888777776665543 346789999999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.38 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=218.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45689999999999999999999999999999999997655445555688999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE--- 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc---
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.....+.
T Consensus 188 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (309)
T 2h34_A 188 -----------------------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244 (309)
T ss_dssp --------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred -----------------------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence 011122456999999999999999999999999999999999999999987766554
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCC-CHHHHHHHHcCcccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRL-GANGAAEVFHCKIFI 975 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRP-SA~EIlEiL~HPfF~ 975 (995)
..+..........+..++..+.+||.+||+.||.+|| ++.++.+.|+..+-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 245 AHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 4444333333345678999999999999999999999 899999988754433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=390.17 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=204.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~----- 759 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 358999999999999999999999999999999998653 23445667889999999999999999999998754
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
...|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 4589999999 7899999865 569999999999999999999999999999999999999999999999999987310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 184 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 184 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp -------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01223579999999999987 67899999999999999999999999998
Q ss_pred CHHHHHHHHHccCC-----------------------CCC-----CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRKI-----------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~~-----------------------~~p-----~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+....+..+..... ..+ ......++.+.+||.+||+.||.+||| +.++|
T Consensus 234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t---~~e~L 310 (367)
T 2fst_X 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQAL 310 (367)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC---HHHHh
Confidence 87776666543110 001 112457889999999999999999999 78889
Q ss_pred cCcccccccc
Q 001924 970 HCKIFIKKTE 979 (995)
Q Consensus 970 ~HPfF~~~~~ 979 (995)
+||||.....
T Consensus 311 ~hp~~~~~~~ 320 (367)
T 2fst_X 311 AHAYFAQYHD 320 (367)
T ss_dssp TSGGGTTTCC
T ss_pred cChhhhhccC
Confidence 9999997643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=367.48 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=222.8
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
..+....++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 44556678999999999999999999985 4567899999997543 234567899999999999 999999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCC
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~~------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKP 815 (995)
+++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999999999999997653 389999999999999999999999999999999
Q ss_pred CcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 816 eNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
+|||++.++.+||+|||++....... .........||+.|+|||++.+..++.++
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 228 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFES 228 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT-------------------------TSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ceEEEcCCCCEEEccccccccccccc-------------------------cceeccCCCCcceeeChHHhcCCCCChHH
Confidence 99999999999999999987421100 01112234578899999999999999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 896 DIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||||||+++|+|++ |..||.+................. ..+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 229 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 99999999999999 999998876655555555444332 2356789999999999999999999999999998864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=380.99 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=208.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--------CCceEEEee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--------NPFVVRFFY 754 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk--------HPNIVkL~g 754 (995)
....++|++.+.||+|+||+||+|.+..+++.||||+++.. ....+.+.+|+.+++.+. ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34468999999999999999999999999999999998753 345577889999999885 788999999
Q ss_pred eee----ccCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCC---
Q 001924 755 SFT----CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDG--- 824 (995)
Q Consensus 755 vf~----~~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG--- 824 (995)
++. ....+++||||+ +++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 988 556799999999 66777776544 4699999999999999999999999 999999999999998775
Q ss_pred ----------------------------------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 001924 825 ----------------------------------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858 (995)
Q Consensus 825 ----------------------------------------------~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~ 858 (995)
.+||+|||++....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-------------------- 247 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-------------------- 247 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--------------------
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--------------------
Confidence 79999999987411
Q ss_pred CCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHc--cC
Q 001924 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------EIIFDNILN--RK 930 (995)
Q Consensus 859 ~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~------~ei~qkIl~--~~ 930 (995)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ......+.. +.
T Consensus 248 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 317 (397)
T 1wak_A 248 ----------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317 (397)
T ss_dssp ----------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS
T ss_pred ----------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC
Confidence 112234799999999999999999999999999999999999999976542 222222211 00
Q ss_pred CC-------------------CC------------------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 931 IP-------------------WP------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 931 ~~-------------------~p------------------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
.+ +. ..+...+..+.+||.+||+.||.+||| +.++|+|||
T Consensus 318 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~ 394 (397)
T 1wak_A 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT---AAECLRHPW 394 (397)
T ss_dssp CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC---HHHHHTSGG
T ss_pred CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC---HHHHhhCcc
Confidence 00 00 011233467889999999999999999 788899999
Q ss_pred ccc
Q 001924 974 FIK 976 (995)
Q Consensus 974 F~~ 976 (995)
|++
T Consensus 395 ~~~ 397 (397)
T 1wak_A 395 LNS 397 (397)
T ss_dssp GGC
T ss_pred ccC
Confidence 974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=368.71 Aligned_cols=264 Identities=28% Similarity=0.400 Sum_probs=213.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee-------
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT------- 757 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~------- 757 (995)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 357899999999999999999999999999999998753 3455678999999999999999999998874
Q ss_pred -------ccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec-cCCcEEEE
Q 001924 758 -------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLT 829 (995)
Q Consensus 758 -------~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD-enG~VKLs 829 (995)
.....|+||||++ |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 699999864 5699999999999999999999999999999999999997 56799999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHH
Q 001924 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 830 DFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELL 908 (995)
|||+++...... ..........||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 164 Dfg~~~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 164 DFGLARIMDPHY------------------------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp CCTTCBCC--------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCc------------------------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 999987421000 00112233468999999999876 67899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHccCCCC---------------------------CCCCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 909 TGIPPFTAESPEIIFDNILNRKIPW---------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 909 TGr~PF~g~s~~ei~qkIl~~~~~~---------------------------p~lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
+|+.||.+.+.......+....... ...+..++..+.+||.+||+.||.+|||
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 9999999988777766665432110 0122468999999999999999999999
Q ss_pred HHHHHHHHcCccccccccc
Q 001924 962 ANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 962 A~EIlEiL~HPfF~~~~~n 980 (995)
+.++++||||+...+.
T Consensus 300 ---~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 300 ---AEEALSHPYMSIYSFP 315 (320)
T ss_dssp ---HHHHHTSHHHHTTCC-
T ss_pred ---HHHHhCCcccccccCc
Confidence 7888999999977654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=387.56 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=223.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.+....++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 3445668999999999999999999999999999999998753 23344567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.+|+||||+++|+|.+++...+ .++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999999997654 599999999999999999999999999999999999999999999999999874111
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
... ........+++.|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 266 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 266 GVY-------------------------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp SEE-------------------------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred Cce-------------------------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 000 001112335778999999998899999999999999999998 999999998
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
..+....+..+.. ...+..++..+.+||.+||+.||.+|||+.++.+.|+
T Consensus 321 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 321 NQQTREFVEKGGR--LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 8887776655432 2245678999999999999999999999999998775
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=365.27 Aligned_cols=262 Identities=21% Similarity=0.361 Sum_probs=227.0
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..+....++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45566778999999999999999999999999999999998753 23567889999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999864 34899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g 916 (995)
... .........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 162 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 162 TGD--------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CSS--------------------------SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCC--------------------------ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 100 0111223457889999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
.+.......+..... +..+..+++.+.+||.+||..||.+|||+.++++.|+.-+
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 216 IDLSQVYELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHhccCC--CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 888777776655432 2345789999999999999999999999999999886543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=397.62 Aligned_cols=264 Identities=32% Similarity=0.567 Sum_probs=212.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..++|.+.+.||+|+||.||+|.+..+++.||||++.+.... .......+.+|+.++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999999999999999999764322 11223357899999999999999999999754
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEEEEecCCccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 836 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VKLsDFGLArv 836 (995)
+..|+||||+++|+|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 55899999999999999998888899999999999999999999999999999999999997554 599999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
.. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..|
T Consensus 292 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 292 LG----------------------------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CC---------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cC----------------------------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 21 0112234679999999999864 5688999999999999999999999
Q ss_pred CCCCCHH-HHHHHHHccCCCCC-CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 914 FTAESPE-IIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 914 F~g~s~~-ei~qkIl~~~~~~p-~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
|...... .....+..+...++ ..+..++..+.+||.+||+.||.+||| +.++|+||||++..+.
T Consensus 344 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMK 409 (419)
T ss_dssp SCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCCHHHH
T ss_pred CCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCChhHH
Confidence 9865433 34444555444332 223568999999999999999999999 7788999999876553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=361.84 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=213.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHH----HHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI----ERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~----e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...++|++.+.||+|+||.||+|.+..+++.||+|++........... +.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 456899999999999999999999999999999999875443222221 6789999999999999999999998765
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCc-----EEEEec
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGH-----IKLTDF 831 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~-----VKLsDF 831 (995)
. ++||||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 7999999999999888654 46999999999999999999999999 999999999999988776 999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc--CCCCCchHHHHHHHHHHHHHHc
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~--g~~ys~KSDIWSLGVILyELLT 909 (995)
|+++... .......||+.|+|||++. ...++.++||||||+++|+|++
T Consensus 174 g~~~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 174 GLSQQSV------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp TTCBCCS------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred Ccccccc------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 9987310 1122356999999999994 4557899999999999999999
Q ss_pred CCCCCCCCCHHHH--HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 910 GIPPFTAESPEII--FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 910 Gr~PF~g~s~~ei--~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|+.||........ ...+..... .+..+..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 224 g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 224 GEGPFDEYSYGKIKFINMIREEGL-RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp SSCTTTTCCCCHHHHHHHHHHSCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCccccccHHHHHHHHhccCC-CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 9999987654333 444444333 34566789999999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=368.66 Aligned_cols=270 Identities=20% Similarity=0.284 Sum_probs=230.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~g 754 (995)
..+....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 455667789999999999999999999876 467899999987532 3345567899999999999999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~----------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
++...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999753 3568999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.+||+|||+++...... .........||+.|+|||++.+..++.++||||||+++
T Consensus 176 ~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230 (322)
T ss_dssp CEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eEEECcCcccccccccc-------------------------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence 99999999987421110 01122234678999999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC---ccccccc
Q 001924 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC---KIFIKKT 978 (995)
Q Consensus 905 yELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H---PfF~~~~ 978 (995)
|+|++ |..||.+.+.......+..... +..+..++..+.+||.+||+.||.+|||+.++++.|+. ++|....
T Consensus 231 ~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HHHHhcCCCccccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 99999 8999999998888888776653 33457899999999999999999999999999998876 5555544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=372.49 Aligned_cols=272 Identities=27% Similarity=0.398 Sum_probs=218.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~----- 759 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4589999999999999999999999999999999986432 344566788999999999999999999987764
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
...++||||+. |+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67899999996 699999876 5699999999999999999999999999999999999999999999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
...... ............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 165 ~~~~~~-----------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 165 SAADNS-----------------EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccc-----------------CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 110000 00001112234679999999998765 678999999999999999999999999887
Q ss_pred HHHHHHHHHccCC------------------------CCC-----CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 919 PEIIFDNILNRKI------------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 919 ~~ei~qkIl~~~~------------------------~~p-----~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
.......+..... ..+ ..+..+++.+.+||.+||+.||.+||| +.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell 304 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT---AKEAL 304 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC---HHHHh
Confidence 7665544432100 000 012468899999999999999999999 77889
Q ss_pred cCccccccccc
Q 001924 970 HCKIFIKKTEN 980 (995)
Q Consensus 970 ~HPfF~~~~~n 980 (995)
+||||+...+.
T Consensus 305 ~hp~~~~~~~~ 315 (353)
T 2b9h_A 305 EHPYLQTYHDP 315 (353)
T ss_dssp TSGGGTTTCCT
T ss_pred cCccccccCCc
Confidence 99999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=364.37 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=211.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....++|++.+.||+|+||.||+|.+..+ +..||+|+++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 45568999999999999999999998654 4579999876532 3445678999999999999999999999984 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67899999999999999997654 69999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.. .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 168 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 168 DS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cc--------------------------cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 10 0011223457889999999999999999999999999999997 99999998
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+....+..... +..+..+++.+.+||.+||+.||.+|||+.++.+.|+.
T Consensus 222 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 222 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 88888777766543 23457899999999999999999999999999887753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=378.62 Aligned_cols=262 Identities=34% Similarity=0.581 Sum_probs=214.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46899999999999999999999999999999998754321 1223345789999999999999999999987655
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc---EEEEecCCcccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIG 837 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~---VKLsDFGLArv~ 837 (995)
.|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987664 999999998741
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
.. ........||+.|+|||++. +..++.++||||||+++|+|++|..||
T Consensus 168 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 168 GE----------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp CC----------------------------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cc----------------------------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 10 01112346899999999974 567899999999999999999999999
Q ss_pred CCCCHH-HHHHHHHccCCCC-CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 915 TAESPE-IIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 915 ~g~s~~-ei~qkIl~~~~~~-p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
...... .....+..+...+ +..+..++..+.+||.+||+.||.+||+ +.++|+||||.+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDM 283 (322)
T ss_dssp CSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCHHH
T ss_pred cccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCHHH
Confidence 765432 3344444444332 2223568999999999999999999999 778899999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=374.31 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=221.0
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
.+....++|++.+.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+++++ .||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566789999999999999999999973 356789999997532 233457899999999999 8999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------------------CLEEDVARIYIAELVLALEYLHSLGIVHR 811 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~~-----------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHR 811 (995)
++...+.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37899999999999999999999999999
Q ss_pred ecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC
Q 001924 812 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 891 (995)
Q Consensus 812 DLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y 891 (995)
||||+|||++.++.+||+|||++....... .........||+.|+|||++.+..+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS-------------------------NYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------TSEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc-------------------------cceeccCccCccCccCHHHhccCCC
Confidence 999999999999999999999987421110 0111223457889999999999999
Q ss_pred CchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 892 GYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 892 s~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+.++||||||+++|+|++ |..||.+......+..++..... +..+..+++.+.+||.+||..||.+|||+.++++.|+
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 999999999999999998 99999887766555565555443 3345678999999999999999999999999999887
Q ss_pred Ccc
Q 001924 971 CKI 973 (995)
Q Consensus 971 HPf 973 (995)
...
T Consensus 331 ~~~ 333 (344)
T 1rjb_A 331 CQL 333 (344)
T ss_dssp HHC
T ss_pred HHH
Confidence 543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=382.88 Aligned_cols=258 Identities=29% Similarity=0.404 Sum_probs=217.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee--
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL-- 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l-- 762 (995)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 4589999999999999999999999999999999997533 3445567889999999999999999999999887765
Q ss_pred ----EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 763 ----YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 763 ----yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
|+||||+. ++|.+++. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999996 68888874 349999999999999999999999999999999999999999999999999987310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 196 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 196 ------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 11224568999999999987 67899999999999999999999999998
Q ss_pred CHHHHHHHHHccCCC----------------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~~~----------------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+..+.+..+...... +...+..+++.+.+||.+||+.||.+||| +.++|
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell 322 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQAL 322 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC---HHHHH
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC---HHHHh
Confidence 877776665431110 01123467899999999999999999999 78899
Q ss_pred cCcccccccc
Q 001924 970 HCKIFIKKTE 979 (995)
Q Consensus 970 ~HPfF~~~~~ 979 (995)
+||||+....
T Consensus 323 ~hp~f~~~~~ 332 (371)
T 4exu_A 323 THPFFEPFRD 332 (371)
T ss_dssp TSGGGTTTCC
T ss_pred cCcccccCCC
Confidence 9999987643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=389.70 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=215.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc------CCCceEEEeeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV------RNPFVVRFFYSFT 757 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L------kHPNIVkL~gvf~ 757 (995)
....+|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4467899999999999999999999999999999998753 23456677888888877 5779999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc--EEEEecCC
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGL 833 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~--VKLsDFGL 833 (995)
....+++||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999995 69999997654 4999999999999999999999999999999999999999887 99999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
++.. .......+||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 249 a~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p 298 (429)
T 3kvw_A 249 SCYE------------------------------HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298 (429)
T ss_dssp CEET------------------------------TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceec------------------------------CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence 8731 0112345799999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHccCCC--------------------CC------------------------------------CCC
Q 001924 914 FTAESPEIIFDNILNRKIP--------------------WP------------------------------------CVP 937 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~~~~--------------------~p------------------------------------~lp 937 (995)
|.+.+..+.+..+...... ++ .++
T Consensus 299 f~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 378 (429)
T 3kvw_A 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378 (429)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT
T ss_pred CCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc
Confidence 9998887776655432100 00 011
Q ss_pred CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 938 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 938 s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
...++.+.+||.+||++||.+||| +.++|+||||++.....
T Consensus 379 ~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 379 GCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRRLPKP 419 (429)
T ss_dssp TCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC------
T ss_pred ccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccCCCCC
Confidence 234788999999999999999999 78889999999865443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=387.46 Aligned_cols=258 Identities=30% Similarity=0.436 Sum_probs=211.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~------ 759 (995)
..+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3579999999999999999999999999999999865321 234699999999999999999988542
Q ss_pred CeeEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCc
Q 001924 760 DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLS 834 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~----k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLA 834 (995)
..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 237799999975 6766654 24679999999999999999999999999999999999999965 67899999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~P 913 (995)
+.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.|
T Consensus 205 ~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 205 KQLVR----------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp EECCT----------------------------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhccc----------------------------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 84210 0112245789999999999775 789999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcc-----------------CCCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHH
Q 001924 914 FTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 967 (995)
Q Consensus 914 F~g~s~~ei~qkIl~~-----------------~~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlE 967 (995)
|.+.+..+.+..++.. .+.++. ++..+++++.+||.+||++||.+||+ +.+
T Consensus 257 f~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t---~~e 333 (420)
T 1j1b_A 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLE 333 (420)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC---HHH
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC---HHH
Confidence 9998877666655431 111221 23467899999999999999999999 778
Q ss_pred HHcCccccccccccc
Q 001924 968 VFHCKIFIKKTENCV 982 (995)
Q Consensus 968 iL~HPfF~~~~~n~~ 982 (995)
+++||||...++...
T Consensus 334 ~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 334 ACAHSFFDELRDPNV 348 (420)
T ss_dssp HHTSGGGGGGGCTTC
T ss_pred HhCCHhhcccccccc
Confidence 899999988765443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=378.17 Aligned_cols=265 Identities=27% Similarity=0.394 Sum_probs=206.2
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.....++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+++..+..++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 34567899999999999999999999999999999998865332 23356778888899999999999999876443
Q ss_pred -------eEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HcCceeeecCCCcEEecc-CCcEE
Q 001924 762 -------LYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIAH-DGHIK 827 (995)
Q Consensus 762 -------lyLVmEym~GGSL~d~L~----k~~~Lsee~ir~Ia~QIa~GLaYLH--s~GIIHRDLKPeNILLDe-nG~VK 827 (995)
+++||||+++ +|.+.+. ....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 8899999976 5554443 4567899999999999999999999 999999999999999997 89999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFE 906 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyE 906 (995)
|+|||+++... .........||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 173 l~Dfg~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~e 224 (360)
T 3e3p_A 173 LCDFGSAKKLS----------------------------PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224 (360)
T ss_dssp ECCCTTCBCCC----------------------------TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred EeeCCCceecC----------------------------CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 99999987421 011123456899999999997654 8999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHccCCC-----------------------------CCCCCCCCCHHHHHHHHHHhhcCcc
Q 001924 907 FITGIPPFTAESPEIIFDNILNRKIP-----------------------------WPCVPSDMSFEAQDLINRFLIHDPN 957 (995)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~~~~~-----------------------------~p~lps~lS~eL~dLIkkCLq~DPe 957 (995)
|++|+.||.+.+....+..+...... ++..+...+..+.+||.+||+.||.
T Consensus 225 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 304 (360)
T 3e3p_A 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304 (360)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcc
Confidence 99999999998887777766542100 1112233678999999999999999
Q ss_pred CCCCHHHHHHHHcCccccccccccc
Q 001924 958 QRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 958 KRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
+||| +.++|+||||++..+...
T Consensus 305 ~Rpt---~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 305 ERMK---PYEALCHPYFDELHDPAT 326 (360)
T ss_dssp GSCC---HHHHTTSGGGGGGGCTTC
T ss_pred ccCC---HHHHhcCccccccCCccc
Confidence 9999 788899999998865443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=383.63 Aligned_cols=259 Identities=21% Similarity=0.318 Sum_probs=220.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
....++|++.+.||+|+||.||+|.+ ..++..||||+++.. ........+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34567899999999999999999994 456789999998643 23445667899999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---cEE
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIK 827 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~-------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG---~VK 827 (995)
.....++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997653 489999999999999999999999999999999999999555 599
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
|+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||
T Consensus 225 L~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 225 IGDFGMARDIYRAG-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp ECCCHHHHHHHHHS-------------------------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCcccccccccc-------------------------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99999997421111 01122345689999999999999999999999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
++ |..||.......+...+..+... ..+..++..+.+||.+||+.||.+|||+.++++.|+
T Consensus 280 lt~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 280 FSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 98 99999999999888888776532 335788999999999999999999999888877664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=390.31 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=198.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCceEEEee-------ee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFY-------SF 756 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L--kHPNIVkL~g-------vf 756 (995)
..+|++.+.||+|+||.||+|.+..+|+.||||+++..........+.+.+|+.++..+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 35699999999999999999999999999999999876554555667788886555544 6999888653 33
Q ss_pred ecc-----------------CeeEEEEeecCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCceeee
Q 001924 757 TCR-----------------DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVA------RIYIAELVLALEYLHSLGIVHRD 812 (995)
Q Consensus 757 ~~~-----------------~~lyLVmEym~GGSL~d~L~k~-~~Lsee~i------r~Ia~QIa~GLaYLHs~GIIHRD 812 (995)
... ..+|+||||++ |+|.+++... ..++...+ ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 322 34899999998 8999999864 33444444 56779999999999999999999
Q ss_pred cCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CC
Q 001924 813 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TE 890 (995)
Q Consensus 813 LKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ 890 (995)
|||+|||++.+|.+||+|||+|+... .......||+.|+|||++.+ ..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVG------------------------------TRGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETT------------------------------CEEEGGGSCGGGCCHHHHTCSEEE
T ss_pred CCHHHEEECCCCCEEEEecceeeecC------------------------------CCccCccCCcCCcChhhccCCCCC
Confidence 99999999999999999999997411 01113457799999999988 67
Q ss_pred CCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-----HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH
Q 001924 891 HGYAADWWSVGIILFEFITGIPPFTAESPEII--FDN-----ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 963 (995)
Q Consensus 891 ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei--~qk-----Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~ 963 (995)
++.++|||||||++|||++|+.||.+..+... +.. .......++ .+..+++.+.+||.+||+.||++|||
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt-- 346 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLL-- 346 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCC--
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCC--
Confidence 99999999999999999999999987643211 000 000111112 22478999999999999999999999
Q ss_pred HHHHHHcCcccccccccc
Q 001924 964 GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 964 EIlEiL~HPfF~~~~~n~ 981 (995)
+.++|+||||++..+..
T Consensus 347 -~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 347 -PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp -HHHHTTSHHHHHHHHHH
T ss_pred -HHHHhcCHHHHHHHHHH
Confidence 78889999999887654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=370.44 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=216.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc------eEEEeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF------VVRFFYSF 756 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG-~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN------IVkL~gvf 756 (995)
...++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+.+|+.+++.+.|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 34689999999999999999999998777 69999998753 234567888999999987765 99999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe--------------
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-------------- 820 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL-------------- 820 (995)
...+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 668887776543 69999999999999999999999999999999999999
Q ss_pred -----ccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 821 -----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 821 -----DenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
+.++.+||+|||+++... .......||+.|+|||++.+..++.++
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH------------------------------EHHTTIVATRHYRPPEVILELGWAQPC 220 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT------------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHH
T ss_pred ccccccCCCcEEEeecCcccccc------------------------------ccccCCcCCCcccCCeeeecCCCCCcc
Confidence 567899999999987410 111245799999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCC----------------------------------------
Q 001924 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPC---------------------------------------- 935 (995)
Q Consensus 896 DIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~---------------------------------------- 935 (995)
|||||||++|||++|..||...........+.......|.
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (355)
T 2eu9_A 221 DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300 (355)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC
T ss_pred chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccc
Confidence 9999999999999999999988776655444332111110
Q ss_pred -CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 936 -VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 936 -lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
.....+..+.+||.+||+.||.+||| +.++|+||||.+..+...+
T Consensus 301 ~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 301 LQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp SCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC
T ss_pred cccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhcc
Confidence 01112457889999999999999999 7888999999998765444
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=372.41 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=207.2
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC--ee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--~l 762 (995)
..++|++.+.||+|+||+||+|.+..+|+.||||+++.... ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 45789999999999999999999999999999999976443 233567889999999999999999999988765 78
Q ss_pred EEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe----ccCCcEEEEecCCcc
Q 001924 763 YLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 835 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL----DenG~VKLsDFGLAr 835 (995)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997653 39999999999999999999999999999999999999 778889999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc--------CCCCCchHHHHHHHHHHHHH
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--------GTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~--------g~~ys~KSDIWSLGVILyEL 907 (995)
.... ........||+.|+|||++. +..++.++|||||||++|||
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp ECCT----------------------------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred ecCC----------------------------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 4210 11122456999999999986 57789999999999999999
Q ss_pred HcCCCCCCCCC----HHHHHHHHHccCCC-------------------CC---CCCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 908 ITGIPPFTAES----PEIIFDNILNRKIP-------------------WP---CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 908 LTGr~PF~g~s----~~ei~qkIl~~~~~-------------------~p---~lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
++|+.||.... .......+..+... .+ .++..++..+.+||.+||+.||++|||
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s 296 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc
Confidence 99999996432 24445555544321 01 112234567889999999999999999
Q ss_pred HHHHHH
Q 001924 962 ANGAAE 967 (995)
Q Consensus 962 A~EIlE 967 (995)
+.++++
T Consensus 297 ~~ell~ 302 (319)
T 4euu_A 297 FDQFFA 302 (319)
T ss_dssp HHHHHH
T ss_pred HHHhhh
Confidence 554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=377.03 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=225.9
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 751 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~T-------G~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVk 751 (995)
..+....++|.+.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+++++.+ +||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34456678999999999999999999997543 358999998754 2345567899999999999 9999999
Q ss_pred EeeeeeccCeeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCC
Q 001924 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (995)
Q Consensus 752 L~gvf~~~~~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKP 815 (995)
+++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998653 489999999999999999999999999999999
Q ss_pred CcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 816 eNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
+|||++.++.+||+|||+++...... .........||+.|+|||++.+..++.++
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHID-------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCC-------------------------TTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred ceEEEcCCCcEEEcccCccccccccc-------------------------ccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 99999999999999999987421100 01112234578899999999999999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 896 DIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|||||||++|+|++ |..||.+....++...+..+.. +..+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 99999999999999 9999999998888877766543 33457899999999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.21 Aligned_cols=254 Identities=21% Similarity=0.356 Sum_probs=220.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 45678999999999999999999987 578899999976432 2367899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-- 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-- 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH--
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc--
Confidence 999999999999999765 46899999999999999999999999999999999999999999999999998742110
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~e 921 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 158 ------------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp ------------------------HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ------------------------cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 0111223457889999999998899999999999999999999 999999998888
Q ss_pred HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 922 i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
....+..+... ..+...+..+.+|+.+||+.||.+||++.++++.|+
T Consensus 214 ~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 214 VVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp HHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCcC--CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 88887665432 235678999999999999999999999999988775
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=375.53 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=216.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe----
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~---- 761 (995)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999987532 344556788999999999999999999999987654
Q ss_pred --eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 762 --LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 762 --lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
+|+||||+. |+|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~- 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC-
Confidence 499999996 588887743 58999999999999999999999999999999999999999999999999987310
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 178 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 -----------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp -----------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred -----------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123568999999999987 678999999999999999999999999888
Q ss_pred HHHHHHHHHcc----------------------------CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~----------------------------~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
....+..+... ...+...+..+++.+.+||.+||+.||.+||| +.++|+
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~ 305 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQALT 305 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC---HHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC---HHHHhc
Confidence 76666555431 11223344578999999999999999999999 788899
Q ss_pred Ccccccccc
Q 001924 971 CKIFIKKTE 979 (995)
Q Consensus 971 HPfF~~~~~ 979 (995)
||||.....
T Consensus 306 hp~f~~~~~ 314 (353)
T 3coi_A 306 HPFFEPFRD 314 (353)
T ss_dssp SGGGTTTCC
T ss_pred CcchhhccC
Confidence 999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=360.46 Aligned_cols=272 Identities=31% Similarity=0.520 Sum_probs=210.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------- 758 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~------- 758 (995)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 36799999999999999999999999999999998642 3456788999999999999999999998765
Q ss_pred ------cCeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 759 ------RDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 759 ------~~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
...+|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 456899999999999999997543 5788899999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcC
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTG 910 (995)
|++........ .... . ...............||+.|+|||++.+. .++.++||||||+++|+|++
T Consensus 161 g~~~~~~~~~~--~~~~--------~---~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 161 GLAKNVHRSLD--ILKL--------D---SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp CCCSCTTC--------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred cchhhcccccc--hhcc--------c---cccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 99874211100 0000 0 00000011223456799999999999865 68999999999999999998
Q ss_pred CCCCCC-CCHHHHHHHHHccCCCCC-CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 911 IPPFTA-ESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 911 r~PF~g-~s~~ei~qkIl~~~~~~p-~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
||.. .........+......++ ..+...+..+.+||.+||+.||.+||| +.++++||||....+.
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGWLPVKHQD 293 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSCSCCCCHH
T ss_pred --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCCcCCCChH
Confidence 6643 334445555555444433 245667888999999999999999999 7788899999876443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.09 Aligned_cols=265 Identities=20% Similarity=0.335 Sum_probs=223.8
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~-----~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
.......++|++.+.||+|+||.||+|.+..++. .||+|+++... .......+.+|+.+++.+ +||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3456677999999999999999999999977665 79999987543 334567899999999999 899999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEE
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV--------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~--------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNIL 819 (995)
+++...+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999753 35799999999999999999999999999999999999
Q ss_pred eccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHH
Q 001924 820 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (995)
Q Consensus 820 LDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (995)
++.++.+||+|||++....... .........||+.|+|||++.+..++.++||||
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 251 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS-------------------------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT-------------------------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred ECCCCeEEECcccccccccccc-------------------------ceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence 9999999999999987421110 011122345788999999999999999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 900 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 900 LGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
||+++|+|++ |..||.+.........+....... ..+...+..+.+||.+||+.||.+|||+.++++.|+..
T Consensus 252 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 9999999998 999998876655555555554432 24567899999999999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=381.60 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=210.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4589999999999999999999999999999999997532 34455678899999999999999999999997765
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..|+||||++ |+|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 6899999996 48888885 458999999999999999999999999999999999999999999999999987411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 179 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 179 ----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ---------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0011234579999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHHccCCCC-------------------CCC--------------CC------CCCHHHHHHHHHHhhcCccCC
Q 001924 919 PEIIFDNILNRKIPW-------------------PCV--------------PS------DMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~-------------------p~l--------------ps------~lS~eL~dLIkkCLq~DPeKR 959 (995)
....+..+....... +.. +. ..+..+.+||.+||+.||.+|
T Consensus 231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 877777766532110 000 00 015678999999999999999
Q ss_pred CCHHHHHHHHcCcccccc
Q 001924 960 LGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~~ 977 (995)
|| +.++|+||||+..
T Consensus 311 ~t---~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 311 IS---VDEALQHPYINVW 325 (371)
T ss_dssp CC---HHHHHHSHHHHTT
T ss_pred CC---HHHHhCCcchhhh
Confidence 99 7788999999853
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.68 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=217.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ +|+|++++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34578999999999999999999999999999999986533 224578899999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc-----EEEEecCCccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKI 836 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~-----VKLsDFGLArv 836 (995)
++||||+ +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 999999998654 5999999999999999999999999999999999999987775 99999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
....... ............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+
T Consensus 161 ~~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 161 YRDPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp SBCTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccccccc--------------------ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 3211100 00011223456799999999999999999999999999999999999999987
Q ss_pred C---CHHHHHHHHHccCC--CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 917 E---SPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 917 ~---s~~ei~qkIl~~~~--~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
. .....+..+..... +.+.....++..+.+||.+||+.||.+||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 221 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 4 34444444443321 2222345789999999999999999999999999888764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=363.36 Aligned_cols=259 Identities=29% Similarity=0.488 Sum_probs=211.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||+++............+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999999999999998655555667788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 35689999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC--
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-- 917 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~-- 917 (995)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 189 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 241 (310)
T 2wqm_A 189 ---------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241 (310)
T ss_dssp -------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C
T ss_pred ---------------------------CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 011122356899999999999999999999999999999999999999764
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
........+.....+ +..+..++..+.+||.+||..||.+|||+.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 242 NLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp CHHHHHHHHHTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hHHHHHHHhhcccCC-CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 334455555444432 2223678999999999999999999999999988774
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=364.07 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=210.3
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~----~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...++|++.+.||+|+||.||+|. +..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345889999999999999999998 5668999999998753 345567899999999999999999999998654
Q ss_pred --CeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 760 --DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 760 --~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 45899999999999999997654 499999999999999999999999999999999999999999999999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
...... .........||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 164 ~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 164 LPQDKE------------------------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCCcc------------------------eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 211100 00112234577889999999999999999999999999999999999865
Q ss_pred CCHH----------------HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 917 ESPE----------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 917 ~s~~----------------ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.... .....+. .... ...+..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 220 PPAEFMRMIGNDKQGQMIVFHLIELLK-NNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ChHHHHhhhcCccccchhHHHHHHHHh-ccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 3221 1122222 2222 2345789999999999999999999999999998875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=362.74 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=212.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 756 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG-------~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf 756 (995)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34578999999999999999999998877 479999986533 34567899999999999999999999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc--------EE
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IK 827 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~~~-Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~--------VK 827 (995)
...+..++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999998887 99
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 906 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyE 906 (995)
|+|||++.... ......||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 162 l~Dfg~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (289)
T 4fvq_A 162 LSDPGISITVL-------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210 (289)
T ss_dssp ECCCCSCTTTS-------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHH
T ss_pred eccCccccccc-------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 99999986310 0112357889999999988 678999999999999999
Q ss_pred HHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 907 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 907 LLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
|++ |.+||............ ..... .+...+..+.+||.+||+.||.+|||+.++++.|+.-+
T Consensus 211 l~~g~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 211 ICSGGDKPLSALDSQRKLQFY-EDRHQ---LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHTTTCCTTTTSCHHHHHHHH-HTTCC---CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HHcCCCCCccccchHHHHHHh-hccCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 999 45566665555444333 33322 33566788999999999999999999999999887543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=373.04 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=214.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ly 763 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34789999999999999999999999999999999875332 23578999999999 9999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc-----EEEEecCCcccc
Q 001924 764 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIG 837 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~-----VKLsDFGLArv~ 837 (995)
+||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 99999999863 67999999999999999999999999999999999999998887 999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
...... ...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 161 ~~~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 161 IDPETK--------------------KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp BCTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecCCCC--------------------ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 211100 000111234568999999999999999999999999999999999999999874
Q ss_pred ---CHHHHHHHHHccCCCCC--CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 ---SPEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 ---s~~ei~qkIl~~~~~~p--~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+.+..+.......+ .....++ .+.+||..||+.||.+||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 221 KADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 34444555543332221 1123345 99999999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=367.47 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=223.3
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 752 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k-------~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL 752 (995)
.+....++|++.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 34455689999999999999999999985 457799999987532 345567899999999999 89999999
Q ss_pred eeeeeccCeeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCC
Q 001924 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (995)
Q Consensus 753 ~gvf~~~~~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPe 816 (995)
++++...+.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997643 3889999999999999999999999999999999
Q ss_pred cEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHH
Q 001924 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (995)
Q Consensus 817 NILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSD 896 (995)
|||++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++|
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTS-------------------------SEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred eEEEcCCCCEEEccccccccccccc-------------------------cccccCCCCcccceeChHHhcCCCcChHHH
Confidence 9999999999999999987421100 001122345788999999999888999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 897 IWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
|||||+++|+|++ |..||.+....++...+..+.. +..+..++..+.+||.+||+.||.+|||+.++++.|+.-
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999 9999999988888877766542 234578999999999999999999999999999887653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=360.83 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=219.9
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIK-PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk-~LG~GgFGtVYka~~--k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...++|.+.+ .||+|+||.||+|.+ ..+++.||||+++... ......+.+.+|+.+++.++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 3457899998 999999999999954 5667899999997543 2334467899999999999999999999999 566
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999998888999999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
. ..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 171 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 171 E------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp C------------------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred C------------------------CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 00011123357889999999998889999999999999999999 9999999988
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
......+..+.. +..+..++..+.+||.+||+.||.+||++.++++.|+.-
T Consensus 227 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 227 SEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 888777766542 345678999999999999999999999999999988753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=382.33 Aligned_cols=258 Identities=31% Similarity=0.438 Sum_probs=209.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
...+|++.+.||+|+||+||+|.+..++. ||+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34679999999999999999999987666 888877543211 236999999999999999999986544
Q ss_pred --eeEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec-cCCcEEEEecCC
Q 001924 761 --NLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGL 833 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~----k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD-enG~VKLsDFGL 833 (995)
.+++||||++++ +...+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 388999999764 444332 346799999999999999999999999999999999999999 799999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~ 912 (995)
|+.... ........||+.|+|||++.+. .|+.++|||||||++|||++|+.
T Consensus 189 a~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 189 AKILIA----------------------------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp CEECCT----------------------------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccC----------------------------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 974210 1112345789999999999775 58999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccC-----------------CCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 913 PFTAESPEIIFDNILNRK-----------------IPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~-----------------~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
||.+.+..+.+..+.... ..++. ++..+++++.+||.+||++||.+||| +.
T Consensus 241 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~ 317 (394)
T 4e7w_A 241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT---AI 317 (394)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC---HH
Confidence 999988777666655421 11111 23458899999999999999999999 78
Q ss_pred HHHcCccccccccccc
Q 001924 967 EVFHCKIFIKKTENCV 982 (995)
Q Consensus 967 EiL~HPfF~~~~~n~~ 982 (995)
++++||||+..++...
T Consensus 318 e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 318 EALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHTSGGGSTTTSSCC
T ss_pred HHhcChhhhhhccccc
Confidence 8899999998876544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=373.71 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=211.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc--------cchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAERNILITVRNPFVVRFFY 754 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~--------~se~e~e~flrEieILs~LkHPNIVkL~g 754 (995)
....++|++.+.||+|+||.||+|.+.. |..||||++..... ......+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3456899999999999999999999865 99999999865322 12233578999999999999999999999
Q ss_pred eeec-----cCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEE
Q 001924 755 SFTC-----RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 755 vf~~-----~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKL 828 (995)
++.. ...+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9844 346899999997 6888888654 46999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyEL 907 (995)
+|||+++... .........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 176 ~Dfg~~~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 176 CDFNLAREDT----------------------------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp CCTTC-------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred EecCcccccc----------------------------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHH
Confidence 9999987311 0111234578999999999987 6789999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHccCC------------------------CC-----CCCCCCCCHHHHHHHHHHhhcCccC
Q 001924 908 ITGIPPFTAESPEIIFDNILNRKI------------------------PW-----PCVPSDMSFEAQDLINRFLIHDPNQ 958 (995)
Q Consensus 908 LTGr~PF~g~s~~ei~qkIl~~~~------------------------~~-----p~lps~lS~eL~dLIkkCLq~DPeK 958 (995)
++|+.||.+.+.......+..... .. ...+...++.+.+||.+||+.||.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 999999999887777666543110 00 0123467889999999999999999
Q ss_pred CCCHHHHHHHHcCccccccc
Q 001924 959 RLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 959 RPSA~EIlEiL~HPfF~~~~ 978 (995)
||| +.++|+||||+...
T Consensus 308 Rpt---~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 308 RIS---TEQALRHPYFESLF 324 (362)
T ss_dssp SCC---HHHHHTSGGGTTTC
T ss_pred CCC---HHHHHcCchhhhcc
Confidence 999 78889999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=394.34 Aligned_cols=275 Identities=21% Similarity=0.358 Sum_probs=233.4
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.+....++|++.+.||+|+||.||+|.+..++..||||+++... ...+.+.+|+.+|++++||||+++++++....
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34556788999999999999999999999999999999987533 23577999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999764 458999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 370 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 370 GDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TCC--------------------------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCc--------------------------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 100 011123456789999999999899999999999999999999 99999998
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhhc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIELK 993 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~~ 993 (995)
+..++...+..+. . ...+..++..+.+||.+||+.||.+|||+.++++.|+.-+ ...++.+.++.|+.
T Consensus 424 ~~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~------~~~~~~~~~~~~l~ 491 (495)
T 1opk_A 424 DLSQVYELLEKDY-R-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF------QESSISDEVEKELG 491 (495)
T ss_dssp CGGGHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC------SSSCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH------hccccchHHHHHhc
Confidence 8877776665432 2 2345789999999999999999999999999999997654 23455666666653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.13 Aligned_cols=271 Identities=25% Similarity=0.442 Sum_probs=208.5
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.++..+++.++||||+++++++...+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 4567899999999999999999999999999999999976432 222334444555678888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
++||||+ ++.+..+... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 177 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD- 177 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence 9999999 5566665543 46799999999999999999999995 999999999999999999999999999863110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||.
T Consensus 178 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 178 ---------------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp ------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 01122346999999999994 4568899999999999999999999998
Q ss_pred C-CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchh
Q 001924 916 A-ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 916 g-~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
. .........+.....+.......++..+.+||.+||+.||.+||+ +.++++||||++.......+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~~~~~ 299 (318)
T 2dyl_A 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRYETLEVDVAS 299 (318)
T ss_dssp TCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHHHHSCCCHHH
T ss_pred CCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhcccccchhHH
Confidence 7 455566666666554433233568999999999999999999999 7788999999987655554443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.37 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=217.3
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~-----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
.+....++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.++.++ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3345568999999999999999999985 3567899999997543 344567899999999999 7899999999
Q ss_pred eeeccC-eeEEEEeecCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCc
Q 001924 755 SFTCRD-NLYLVMEYLNGGDLYSLLRKVGC----------------LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (995)
Q Consensus 755 vf~~~~-~lyLVmEym~GGSL~d~L~k~~~----------------Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeN 817 (995)
++...+ .+++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987755 58999999999999999986543 8899999999999999999999999999999999
Q ss_pred EEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHH
Q 001924 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (995)
Q Consensus 818 ILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDI 897 (995)
|+++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++||
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~-------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 233 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTC-------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred EEECCCCCEEECCCccccccccC-------------------------ccceeccCCCcceeecCchhhccccccchhHH
Confidence 99999999999999998742100 00111234567899999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 898 WSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||||+++|+|++ |..||.+................ +..+..+++.+.++|.+||+.||.+|||+.++++.|+.
T Consensus 234 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999998 99999886644433333333322 23456789999999999999999999999999888754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=386.36 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=217.3
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC-
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 760 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~- 760 (995)
+....++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++||||+++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 3456688999999999999999999885 7899999997532 3567999999999999999999999987665
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||||+++|+|.+++...+. ++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999987643 7999999999999999999999999999999999999999999999999987310
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus 341 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 341 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp ------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred ------------------------------ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112357889999999999999999999999999999998 99999998
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...++...+..+. . +..+..+++.+.+||.+||+.||.+|||+.++.+.|+.
T Consensus 391 ~~~~~~~~i~~~~-~-~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 391 PLKDVVPRVEKGY-K-MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CTTTHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCC-C-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 8777777766543 2 23467899999999999999999999999999987754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.87 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=219.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEE--EEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~V--AVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~ 760 (995)
...++|++.+.||+|+||.||+|.+..++..+ |+|.++... .......+.+|+.+++++ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34589999999999999999999999888865 999887432 334556789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~----------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997653 689999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.+||+|||+++... .........+|+.|+|||++.+..++.++||||||+++
T Consensus 180 ~~kL~Dfg~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 180 VAKIADFGLSRGQE----------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp CEEECCTTCEESSC----------------------------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred eEEEcccCcCcccc----------------------------ccccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 99999999987310 01112234578899999999988899999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 905 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 905 yELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
|+|++ |..||.+.........+..+.. +..+..++..+.+||.+||+.||.+|||+.++++.|+.-.-..
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 99998 9999999988888777665532 2345678999999999999999999999999998877544333
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=369.52 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=210.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~V----AVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...++|++.+.||+|+||+||+|.+..+++.+ |+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 34578999999999999999999998888755 666654322 234457899999999999999999999999875
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
. .++|++|+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 78999999999999999764 569999999999999999999999999999999999999999999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 169 ~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 169 AEE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp TTC-------------------------C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCc-------------------------ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 110 0111223457889999999999999999999999999999999 99999998
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+...+..+.. ...+..++..+.+|+.+||+.||.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 224 PASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 88777666655432 22456789999999999999999999999999887653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=354.53 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=220.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.+....++|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|+++++.++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 44566789999999999999999999976 56789999987533 235678999999999999999999998864 5
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999997543 69999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 161 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 161 DNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred Ccc--------------------------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 100 011123457889999999998889999999999999999999 99999998
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
...+....+..+.. +..+..++..+.+||.+||..||++|||+.++.+.|+.-+
T Consensus 215 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhcccC--CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 88888777765532 2345688999999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=357.03 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=210.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-
Q 001924 685 SIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 759 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~----~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~- 759 (995)
....|++.+.||+|+||.||+|. +..+++.||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34679999999999999999999 46789999999987543 233457889999999999999999999999877
Q ss_pred -CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 -DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 -~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
..+++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 6689999999999999999544 56999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.... ..........||..|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 177 ~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 177 ETDK------------------------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp CTTC------------------------CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cCCC------------------------cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 1100 0011223456889999999999999999999999999999999999886422
Q ss_pred --------------CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 --------------SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 --------------s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
............... ...+..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 233 MALFLKMIGPTHGQMTVTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHHHHCSCCGGGHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred hhHHhhccCCcccccCHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 111122222222222 2345789999999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=384.25 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=224.1
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..+....++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 345667789999999999999999999986 47789999997533 24678999999999999999999999986 5
Q ss_pred CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
+.+|+||||+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6789999999999999999754 36899999999999999999999999999999999999999999999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g 916 (995)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+
T Consensus 335 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 335 EDNE--------------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CCHH--------------------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCc--------------------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 1110 011123447889999999998999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+..++...+..+. .++ .+..+++.+.+||.+||+.||.+|||+.++.+.|+.-+-
T Consensus 389 ~~~~~~~~~i~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 389 MSNPEVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCHHHHHHHHHHTC-CCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99888887776553 222 357899999999999999999999999999999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=359.47 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=202.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeec---
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTC--- 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~--LkHPNIVkL~gvf~~--- 758 (995)
...++|++.+.||+|+||+||+|.+ +|+.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567899999999999999999987 5899999998642 34556777777776 799999999998654
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeeecCCCcEEeccCCcEEEE
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKLT 829 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLH--------s~GIIHRDLKPeNILLDenG~VKLs 829 (995)
...+++||||+++|+|.++++. ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3468999999999999999954 56999999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC------CCCchHHHHHHHHH
Q 001924 830 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGII 903 (995)
Q Consensus 830 DFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~------~ys~KSDIWSLGVI 903 (995)
|||+++....... ..........||+.|+|||++.+. .++.++||||||++
T Consensus 156 Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~i 212 (301)
T 3q4u_A 156 DLGLAVMHSQSTN-----------------------QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212 (301)
T ss_dssp CCTTCEEEETTTT-----------------------EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHH
T ss_pred eCCCeeecccccc-----------------------cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHH
Confidence 9999974221100 001112345799999999999886 45579999999999
Q ss_pred HHHHHcC----------CCCCCCCC----HHHHHHHHHccCCCCCCCC-----CCCCHHHHHHHHHHhhcCccCCCCHHH
Q 001924 904 LFEFITG----------IPPFTAES----PEIIFDNILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANG 964 (995)
Q Consensus 904 LyELLTG----------r~PF~g~s----~~ei~qkIl~~~~~~p~lp-----s~lS~eL~dLIkkCLq~DPeKRPSA~E 964 (995)
+|||++| ..||.... ...............+..+ ...+..+.+||.+||+.||.+|||+.+
T Consensus 213 l~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 9999999 88886532 2223333333222223222 225578999999999999999999999
Q ss_pred HHHHHc
Q 001924 965 AAEVFH 970 (995)
Q Consensus 965 IlEiL~ 970 (995)
+++.|+
T Consensus 293 i~~~L~ 298 (301)
T 3q4u_A 293 IKKTLT 298 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=357.62 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=224.5
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIK-PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk-~LG~GgFGtVYka~~k--~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...++|.+.. .||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4457788887 9999999999999864 467889999997642 345677899999999999999999999999 456
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 789999999999999999644 4699999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus 163 ~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 163 DD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp CS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Cc------------------------ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 00 00111223457899999999998889999999999999999998 999999988
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
..+....+..+.. +..+..+++.+.+||.+||+.||.+||++.++++.|+.-|+....
T Consensus 219 ~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 219 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp THHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCc--CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 8887777766542 345678999999999999999999999999999999887765543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=360.97 Aligned_cols=272 Identities=26% Similarity=0.387 Sum_probs=215.9
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeec
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTC 758 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk--HPNIVkL~gvf~~ 758 (995)
......++|++.+.||+|+||.||+|.+. +++.||||++.... ........+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33455678999999999999999999986 58999999997543 23456778999999999997 5999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+.+++||| +.+++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 999999999 55889999999888899999999999999999999999999999999999996 5899999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-----------CCCCchHHHHHHHHHHHHH
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----------TEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-----------~~ys~KSDIWSLGVILyEL 907 (995)
... .........||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 178 ~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 178 PDT-------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp -------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred Ccc-------------------------ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 100 0111234579999999999976 4688999999999999999
Q ss_pred HcCCCCCCCCC-HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccch
Q 001924 908 ITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 908 LTGr~PF~g~s-~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q 985 (995)
++|+.||.... .......+...... ...+...+..+.+||.+||+.||.+||+ +.++++||||+........++
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~~~~~~~~~~~~~ 307 (313)
T 3cek_A 233 TYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQTHPVNQMA 307 (313)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHCC--------
T ss_pred HhCCCchhhHHHHHHHHHHHHhcccc-cCCcccchHHHHHHHHHHccCCcccCcC---HHHHhcCccccCCCCchhhhh
Confidence 99999998754 33344444443332 2345667899999999999999999999 788999999998765554443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=376.07 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=213.4
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC-----ceEEEeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NP-----FVVRFFYSF 756 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HP-----NIVkL~gvf 756 (995)
....++|++.+.||+|+||+||+|.+..+++.||||+++.. ......+..|+.++..+. |+ +|+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 45578999999999999999999999999999999999742 234567788888888875 44 499999999
Q ss_pred eccCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCceeeecCCCcEEec--cCCcEEEEe
Q 001924 757 TCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH--SLGIVHRDLKPDNLLIA--HDGHIKLTD 830 (995)
Q Consensus 757 ~~~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLH--s~GIIHRDLKPeNILLD--enG~VKLsD 830 (995)
...+.+++||||++ |+|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999995 5999999765 45999999999999999999999 57999999999999995 477899999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG 910 (995)
||+++... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 205 FG~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 254 (382)
T 2vx3_A 205 FGSSCQLG------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254 (382)
T ss_dssp CTTCEETT------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccCceecc------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99997410 112245799999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHccCCCCCC---------------C------------------CCC------------------
Q 001924 911 IPPFTAESPEIIFDNILNRKIPWPC---------------V------------------PSD------------------ 939 (995)
Q Consensus 911 r~PF~g~s~~ei~qkIl~~~~~~p~---------------l------------------ps~------------------ 939 (995)
+.||.+.+..+.+..+.......+. + ++.
T Consensus 255 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 334 (382)
T 2vx3_A 255 EPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334 (382)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGT
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcc
Confidence 9999998887777766542111000 0 000
Q ss_pred ----------CCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 940 ----------MSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 940 ----------lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
.++.+.+||.+||+.||++||| +.++|+||||++..+
T Consensus 335 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred ccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 0137899999999999999999 788899999987653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=356.66 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=212.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~-TG~--~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...++|++.+.||+|+||.||+|.+.. ++. .||||+++..........+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 445789999999999999999998643 333 68999987654444556788999999999999999999999998765
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 89999999999999999764 5699999999999999999999999999999999999999999999999999874211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 174 ~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 174 ND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp -C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc------------------------cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 00 00111223467889999999998889999999999999999999 999999999
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
.......+.......+ .+..++..+.+||.+||..||.+|||+.++++.|+..
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 230 GSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp HHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCCCC-CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 8888888876655433 4568999999999999999999999999999887643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=367.00 Aligned_cols=275 Identities=22% Similarity=0.393 Sum_probs=203.7
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeec
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEie-ILs~LkHPNIVkL~gvf~~ 758 (995)
..+....++|++.+.||+|+||.||+|.+..+|+.||||+++... .......+..|+. +++.++||||+++++++..
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 445567799999999999999999999999999999999997542 2334456666666 6777899999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEeccCCcEEEEecC
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFG 832 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k-----~~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDenG~VKLsDFG 832 (995)
.+..++||||+++ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 88888763 46799999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh----cCCCCCchHHHHHHHHHHHHHH
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL----~g~~ys~KSDIWSLGVILyELL 908 (995)
+++.... ........||+.|+|||++ .+..++.++||||||+++|+|+
T Consensus 172 ~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 172 ISGQLVD----------------------------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp SSCC----------------------------------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred Cceeccc----------------------------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 9874210 0111234699999999999 4567899999999999999999
Q ss_pred cCCCCCCCCCHH-HHHHHHHccCCC-CC-CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccch
Q 001924 909 TGIPPFTAESPE-IIFDNILNRKIP-WP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQ 985 (995)
Q Consensus 909 TGr~PF~g~s~~-ei~qkIl~~~~~-~p-~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q 985 (995)
+|..||...... .....+..+..+ ++ ..+..++..+.+||.+||+.||.+||| +.++++||||....+......
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~~~~~~ 300 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLKHPFILMYEERAVEVA 300 (327)
T ss_dssp HSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHHHHHSCCCHH
T ss_pred HCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHhChHHHHhHhhHHHHH
Confidence 999999875432 222222222211 11 122468999999999999999999999 788899999998877766554
Q ss_pred hHh
Q 001924 986 SKL 988 (995)
Q Consensus 986 ~~l 988 (995)
..+
T Consensus 301 ~~~ 303 (327)
T 3aln_A 301 CYV 303 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.36 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=216.3
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~---TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....++|++.+.||+|+||.||+|.+.. ++..||+|+++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 4456899999999999999999998754 33469999987542 33456789999999999999999999999865
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 4578999999999999999765 459999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.. .........||+.|+|||++.+..++.++||||||+++|+|++ |+.||...
T Consensus 165 ~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 165 DE--------------------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cc--------------------------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 10 0011223457889999999998999999999999999999998 99999887
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
........+..... +..+..+++.+.+||.+||..||.+||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 219 ENKDVIGVLEKGDR--LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp CGGGHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 77777666655432 22356789999999999999999999999999988764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.38 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=215.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee-
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL- 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l- 762 (995)
-.|.+.+.||+|+||+||+|.+..++. .||+|++... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 357788999999999999999866555 7999998653 2345567899999999999999999999999876665
Q ss_pred EEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999976 3568999999999999999999999999999999999999999999999999987421111
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
. ..........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 179 ~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 179 Y-----------------------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp G-----------------------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred c-----------------------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 0 01122234568899999999999999999999999999999999 56667777777
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.....+..... +..+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 236 DLTHFLAQGRR--LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp GHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhhcCCC--CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 76666655442 23456789999999999999999999999999888754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=369.85 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=213.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~----VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..++|++.+.||+|+||.||+|.+..++.. ||+|++.... .......+.+|+.+++.++||||+++++++. .+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 457899999999999999999999888876 6666654322 1223356778999999999999999999886 56
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 689999999999999999764 5789999999999999999999999999999999999999999999999999985211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
.. .........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 168 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 168 DD-------------------------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CT-------------------------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cc-------------------------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 10 0111234568889999999999999999999999999999999 999999988
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.......+..... +..+..++..+.+||.+||+.||.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 223 LAEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp TTHHHHHHHTTCB--CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7777777665532 2334668889999999999999999999999998774
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=368.39 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=216.8
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhcC--CCceEEEee
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVR--NPFVVRFFY 754 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---~e~e~flrEieILs~Lk--HPNIVkL~g 754 (995)
.......++|++.+.||+|+||.||+|.+..+++.||||+++....... .....+.+|+.+++.+. ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3344567899999999999999999999999999999999976433221 12245678999999996 599999999
Q ss_pred eeeccCeeEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec-cCCcEEEEecC
Q 001924 755 SFTCRDNLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFG 832 (995)
Q Consensus 755 vf~~~~~lyLVmEym~G-GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD-enG~VKLsDFG 832 (995)
++...+..++||||+.+ ++|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999976 89999999888899999999999999999999999999999999999999 78999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr 911 (995)
+++... ........||+.|+|||++.+..+ +.++||||||+++|||++|+
T Consensus 196 ~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 196 SGALLK-----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp TCEECC-----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred cccccc-----------------------------cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 987421 011123469999999999987665 78899999999999999999
Q ss_pred CCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 912 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
.||.... .+...... .+..++..+.+||.+||+.||.+||| +.++++||||++...
T Consensus 247 ~pf~~~~------~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 247 IPFEHDE------EIIRGQVF---FRQRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLL 302 (320)
T ss_dssp CSCCSHH------HHHHCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCC
T ss_pred CCCCChh------hhhccccc---ccccCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcCccC
Confidence 9997632 22333332 34678999999999999999999999 778899999998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=364.00 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=205.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---hHHHHHHHHHHHHHhc----CCCceEEEeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITV----RNPFVVRFFYS 755 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---~e~e~flrEieILs~L----kHPNIVkL~gv 755 (995)
....++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4456889999999999999999999999999999999975433211 1233456799999988 89999999999
Q ss_pred eeccCeeEEEEee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec-cCCcEEEEecCC
Q 001924 756 FTCRDNLYLVMEY-LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGL 833 (995)
Q Consensus 756 f~~~~~lyLVmEy-m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD-enG~VKLsDFGL 833 (995)
+...+..++|||| +.+++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888899999999999999999999999999999999999999 789999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~ 912 (995)
+..... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.
T Consensus 187 ~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 187 GALLHD-----------------------------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp CEECCS-----------------------------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred hhhccc-----------------------------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 874210 11223568999999999987666 458999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
||.... .+...... .+..++..+.+||.+||+.||.+||| +.++++||||+...++
T Consensus 238 pf~~~~------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 238 PFERDQ------EILEAELH---FPAHVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTPAED 293 (312)
T ss_dssp SCCSHH------HHHHTCCC---CCTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC----
T ss_pred CCCChH------HHhhhccC---CcccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCchhc
Confidence 997632 23333333 34678999999999999999999999 7788899999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=378.56 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=211.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k---~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...++|++.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.++++++||||+++++++....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 44578999999999999999999886 467789999987532 3455678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999999997654 699999999999999999999999999999999999999999999999999975211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
... .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 200 ~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 200 DPE------------------------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp --------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred CCc------------------------cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 100 0011112346788999999999999999999999999999998 999999998
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.......+..+.. ...+..++..+.+||.+||+.||.+||++.++++.|+.
T Consensus 256 ~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 256 NQDVIKAVDEGYR--LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp HHHHHHHHHTTEE--CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 8888777665432 12346789999999999999999999999999887754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=357.33 Aligned_cols=260 Identities=20% Similarity=0.318 Sum_probs=206.0
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
..+...++|++.+.||+|+||.||+|.+. ..||+|+++... ......+.+.+|+.+++.++||||+++++++ ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 34566789999999999999999999864 359999987543 3455677899999999999999999999965 556
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 789999999999999999643 5699999999999999999999999999999999999999999999999999874110
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
. ..........||+.|+|||++. +..++.++||||||+++|+|++|+.||..
T Consensus 173 ~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 173 W-------------------------SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred c-------------------------cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 0 0111223456999999999997 56789999999999999999999999988
Q ss_pred CCHHHHHHHHH-ccCCC--CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 917 ESPEIIFDNIL-NRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 917 ~s~~ei~qkIl-~~~~~--~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
........... .+... +......+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp CCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 65544444433 33222 23345678999999999999999999999999998875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.20 Aligned_cols=259 Identities=20% Similarity=0.271 Sum_probs=213.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee-ccCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG---~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~-~~~~ 761 (995)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.++++++||||+++++++. ..+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 457999999999999999999976443 36899988653 23455678999999999999999999999854 5567
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.++||||+++|+|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 89999999999999999753 45899999999999999999999999999999999999999999999999998742111
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.....
T Consensus 182 ~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 182 EY-----------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GG-----------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ch-----------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 10 01122234568899999999999999999999999999999999 7778888777
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
......+...... ..+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 239 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 239 FDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp TTHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 7776666665433 3356789999999999999999999999999988754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=370.80 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=207.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCceEEE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRF 752 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-----------HPNIVkL 752 (995)
...++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++++. ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 3457999999999999999999999999999999998752 234567888999998876 8999999
Q ss_pred eeeeeccC----eeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CceeeecCCCcEEecc---
Q 001924 753 FYSFTCRD----NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAH--- 822 (995)
Q Consensus 753 ~gvf~~~~----~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~-GIIHRDLKPeNILLDe--- 822 (995)
++++...+ .+++||||+ +++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99988654 789999999 88999999763 4599999999999999999999998 9999999999999953
Q ss_pred ---CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHH
Q 001924 823 ---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 899 (995)
Q Consensus 823 ---nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWS 899 (995)
.+.+||+|||++.... .......||+.|+|||++.+..++.++||||
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 220 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWS 220 (373)
T ss_dssp TTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHH
T ss_pred CcCcceEEEcccccccccC------------------------------CCCCCCCCCccccCcHHHhCCCCCchHhHHH
Confidence 4489999999987411 0112346899999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCH------HHHHHHHHccCCCC---------------------------------------C
Q 001924 900 VGIILFEFITGIPPFTAESP------EIIFDNILNRKIPW---------------------------------------P 934 (995)
Q Consensus 900 LGVILyELLTGr~PF~g~s~------~ei~qkIl~~~~~~---------------------------------------p 934 (995)
|||++|||++|..||.+... ......+....... .
T Consensus 221 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (373)
T 1q8y_A 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300 (373)
T ss_dssp HHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc
Confidence 99999999999999986542 22222222100000 0
Q ss_pred CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 935 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 935 ~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
..+...+..+.+||.+||+.||.+||| +.++|+||||++..
T Consensus 301 ~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 301 KFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTL 341 (373)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCT
T ss_pred cCCcchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhccc
Confidence 122345678899999999999999999 77889999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=359.11 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=213.0
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~---TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....++|.+.+.||+|+||.||+|.+.. ++..||+|+++... ......+.+.+|+.++++++||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3456889999999999999999998765 45689999987533 2345567899999999999999999999999876
Q ss_pred C-----eeEEEEeecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEE
Q 001924 760 D-----NLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 760 ~-----~lyLVmEym~GGSL~d~L~k------~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKL 828 (995)
. ..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 35999999999999999942 346999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 908 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELL 908 (995)
+|||+++...... .........+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 189 ~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 189 ADFGLSKKIYSGD-------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp CSCSCC-----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred eecCcceeccccc-------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 9999987421100 001122345788999999999999999999999999999999
Q ss_pred c-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 909 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 909 T-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+ |..||.+.........+..+.. +..+..++..+.+||.+||..||.+|||+.++++.|+.
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCC--CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCCCccCCHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9 9999999888888877766543 33457899999999999999999999999999988753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=368.42 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=206.0
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
......++|++.+.||+|+||.||+|.+. ++.||||+++... ........|+.++++++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 33456689999999999999999999876 8999999986532 33445667889999999999999999998754
Q ss_pred ----eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CceeeecCCCcEEeccCCcE
Q 001924 761 ----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------GIVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 761 ----~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~----------GIIHRDLKPeNILLDenG~V 826 (995)
.+++||||+++|+|.+++... .+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 379999999999999999764 599999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-----CCCchHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVG 901 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-----~ys~KSDIWSLG 901 (995)
||+|||+++...... .........||+.|+|||++.+. .++.++||||||
T Consensus 171 kL~DFg~a~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 171 CIADFGLALKFEAGK-------------------------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp EECCCTTCEEECTTS-------------------------CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred EEccCCccccccccc-------------------------CccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 999999997421100 01122345799999999999873 456789999999
Q ss_pred HHHHHHHcCCCCCCCCC----------------HHHHHHHHHccCCCCCCCCC-----CCCHHHHHHHHHHhhcCccCCC
Q 001924 902 IILFEFITGIPPFTAES----------------PEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRL 960 (995)
Q Consensus 902 VILyELLTGr~PF~g~s----------------~~ei~qkIl~~~~~~p~lps-----~lS~eL~dLIkkCLq~DPeKRP 960 (995)
|++|||++|+.||.+.. .......+..... .+..+. ..+..+.+||.+||+.||.+||
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC-CCCccccccccchHHHHHHHHHHHccCChhhCc
Confidence 99999999999997532 2233333333222 222221 2245699999999999999999
Q ss_pred CHHHHHHHHc
Q 001924 961 GANGAAEVFH 970 (995)
Q Consensus 961 SA~EIlEiL~ 970 (995)
|+.++++.|+
T Consensus 305 s~~ell~~L~ 314 (322)
T 3soc_A 305 SAGCVGERIT 314 (322)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 9999998875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=354.86 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=210.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-Ce
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-~~ 761 (995)
....++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 445689999999999999999999874 8899999987532 456789999999999999999999987654 47
Q ss_pred eEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~--Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
+++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~- 168 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS- 168 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc-
Confidence 8999999999999999976543 8999999999999999999999999999999999999999999999999987311
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 169 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 169 -----------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred -----------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 01112357889999999999999999999999999999998 999999888
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.......+..+.. +..+..+++.+.+||.+||..||.+|||+.++++.|++
T Consensus 220 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 220 LKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp GGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 7777776655432 33457899999999999999999999999999988764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=363.04 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=214.9
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEE-----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~-----~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
....++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3456899999999999999999999 55678899999986432 3455678999999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEE
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIK 827 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~-------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VK 827 (995)
.....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 4889999999999999999999999999999999999984 44699
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyEL 907 (995)
|+|||++....... .........||+.|+|||++.+..++.++||||||+++|+|
T Consensus 184 l~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 184 IGDFGMARDIYRAS-------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp ECCCHHHHHHHC-------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ECcccccccccccc-------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHH
Confidence 99999987421110 01112235689999999999999999999999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 908 LT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
++ |..||...........+..+.. +..+..++..+.+||.+||+.||.+||++.++++.|+
T Consensus 239 lt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 239 FSLGYMPYPSKSNQEVLEFVTSGGR--MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HcCCCCCCCCcCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 98 9999999888888877776543 2345788999999999999999999999777776654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.56 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=217.1
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 758 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG----~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~ 758 (995)
....++|++.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 455689999999999999999999987554 359999987532 34456678999999999999999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999764 57999999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g 916 (995)
..... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 198 ~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 198 EDDPE------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp -------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccc------------------------cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 11100 0011122346889999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....++...+..+.. +..+..++..+.+||.+||+.||.+||++.++++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 254 LSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp CCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHCCCc--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 988888877766532 22356789999999999999999999999999988764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=378.95 Aligned_cols=261 Identities=25% Similarity=0.439 Sum_probs=195.0
Q ss_pred CCeEE-EEeeccCCCeEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec--cCe
Q 001924 687 DDFEI-IKPISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDN 761 (995)
Q Consensus 687 ~dYeI-lk~LG~GgFGtVYka~~k--~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~--~~~ 761 (995)
+.|++ .++||+|+||+||+|.++ .+++.||||++.... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44666 457999999999999976 468899999987532 22467899999999999999999999954 678
Q ss_pred eEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe----ccCCcEEE
Q 001924 762 LYLVMEYLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKL 828 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~---------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL----DenG~VKL 828 (995)
+|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999996 5888888532 248999999999999999999999999999999999999 67789999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEF 907 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyEL 907 (995)
+|||+|+..... ..........+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 174 ~Dfg~a~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 174 ADMGFARLFNSP------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCTTCCC----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred EECCCceecCCC------------------------CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 999999742100 0011223346799999999999884 589999999999999999
Q ss_pred HcCCCCCCCCCHH---------HHHHHHHcc-CCC----CCC------------------------------CCCCCCHH
Q 001924 908 ITGIPPFTAESPE---------IIFDNILNR-KIP----WPC------------------------------VPSDMSFE 943 (995)
Q Consensus 908 LTGr~PF~g~s~~---------ei~qkIl~~-~~~----~p~------------------------------lps~lS~e 943 (995)
++|+.||.+.... +.+..+... +.+ |+. .....+..
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 9999999765432 333333221 111 000 01123678
Q ss_pred HHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 944 AQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 944 L~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
+.+||.+||+.||.+||| +.++|+||||.+..+.
T Consensus 310 ~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCC
T ss_pred HHHHHHHHccCCcccCCC---HHHHhcChhhccCCCC
Confidence 999999999999999999 7889999999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=363.76 Aligned_cols=268 Identities=25% Similarity=0.373 Sum_probs=216.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEE----ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee--c
Q 001924 685 SIDDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT--C 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~----~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~--~ 758 (995)
..++|++.+.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 34789999999999999999999 4678899999998753 3445677999999999999999999999886 4
Q ss_pred cCeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
...+++||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 55689999999999999999763 56999999999999999999999999999999999999999999999999999752
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.... ..........||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 178 ~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 178 PLDK------------------------DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CTTC------------------------SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccCC------------------------ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 1100 0111223456889999999999989999999999999999999999998654
Q ss_pred CHH---------------HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccc
Q 001924 918 SPE---------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 918 s~~---------------ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~ 981 (995)
... .....+ ..... +..+..+++.+.+||.+||+.||.+|||+.++++.|+..|.....+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 234 SAEFLRMMGCERDVPALSRLLELL-EEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHHHHHHCC----CCHHHHHHHHH-HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred cchhhhhcccccccccHHHHHHHh-hcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 322 222222 22222 234578999999999999999999999999999999988877665543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.52 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=212.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEE----EEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~V----AVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...++|++.+.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34588999999999999999999998888866 55554432 2334567899999999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
. .++|++|+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 78999999999999999764 569999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
... .........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 169 ~~~-------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 169 AEE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred Ccc-------------------------ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 100 0111223457889999999999999999999999999999999 99999998
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+...+..... ...+..++..+.+||.+||+.||.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 224 PASEISSILEKGER--LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 88877766655442 22356789999999999999999999999999987764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=368.56 Aligned_cols=257 Identities=29% Similarity=0.480 Sum_probs=186.0
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec----
Q 001924 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC---- 758 (995)
Q Consensus 684 ~s~~dYeIlk-~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~---- 758 (995)
...++|.+.+ .||+|+||.||+|.+..+|+.||||++.... . ........++.+.||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----K---ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----H---HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4568999965 6999999999999999999999999986521 1 11222334667899999999999876
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecCC
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGL 833 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFGL 833 (995)
...+++||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 455899999999999999998654 6999999999999999999999999999999999999976 45699999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 913 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P 913 (995)
++... .......+||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 178 ~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 178 AKETT-----------------------------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CEEC---------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ceecc-----------------------------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 87411 1112245689999999999888899999999999999999999999
Q ss_pred CCCCCHHHHH----HHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 914 FTAESPEIIF----DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 914 F~g~s~~ei~----qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
|......... ..+......++. ....++..+.+||.+||+.||.+||| +.++++||||++...
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWINQSMV 296 (336)
T ss_dssp C---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHHTGGG
T ss_pred CCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccccccc
Confidence 9876554432 222222222221 22578999999999999999999999 778889999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.37 Aligned_cols=252 Identities=29% Similarity=0.448 Sum_probs=206.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|.+. ++.||||++.. ....+.+.+|+.++++++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 4578999999999999999999875 78999998864 2356789999999999999999999998874 4899
Q ss_pred EEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCceeeecCCCcEEeccCCc-EEEEecCCcccc
Q 001924 765 VMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHS---LGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIG 837 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs---~GIIHRDLKPeNILLDenG~-VKLsDFGLArv~ 837 (995)
||||+++|+|.+++.... .++...+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999998654 47889999999999999999999 89999999999999998886 799999998631
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 157 ~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 157 Q------------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred c------------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 0 0112235899999999999999999999999999999999999999864
Q ss_pred C--HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC--cccccc
Q 001924 918 S--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC--KIFIKK 977 (995)
Q Consensus 918 s--~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H--PfF~~~ 977 (995)
. .......+.... .+..+..++..+.+||.+||+.||.+|||+.++++.|+. ++|...
T Consensus 207 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 207 GGPAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CSSHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred CccHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 3 223333333332 234457899999999999999999999999999998875 444433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.38 Aligned_cols=244 Identities=24% Similarity=0.410 Sum_probs=205.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec------
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~------ 758 (995)
...+|++.+.||+|+||.||+|.+..+|+.||+|+++... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3467999999999999999999999999999999987532 246789999999999999999998864
Q ss_pred ----------cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcE
Q 001924 759 ----------RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 759 ----------~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~V 826 (995)
...+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 44589999999999999999754 579999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyE 906 (995)
||+|||++..... ........||+.|+|||++.+..++.++||||||+++|+
T Consensus 162 kl~Dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 162 KIGDFGLVTSLKN----------------------------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213 (284)
T ss_dssp EECCCTTCEESSC----------------------------CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHH
T ss_pred EECcchhheeccc----------------------------cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHH
Confidence 9999999874210 011223469999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 907 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 907 LLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|++|..||... ......+.... .+..++..+.+||.+||..||.+|||+.++++.|+
T Consensus 214 l~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 214 LLHVCDTAFET--SKFFTDLRDGI-----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp HHSCCSSHHHH--HHHHHHHHTTC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCcchhH--HHHHHHhhccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999987532 23333333322 23568899999999999999999999777666553
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=373.20 Aligned_cols=267 Identities=15% Similarity=0.193 Sum_probs=206.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCceE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVV 750 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~T-----G~~VAVKVIkk~~~~se~e--------~e~flrEieILs~LkHPNIV 750 (995)
...++|++.+.||+|+||.||+|.+..+ ++.||||++.........+ ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4567999999999999999999998765 5889999987543111111 12344566677788899999
Q ss_pred EEeeeeecc----CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec--cC
Q 001924 751 RFFYSFTCR----DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HD 823 (995)
Q Consensus 751 kL~gvf~~~----~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD--en 823 (995)
++++++... ...|+||||+ +++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998875 4589999999 99999999865 5799999999999999999999999999999999999999 88
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHH
Q 001924 824 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (995)
Q Consensus 824 G~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (995)
+.+||+|||+++......... ..........+||+.|+|||++.+..++.++|||||||+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHK--------------------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCC--------------------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeEEEEECCcceecccCCccc--------------------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 999999999997532111100 001112234579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHccC--CCCC------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 904 LFEFITGIPPFTAESPEIIFDNILNRK--IPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 904 LyELLTGr~PF~g~s~~ei~qkIl~~~--~~~p------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+|||++|+.||.+.............. ...+ ..+..++.++.+||..||+.||.+||++.++.++|+.
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 999999999998643222111111100 0000 0125788999999999999999999999998887764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.41 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=212.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-eccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf-~~~~~ly 763 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+ ......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45899999999999999999999999999999999875432 23588999999999988766555444 5667789
Q ss_pred EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLArv~~~ 839 (995)
+||||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8999999974 4579999999999999999999999999999999999999 4889999999999985221
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s- 918 (995)
.... ............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccc--------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 1100 0001122345679999999999999999999999999999999999999998643
Q ss_pred --HHHHHHHHHccCCCC--CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 919 --PEIIFDNILNRKIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 919 --~~ei~qkIl~~~~~~--p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
....+..+....... +..+..+++.+.+||.+||+.||.+|||+.++.+.|+.-+-.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 223333333322211 123357899999999999999999999999999998865443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.54 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=206.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-eccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf-~~~~~ly 763 (995)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 35789999999999999999999999999999998765332 23578899999999988766665544 6667889
Q ss_pred EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLArv~~~ 839 (995)
+||||+ +|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999999974 4579999999999999999999999999999999999999 7889999999999985221
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
.... ............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 161 ~~~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTC--------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccC--------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 1100 00011223456799999999999999999999999999999999999999976432
Q ss_pred ---HHHHHHHHccCCCC--CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 ---EIIFDNILNRKIPW--PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ---~ei~qkIl~~~~~~--p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+..+....... +.....+++.+.+||.+||+.||.+|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 12222322222111 12235678999999999999999999999999988765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.27 Aligned_cols=269 Identities=23% Similarity=0.333 Sum_probs=193.8
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeee--
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT-- 757 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~-- 757 (995)
.......+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.++.++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3345557899999999999999999999999999999988653 2345677899999999996 999999999983
Q ss_pred ------ccCeeEEEEeecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEeccCCcE
Q 001924 758 ------CRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 758 ------~~~~lyLVmEym~GGSL~d~L~k---~~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLDenG~V 826 (995)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3445899999995 799998864 456999999999999999999999999 9999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh---cCCCCCchHHHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGII 903 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL---~g~~ys~KSDIWSLGVI 903 (995)
||+|||+++......... +...............||+.|+|||++ .+..++.++||||||++
T Consensus 178 kl~Dfg~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYS---------------WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp EBCCCTTCBCCSSCC----------------------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred EEecCccceeccccCccc---------------ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 999999998522111100 000000111222356799999999998 56678999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 904 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 904 LyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
+|+|++|..||.......... .....+ .+...+..+.+||.+||+.||.+|||+.++++.|+.-.
T Consensus 243 l~el~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIVN----GKYSIP-PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp HHHHHHSSCCC----------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCcchhHHHhhc----CcccCC-cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999998765443332 222222 23566788999999999999999999999988876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=363.57 Aligned_cols=270 Identities=21% Similarity=0.279 Sum_probs=214.6
Q ss_pred CCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 678 s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
+........++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 34555667899999999999999999999854 6899999998754321 12236889999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CceeeecCCCcEEeccCCcEEEEe
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTD 830 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~----~Lsee~ir~Ia~QIa~GLaYLHs~---GIIHRDLKPeNILLDenG~VKLsD 830 (995)
.....++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997543 489999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 001924 831 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 831 FGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG 910 (995)
||+++.... ..........||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 178 fg~~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 178 FGLAKLMDY--------------------------KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp CSSCEECCS--------------------------SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred CccccccCc--------------------------ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 999974210 011122345699999999999988899999999999999999999
Q ss_pred CCCCCCC----CHHHHHHHHHccCCC---CC---------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 911 IPPFTAE----SPEIIFDNILNRKIP---WP---------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 911 r~PF~g~----s~~ei~qkIl~~~~~---~p---------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
+.||... ............... .. ..+...+..+.+|+.+||+.||.+|||+.++++.|+...+
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 9999521 111111111111111 00 0112234679999999999999999999999999987666
Q ss_pred cc
Q 001924 975 IK 976 (995)
Q Consensus 975 ~~ 976 (995)
..
T Consensus 312 ~~ 313 (326)
T 3uim_A 312 AE 313 (326)
T ss_dssp SS
T ss_pred hh
Confidence 65
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.92 Aligned_cols=272 Identities=18% Similarity=0.188 Sum_probs=210.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC---CCcEEEEEEeecccccch--------hHHHHHHHHHHHHHhcCCCceEEE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK--------NDIERILAERNILITVRNPFVVRF 752 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~---TG~~VAVKVIkk~~~~se--------~e~e~flrEieILs~LkHPNIVkL 752 (995)
...++|++.+.||+|+||.||+|.+.. ++..||+|++........ .....+.+|+.+++.+.||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 788999999875432111 112346778899999999999999
Q ss_pred eeeeec----cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC--cE
Q 001924 753 FYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HI 826 (995)
Q Consensus 753 ~gvf~~----~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG--~V 826 (995)
++++.. ....|+||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 67899999999 999999998777899999999999999999999999999999999999999887 99
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 906 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyE 906 (995)
||+|||+++......... ...........||+.|+|||++.+..++.++|||||||++||
T Consensus 193 kL~Dfg~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 252 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHK--------------------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252 (345)
T ss_dssp EECCCTTCEESSGGGCCC--------------------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred EEEeCCCceecccccccc--------------------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 999999997532111000 001112245679999999999999999999999999999999
Q ss_pred HHcCCCCCCCC--CHHHHHHHHHccCCCCCC------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 907 FITGIPPFTAE--SPEIIFDNILNRKIPWPC------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 907 LLTGr~PF~g~--s~~ei~qkIl~~~~~~p~------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
|++|+.||.+. ................+. ....++..+.+||.+||..||.+||++.++++.|+...+.-
T Consensus 253 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 253 WLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 99999999652 332222211111111110 11278899999999999999999999999999999877643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=378.48 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=218.6
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
.+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++++||||+++++++.. +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345567889999999999999999999875 46799999875432 34678999999999999999999999876 6
Q ss_pred eeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999743 569999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.
T Consensus 332 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 332 DNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCc--------------------------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 100 011123347889999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
...+....+..+. . ...+..++..+.+||.+||+.||++|||+.++.+.|+.-+
T Consensus 386 ~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 386 VNREVLDQVERGY-R-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CHHHHHHHHHTTC-C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CHHHHHHHHHcCC-C-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9888888776553 2 2245789999999999999999999999999999987644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.39 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=212.3
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
......++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34556789999999999999999999964 68999999876532 345678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~----~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999986543 589999999999999999999999999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
.... ..........||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 189 ~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 189 GTEL-------------------------DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp CSSS-------------------------SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred cccc-------------------------cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 2100 001112345689999999999988999999999999999999999999976
Q ss_pred CCHHHHH-------HHHHccCCC---CC----CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 917 ESPEIIF-------DNILNRKIP---WP----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 917 ~s~~ei~-------qkIl~~~~~---~p----~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
..+.... ......... .+ ..+...+..+.+|+.+||+.||++|||+.++++.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp SSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 5432111 111111111 01 1123345678999999999999999999999887753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=361.25 Aligned_cols=267 Identities=21% Similarity=0.335 Sum_probs=210.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee----
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT---- 757 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~---- 757 (995)
.....++|++.+.||+|+||.||++.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 344567899999999999999999999999999999998653 3455678899999999999999999999987
Q ss_pred ccCeeEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
.....++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 34478999999999999999975 35699999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC---CCchHHHHHHHHHHHHHHcC
Q 001924 834 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITG 910 (995)
Q Consensus 834 Arv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~---ys~KSDIWSLGVILyELLTG 910 (995)
+........ ...............||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 181 ~~~~~~~~~------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 242 (317)
T 2buj_A 181 MNQACIHVE------------------GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242 (317)
T ss_dssp CEESCEEEE------------------SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred chhcccccc------------------cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence 874210000 000000001112345899999999997654 68899999999999999999
Q ss_pred CCCCCCCC--HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 911 IPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 911 r~PF~g~s--~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+.||.... .......+ ......+ .+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 243 ~~p~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 243 EGPYDMVFQKGDSVALAV-QNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp SCTTHHHHHTTSCHHHHH-HCC--CC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCChhhhhcccchhhHHh-hccCCCC-ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 99995421 11112222 2232222 235789999999999999999999999999888753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=373.61 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=210.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC--ee
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NL 762 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~--~l 762 (995)
..++|++.+.||+|+||.||+|.+..+|+.||||+++.... ....+.+.+|+++++.++||||+++++++.... ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 45789999999999999999999999999999999976433 233567889999999999999999999988765 68
Q ss_pred EEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe----ccCCcEEEEecCCcc
Q 001924 763 YLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 835 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL----DenG~VKLsDFGLAr 835 (995)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997543 39999999999999999999999999999999999999 777889999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--------CCCCchHHHHHHHHHHHHH
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--------TEHGYAADWWSVGIILFEF 907 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--------~~ys~KSDIWSLGVILyEL 907 (995)
.... .......+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 165 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 165 ELED----------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp ECCC----------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred EccC----------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 4210 112234579999999999865 4678899999999999999
Q ss_pred HcCCCCCCCC----CHHHHHHHHHccCCCC-------------------C---CCCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 908 ITGIPPFTAE----SPEIIFDNILNRKIPW-------------------P---CVPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 908 LTGr~PF~g~----s~~ei~qkIl~~~~~~-------------------p---~lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
++|+.||... ...+....+..+.... + .++..++..+.+||.+||+.||++||+
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 9999999642 3345555555543210 0 111234567889999999999999999
Q ss_pred HHHHHHHHc
Q 001924 962 ANGAAEVFH 970 (995)
Q Consensus 962 A~EIlEiL~ 970 (995)
+.++.+.+.
T Consensus 297 ~~e~l~~l~ 305 (396)
T 4eut_A 297 FDQFFAETS 305 (396)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 988776553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=355.32 Aligned_cols=267 Identities=25% Similarity=0.347 Sum_probs=197.8
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH--HhcCCCceEEEeeeeec--
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL--ITVRNPFVVRFFYSFTC-- 758 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieIL--s~LkHPNIVkL~gvf~~-- 758 (995)
....++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|.+++ ..++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 45678999999999999999999976 58999999987432 33444555554 45899999999975432
Q ss_pred ---cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeeecCCCcEEeccCCcE
Q 001924 759 ---RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHI 826 (995)
Q Consensus 759 ---~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~---------GIIHRDLKPeNILLDenG~V 826 (995)
...+++||||+++|+|.+++.... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 336789999999999999997654 58889999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-------CCCCchHHHHH
Q 001924 827 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWS 899 (995)
Q Consensus 827 KLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-------~~ys~KSDIWS 899 (995)
||+|||+++......... ...........+||+.|+|||++.+ ..++.++||||
T Consensus 160 kL~DFG~a~~~~~~~~~~-------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws 220 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVR-------------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220 (336)
T ss_dssp EECCCTTCEECSSSSCC----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred EEeeccceeecccccccC-------------------ccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence 999999998532111000 0011122334579999999999987 35567999999
Q ss_pred HHHHHHHHHcCCCCCCCC-C----------------HHHHHHHHHccCCCCCCCCCC------CCHHHHHHHHHHhhcCc
Q 001924 900 VGIILFEFITGIPPFTAE-S----------------PEIIFDNILNRKIPWPCVPSD------MSFEAQDLINRFLIHDP 956 (995)
Q Consensus 900 LGVILyELLTGr~PF~g~-s----------------~~ei~qkIl~~~~~~p~lps~------lS~eL~dLIkkCLq~DP 956 (995)
|||++|||++|..||... . ...............+.++.. ++..+.+||.+||+.||
T Consensus 221 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (336)
T 3g2f_A 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300 (336)
T ss_dssp HHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCCh
Confidence 999999999997765321 1 111222222222222333333 34579999999999999
Q ss_pred cCCCCHHHHHHHHcC---cccccc
Q 001924 957 NQRLGANGAAEVFHC---KIFIKK 977 (995)
Q Consensus 957 eKRPSA~EIlEiL~H---PfF~~~ 977 (995)
++|||+.++++.|+. +|-++.
T Consensus 301 ~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 301 EARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp GGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hhCcchHHHHHHHHHHHHHHHhcc
Confidence 999999998887654 555544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=363.83 Aligned_cols=257 Identities=18% Similarity=0.214 Sum_probs=206.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCC--------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEE------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTT--------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR------ 751 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~T--------G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVk------ 751 (995)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999998753 35788999999999999987
Q ss_pred ---------Eeeeeec-cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEE
Q 001924 752 ---------FFYSFTC-RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 819 (995)
Q Consensus 752 ---------L~gvf~~-~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNIL 819 (995)
+++++.. ....|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5566665 67899999999 99999999875 67999999999999999999999999999999999999
Q ss_pred eccCC--cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHH
Q 001924 820 IAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (995)
Q Consensus 820 LDenG--~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDI 897 (995)
++.++ .+||+|||+++......... ...........||+.|+|||++.+..++.++||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHV--------------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCC--------------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCccc--------------------cccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99998 99999999997532111000 001112234579999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCC--HHHHHHHHH---ccCCCCCC---CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 898 WSVGIILFEFITGIPPFTAES--PEIIFDNIL---NRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 898 WSLGVILyELLTGr~PF~g~s--~~ei~qkIl---~~~~~~p~---lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
||||+++|+|++|+.||.... ...+..... .....++. ....++..+.+||.+||+.||.+||++.++++.|
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 999999999999999998753 333333222 12211111 1125689999999999999999999999998887
Q ss_pred cC
Q 001924 970 HC 971 (995)
Q Consensus 970 ~H 971 (995)
+.
T Consensus 332 ~~ 333 (352)
T 2jii_A 332 EA 333 (352)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=354.54 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=201.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc--CCCceEEEeeeeecc
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFFYSFTCR 759 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L--kHPNIVkL~gvf~~~ 759 (995)
.....++|++.+.||+|+||.||+|.+. |+.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3445688999999999999999999875 899999998642 234455666666554 899999999999887
Q ss_pred ----CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeeecCCCcEEeccCCcEE
Q 001924 760 ----DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIK 827 (995)
Q Consensus 760 ----~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--------GIIHRDLKPeNILLDenG~VK 827 (995)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 6799999999999999999654 699999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCch------HHHHHHH
Q 001924 828 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA------ADWWSVG 901 (995)
Q Consensus 828 LsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~K------SDIWSLG 901 (995)
|+|||+++....... .........+||+.|+|||++.+..++.. +||||||
T Consensus 183 l~Dfg~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 239 (337)
T 3mdy_A 183 IADLGLAVKFISDTN-----------------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239 (337)
T ss_dssp ECCCTTCEECC--------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHH
T ss_pred EEeCCCceeeccccc-----------------------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHH
Confidence 999999874211000 00111234579999999999988766554 9999999
Q ss_pred HHHHHHHcC----------CCCCCCCC----HHHHHHHHHccCCCCCCCC-----CCCCHHHHHHHHHHhhcCccCCCCH
Q 001924 902 IILFEFITG----------IPPFTAES----PEIIFDNILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 902 VILyELLTG----------r~PF~g~s----~~ei~qkIl~~~~~~p~lp-----s~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
|++|||++| ..||.... ...............+..+ ..++..+.+||.+||+.||.+|||+
T Consensus 240 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 999999999 77775432 1222222222222222222 2456779999999999999999999
Q ss_pred HHHHHHHc
Q 001924 963 NGAAEVFH 970 (995)
Q Consensus 963 ~EIlEiL~ 970 (995)
.++++.|+
T Consensus 320 ~ell~~L~ 327 (337)
T 3mdy_A 320 LRVKKTLA 327 (337)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=390.97 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=221.8
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIK-PISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk-~LG~GgFGtVYka~~k~--TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~ 760 (995)
...++|.+.+ .||+|+||.||+|.+.. ++..||||+++... .....+.+.+|+++|++++|||||++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3456677777 89999999999998753 55689999997642 23456789999999999999999999999976 5
Q ss_pred eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999754 4599999999999999999999999999999999999999999999999999984211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s 918 (995)
... .........+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+
T Consensus 489 ~~~------------------------~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 489 DDS------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp -------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCc------------------------eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 100 0011122346789999999999999999999999999999998 999999998
Q ss_pred HHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
..++...+..+.. ...+..+++.+.+||.+||+.||.+||++.++.+.|++.|+.-..
T Consensus 545 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 545 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp SHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 8888887776542 334578999999999999999999999999999999998876544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=382.29 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=222.9
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|++++||||+++++++..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3445667889999999999999999999875 46799999975432 34678999999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 6789999999999999999743 56999999999999999999999999999999999999999999999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g 916 (995)
.... ........+|..|+|||++.+..++.++|||||||+||||++ |+.||.+
T Consensus 414 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 414 EDNE--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCHH--------------------------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCCc--------------------------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1100 011123457889999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
....++...+..+. .+ ..+..++..+.+||.+||+.||++|||+.++++.|+.-+-
T Consensus 468 ~~~~~~~~~i~~~~-~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 468 MVNREVLDQVERGY-RM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCHHHHHHHHHTTC-CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCHHHHHHHHHcCC-CC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 99888888776543 22 2356899999999999999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.73 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=217.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..+....++|++.+.||+|+||.||+|.+.. .||+|+++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4556678999999999999999999998863 499999875332 223345677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
...++||||+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999997654 689999999999999999999999999999999999998 7899999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---------CCCCchHHHHHHHHHHHHHHc
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---------TEHGYAADWWSVGIILFEFIT 909 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---------~~ys~KSDIWSLGVILyELLT 909 (995)
.... ...........||+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 181 ~~~~----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 181 VLQA----------------------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp -----------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred cccc----------------------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 0000 011122234569999999999975 457899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 910 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 910 Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
|..||...........+..+..+. ..+..++..+.+||.+||..||.+|||+.++++.|+.-.
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQMGTGMKPN-LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp SSCSSSSCCHHHHHHHHHTTCCCC-CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCCCCCCCHHHHHHHhccCCCCC-CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 999999998888887776654432 223468889999999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=367.69 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=207.6
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-cCee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG---~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-~~~l 762 (995)
..|++.+.||+|+||.||+|.+..++ ..||+|.++.. ........+.+|+.++++++||||+++++++.. .+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 45889999999999999999986433 36899988643 234567889999999999999999999998654 5678
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999754 458899999999999999999999999999999999999999999999999997421110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
. ..........||+.|+|||++.+..++.++||||||+++|||++ |.+||...+..
T Consensus 247 ~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 247 F-----------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred c-----------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 0 00111223457889999999999999999999999999999999 78899887776
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
+....+..+.. +..+..++..+.+||.+||+.||.+|||+.++++.|+.
T Consensus 304 ~~~~~~~~~~~--~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 304 DITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 66666665543 23457789999999999999999999999999988765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=362.35 Aligned_cols=259 Identities=15% Similarity=0.213 Sum_probs=205.8
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEE-----EECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEE
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLA-----RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVR 751 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka-----~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk---HPNIVk 751 (995)
.......++|.+.+.||+|+||+||+| .+..+++.||||+++.. ....+..|+.++..++ |+||++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhh
Confidence 344556788999999999999999999 46778999999998753 2456778888888887 899999
Q ss_pred EeeeeeccCeeEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc----
Q 001924 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---- 822 (995)
Q Consensus 752 L~gvf~~~~~lyLVmEym~GGSL~d~L~k-----~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---- 822 (995)
+++++...+..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 823 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 823 -------nG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
++.+||+|||+|+..... .........+||+.|+|||++.+..|+.++
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 266 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLF-------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGS-------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHH
T ss_pred ccccccccCCEEEeeCchhhhhhcc-------------------------CCCceeeeecCCCCCCChHHhcCCCCCccc
Confidence 899999999999742100 011223456799999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC-HHHHHHHHcCccc
Q 001924 896 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVFHCKIF 974 (995)
Q Consensus 896 DIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS-A~EIlEiL~HPfF 974 (995)
|||||||++|||++|+.||........ .....+.. ...+..+.+++..||+.+|.+|++ +.++.+.|+ .||
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~-~~l 338 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK-KVF 338 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTEE-----EECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH-HHH
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCce-----eechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH-HHH
Confidence 999999999999999999965322110 00111111 134677899999999999999954 666666555 344
Q ss_pred ccc
Q 001924 975 IKK 977 (995)
Q Consensus 975 ~~~ 977 (995)
.+.
T Consensus 339 ~~~ 341 (365)
T 3e7e_A 339 QQH 341 (365)
T ss_dssp HHH
T ss_pred HHh
Confidence 443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=352.60 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=203.3
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeec
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 769 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym 769 (995)
..+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 347899999999999986 588999999875332 23345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 770 NGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 770 ~GGSL~d~L~k---~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 186 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF------ 186 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC------
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc------
Confidence 99999999974 345899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----H
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----I 922 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e----i 922 (995)
..........||+.|+|||++.+ .++.++||||||+++|+|++|..||....... +
T Consensus 187 -------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 187 -------------------AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp -------------------SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred -------------------cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 00111234579999999999875 58899999999999999999999998654322 2
Q ss_pred HHHHHccCC--------CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 923 FDNILNRKI--------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 923 ~qkIl~~~~--------~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
...+..... .++..+...+..+.+|+.+||+.||.+|||+.++++.|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 222221111 111122344567899999999999999999999998875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=389.92 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=216.2
Q ss_pred CeEEE-EeeccCCCeEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 688 DFEII-KPISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 688 dYeIl-k~LG~GgFGtVYka~~--k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
.+.+. +.||+|+||.||+|.+ ..+++.||||+++... ......+.+.+|+.+|++++|||||++++++.. +.+++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999965 4567899999997643 334456789999999999999999999999864 56899
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-- 524 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-- 524 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc--
Confidence 999999999999999888899999999999999999999999999999999999999999999999999985221110
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++.
T Consensus 525 ----------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 582 (635)
T 4fl3_A 525 ----------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582 (635)
T ss_dssp --------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ----------------------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 0011223457889999999999999999999999999999998 99999999998888
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
..+..+.. +..+..++.++.+||..||+.||++||++.++++.|+.-|
T Consensus 583 ~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 583 AMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 88776542 3346789999999999999999999999999999987533
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.05 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=208.8
Q ss_pred CCe-EEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc--
Q 001924 687 DDF-EIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 759 (995)
Q Consensus 687 ~dY-eIlk~LG~GgFGtVYka~~----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-- 759 (995)
++| ++.+.||+|+||.||++.+ ..+++.||||+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 444 9999999999999988764 347889999999754 2345567899999999999999999999999874
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 5789999999999999999764 499999999999999999999999999999999999999999999999999974211
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
.. ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 187 ~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 187 GH------------------------EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp TC------------------------SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred cc------------------------cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 00 001122345688899999999998999999999999999999999999975422
Q ss_pred H--------------HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 E--------------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~--------------ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
. ............ +..+..++..+.+||.+||+.||.+|||+.++++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 011222222222 3345789999999999999999999999999998875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.49 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=210.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~----k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
...++|++.+.||+|+||.||+|.. ..+|+.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3457899999999999999999984 568999999998753 344567899999999999999999999988765
Q ss_pred C--eeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 760 D--NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 760 ~--~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
+ .+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 789999999999999999865 4599999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
...... .........+|..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 195 ~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKE------------------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCS------------------------EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cccccc------------------------ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 211000 00112234578889999999988899999999999999999999999864
Q ss_pred CCHH------------H---HHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 917 ESPE------------I---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 917 ~s~~------------e---i~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.... . .....+..... +..+..++..+.+||.+||+.||.+|||+.++++.|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 251 PPAEFMRMIGNDKQGQMIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHhhccccchhhhHHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 3111 0 11122222222 2245789999999999999999999999999998775
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=348.32 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=206.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeeccC
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD 760 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~--LkHPNIVkL~gvf~~~~ 760 (995)
....++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34457899999999999999999987 4899999998642 34567889999887 78999999999998876
Q ss_pred ----eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeeecCCCcEEeccCCcEEE
Q 001924 761 ----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------SLGIVHRDLKPDNLLIAHDGHIKL 828 (995)
Q Consensus 761 ----~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLH--------s~GIIHRDLKPeNILLDenG~VKL 828 (995)
.+++||||+++|+|.+++.+ ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred CccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 78999999999999999976 46999999999999999999999 899999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC------CCchHHHHHHHH
Q 001924 829 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGI 902 (995)
Q Consensus 829 sDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~------ys~KSDIWSLGV 902 (995)
+|||++........ ..........||+.|+|||++.+.. ++.++||||||+
T Consensus 189 ~Dfg~~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 189 ADLGLAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp CCCTTCEEEETTTT-----------------------EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred EECCCceecccccc-----------------------ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 99999874211100 0011223457999999999998763 347899999999
Q ss_pred HHHHHHcC----------CCCCCCC-----CHHHHHHHHHccCCCCCCCCC-----CCCHHHHHHHHHHhhcCccCCCCH
Q 001924 903 ILFEFITG----------IPPFTAE-----SPEIIFDNILNRKIPWPCVPS-----DMSFEAQDLINRFLIHDPNQRLGA 962 (995)
Q Consensus 903 ILyELLTG----------r~PF~g~-----s~~ei~qkIl~~~~~~p~lps-----~lS~eL~dLIkkCLq~DPeKRPSA 962 (995)
++|||++| ..||... ....+...+...... +.++. ..+..+.+||.+||+.||.+|||+
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 324 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence 99999999 7898764 234444444433322 22222 334678999999999999999999
Q ss_pred HHHHHHHcC
Q 001924 963 NGAAEVFHC 971 (995)
Q Consensus 963 ~EIlEiL~H 971 (995)
.++++.|+.
T Consensus 325 ~~i~~~L~~ 333 (342)
T 1b6c_B 325 LRIKKTLSQ 333 (342)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999988764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=363.27 Aligned_cols=256 Identities=27% Similarity=0.369 Sum_probs=196.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~lyL 764 (995)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.....+|+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3556777899999999998754 457999999988642 235678899999876 89999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-------------C
Q 001924 765 VMEYLNGGDLYSLLRKVGCLE-------EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-------------G 824 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Ls-------ee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-------------G 824 (995)
||||+. |+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 69999997654332 22356789999999999999999999999999999754 4
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-------CCCCchHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADW 897 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-------~~ys~KSDI 897 (995)
.+||+|||+++....... .........+||+.|+|||++.+ ..++.++||
T Consensus 166 ~~kL~DFG~a~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQS-----------------------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp EEEECCCTTCEECCC-------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred EEEEcccccceecCCCCc-----------------------cceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 899999999985211000 00011234579999999999976 568999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCC----CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCc
Q 001924 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVP----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCK 972 (995)
Q Consensus 898 WSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lp----s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HP 972 (995)
|||||++|||++ |..||....... ..+..+....+..+ ..++.++.+||.+||+.||.+||| +.++++||
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~hp 297 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT---AMKVLRHP 297 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHTSG
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC---HHHHHhCC
Confidence 999999999999 999997765433 34444444433221 234578999999999999999999 77889999
Q ss_pred ccccc
Q 001924 973 IFIKK 977 (995)
Q Consensus 973 fF~~~ 977 (995)
||...
T Consensus 298 ~f~~~ 302 (434)
T 2rio_A 298 LFWPK 302 (434)
T ss_dssp GGSCH
T ss_pred ccCCc
Confidence 99764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.73 Aligned_cols=241 Identities=30% Similarity=0.509 Sum_probs=195.3
Q ss_pred cccCCCeEEE-EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeeec--
Q 001924 683 RTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTC-- 758 (995)
Q Consensus 683 ~~s~~dYeIl-k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieIL-s~LkHPNIVkL~gvf~~-- 758 (995)
....++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3456889988 7899999999999999999999999998642 3467788887 66799999999999887
Q ss_pred --cCeeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEec
Q 001924 759 --RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDF 831 (995)
Q Consensus 759 --~~~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDF 831 (995)
...+++||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 677999999999999999998754 6999999999999999999999999999999999999998 789999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 001924 832 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911 (995)
Q Consensus 832 GLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr 911 (995)
|++... .+..++.++|||||||++|+|++|+
T Consensus 165 g~a~~~-------------------------------------------------~~~~~~~~~DiwslG~il~el~tg~ 195 (299)
T 3m2w_A 165 GFAKET-------------------------------------------------TGEKYDKSCDMWSLGVIMYILLCGY 195 (299)
T ss_dssp TTCEEC-------------------------------------------------TTCGGGGHHHHHHHHHHHHHHHHSS
T ss_pred cccccc-------------------------------------------------ccccCCchhhHHHHHHHHHHHHHCC
Confidence 998731 0134678999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHccCCC-CCCCC----CCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccccccc
Q 001924 912 PPFTAESPEIIFDNILNRKIP-WPCVP----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983 (995)
Q Consensus 912 ~PF~g~s~~ei~qkIl~~~~~-~p~lp----s~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s 983 (995)
.||.+.........+...... ....+ ..++.++.+||.+||+.||.+||| +.++++||||.+.......
T Consensus 196 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQSTKVPQT 269 (299)
T ss_dssp CSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTGGGSCCC
T ss_pred CCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhcccccCCCC
Confidence 999876544332211111100 01111 468999999999999999999999 7888999999887654443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=368.96 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=199.4
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCee
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~l 762 (995)
....+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+++.+ +|||||++++++......
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3445799999999999999764 3345799999999865322 2356799999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---C--CcEEEEecCCccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---D--GHIKLTDFGLSKI 836 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---n--G~VKLsDFGLArv 836 (995)
|+||||+. |+|.+++.... .+....+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|+.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999996 69999997654 3555566789999999999999999999999999999953 2 3588999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc---CCCCCchHHHHHHHHHHHHHHc-CCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT-GIP 912 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~---g~~ys~KSDIWSLGVILyELLT-Gr~ 912 (995)
..... .........+||+.|+|||++. +..++.++|||||||++|||++ |..
T Consensus 173 ~~~~~------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~ 228 (432)
T 3p23_A 173 LAVGR------------------------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228 (432)
T ss_dssp C------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred ccCCC------------------------cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 21110 0011223467999999999997 4567889999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 913 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
||...........+..........+...+..+.+||.+||+.||.+||| +.++++||||....+
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFWSLEK 292 (432)
T ss_dssp TTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTCCHHH
T ss_pred CcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCccccChHH
Confidence 9976654444332222222222122334566899999999999999999 788999999987665
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=379.74 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=217.6
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~T---G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
....++|++.+.||+|+||.||+|.+..+ +..||+|.++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44567899999999999999999998654 4579999876432 3445678999999999999999999999985 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 56899999999999999997654 68999999999999999999999999999999999999999999999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.. .........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.
T Consensus 543 ~~--------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 543 DS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp C------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CC--------------------------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 10 0011123457889999999999999999999999999999997 99999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
...+....+..+.. +..+..+++.+.+||.+||..||.+|||+.++.+.|+.
T Consensus 597 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 597 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 98888888776543 23457899999999999999999999999999988754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=367.46 Aligned_cols=274 Identities=21% Similarity=0.283 Sum_probs=219.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH-PNIVkL~gvf~~~~~ly 763 (995)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| +++..+..++...+..+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 35789999999999999999999999999999998875432 2347889999999987 56666667777788899
Q ss_pred EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEe---ccCCcEEEEecCCcccccc
Q 001924 764 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI---AHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILL---DenG~VKLsDFGLArv~~~ 839 (995)
|||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 4579999999999999999999999999999999999999 6889999999999985321
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 918 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s- 918 (995)
.... ...........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..
T Consensus 159 ~~~~--------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 159 TSTH--------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp TTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred Cccc--------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 1100 0001122335679999999999999999999999999999999999999998753
Q ss_pred --HHHHHHHHHccCCC--CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc-------Cccccccccccccc
Q 001924 919 --PEIIFDNILNRKIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH-------CKIFIKKTENCVSM 984 (995)
Q Consensus 919 --~~ei~qkIl~~~~~--~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~-------HPfF~~~~~n~~s~ 984 (995)
....+..+...... ...++..++.++.+||..||+.||.+||++.++.++|+ ++|+...+|.....
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred hhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 33334443332211 11223578899999999999999999999988877665 56777777765533
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=365.00 Aligned_cols=255 Identities=16% Similarity=0.168 Sum_probs=198.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-Cce-------------
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFV------------- 749 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH-PNI------------- 749 (995)
....+|...+.||+|+||+||+|.+..+|+.||||+++..........+.+.+|+.++..+.| +|.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345669999999999999999999999999999999885444444456788999999999987 221
Q ss_pred --EE------Eeeeeec-----cCeeEEEEeecCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 001924 750 --VR------FFYSFTC-----RDNLYLVMEYLNGGDLYSLLRK-------VGCLEEDVARIYIAELVLALEYLHSLGIV 809 (995)
Q Consensus 750 --Vk------L~gvf~~-----~~~lyLVmEym~GGSL~d~L~k-------~~~Lsee~ir~Ia~QIa~GLaYLHs~GII 809 (995)
+. ++.++.. ....+++|+++ +++|.+++.. ...+++..+..++.|++.||+|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11 1111111 12357777766 6899999852 23467778888999999999999999999
Q ss_pred eeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhh---
Q 001924 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 886 (995)
Q Consensus 810 HRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL--- 886 (995)
||||||+|||++.++.+||+|||+++... ......+| +.|+|||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~------------------------------~~~~~~~g-~~y~aPE~~~~~ 282 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG------------------------------ASAVSPIG-RGFAPPETTAER 282 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT------------------------------EEECCCCC-TTTCCHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC------------------------------CccccCCC-CceeCchhhhcc
Confidence 99999999999999999999999987411 01234578 999999999
Q ss_pred -------cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCC
Q 001924 887 -------LGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 887 -------~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKR 959 (995)
.+..++.++|||||||++|||++|+.||...........+... ...++..+.+||.+||+.||.+|
T Consensus 283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGGGS
T ss_pred ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhh-------cccCCHHHHHHHHHHccCChhhC
Confidence 5566889999999999999999999999887654443333222 23678999999999999999999
Q ss_pred CCHHHHHHHHcCccccccccc
Q 001924 960 LGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~~~~n 980 (995)
|+ +.++++||||+...+.
T Consensus 356 pt---~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 356 LL---PLQAMETPEYEQLRTE 373 (413)
T ss_dssp CC---HHHHTTSHHHHHHHHH
T ss_pred cC---HHHHHhCHHHHHHHHH
Confidence 99 7788889999887543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.16 Aligned_cols=247 Identities=19% Similarity=0.249 Sum_probs=193.4
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcC---------CCceE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVR---------NPFVV 750 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-----~se~e~e~flrEieILs~Lk---------HPNIV 750 (995)
..++|++.+.||+|+||+||+|++ +|+.||||+++.... ......+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999998 689999999986532 12334577899999998886 55555
Q ss_pred EEeee-----------------eec-------------cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 001924 751 RFFYS-----------------FTC-------------RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800 (995)
Q Consensus 751 kL~gv-----------------f~~-------------~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GL 800 (995)
++.++ +.. ...+|+||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 55544 443 6789999999999987766644 5689999999999999999
Q ss_pred HHHH-HcCceeeecCCCcEEeccCC--------------------cEEEEecCCcccccccccccCCCCCCCCCCCCCCC
Q 001924 801 EYLH-SLGIVHRDLKPDNLLIAHDG--------------------HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859 (995)
Q Consensus 801 aYLH-s~GIIHRDLKPeNILLDenG--------------------~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ 859 (995)
+||| ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~--------------------- 233 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER--------------------- 233 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE---------------------
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC---------------------
Confidence 9999 99999999999999999887 89999999998421
Q ss_pred CCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHHccC-CC---C
Q 001924 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII-LFEFITGIPPFTAESP-EIIFDNILNRK-IP---W 933 (995)
Q Consensus 860 ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI-LyELLTGr~PF~g~s~-~ei~qkIl~~~-~~---~ 933 (995)
....+||+.|+|||++.+.. +.++||||||++ .++++.|..||..... ......+.... .. .
T Consensus 234 -----------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (336)
T 2vuw_A 234 -----------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCN 301 (336)
T ss_dssp -----------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCC
T ss_pred -----------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccc
Confidence 01347999999999998776 899999998777 7778889999854321 22333333221 11 1
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH-cCcccc
Q 001924 934 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF-HCKIFI 975 (995)
Q Consensus 934 p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL-~HPfF~ 975 (995)
+..+..+++++.+||.+||++| | +.++| +||||+
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 1112347889999999999987 5 88899 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.53 Aligned_cols=233 Identities=14% Similarity=0.142 Sum_probs=194.9
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.++..++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34578999999999999999999999999999999998765555566788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+||||++|++|.+++... .....+..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999999543 4556778899999999999999999999999999999999999988544
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
|++ .++.++|||||||++|||++|+.||.+.+.....
T Consensus 175 ------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 175 ------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp ------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred ------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 222 2688999999999999999999999876543211
Q ss_pred H---HHHccCCCC-CCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 924 D---NILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 924 q---kIl~~~~~~-p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
. ......... ...+..+++.+.+||.+||+.||.+| |+.++++.|+..-
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 212 APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0 111111110 11336789999999999999999999 9999999887643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=379.89 Aligned_cols=260 Identities=28% Similarity=0.399 Sum_probs=207.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec------
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~------ 758 (995)
..++|++.+.||.|+||.||+|.+..+|+.||||+++.. ......+.+.+|+.++++++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 458899999999999999999999999999999998753 234556789999999999999999999998766
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCc---EEEEecC
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFG 832 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~---~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~---VKLsDFG 832 (995)
.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 667899999999999999998654 5899999999999999999999999999999999999997764 9999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 170 ~a~~~~~----------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~ 221 (676)
T 3qa8_A 170 YAKELDQ----------------------------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221 (676)
T ss_dssp CCCBTTS----------------------------CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCS
T ss_pred ccccccc----------------------------ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCC
Confidence 9874210 111234579999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHH--------------HHccCCCCC-------CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 913 PFTAESPEIIFDN--------------ILNRKIPWP-------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 913 PF~g~s~~ei~qk--------------Il~~~~~~p-------~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
||.+......+.. ...+...+. .++..++..+.+||.+||..||.+||| +.++++|
T Consensus 222 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT---a~elL~h 298 (676)
T 3qa8_A 222 PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT---DPQNPNV 298 (676)
T ss_dssp SCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C---CTTCCCC
T ss_pred CCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC---HHHHhcC
Confidence 9976533221100 011111111 122346788999999999999999999 6677899
Q ss_pred cccccc
Q 001924 972 KIFIKK 977 (995)
Q Consensus 972 PfF~~~ 977 (995)
|||...
T Consensus 299 p~F~~l 304 (676)
T 3qa8_A 299 GCFQAL 304 (676)
T ss_dssp TTHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=367.24 Aligned_cols=232 Identities=29% Similarity=0.412 Sum_probs=190.8
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe-
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN- 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~-TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~- 761 (995)
...++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 345899999999999999999999976 78999999886532 34456778999999999999999999999988765
Q ss_pred ----eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 762 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 762 ----lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
.|+||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998755 69999999999999999999999999999999999999875 9999999998741
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
. .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.
T Consensus 232 ~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 232 N-------------------------------SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp T-------------------------------CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred c-------------------------------cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 0 01235699999999999765 489999999999999999999998753
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCC
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPS 961 (995)
... ..+........++.+.+||.+||+.||.+||+
T Consensus 280 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~ 314 (681)
T 2pzi_A 280 YVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT 314 (681)
T ss_dssp ECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred ccc---------cccccccccccCHHHHHHHhhhccCChhhCCC
Confidence 110 11100001124578999999999999999997
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=304.59 Aligned_cols=190 Identities=18% Similarity=0.140 Sum_probs=137.2
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccCeeE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-------se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~~ly 763 (995)
....+.|++|.+..++...+|+.||+|++.+.... .+...+++.+|+++|+++ .|+||+++++++.+++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34577888888888888889999999999764211 233456799999999999 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|||||++|++|.++|...+.++.. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~---- 391 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ---- 391 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC----
Confidence 999999999999999988888765 4788999999999999999999999999999999999999999984210
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
......+.+||+.|||||++.+ .+..++|+||+|+++++|.++..
T Consensus 392 -----------------------~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 -----------------------DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -----------------------CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 1122345689999999999976 46778999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=264.00 Aligned_cols=194 Identities=18% Similarity=0.130 Sum_probs=145.1
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
...+.||+|+||.||+|. ..+..+++|.+...... .....+.+.+|++++++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446789999999999994 35788999986542221 11224568999999999999999966555557777899
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++|+|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~-- 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED-- 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH--
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc--
Confidence 9999999999999875 5688999999999999999999999999999988 999999999985211000
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g--~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
............+||+.|||||++.+ ..|+...|+|+..+-..+.+.++.+|.
T Consensus 485 ------------------~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 ------------------KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ------------------HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ------------------cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00000001235679999999999977 567888899999999888888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-24 Score=226.31 Aligned_cols=136 Identities=21% Similarity=0.201 Sum_probs=110.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch---------------hHHHHHHHHHHHHHhcCCCceEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---------------NDIERILAERNILITVRNPFVVR 751 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se---------------~e~e~flrEieILs~LkHPNIVk 751 (995)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.+++.++| ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 4466779999999999999999 7899999999864321110 235678999999999994 55
Q ss_pred EeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEec
Q 001924 752 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 831 (995)
Q Consensus 752 L~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDF 831 (995)
+++++. .+..|+||||++||+|.+ +. . .....++.|++.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 166 v~~~~~-~~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 166 VPKVYA-WEGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp SCCEEE-EETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred cCeEEe-ccceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 555443 356799999999999988 42 1 23456899999999999999999999999999999 999999999
Q ss_pred CCcc
Q 001924 832 GLSK 835 (995)
Q Consensus 832 GLAr 835 (995)
|+|+
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=188.46 Aligned_cols=139 Identities=21% Similarity=0.192 Sum_probs=108.7
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcE--EEEEEeeccccc---------------------chhHHHHHHHHHHHHHhcC
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMI---------------------RKNDIERILAERNILITVR 745 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~--VAVKVIkk~~~~---------------------se~e~e~flrEieILs~Lk 745 (995)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... .......+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778999 999997643211 0112246788999999998
Q ss_pred CCce--EEEeeeeeccCeeEEEEeecCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCceeeecCCCc
Q 001924 746 NPFV--VRFFYSFTCRDNLYLVMEYLNG-G----DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDN 817 (995)
Q Consensus 746 HPNI--VkL~gvf~~~~~lyLVmEym~G-G----SL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLH-s~GIIHRDLKPeN 817 (995)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8753 334432 357899999942 4 67766432 234567788999999999999 9999999999999
Q ss_pred EEeccCCcEEEEecCCccc
Q 001924 818 LLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 818 ILLDenG~VKLsDFGLArv 836 (995)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999873
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-16 Score=180.04 Aligned_cols=136 Identities=13% Similarity=0.156 Sum_probs=98.3
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-----------chhHHH--------HHHHHHHHHHhcCCCce
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----------RKNDIE--------RILAERNILITVRNPFV 749 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~-----------se~e~e--------~flrEieILs~LkHPNI 749 (995)
|++...||.|+||.||+|.+. +|+.||||+++..... ...... ....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999975 6999999998642110 000011 12345666666644332
Q ss_pred --EEEeeeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC---
Q 001924 750 --VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 824 (995)
Q Consensus 750 --VkL~gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG--- 824 (995)
...++. ...+|||||++|++|..+.. ......++.|++.+|.|||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 222221 12379999999988865431 223456788999999999999999999999999998876
Q ss_pred -------cEEEEecCCcc
Q 001924 825 -------HIKLTDFGLSK 835 (995)
Q Consensus 825 -------~VKLsDFGLAr 835 (995)
.+.|+||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 38999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.4e-11 Score=124.08 Aligned_cols=142 Identities=15% Similarity=0.138 Sum_probs=113.0
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ly 763 (995)
.+..|++...++.|+++.||++... +..+++|+...... .....+.+|+.+++.+. +.++.++++++...+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3467999999999999999998743 68899998864221 11235888999999884 677888999888888999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 805 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-------------------------------------- 805 (995)
+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999877531 122234677899999999998
Q ss_pred ---------------------cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 ---------------------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 ---------------------~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766678999998863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.1e-10 Score=116.12 Aligned_cols=138 Identities=14% Similarity=0.134 Sum_probs=101.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEeeeeeccCe
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYSFTCRDN 761 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN--IVkL~gvf~~~~~ 761 (995)
....+|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++.++...+.
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 3445677655555666799999964 45778999987542 1234678899988886444 5668888887788
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG---------------------------------- 807 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~G---------------------------------- 807 (995)
.++||||++|.+|. . ..... ..++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999999998883 2 11222 245667777888888643
Q ss_pred ------------------------ceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 808 ------------------------IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 808 ------------------------IIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776678999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-09 Score=118.94 Aligned_cols=140 Identities=16% Similarity=0.285 Sum_probs=105.0
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEee--cccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeecc---CeeE
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCR---DNLY 763 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIk--k~~~~se~e~e~flrEieILs~Lk--HPNIVkL~gvf~~~---~~ly 763 (995)
.++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.+. +.++++++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4677999999999998754 5678888765 3211 112346788999999887 45678888887766 4589
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-------------------------------------- 805 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-------------------------------------- 805 (995)
+||||++|..+.+. ....++......++.+++..|+.||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877432 12346778888889999999999997
Q ss_pred --------------------cCceeeecCCCcEEeccCCc--EEEEecCCccc
Q 001924 806 --------------------LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKI 836 (995)
Q Consensus 806 --------------------~GIIHRDLKPeNILLDenG~--VKLsDFGLArv 836 (995)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35999999999999987753 79999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2.1e-09 Score=114.05 Aligned_cols=132 Identities=20% Similarity=0.229 Sum_probs=97.8
Q ss_pred EeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CC--ceEEEeeeeeccC---eeEEEE
Q 001924 693 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NP--FVVRFFYSFTCRD---NLYLVM 766 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HP--NIVkL~gvf~~~~---~lyLVm 766 (995)
+.++.|.+..||++. ..+++|+... ......+.+|+.+++.+. +. .+.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 358999999999863 4588997543 234567889999998873 32 2444554443333 358999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS----------------------------------------- 805 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs----------------------------------------- 805 (995)
++++|.+|.+... ..++......++.+++..|+.||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988865432 246777778888888888888886
Q ss_pred -----------------cCceeeecCCCcEEecc--CCcEEEEecCCccc
Q 001924 806 -----------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 836 (995)
Q Consensus 806 -----------------~GIIHRDLKPeNILLDe--nG~VKLsDFGLArv 836 (995)
..++|+|++|.||+++. .+.+.|+||+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13799999999999988 56789999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.9e-06 Score=89.96 Aligned_cols=133 Identities=17% Similarity=0.242 Sum_probs=92.4
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeee-ccCeeEEEEe
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFT-CRDNLYLVME 767 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP---NIVkL~gvf~-~~~~lyLVmE 767 (995)
++.++.|....||+. |..+++|+... ......+.+|..+|..+.+. .+.+.+.++. ..+..|+||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345789999999988 56688897432 23456788999999998752 3555665553 4456789999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL----------------------------------------- 806 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~----------------------------------------- 806 (995)
|++|.+|.+..- ..++......++.++...|+.||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988866321 1234444444555555555555532
Q ss_pred -------------------CceeeecCCCcEEecc---CCc-EEEEecCCccc
Q 001924 807 -------------------GIVHRDLKPDNLLIAH---DGH-IKLTDFGLSKI 836 (995)
Q Consensus 807 -------------------GIIHRDLKPeNILLDe---nG~-VKLsDFGLArv 836 (995)
.++|+|++|.|||++. ++. +.|+||+.+.+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 344 58999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=9.2e-06 Score=83.75 Aligned_cols=133 Identities=19% Similarity=0.193 Sum_probs=96.4
Q ss_pred eeccCCCe-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEEEEeecCC
Q 001924 694 PISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 771 (995)
Q Consensus 694 ~LG~GgFG-tVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyLVmEym~G 771 (995)
.+..|..| .||+......+..+++|+-.. .....+.+|..+|+.+. +-.+.+++.++.+.+..|+||++++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34555555 699988777778899997653 23456788999998774 33467788888888899999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 001924 772 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------------------------------------------- 806 (995)
Q Consensus 772 GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~--------------------------------------------- 806 (995)
.++.+..... ......+..++...|.-||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8887765431 112233445555555555531
Q ss_pred -------------CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 807 -------------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 807 -------------GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999999877788999998874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.2e-05 Score=88.46 Aligned_cols=79 Identities=27% Similarity=0.291 Sum_probs=49.9
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cc---hhHHHHHHHHHHHHHhcCC--C-ceEEEeeeeeccCeeEE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IR---KNDIERILAERNILITVRN--P-FVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~-~s---e~e~e~flrEieILs~LkH--P-NIVkL~gvf~~~~~lyL 764 (995)
.+.||.|.++.||++....+++.++||....... .. .....++..|.++++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5679999999999997665678899997653211 00 0123456778888887642 3 34455543 3445689
Q ss_pred EEeecCCC
Q 001924 765 VMEYLNGG 772 (995)
Q Consensus 765 VmEym~GG 772 (995)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00012 Score=77.30 Aligned_cols=31 Identities=19% Similarity=0.349 Sum_probs=28.1
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4799999999999998888999999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=5.9e-05 Score=81.29 Aligned_cols=85 Identities=14% Similarity=0.144 Sum_probs=54.1
Q ss_pred EEEEee-ccCCCeEEEEEEEC--C----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeeecc
Q 001924 690 EIIKPI-SRGAFGRVFLARKR--T----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTCR 759 (995)
Q Consensus 690 eIlk~L-G~GgFGtVYka~~k--~----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH---PNIVkL~gvf~~~ 759 (995)
...+.| +.|....+|++... . ++..+++|+..............+.+|+.+++.+.. ..+.+++.++...
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88999999988653 1 156788997653220000001346678888777642 3566777766554
Q ss_pred ---CeeEEEEeecCCCCH
Q 001924 760 ---DNLYLVMEYLNGGDL 774 (995)
Q Consensus 760 ---~~lyLVmEym~GGSL 774 (995)
+..|+||||++|.++
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 357899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00038 Score=77.55 Aligned_cols=31 Identities=19% Similarity=0.413 Sum_probs=27.7
Q ss_pred HcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 805 s~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45799999999999998776 99999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0017 Score=70.74 Aligned_cols=76 Identities=14% Similarity=0.132 Sum_probs=59.6
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeeccCeeEEEEe
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk---HPNIVkL~gvf~~~~~lyLVmE 767 (995)
-.+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.+. ...+++++.++...+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 456799999999999874 4678889976532 3566788998888774 3568888888877788999999
Q ss_pred ecCCCCH
Q 001924 768 YLNGGDL 774 (995)
Q Consensus 768 ym~GGSL 774 (995)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0091 Score=63.11 Aligned_cols=142 Identities=15% Similarity=0.092 Sum_probs=95.1
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCC
Q 001924 772 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 849 (995)
Q Consensus 772 GSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~ 849 (995)
-+|.++|... .++++++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3799999754 579999999999999999877621 1112233457889999999888763 2111
Q ss_pred CCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcc
Q 001924 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 850 t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl~~ 929 (995)
.....+.|||.+. ...+.+.=|||||+++|.-+--..|
T Consensus 98 -------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------- 135 (229)
T 2yle_A 98 -------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------- 135 (229)
T ss_dssp ----------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC----------------
T ss_pred -------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC----------------
Confidence 0122456787763 3557889999999999998863332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhc-------------------------CccCCCCHHHHHHHHcCccc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIH-------------------------DPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~-------------------------DPeKRPSA~EIlEiL~HPfF 974 (995)
+..+..+++.+..||..|... .+..|++..+|+++-.....
T Consensus 136 ----e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 136 ----ENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp ----TTEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred ----cccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 222356889999999999765 24678888888887665544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0014 Score=69.31 Aligned_cols=140 Identities=17% Similarity=0.153 Sum_probs=78.5
Q ss_pred EEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeee------eeccCe
Q 001924 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRDN 761 (995)
Q Consensus 690 eIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHP--NIVkL~gv------f~~~~~ 761 (995)
.-.+.|+.|....+|++... +..+++|+..... ....+..|..++..+... .+.+++.. ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 44567888999999998754 3368899876521 122345577776665321 13333321 122356
Q ss_pred eEEEEeecCCCCHH-----------HH---HHhc-CCC--------C---HHHH-HH-----------HHHHHHHHHHHH
Q 001924 762 LYLVMEYLNGGDLY-----------SL---LRKV-GCL--------E---EDVA-RI-----------YIAELVLALEYL 803 (995)
Q Consensus 762 lyLVmEym~GGSL~-----------d~---L~k~-~~L--------s---ee~i-r~-----------Ia~QIa~GLaYL 803 (995)
.+++|+|++|..+. .. ++.. ..+ . +... .. +...+...+.++
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999885431 01 1111 001 1 1100 00 001234455566
Q ss_pred HH-------cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 804 HS-------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 804 Hs-------~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 53 3699999999999998776678999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0016 Score=68.91 Aligned_cols=132 Identities=15% Similarity=0.113 Sum_probs=72.0
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeeccCeeEEEEeec-
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYL- 769 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI-VkL~gvf~~~~~lyLVmEym- 769 (995)
++.|+.|....+|++ ..+++|+...... ......+|+.+++.+....+ .+++... .+.-+++++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 577999999999998 4588998754211 01112457766665532111 3444433 33347899999
Q ss_pred CCCCHHH---------------HH---HhcC-CC----C-HHHHHHHHH--------------HHHHHHHHHH----H--
Q 001924 770 NGGDLYS---------------LL---RKVG-CL----E-EDVARIYIA--------------ELVLALEYLH----S-- 805 (995)
Q Consensus 770 ~GGSL~d---------------~L---~k~~-~L----s-ee~ir~Ia~--------------QIa~GLaYLH----s-- 805 (995)
+|.+|.. .+ +... .+ + ...+..+.. .+...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6544421 00 1111 01 1 111111111 1111122221 1
Q ss_pred --cCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 --LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 --~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13899999999999 5667789999998874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0048 Score=65.95 Aligned_cols=31 Identities=32% Similarity=0.556 Sum_probs=27.4
Q ss_pred cCceeeecCCCcEEeccC----CcEEEEecCCccc
Q 001924 806 LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKI 836 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDen----G~VKLsDFGLArv 836 (995)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 369999999999999874 6899999999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0057 Score=69.12 Aligned_cols=74 Identities=18% Similarity=0.219 Sum_probs=48.9
Q ss_pred EEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeeccCee
Q 001924 691 IIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNL 762 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~-------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~~~l 762 (995)
-++.|+.|....||++.... ++..+++|+..... ....+..|..++..+...+ .+++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678899999999998653 25789999874311 1134557888888774323 3556665542
Q ss_pred EEEEeecCCCC
Q 001924 763 YLVMEYLNGGD 773 (995)
Q Consensus 763 yLVmEym~GGS 773 (995)
.+|++|++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999997633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.39 E-value=0.011 Score=62.78 Aligned_cols=135 Identities=15% Similarity=0.168 Sum_probs=76.2
Q ss_pred eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee-----eeccCeeEEEE
Q 001924 694 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS-----FTCRDNLYLVM 766 (995)
Q Consensus 694 ~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH--PNIVkL~gv-----f~~~~~lyLVm 766 (995)
.|+ |....||++.. .+|+.+++|+...... ....+..|..++..+.. -.+++++.. ....+..+++|
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 466 88889998754 3466799998863211 23456667777776642 224444432 12244568899
Q ss_pred eecCCCCHH-----H------HH---Hhc----C-----CCCHHHH----HHHH---------------HHHHHHHHHHH
Q 001924 767 EYLNGGDLY-----S------LL---RKV----G-----CLEEDVA----RIYI---------------AELVLALEYLH 804 (995)
Q Consensus 767 Eym~GGSL~-----d------~L---~k~----~-----~Lsee~i----r~Ia---------------~QIa~GLaYLH 804 (995)
+|++|..+. . .+ +.. . ..+.... ..++ ..+-..+..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999874321 1 11 110 0 1111110 0011 01111223332
Q ss_pred -------HcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 805 -------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 805 -------s~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 23589999999999998 4 899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.05 Score=57.11 Aligned_cols=79 Identities=13% Similarity=-0.046 Sum_probs=54.8
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeeeccCeeEE
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH---PNIVkL~gvf~~~~~lyL 764 (995)
...-+..+|.|..+.||++... +|+.|.+|+...... .....+..|+..|+.+.- -.+++++.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4567788999999999999854 689999997653221 122357789999888742 2345555442 2478
Q ss_pred EEeecCCCCH
Q 001924 765 VMEYLNGGDL 774 (995)
Q Consensus 765 VmEym~GGSL 774 (995)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.007 Score=67.79 Aligned_cols=136 Identities=14% Similarity=0.234 Sum_probs=79.5
Q ss_pred EeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCeeEE
Q 001924 693 KPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~-------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~lyL 764 (995)
+.|..|-...+|++.... +++.|++|+.... ........+|..+++.+. +.-..++++.+.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 457778888889887642 3578999986331 112445668999888774 2223555665543 28
Q ss_pred EEeecCCCCHH--------------HHHH---hcC-----CCC--HHHHHHHHHHHH-------------------HHHH
Q 001924 765 VMEYLNGGDLY--------------SLLR---KVG-----CLE--EDVARIYIAELV-------------------LALE 801 (995)
Q Consensus 765 VmEym~GGSL~--------------d~L~---k~~-----~Ls--ee~ir~Ia~QIa-------------------~GLa 801 (995)
||||++|.+|. +.|. ... ... +..+..+..++- ..+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875442 1111 110 111 234444444332 1233
Q ss_pred HHH----H----cCceeeecCCCcEEeccC----CcEEEEecCCccc
Q 001924 802 YLH----S----LGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKI 836 (995)
Q Consensus 802 YLH----s----~GIIHRDLKPeNILLDen----G~VKLsDFGLArv 836 (995)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 2 259999999999999876 7899999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0066 Score=66.11 Aligned_cols=74 Identities=15% Similarity=0.182 Sum_probs=42.3
Q ss_pred EEeeccCCCeEEEEEEECC--------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeeccCee
Q 001924 692 IKPISRGAFGRVFLARKRT--------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNL 762 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~--------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~~~l 762 (995)
.+.|+.|....+|++.... .+..+++|+...... .......|..++..+...+ +.++++.+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4578888889999998653 136888998754211 1112356777777664222 345554431 3
Q ss_pred EEEEeecCCCC
Q 001924 763 YLVMEYLNGGD 773 (995)
Q Consensus 763 yLVmEym~GGS 773 (995)
++||+|++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.43 E-value=0.11 Score=56.54 Aligned_cols=30 Identities=20% Similarity=0.461 Sum_probs=27.5
Q ss_pred CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 807 GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 699999999999999888899999998774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.072 Score=61.05 Aligned_cols=74 Identities=15% Similarity=0.197 Sum_probs=46.9
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeeccCeeEEEEeecC
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNI-VkL~gvf~~~~~lyLVmEym~ 770 (995)
++.|+.|-...+|++.....+..+++|+...... ..+ ...+|..++..+...++ .++++.+. + .+||+|++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4678889999999998764457899998753210 001 12478888888864444 45666653 2 35999998
Q ss_pred CCC
Q 001924 771 GGD 773 (995)
Q Consensus 771 GGS 773 (995)
|.+
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.11 E-value=0.44 Score=54.17 Aligned_cols=75 Identities=12% Similarity=0.134 Sum_probs=46.3
Q ss_pred EEEeeccCCCeEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCee
Q 001924 691 IIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~T-------G~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~l 762 (995)
-++.|..|-...+|++..... +..|++++..... . ..-...+|..+++.+. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 345678888999999987521 5789999864321 1 1112346777777664 222344554332 2
Q ss_pred EEEEeecCCCC
Q 001924 763 YLVMEYLNGGD 773 (995)
Q Consensus 763 yLVmEym~GGS 773 (995)
++||+|++|.+
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 78999998865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.26 E-value=1.1 Score=49.77 Aligned_cols=29 Identities=28% Similarity=0.505 Sum_probs=25.4
Q ss_pred ceeeecCCCcEEe------ccCCcEEEEecCCccc
Q 001924 808 IVHRDLKPDNLLI------AHDGHIKLTDFGLSKI 836 (995)
Q Consensus 808 IIHRDLKPeNILL------DenG~VKLsDFGLArv 836 (995)
++|+|+.+.|||+ ++++.++|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 7899999999999 4467899999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 995 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-80 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-79 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-74 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-74 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-72 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-71 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-71 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-71 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-70 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-70 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-69 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-68 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-66 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-65 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-63 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-57 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-54 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-52 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-51 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-47 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (666), Expect = 1e-80
Identities = 88/278 (31%), Positives = 143/278 (51%), Gaps = 32/278 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
R+P ++R + F +YL++EY G +Y L+K+ +E YI EL AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ R + GT DYL PE++ G H D WS+G++ +EF+ G PPF A + + +
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I + + P ++ A+DLI+R L H+P+QR
Sbjct: 215 RISRVEFTF---PDFVTEGARDLISRLLKHNPSQRPML 249
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (655), Expect = 9e-79
Identities = 90/280 (32%), Positives = 154/280 (55%), Gaps = 28/280 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +DF+ K + G+F V LAR+ T +AIK+L+K +I++N + + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
+ +PF V+ +++F + LY + Y G+L +RK+G +E R Y AE+V ALEY
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-------------------------L 158
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
++ +S VGT Y++PE+L ++D W++G I+++ + G+PPF A + +I
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
F I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 219 FQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGC 255
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 4e-74
Identities = 73/292 (25%), Positives = 134/292 (45%), Gaps = 31/292 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+GI HRD+KP+NLL+ ++K++DFGL+ + NN
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------------------------ 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
R + GT Y+APE+L E H D WS GI+L + G P+ S
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976
+ K + + L+++ L+ +P+ R+ ++ + + K
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 6e-74
Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 36/282 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +EII + GAFG+V+ A+ + T L A KV+ + ++E + E +IL + +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
P +V+ +F +NL++++E+ GG + +++ ++ L E ++ + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK N+L DG IKL DFG+S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN---------------------------T 161
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ I + P PS S +D + + L + + R
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (614), Expect = 2e-72
Identities = 102/282 (36%), Positives = 158/282 (56%), Gaps = 31/282 (10%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITV 744
I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S GIV+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--------------------------- 153
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF + E +F
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 966
+I + P + EA+DL+ + + +P +RLG G
Sbjct: 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 6e-72
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 41/287 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+D+E++ I G++GR R+++ G + K L + + + + +++E N+L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62
Query: 747 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLAL 800
P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 801 EYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
+ H ++HRDLKP N+ + ++KL DFGL++I
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------- 163
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
D + VGTP Y++PE + + +D WS+G +L+E +PPFT
Sbjct: 164 --------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 916 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
A S + + I K P S E ++I R L R
Sbjct: 216 AFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRPSV 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 239 bits (611), Expect = 1e-71
Identities = 73/296 (24%), Positives = 132/296 (44%), Gaps = 35/296 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
P K +D ++I + + GAFG V +R TG+ FA K + +D E
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKET 69
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIY 792
+ E + +R+P +V +F + + ++ E+++GG+L+ + + + ED A Y
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 129
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPET 850
+ ++ L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------------- 174
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
++ GT ++ APE+ G GY D WSVG++ + ++G
Sbjct: 175 -------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 911 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ PF E+ + N+ + S +S + +D I + L+ DPN R+ + A
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (603), Expect = 2e-71
Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 35/286 (12%)
Query: 681 KERTSIDD----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 736
+ S+ D + + I +GA G V+ A TG AI+ + +K E I+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIIN 66
Query: 737 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
E ++ +NP +V + S+ D L++VMEYL GG L ++ + C++E E
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ ALE+LHS ++HRD+K DN+L+ DG +KLTDFG
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------- 164
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 916
+ R + VGTP ++APE++ +G D WS+GI+ E I G PP+
Sbjct: 165 ------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
E+P I P P +S +D +NR L D +R A
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSA 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 234 bits (599), Expect = 5e-71
Identities = 76/290 (26%), Positives = 123/290 (42%), Gaps = 42/290 (14%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNI 740
+++E + + RG V + T +A+K++ + E L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 741 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 799
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 913
Q GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 159 ----QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 914 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGA 962
F ++ I++ + D S +DL++RFL+ P +R A
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-70
Identities = 108/294 (36%), Positives = 166/294 (56%), Gaps = 32/294 (10%)
Query: 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 742
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
LHS +V+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 156 --ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV + F
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 236 bits (602), Expect = 2e-70
Identities = 65/296 (21%), Positives = 129/296 (43%), Gaps = 35/296 (11%)
Query: 674 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 733
P K+ + D ++I++ + GAFG V ++ TG +F K + + K ++
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 734 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 792
E +I+ + +P ++ +F + + L++E+L+GG+L+ + + E Y
Sbjct: 76 ---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINNTIDLSGPET 850
+ + L+++H IVH D+KP+N++ +K+ DFGL+
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT--------------- 177
Query: 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 910
+ + T ++ APEI+ G+ D W++G++ + ++G
Sbjct: 178 -------------KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 911 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
+ PF E N+ + S +S EA+D I L +P +RL + A
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (591), Expect = 2e-69
Identities = 86/311 (27%), Positives = 142/311 (45%), Gaps = 37/311 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D ++ + GAF V LA + T L AIK + K + + + E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +V + +LYL+M+ ++GG+L+ + + G E A I +++ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 807 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
GIVHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+ +A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 160 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 924 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982
+ IL + + D+S A+D I + DP +R + T
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALDK 275
Query: 983 SMQSKLEIELK 993
++ + ++K
Sbjct: 276 NIHQSVSEQIK 286
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 231 bits (589), Expect = 4e-69
Identities = 103/292 (35%), Positives = 164/292 (56%), Gaps = 35/292 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
+PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S I++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------------------------- 154
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924
++ GTPDY+APE++ + + DWWS GI+++E + G PF + ++
Sbjct: 155 ---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
ILN ++ + P + + +DL++R + D +QRLG NG +V + F
Sbjct: 212 KILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (586), Expect = 1e-68
Identities = 69/308 (22%), Positives = 116/308 (37%), Gaps = 38/308 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRD+K N+L++ G +KL DFG + I
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 867 DNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIF 923
+S VGTP ++APE++L + G D WS+GI E PP +
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVS 983
+I + P S ++ ++ L P R + + + +++ V
Sbjct: 224 YHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRERPPTVI 279
Query: 984 MQSKLEIE 991
M +
Sbjct: 280 MDLIQRTK 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 1e-68
Identities = 80/319 (25%), Positives = 127/319 (39%), Gaps = 73/319 (22%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 805
P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRD+KP N+L+ G IKL DFG+S Q
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----------------------------Q 154
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
+ +S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 926 ILNR----------------------------------------KIPWPCVPSD-MSFEA 944
+ P P +PS S E
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 945 QDLINRFLIHDPNQRLGAN 963
QD +N+ LI +P +R
Sbjct: 275 QDFVNKCLIKNPAERADLK 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 230 bits (586), Expect = 5e-68
Identities = 93/296 (31%), Positives = 144/296 (48%), Gaps = 35/296 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+++DF + + I RG FG V+ RK TG ++A+K L K + K L ER +L V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 745 RN---PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
PF+V Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
++H+ +V+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF +
Sbjct: 156 ---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVFHCKIF 974
+ +P S E + L+ L D N+RLG GA EV F
Sbjct: 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 2e-66
Identities = 69/299 (23%), Positives = 130/299 (43%), Gaps = 39/299 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 805
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 806 LGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 863
I H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 864 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
Q N P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 924 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENC 981
+NI+N + + ++S EA D ++R L+ + R+ A+E +K E
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQKIERV 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 221 bits (565), Expect = 3e-66
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 31/289 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +E+ + + G V LAR A+KVL+ + R E + +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 747 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
H GI+HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------------------AIA 162
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+ +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 923 FDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970
+ IP +S + ++ + L +P R AAE+
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 9e-65
Identities = 58/288 (20%), Positives = 118/288 (40%), Gaps = 40/288 (13%)
Query: 684 TSIDD--FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
S D + I RG+F V+ T A L+ + K++ +R E +L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEML 62
Query: 742 ITVRNPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
+++P +VRF+ S+ + + LV E + G L + L++ ++ V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 798 LALEYLHSLG--IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
L++LH+ I+HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +GTP+++APE+ ++ + D ++ G+ + E T P+
Sbjct: 165 -----------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212
Query: 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ + + E +++I + + ++R
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSI 260
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-63
Identities = 111/307 (36%), Positives = 173/307 (56%), Gaps = 36/307 (11%)
Query: 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRK-NDIER 733
+ H E+ I++FE++K + GA+G+VFL RK TG L+A+KVLKK +++K E
Sbjct: 15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 734 ILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 792
ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L + E +IY
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 852
+ E+VLALE+LH LGI++RD+K +N+L+ +GH+ LTDFGLS
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS------------------ 176
Query: 853 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG 910
E+ + + GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG
Sbjct: 177 --------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 911 IPPFTAESPEIIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAE 967
PFT + + I R + P P +MS A+DLI R L+ DP +RLG A E
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 968 VFHCKIF 974
+ F
Sbjct: 289 IKEHLFF 295
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-63
Identities = 54/280 (19%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I G+FG V+ + A+K+L ++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 805
++ F ++ L +V ++ G LY L + E + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
I+HRDLK +N+ + D +K+ DFGL+ + + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------------------KSRW 157
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEII 922
+ + G+ ++APE++ + + +D ++ GI+L+E +TG P++ +
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
Query: 923 FDNILNRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQR 959
++ R P V S+ + L+ L ++R
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (547), Expect = 7e-63
Identities = 106/296 (35%), Positives = 166/296 (56%), Gaps = 35/296 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 740
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR------------------------ 190
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 191 ------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIF 974
I++ I++ K+ + PS S + +DL+ L D +R G NG ++ + K F
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-62
Identities = 76/311 (24%), Positives = 139/311 (44%), Gaps = 40/311 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILIT 743
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 744 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 803
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 804 HSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
HSL I H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919
+ + GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 166 ----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 920 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978
+ N+ + S+ S A+D I R L+ DP +R+ + +IK
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHP-WIKPK 277
Query: 979 ENCVSMQSKLE 989
+ ++ S
Sbjct: 278 DTQQALSSAWS 288
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-59
Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 52/299 (17%)
Query: 681 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 739
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 740 ILITV-RNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIY 792
+ + P +VR + R L +VME L+GG+L+S ++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 793 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 849
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 850 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 909
+ T + + + TP Y+APE+L ++ + D WS+G+I++ +
Sbjct: 163 --------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 910 GIPPFTAESP----EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGAN 963
G PPF + + I + +P S++S E + LI L +P QR+
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-59
Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
++ + ++++ I +G FG V L R G+ A+K +K + LAE +++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 745 RNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 801
R+ +V+ + LY+V EY+ G L LR G L D + ++ A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL VHRDL N+L++ D K++DFGL+K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------------ 153
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920
+ + + + APE L + +D WS GI+L+E + G P+ +
Sbjct: 154 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207
Query: 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ + P +++ D R
Sbjct: 208 DVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRPSF 247
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-58
Identities = 59/293 (20%), Positives = 114/293 (38%), Gaps = 35/293 (11%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAER 738
++ +++D K + G FG V + + A+K+LK + + +LAE
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEA 59
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
N++ + NP++VR ++ LVME G L L++ +++ + ++ +
Sbjct: 60 NVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 858
++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL--------------------- 157
Query: 859 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917
+ + + + APE + + +D WS G++++E + G P+
Sbjct: 158 ---RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970
+ + + P+ E DL+N +D R G
Sbjct: 215 KGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-58
Identities = 66/284 (23%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---RILAERNILIT 743
+++ + G FG V+ + + AIK ++K + ++ R+ E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 744 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLAL 800
V + V+R F D+ L++E DL+ + + G L+E++AR + +++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 801 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
+ H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 918
+ GT Y PE + HG +A WS+GI+L++ + G PF +
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
+ I+ ++ + +S E Q LI L P+ R
Sbjct: 214 -----EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRPTF 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-58
Identities = 75/301 (24%), Positives = 114/301 (37%), Gaps = 55/301 (18%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVRNP 747
E + + G F V+ AR + T + AIK +K D L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
++ +F + N+ LV +++ + L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 808 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 867
I+HRDLKP+NLL+ +G +KL DFGL+K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 868 NRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926
NR V T Y APE+L G +G D W+VG IL E + +P +S I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 927 LN-------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
IP + S + DLI + +P R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273
Query: 962 A 962
A
Sbjct: 274 A 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 31/280 (11%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNIL 741
D +++ + G+FG V A+K LK + + ++ + E N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLAL 800
++ + ++R + + +V E G L L + G Y ++ +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
YL S +HRDL NLL+A +K+ DFGL +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL----------------------- 161
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919
+ + APE L +A+D W G+ L+E T G P+ +
Sbjct: 162 -PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I I P P D + +++ + H P R
Sbjct: 221 SQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-57
Identities = 74/319 (23%), Positives = 119/319 (37%), Gaps = 62/319 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+ +E + I +G FG VF AR R TG A+K + + ++ L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLL 66
Query: 745 RNPFVVRFFYSFT--------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 796
++ VV C+ ++YLV ++ L + + + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 797 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 856
+ L Y+H I+HRD+K N+LI DG +KL DFGL++
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-------------------- 166
Query: 857 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915
+ + + + V T Y PE+LLG ++G D W G I+ E T P
Sbjct: 167 ---FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
Query: 916 AESPEIIFDNILN-----------------------------RKIPWPCVPSDMSFEAQD 946
+ + I RK+ A D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 947 LINRFLIHDPNQRLGANGA 965
LI++ L+ DP QR+ ++ A
Sbjct: 284 LIDKLLVLDPAQRIDSDDA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 196 bits (498), Expect = 5e-57
Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 56/306 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + E +IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+V+ + + L LV E+L+ L G LE A+ ++ +L+ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA---------------------------FGI 152
Query: 867 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925
R + T Y AP++L+G++ + D WSVG I E + G P F S
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 926 ILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
I +PW + DL+++ L DPNQR
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 960 LGANGA 965
+ A A
Sbjct: 273 ITAKQA 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 67/283 (23%), Positives = 108/283 (38%), Gaps = 37/283 (13%)
Query: 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAER 738
++ I D E+ G FG V R AIKVLK+ K D E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--GTEKADTEEMMREA 60
Query: 739 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 797
I+ + NP++VR L LVME GG L+ L K + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916
+ R + + APE + + +D WS G+ ++E ++ G P+
Sbjct: 159 ---LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215
Query: 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ I K P + E L++ I+ R
Sbjct: 216 MKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDR 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 52/275 (18%), Positives = 110/275 (40%), Gaps = 35/275 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D +K + G FG V + R AIK++K+ M + + E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 805
+V+ + T + ++++ EY+ G L + LR + ++ A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
+HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------YVLD 152
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ + + + PE+L+ ++ +D W+ G++++E + G P+ + +
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+I + P S + ++ ++R
Sbjct: 213 HIAQGLRLYR--PHLASEKVYTIMYSCWHEKADER 245
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-55
Identities = 62/317 (19%), Positives = 117/317 (36%), Gaps = 58/317 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 741
++ E K + GAFG+V A A+K+LK+ ++ E +++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMM 94
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-------------------- 780
+ + +V + T +YL+ EY GDL + LR
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 781 ---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
+ L + + ++ +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
++ R +A ++APE L + +D
Sbjct: 214 ------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
WS GI+L+E + G+ P+ + F ++ P + E ++ D
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDS 308
Query: 957 NQRLGANGAAEVFHCKI 973
+R C++
Sbjct: 309 RKRPSFPNLTSFLGCQL 325
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (486), Expect = 3e-55
Identities = 55/300 (18%), Positives = 99/300 (33%), Gaps = 35/300 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 747 P-FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 805
+ + D +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 806 LGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922
+Q R + GT Y + LG E D S+G +L F G P+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 923 FDNILNRK-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977
P + E +N + + + ++F +F ++
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR-NLFHRQ 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 55/276 (19%), Positives = 109/276 (39%), Gaps = 37/276 (13%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++++ + G FG V++ A+K LK+ + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQH 67
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 804
+VR Y+ ++ +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL+ N+L++ K+ DFGL+++ +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL--------------------------IE 160
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ R A + APE + +D WS GI+L E +T G P+ + +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
N+ + P + E L+ P R
Sbjct: 221 QNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 9e-55
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ I G FG V L D AIK +++ E + E +++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSH 59
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 805
P +V+ + + + LV E++ G L LR L + ++ + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 865
++HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------------------------VLD 153
Query: 866 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 924
+ + +PE+ + + +D WS G++++E + G P+ S + +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+I + P S ++N P R
Sbjct: 214 DISTGFRLYK--PRLASTHVYQIMNHCWKERPEDR 246
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-54
Identities = 76/308 (24%), Positives = 130/308 (42%), Gaps = 56/308 (18%)
Query: 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 745
+++F+ ++ I G +G V+ AR + TG++ A+K ++ D + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 804
+P +V+ + LYLV E+L+ + + + + Y+ +L+ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S ++HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------F 152
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923
R V T Y APEILLG ++ A D WS+G I E +T F +S
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 924 DNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPN 957
I + + V + + + L+++ L +DPN
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
Query: 958 QRLGANGA 965
+R+ A A
Sbjct: 273 KRISAKAA 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-54
Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 744
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 745 RN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCLEED 787
+ P ++ + R LYL +EY G+L LRK L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 788 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----------- 176
Query: 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 907
Q + ++A E L + + +D WS G++L+E
Sbjct: 177 -----------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 908 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
++ G P+ + +++ + P + E DL+ + P +R
Sbjct: 220 VSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYER 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-54
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 60/312 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I GA+G V A AIK + + + +R L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 747 PFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ ++ +L G DLY LL+ L D ++ +++ L+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124
Query: 803 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+HS ++HRDLKP NLL+ +K+ DFGL+++ +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------------------D 160
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
V T Y APEI+L + + D WSVG IL E ++ P F +
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 922 IFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLI 953
++IL K+PW + + +A DL+++ L
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 954 HDPNQRLGANGA 965
+P++R+ A
Sbjct: 281 FNPHKRIEVEQA 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 59/287 (20%), Positives = 103/287 (35%), Gaps = 37/287 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + + +G FG V++ T AIK LK E L E ++ +R+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLRH 71
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLH 804
+V+ Y+ + +Y+V EY++ G L L A++ + Y+
Sbjct: 72 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+ VHRDL+ N+L+ + K+ DFGL+++ +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARL--------------------------IE 164
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ R A + APE L +D WS GI+L E T G P+ +
Sbjct: 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970
D + P + DL+ + +P +R
Sbjct: 225 DQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 2e-54
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNI 740
+ I +I + I G FG V + G +K L + L+E +I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 741 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 799
+ +P V+ T + ++ E++ G L S LR G + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 800 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 859
++YL + VHRDL N+L+ + K++DFGLS+ + D
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----------------FLEDDTS 183
Query: 860 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 918
P Y + APE + + A+D WS GI+++E ++ G P+ +
Sbjct: 184 DPTYTSALGG-----KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 919 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + + I P P D L+ D N R
Sbjct: 239 NQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 2e-54
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 59/303 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALM 70
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------- 782
NP +V+ + L+ EY+ GDL LR +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 783 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837
L ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 189
Query: 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897
Y + + ++ PE + + +D
Sbjct: 190 ------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 898 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 956
W+ G++L+E + G+ P+ + E + + + I P + E +L+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLP 283
Query: 957 NQR 959
R
Sbjct: 284 ADR 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-53
Identities = 83/330 (25%), Positives = 125/330 (37%), Gaps = 65/330 (19%)
Query: 685 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKN--DIERILAERNIL 741
+ +E + I GA+G+VF AR + G A+K ++ R +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 742 ITVRNPFVVRFFYSFTC-----RDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAE 795
T +P VVR F T L LV E+++ Y + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 796 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 855
L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------- 165
Query: 856 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 915
+ S V T Y APE+LL + + D WSVG I E P F
Sbjct: 166 ---------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 916 AESPEIIFDNILN------------------------RKIPWPCVPSDMSFEAQDLINRF 951
S IL+ P +D+ +DL+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 952 LIHDPNQRLGANGAAEVFHCKIFIKKTENC 981
L +P +R+ A A H + + E C
Sbjct: 277 LTFNPAKRISAYSALS--HP--YFQDLERC 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 58/279 (20%), Positives = 108/279 (38%), Gaps = 32/279 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 745
+ E+ + I G FG V + + +K + + E+ L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 746 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 804
+P +V+ T + ++++ME G+L S L + L+ +Y +L AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
S VHRD+ N+L++ + +KL DFGLS+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------------------ME 159
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ ++APE + A+D W G+ ++E + G+ PF +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
I N + +P + L+ + +DP++R
Sbjct: 220 GRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRPRF 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 184 bits (467), Expect = 1e-52
Identities = 48/282 (17%), Positives = 96/282 (34%), Gaps = 36/282 (12%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 747
+++ + I G+FG +F AIK + ++D ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 748 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 807
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 808 IVHRDLKPDNLLIA-----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 862
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 863 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESP 919
Q R + + GT Y++ LG E D ++G + F+ G A +
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 920 EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 959
+ ++ I +K P + + E ++ +
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 5e-52
Identities = 55/276 (19%), Positives = 102/276 (36%), Gaps = 30/276 (10%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV-LKKL-DMIRKNDIERILAERNILITV 744
+F+ IK + GAFG V+ G+ I V +K+L + + IL E ++ +V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 745 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 804
NP V R + G L + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
+ ++A E +L + + +D WS G+ ++E +T G P+ I
Sbjct: 167 ---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ + P + + ++ + + D + R
Sbjct: 224 SILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSR 257
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-52
Identities = 82/334 (24%), Positives = 125/334 (37%), Gaps = 74/334 (22%)
Query: 669 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 728
++ V+TP +R + K I G+FG V+ A+ +G+L AIK + +
Sbjct: 4 TTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------ 55
Query: 729 NDIERILAERNILITVRNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLL---R 779
D E I+ + + +VR Y F L LV++Y+ R
Sbjct: 56 -DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 780 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 838
L ++Y+ +L +L Y+HS GI HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADW 897
Q S + + Y APE++ G ++ + D
Sbjct: 172 -------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 898 WSVGIILFEFITGIPPFTAESPEIIFDNILN-------------------------RKIP 932
WS G +L E + G P F +S I+ + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 933 WPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGA 965
W V EA L +R L + P RL A
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 2e-51
Identities = 55/287 (19%), Positives = 107/287 (37%), Gaps = 35/287 (12%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
D + + G +G V+ + A+K LK+ ++E L E ++ +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 804
P +V+ T Y++ E++ G+L LR+ + V ++ A+EYL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 805 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 864
+HRDL N L+ + +K+ DFGLS++
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------------------MT 166
Query: 865 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923
A + APE L + +D W+ G++L+E T G+ P+ ++
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970
+ + P + +L+ +P+ R + F
Sbjct: 227 ELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-51
Identities = 67/304 (22%), Positives = 114/304 (37%), Gaps = 56/304 (18%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+E ++ I G +G VF A+ R T ++ A+K ++ D + L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 747 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 806
+VR L LV E+ + G L+ ++ + ++ +L+ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 807 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 866
++HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA---------------------------FGI 153
Query: 867 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITG-IPPFTAESPEIIFD 924
R + V T Y P++L G + + + D WS G I E P F +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 925 NILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 958
I V ++ +DL+ L +P Q
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 959 RLGA 962
R+ A
Sbjct: 274 RISA 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-50
Identities = 77/314 (24%), Positives = 121/314 (38%), Gaps = 68/314 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++P+ GA+G V A TG AIK L + + +R E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 747 PFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 800
V+ FT + + YLVM ++ G L K L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 801 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 860
Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------------------- 171
Query: 861 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919
+ V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 172 -------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 920 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRF 951
I+ K + + ++ S A +L+ +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 952 LIHDPNQRLGANGA 965
L+ D QR+ A A
Sbjct: 285 LVLDAEQRVTAGEA 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ K + GAFG+V A K A+K+LK + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 742 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----------------- 783
+ N +V + T ++ EY GDL + LR+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 784 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
L+ + + ++ + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI----- 195
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
++ + +A ++APE + + + +D WS GI
Sbjct: 196 --------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
L+E + G P+ + F ++ P E D++ DP +R
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 174 bits (441), Expect = 8e-49
Identities = 74/324 (22%), Positives = 129/324 (39%), Gaps = 77/324 (23%)
Query: 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
E + DD+++++ + RG + VF A T + +K+LK ++I E IL
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKIL 83
Query: 742 ITVR-NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 798
+R P ++ + LV E++N D L + L + R Y+ E++
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140
Query: 799 ALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-------------------- 180
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 916
+ + V + + PE+L+ + + Y+ D WS+G +L I PF
Sbjct: 181 --------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 917 ESPEI----------------------------IFDNILNR-------KIPWPCVPSDMS 941
F++IL R + +S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 942 FEAQDLINRFLIHDPNQRLGANGA 965
EA D +++ L +D RL A A
Sbjct: 293 PEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-48
Identities = 64/325 (19%), Positives = 124/325 (38%), Gaps = 63/325 (19%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERN 739
D + KP+ GAFG+V LA A+K+LK + D+ +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEME 70
Query: 740 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------- 783
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 784 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842
L ++ +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185
Query: 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 902
+ + + ++APE L + + +D WS G+
Sbjct: 186 --------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 903 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 961
+L+E T G P+ E +F + PS+ + E ++ P+QR
Sbjct: 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRP- 282
Query: 962 ANGAAEVFHCKIFIKKTENCVSMQS 986
++ ++ + V++ S
Sbjct: 283 --TFKQL------VEDLDRIVALTS 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-48
Identities = 56/289 (19%), Positives = 103/289 (35%), Gaps = 45/289 (15%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
+ + + + +G+FG V+ K AIK + + +R + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 742 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----------KVGCLEEDVARI 791
VVR + ++ME + GDL S LR +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 792 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 851
E+ + YL++ VHRDL N ++A D +K+ DFG+
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------ 179
Query: 852 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 911
Y+ R + +++PE L +D WS G++L+E T
Sbjct: 180 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 912 -PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
P+ S E + ++ + P + +L+ ++P R
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMR 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-47
Identities = 75/313 (23%), Positives = 122/313 (38%), Gaps = 66/313 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ ++ + P+ GA+G V A TG A+K L + +R E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 747 PFVVRFFYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 801
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
Y+HS I+HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 920
+ + V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 169 ---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 921 IIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFL 952
IL K+ + V + A DL+ + L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 953 IHDPNQRLGANGA 965
+ D ++R+ A A
Sbjct: 286 VLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 9e-47
Identities = 67/327 (20%), Positives = 127/327 (38%), Gaps = 77/327 (23%)
Query: 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 743
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 744 VRNPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 797
V + ++ FT + ++YLVME ++ + ++ + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 129
Query: 798 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 857
+++LHS GI+HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------------- 168
Query: 858 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 917
+ V T Y APE++LG + D WSVG I+ E + F
Sbjct: 169 -------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 918 SPEIIFDNILN---------------------------RKIPWPCVPSD----------- 939
++ ++ + +P + D
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 940 -MSFEAQDLINRFLIHDPNQRLGANGA 965
+ +A+DL+++ L+ DP +R+ + A
Sbjct: 282 LKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 56/278 (20%), Positives = 95/278 (34%), Gaps = 32/278 (11%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 742
K I G FG V+ +T+ AIK LK + L E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMG 64
Query: 743 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALE 801
+ ++R + + ++ EY+ G L K G + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 802 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 861
YL ++ VHRDL N+L+ + K++DFGLS++
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------------------------ 160
Query: 862 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921
E + APE + + A+D WS GI+++E +T E
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 922 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+N P P D L+ + + +R
Sbjct: 221 EVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 52/300 (17%)
Query: 687 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 741
D ++ KP+ RGAFG+V A K T A+K+LK+ ++ +++E IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 742 ITVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----------------C 783
I + + V + L +++E+ G+L + LR
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 784 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843
L + Y ++ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD------- 183
Query: 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903
Y+ D + A ++APE + + +D WS G++
Sbjct: 184 ------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225
Query: 904 LFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 962
L+E + P+ + F L P + E + +P+QR
Sbjct: 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTF 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-45
Identities = 55/313 (17%), Positives = 106/313 (33%), Gaps = 67/313 (21%)
Query: 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 746
+ + I +G FG V+ + G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 747 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 802
++ F + + L+LV +Y G L+ L + E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 803 LHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 854
LH I HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIILFEFI 908
+ T + + VGT Y+APE+L + + AD +++G++ +E
Sbjct: 157 ----RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 909 TGIPPFTAESP-------------------EIIFDNILNRKIPWPCVPSDMSFEAQDLIN 949
+++ + L IP + ++
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 950 RFLIHDPNQRLGA 962
+ RL A
Sbjct: 273 ECWYANGAARLTA 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-45
Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 695 ISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 751
I RG FG V+ A+K L ++ ++ + L E I+ +P V+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 752 FF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 809
+ +V+ Y+ GDL + +R I ++ +++L S V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 810 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 869
HRDL N ++ +K+ DFGL++ + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARD-----------------------MYDKEFDSVH 189
Query: 870 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 928
N+ A ++A E L + +D WS G++L+E +T G PP+ + I +L
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 929 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 959
+ P +++ + R
Sbjct: 250 GRRLLQ--PEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (330), Expect = 9e-34
Identities = 55/336 (16%), Positives = 115/336 (34%), Gaps = 84/336 (25%)
Query: 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-------L 741
+ +++ + G F V+LA+ A+K+++ + + + I + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 742 ITVRNPFVVRFFYSFT--CRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAEL 796
++ +++ F + +++VM + G + + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 797 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 854
+L L+Y+ GI+H D+KP+N+L+ L ++ +G +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 855 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914
+ +++ T +Y +PE+LLG G AD WS ++FE ITG F
Sbjct: 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 915 TAESPEIIFDNI------------------------------------LNRKIPWPC--- 935
+ + +++ WP
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 936 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGA 965
D + E D ++ L DP +R A G
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 3e-19
Identities = 27/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 690 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAER---- 738
I K + G VF +K K K+ R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 739 ----NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 794
L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 795 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835
++ + + GIVH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 995 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.55 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=476.57 Aligned_cols=272 Identities=34% Similarity=0.664 Sum_probs=241.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|.++.+|+.||||++++.........+.+.+|++++++++||||+++++++.+.+.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34789999999999999999999999999999999987555455567789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~---- 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---- 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC----
Confidence 9999999999999998899999999999999999999999999999999999999999999999999999852100
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...++.
T Consensus 162 ---------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 220 (288)
T d1uu3a_ 162 ---------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220 (288)
T ss_dssp -----------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ---------------------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH
Confidence 01122335679999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHH---HHHcCccccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA---EVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIl---EiL~HPfF~~~~~n~~s~ 984 (995)
++......+| ..+++++.+||.+||+.||.+|||+.++. .+++||||++++|..+.-
T Consensus 221 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 221 KIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 9988876544 68999999999999999999999988764 579999999999876643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=469.22 Aligned_cols=258 Identities=35% Similarity=0.631 Sum_probs=234.8
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
.+++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 46789999999999999999999999999999999987554445556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~------ 157 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------ 157 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC------
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC------
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997411
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.
T Consensus 158 -----------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 214 (263)
T d2j4za1 158 -----------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214 (263)
T ss_dssp -----------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred -----------------------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 111234579999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.+......+| ..+++++.+||.+||+.||.+||| +.++|+||||...
T Consensus 215 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~~~ 261 (263)
T d2j4za1 215 RISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITAN 261 (263)
T ss_dssp HHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHHHH
T ss_pred HHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcCCc
Confidence 9888776544 679999999999999999999999 7788999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=475.57 Aligned_cols=268 Identities=40% Similarity=0.761 Sum_probs=243.0
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45689999999999999999999999999999999998765555566788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~----- 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998411
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...++
T Consensus 157 ----------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 157 ----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp ----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH
Confidence 0112234578999999999999999999999999999999999999999999999999
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCcccccccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENC 981 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~ 981 (995)
..+......+| ..+++++.+||.+||++||.+|++.. .+.++++||||.++.|..
T Consensus 215 ~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~ 271 (337)
T d1o6la_ 215 ELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp HHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHhcCCCCCC---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHH
Confidence 99988876654 68999999999999999999999632 478899999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=462.95 Aligned_cols=263 Identities=27% Similarity=0.456 Sum_probs=221.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.++++++|||||++++++.+.+.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 35789999999999999999999999999999999976432 2334678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....+.
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~--- 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998522111
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ei~ 923 (995)
........+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........
T Consensus 158 ----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 158 ----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp ----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred ----------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 1122345689999999999988876 67899999999999999999999876543333
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.............+..+++++.+||.+||+.||++||| +.++|+||||++.
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~ 266 (271)
T d1nvra_ 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCcC
Confidence 33333333333334678999999999999999999999 7778999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-54 Score=466.73 Aligned_cols=265 Identities=38% Similarity=0.729 Sum_probs=239.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
++++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999987554445567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||||+||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec------
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.
T Consensus 156 ------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 156 ------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp ------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 11234689999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
++..+...+| ..+++++.++|.+||+.||.+|++.. .+.++++||||+++.|..+
T Consensus 212 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l 268 (316)
T d1fota_ 212 KILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268 (316)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence 9988876544 68999999999999999999997321 3788899999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=461.39 Aligned_cols=256 Identities=33% Similarity=0.535 Sum_probs=228.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++.+.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+|+.+++.++|||||++++++...+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976432 23567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
|||+||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~------- 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------- 168 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc-------
Confidence 99999999998865 5699999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 926 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkI 926 (995)
........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+
T Consensus 169 --------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 169 --------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp --------------------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred --------------------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 111233567999999999999999999999999999999999999999998888877777
Q ss_pred HccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 927 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 927 l~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.....+....+..+++.+.+||.+||+.||.+||| +.++|+||||+.
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 77655544556789999999999999999999999 777899999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-54 Score=462.24 Aligned_cols=270 Identities=31% Similarity=0.536 Sum_probs=223.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46699999999999999999999999999999999864432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec---cCCcEEEEecCCccccccccc
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD---enG~VKLsDFGLArv~~~~~s 842 (995)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc----
Confidence 99999999999999888999999999999999999999999999999999999995 57899999999997421
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+.
T Consensus 162 ------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 162 ------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp -----------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 11122356799999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHh
Q 001924 923 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKL 988 (995)
Q Consensus 923 ~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l 988 (995)
...+......++. .+..+|+++.+||.+||+.||++||| +.++|+||||.+.......++..+
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~~~~~~~ 281 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAGDTALDKNIHQSV 281 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTSSCCCCCCCHHHH
T ss_pred HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCCccccccchhH
Confidence 9999888766543 34679999999999999999999999 677899999987665555555444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=459.43 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=229.3
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
+.|++++.||+|+||+||+|+++.+|..||||+++... ....+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 56999999999999999999999999999999997642 344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~------- 161 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT------- 161 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH-------
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC-------
Confidence 99999999999765 4569999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~-----g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.........+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..
T Consensus 162 --------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 162 --------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp --------------------HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred --------------------CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 0111233568999999999984 456899999999999999999999999999999
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
+.+.++.....+....+..+++++.+||.+||+.||.+||| +.++|+||||+..
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~~ 275 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTVD 275 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCCC
T ss_pred HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCC
Confidence 99999888876655556789999999999999999999999 7788999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=453.38 Aligned_cols=266 Identities=28% Similarity=0.476 Sum_probs=232.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR---KNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s---e~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
.++|++.+.||+|+||+||+|+++.+|+.||||++++..... ....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999999999999999997644322 22367899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC----cEEEEecCCccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGL 838 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG----~VKLsDFGLArv~~ 838 (995)
|+|||||++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999999999999999999999999998776 59999999997421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 169 ----------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 169 ----------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp ----------------------------TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 0112234679999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccc
Q 001924 919 PEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 919 ~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~ 982 (995)
..+.+..+......++. .+..++..+.+||++||+.||.+||| +.++|+||||+.+.++..
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC------
T ss_pred HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHh
Confidence 99999999888766542 34678999999999999999999999 667789999998776543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=462.19 Aligned_cols=267 Identities=30% Similarity=0.497 Sum_probs=226.1
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999999999999999997532 3445678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+||||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC----
Confidence 999999999999999988899999999999999999999997 599999999999999999999999999998421
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
.....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 157 -------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 157 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp -------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred -------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 1122356899999999999999999999999999999999999999976543221
Q ss_pred HH------------------------------------------HHHccCCCCCCCC-CCCCHHHHHHHHHHhhcCccCC
Q 001924 923 FD------------------------------------------NILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQR 959 (995)
Q Consensus 923 ~q------------------------------------------kIl~~~~~~p~lp-s~lS~eL~dLIkkCLq~DPeKR 959 (995)
.. .+... ..+..+ ..++.++.+||.+||++||.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 10 11111 111122 2468899999999999999999
Q ss_pred CCHHHHHHHHcCccccccccccccchh
Q 001924 960 LGANGAAEVFHCKIFIKKTENCVSMQS 986 (995)
Q Consensus 960 PSA~EIlEiL~HPfF~~~~~n~~s~q~ 986 (995)
|| +.++|+||||++.++..+-+..
T Consensus 290 ~t---a~e~L~Hpf~~~~~~~~~d~~~ 313 (322)
T d1s9ja_ 290 AD---LKQLMVHAFIKRSDAEEVDFAG 313 (322)
T ss_dssp CC---HHHHHTSHHHHHHHHSCCCHHH
T ss_pred cC---HHHHhhCHhhCcCCcccccHHH
Confidence 99 7889999999988877666544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-53 Score=466.36 Aligned_cols=264 Identities=40% Similarity=0.777 Sum_probs=238.1
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.....+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999999999999999999865544455677899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~------- 192 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------- 192 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-------
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999998411
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 925 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qk 925 (995)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...++..
T Consensus 193 -----------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 249 (350)
T d1rdqe_ 193 -----------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249 (350)
T ss_dssp -----------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -----------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH
Confidence 112346799999999999999999999999999999999999999999999999999
Q ss_pred HHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCH--HHHHHHHcCccccccccccc
Q 001924 926 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 926 Il~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA--~EIlEiL~HPfF~~~~~n~~ 982 (995)
+......+ +..+++++.+||++||+.||.+|+.. ..+.++++||||++.+|..+
T Consensus 250 i~~~~~~~---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~ 305 (350)
T d1rdqe_ 250 IVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp HHHCCCCC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred HhcCCCCC---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHH
Confidence 98887654 46899999999999999999999511 12778899999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=447.75 Aligned_cols=252 Identities=23% Similarity=0.432 Sum_probs=217.6
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec----cCeeEE
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 764 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~----~~~lyL 764 (995)
|++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+++|++++|||||++++++.. ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4778899999999999999999999999999976443 44567789999999999999999999999865 346899
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeeecCCCcEEec-cCCcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~G--IIHRDLKPeNILLD-enG~VKLsDFGLArv~~~~~ 841 (995)
||||+++|+|.+++.+...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 9999999999999998889999999999999999999999998 99999999999996 57899999999997411
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-HH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s-~~ 920 (995)
.......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.. ..
T Consensus 167 --------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 167 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence 112234679999999999876 59999999999999999999999998754 44
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
.++..+..+ ...+..+...++++.+||.+||+.||++||| +.++|+||||+
T Consensus 220 ~~~~~i~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 220 QIYRRVTSG-VKPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHTTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHHHHHHcC-CCCcccCccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 555555444 3334455678999999999999999999999 78889999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-53 Score=456.67 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=229.7
Q ss_pred CeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEe
Q 001924 688 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 767 (995)
Q Consensus 688 dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmE 767 (995)
.|+.++.||+|+||+||+|++..+|+.||||+++..........+.+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987665556667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCC
Q 001924 768 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 847 (995)
Q Consensus 768 ym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg 847 (995)
||++|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---------
Confidence 99999998888777889999999999999999999999999999999999999999999999999997410
Q ss_pred CCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 848 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 848 ~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g---~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+.
T Consensus 167 ----------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 167 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp ----------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 1124579999999999965 458999999999999999999999999998888888
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKT 978 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~ 978 (995)
.+..+..+.+ .+..+++.+.+||.+||+.||.+||| +.++|+||||.+..
T Consensus 225 ~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 225 HIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSCC
T ss_pred HHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcCCC
Confidence 8887765432 34678999999999999999999999 67789999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=448.80 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=217.6
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec--cCeeE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLY 763 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~--~~~ly 763 (995)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .+...+.+.+|++++++++|||||++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3689999999999999999999999999999999976543 45567789999999999999999999999865 45689
Q ss_pred EEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 764 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k----~~~Lsee~ir~Ia~QIa~GLaYLHs~G-----IIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
+|||||++|+|.+++.+ ...+++..++.++.||+.||+|||+.| ||||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357999999999999999999999976 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
+.... ........+||+.|||||++.+..|+.++|||||||++|||++|+.||
T Consensus 162 ~~~~~---------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 162 RILNH---------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeccc---------------------------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 85210 111223568999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccc
Q 001924 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIF 974 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF 974 (995)
.+.+..++...+..+... .++..+++++.+||.+||+.||.+||| +.++|+|||.
T Consensus 215 ~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 215 TAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 999999999888877643 456789999999999999999999999 7788999995
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-53 Score=466.42 Aligned_cols=269 Identities=34% Similarity=0.549 Sum_probs=225.9
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrE---ieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
+.++|++.+.||+|+||.||+|+++.+|+.||||++.+...........+.+| +.+++.++|||||++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46899999999999999999999999999999999976444333333444444 566677789999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+|||||+||+|.+++.+...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~--- 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--- 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS---
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..
T Consensus 159 --------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 159 --------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp --------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred --------------------------CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 112234579999999999975 56899999999999999999999999876543
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
.............+..+..+++++.+||.+||+.||.+|||.. .+.++++||||+++.|..+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp CHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence 3322222222222345578999999999999999999999953 3789999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=456.52 Aligned_cols=263 Identities=39% Similarity=0.741 Sum_probs=234.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hcCCCceEEEeeeeeccCeeEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs-~LkHPNIVkL~gvf~~~~~lyL 764 (995)
+++|++.+.||+|+||+||+|.++.+|+.||||++++.........+.+..|..++. .++|||||++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 378999999999999999999999999999999998755444556677888888765 6899999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~------ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------ 154 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC------
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc------
Confidence 99999999999999998899999999999999999999999999999999999999999999999999997411
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.
T Consensus 155 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 155 ---------------------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp ---------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ---------------------cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01122234679999999999999999999999999999999999999999999999999
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
.+..+...+ |..+++++.+||.+||+.||.+||++. .++++||||++..|.
T Consensus 214 ~i~~~~~~~---p~~~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWE 264 (320)
T ss_dssp HHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHH
T ss_pred HHHcCCCCC---CccCCHHHHHHHHHhcccCCCCCcCHH--HHHHhCchhccCCHH
Confidence 988776544 468999999999999999999999942 257899999988654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-52 Score=459.45 Aligned_cols=261 Identities=27% Similarity=0.502 Sum_probs=231.6
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999987543 3445778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc--CCcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe--nG~VKLsDFGLArv~~~~~ 841 (995)
|||||+||+|.+++. ..+.+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 999999999999995 4467999999999999999999999999999999999999964 6789999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 178 -------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 178 -------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp -------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 0112234679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
.+..+......++. .+..+++++.+||.+||+.||++||| +.++|+||||+...+
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTC
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCC
Confidence 99999887765543 23568999999999999999999999 777899999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-52 Score=458.18 Aligned_cols=263 Identities=24% Similarity=0.449 Sum_probs=233.2
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeE
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 763 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ly 763 (995)
...++|++++.||+|+||+||+|++..+|+.||||++++.. ......+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999999999999999987643 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEec--cCCcEEEEecCCccccccc
Q 001924 764 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 764 LVmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLD--enG~VKLsDFGLArv~~~~ 840 (995)
||||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~-- 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC--
Confidence 9999999999999876544 699999999999999999999999999999999999998 57899999999998421
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 920 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ 920 (995)
.........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 181 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 181 --------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp --------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred --------------------------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 111223467999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccc
Q 001924 921 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTEN 980 (995)
Q Consensus 921 ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n 980 (995)
+.+..+......++. .+..+++++.+||.+||+.||.+||| +.++|+||||++...+
T Consensus 235 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHSN 292 (352)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCTT
T ss_pred HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCCcch
Confidence 999999888776543 45679999999999999999999999 7788999999876544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-51 Score=435.22 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=230.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhcC-CCceEEEeeeeec
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVR-NPFVVRFFYSFTC 758 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~s------e~e~e~flrEieILs~Lk-HPNIVkL~gvf~~ 758 (995)
.++|++.+.||+|+||+||+|++..+|+.||||++++..... +...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999997644321 223457889999999997 9999999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
++.+|||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC------CCCCchHHHHHHHHHHHHHHcCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g------~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
. .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.
T Consensus 162 ~----------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 162 P----------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp T----------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred C----------------------------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 0 112234679999999999853 357889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 913 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 913 PF~g~s~~ei~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
||.+.+.......+..+...++. ....+|+++.+||.+||+.||++||| +.++|+||||++
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~ 275 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 275 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHH
Confidence 99999999999999888765543 23479999999999999999999999 778899999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-52 Score=440.61 Aligned_cols=277 Identities=21% Similarity=0.337 Sum_probs=230.9
Q ss_pred CCccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 678 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 678 s~~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
+...++...++|++.+.||+|+||+||+|.++.+|+.||||+++... ...+.+.+|+.+|++++|||||++++++.
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 33556677789999999999999999999999999999999987533 24567999999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
+.+.+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999999754 568999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC-C
Q 001924 836 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-F 914 (995)
Q Consensus 836 v~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~P-F 914 (995)
....+. ........||+.|+|||++.+..|+.++|||||||++|||++|..| |
T Consensus 164 ~~~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 164 LMTGDT--------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp TCCSSS--------------------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ecCCCC--------------------------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 521110 0111234589999999999999999999999999999999996555 5
Q ss_pred CCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccchhHhHHhh
Q 001924 915 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSMQSKLEIEL 992 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~q~~l~~e~ 992 (995)
.+.+...++..+..+ .. +..+..+++.+.+||.+||+.||++|||+.++.+.|+. +++ ..+++++++.||
T Consensus 218 ~~~~~~~~~~~i~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~-~~~-----~~~~~~~i~k~l 287 (287)
T d1opja_ 218 PGIDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET-MFQ-----ESSISDEVEKEL 287 (287)
T ss_dssp TTCCHHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH-TTS-----SSCHHHHHHHHC
T ss_pred CcchHHHHHHHHhcC-CC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH-HHH-----hCCCChHhhccC
Confidence 566666666555443 32 34567899999999999999999999999999887753 222 235666666654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=444.13 Aligned_cols=260 Identities=26% Similarity=0.472 Sum_probs=230.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|.++.+|+.||||+++... .....+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997632 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC--CcEEEEecCCcccccccc
Q 001924 765 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~~-~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen--G~VKLsDFGLArv~~~~~ 841 (995)
|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998665 69999999999999999999999999999999999999854 489999999987411
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
........+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence 1112234579999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCCCC-CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 922 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 922 i~qkIl~~~~~~p~-lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
++..+......++. .+..+++++.+||.+||+.||.+||| +.++|+||||++..+
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHSCGG
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhccCcc
Confidence 99999988776543 23478999999999999999999999 677789999986533
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=435.30 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=214.9
Q ss_pred EEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEee
Q 001924 691 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 768 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se--~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEy 768 (995)
.++.||+|+||+||+|+++.+|+.||||+++....... .....+.+|+.++++++|||||++++++...+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999999999999999875432211 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCC
Q 001924 769 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 848 (995)
Q Consensus 769 m~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~ 848 (995)
+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~---------- 151 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------- 151 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT----------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC----------
Confidence 9988887777667789999999999999999999999999999999999999999999999999987311
Q ss_pred CCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 001924 849 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 927 (995)
Q Consensus 849 ~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~qkIl 927 (995)
.........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+.
T Consensus 152 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 152 -----------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp -----------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -----------------CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 011222346799999999998754 57999999999999999999999999999888877765
Q ss_pred ccCCC-----CC---------------C-----CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 928 NRKIP-----WP---------------C-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 928 ~~~~~-----~p---------------~-----lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
..... ++ . ....+++++.+||.+||++||++||| +.++|+||||++...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNRPG 288 (299)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSSSC
T ss_pred HhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHHHhCCHhhCCCCC
Confidence 42100 00 0 12357889999999999999999999 777899999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=432.48 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=218.7
Q ss_pred EeeccCCCeEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEEeecC
Q 001924 693 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 770 (995)
Q Consensus 693 k~LG~GgFGtVYka~~k~--TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVmEym~ 770 (995)
++||+|+||+||+|.+.. +++.||||+++... .+....+.+.+|+.+|++++|||||++++++.. +.+++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 479999999999998653 55789999997543 334456789999999999999999999999865 56789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCC
Q 001924 771 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 850 (995)
Q Consensus 771 GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t 850 (995)
+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~--------- 161 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------- 161 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC---------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc---------
Confidence 99999999988889999999999999999999999999999999999999999999999999998421110
Q ss_pred CCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcc
Q 001924 851 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 929 (995)
Q Consensus 851 ~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~ 929 (995)
..........||+.|||||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+
T Consensus 162 ---------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 162 ---------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp ---------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ---------------cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 01112234579999999999999999999999999999999998 89999999988888877765
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 930 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 930 ~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.. +..|..+|+++.+||.+||+.||++|||+.++.+.|+|+||+-.
T Consensus 227 ~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 227 ER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CC--CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 42 34567899999999999999999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-50 Score=422.50 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=219.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----e
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----N 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----~ 761 (995)
.++|++.+.||+|+||+||+|.+..+|+.||||++++....+......+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998766555666778999999999999999999999988754 3
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~- 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS- 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc-
Confidence 8999999999999999998889999999999999999999999999999999999999999999999999988742110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 165 -----------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 165 -----------------------GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp -------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 011123345689999999999999999999999999999999999999999999988
Q ss_pred HHHHHHccCCCCC-CCCCCCCHHHHHHHHHHhhcCccCCC-CHHHHHHH
Q 001924 922 IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRL-GANGAAEV 968 (995)
Q Consensus 922 i~qkIl~~~~~~p-~lps~lS~eL~dLIkkCLq~DPeKRP-SA~EIlEi 968 (995)
.+.+++......+ ..+..+|+++.+||.+||+.||.+|| |+.++.+-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~ 270 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence 8888877765443 34568999999999999999999999 66665543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=430.18 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=215.0
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
++...++|++.+.||+|+||+||+|++. ..||||+++... ......+.|.+|+.+|++++|||||++++++.. +.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 4566789999999999999999999754 469999997543 344567889999999999999999999998754 56
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+++|||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999754 56999999999999999999999999999999999999999999999999999752110
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC---CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~---~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
..........||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.
T Consensus 158 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ---------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 011122356799999999999653 5899999999999999999999999987
Q ss_pred CHHHHHHHHHccCCCCC---CCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 SPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p---~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+.......+.......| ..+..+++++.+||.+||+.||.+|||+.++++.|+
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 76655555555443333 356789999999999999999999999999888764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=421.33 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=212.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEE
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyL 764 (995)
..++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+.++++++|||||++++++...+.+++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 3578999999999999999999987 57789999987533 234679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~--- 154 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--- 154 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC---
Confidence 99999999999998755 56889999999999999999999999999999999999999999999999999742110
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei 922 (995)
.........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..++
T Consensus 155 -----------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 155 -----------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp ---------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred -----------------------CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH
Confidence 1111234569999999999999999999999999999999999 6778888888888
Q ss_pred HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 923 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 923 ~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
...+..+.. +..|..+++++.+||.+||+.||++|||+.++++.|+
T Consensus 212 ~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 212 VEDISTGFR--LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp HHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCC--CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 888776543 2345788999999999999999999999998888764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=430.28 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=224.9
Q ss_pred cCCCeEEEEe-eccCCCeEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKP-ISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~-LG~GgFGtVYka~~k~T--G~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..++|.+.+. ||+|+||+||+|.++.+ +..||||+++... .....+.+.+|+++|++++|||||++++++.. +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3467888885 99999999999987643 4589999997532 34567889999999999999999999999865 56
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 89999999999999998654 57999999999999999999999999999999999999999999999999999852211
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
. ..........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus 163 ~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 163 D------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp S------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred c------------------------cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 1 01112234569999999999999999999999999999999998 9999999888
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
.++...+..+.. +..|..+++++.+||.+||+.||++|||+.++.+.|+|+|+.-
T Consensus 219 ~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 219 PEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 888887776543 3456789999999999999999999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=435.31 Aligned_cols=264 Identities=24% Similarity=0.373 Sum_probs=222.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~-----~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
..++...++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++.++ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 3445566899999999999999999999876554 69999886432 233456789999999998 899999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKV-----------------------GCLEEDVARIYIAELVLALEYLHSLGIVH 810 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~-----------------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIH 810 (995)
+++...+.+|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++||||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9999999999999999999999999753 24889999999999999999999999999
Q ss_pred eecCCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC
Q 001924 811 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 890 (995)
Q Consensus 811 RDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ 890 (995)
|||||+|||++.++.+||+|||+|+...... .........||+.|||||++.+..
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-------------------------NYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------TSEEETTEEECGGGCCHHHHHHCC
T ss_pred ccCchhccccccCCeEEEeeccccccccCCC-------------------------ceeeeccccCCCccCChHHHcCCC
Confidence 9999999999999999999999998422110 011123456899999999999999
Q ss_pred CCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 891 HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 891 ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
|+.++|||||||++|||++ |..||.+.+....+..++.....+ ..|..+++++.+||.+||+.||++|||+.++++.|
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999998 899999887777777777766543 35678999999999999999999999999999988
Q ss_pred cC
Q 001924 970 HC 971 (995)
Q Consensus 970 ~H 971 (995)
.+
T Consensus 322 ~~ 323 (325)
T d1rjba_ 322 GC 323 (325)
T ss_dssp HH
T ss_pred hC
Confidence 64
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-50 Score=428.35 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=212.1
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~---~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
..++|++.+.||+|+||+||+|.++.+++ .||||.+.... .....+.|.+|+.+|++++|||||++++++...+.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 35789999999999999999999987765 58888775432 34556789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
+|+|||||++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999988764 56999999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
... ..........||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+.
T Consensus 182 ~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 182 TSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp ------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCc----------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 100 00111223468999999999999999999999999999999998 8999999999
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.++...+..+.. +..+..++..+.+||.+||+.||.+|||+.++++.|+
T Consensus 240 ~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 240 QDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 988888776543 2345789999999999999999999999999887764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=425.25 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=214.9
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchh---HHHHHHHHHHHHHhcC--CCceEEEeeeeeccC
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILITVR--NPFVVRFFYSFTCRD 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~---e~e~flrEieILs~Lk--HPNIVkL~gvf~~~~ 760 (995)
.++|++.+.||+|+||+||+|++..+|+.||||++++....... ...++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999999999999999999864332211 1234678999999987 899999999999999
Q ss_pred eeEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccC-CcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~G-GSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDen-G~VKLsDFGLArv~~ 838 (995)
..|+||||+.+ +++.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888999888899999999999999999999999999999999999999854 799999999997411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.
T Consensus 163 -----------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 -----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp -----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred -----------------------------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 112234679999999999987765 67899999999999999999999763
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..+......+ +..+|+++.+||.+||+.||++||| +.++|+||||+++
T Consensus 214 ------~~i~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 214 ------EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDV 261 (273)
T ss_dssp ------HHHHHCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSC
T ss_pred ------hHHhhcccCC---CCCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCC
Confidence 2344555443 4689999999999999999999999 7778999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=422.74 Aligned_cols=264 Identities=30% Similarity=0.410 Sum_probs=216.7
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeec--
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC-- 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~T-G~~VAVKVIkk~~~~se~e~e~flrEieILs~L---kHPNIVkL~gvf~~-- 758 (995)
+.++|++++.||+|+||+||+|++..+ ++.||||+++.... .+.....+.+|+.+++.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 457999999999999999999999755 66899999975432 222233466777777665 79999999999853
Q ss_pred ---cCeeEEEEeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCc
Q 001924 759 ---RDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 834 (995)
Q Consensus 759 ---~~~lyLVmEym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLA 834 (995)
...++++|||+.+|.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 346899999998877655443 3356999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 001924 835 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 914 (995)
Q Consensus 835 rv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF 914 (995)
+... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||
T Consensus 164 ~~~~----------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhc----------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 7411 112234567999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccCC------------------------CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 915 TAESPEIIFDNILNRKI------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 915 ~g~s~~ei~qkIl~~~~------------------------~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
.+.+..+.+..+..... +.+..+..+++.+.+||.+||++||++||| +.++|+
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e~L~ 292 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALS 292 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHHT
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC---HHHHhc
Confidence 99988888777654210 011134568999999999999999999999 678899
Q ss_pred Cccccccccc
Q 001924 971 CKIFIKKTEN 980 (995)
Q Consensus 971 HPfF~~~~~n 980 (995)
||||+++++.
T Consensus 293 Hpff~~i~~~ 302 (305)
T d1blxa_ 293 HPYFQDLERC 302 (305)
T ss_dssp SGGGTTCCCC
T ss_pred ChhhcCchhh
Confidence 9999988653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=422.67 Aligned_cols=261 Identities=22% Similarity=0.353 Sum_probs=220.9
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
+.++...++|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.++++++|||||++++++..
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 344566789999999999999999999986 57889999997533 234679999999999999999999998754
Q ss_pred CeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 5679999999999999987543 35999999999999999999999999999999999999999999999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g 916 (995)
..+ .........||+.|+|||++.+..++.++|||||||++|||+| |.+||..
T Consensus 160 ~~~--------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 160 EDN--------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp SSS--------------------------CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCC--------------------------ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 211 1112234568999999999999999999999999999999999 5666777
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFI 975 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~ 975 (995)
.+..++...+..+.. +..|..+++++.+||.+||+.||++|||+.++++.|+. ||.
T Consensus 214 ~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~-~ft 269 (272)
T d1qpca_ 214 MTNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED-FFT 269 (272)
T ss_dssp CCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH-HHH
T ss_pred CCHHHHHHHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh-hhh
Confidence 788888877766532 33467899999999999999999999999999888764 543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=423.12 Aligned_cols=263 Identities=30% Similarity=0.502 Sum_probs=217.5
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++++.||+|+||+||+|.+..+|+.||||+++... ..+.....+.+|+++|++++|||||++++++.+...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 368999999999999999999999999999999996533 2333457889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccc
Q 001924 766 MEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 843 (995)
Q Consensus 766 mEym~GGSL~d~L~--k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~ 843 (995)
|||+.+ ++.+++. ....+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~----- 153 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----- 153 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC-----
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc-----
Confidence 999965 4555543 23569999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 001924 844 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEII 922 (995)
Q Consensus 844 dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~y-s~KSDIWSLGVILyELLTGr~PF~g~s~~ei 922 (995)
..........||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.
T Consensus 154 ----------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 154 ----------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp ----------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ----------------------CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH
Confidence 11122334579999999999877664 7899999999999999999999999888777
Q ss_pred HHHHHccCCC-----CCC---------------------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 923 FDNILNRKIP-----WPC---------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 923 ~qkIl~~~~~-----~p~---------------------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
...+...... ++. ....++.++.+||.+||..||++||| +.++|+||||++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~ff~~ 288 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPFFQD 288 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGTT
T ss_pred HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhCCHhhcc
Confidence 6665432110 000 11356789999999999999999999 778899999988
Q ss_pred cccc
Q 001924 977 KTEN 980 (995)
Q Consensus 977 ~~~n 980 (995)
..+-
T Consensus 289 ~~~p 292 (298)
T d1gz8a_ 289 VTKP 292 (298)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 7553
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-49 Score=417.43 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=218.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++++.||+|+||+||+|+++ +|+.||||+++.... .+...+.+.+|+.+|++++|||||++++++...+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999986 789999999976432 344467899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 766 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 766 mEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|+|+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~------- 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------- 151 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC-------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc-------
Confidence 9999888777777777889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~~ei~q 924 (995)
..........|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 152 --------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 152 --------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp --------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred --------------------cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence 011122345689999999999765 46899999999999999999999999988877776
Q ss_pred HHHccCCC--------------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccc
Q 001924 925 NILNRKIP--------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIK 976 (995)
Q Consensus 925 kIl~~~~~--------------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~ 976 (995)
++...... +......+++.+.+||++||+.||++||| +.++|+||||++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCc
Confidence 65431100 01124567899999999999999999999 778899999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=413.65 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=221.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLV 765 (995)
.++|++.++||+|+||+||+|+++ +++.||||++++... ..+.+++|+.++++++||||+++++++.+.+.+++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 578999999999999999999985 688999999986443 345799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccccc
Q 001924 766 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 844 (995)
Q Consensus 766 mEym~GGSL~d~L~k-~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~d 844 (995)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~---- 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 153 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS----
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC----
Confidence 999999999999764 456899999999999999999999999999999999999999999999999999742111
Q ss_pred CCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 001924 845 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 923 (995)
Q Consensus 845 lsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ei~ 923 (995)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.
T Consensus 154 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~ 211 (258)
T d1k2pa_ 154 ----------------------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211 (258)
T ss_dssp ----------------------SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH
T ss_pred ----------------------CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH
Confidence 1112223579999999999999999999999999999999998 89999999999998
Q ss_pred HHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 924 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 924 qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
..+..+.. +..|..+++.+.+||.+||+.||++|||+.++++.|.
T Consensus 212 ~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 212 EHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhCCC--CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 88876543 3356789999999999999999999999888887663
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=432.78 Aligned_cols=257 Identities=30% Similarity=0.502 Sum_probs=210.9
Q ss_pred ccCCCeEEEE-eeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeec---
Q 001924 684 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC--- 758 (995)
Q Consensus 684 ~s~~dYeIlk-~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~-LkHPNIVkL~gvf~~--- 758 (995)
...++|.+.. .||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3467899885 599999999999999999999999998742 346789988765 589999999999875
Q ss_pred -cCeeEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecC
Q 001924 759 -RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 832 (995)
Q Consensus 759 -~~~lyLVmEym~GGSL~d~L~k~--~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFG 832 (995)
...+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 45689999999999999999764 36999999999999999999999999999999999999985 5679999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 912 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~ 912 (995)
+|+.... .......+||+.|||||++.+..|+.++|||||||++|+|++|+.
T Consensus 160 ~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 160 FAKETTS----------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp TCEECCC----------------------------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred eeeeccC----------------------------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 9984211 112234679999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHH----ccCCCCCCC-CCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccccc
Q 001924 913 PFTAESPEIIFDNIL----NRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTE 979 (995)
Q Consensus 913 PF~g~s~~ei~qkIl----~~~~~~p~l-ps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~ 979 (995)
||.+.+.......+. .....++.. +..+++++.+||.+||+.||++||| +.++|+||||.+...
T Consensus 212 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQSTK 280 (335)
T ss_dssp SCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHTTTS
T ss_pred CCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhhCCCC
Confidence 998766544443332 233333321 1358999999999999999999999 677899999976543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=413.38 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=213.5
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG----~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
+.++.|++.+.||+|+||.||+|.++.++ ..||||+++... .......+++|++++++++|||||++++++...
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 45678999999999999999999987655 479999986532 344566799999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+.+++||||+.+|++.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999988655 579999999999999999999999999999999999999999999999999998522
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC-CCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG-r~PF~g~ 917 (995)
.... .........||+.|||||++.+..++.++|||||||++|||++| .+||...
T Consensus 162 ~~~~------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 162 DDPE------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp ------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCc------------------------cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 1100 01112234689999999999999999999999999999999995 5556667
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+..+++..+..+.. +..+..++..+.+||.+||+.||++|||+.++++.|+
T Consensus 218 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 218 SNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CHHHHHHHHhccCC--CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 77777777665532 3346789999999999999999999999999988774
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=411.69 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=211.7
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG---~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
+...++|++.+.||+|+||.||+|.+..++ ..||||.++.. ......+.+.+|+.++++++|||||++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 344578999999999999999999987554 46888887543 24455678999999999999999999999986 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 6789999999999999987654 468999999999999999999999999999999999999999999999999998421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.. .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 160 ~~--------------------------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 160 DS--------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CC--------------------------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 10 1112234568999999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+..+++..+..+.. +..+..+|+.+.+||.+||+.||++|||+.++++.|+
T Consensus 214 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 214 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999888877653 3456789999999999999999999999998887764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=414.52 Aligned_cols=266 Identities=27% Similarity=0.375 Sum_probs=215.3
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec------
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 758 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~------ 758 (995)
..++|++++.||+|+||+||+|++..+|+.||||++..... .+.....+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 35899999999999999999999999999999999876432 34456778999999999999999999998865
Q ss_pred --cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 759 --RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 759 --~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
...+|+||||+.++.+..+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 345899999998877766666667899999999999999999999999999999999999999999999999999974
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
..... ..........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.
T Consensus 167 ~~~~~-----------------------~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 167 FSLAK-----------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccc-----------------------ccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 21110 0111223346799999999999875 68999999999999999999999999
Q ss_pred CCCHHHHHHHHHccCCCCCC-CC----------------------------CCCCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 916 AESPEIIFDNILNRKIPWPC-VP----------------------------SDMSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 916 g~s~~ei~qkIl~~~~~~p~-lp----------------------------s~lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
+.+.......+.......+. .. ...++++.+||.+||++||++||| +.
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---a~ 300 (318)
T d3blha1 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SD 300 (318)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---HH
T ss_pred CCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC---HH
Confidence 98887776665442211110 00 013677889999999999999999 77
Q ss_pred HHHcCcccccc
Q 001924 967 EVFHCKIFIKK 977 (995)
Q Consensus 967 EiL~HPfF~~~ 977 (995)
++|+||||...
T Consensus 301 elL~Hpff~~~ 311 (318)
T d3blha1 301 DALNHDFFWSD 311 (318)
T ss_dssp HHHHSGGGSSS
T ss_pred HHHcChhhccC
Confidence 88999999853
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-48 Score=412.78 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=223.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeee
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 757 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~ 757 (995)
+...++|++.+.||+|+||+||+|+++ .+++.||||+++... .......+.+|+.++++++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 334578999999999999999999975 356799999987532 3445678999999999999999999999999
Q ss_pred ccCeeEEEEeecCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeec
Q 001924 758 CRDNLYLVMEYLNGGDLYSLLRKVG------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDL 813 (995)
Q Consensus 758 ~~~~lyLVmEym~GGSL~d~L~k~~------------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDL 813 (995)
..+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999996432 3788999999999999999999999999999
Q ss_pred CCCcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCc
Q 001924 814 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 893 (995)
Q Consensus 814 KPeNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~ 893 (995)
||+|||++.++.+||+|||+|+...... .........||+.|+|||++.+..|+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred cccceEECCCCcEEEccchhheeccCCc-------------------------cccccCCCCcCcCcCCHHHHccCCCCh
Confidence 9999999999999999999998422111 111223567899999999999999999
Q ss_pred hHHHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 894 AADWWSVGIILFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 894 KSDIWSLGVILyELLTGr-~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
++|||||||++|||++|. +||.+.+..++...+..+.. +..|..+++++.+||.+||+.||++|||+.++.+.|+
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999999999984 78999999999888877653 4456789999999999999999999999999998875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=418.61 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=213.5
Q ss_pred cCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----
Q 001924 685 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 685 s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~---- 760 (995)
..++|++++.||+|+||+||+|.++.+|+.||||++++. ...+...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh-hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 458999999999999999999999999999999999753 335566788999999999999999999999998765
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 --~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||||+ +++|..+++ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|+...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 479999999 567777764 4579999999999999999999999999999999999999999999999999997410
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~ 917 (995)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 173 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 173 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 112346799999999999775 5689999999999999999999999988
Q ss_pred CHHHHHHHHHccC----------------------------CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 918 SPEIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 918 s~~ei~qkIl~~~----------------------------~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
+....+..+.... ..+......+++.+.+||.+||..||.+||| +.++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~eiL 299 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 299 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC---HHHHh
Confidence 7766554443211 1122234578999999999999999999999 77889
Q ss_pred cCcccccccc
Q 001924 970 HCKIFIKKTE 979 (995)
Q Consensus 970 ~HPfF~~~~~ 979 (995)
+||||+...+
T Consensus 300 ~Hp~f~~~~~ 309 (346)
T d1cm8a_ 300 AHPYFESLHD 309 (346)
T ss_dssp HSGGGTTTC-
T ss_pred cChhhCcCCC
Confidence 9999988643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=401.82 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=222.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCeeEEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 766 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~lyLVm 766 (995)
++|++++.||+|+||+||+|++..+|+.||||+++... ........+.+|+.+++.++||||+++++++......++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999997644 34556788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccCC
Q 001924 767 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 846 (995)
Q Consensus 767 Eym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dls 846 (995)
+++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~------- 153 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------- 153 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS-------
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC-------
Confidence 9999999999998888999999999999999999999999999999999999999999999999999974211
Q ss_pred CCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHH
Q 001924 847 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIFD 924 (995)
Q Consensus 847 g~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF-~g~s~~ei~q 924 (995)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+.+.
T Consensus 154 --------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 154 --------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp --------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred --------------------CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 111222345788999999998765 689999999999999999999885 5556665555
Q ss_pred HHHccCC--------------------------CCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 925 NILNRKI--------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 925 kIl~~~~--------------------------~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
.+..... .....+..+++.+.+||.+||+.||.+||| +.++|+||||++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGSSC
T ss_pred HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---HHHHhcChhhcCC
Confidence 5432110 111234567899999999999999999999 7789999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=410.80 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=212.3
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~-TG~--~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~l 762 (995)
.++|++.+.||+|+||+||+|.+.. +++ .||||++++.........+.|.+|+.+|++++|||||++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4789999999999999999998753 333 789999887655555667889999999999999999999999975 568
Q ss_pred EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~ 841 (995)
++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999999887654 569999999999999999999999999999999999999999999999999998521110
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 920 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~~ 920 (995)
..........||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..
T Consensus 166 ------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 166 ------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp ------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ------------------------CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 01112234568899999999999999999999999999999998 89999999999
Q ss_pred HHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 921 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 921 ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+....+....... ..+..+|+.+.+||.+||..||++|||+.++.++|.
T Consensus 222 ~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 222 QILHKIDKEGERL-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp HHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999888776553 356789999999999999999999999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=409.59 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=217.6
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 759 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~ 759 (995)
..+....++|++.+.||+|+||+||+|++..+ ..||||+++... ...+.|.+|+.++++++|||||++++++..
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 34456678999999999999999999998754 579999997543 234679999999999999999999999854
Q ss_pred CeeEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 837 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k--~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~ 837 (995)
+..++||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 568999999999999998854 357999999999999999999999999999999999999999999999999999742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 001924 838 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTA 916 (995)
Q Consensus 838 ~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTG-r~PF~g 916 (995)
... .........||+.|+|||++.+..++.++|||||||++|||++| .+||.+
T Consensus 164 ~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 164 EDN--------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCC--------------------------CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 110 01122345699999999999999999999999999999999995 566677
Q ss_pred CCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 917 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 917 ~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
....+++..+..+.. +..+..+++++.+||.+||+.||++|||+.++.++|+. ||...
T Consensus 218 ~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~-~~~~~ 275 (285)
T d1fmka3 218 MVNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED-YFTST 275 (285)
T ss_dssp CCHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT-TTSCS
T ss_pred CCHHHHHHHHHhcCC--CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh-hhcCC
Confidence 777778777765532 23567899999999999999999999999999888776 55443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=409.00 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=208.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 754 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~g 754 (995)
+++...++|++.+.||+|+||.||+|.+.. +++.||||+++... .....+.+.+|..++.++ +|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 344556889999999999999999999754 44689999987533 344567788888888776 6899999999
Q ss_pred eeecc-CeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCc
Q 001924 755 SFTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 817 (995)
Q Consensus 755 vf~~~-~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeN 817 (995)
++... ..+++|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 87664 4689999999999999999643 248899999999999999999999999999999999
Q ss_pred EEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHH
Q 001924 818 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 897 (995)
Q Consensus 818 ILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDI 897 (995)
||++.++.+||+|||+|+..... .........+||+.|+|||++.+..++.++||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDi 219 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219 (299)
T ss_dssp EEECGGGCEEECC------CCSC-------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHH
T ss_pred eeECCCCcEEEccCcchhhcccc-------------------------ccccccCceeeCccccchhHhhcCCCCcccce
Confidence 99999999999999999842110 01112335679999999999999999999999
Q ss_pred HHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 898 WSVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 898 WSLGVILyELLTG-r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||||++|||++| .+||.+......+..++..... +..+..+++++.+||.+||+.||++|||+.++++.|+
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999999999986 5688877655555555544433 3456789999999999999999999999999888775
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=424.21 Aligned_cols=270 Identities=40% Similarity=0.738 Sum_probs=225.6
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEE---CCCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCC-CceEEEeeeeec
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRN-PFVVRFFYSFTC 758 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~---k~TG~~VAVKVIkk~~~~-se~e~e~flrEieILs~LkH-PNIVkL~gvf~~ 758 (995)
+..++|++++.||+|+||+||+|.+ +.+|+.||||++++.... .....+.+.+|++++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3568899999999999999999997 447899999999764332 22345678899999999976 899999999999
Q ss_pred cCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 759 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 759 ~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
...+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTA 916 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~--~ys~KSDIWSLGVILyELLTGr~PF~g 916 (995)
. .......+..||+.|+|||.+.+. .++.++|||||||+||+|++|+.||.+
T Consensus 181 ~--------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 181 A--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp G--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred c--------------------------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 1 112223456799999999999765 468899999999999999999999977
Q ss_pred CCHHHH----HHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHH--HHHHHHcCccccccccccc
Q 001924 917 ESPEII----FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVFHCKIFIKKTENCV 982 (995)
Q Consensus 917 ~s~~ei----~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~--EIlEiL~HPfF~~~~~n~~ 982 (995)
.+.... ......... ..+..+++++.+||.+||++||.+|||+. .+.++|+||||+++.|..+
T Consensus 235 ~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l 303 (322)
T d1vzoa_ 235 DGEKNSQAEISRRILKSEP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303 (322)
T ss_dssp TTSCCCHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred CCHHHHHHHHHHhcccCCC---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHH
Confidence 654333 333333333 34568999999999999999999999753 5888999999999876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=407.79 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=213.1
Q ss_pred ccccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-cC
Q 001924 682 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RD 760 (995)
Q Consensus 682 ~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-~~ 760 (995)
|+...++|++.+.||+|+||.||+|.++ |..||||++++. ...+.+.+|++++++++||||+++++++.. .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4567789999999999999999999985 789999999753 245679999999999999999999998865 45
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 838 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~--~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~ 838 (995)
.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 6899999999999999996543 58999999999999999999999999999999999999999999999999987411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 917 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~ 917 (995)
.......+|+.|+|||++.+..++.++|||||||++|||++ |++||...
T Consensus 155 ------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 155 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 11223458899999999999999999999999999999998 79999999
Q ss_pred CHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 918 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 918 s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
+..++...+..+.. +..+..+++++.+||.+||..||.+|||+.++++.|+
T Consensus 205 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 205 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 88888888766532 3456789999999999999999999999999988775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=411.69 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=210.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccCe
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 761 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~----~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~~ 761 (995)
.++|++++.||+|+||+||+|.+..+|+ +||+|.++... .....+.+.+|+.++++++|||||++++++.+. .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3679999999999999999999988886 57777775432 334567899999999999999999999999864 5
Q ss_pred eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 762 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
.+++|+|+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 67889999999999988754 57999999999999999999999999999999999999999999999999999852111
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLT-Gr~PF~g~s~ 919 (995)
. .........||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+.
T Consensus 165 ~-------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 165 E-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp C-------------------------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred c-------------------------ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 0 0111223468999999999999999999999999999999998 8999999888
Q ss_pred HHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 920 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
.++...+..+.. +..|..+++.+.+||.+||+.||.+|||+.++++.|
T Consensus 220 ~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 220 SEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp GGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 888777766542 234578999999999999999999999988887654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=414.58 Aligned_cols=257 Identities=30% Similarity=0.413 Sum_probs=210.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc------C
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------D 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~------~ 760 (995)
-+|+.+++||+|+||+||+|++..+|+.||||++++... ...+|+++|++++||||++++++|... .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 369999999999999999999999999999999976432 234799999999999999999998543 3
Q ss_pred eeEEEEeecCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCccc
Q 001924 761 NLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKI 836 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L---~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv 836 (995)
.+|+||||+++|.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 478999999765433332 3445799999999999999999999999999999999999999775 899999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 001924 837 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 915 (995)
Q Consensus 837 ~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~ 915 (995)
.. ......+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||.
T Consensus 173 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 173 LV----------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CC----------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cc----------------------------CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 21 0112234679999999999876 468999999999999999999999999
Q ss_pred CCCHHHHHHHHHcc-----------------CCCCCC---------CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHH
Q 001924 916 AESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVF 969 (995)
Q Consensus 916 g~s~~ei~qkIl~~-----------------~~~~p~---------lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL 969 (995)
..+..+.+..+... ...++. ....+++++.+||.+||++||++||| +.++|
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L 301 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEAC 301 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC---HHHHh
Confidence 98877776666431 011111 12457899999999999999999999 77789
Q ss_pred cCcccccccccc
Q 001924 970 HCKIFIKKTENC 981 (995)
Q Consensus 970 ~HPfF~~~~~n~ 981 (995)
+||||++.....
T Consensus 302 ~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 302 AHSFFDELRDPN 313 (350)
T ss_dssp TSGGGGGGGCTT
T ss_pred cCHhhccccCCC
Confidence 999999876543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=411.60 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=216.7
Q ss_pred ccCCCeEEEEeeccCCCeEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeeccC
Q 001924 684 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 760 (995)
Q Consensus 684 ~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~--VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~gvf~~~~ 760 (995)
+..++|++.+.||+|+||+||+|.++.+|.. ||||.++.. ......+.+.+|+++|+++ +|||||++++++...+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 3558999999999999999999999988875 566665432 2334566799999999998 7999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999643 4689999999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
.+||+|||+|+... .........||+.|+|||.+.+..|+.++|||||||++
T Consensus 165 ~~kl~DfG~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 165 VAKIADFGLSRGQE----------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp CEEECCTTCEESSC----------------------------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred ceEEcccccccccc----------------------------ccccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence 99999999997411 11122345689999999999999999999999999999
Q ss_pred HHHHcC-CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 905 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 905 yELLTG-r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
|||++| .+||.+.+..+++..+..+.. +..+..+++++.+||.+||+.||++|||+.++++.|+.
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 999996 568999999998888776532 34567899999999999999999999999999887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=405.91 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=219.7
Q ss_pred cccccCCCeEEEEeeccCCCeEEEEEEECCCC-------cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEE
Q 001924 681 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 752 (995)
Q Consensus 681 e~~~s~~dYeIlk~LG~GgFGtVYka~~k~TG-------~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL 752 (995)
.+....++|++.+.||+|+||.||+|+...++ ..||||++++.. .......+.+|...+.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 35566789999999999999999999976554 379999987533 345567889999999888 79999999
Q ss_pred eeeeeccCeeEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCC
Q 001924 753 FYSFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 816 (995)
Q Consensus 753 ~gvf~~~~~lyLVmEym~GGSL~d~L~k~----------------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPe 816 (995)
++++.+.+.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999644 24899999999999999999999999999999999
Q ss_pred cEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHH
Q 001924 817 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 896 (995)
Q Consensus 817 NILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSD 896 (995)
|||++.++.+||+|||+++..... ..........||+.|+|||++.+..|+.++|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGC-------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred ceeecCCCCeEeccchhhcccccc-------------------------ccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence 999999999999999999842111 1112234567899999999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 897 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 897 IWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||||+++|||++ |.+||.+.+...++..+..+.. +..|..+++.+.+||.+||+.||.+|||+.++++.|+
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 9999999999998 7999999998888877765432 4456789999999999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=412.87 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=212.4
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeeccC----ee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 762 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~~----~l 762 (995)
++|++++.||+|+||+||+|.+..+|+.||||++++.. .....+.+++|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 67999999999999999999999999999999997543 3455678999999999999999999999987654 23
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 842 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s 842 (995)
+++++|+.+|+|.+++... .+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~- 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH- 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG-
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC-
Confidence 4555667799999999654 69999999999999999999999999999999999999999999999999998522111
Q ss_pred ccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 843 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 843 ~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g-~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.........+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+...
T Consensus 164 -----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 164 -----------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp -----------------------CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 11122345679999999999855 567899999999999999999999999887665
Q ss_pred HHHHHHccC----------------------------CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcc
Q 001924 922 IFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKI 973 (995)
Q Consensus 922 i~qkIl~~~----------------------------~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPf 973 (995)
......... .++......+++++.+||.+||++||.+||| +.++|+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHh
Confidence 554433210 0111123567889999999999999999999 778899999
Q ss_pred cccc
Q 001924 974 FIKK 977 (995)
Q Consensus 974 F~~~ 977 (995)
|...
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred hccC
Confidence 9855
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=406.13 Aligned_cols=268 Identities=20% Similarity=0.279 Sum_probs=231.0
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 754 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k~-----TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~g 754 (995)
+.++...++|++.+.||+|+||+||+|.++. ++..||||+++... .......+.+|+.++++++|||||++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 3456677999999999999999999998853 35789999987533 3455678999999999999999999999
Q ss_pred eeeccCeeEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC
Q 001924 755 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 824 (995)
Q Consensus 755 vf~~~~~lyLVmEym~GGSL~d~L~k~----------~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG 824 (995)
++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999999998643 2468899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHH
Q 001924 825 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 904 (995)
Q Consensus 825 ~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVIL 904 (995)
++||+|||+|+...... .........||+.|+|||.+.+..++.++||||||+++
T Consensus 171 ~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp CEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eEEEeecccceeccCCc-------------------------ceeeccceecccccCCHHHHccCCCCcccccccHHHHH
Confidence 99999999998522111 11122345689999999999999999999999999999
Q ss_pred HHHHcC-CCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc---Cccccc
Q 001924 905 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH---CKIFIK 976 (995)
Q Consensus 905 yELLTG-r~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~---HPfF~~ 976 (995)
|||++| .+||.+.+..+.+..+..+.. +..+..+++.+.+||.+||+.||.+|||+.++++.|+ +|+|++
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 999997 688999999999988877653 4456789999999999999999999999999999888 677754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=405.46 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=224.4
Q ss_pred ccccccCCCeEEEEeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEe
Q 001924 680 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 753 (995)
Q Consensus 680 ~e~~~s~~dYeIlk~LG~GgFGtVYka~~k-----~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~L-kHPNIVkL~ 753 (995)
.+++...++|++.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++.+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 455667789999999999999999999863 466799999997643 344566899999999999 699999999
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeeecCC
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 815 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~~------------------~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKP 815 (995)
+++...+.+++|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999997543 588999999999999999999999999999999
Q ss_pred CcEEeccCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchH
Q 001924 816 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 895 (995)
Q Consensus 816 eNILLDenG~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KS 895 (995)
+|||++.++.+|++|||+++...... ........+||+.|+|||++.+..++.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT-------------------------TSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred ccccccccCcccccccchheeccCCC-------------------------cceEeeecccChHHcCHHHhcCCCCCCcc
Confidence 99999999999999999998421110 01122345799999999999999999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHc
Q 001924 896 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFH 970 (995)
Q Consensus 896 DIWSLGVILyELLT-Gr~PF~g~s~~ei~qkIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~ 970 (995)
|||||||++|||++ |.+||...+....+..++..+.. +..+..++..+.+||.+||+.||.+|||+.+++++|+
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99999999999998 67777777776666666666554 3456788999999999999999999999999998775
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.9e-47 Score=405.83 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=208.2
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeec--cCee
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--RDNL 762 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~--~~~l 762 (995)
.++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|+.++ ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 47899999999999999999999999999999998753 2457889999999995 9999999999874 4569
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCC-cEEEEecCCcccccccc
Q 001924 763 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 841 (995)
Q Consensus 763 yLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG-~VKLsDFGLArv~~~~~ 841 (995)
++||||+.+|+|..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~--- 181 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--- 181 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC---
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc---
Confidence 9999999999997764 4699999999999999999999999999999999999998655 69999999997421
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCH-
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP- 919 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~-~ys~KSDIWSLGVILyELLTGr~PF~g~s~- 919 (995)
........+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.....
T Consensus 182 -------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 182 -------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp -------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred -------------------------CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 01122345799999999998875 479999999999999999999999976432
Q ss_pred HHHHHHHHc-------------cCCC---------------------CCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHH
Q 001924 920 EIIFDNILN-------------RKIP---------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 965 (995)
Q Consensus 920 ~ei~qkIl~-------------~~~~---------------------~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EI 965 (995)
......+.. .... .......+++++.+||++||++||.+||| +
T Consensus 237 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a 313 (328)
T d3bqca1 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT---A 313 (328)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC---H
Confidence 222211110 0000 00012347899999999999999999999 7
Q ss_pred HHHHcCcccccccc
Q 001924 966 AEVFHCKIFIKKTE 979 (995)
Q Consensus 966 lEiL~HPfF~~~~~ 979 (995)
.++|+||||+.+.|
T Consensus 314 ~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 314 REAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHTSGGGTTSCC
T ss_pred HHHhcCcccCCCCC
Confidence 77889999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=408.84 Aligned_cols=258 Identities=29% Similarity=0.385 Sum_probs=215.4
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc-----C
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 760 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~-----~ 760 (995)
.++|++++.||+|+||+||+|++..+|+.||||++++.. ......+.+.+|+++|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 578999999999999999999999999999999997643 3445567899999999999999999999998643 3
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCccccccc
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 840 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~ 840 (995)
..+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--- 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC---
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc---
Confidence 34667778889999999854 46999999999999999999999999999999999999999999999999998631
Q ss_pred ccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 841 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 841 ~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~-ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.
T Consensus 172 ---------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 ---------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp ---------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 11223467999999999987765 58999999999999999999999999888
Q ss_pred HHHHHHHHccCCCCC-----------------------C-----CCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 920 EIIFDNILNRKIPWP-----------------------C-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 920 ~ei~qkIl~~~~~~p-----------------------~-----lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
......+.......+ . ....+++++.+||.+||+.||.+||| +.++|+|
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL~H 301 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 301 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC---HHHHhcC
Confidence 777766654322110 0 12467899999999999999999999 7788999
Q ss_pred ccccccc
Q 001924 972 KIFIKKT 978 (995)
Q Consensus 972 PfF~~~~ 978 (995)
|||++..
T Consensus 302 p~f~~~~ 308 (348)
T d2gfsa1 302 AYFAQYH 308 (348)
T ss_dssp GGGTTTC
T ss_pred HhhCCCC
Confidence 9998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=404.18 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=206.0
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeecc------
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 759 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~~------ 759 (995)
.++|+++++||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.++++++|||||+++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 478999999999999999999999999999999997643 3455667899999999999999999999999643
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccc
Q 001924 760 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 839 (995)
Q Consensus 760 ~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~ 839 (995)
..+|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc-
Confidence 578999999966 4555543 468999999999999999999999999999999999999999999999999987411
Q ss_pred cccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Q 001924 840 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 919 (995)
Q Consensus 840 ~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~ 919 (995)
........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.
T Consensus 171 ---------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 171 ---------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp -------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 11122345799999999999999999999999999999999999999998887
Q ss_pred HHHHHHHHccCC----------------------CCCC-----------C------CCCCCHHHHHHHHHHhhcCccCCC
Q 001924 920 EIIFDNILNRKI----------------------PWPC-----------V------PSDMSFEAQDLINRFLIHDPNQRL 960 (995)
Q Consensus 920 ~ei~qkIl~~~~----------------------~~p~-----------l------ps~lS~eL~dLIkkCLq~DPeKRP 960 (995)
......+..... .... . +...++++.+||++||..||++||
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 766655542111 1000 0 011356789999999999999999
Q ss_pred CHHHHHHHHcCcccccc
Q 001924 961 GANGAAEVFHCKIFIKK 977 (995)
Q Consensus 961 SA~EIlEiL~HPfF~~~ 977 (995)
| +.++|+||||+..
T Consensus 304 t---a~elL~Hpw~~~~ 317 (355)
T d2b1pa1 304 S---VDDALQHPYINVW 317 (355)
T ss_dssp C---HHHHHTSTTTGGG
T ss_pred C---HHHHhcCcccCCC
Confidence 9 7788999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=390.61 Aligned_cols=272 Identities=21% Similarity=0.268 Sum_probs=213.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeeccCeeEEE
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 765 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN-IVkL~gvf~~~~~lyLV 765 (995)
++|++.+.||+|+||+||+|++..+|+.||||++..... ...+..|+++++.++|+| |+.+.+++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999875332 234788999999998766 55556667777889999
Q ss_pred EeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc---CCcEEEEecCCcccccccc
Q 001924 766 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 841 (995)
Q Consensus 766 mEym~GGSL~d~L~-k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe---nG~VKLsDFGLArv~~~~~ 841 (995)
|||+ +|+|.+.+. ....+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 556666654 4567999999999999999999999999999999999999864 4579999999998532211
Q ss_pred cccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 001924 842 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 921 (995)
Q Consensus 842 s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s~~e 921 (995)
.. ...........+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 161 ~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 161 TH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred cc--------------------cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 10 0011223345689999999999999999999999999999999999999998765544
Q ss_pred HHHHHH---cc--CCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCccccccccccccc
Q 001924 922 IFDNIL---NR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKKTENCVSM 984 (995)
Q Consensus 922 i~qkIl---~~--~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~~~n~~s~ 984 (995)
....+. .. ..+.+..+..+|+++.+||..||+.||++||++.++.++|+|+|.+..-....+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~ 288 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCC
T ss_pred HHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCc
Confidence 332221 11 1122223467899999999999999999999999999999999876654444443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=391.91 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=207.1
Q ss_pred EEEeeccCCCeEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeec-cCeeEEEE
Q 001924 691 IIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLYLVM 766 (995)
Q Consensus 691 Ilk~LG~GgFGtVYka~~k~TG---~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPNIVkL~gvf~~-~~~lyLVm 766 (995)
+.++||+|+||+||+|.+..++ ..||||.+++. ......+.+.+|+++|++++|||||++++++.. ....++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3578999999999999987654 36899998643 345667889999999999999999999999875 45799999
Q ss_pred eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCCcccccccccccC
Q 001924 767 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 845 (995)
Q Consensus 767 Eym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGLArv~~~~~s~dl 845 (995)
|||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~--- 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--- 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC---
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc---
Confidence 999999999998754 4577888999999999999999999999999999999999999999999999985221110
Q ss_pred CCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC-CCHHHHHH
Q 001924 846 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFD 924 (995)
Q Consensus 846 sg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g-~s~~ei~q 924 (995)
..........||+.|+|||.+.+..++.++||||||+++|||++|..||.. .+..++..
T Consensus 186 --------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 186 --------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp --------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred --------------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 011122335799999999999999999999999999999999997766654 45555666
Q ss_pred HHHccCCCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 925 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 925 kIl~~~~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
.+..+.. +..|..+++.+.+||.+||+.||++||++.++++.|+.
T Consensus 246 ~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 246 YLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 6665543 44567899999999999999999999999988887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-44 Score=379.05 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=212.8
Q ss_pred CCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeeccCeeEE
Q 001924 686 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 686 ~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkH-PNIVkL~gvf~~~~~lyL 764 (995)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.| +|++.+++++......++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 468999999999999999999999999999999986533 22346788999999976 899999999999999999
Q ss_pred EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEecc-----CCcEEEEecCCccccc
Q 001924 765 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-----DGHIKLTDFGLSKIGL 838 (995)
Q Consensus 765 VmEym~GGSL~d~L~k~-~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDe-----nG~VKLsDFGLArv~~ 838 (995)
||||+ +|+|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999998765 46999999999999999999999999999999999999974 5789999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 001924 839 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 918 (995)
Q Consensus 839 ~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVILyELLTGr~PF~g~s 918 (995)
..... ...........+||+.|||||++.+..++.++|||||||++|||++|..||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 158 DPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCccc--------------------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 11110 0011123345689999999999999999999999999999999999999997643
Q ss_pred ---HHHHHHHHHccC--CCCCCCCCCCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcC
Q 001924 919 ---PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVFHC 971 (995)
Q Consensus 919 ---~~ei~qkIl~~~--~~~p~lps~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~H 971 (995)
....+..+.... .+.+.++.++|+++.+|+..|+..+|++||++..+.++|+.
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred chhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 333333333221 12222446789999999999999999999999888887654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=383.18 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=195.0
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH--HHHhcCCCceEEEeeeeeccC----
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN--ILITVRNPFVVRFFYSFTCRD---- 760 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEie--ILs~LkHPNIVkL~gvf~~~~---- 760 (995)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.. ....+..|.+ .++.++|||||++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 5789999999999999999986 5899999998642 2233444444 456789999999999998754
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCceeeecCCCcEEeccCCcEEEEecC
Q 001924 761 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFG 832 (995)
Q Consensus 761 ~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs--------~GIIHRDLKPeNILLDenG~VKLsDFG 832 (995)
.+|+|||||++|+|.+++++. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 589999999999999999765 58999999999999999999996 599999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCC------CCchHHHHHHHHHHHH
Q 001924 833 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFE 906 (995)
Q Consensus 833 LArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~------ys~KSDIWSLGVILyE 906 (995)
+++....... .........+||+.|+|||++.+.. ++.++|||||||+|||
T Consensus 154 l~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 154 LAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTT-----------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCc-----------------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHH
Confidence 9985321110 1111233568999999999997653 5779999999999999
Q ss_pred HHcCCCCCCCC---------------CHHHHHHHHHccCCCCCCCCCC-----CCHHHHHHHHHHhhcCccCCCCHHHHH
Q 001924 907 FITGIPPFTAE---------------SPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAA 966 (995)
Q Consensus 907 LLTGr~PF~g~---------------s~~ei~qkIl~~~~~~p~lps~-----lS~eL~dLIkkCLq~DPeKRPSA~EIl 966 (995)
|++|..||... ........+...... |.++.. ....+.+|+.+||+.||++|||+.++.
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred HhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccC-CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 99998877321 223333333333322 322222 234588999999999999999999998
Q ss_pred HHHc
Q 001924 967 EVFH 970 (995)
Q Consensus 967 EiL~ 970 (995)
+.|+
T Consensus 290 ~~L~ 293 (303)
T d1vjya_ 290 KTLS 293 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8774
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-40 Score=358.02 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=193.7
Q ss_pred CCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----------CCceEEEeee
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRFFYS 755 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-----------HPNIVkL~gv 755 (995)
++|+++++||+|+||+||+|++..+|+.||||++++.. ...+.+.+|+.+++.+. |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999999999999999997632 23456788888888775 5789999988
Q ss_pred eecc--CeeEEEEeecCCCCHHHHH-H--hcCCCCHHHHHHHHHHHHHHHHHHHH-cCceeeecCCCcEEeccCC-----
Q 001924 756 FTCR--DNLYLVMEYLNGGDLYSLL-R--KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG----- 824 (995)
Q Consensus 756 f~~~--~~lyLVmEym~GGSL~d~L-~--k~~~Lsee~ir~Ia~QIa~GLaYLHs-~GIIHRDLKPeNILLDenG----- 824 (995)
+... ...+++|.++..+...... . ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 7653 4566777776555433322 2 33578999999999999999999998 8999999999999998765
Q ss_pred -cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCccccccccCCcCCCCCCcccChhhhcCCCCCchHHHHHHHHH
Q 001924 825 -HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 903 (995)
Q Consensus 825 -~VKLsDFGLArv~~~~~s~dlsg~~t~gi~~s~~~ys~~~~~~~~~s~t~vGTp~YmAPEvL~g~~ys~KSDIWSLGVI 903 (995)
.++++|||.|... .......+||+.|+|||++.+..|+.++|||||||+
T Consensus 169 ~~~kl~dfg~s~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 218 (362)
T d1q8ya_ 169 IQIKIADLGNACWY------------------------------DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 218 (362)
T ss_dssp EEEEECCCTTCEET------------------------------TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred ceeeEeeccccccc------------------------------ccccccccccccccChhhccccCCCccccccchHHH
Confidence 4999999998731 112234679999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHH------HHHHHHHc--cC------------------C----CCC---------------CCCC
Q 001924 904 LFEFITGIPPFTAESPE------IIFDNILN--RK------------------I----PWP---------------CVPS 938 (995)
Q Consensus 904 LyELLTGr~PF~g~s~~------ei~qkIl~--~~------------------~----~~p---------------~lps 938 (995)
+++|++|+.||...... ........ +. . ... ..+.
T Consensus 219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (362)
T d1q8ya_ 219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298 (362)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCc
Confidence 99999999999754321 11111100 00 0 000 0112
Q ss_pred CCCHHHHHHHHHHhhcCccCCCCHHHHHHHHcCcccccc
Q 001924 939 DMSFEAQDLINRFLIHDPNQRLGANGAAEVFHCKIFIKK 977 (995)
Q Consensus 939 ~lS~eL~dLIkkCLq~DPeKRPSA~EIlEiL~HPfF~~~ 977 (995)
..++.+.+||.+||.+||.+||| +.++|+||||++.
T Consensus 299 ~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 299 DEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred ccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCC
Confidence 34678999999999999999999 6677899999844
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.1e-23 Score=206.47 Aligned_cols=135 Identities=20% Similarity=0.171 Sum_probs=106.8
Q ss_pred eEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccc---------------cchhHHHHHHHHHHHHHhcCCCceEEEe
Q 001924 689 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM---------------IRKNDIERILAERNILITVRNPFVVRFF 753 (995)
Q Consensus 689 YeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~---------------~se~e~e~flrEieILs~LkHPNIVkL~ 753 (995)
+.+.++||+|+||+||+|.+. +|+.||||+++.... ...........|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999985 689999998763211 0111233456788899999999999887
Q ss_pred eeeeccCeeEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCceeeecCCCcEEeccCCcEEEEecCC
Q 001924 754 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 833 (995)
Q Consensus 754 gvf~~~~~lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs~GIIHRDLKPeNILLDenG~VKLsDFGL 833 (995)
++.. .+++|||++++.+.+ ++...+..++.|++.||+|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 379999998765432 4555667889999999999999999999999999999865 589999999
Q ss_pred ccc
Q 001924 834 SKI 836 (995)
Q Consensus 834 Arv 836 (995)
|..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 873
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=2.2e-06 Score=85.59 Aligned_cols=144 Identities=13% Similarity=0.108 Sum_probs=95.2
Q ss_pred cccCCCeEEEEeeccCCCeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeeccCe
Q 001924 683 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 761 (995)
Q Consensus 683 ~~s~~dYeIlk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~~~~ 761 (995)
......|++.+..+.++.+.||++. .++..++||+...... .....+.+|...+..+. +-.+.+++.++...+.
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 3445678888776666667999875 3566788887754322 12334667888877664 3346677777778888
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 001924 762 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------ 805 (995)
Q Consensus 762 lyLVmEym~GGSL~d~L~k~~~Lsee~ir~Ia~QIa~GLaYLHs------------------------------------ 805 (995)
.++||++++|.++.+..... .....++.++...+..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999998775543211 0111223333333444431
Q ss_pred -----------------c------CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 806 -----------------L------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 806 -----------------~------GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 289999999999998776677999998874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.60 E-value=7.4e-05 Score=80.64 Aligned_cols=80 Identities=25% Similarity=0.268 Sum_probs=49.3
Q ss_pred EEeeccCCCeEEEEEEECCCCcEEEEEEeecc-ccc---chhHHHHHHHHHHHHHhcC-C--CceEEEeeeeeccCeeEE
Q 001924 692 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMI---RKNDIERILAERNILITVR-N--PFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 692 lk~LG~GgFGtVYka~~k~TG~~VAVKVIkk~-~~~---se~e~e~flrEieILs~Lk-H--PNIVkL~gvf~~~~~lyL 764 (995)
.+.||.|....||++....+++.|+||.-... ... -.....+...|.+.|..+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999998777889999964321 100 0112345566888777653 2 345666654 3455689
Q ss_pred EEeecCCCC
Q 001924 765 VMEYLNGGD 773 (995)
Q Consensus 765 VmEym~GGS 773 (995)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.50 E-value=0.00011 Score=72.40 Aligned_cols=141 Identities=13% Similarity=0.106 Sum_probs=84.0
Q ss_pred CeEEEEeeccCCC-eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeeccCeeEE
Q 001924 688 DFEIIKPISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYL 764 (995)
Q Consensus 688 dYeIlk~LG~GgF-GtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk--HPNIVkL~gvf~~~~~lyL 764 (995)
.++.. .+..|.. +.||+... ..+..+++|...... ...+..|...++.+. .-.+.+++.+..+.+..++
T Consensus 12 g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 12 GYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp TCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 34443 3445553 67898874 356678889765432 223566777776653 2346777888888888999
Q ss_pred EEeecCCCCHHH--------------HHHhc-------CCCC--HHHHH-----HH---------------HHHHHHHHH
Q 001924 765 VMEYLNGGDLYS--------------LLRKV-------GCLE--EDVAR-----IY---------------IAELVLALE 801 (995)
Q Consensus 765 VmEym~GGSL~d--------------~L~k~-------~~Ls--ee~ir-----~I---------------a~QIa~GLa 801 (995)
||++++|.++.+ .+.+- ..+. ..... .+ .......+.
T Consensus 84 v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp EEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 999998765421 11110 0000 00000 00 001122333
Q ss_pred HHHHc-------CceeeecCCCcEEeccCCcEEEEecCCccc
Q 001924 802 YLHSL-------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 836 (995)
Q Consensus 802 YLHs~-------GIIHRDLKPeNILLDenG~VKLsDFGLArv 836 (995)
.+..+ .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 44332 389999999999998876778999998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.39 E-value=0.0026 Score=66.22 Aligned_cols=68 Identities=16% Similarity=0.199 Sum_probs=42.1
Q ss_pred CeEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEe-----eeeeccCeeEEEEeecCCC
Q 001924 700 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFF-----YSFTCRDNLYLVMEYLNGG 772 (995)
Q Consensus 700 FGtVYka~~k~TG~~VAVKVIkk~~~~se~e~e~flrEieILs~LkHPN--IVkL~-----gvf~~~~~lyLVmEym~GG 772 (995)
--.||++.. .+|..|++|+.+... ...+.+..|...+..|.... ++... ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999875 468889999986532 13455677887777664221 11111 1223345678899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.88 E-value=0.013 Score=62.35 Aligned_cols=77 Identities=17% Similarity=0.251 Sum_probs=50.5
Q ss_pred CCeEEEEeeccCCCeEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeec
Q 001924 687 DDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC 758 (995)
Q Consensus 687 ~dYeIlk~LG~GgFGtVYka~~k~-------TG~~VAVKVIkk~~~~se~e~e~flrEieILs~Lk-HPNIVkL~gvf~~ 758 (995)
+++++ +.|+.|-.-.+|++.... .+..|.+++.-... ......+|..+++.+. +.-..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 578889999999998653 34578888765321 1234557888888775 3334466776643
Q ss_pred cCeeEEEEeecCCCC
Q 001924 759 RDNLYLVMEYLNGGD 773 (995)
Q Consensus 759 ~~~lyLVmEym~GGS 773 (995)
++|++|++|.+
T Consensus 117 ----g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ----GRLEEYIPSRP 127 (395)
T ss_dssp ----EEEECCCCEEE
T ss_pred ----ceEEEEecccc
Confidence 68999998744
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.55 E-value=0.014 Score=59.42 Aligned_cols=30 Identities=33% Similarity=0.483 Sum_probs=27.3
Q ss_pred cCceeeecCCCcEEeccCCcEEEEecCCcc
Q 001924 806 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 835 (995)
Q Consensus 806 ~GIIHRDLKPeNILLDenG~VKLsDFGLAr 835 (995)
.|+||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988778899999887
|